,filename,label,label_predict,score,precision_5,precision_10,precision_15
0,Arch_Gynecol_Obstet-2-2-1705528.txt,symptom||day||viral replic||genit herp||full outbreak||recurr genit herp outbreak||patient||single-day treatment||recurr||onset||treatment||progress||patient-initi episod therapi,1||3||2 15||2 day||herp||1 effect||refer 1||patient||genit herp||5||springer-verlag 2006||5 day||day||viru type 2||patient complianc,0.03||0.022||0.021||0.021||0.02||0.018||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.013,0.0,0.2,0.2
1,Eur_J_Pharmacol-2-1-2258315.txt,serum||studi||reactiv oxygen speci||effect||biolog activ||hepat stellat cell||anti-fibrot agent||hepatocyt injuri||treatment||cell||mice||cell death||liver fibrosi||death||liver||anti-fibrot activ||hepatocyt||fucoidan||hepat fibrosi||fibrosi||result,4 4||4||fig. 2 4 4||fig. 3 4 4 4||abstract 4 4 4 4||cell||2007 4||stellat cell||2001 4||1999 4||hepat stellat cell||1||1976 5 2 4||studi||method 2.1 reagent 4 4 4,0.031||0.031||0.03||0.027||0.025||0.024||0.022||0.02||0.019||0.018||0.018||0.018||0.017||0.017||0.016,0.0,0.1,0.2
2,Pediatr_Radiol-4-1-2367394.txt,rare tumour||follow-up||soft-tissu sarcoma||protocol||mri||imag||locat||studi||seri||patient||present||child||chemotherapi||transfus||rm||rhabdomyosarcoma||site||paediatr oncologist||bone scintigraphi||cell||treatment||metastat diseas||tumour||intergroup rhabdomyosarcoma studi group||alveolar histolog||case report||prognosi||surgeri||primari site||epssg protocol||primari tumour||group||biopsi||order||bone||malign tumour||pet||BP tumour||diseas||diagnosi||work-up||children,1||rhabdomyosarcoma||3 1||1 2 fig. 1 embryon rm||5 fig. 5||fig. 2 embryon rm||3 8 fig. 3||embryon rhabdomyosarcoma||rm||6 6 7 fig. 6||2008 rhabdomyosarcoma||1 28||embryon rm fig. 13||primari rhabdomyosarcoma||alveolar rhabdomyosarcoma,0.019||0.018||0.016||0.016||0.014||0.014||0.013||0.013||0.012||0.011||0.011||0.011||0.011||0.011||0.011,0.2,0.2,0.13333333333333333
3,Evid_Based_Complement_Alternat_Med-3-4-1697739.txt,herb||studi||effect||review||articl||cognit impair||clinic trial||dementia||treatment||psycholog symptom||product||research||herbal medicin||melissa||symptom||random clinic trial||drug||formul||trial||diseas||systemat review||result,1||1 month||officinali||2||1 13 14||2 month||issu 1||12 month||studi||2006||12 13 14||13 14||clinic studi||3 ml||trial,0.026||0.02||0.018||0.017||0.017||0.016||0.015||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.012,0.0,0.1,0.13333333333333333
4,Bioinformation-2-1-2139988.txt,inform||diabet||medicin plant||databas||antimicrobi properti||literatur||plant,step 2||1 2 3 4 5||step 3||methodolog step 1||diab figur 1||figur 1 momordia charantia||plant||2007 biomed informat publish group 2007||medicin plant||antimicrobi effect||antioxid effect||effect treatment||antidiabet effect||plant control||antidiabet plant,0.065||0.058||0.052||0.048||0.041||0.035||0.028||0.027||0.026||0.023||0.022||0.019||0.019||0.018||0.018,0.0,0.2,0.13333333333333333
5,J_Immunol_Methods-2-1-2225449.txt,glass coverslip||imag analysi softwar||primari human macrophag||method||dapi||lp||analysi||cell line||data||macrophag||nuclear||cell||binari mask,fig. 2 nuclear||3||cell||2||fig. 6||1||fig. 5 3 csk4||fig. 3 immunofluoresc stain||nuclear||imag||5||fig. 6 630 3 csk4||nf-Îºb||fig. 4 immunofluoresc stain||3 csk4,0.025||0.024||0.022||0.022||0.021||0.021||0.02||0.018||0.018||0.018||0.017||0.015||0.015||0.015||0.015,0.2,0.2,0.13333333333333333
6,Invert_Neurosci-4-1-2257991.txt,cys-loop lgic||subunit||glutam acid||receptor||cys-loop lgic superfamili||ion channel||cation channel||nematod||glutamate-g chlorid channel||gaba||function||group,1||1 1 C. elegan C.||1 2005||C.||C. briggsa C. elegan||ggr-3 group 1 1 2005 C.||note fig. 1 C. elegan C.||ggr-1 group 1 2006 C.||C. briggsa 2007 C.||springer-verlag 2008 caenorhabd elegan C.||glc-1 elegan C. briggsa||2007 2003 C.||haemonchu contortu 2002 1 2005||method C.||caenorhabd elegan embo,0.048||0.044||0.043||0.039||0.033||0.032||0.03||0.026||0.026||0.025||0.023||0.022||0.021||0.021||0.02,0.0,0.0,0.0
7,Surg_Endosc-4-1-2292805.txt,type||cardin health||urinari tract||data||appendectomi||patient||admiss||risk||present||complex||nim rate||open surgeri||infect||cmi||approach||hospit||insur||analysi||odd||cholecystectomi||respiratori tract||differ||laparoscop||nim||multivari logist regress analys||nosocomi infect||procedur||laparoscop approach||hysterectomi||nosocomi infect risk||result,1||infect||data 1||nosocomi infect||4||2||4 year||infect risk||nosocomi infect risk||refer 1||llc 2008 1 2||issu 1||comorbid 1||1 drg||2007,0.023||0.02||0.016||0.016||0.015||0.015||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.012,0.4,0.3,0.2
8,Exp_Brain_Res-4-1-2373857.txt,vertic||condit||cue||obliqu effect||respons||system||streri||product task||find||exploratori movement||horizont||anisotrop||obliqu orient||studi||hypothesi||stimulu||spatial orient||sensori motor trace||contralater hand||orient||refer frame||haptic||effect||space||process||sagitt plane||reproduct||percept||review||discrimin||plane||test||cognit resourc||adult||visual system||frontal plane||sensori modal||hatwel||haptic modal||frame||haptic discrimin||subjective-refer frame||paramet||cognit level||haptic percept||task||modal||bodi||diagon||gravit cue||rod||refer||visual modal||systemat bia||obliqu||error||gravit forc||hand||angl||gentaz||result,haptic||obliqu||haptic percept||percept||haptic obliqu effect||haptic orient||obliqu orient||1||orient percept||obliqu effect||orient||effect||5||visual obliqu effect||2003,0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011,0.8,0.6,0.5333333333333333
9,Breast_Cancer_Res_Treat-3-1-2001225.txt,follow-up||time||contralater breast||letrozol||lymph node-posit breast cancer||breast cancer||elig patient||initi therapi||tamoxifen||studi||year||recurr||distant metastas||risk||exclus criteria||aromatas inhibitor||ai||secondari end point||event||postmenopaus women||treatment||therapi||primari object||random||face trial||analysi||greater clinic benefit||anastrozol||differ||tumor||earli breast cancer||contralater breast cancer,cancer||breast cancer||breast cancer breast cancer||1||earli breast cancer||posit breast cancer||invas breast cancer||primari breast cancer||contralater breast cancer||receptor-posit breast cancer||advanc breast cancer||breast cancer chemoprevent||early-stag breast cancer||earli breast cancer 2005||adjuv breast cancer treatment,0.031||0.029||0.029||0.022||0.021||0.021||0.02||0.02||0.02||0.02||0.02||0.02||0.02||0.018||0.018,0.4,0.3,0.2
10,Plant_Mol_Biol-3-1-2140092.txt,smallest polypeptid||transit||protein level||dormanc||dormancy-to-growth transit||pea||prb||observ||amino acid sequenc||similar||signal||phosphoryl||cell||gene||transcript||protein||experi||molecular mass||cell cycl||intact plant||cdna||axillari bud||hp-form||retinoblastoma-rel protein||plant||result,protein||psrbr1 protein||psrbr1||psrbr1 psrbr1 psrbr1 psrbr1 gene||phosphoryl psrbr1 protein||psrbr1 35 psrbr1||authent psrbr1 protein||vitro-dephosphoryl psrbr1 protein||1 psrbr1 protein bind||psrbr1 protein undergo||non-modifi psrbr1 protein||vivo-dephosphoryl psrbr1 protein||1||cell||rb-relat protein psrbr1 psrbr1 cdna,0.031||0.03||0.029||0.025||0.023||0.02||0.02||0.02||0.02||0.02||0.02||0.02||0.019||0.019||0.019,0.2,0.1,0.13333333333333333
11,J_Hum_Genet-3-1-1915643.txt,effect||risk||snp||femal control||TT genotyp||plasma folat concentr||mother||plasma homocystein||risk factor||spina bifida||studi||pediatr control||children,nos3 nos3 nos3 894g||nos3 nos3 nos3 mthfr 677c||mthfr nos3 nos3 894gt||refer group nos3 nos3||nos3 1999 2003 nos3 2004||1||keyword nos3 894g||nos3 894tt genotyp||2||result case-control studi nos3||nos3 locu birth defect||refer group nos3 mthfr 677tt genotyp||genotyp determin nos3 1999 mbo||transmiss disequilibrium test nos3 1993 2003||studi,0.046||0.039||0.034||0.032||0.03||0.024||0.023||0.022||0.022||0.021||0.016||0.016||0.016||0.014||0.014,0.0,0.0,0.06666666666666667
12,Purinergic_Signal-4-1-2246001.txt,rip||anim||oligodendrocyt||endogen progenitor cell||matur oligodendrocyt||spinal cord injuri||function recoveri||section||increas||spinal cord||lesion||astrocyt||cell prolifer||guanosin||treatment||cell||rat||day||myelin||prolifer||function improv||guanin||analysi||remyelin||usa||cord||brdu||open field||number||sci,1||1 1 1 fig. 1||discuss 1 1 1||3||2||2 2 2||cell||2 fig. 2||fig. 3||2 1 depart||progenitor cell||refer 1||3 49 3||oligodendrocyt progenitor cell||cord,0.019||0.017||0.014||0.014||0.014||0.014||0.014||0.013||0.012||0.012||0.01||0.01||0.01||0.01||0.009,0.0,0.1,0.13333333333333333
13,Matern_Child_Health_J-2-2-1592156.txt,birth||pregnanc||rate||normal immun function||risk||human||listeria||infect||preconcept care||educ||toxoplasmosi||pregnant women||women||age||food||listeriosi||cmv||cytomegaloviru||transmiss||diseas||viru,1||1 2 2||2||infect||1 3 4 T. gondii T.||cytomegaloviru infect||refer 1||mlynch1@cdc.gov 3 1 center||toxoplasma gondii||congenit toxoplasma gondii infect||congenit cytomegaloviru infect||cytomegaloviru||toxoplasmosi toxoplasma gondii T. gondii T.||cytomegaloviru diseas||age 1 year,0.027||0.023||0.021||0.018||0.017||0.015||0.015||0.015||0.013||0.013||0.013||0.013||0.012||0.012||0.011,0.2,0.1,0.13333333333333333
14,Environ_Manage-4-1-2233706.txt,ecolog investig||flow||histori||snake river||data||model||studi||comparison||compar studi||strategi||river dam||riparian ecosystem||landscap||aerial photograph||veget||spatial comparison||similar||analys||impact||downstream||natur||ecolog consequ||dam||approach||coincident influenc||valley characterist||research||snake||research strategi||hell canyon||sediment||natur variat||multipl reach||river,2||2 2||2 1 2||1||river||1995 1||4 2||result 1 2||river canyon||river flow||5 1 2 2000 2005||river dam||river research||tempor comparison 1 1||river regul,0.021||0.021||0.021||0.021||0.02||0.016||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012,0.2,0.1,0.13333333333333333
15,Histochem_Cell_Biol-4-1-2386527.txt,role||muscl||eukaryot cell||chromatin||nucleu||larg famili||review||structur||actin||form||nucleocytoplasm traffick||non-muscl cell||cell||gene||arp||transcript||protein||chromatin remodel||activ||jockusch||cytoplasm||nuclear actin||myosin||function,cell||protein||actin||nuclear actin||1||2004 2004 2004 2006 2002 2000||cell biolog||cell biol fig. 2 2005 blue||cell nucleu||nuclear protein complex||2||2003 2004||eukaryot cell||studi protein||mast cell,0.027||0.024||0.019||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014,0.8,0.4,0.3333333333333333
16,Surg_Endosc-3-1-2169271.txt,endoscopist||level||endoscopi||case||time||expert||data||studi||represent||intermedi||colonoscopi||GI mentor II simul||valid||train||GI mentor II||task||simul||group||number||particip||novic||novic endoscopist,1 0 0||1 0||1||100 0 0 0||3 0||100 0 0||1 1 depart||4 0||2||case 1||rang 0||6 0||12 1||10 0||tabl 1,0.051||0.051||0.051||0.04||0.037||0.035||0.035||0.035||0.034||0.032||0.032||0.03||0.03||0.03||0.029,0.0,0.0,0.0
17,Clin_Auton_Res-3-1-1797061.txt,discharg||muscl||respons||experiment anim||paravertebr chain||spinal cord injuri||vasoconstrictor pathway||autonom nervou system||cutan||nerv||increas||spinal transect||natur activ||postganglion neuron||ongo||axon||sympathet nervou system||short burst||signal||vasoconstrict||perivascular nerv||preganglion input||vascular bed||injuri||activ||ganglia||arteri||autonom dysreflexia||vessel||input||transmiss||segment||tail arteri||sympathet ganglia||neurovascular transmiss,1||2||25 1||1 Hz||refer 1||sympathet neuron||5 12 29 6 7 2||sympathet preganglion neuron||sympathet vasoconstrictor||3||physiol||sympathet activ||gate 1 barker street||2006||sympathet ganglia 21 22 30 2,0.039||0.026||0.023||0.022||0.021||0.016||0.014||0.014||0.012||0.012||0.012||0.012||0.012||0.012||0.012,0.0,0.0,0.0
18,J_Abnorm_Child_Psychol-4-1-2268722.txt,computer task||delay||low arous||measur||respons||behavior||mother||affect||pregnanc||problem||comput||inhibitori control||studi||prenat smoke||question||extern behavior||cool EF||exampl||domin hand respons||frustrat||prepot respons||smoke||hyperact||hot||trial delay||button||task||associ||ambigu||conduct problem||prenat||order||trial||signific differ||adhd||particip||score||emot||children,2006||1||1 1||2005 2006||2||J.||2007||2005 2006 1999 2003 2005||2005 2001 2006 2006 1994 2004||2002a 2004 2003 2006 2002 2006||J. R.||2002||2007 2001 2004 2002||2005 1997||execut function 2002 2006,0.016||0.014||0.014||0.014||0.013||0.011||0.011||0.011||0.01||0.01||0.009||0.009||0.009||0.009||0.009,0.0,0.0,0.0
19,Osteoporos_Int-3-1-1820755.txt,program||balanc train program||visual conflict||home-bas exercis program||studi||patient||initi evalu||final evalu||effect||risk||condit 5||walk||test||improv||intervent||signific||fractur||unstabl surfac||eye||fall||control||exercis program||train||women||research||ctsib||mobil||exercis||clinic data||group||differ||osteoporosi||sensori condit||number||adher||firm surfac||balanc||result,1||condit 1||1 data||3||result 1||2||refer 1||balanc||condit 3||6||condit 2||55-11-30617490 rosamariarp@yahoo.com 1 2 1 divis||balanc train||condit 6||balanc exercis,0.031||0.021||0.019||0.019||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013,0.0,0.1,0.06666666666666667
20,Eur_J_Epidemiol-4-1-2190782.txt,follow-up||diabet||patient||risk differ||year||admiss||mortal||risk||inform||epidemiolog||netherland||long-term mortal||acut myocardi infarct||signific||analys||popul regist||diabet men||day||hospit||women||result||prognosi||gender||coronari heart diseas||death||myocardi infarct||surviv||differ||date||nation hospit discharg regist||diabet mellitu||ami||cardiovascular diseas,2||diabet||diabet patient||type 2 diabet||4||5 year||year||patient||diabet mellitu||3||result 1||studi||refer 1||1 characterist||diabet men,0.025||0.021||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014,0.2,0.4,0.3333333333333333
21,Pediatr_Nephrol-4-1-2214827.txt,chronic kidney diseas||hypertens||ckd||patient||renal diseas||calcium channel antagonist||effect||risk||sympathet hyperactiv||increas||blood pressur||renal||adult||antihypertens treatment||beta blocker||treatment||therapi||control||esrd||end-organ damag||chronic hyperparathyroid||antihypertens drug||fluid||first-lin therapi||import factor||activ||multipl drug therapi||antihypertens therapi||ace||pathophysiolog||import||fluid overload||drug||low sodium dialys||children,renal||renal hypertens||renal diseas||renal transplant||2||3||renal function||pediatr renal transplant||hypertens||chronic renal failur||renal nerve-depend hypertens||renal cyst||chronic renal failur pediatr||5||2 2 42,0.021||0.016||0.014||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.01||0.01||0.01,0.4,0.3,0.2
22,Exp_Brain_Res-4-1-2248215.txt,condit||main find||sham condit||subject pain rate score||acut pain percept||time||magnet stimul||experiment session||studi||subject pain percept||effect||left SI||theta burst stimul||tb||amplitud||primari somatosensori cortex||signific effect||pain process||stimul||lep||result||eeg||pain||yag laser stimul||subject||low-intens stimuli||laser-evok potenti||ctb||germani||peak||hand||itb||compon,1||pain||2007 2007||2007||2||2 2 2 2||2 fig. 2||2007 2007 2000 2005 2005||2004 2005 2007 2007 2004||2006 2007 2007 2007 2007 2005||2005||2006 2007 2007||2000 2005||2005 2005 2005 2006||1999 2003 1 fig. 1 mri,0.021||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.013||0.013,0.2,0.1,0.06666666666666667
23,Ulster_Med_J-76-3-2075581.txt,standard practic||author||mechan bowel prepar||practic||rate||studi||patient||colorect surgeri||primari anastomosi||anastomot leakag||anastomosi||clinic practic||rectal carcinoma||signific||evid||infect||mbp group||relev journal||elect procedur||small tumour||small sampl size||surgeri||bowel prepar||mbp||medic literatur||pre-op prepar||infecti complic||group||differ||number||trial||randomis||post-op infecti complic||rct||result,1||2||1 15 1||al 1||1 15||10||10 1 9 11||signific 1 2 7 9 15||10 11 13 9||discuss 1 2 7 9 15||9||11||1 guenaga||al 15||2 bucher,0.034||0.029||0.028||0.027||0.025||0.025||0.024||0.021||0.02||0.019||0.019||0.019||0.018||0.017||0.017,0.0,0.0,0.0
24,Environ_Manage-3-1-1866215.txt,weed||time||commun||speci rich||xeric condit||drawdown||year||valu||horsetooth site||remov||water||total cover||colorado||drawdown rate||total||seedl||site||water surfac||veget||recruit||plant||cottonwood||establish||elev||dam||veget colon||dam remov||upland veget||zone||recruit box model||surfac||cover||nativ||sediment||upland||exposur||bare ground||dam construct||number||perenni||speci||plot||horsetooth reservoir||upland plant commun,1||1 2||2||3||veget||plant||4 01 02||2002||tabl 2||water||1 mccune||1 SE||june 1||veget cover||upland veget,0.015||0.014||0.014||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.008||0.008||0.008||0.008||0.007,0.2,0.3,0.26666666666666666
25,Arch_Dermatol_Res-2-2-1705513.txt,condit||inflamm||psoriasi||lipoprotein||atherosclerosi||preval||studi||diseas associ||patient||common inflammatori pathway||effect||mortal||risk||marker||comorbid||common||synthet antimalari drug||treatment||cell||concomit therapi||inflammatori condit||psoriasi patient||popul||methotrex||psoriasi treatment||atop dermat||drug||cardiovascular event||diseas||diagnosi||cardiovascular diseas,2005||diseas||psoriasi||psoriasi patient||diseas associ||comorbid diseas||cardiovascular diseas||dermatol||psoriasi treatment||2||psoriasi drug||psoriasi therapi||vascular diseas||diseas activ||psoriasi suscept 1 gene,0.018||0.017||0.016||0.013||0.012||0.011||0.011||0.011||0.011||0.01||0.01||0.01||0.01||0.01||0.01,0.8,0.6,0.4
26,Ann_Biomed_Eng-2-2-1705482.txt,thermal histori||arrheniu paramet||hr||time||data||studi||valu||signific amount||hold period||increas||optim clinic protocol||total time||rise||pt||temperatur||signific||clinic thermal therapi protocol||hold time||treatment||cell||non-isotherm portion||applic||tissu||heat rate||drop||hold||break point||total number||total treatment time||injuri||min||cell surviv||energi sourc||tumor||surviv||differ||activ energi||data point||thermal therapi||heat||result,1||cell||1 figur 1||2||stage 1 1||1 4||1 min||1 6||1 5||1 15||1 31||1 8||1 figur 4||1 figur 6||tabl 1,0.033||0.029||0.026||0.024||0.022||0.022||0.022||0.022||0.022||0.02||0.019||0.019||0.019||0.019||0.018,0.2,0.1,0.06666666666666667
27,Osteoporos_Int-3-1-1766477.txt,signific risk factor||vertebr fractur||grade||deform||preval||studi||vertebr deform||patient||lumbar spine||risk||fractur||bmd||women||multipl||age||popul||mxa||scan||dxa||osteoporosi||normal lumbar spine bmd||hip fractur||normal bmd||vertebr morphometri,vertebr fractur||fractur||2 2||2||2 2 2||fractur 1||vertebr deform||deform fractur||grade 1 fractur||prior vertebr fractur||vertebr fractur assess||multipl vertebr fractur||preval vertebr fractur||vertebr fractur statu||addit vertebr fractur,0.037||0.036||0.031||0.031||0.031||0.03||0.029||0.028||0.026||0.026||0.026||0.026||0.025||0.025||0.025,0.4,0.3,0.2
28,Law_Hum_Behav-4-1-2175020.txt,eyewit identif||field studi,3||2||4||studi||5||field studi||mecklenburg studi||illinoi studi||report||PA 15213 usa 3 depart||sequenti procedur field studi||procedur||1-951-7889269 robert.rosenthal@ucr.edu 6 1 depart||laboratori studi||illinoi pilot studi,0.03||0.024||0.022||0.022||0.021||0.018||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.013,0.0,0.1,0.06666666666666667
29,Diabetologia-4-1-2292427.txt,type||diabet patient||level||progress renal impair||glomerular filtrat barrier||diabet||vegf||hypertens||key player||hyperglycaemia||metabol pathway||filtrat rate||permeabl||develop||observ||normal gfb||increas||glomerular endotheli cell||key||direct cellular effect||signific||vascular diseas||podocyt loss||glycocalyx||diabet nephropathi||genet risk||protein||microalbuminuria||albumin||factor||podocyt||import||gfb||risk factor||import contributor||diabet popul||diseas||diabet complic||inflammatori cytokin,diabet||2 diabet||diabet nephropathi||type 1 diabet||type 2 diabet||diabet microalbuminuria||diabet patient||diabet mellitu||experiment diabet||diabet popul||diabet complic||long-term diabet||diabet suggest||diabet milieu||diabet angiopathi,0.037||0.027||0.022||0.022||0.022||0.022||0.021||0.02||0.02||0.019||0.019||0.019||0.019||0.019||0.019,0.4,0.4,0.3333333333333333
30,Pediatr_Radiol-3-1-1950217.txt,follow-up||level||inhal CS||signific reduct||reduct||growth hormon||low bmd||patient||year||cranial irradi||oral contracept||full bmd recoveri||idiopath short statur||bone miner||correl||normal hormon level||pediatr||lower extrem||increas||matur||nonambulatori||improv||fractur||treatment||therapi||calcium||CS therapi||bmd||lean tissu mass||chronic condit||normal valu||result||low bone mass||short statur||peak bone mass||normal||puberti||LS bmd||factor||height||dxa||osteoporosi||physic activ||bone deposit||hip bmd||abnorm dxa find||diseas||diagnosi||bone diseas||bone miner densiti||children||dxa find,bone||bone miner||bone diseas||bone densiti||pediatr||bone miner densiti||normal bone miner||bone miner metabol||bone mass||bone metabol||diseas||abnorm bone miner||bone sarcoma pediatr||bone miner content||bone miner accrual,0.033||0.027||0.026||0.021||0.021||0.021||0.02||0.019||0.019||0.018||0.018||0.018||0.018||0.018||0.018,0.6,0.4,0.3333333333333333
31,Purinergic_Signal-3-4-2072927.txt,role||extracellular concentr||human mesenchym stem cell||releas||data||adenosin||neurotransmiss||atp||effect||increas||cell divis||receptor||evid||inhibit||cell||rat||brain||stimul||hippocampu||action||ischemia||tonic activ||activ||extracellular space||ntpdase||glutam||antagonist||protect,1||1 receptor||receptor||1 2A 3 receptor||adenosin receptor||3||1 receptor activ||1 1 depart||adenosin||adenosin a2a receptor||a2a receptor||3 receptor stimul||2||P2 receptor||adenosin A3 receptor,0.033||0.032||0.03||0.025||0.025||0.023||0.023||0.023||0.02||0.019||0.019||0.018||0.018||0.017||0.017,0.2,0.2,0.13333333333333333
32,Purinergic_Signal-4-2-2377322.txt,muscl||respons||stimulatori effect||releas||human plasma||perfus||atp||activ skelet muscl||potassium channel||effect||purin||bodi exercis||extracellular atp||cell||acetylcholin||hypoxia||solut||tissu||exercis||depolar||identif||erythrocyt||human muscl||bath solut||motor nerv||substanc||serendip||human erythrocyt||procedur||heart||membran,1||1 fig. 1||1 6||1 19||refer 1||3 fig. 2||cell||1 6 17||6||human cell||situ 1 vagusstoff||fig. 16b||heart cell||cell function||frog musculatur 1 23,0.034||0.03||0.024||0.018||0.018||0.018||0.018||0.017||0.013||0.013||0.012||0.012||0.011||0.011||0.011,0.0,0.1,0.06666666666666667
33,Sci_Eng_Ethics-4-1-2225997.txt,independ physician||clinic test||case||critic care situat||time||intens care condit||risk-benefit ratio||prospect||efficaci||brain injuri||studi||good clinic practic||patient||agent||inclus||elderli peopl||short therapeut time window||clinic trial||pharmacolog trial||countri||treatment||tbi||defer consent||acut neurolog||specif ethic issu||emerg research||pharmacolog neuroprotect agent||random||sever traumat brain injuri||consent||acut emerg situat||european||proxi||direct||injuri||time window||proxi consent||clinic research||ethic||sever tbi||trial||signific advers side effect||benefit||waiver,3||40 1||care||research||emerg medicin||3 4 6||refer 1||1 time window||consent||march 1||intens care medicin||2007 introduct 1 2||clinic research||consent patient||emerg research,0.017||0.014||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.012,0.0,0.1,0.2
34,Surg_Endosc-4-1-2358937.txt,blood loss||transect||anim||materi||time||routin blood test||complic||stapl line reinforc||liver resect||surgeri||substanti liver parenchyma||devic||bile leak||addit||liver,1||2||1 day||refer 1||1 fig. 1 schemat illustr||2 day||3||5||porcin model 2 fig. 2||studi||netherland 2 depart||3 day||4||liver||2 9 30 32,0.042||0.03||0.025||0.022||0.021||0.019||0.019||0.018||0.017||0.016||0.014||0.013||0.013||0.012||0.012,0.0,0.0,0.06666666666666667
35,Skeletal_Radiol-4-1-2271083.txt,bone marrow-stimul agent||case||spine||mri||imag||histori||patholog report||studi||patient||benign||fdg uptak||pet imag||lesion||fractur||neg predict valu||CT find||patholog result||repeat imag||clinic follow-up||uptak||acut benign fractur||report||compress fractur||suv||benign fractur||malign||emiss imag||fdg-pet,patient||1||6 patient||2||fig. 2||4 patient||9 patient||3||24 patient||12 patient||5||33 patient||14 patient||elderli patient||compress fractur,0.031||0.029||0.023||0.023||0.022||0.021||0.021||0.019||0.019||0.019||0.018||0.018||0.018||0.017||0.017,0.2,0.1,0.13333333333333333
36,Brain_Struct_Funct-4-1-2226080.txt,maze test||anim||stereolog||time||revers trial||total neuron number||matern separ||open arm||section||volum||test||anxieti||total||hole||dentat gyru||escap box||behaviour||maze||day||distanc||open field test||paramet||separ||estim||hippocampu||total distanc||mice||neuron||total number||pnd||experiment group||arm||group||open field||number||barn maze||trial||signific differ||box,2||3||1||3 fig. 3||7 3||8 3||3 femal||CE 3||4||3 total||2 male||time 2||2 section||1 week||2 day,0.019||0.019||0.019||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.01||0.01,0.0,0.0,0.0
37,Appl_Psychophysiol_Biofeedback-4-1-2259255.txt,condit||find||eeg abnorm||delta activ||behavior||eeg biofeedback||depend||problem||data||alpha absolut power||studi||patient||clinic outcom||alpha||state||chronic||function brain activ||cortic area||effect||sud||quantit eeg||frequenc||section||femal||beta||scale||increas||criteria||amplitud||slow-beta coher||abstin||low-voltag background activ||qeeg alter||disord||frontal||evid||mix substanc abus||classif||treatment||therapi||eeg coher||cocain||qeeg techniqu||control||acut||cognit||power||stimul||approach||alcohol||alpha-theta biofeedback||research||biofeedback||result||function connect||theta||qeeg||subject||neurotherapi||neurofeedback||genet factor||activ||heroin user||theta band||eeg characterist||heroin addict||report||group||clinic research||abus||drug||kulkoski||alpha-theta train||mental rehears||erp||alpha activ||techniqu,1||eeg||eeg studi||M. eeg||studi||2||A. eeg||alcohol eeg||clinic studi||treatment studi||eeg biofeedback||eeg biofeedback treatment||treatment||alcohol eeg journal||eeg effect,0.011||0.011||0.01||0.009||0.009||0.009||0.009||0.009||0.009||0.008||0.008||0.008||0.008||0.008||0.008,0.2,0.1,0.2
38,Diabetologia-3-1-1794135.txt,type 2 diabet||quantit trait||diabet||variant||data||studi||bmi||effect||risk||insulin sensit||receptor||sir cohort||genotyp||evid||adiponectin gene||associ studi||gene||cohort||control||result||analysi||polymorph||popul||associ||report||snp||UK popul||insulin resist||haplotyp||sequenc||adiponectin receptor,2||2 diabet||2 1 1 adipor1||adipor1||adipor1 adipor2||1 adipor1 adipor2 adipor1 adipor2||type 2||1||type 2 diabet||adipor2||2 diabet risk||tabl 2||diabet||2 11||tabl 1 adipor1 adipor2,0.042||0.033||0.032||0.03||0.028||0.028||0.028||0.027||0.026||0.026||0.024||0.024||0.023||0.023||0.022,0.0,0.1,0.13333333333333333
39,J_Med_Internet_Res-7-5-1550689.txt,document||filter||time||system||data||technic perform||inform||total search time||meta-search filter||user||sourc||evid||meta-search engin||wrapper||approach||parallel process||evidence-bas medicin||pubm||small peak||paper||onlin evid retriev method||clinician||standard||unifi respons languag||capabl||search||intern compon||number||diseas||profil||design||search profil||result,search||1||tabl figur 1||figur 2||search time||search time figur 6||figur 6||figur 5||system time figur 5 figur 7||figur 8||system||tabl 1 4||search result||sourc||search system design,0.027||0.025||0.022||0.022||0.02||0.02||0.02||0.02||0.019||0.019||0.018||0.017||0.016||0.016||0.016,0.2,0.1,0.2
40,Eur_Radiol-2-2-1705542.txt,unclear shoulder pain||imag||arthrographi||superior||complex||coron obliqu||lesion||ighl||secondari imping||tear||shoulder disloc||common form||diagnost work-up||magnet reson||labro-ligament complex||acut||labrum||anterior instabl||bankart||diagnost arthroscopi||bicep||injuri||pain athlet shoulder||athlet||normal anatomi||therapeut decis,2||2 1 2 4||instabl 2||1 2 6||lesion 1||2 37||2 fig. 2a||46 2 11 2 fig. 11a||refer 1||lesion||1 mnemon||shoulder||1 5 9 12 fig. 1a||springer-verlag 2006 introduct 1 5||glenohumer instabl,0.039||0.03||0.028||0.026||0.023||0.021||0.019||0.018||0.017||0.016||0.016||0.016||0.015||0.013||0.013,0.0,0.1,0.06666666666666667
41,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2413120.txt,type||arthroscop view||time||time-disturb analysi||exact sig||disturb||qualiti||turbid||studi||comparison||knee joint||effect||view||arthroscop pump system||straightforward arthroscop knee surgeri||oper||frame||percentag||analysi||group||differ||presenc||arthroscopi||number||loos fibrou tissu||signific differ||result,2||1||2 fig. 2||result 1 1 2||1 1 depart||22.2 2||11 11 1 11 fig. 1||1 match||method 2 4||refer 1||11 10 2 4 6 11||netherland 2 depart||2 standard oper||pump group discuss 2 4 6||4,0.058||0.05||0.046||0.042||0.036||0.03||0.03||0.029||0.029||0.028||0.025||0.024||0.024||0.024||0.022,0.0,0.0,0.0
42,Purinergic_Signal-4-1-2246000.txt,atp||microglia||propag||microgli cell||wave||work||lane||receptor||astrocyt||releas||site||calcium wave||transmiss||model||diffus substanc||valu||initi||cell||densiti||calcium,2||2 2||1 2 1 2||12 2||3 2||3 fig. 2 2||4 2||5 2||2 12 12 2 12 receptor||8 2||7 1 2||9 2||4 12 2||2007 2||fig. 12 2,0.059||0.059||0.043||0.042||0.038||0.037||0.036||0.035||0.034||0.034||0.033||0.032||0.032||0.032||0.032,0.0,0.0,0.0
43,Neurochem_Res-4-1-2295255.txt,level||nos-2||patient||control mice||region||astrocyt||infect||brain||day||gfap||glial cell||hippocampu||mice||olfactori bulb||capillari blood vessel||model mous||report||infect mous brain||influenza viru||viru||blood vessel||result,2||immunohistochemistri 2 2 2 2||3 2 3||nos-1 2 2 2 fig. 2||1||2 4 2 8||3||fig. 1||fig. 3||3 day||1 5 7||hplc-uv method 2 3||llc 2008 introduct 1 2 3||4 5||viru,0.044||0.036||0.033||0.032||0.029||0.028||0.027||0.022||0.021||0.021||0.02||0.019||0.018||0.017||0.017,0.0,0.0,0.06666666666666667
44,Cancer_Causes_Control-2-2-1705538.txt,posit associ||birth||histori||data||studi||menopaus statu||bmi||densiti||continu form||multivari model||risk||effect||mammogram||clinic assess form||cutpoint||famili histori||patient intak form||analys||breast cancer risk factor||breast cancer risk||breast densiti||pariti||menarch||nhmn record||women||posit effect||age||previou studi||factor||hormon replac therapi||influenc||mammograph breast densiti||interact||larg popul||breast||current visit,breast||breast cancer||breast cancer breast cancer||cancer||2||1||breast cancer risk||histori breast cancer||breast densiti||breast cancer 0.09||breast cancer Br||breast cancer prevent||cancer risk||breast cancer prognosi||breast cancer risk factor,0.026||0.025||0.025||0.025||0.022||0.021||0.02||0.018||0.018||0.017||0.017||0.017||0.017||0.017||0.016,0.2,0.3,0.26666666666666666
45,J_Occup_Rehabil-3-1-2039785.txt,categori||low job satisfact||case||high effort||object instrument||measur||product loss||studi popul||pain intens||studi||dichotom variabl||musculoskelet symptom||select||mous usag||neck||worker||logist regress analys||sick leav||comput worker||presente||analys||psychosoci factor||product||pain||associ||product due||popul||subject||sick absenc||previou research||psychosoci load||respond||intens||factor||symptom||comput usag||descript statist||loss||mous posit||result,studi||1||1 2||2||product||product loss||product loss 1 tabl 1||loss||symptom||symptom 2 fig. 2||studi popul||1 1 tno work||result product loss 1 fig. 1||work||present studi,0.02||0.018||0.018||0.017||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012,0.4,0.5,0.4
46,Pediatr_Nephrol-4-1-2259256.txt,condit||time||infant||detrusor overact||lower extrem function||abnorm||intraves pressur||myelodysplasia||present||lower urinari tract||lower extrem||increas||spinal cord||lesion||pressur||newborn||bladder||urodynam studi||reflux||cerebr palsi||sphincter||urodynam||assess||dysfunct||renal function||low pressur||injuri||cic||cord||high||anticholinerg medic||sacral agenesi||incontin||complianc||children,2||9 2||1 4||level 1||urodynam lesion 2||lesion 1||spinal cord||abrupt 2 2 hypoglycemia||bladder capac 2||cord||urodynam||3||bladder||birth 1 3||spinal cord injuri,0.019||0.012||0.012||0.012||0.011||0.011||0.011||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.009,0.0,0.2,0.26666666666666666
47,Virchows_Arch-3-1-2039779.txt,method||ileal mucosa||studi||comparison||patient||lower number||cell kinet||apoptot index||section||affer loop||famili adenomat polyposi||adenoma||investig||increas||tissu section||pouch||cell prolifer||restor proctocolectomi||apoptot rate||cell||prolifer||tissu area||apoptosi||semiquantit||rang||photograph||biopsi||differ||number||fap||signific differ||crypt||index,1||1 patient||patient||1 fig. 1||2 2 2 fig. 2 2||3 patient||5 patient||2 5||cell||cell prolifer||M. 1 1 depart||fig. 7 0 1 2||cell prolifer studi||9 patient||20 patient,0.025||0.023||0.021||0.021||0.019||0.018||0.017||0.017||0.017||0.015||0.015||0.014||0.014||0.014||0.014,0.2,0.3,0.2
48,Diabetologia-4-1-2270365.txt,effect||risk||gene||power||case-control data||loci||joint effect||trio||type 1 diabet||interact||diseas||data||genotyp||hla||supplementari materi||result,1||1 diabet||1 ctla4 1||1 3||tabl 1||type 1 diabet||type 1 diabet risk||1 iii||1 jo27||refer 1||type 1 diabet pediatr||late-onset type 1 diabet||childhood-onset type 1 diabet||type 1 diabet bjÃ¸rnvold||esm tabl 1,0.037||0.029||0.028||0.024||0.024||0.023||0.02||0.02||0.02||0.019||0.018||0.017||0.017||0.017||0.017,0.0,0.1,0.06666666666666667
49,Purinergic_Signal-4-2-2377325.txt,role||level||respons||releas||photoreceptor||adenosin||agonist||effect||space||transport||evid||signal||rpe||light-sensit signal||cell||stimuli||stimul||epinephrin||rpe cell||microenviron||membran||subretin space||rod||consist||ectoenzym activ||atp releas||glutam||cftr,2||photoreceptor 2 18 2 2||31 2||48 2||50 2||30 2||2 53||2 23 2 24 7 25||subretin space 1 2 3||58 43 2||receptor||cell||refer 1||pigment||6,0.035||0.022||0.02||0.019||0.019||0.018||0.018||0.015||0.015||0.014||0.012||0.012||0.01||0.01||0.01,0.0,0.0,0.06666666666666667
50,Eur_Radiol-3-1-1914269.txt,percentu width||measur||heart phantom||method||cardiac cycl||tempor resolut||longitudin plane||CT imag||imag||studi||stent||attenu profil||imag qualiti||plane||increas||coronari stent||heart rate||lumen visibl||averag spearman coeffici||highest score||CT attenu||64-slice mdct||coronari arteri||averag decreas||movement||attenu||heart||stent lumen||result,1||2||2 2 2 fig. 2||fig. 1||7||3||tabl 1||2 3 7 8||fig. 3||tabl 2||method 2||tabl 3||2006||fig. 9||5 6 7 8,0.024||0.022||0.02||0.02||0.019||0.018||0.018||0.017||0.017||0.016||0.015||0.014||0.014||0.014||0.013,0.0,0.0,0.0
51,J_Gastrointest_Surg-3-1-1852377.txt,poor outcom||hepatocellular carcinoma||studi||patient||recurr||liver transplant||signific||microvi||df||present studi||multivari analysi||analysi||microvascular invas||vascular invas||hcc||liver||factor||tumor||surviv||histolog grade||number||liver explant||stage||outcom,liver||1||liver transplant||transplant||2||4||surviv 1 1||orthotop liver transplant||figur 1||analysi 2||patient||liver transplant versu liver resect||3||refer 1||liver explant,0.022||0.021||0.02||0.018||0.018||0.017||0.016||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.012,0.4,0.2,0.26666666666666666
52,Clin_Rheumatol-3-1-1820749.txt,mechan||chronic fatigu syndrom||physiolog mechan||cognit emot sensit||respons||central process||knowledg||pain complaint||studi||theoret background||patient||function brain activ||central nervou system||chronic widespread pain||sensit||investig||spinal cord||pain process||evid||similar||stimuli||brain abnorm||multipl spinal segment||tempor summat||cognit||electr stimul||chronic fatigu||catastroph thought||pain||musculoskelet pain||hyperalgesia||cf||central sensit||chronic pain||allodynia||wind-up||fibromyalgia||central mechan||inhibitori pathway||spatial summat||pathway||hypothesi||result,pain||chronic pain||pain patient||clinic pain||musculoskelet pain||widespread pain||pain complaint||pain process||chronic pain syndrom||pain modul||pain pathway||pain term||pain popul||pain disabl||persist pain,0.042||0.027||0.026||0.023||0.022||0.022||0.022||0.022||0.022||0.022||0.022||0.021||0.021||0.021||0.021,0.6,0.5,0.3333333333333333
53,Environ_Manage-3-1-1914239.txt,legal entiti||skill||case||oper entiti||design oper entiti||cameroon||commun||project||capac||figur||cdm implement||studi||argument||develop||inform||carbon||sustain||project develop||impact||institut arrang||manag||resourc||cost||ngo||bimbia||rule||clean develop mechan project||commun forest||sustain develop||resourc tenur||clean develop mechan||environment impact||biodivers||cdm||reforest||materi||activ||implement||timber exploit||environment servic||impact assess||commun capac||emiss||tinto||requir||capac requir||forest||nation fund||current modal||commun manag||plan||addition||carbon sequestr,commun||commun forest||commun manag||commun forest manag||forest||forest manag||commun forestri||commun project develop||tinto commun forest||bimbia commun||commun capac||manag||tinto commun||90 commun forest||200 commun forest,0.026||0.023||0.021||0.021||0.02||0.018||0.018||0.018||0.017||0.016||0.016||0.016||0.016||0.015||0.015,0.8,0.4,0.4
54,Eur_J_Pediatr-3-1-1914268.txt,domain read||find||case||system||children||perinat asphyxia||ambigu result||problem||mild NE||studi||normal rang||young age||school||behavior problem||heterogen group||moder NE||difficulti||criteria||review||abil||behavior consequ||neonat encephalopathi||sever NE||brain||neuropsycholog function||mild||inclus criteria||sarnat||cognit||research||futur research||long-term follow-up||age||educ achiev||gener||group||school age||asphyxia||intellig||healthi peer||area||read||averag rang||addit||score||function||outcom||result,1||group 1||group||group 2||2||control group||control group NE||1 year||languag group 1||execut group 1||sensorimotor group 1||visuospati group 1||NE||1 SD||control group mild NE,0.024||0.023||0.022||0.021||0.02||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.014,0.2,0.1,0.06666666666666667
55,Sci_Eng_Ethics-4-1-2413106.txt,futur||fuel||time||main object||justic||line||cfc||fuel cycl||valu||reactor||risk||recycl||period||plutonium||nuclear reactor||ofc||trade-off||addit risk||moral discuss||sustain||countri||short-term||energi||long-term benefit||intergener justic||nea||iaea||prolifer||open||long-term radiolog risk||world||futur gener||product||secur concern||analysi||framework||materi||reprocess||present gener||reason||gener||option||order||wast||natur uranium||public||uranium||radiotox||benefit||nuclear wast||plant||safeti,1||nuclear wast||2 2||2||nuclear energi||3||wast||2 justic||1 5||futur gener 3 3||energi||justic||nuclear fuel cycl||fuel||nuclear energi agenc,0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.011||0.011||0.011||0.011||0.01||0.01||0.01,0.2,0.2,0.3333333333333333
56,Evid_Based_Complement_Alternat_Med-4-4-2176145.txt,type||program||health benefit||week||diabet||hypertens||glucos level||studi||session||cholesterol||yoga||overweight||effect||high cholesterol||review||intervent||adult||day||health condit||glucos||chronic diseas||subject||weight||bodi weight||cardiovascular diseas||benefit||systol BP||articl,studi||1||diabet studi||yoga||diabet||health||type 2 diabet||1 11||type 2||yoga program||hypertens type 2||studi result||yoga train||risk||11,0.022||0.02||0.02||0.019||0.018||0.017||0.017||0.016||0.016||0.015||0.013||0.013||0.013||0.012||0.012,0.6,0.3,0.2
57,Ann_Surg_Oncol-4-1-2277451.txt,cancer||adjuv therapi||surgic volum||hospit||volum||surgeon||studi||centr||servic||literatur||poor qualiti||patient||oper||manag||institut||outcom,1||1 1||cancer||cancer outcom||1 2||refer 1||version 1||outcom||cancer care||colorect cancer outcom||patient outcom||cancer specif||breast cancer||colorect cancer||keyword cancer volum outcom,0.04||0.04||0.031||0.026||0.025||0.023||0.022||0.021||0.019||0.019||0.018||0.018||0.018||0.018||0.017,0.2,0.2,0.13333333333333333
58,Pharm_World_Sci-3-1-2082655.txt,chronic ill experi||find||meta-synthesi||in-depth interview||individu||studi||patient||encount||effect||process||medic||health care practition||theme||interview transcript||medic experi||natur||control||understand||pharmaceut care||research||chronic condit||bodi||practic concept||pharmaceut care practic||practition||sens||ill||particip,1||method 1||2||medic||PC 1||refer 1||2008 introduct 1 1 3||medic experi||1 studiesâ method||patient âs medic experi||experi||10 2||medic practic||patient âs experi||patientsâ medic experi,0.043||0.025||0.025||0.024||0.023||0.023||0.022||0.02||0.018||0.017||0.017||0.015||0.015||0.015||0.015,0.2,0.2,0.13333333333333333
59,Bioinformation-1-4-1891668.txt,record||number||diabet||medicin plant||databas||diseas||data||diamedbas||plant,1 1 3 2||2006||4||bioinform 1||4 5 6 7 8||530016 2 depart||plant||medicin plant||diamedbas alo vera figur 1||refer 1 grover JK||2006 biomed informat publish group 2006||diabet babu padavala ajay 1||530045 3 sri venkateswara colleg||plant research||blind 6 donnelli,0.065||0.046||0.046||0.039||0.032||0.028||0.027||0.026||0.024||0.023||0.023||0.02||0.018||0.017||0.016,0.0,0.2,0.13333333333333333
60,Biogerontology-3-1-2040177.txt,measur||major gene||individu||rate||sampl||chuvashia||herit||oss measur||effect||correl||biolog age||investig||residu varianc||sex||signific||parsimoni model||segreg analysi||present studi||BA index||livshit||age adjust||gene||women||age||analysi||popul||MG genotyp||genet factor||group||famili||skelet||oss||index||biomark,2 2 2||2||1 1 1 2 2 2||1 2 2 2 1 1||1 1 1 2||1||1 1||1 1 1 1||age||6 2 1 1||1 2 2 1 1995 3||2007 2||model 2||2003 2||biolog age,0.032||0.032||0.03||0.03||0.03||0.029||0.029||0.029||0.027||0.024||0.024||0.02||0.02||0.019||0.018,0.0,0.1,0.13333333333333333
61,Behav_Genet-3-1-1914288.txt,measur invari||parent rate||boy||sex differ||behavior||adhd index||conner teacher rate scale||data||model||equal||correl||scale||teacher rate||MI criteria||sex||environment influenc||factor structur||item||preval differ||girl||varianc||estim||twin||odd||analysi||parent||genet||teacher||factor||differ||influenc||adhd||children,1||2||1 1 depart||differ||genet||3||genet factor||3 genet model||genet model||factor||1 promax||2002 1 2001 2001||teacher||genet model twin||model,0.023||0.021||0.017||0.015||0.014||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.011,0.4,0.3,0.3333333333333333
62,Eur_J_Nucl_Med_Mol_Imaging-4-1-2275773.txt,normal tissu||tumour-specif apoptot respons||respons||protocol||radiat||roi||imag||baselin||studi||patient||earli apoptosi||effect||abil||dose||hnscc||tumour||apoptosi||lymph node||spect||primari tumour||parotid gland||differ||radiat dose||treatment-induc annexin uptak||salivari gland function||scintigraphi||submandibular gland||convent gamma camera||annexin,1||2||3||result 1 99m 1 fig. 1||method 2 2||3 field||patient fig. 3||2 verheij marcel 1 1 depart||tabl 1 patient||refer 1||4||patient||treatment||fig. 4||neck cancer,0.022||0.018||0.017||0.015||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.01,0.0,0.0,0.06666666666666667
63,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-1915601.txt,mechan||antibodi||sphingosine-1-phosph receptor||membran||luminesc signal||time||fluoresc||BM chemiluminesc blot substrat||hisg-tag||protein||non-radioact method||receptor||fluoresc microscop||internalis||signal||detect method||cell||detect||cell membran||result,1||1 receptor||1 2||1 3||receptor||fig. 2 1||squar 1 receptor||bar 1||fig. 4 1 receptor||day 1||springer-verlag 2007 1 receptor||method materi 1 receptor||experi fig. 5 1||7 fig. 6 1||minneman KP 1,0.066||0.052||0.044||0.041||0.039||0.036||0.035||0.034||0.034||0.034||0.032||0.029||0.026||0.025||0.023,0.2,0.1,0.06666666666666667
64,Environ_Health_Perspect-114-2-1367850.txt,measur||method||neurolog examin||data||studi||specif aspect||year||seychel island||question||psycholog test||prenat exposur||develop||development effect||effect||inform||review||investig||mehg||consensu||test||development outcom||methylmercuri||mehg exposur||outcom||cognit process||exposur assess||neurobehavior test||research||futur research||assess||age||faro island||associ||subject||literatur||matern hair||report||import||exposur||field||current uncertainti||prenat mehg exposur||development rate scale||systemat review||outcom measur||children||result,1||1 2||2||tabl 1||tabl tabl 1||tabl 2||studi||health||vol 1||test||exposur||methylmercuri studi||2 week||neurobehavior studi||health effect,0.025||0.022||0.019||0.018||0.015||0.015||0.015||0.015||0.014||0.013||0.013||0.011||0.011||0.011||0.011,0.0,0.2,0.2
65,Eur_Child_Adolesc_Psychiatry-2-2-1705530.txt,depress symptom||mother||birth||pre-nat smoke||studi||depress||effect||risk||famili risk||child||lbw||variabl||birth-weight||unit increas||analys||coeffici||genet risk||twin||age||social class||associ||standard||weight||birth weight||factor||regress analysi||parent report||gestat||report||influenc||symptom||interact||depress disord||children||result,1||2||twin 1||depress||1 tabl 2 genet risk||psyc 178||psyc 175:380||psyc 157:190||psyc 155:172||psyc 184:446||psyc 179:450||psyc 160:625||psyc 179:230||psyc 152:833||psyc 156:133,0.021||0.017||0.015||0.015||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
66,Appl_Microbiol_Biotechnol-4-1-2266784.txt,jar fermentor||heterolog protein||cultur||signal peptid||product||secret||amino acid||kikuchi||industri product||industri scale protein product,C. glutamicum C.||C. ammoniagen C.||2 C. glutamicum C.||2 C.||C. glutamicum corynebacterium||C. glutamicum 2003||C. ammoniagen C. ammoniagen atcc6872||discuss C.||C. ammoniagen atcc6872||18 C. ammoniagen||corynebacterium glutamicum||10 11 C. glutamicum||12 13 C. glutamicum||8 9 C. glutamicum||pro-tg secret C.,0.064||0.059||0.058||0.056||0.047||0.047||0.042||0.037||0.036||0.035||0.034||0.034||0.034||0.033||0.027,0.0,0.0,0.0
67,Fam_Cancer-4-1-2253650.txt,risk||potenti role||cancer||gene||syndrom||case||women||dgc||mutat carrier||studi||prophylact gastrectomi||lbc||lobular carcinoma||lobular breast cancer||loss||mutat||breast||predict genet test||famili,cancer||breast cancer||gastric cancer||famili breast cancer breast cancer||breast cancer genet||cancer risk||fam cancer famili cancer||breast cancer patient clin cancer||cancer hdgc||breast cancer famili||famili breast cancer||cancer suscept||cancer lbc||cdh1||primari cancer,0.045||0.032||0.029||0.027||0.027||0.026||0.024||0.024||0.024||0.024||0.024||0.023||0.023||0.023||0.023,0.2,0.1,0.06666666666666667
68,Diabetologia-3-1-2100429.txt,type 2 diabet||mother||pregnanc||studi||offspr||matern nutrit variabl||newborn||adipos||bodi composit||women||thci||matern nutrit||indian||fat mass||size||folat||risk factor||insulin resist||nutrit measur||mma||children,12||12 12||1||12 12 12 12 30 1||12 12 concentr||folat statu 12 12 1 12||2||model 1||method 12||12 concentr||result 12||statist 12 12 16 12 17||0.001 12||micronutri 12||0.08 0.7 12 12,0.029||0.029||0.025||0.024||0.02||0.02||0.019||0.017||0.016||0.016||0.016||0.016||0.016||0.015||0.015,0.0,0.0,0.0
69,Cancer_Immunol_Immunother-3-1-2082063.txt,antigen process machineri||independ predictor||prognost paramet||apm defect||case||patient||stromal cell||express||erap||df||tumour||human carcinoma||tap||erap1||intern posit control||signific associ||independ prognost paramet||defect express||apm compon||surviv||apm||normal express||cervic cancer||cervic carcinoma||cervic carcinoma patient||loss||clinicopatholog paramet||down-regul||score||compon,2||1 2||1||0.001 2||tabl 2||express fig. 2||30 33 37 2 2||express||springer-verlag 2007 2||jan 1 1 depart||refer 1||2 33 35||0.017 1||0.100 1||0.284 1,0.026||0.023||0.02||0.016||0.015||0.014||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011,0.0,0.1,0.06666666666666667
70,Apoptosis-4-1-2423419.txt,cancer||studi||icad||express level||region||promot||site||express||cell||myc||gene||dna fragment||function import||transcript||apoptosi||activ||human cancer||transcript regul||report||dff||ectop express||icad protein||construct||myc-bind site||result,icad||icad icad||2008 icad icad icad||icad myc icad||icad 5 icad||icad gene||icad gene icad icad ecor||icad promot||myc icad 3 icad icad promot||icad express||c-myc icad||icad protein||icad 39 icad gene regul||icad promot activ||cell,0.058||0.058||0.044||0.041||0.041||0.039||0.039||0.035||0.033||0.033||0.033||0.032||0.028||0.027||0.025,0.2,0.1,0.2
71,Neuroradiology-4-1-2275774.txt,follow-up||imag||patient||stent||volum||contrast medium||intracrani stent||rotat acquisit||examin||volum dataset||invas techniqu||intraven administr||brain parenchyma||act||CT angiogram||cta||ica||vessel||cerebrovascular diseas||inject||stent lumen,1||2 2 10 fig. 2||case 2 3 3 fig. 3||4 4 fig. 4||refer 1||3||germani 2 depart||7 8||10||2007||imag||germani||studi result||5 ml||follow-up imag,0.055||0.046||0.034||0.031||0.031||0.03||0.027||0.014||0.014||0.012||0.012||0.012||0.011||0.011||0.01,0.0,0.0,0.06666666666666667
72,Brain_Struct_Funct-4-1-2248604.txt,condit||function imag||respons||lexic statu||block||gyru||sensori compon||middl posit||roi||posit differenti bold||oddbal block||word deviant||motion||effect||oddbal||speech||posterior auditori cortex||test||sensori mechan||deh||stimuli||day||control||map||bonferroni||result||standard||subject||acoust factor||primari auditori cortex||activ||cognit mechan||anterior||speech stimulu interact||deviant||contrast||middl||standard-devi pair||sound||outlier,2||2 1 2 2004||map||1||2 2 2006 5 2||4||4 4||4 deviant map 1||deviant map||2005||3||deviant map deviant control map||4 4 7 3 6 2005||2005 2003 2005 2006 2004||2004,0.022||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
73,Arch_Orthop_Trauma_Surg-4-1-2228384.txt,delay||signific pain reduct||studi||patient||durat||effect||adant||viscosupplement||infiltr||hh||hyaluronan||non-op treatment||treatment||hyaluron acid||product||hip||pain||prepar||hip osteoarthr||group||differ||signific differ||inject||tha||statist signific differ,2||2 2||2 3 fig. 2||1||1 fig. 1||3 month||2 year||3 year||9 3||1 month||2 evolut||3 evolut||2 mulier||32-16-338824 michiel.mulier@uz.kuleuven.ac.b 2 3 1 depart||treatment group 2,0.04||0.04||0.035||0.034||0.029||0.026||0.024||0.024||0.023||0.023||0.022||0.022||0.021||0.021||0.019,0.0,0.0,0.0
74,Ann_Surg_Oncol-4-1-2234450.txt,superfici lymphat||system||first-tier lymph node||radiograph||intern thorac arteri||sentinel node biopsi||femal||anatom analysi||node||lymph vessel||cross-sect studi||dye||axilla||peritumor inject||thin adult cadav||tissu||neg sentinel node studi||lymph node||previou studi||anterior upper torso||subareolar inject||intern mammari lymphat||sentinel node||lymphat||specimen||germani||cadav||vessel||subareolar plexu||inject||sappey||branch||pathway||breast||sentinel lymph node biopsi||result,2||breast||4||breast cancer||breast cancer breast cancer||breast lymphat||breast cancer sentinel lymph node||node||surg 1999||cancer cell||breast cancer anz||breast cancer treatment||lymph node||femal breast||invas breast cancer,0.02||0.019||0.019||0.018||0.018||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012,0.2,0.2,0.2
75,Antonie_Van_Leeuwenhoek-3-1-2140094.txt,conidiophor||uniqu||extrolit||ascospor||diam||aerial hypha||cultur||cya||coloni||mea||speci||promin equatori furrow,N.||3 Î¼m||2 Î¼m||5 Î¼m||fumigati N.||3 Î¼m diam||25 Î¼m||3.5 Î¼m||80 Î¼m||aspergillu||230 Î¼m||neosartorya aspergillu N. indohii N.||5 Î¼m diam||N. denticulata||6 Î¼m diam,0.03||0.025||0.024||0.023||0.021||0.02||0.02||0.019||0.019||0.019||0.019||0.019||0.019||0.017||0.017,0.0,0.0,0.0
76,Dig_Dis_Sci-3-1-1914222.txt,bmp||morpholog||level||high-dos dox treatment||epitheli homeostasi||mucos||epitheli||increas||express||villi||dose||differenti||treatment||cell||damag||day||control||sever villu atrophi||prolifer||mice||medium dose||protein||group||decreas||dox||tcf4||length||pathway||crypt||stem cell||wnt pathway||mtx,1||1 1 1 1 1 1||day 1||day||day 4||day 2||4||cell||day 3||3 day||2||day 7||b.dekoning@erasmusmc.nl 1 2 4||intestin cell||protein 4,0.024||0.024||0.023||0.023||0.021||0.02||0.02||0.019||0.018||0.018||0.018||0.016||0.016||0.016||0.015,0.2,0.2,0.13333333333333333
77,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2367393.txt,posterior capsul||vitreou entrap||case||flare||optic edg||year||natur barrier effect||len epitheli cell||hyaloid||routin procedur||posterior capsul opacif||retin detach||anterior vitrectomi||optic buttonhol||eye||lec||primari posterior capsulorhexi||edg||potenti||intraocular lens||techniqu||after-cataract||pobh||surgeri||ppccc||central posterior capsul||peripher retina||iol||anterior||standard in-the-bag implant||capsular diaphragm||toric iol||optic centrat||after-cataract prevent||ovd||optic rim||optic||regeneratori lec prolifer||fibrosi||barrier,1||2||posterior||4||1 mm||optic||fig. 13||fig. 9 posterior capsul||posterior capsul||3||4 mm||eye 2||capsul||posterior capsul rim fig. 4 hoya||2 3 8,0.021||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.012,0.0,0.2,0.13333333333333333
78,Qual_Life_Res-3-1-1915604.txt,dutch huntington associ||consequ||qualiti||studi||patient||life||amount||durat||ill percept||percept||scale||qol||mental health||spous||analys||huntington||coupl||treatment||control||higher score||total motor score||research||gener health||futur research||social function||subscal||long durat||ill||belief||symptom||patient qol||partner||diseas||vital||result,ill||health||ill psycholog||patient||health psycholog||1||ill percept 1||psycholog||patient âs ill||ill percept||2||patient âs||3||qol 2 3 2||percept,0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.012||0.012||0.011||0.011,0.4,0.3,0.26666666666666666
79,J_Abnorm_Child_Psychol-4-1-2277450.txt,cost diari||anxiou children||anxieti disord||method||inform care||children||preval||data||sever score||studi||year||annual societ cost-of-il||discrimin valid||school||physic problem||converg valid||mental health treatment||anxieti||disord||aim||treatment||childhood anxieti disord||resourc||cost||percentag||parent||psycholog problem||care||gener practition||clinic anxieti disord||reason||famili||group||differ||work||top-down data||cost-of-il||mental disord||diari||gener popul||result,cost||1||health care cost||cost 2005||total cost||cost diari||2||hospit care cost||total health care cost||care||medic health care cost||mental health care cost||cost data||famili cost||health care,0.025||0.018||0.018||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.2,0.3,0.2
80,Mol_Neurobiol-3-1-2039847.txt,AD brain||level||system||AD lesion||protein aggreg||data||apolipoprotein||strategi||hsp||aggreg||human||microgli cell||chaperon||amateur chaperon||profession chaperon||profession||transport||cell||brain||heat shock protein||tpa||gag||heparan sulfat proteoglycan||mice||protein||format||apo||hyperphosphoryl tau||activ||accumul||bind||shsp||earli develop||clearanc||toxic||neurodegen diseas||amyloid||addit||tau||amyloid beta-protein||vivo||result,protein||1||2||diseas||alzheim âs diseas||alzheim âs||cell||alzheim diseas||alzheim âs diseas brain||M. 1 2||protein aggreg||alzheim||beta-amyloid protein||alzheim âs amyloid precursor protein||alzheim diseas brain,0.018||0.017||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011,0.2,0.2,0.2
81,Purinergic_Signal-2-2-2254478.txt,ntpdase||nervou tissu||platelet||cd39||immunolog||ecto-atpas||vasculatur||ectonucleotidas||liver||apyras,1||cell||2||1 receptor||entpd 1 1 1||triphosph diphosphohydrolas 1||ntpdase 1||liver cell||endotheli cell||fig. 1||diphosphohydrolas||cell type||region 1||nucleotid triphosph diphosphohydrolas 1||refer 1,0.014||0.013||0.012||0.01||0.01||0.008||0.008||0.008||0.008||0.008||0.008||0.007||0.007||0.007||0.007,0.0,0.0,0.0
82,Naunyn_Schmiedebergs_Arch_Pharmacol-4-1-2323035.txt,peptid YY||dpp-iv||cd26||diabet||dipeptidyl peptidas IV||glucagon-lik peptide-1,3||36 3||36 2008 3||36 2005 3||diabet||36 2006 3||36||36 2002 3||type 2 diabet||2008||1993 3||netherland 3 depart||diabet patient||36 2 5 1998||2005,0.041||0.034||0.031||0.029||0.029||0.029||0.027||0.026||0.024||0.024||0.022||0.021||0.02||0.02||0.02,0.2,0.1,0.06666666666666667
83,J_Mol_Biol-1-5-1885970.txt,crystal||activ form||catalyt zinc||linker region||matrix metalloproteinas||contact||water molecul||catalyt domain||structur||form||pro-peptid domain||extracellular matrix||domain||region||asymmetr unit||activ enzym||triple-hel collagen||collagen||enzym||residu||hemopexin-lik domain||activ||peptid hydrolysi||hydrogen bond||crystal structur||activ site mutant||interact||water proton,2||2 tabl 1||1||tabl 3||2 3 4 5||4 figur 4 figur 4||3||4||structur||5||figur 2 20||Ã 2||2 Î¼l||catalyt domain figur 2||figur 5 30,0.028||0.025||0.024||0.022||0.021||0.021||0.02||0.019||0.018||0.018||0.018||0.016||0.015||0.015||0.015,0.0,0.1,0.06666666666666667
84,J_Med_Internet_Res-1-1-1761705.txt,grade||author||measur||method||system||internet user||sampl||qualiti||studi||correl||inform||articl||webometr||daili visit||content||updat||inbound link||journal||resourc||websit||evalu||medic websit||averag||citat||internet||rate system||medic matrix||citat analysi||visit||sens||number||world wide web||impact factor||qualiti indic||work||link||index||media||result,1||2||3||6 Âº)||15 Âº)||tabl 1||25 Âº)||tabl 2 tabl 3||tabl 3||3 60||figur 1 figur 2||qualiti||figur 2||tabl figur 1||websit,0.026||0.023||0.021||0.02||0.019||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014,0.0,0.0,0.13333333333333333
85,Diabetologia-3-1-1975734.txt,anim||lentivir deliveri||long-term transgen express||diabet||diabet mice||studi||gene therapi||lentivir vector||vitro||type 1 diabet||partial hepatectomi||deliveri||normal pancrea||insulin||express||cell||rat||gene||transduct effici||beta cell transcript factor||physiolog glucos control||intraven glucos toler test||ffo||liver||group||hepatocyt||pancreat beta cell||ins-fur||procedur||insulin storag||transduct||vivo,"1||3 1 1 5 fig. 1||gene||cell||insulin gene||diabet||group 1||2||2 2 2||type 1 diabet||ann.simpson@uts.edu.au 1 1 depart||5||refer 1||experi 1 1 d,e||insulin",0.024||0.018||0.017||0.017||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013,0.4,0.4,0.3333333333333333
86,Histochem_Cell_Biol-4-1-2323033.txt,mechan||cancer cell||cancer||alpha-hel bundl||form||syncytin||receptor||express||macrophag||placenta||cell||gene||membran microdomain||fusion||host cell||protein||regul||bind||fusogen||tumor||import||mous||cell fusion||molecul||membran,cell||cell fusion||cancer cell||cell fusion fusion||cancer cell fusion||tumor cell||cell hybrid||fuse cell||cell biolog||host cell||sarcoma cell||satellit cell||bewo cell||co-cultur cell||bone-marrow-deriv cell,0.043||0.03||0.029||0.026||0.025||0.023||0.023||0.023||0.022||0.022||0.022||0.022||0.022||0.022||0.022,0.6,0.4,0.26666666666666666
87,J_Occup_Rehabil-3-1-1915618.txt,measur||capac||fce||pain intens||sampl||studi||patient||function capac||tampa scale||fear avoid belief questionnair||chronic low back pain||test||tsk||high intens perform level||variabl||analys||dynam||high intens lift||weak||rehabilit||relationship||effort||pain||regress equat||activ||intens||clbp||univers medic center groningen||avoid behavior||fabq||perform||fear||lift||hand||result,1||studi 1||2||pain||2 1 12||1 3 4 1 center||studi 2||result 1||1 fig. 1 plot||1 age||refer 1||sampl 2||2 sampl||studi sampl 2||studi,0.038||0.028||0.027||0.023||0.023||0.023||0.022||0.021||0.02||0.02||0.02||0.019||0.019||0.018||0.017,0.2,0.1,0.13333333333333333
88,Bioinformation-1-10-1896055.txt,transcriptom||integr analysi||embryo||organ system||sampl||seri||microarray data||probe||express profil||dataset||biolog replic||file||gene||compar bioinformat analysi||annot||analysi||refer collect||mous||number||express data||birth defect||mous embryo,1 2||0.001||2||1 differenti||0.001 12||figur 1 metasampl metachip ciaeasi||figur 2 http://www.genome.ad.jp/kegg/ tabl 1||bioinform 1||6||0.001 33||0.001 24||10||system 6 figur 3 2||0.001 22||0.001 21,0.023||0.022||0.02||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.012||0.012,0.0,0.0,0.0
89,Histochem_Cell_Biol-3-1-2137945.txt,mechan||target||retent||method||nuclear architectur||cajal bodi||distinct structur element||releas||rna motion||bind site||motion||transcript factor||chromatin||nucleu||intranuclear traffick||site||fundament question||key||dynam natur||sequestr||dynam||cell||nuclear bodi||gene||transcript||protein||bodi||nucleolu||rapid||nuclear compart||diffus||nuclear environ||interact||nuclear motion||molecul||dynam properti||rna,cell||1||2007 2007||2007||2006 2007||2006||mol cell biol||2006 2004 2006||1 2006 2004 2006 2004||cell nucleu||live cell||cell biolog||mammalian cell||mol cell biol 17:1239||histochem cell biol histochemistri,0.039||0.031||0.029||0.029||0.028||0.028||0.025||0.024||0.024||0.023||0.021||0.021||0.02||0.019||0.018,0.2,0.1,0.06666666666666667
90,J_Gastrointest_Surg-3-1-1852389.txt,superior mesenter arteri||follow-up||left renal vein||smv||interposit graft||patient||involv||renal vein||pancreat cancer||creatinin level||superior mesenter vein||venou resect||left gonad||periop morbid||oper||superior border||portal vein||graft||pancreaticoduodenectomi||renal function||primari end-to-end anastomosi||eu||vein||resect||length||addit choic||reconstruct,1||1 1 figur 1||3 3 figur 3||2 2 figur 2||figur 6||figur 7||4 4 4 figur 4||refer 1||5||patient||1.1 mg||vein||addit patient||renal vein||oper,0.043||0.04||0.032||0.027||0.026||0.024||0.024||0.023||0.019||0.016||0.016||0.015||0.013||0.013||0.011,0.0,0.1,0.26666666666666666
91,Med_Biol_Eng_Comput-4-1-2329731.txt,cross-correl||case||deform||matrix remodel||method||imag analysi||time||compact||imag||studi||local deform||standard deviat||matrix element||singl smooth muscl cell||specif cell||consecut imag||tool||cell||analysi||experi||algorithm||pixel||collagen deform||direct CC||coat||decomposit CC||nois||stage||techniqu,2 2||2||cell||2 1||1||bottom 2 2||2 fig. 2 top||2 2 4 fig. 4 top||muscl cell||cell studi||2 characterist||singl cell||individu cell||cell adhes||specif cell,0.03||0.03||0.027||0.027||0.024||0.022||0.02||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.014,0.2,0.1,0.13333333333333333
92,Lipids-3-1-2039812.txt,ara||fatti acid composit||inflamm||fatti acid incorpor||concentr||data||patient||effect||section||human||proport||intervent||express||temperatur||cell||isotype-match control antibodi||protein||cytokin||fatti acid||activ||intestin inflamm||epa||fish oil||caco-2 cell||ibd||medium||vivo||result,2||1||acid||cell||1 fatti||fatti acid||1 express||fig. 2||4||caco-2 cell||4 2 fig. 3||phospholipid 1 1||total fatti acid||fatti acid OA||polyunsatur fatti acid,0.02||0.018||0.018||0.017||0.016||0.016||0.015||0.014||0.013||0.013||0.013||0.012||0.011||0.011||0.011,0.2,0.3,0.2
93,Mycorrhiza-4-1-2245993.txt,aggreg||effect||plug||chamber||1-octen-3-ol||signific inhibit||bodi||collembola||collembolan||speci||signific effect||methyl cinnam||sawahata,2||2 3 fig. 2 proisotoma||1 fig. 1 proisotoma minuta||proisotoma minuta||fig. 3 proisotoma||1991||1 month||2007 tricholoma matsutak proisotoma minuta T.||T. matsutak 1983 1991||method proisotoma minuta 1991 1994||tricholoma matsutak||cylindr chamber 1||T. matsutak 1991 1983 1983 2006||ecol||2001,0.03||0.025||0.025||0.023||0.022||0.018||0.017||0.016||0.015||0.014||0.014||0.013||0.013||0.012||0.012,0.0,0.0,0.0
94,Reprod_Biol_Endocrinol-1-_-153492.txt,regress||structur luteolysi||term||process||progesteron||corpu luteum||luteolysi||speci||molecular mechan||luteal regress||function luteolysi||cell||function,1||2002 1||5 1||2002||2002 1 terminolog||2002 96 2||2 ctelleri@usd.edu 1 depart||1 11 13||2002 5 4||2002 14 5||2002 35 3||tabl 1 result||novemb 2002||2002 0 7||2002 8 6,0.069||0.057||0.047||0.046||0.04||0.031||0.03||0.03||0.03||0.029||0.027||0.027||0.025||0.024||0.023,0.0,0.0,0.0
95,Ann_Hematol-2-2-1705486.txt,bone marrow microenviron||patient||cytogenet respons||addit chromosom abnorm||clinic trial||treatment||therapi||cytotox effect||month||complet suppress||complex karyotyp||unexpect effect||normal||myelodysplast syndrom||cytogenet remiss||transfus independ||lenalidomid||metaphas||case studi||hemoglobin||md patient||erythroid respons,patient||patient 1||patient 2||1||patient 3||patient 5||patient 4 1||5 1||4 patient||medic patient 3 1||md patient||patient 2 6||2004 1||2||2 3,0.044||0.039||0.035||0.034||0.034||0.033||0.03||0.028||0.028||0.027||0.027||0.027||0.026||0.025||0.024,0.2,0.1,0.13333333333333333
96,Oecologia-3-1-1915602.txt,host||root tissu||qualiti||studi||harvey||effect||root biomass||develop||mortal||indol glucosinol||foliar herbivori||parasitoid||adult||natur enemi||control||herbivor||glucosinol||insect cultur||insect herbivor||interact||root||larva||plant||result,1||1 1 depart||radicum||D.||T. rapa 1||2005||renn 1||plant||2||radicum 2005 2003||tabl 1||rapa 2005||2003||2005 2005 2005 2004||plant root,0.028||0.019||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.015||0.014||0.014||0.013||0.013,0.0,0.1,0.06666666666666667
97,Crit_Care-8-3-468887.txt,norepinephrin||flow||data||studi||patient||sepsi||splanchnic oxygen consumpt||gastric intramucos pH||effect||lower gastric phi||agent||increas||blood pressur||phi||shock||adrenerg drug||low-dos dopamin||splanchnic haemodynam||inflammatori respons||cardiac output||vasopressin||red blood cell transfus||splanchnic circul||epinephrin||iloprost||min||microcirculatori blood flow||dobutamin||cardiac index||group||fraction splanchnic blood flow||septic shock,2||2 3||2 gap||tabl 2||2 hsbf||2 14||2 15||2 gradient||2 38||2 72||2 51||2 56||2 30 28 31 2||1||2 10 16,0.031||0.022||0.021||0.017||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.014||0.014,0.0,0.0,0.0
98,Int_J_Biochem_Cell_Biol-1-5-1885942.txt,condit||kd||epiderm growth factor||liver phenotyp||sigma||western||ksfm||transcript factor||assay||de-differenti||GS||express||rt-pcr||dexamethason||day||urea product||liver function||pa||protein||ugt||differenti properti||dex||hepatocyt||keratinocyt serum-fre medium||cultur||rat hepatocyt||car||pituitari gland extract||medium||result,fig. 1||1||fig. 3 2||2005 fig. 2 fig. 2||cell||1998 fig. 1||fig. 6 2||2||1 min||2003 fig. 4||2 4 3 4 2||3||rabbit 1||1 week||hepatocyt,0.024||0.022||0.019||0.018||0.018||0.018||0.016||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014,0.0,0.0,0.06666666666666667
99,Arch_Dermatol_Res-3-1-1839867.txt,igg||igg subclass||acantholysi||pathogen||blister-induc potenti||complement||studi||patient||type vii collagen||predomin||autoimmun bullou diseas||subepiderm blister||relev||intracellular||pemphigu||subclass||epidermolysi bullosa acquisita||mice||leukocyt||bullou pemphigoid patient||autoimmun||autoimmun respons||blister format||activ||skin||autoantibodi||bullou pemphigoid||diseas||bullou system lupu erythematosu,1||2||desmoglein 3||2007||subclass||igg subclass||3 50||refer 1||diseas||3 31.||human diseas||diseas igg||igg||bullou pemphigoid igg subclass||fig. 4,0.019||0.015||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011,0.2,0.3,0.26666666666666666
100,Breast_Cancer_Res_Treat-3-1-2001219.txt,orr||first-lin endocrin therapi||respons||postmenopaus||ttf||letrozol||endocrin therapi||breast cancer||studi||patient||tamoxifen||diseas progress||superior||effect||aromatas inhibitor||metastas||earliest date||advanc breast cancer||signific||treatment||advers event||therapi||metastat diseas||random||analysi||first-lin therapi||post-menopaus women||surviv||clinic benefit||trial||diseas||signific improv||progress,breast cancer||cancer||metastat breast cancer breast cancer||breast cancer patient||trial breast cancer||metastat breast cancer cancer||1||advanc breast cancer||metastat breast cancer||primari breast cancer||human breast cancer||earli breast cancer||tamoxifen-resist breast cancer||oper breast cancer||metastasi breast cancer,0.026||0.024||0.021||0.02||0.02||0.02||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.017||0.017,0.2,0.2,0.13333333333333333
101,Med_Biol_Eng_Comput-4-1-2329737.txt,find||respons||myocardi oxygen balanc||adenosine-medi vasodil||adenosin||channel||vasodil||coronari circul||hypertrophi||flow perturb||heart failur||coronari resist vessel||coronari vasoconstrict||receptor||endotheli dysfunct||coronari vasculatur||parasympathet control||LV dysfunct||product||coronari arteriol||dysfunct||exercis||activ||myocardi infarct||decreas||influenc||vasodil influenc||heart||swine||coronari blood flow||vivo,2 2||2||1 2 1||1 2 receptor||max 2 fig. 2||2 71||heart||2 balanc||heart failur||coronari||atp||refer 1||tonino PA 2||23 1 23||coronari circul,0.037||0.037||0.03||0.024||0.023||0.021||0.02||0.02||0.017||0.016||0.014||0.014||0.013||0.013||0.013,0.0,0.2,0.2
102,Arch_Dermatol_Res-4-1-2254657.txt,chronic plaque-typ psoriasi||manifest||report||therapi||psoriasi||case||pustulosi||ppp||indic||treatment||psoriat arthriti||infliximab||patient||infliximab therapi||tnf||gpp||tnf-antagonist||pustular skin lesion||factor,1||case 1||discuss 1 1||2||fig. 1||refer 1||3||case 2||1 descript||case 3||case||psoriasi||case 4||dermatol||2 12,0.044||0.032||0.03||0.025||0.024||0.023||0.023||0.023||0.023||0.022||0.021||0.02||0.019||0.018||0.015,0.0,0.0,0.13333333333333333
103,Eur_J_Clin_Pharmacol-4-1-2426926.txt,placebo||tablet||level||dacp||time||week||men||plasma||lipoprotein||concentr||baselin||studi||cholesterol||plant stanol||urinalysi||increas||hypercholesterolemia||higher dose||event||dose||treatment||advers event||blood sampl||singl dose||sitostanol||phase||pharmacokinet||subject||placebo group||stanol||phase 2||physic examin||activ||group||decreas||dasp||fm-vp4||plant sterol||stanol-contain product||low-dens lipoprotein cholesterol||dose group||ldl-c||safeti,1||1 2||2 1||2||2 2||day 1||day||phase 1||3 day||1 1 depart||phase 2||3||3 3||drug 1||tabl 1,0.026||0.025||0.025||0.023||0.023||0.023||0.02||0.019||0.018||0.018||0.018||0.016||0.016||0.015||0.015,0.0,0.0,0.06666666666666667
104,Eur_Arch_Otorhinolaryngol-4-1-2254469.txt,diagnost protocol||find||clinic sign||aspir||standard endoscopi protocol||ventil||ill patient||oral feed||endoscop assess||fee||studi||patient||oral diet||tracheotomi||risk||liquid bolu||naso-gastr tube||examin||swallow||evalu||deglutit||acut symptom||assess||popul||pharyng||fee find||silent aspir||rapid evalu||procedur||compensatori treatment procedur||decis||clinic studi||icu||percutan endoscop gastrostomi,patient||4||2||1 2 3 4||1||2 2 3||ill patient||553 patient||trauma patient||1 symptom||70 patient||patient characterist||patient âs||913 patient||95 patient,0.03||0.027||0.024||0.023||0.023||0.022||0.02||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.015,0.2,0.2,0.13333333333333333
105,Behav_Brain_Res-2-1-2424131.txt,delay||data||opfc||orbit prefront cortex||effect||lamp||lesion||inter-tempor choic||weber fraction||behaviour||rat||disconnect lesion||delay discount||sham-les group||phase||experi||curv||linear indiffer function||acbc||sucros solut||lever||light||callosotomi group||choic||group||size||callosotomi||signific differ||trial||reinforc||prefer function||result,fig. 1||fig. 3||fig. 2||1||1 1||fig. 4||3||fig. 1 É||NJ fig. 1||2||2 2 2 2||É fig. 4||fig. 4 É||prefer function fig. 1||fig. 5 opfc nucleu,0.028||0.027||0.025||0.023||0.023||0.023||0.022||0.02||0.019||0.018||0.018||0.016||0.016||0.016||0.013,0.0,0.0,0.0
106,J_Mol_Biol-1-5-2291451.txt,mechan||core||Ig||nativ state||pack||data||mutat||contact||nucleu||tnfn3||structur||fibronectin type iii||domain||fold||greek key topolog||residu||protein||cafn2||strand||loop||immunoglobulin||mutant||oblig||layer||interact||transit state||sheet||fniii,"figur 1||figur 2||figur 6 figur 1||figur 3||figur 5 figur 1||1||figur 8 figur 3||figur 4||figur 6||figur 7||tabl 2 figur 3||2||figur 1 35,36||figur 2 16,18||tabl 1",0.032||0.03||0.028||0.027||0.027||0.026||0.025||0.024||0.024||0.023||0.023||0.022||0.022||0.021||0.02,0.0,0.0,0.0
107,Purinergic_Signal-3-4-2072918.txt,antibodi||entpd||transfect||purinoceptor||immunoprecipit analys||purinerg||genet immun||protein||immun||result||antipeptid antisera||ecto-enzym||antisera||express||western-blot analys||analys||cell||member||monoclon antibodi||famili,1||cell||1:1600 1||2||1:800 1||1 Î¼g||2007 1 4 7||1:2000 1||refer 1||4||5446 rb 1||7 6 cell||cell surfac||cell function||6 5 cell,0.044||0.028||0.027||0.026||0.025||0.024||0.024||0.023||0.023||0.022||0.02||0.019||0.019||0.019||0.018,0.2,0.1,0.06666666666666667
108,J_Headache_Pain-4-1-2245992.txt,horizont deviat||horizont plane||cerebellum||cerebellar||neuromuscular junction||studi||cerebellar function||movement||singl fiber emg||nmj||migrain||aura||neuromuscular transmiss||mcd||channel||patient||function||median valu,1||headach||12 1 fig. 1||suppl 1||refer 1||migrain headach||headach pain||isernia itali 2 headach||3 fig. 3||2 10 fig. 2 experiment setup||2000 85 1||headach clinic||13 14 2||headach disord||migrain,0.04||0.027||0.024||0.023||0.022||0.021||0.02||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.015,0.0,0.0,0.06666666666666667
109,Diabetologia-4-1-2270364.txt,type 2 diabet||level||diabet||studi||pgc-1Î±||non-diabet donor||insulin secret||oxid phosphoryl||human||insulin releas||dna methyl||express||sirna||human diabet islet||gene||beta cell function||pancreat islet||usa||human islet||GK rat||islet||insulin resist||gene express,ppargc1a||ppargc1a ppargc1a ppargc1a||ppargc1a ppargc1a||ppargc1a ppargc1a ppargc1a 2||ppargc1a ppargc1a 1 ppargc1a||ppargc1a ppargc1a ppargc1a ppargc1a ppargc1a express||1 ppargc1a ppargc1a||2 ppargc1a||method ppargc1a ppargc1a ppargc1a ppargc1a||1 ppargc1a||ppargc1a ppargc1a express||7 ppargc1a ppargc1a ppargc1a ppargc1a express||hypothesi ppargc1a ppargc1a ppargc1a ppargc1a express||7 ppargc1a ppargc1a||ppargc1a 2 18 ppargc1a,0.059||0.059||0.059||0.054||0.052||0.051||0.05||0.049||0.048||0.045||0.043||0.042||0.041||0.041||0.04,0.0,0.0,0.0
110,Mol_Syst_Biol-4-_-2387231.txt,physic complex||set||measur||method||human protein||physic associ||microarray||data||comparison||likelihood||cold aceton||correl||human||tendenc||test||complex||ortholog||valid||ortholog gene||mass spectrometri||gene||control||cce||yeast||annot||protein||pair||analysi||accuraci||associ||nuclear export||distribut||co-express||posit||interact||score,figur 2||figur 3||figur 4||figur 6||figur 7||figur 8||figur 7D||figur 3A||figur 4C||protein||figur 6B||2004 supplementari figur 2||supplementari figur 7||2005 figur 7B figur 7B||supplementari materi supplementari figur,0.023||0.022||0.02||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.015||0.015,0.0,0.1,0.06666666666666667
111,Dev_Genes_Evol-4-1-2265772.txt,annelid||worm||glutamin synthetas||myohara||amino acid ident||express||ejg||ovari||sequenc||regener,gs||japonensi||gs E. japonensi 2006 E. japonensi||gs gene||2||E. japonensi 2006 1993||gs right-hand||enchytraeu japonensi||xenopu 1995 gs E. japonensi regener||enchytraeu japonensi 1999 E. japonensi 1999||1||50 Î¼m E. japonensi||discuss E. japonensi glutamin synthetas||E. bigeminu||1991 gs C.,0.048||0.043||0.038||0.03||0.027||0.026||0.025||0.025||0.025||0.024||0.022||0.022||0.021||0.02||0.018,0.0,0.0,0.0
112,Matern_Child_Health_J-2-2-1592148.txt,chronic hypertens||import opportun||program||etiolog pathway||care coordin||week||infant||hypertens||birth||pregnanc||problem||locat||matern||weight problem||recurr||folic acid||risk assess||effect||internat care||internat visit||nutrit risk||postpartum care||health promot||intervent||content||addit support||psychosoci support||resourc||internat period||health||servic coordin||preconcept care||women||research||preterm birth||clinic intervent||servic||preterm deliveri||famili||import||visit||access||support||six-week postpartum visit||on-go care||oral health servic||children,health||health care||care||2||internat care||health risk||intervent||1||internat intervent||clinic intervent 1||special health care||clinic intervent||famili health||health promot||subsequ internat care,0.016||0.016||0.015||0.014||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.01||0.01||0.01||0.01,0.4,0.3,0.3333333333333333
113,Immunogenetics-3-1-1914236.txt,gene||snp||result||celiac diseas||appli biosystem||analysi||genet associ||sampl||express||studi||dutch popul||famili,spink4||spink spink4 spink4 spink4 spink4||spink4 spink4 spink spink4||spink spink4 spink4||1||2||spink spink spink1 2 5 spink4||diseas||1 spink haplotyp||fig. 2 spink||2 spink tabl 2 spink4 snp||desmoglein 1||celiac diseas||diseas express||spink4 sequenc analysi,0.033||0.032||0.032||0.032||0.032||0.024||0.024||0.023||0.021||0.02||0.02||0.016||0.016||0.016||0.014,0.0,0.0,0.06666666666666667
114,Diabetologia-3-1-1914278.txt,vascular vulner||diabet mellitu||diabet||arteri wall||patient||carotid arteri||cimt||type 1 diabet||sex||plasma hyaluronan||hyaluronan||present studi||endotheli glycocalyx||glycocalyx||control||age||subject||plasma hyaluronan level||hyaluronidas||intima-media thick||imag analyst,1||diabet||type 1 diabet||type 1||type 1 diabet patient||1 1c 2||uncompl type 1 diabet||refer 1||1 demograph||0.05 type 1||diabet control||0.01 type 1||diabet mellitu||result 1 1c||control fig. 1,0.044||0.034||0.032||0.031||0.026||0.025||0.024||0.023||0.022||0.021||0.021||0.021||0.02||0.019||0.018,0.4,0.2,0.2
115,Methods-1-5-1895922.txt,method||indic||concentr||fischer suppli||serial dilut||purifi compound||bacteri strain||microtitr plate||extract||assay||strain||compound||antibiot||resazurin||solut||minimum inhibitori concentr||test materi||mic||bacteri speci||crude extract||antibacteri assay||number||natur product||resazurin method||result,1||2||fig. 1||1 2 3||fig. 1 tabl 1 tabl 2||tabl 1 mic||fig. 2 structur||1 euonymu europaeu||1 centaureum erythraea||1 chrysanthemum segetum||serial dilut 1 introduct||tabl 2 direct comparison||3||resazurin||3 result,0.062||0.045||0.044||0.042||0.039||0.031||0.025||0.023||0.023||0.023||0.019||0.019||0.019||0.017||0.017,0.0,0.0,0.06666666666666667
116,Planta-4-1-2270920.txt,cytosol||metabolit||sugar alcohol concentr||peach||non-aqu fraction||siev tube||subcellular distribut||studi||myo-inositol||sugar alcohol||leaf cell||phloem||compart||sourc||mannitol||common plantain||leav||ratio||sucros||leaf||subcellular compart||vacuol||sugar||mesophyl cell||sea plantain||distribut||sorbitol||celeri||apoplast||speci||fructos||activ transport||stroma||plant,plant||1||1 3||1 concentr||3||4||4 4||plant leav||concentr||plant speci||sucros concentr||plant carbohydr||plant physiol 153:91||physiol plant 101:489||plant sampl,0.022||0.019||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.012,0.2,0.1,0.06666666666666667
117,Purinergic_Signal-4-2-2377319.txt,atp||cyclic nucleotid||ideal||synaps||purinerg||nucleotid||tissu||atp releas||receptor||releas||introductori articl||receptor channel||adenosin||nucleosid||microenviron||cell,1||4||purinerg||purinerg signal purinerg||purinerg signal||1 4 3 4 5 6||2||extracellular purinerg signal||refer 1||paracrin purinerg signal||autocrin purinerg||11 12 5 6 purinerg||autocrin signal||cell||paracrin purinerg,0.028||0.028||0.024||0.024||0.024||0.022||0.018||0.017||0.017||0.016||0.014||0.013||0.013||0.013||0.013,0.2,0.1,0.13333333333333333
118,Bioinformation-1-5-1891680.txt,pfm||sequenc motif||promot||user||web server||sequenc||server||motif||pmsearch||transcript factor,1||2||1 2 3||2006||5||bioinform 1||tabl figur 1||4||3||4 5 6 7||user interfac figur 1||2006 biomed informat publish group 2006||methodolog 4 6 9||2006 34 d95 16381983 4 carthariu||predict bind site,0.067||0.054||0.051||0.047||0.04||0.038||0.035||0.034||0.032||0.028||0.027||0.021||0.02||0.018||0.015,0.0,0.0,0.0
119,Dev_Biol-2-1-2098691.txt,anim||endoderm gene express||transgen||depend||sox site||element||tgf-Î²||effect||direct target||promot element||gfp fluoresc||region||promot||site||lane||veget||express||downstream||gene||endoderm||direct effect||transcript||endoderm differenti||gfp||bind||sox17||vegt||emsa||gastrula||endoderm element||construct||sequenc||network||result,1||fig. 2 fig. 1||xsox17Î± 1||xsox17||xsox17 xsox17||1 gene||xsox17 fig. 4||supplementari fig. 2||1 xsox17 transcript||2||2 2||1 transgen||1 xsox17 schlosser||1996 fig. 1 supplementari tabl 1||e-el fig. 3 fig. 3,0.03||0.027||0.023||0.023||0.023||0.021||0.021||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.017,0.0,0.0,0.0
120,Exp_Brain_Res-3-1-1914230.txt,variat||task constraint||role||trial block||kinemat paramet||heavi||target area||experiment condit||joint action||studi||interperson transfer||joint-act coordin||target region||high speed||effect||observ||action observ||mass||analys||interperson transfer effect||present studi||fittsâ law||experiment task||cylind||task||experi||dyad||repetit||weight||actor||transfer||data analys||size||trial||tabl||movement||particip||area||coordin||object||speed,2||1||2003||1 NS||1 NS object||2 2 show||2 object size||2 role||object||2004 2003||1 NS object size||2 fig. 5||2 result||1 NS role||dyad 1,0.024||0.023||0.018||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.0,0.1,0.06666666666666667
121,Angiogenesis-4-1-2268723.txt,blood suppli||endotheli cell||vasoprolif respons||host||folkman||effect||develop||neovascular||angiogenesi||evid||cell||growth||day||tissu||mice||judah folkman||activ||factor||tumor||vessel||cam||antiangiogen activ||blood vessel||molecul,1||3||tumor||3 6 3||tumor angiogenesi||tumor cell||1 mm||3 day||1 week||tumor growth||human tumor||3 week||1 angiogenesi inhibitor||tumor tissu||13 3,0.026||0.025||0.023||0.019||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014,0.2,0.1,0.06666666666666667
122,J_Biol_Inorg_Chem-3-1-2039866.txt,reaction||bi||attempt||structur||spectrum||sodium pyruv||precipit||solut||complex||chemic||differ fourier map||calc||zinc||signal||reaction mixtur,2 2 2||2 2||2||2 2 2 2||2 2 2 2 2 2||2 2 2 2 1 2||2 2 2 1 2||1 2 2 2 2||2 2 2 2 2 Pr||5 2 2 2 2||2 2 asterisk 2||2 2 2 35||2 2 Pr||2 2 34||38 2 2,0.104||0.104||0.104||0.104||0.104||0.094||0.092||0.092||0.088||0.085||0.078||0.078||0.072||0.07||0.07,0.0,0.0,0.0
123,Health_Qual_Life_Outcomes-2-_-395842.txt,measur||instrument||commun||well-b||rate||qualiti||patient||year||contact||life||cognit rate scale||scale||nurs||dementia||behaviour||sever dementia||item||approach||daili live||assess||mobil||bcr||activ||old-old patient||factor||physician||barthel index||neg affect||life measur||global deterior scale,item||2||barthel item 2||65 item||item level||core item||4 item sever||barthel item 3||item nurs physician 1||barthel item 4||barthel item 5||barthel item 10||nurs barthel item 1||barthel item 9||1,0.032||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015,0.2,0.1,0.06666666666666667
124,Eur_Radiol-2-2-1705470.txt,prospect studi||case||gastric tumor||endolumin RF coil||mri||carcinoma||histopatholog stage||studi||gastric wall||gastric region||gastric wall layer||experiment studi||tumor volum||inform||sensit||cardia||lymphoma||lesion||magnet reson imag||coil concept||suffici imag||suffici detail||serosa||lymph node||opposed-phas sequenc||diffuse-typ gastric carcinoma||factor||tumor||layer||signal intens||imag techniqu||gastric carcinoma||gastric wall differenti||sequenc||intermedi||stage||vivo,1||1 1 2||1 2||4 1||2||2 2||T1 1 2 1||3 2||4||3||4 T2 1 13 1||15 1||sensit 1||refer 1||2 3 4 5 6,0.036||0.033||0.032||0.028||0.028||0.028||0.026||0.024||0.021||0.021||0.021||0.02||0.019||0.019||0.018,0.0,0.0,0.0
125,Pediatr_Nephrol-4-1-2335291.txt,cathet||dryness||capac||boy||indic||peni||birth||patient||year||risk||overact||pelvic floor||stoma||high detrusor pressur||upper urinari tract||pressur||bladder||approach||girl||age||abdomin approach||subject||surgeri||antimuscarin||renal function||high bladder pressur||cic||suspens||detrusorectomi||bladder neck||urinari contin||incontin||good result||spina bifida||children||result,1||1 year||28 1 fig. 1||2||suppl 1||refer 1||bladder 2 2 21 fig. 2||patient||bladder||year||3 fig. 3||3 year||9 year||2 month||3,0.032||0.024||0.021||0.021||0.02||0.017||0.017||0.016||0.016||0.016||0.014||0.014||0.013||0.013||0.013,0.0,0.3,0.2
126,Cancer_Causes_Control-2-2-1705485.txt,hair||incid rate||ear||melanoma||rate||data||hair cover||femal||neck||site||face||women||age||invas melanoma||incid||chang||australia||differ||younger women||scalp||sun exposur||solar UV exposur||solar ultraviolet radiat||hypothesi,1 1||1||2||2 2||australia 1||fig. 1||1 1 queensland institut||1 fig. 1 measur||refer 1||2006||cancer||melanoma||queensland 4029 australia 2 school||australia||8,0.05||0.05||0.042||0.042||0.033||0.031||0.03||0.03||0.028||0.025||0.018||0.016||0.016||0.016||0.015,0.0,0.0,0.13333333333333333
127,Eur_J_Appl_Physiol-3-1-1782100.txt,efl||control||blood||time||averag 52||debt||limit||recoveri||cardiac output||exercis||data||compon,2 2 2||2 2||2||2 2 2 2||2005a 2 2 2 2||1 2 2||2 kinet 2 2 2||2001 2 2||2 1||1 2||2 fig. 2||2 2 debt||flow measur 2 2 2 2||5 2||2 5,0.059||0.059||0.059||0.059||0.05||0.049||0.048||0.045||0.044||0.044||0.042||0.042||0.041||0.039||0.039,0.0,0.0,0.0
128,Pediatr_Nephrol-4-1-2413095.txt,chronic kidney diseas||ra||ckd||CV abnorm||tissu ra||data||studi||renal diseas||patient||allel||risk||pediatr ckd popul||pediatr||increas||gene polymorph||renal||human genom||genotyp||natur||gene||cytokin||polymorph||popul||associ||whole-genom associ studi||genet||factor||snp||atherosclerot CV abnorm||potenti weak||CV diseas||function||error||diseas||haplotyp||preliminari evid||gene express||progress||kidney||cardiovascular diseas,studi||1||1 gene||gene||1 gene polymorph||gene associ studi||associ studi||2||kidney||genet associ studi||gene polymorph associ studi||kidney diseas||gene polymorph||studi type||diseas,0.019||0.018||0.016||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.011,0.4,0.3,0.3333333333333333
129,Eur_J_Pediatr-3-1-2151776.txt,pertussi control||case||infant||pertussi||strategi||childhood diseas||review||increas||adult||newborn||countri||infect||laboratori diagnosi||immun||vaccin strategi||incid||univers immun||cultur||ill||pcr||adolesc||diseas||diagnosi||laboratori techniqu,pertussi||8||8 17 8||pertussi infect||1||8 17 8 13 17||adult pertussi||B. pertussi 24 B. pertussi 24||pertussi control||8 17 31||acellular pertussi||pertussi epidemiolog||8 17 27||pertussi incid||prevent pertussi,0.029||0.023||0.022||0.021||0.021||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.016,0.2,0.2,0.13333333333333333
130,Oecologia-4-1-2311384.txt,competit||concentr||studi||valu||hollow||competit abil||effect||water||bog||increas||cover chang||site||northern||mixtur||temperatur||signific interact||treatment||water level||growth||product||posit effect||biomass product||evapor||global warm||northern site||competit advantag||experi||greenhous||bulk densiti||differ||height||height increment||speci||water tabl,S.||S. balticum S.||S. fuscum S.||S. fuscum S. balticum S.||S. magellanicum S. balticum S.||sphagnum S. balticum S.||S. balticum||S. balticum S. magellanicum S. balticum||S. balticum S. fuscum||S. balticum S. magellanicum||S. magellanicum S. balticum||S. fuscum S. balticum S. fuscum||2 S. balticum S.||S. fuscum||S. balticum S. magellanicum S. cuspidatum,0.069||0.053||0.052||0.049||0.049||0.046||0.046||0.045||0.045||0.044||0.044||0.044||0.043||0.043||0.043,0.0,0.0,0.0
131,Histochem_Cell_Biol-4-1-2248605.txt,type||transport vesicl||imag||endo-lysosom system||studi||endosom||lysosom||cargo||observ||lysosom membran protein||complex||direct pathway||receptor||gga||transport||cell||cd-mpr||enzym||protein||tgn||mannos 6-phosphat receptor||electron microscopi||literatur||escrt||factor||subdomain||specif compart||machineri||acid phosphatas||acid phosphatas activ||function||distinct stage||compon,cell||cell 1961||cell âs||cell biolog||kidney cell||live cell||cell line||exp cell||mammalian cell||hepg2 cell||cell biologist||endosom||histochem cell biol histochemistri||endosom 3||3,0.032||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.015||0.015,0.2,0.1,0.13333333333333333
132,Eur_Child_Adolesc_Psychiatry-3-1-1914287.txt,attent||social commun||high level||level||boy||behavior||infant||sex differ||children||problem||princip compon analysi||sampl||data||studi||young age||develop||pearson correl||social commun problem||stabil||problem behavior||earli age||common||aim||analys||inhibit||item||age||parent||older children||dimens||factor||order||commun sampl||compet||work||total problem score||score||infant develop||result,1||2||3 1||behavior||score 1||1 25 2||refer 1||behavior problem||problem behavior||phd 1 2 1 dept.||1 common||1 14 month 19 month||problem||2 fig. 1 transit||develop problem behavior,0.031||0.021||0.02||0.02||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.016||0.015||0.014||0.014,0.2,0.2,0.2
133,Eur_Radiol-2-2-1705545.txt,excel||coronari angiographi||low vessel opacif||protocol||diamet||bpm||high preval||imag||interv||studi||patient||data analysi||calcif||imag qualiti||diagnost accuraci||low signal-to-nois ratio||agatston score||extens coronari calcif||heart rate||motion artifact||heart rate control||high pre-test probabl||dsct||signific stenos||data acquisit||accuraci||popul||entir heart||nonenhanc dsct||cad||ica||dual-sourc CT||vessel||coronari arteri||coronari arteri stenosi||segment||score,1||1 2||2||2006||1 2 3 4||patient||springer-verlag 2006 2 2||1 1 institut||segment 1||score||angiographi 2||2 9||coronari arteri||27 2||refer 1,0.024||0.024||0.024||0.019||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.013||0.013,0.0,0.2,0.2
134,Int_Arch_Occup_Environ_Health-3-1-1915645.txt,measur||level||time||higher level||passiv leisur||sampl||qualiti||studi||hypothesi||gener questionnair||home activ||worker||weekend||recoveri||variabl||activ leisur activ||hour||analys||sleep complaint||respect||diari studi||higher score||pleasur||effort||relationship||associ professor||high-effort group||experi||employe||job||activ||home||workday||group||differ||single-item report mark||particip||fatigu||support||partner||neg affect||daili basi||ancova||report mark||result,work||work activ||activ||1||2||work time||activ time||activ home activ||activ leisur activ||work activ particip||13 work activ||specif work activ||separ work activ||research activ||2005,0.023||0.023||0.023||0.022||0.02||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.015,0.2,0.2,0.13333333333333333
135,Pediatr_Radiol-4-1-2292499.txt,csf||find||flow||infant||complic||subarachnoid space||import role||extra-axi fluid collect||doppler||studi||patient||sonographi||brain sulci||mening||bacteri mening||ventricul||brain||evalu||earli abscess||fluid||ventricl||postinfecti hydrocephalu||neurolog find||subdur effus||central nervou system infect||diagnosi||children,2 1 depart||fig. 2 arrowhead||refer 1||mening||1 week||springer-verlag 2008 introduct 1 2 4||studi||bacteri mening||38039 turkey 2 depart||16 21 28 16||bacteri||pu fig. 4||11 59 fig. 11||initi studi||neonat bacteri mening,0.026||0.021||0.017||0.017||0.017||0.017||0.016||0.015||0.013||0.013||0.012||0.012||0.011||0.011||0.011,0.2,0.3,0.2
136,J_Abnorm_Child_Psychol-3-1-1915605.txt,condit||neg evalu outcom||measur||find||pre-adolesc children||higher level||depress symptom||respons||mood||time||cdi||social||self-verif||studi||depress||subsequ||peer||effect||self-verif theori||prefer||failur||adult||control condit||evid||analys||state mood||success||real time||feedback||chang||highest score||contest||lowest total score||interact||particip||feedback prefer||peopl||score||children||neg feedback subsequ,1||feedback||2||peer feedback||time 1||feedback manipul 2||neg feedback||feedback prefer||children âs feedback||depress||feedback manipul||3 feedback prefer||feedback condit||time 2||posit feedback,0.021||0.021||0.017||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012,0.2,0.3,0.2
137,Behav_Processes-2-1-2396234.txt,anim||measur||respons||neophilia||time||hole-board||valid measur||studi||central area||frequenc||explor||increas||hole||sex||rodent||head-dip||behaviour||male||rat||head-dip behaviour||research||mice||previou studi||environ||exposur||open field||presenc||trial||apparatu||area||avers condit||object||locomot||result,"fig. 1||tabl 1||trial 1||fig. 2||fig. 3||1,14 tabl 1||post hoc fig. 1||2006||2 materi||trial||4 cm||behaviour||28 cm||behavior||2008",0.017||0.015||0.015||0.013||0.011||0.01||0.01||0.009||0.009||0.007||0.007||0.007||0.007||0.007||0.007,0.0,0.1,0.13333333333333333
138,Eur_Radiol-3-1-2077908.txt,grade||find||time||OA||imag||studi||patient||multipl joint site||total||lesion||womac||cyst||bone marrow edema-lik||anatom locat||pain||associ||chang||bme||decreas||bone||size||knee||total size||diseas||progress,2||1 2||2 year 2||2 year||1||result 1 2 1||3||2 2 fig. 2a||nex 2||3 mm||3 3 3 fig. 3||albinusdreef 2||2 3 4 6 7 5||2 mm slice thick||5 mm,0.047||0.038||0.037||0.033||0.03||0.028||0.028||0.025||0.025||0.024||0.024||0.024||0.022||0.02||0.019,0.0,0.0,0.0
139,Eur_J_Epidemiol-4-1-2413078.txt,mortal||immigr||inform||earlier life condit||german pension scheme||germani||pension insur||foreign||death rate||popul||migrant mortal||host popul||data||death||studi||countri||pension||migrant||migrant background,1||1 1||1 6 1 2 7||2||3||1 comparison||refer 1||mortal||1 8 fig. 1 14 5||migrant mortal||popul||migrant popul||1 1 max planck institut||migrant||migrant health,0.035||0.035||0.023||0.022||0.021||0.02||0.019||0.018||0.018||0.017||0.016||0.016||0.016||0.015||0.015,0.0,0.2,0.26666666666666666
140,Mol_Immunol-1-5-1995235.txt,role||primer||studi||perfus||specif role||blood contamin||blood cell||analys||spermatozoa||testi||cd59a||gene||absent||tissu||protein||motil||liver||mous||abund express||mac||cd59b||mrna||acrosom||amplif||result,fig. 2||1||fig. 3||2006 fig. 1 fig. 1||fig. 6||2004 fig. 2 qin||2004 fig. 4||tabl 1||2004 5 fig. 3 5||2004 tabl 1||2006 fig. 3||4 fig. 3 qin||2004 tabl 2||2004||tabl 1 primer,0.027||0.025||0.024||0.024||0.021||0.02||0.02||0.02||0.019||0.019||0.018||0.018||0.017||0.017||0.016,0.0,0.0,0.0
141,J_Med_Internet_Res-8-4-1794003.txt,geriatr medicin||age-specif search term||databas||exp adult||combin||strategi||hand search||age-specif search strategi||mesh term||research assist||sensit||studi particip||three-term strategi||adult||journal||specif||term||clinician||obstetr||absolut decreas||clinic specialti||medlin||medicin||textword||combin term||precis||particip||neonat medicin||year 2000||articl,1||tabl 1||1 3||1 month||search||tabl 2||1 hayn||tabl 1 comparison||search term||1 month infant||search strategi||3||tabl 1 4 17 4||12 year||tabl 8,0.035||0.027||0.026||0.023||0.023||0.022||0.021||0.019||0.017||0.017||0.016||0.016||0.016||0.015||0.015,0.0,0.0,0.0
142,J_Gastrointest_Surg-3-1-1852385.txt,diverticul||author||case||complic||data||studi||patient||sigmoid diverticul||colon||elect surgeri||recurr episod||signific||diverticular diseas||oper||surgic manag||perfor diverticul||fistula||attack||surgeri||acut diverticul||high rate||surgeon||resect||perfor||procedur||diseas process||diseas||diagnosi,1 1||patient||diseas||1 13 14 1||studi||diverticular diseas||4||young patient||2 10||colon||1 clinic symptom||refer 1||3 11||diverticul||5,0.024||0.02||0.018||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.012,0.6,0.5,0.4
143,Pediatr_Nephrol-4-1-2259257.txt,level||sdn||gfr||control group||studi||year||patient||steroid||rang 2||renal biopsi||treatment||biopsy-proven mcn||csa||studi group||glomerular filtrat rate||drop||remiss||month||renal function||mcn||csa toxic||chronic renal failur||minimal-chang nephrot syndrom||long-term treatment||nephrotox||latest follow-up||function,2 2 2||2 2 2 2||2 2||2||2 5 12 2 2||1 2||2 19 2||result 2 2 2 1 1||fig. 2||rang 2||18 20 2 2||5||12||8 23 2 23||1,0.045||0.045||0.045||0.045||0.038||0.034||0.033||0.031||0.03||0.029||0.027||0.027||0.027||0.026||0.024,0.0,0.1,0.06666666666666667
144,Breast_Cancer_Res_Treat-3-1-2096638.txt,surviv||section||fancd2||prolifer||case||immunohistochemistri||hereditari invas breast cancer||percentag||sporad breast cancer||breast cancer||express||patient||brca1||brca||cell,1||1 1 depart||1 2 3||2||cancer||breast cancer||breast||23 2 2||refer 1||result 1 fig. 1 exampl||3||1 patient characterist||tabl 2||sporad breast cancer||7 1 8,0.035||0.025||0.025||0.024||0.021||0.02||0.019||0.019||0.019||0.016||0.015||0.015||0.015||0.014||0.014,0.0,0.1,0.13333333333333333
145,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-4-1-2335287.txt,uterovagin prolaps||follow-up period||effect size||complic||qualiti||studi||life||anatom outcom||prolaps||domain||bothersom symptom||standard questionnair||symptomat pelvic organ prolaps||urinari leakag||outcom||valid questionnair||urogenit symptom||women||posterior compart||pain||sacrospin ligament||surgeri||recurr cystocel||urinari incontin||sacrospin ligament fixat||sacrospin hysteropexi||symptom||function outcom||follow-up time||procedur||score||pelvic organ prolaps||result,2||1||stage 2||3||women stage 2||2 complic||rang 2||cystocel stage 2||2 week 5||rectocel stage 2||2 week 8||2 week 15||result 1||colporrhaphi 1||1 patient characterist,0.031||0.023||0.023||0.019||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.014||0.014,0.0,0.0,0.0
146,J_Chem_Ecol-4-1-2373414.txt,lima bean||control||odor bind protein||efn secret||compound||lanolin past||signal||heil||plant||voc,2008||2||2006||2006 2006||1||2006 fig. 1||lunatu 2006 2007||2004 2005 2005||germani 3 depar||present studi||phytol 2008 178 41 61 10.1111||CP 36821 guanajuato mÃ©xico 2 depart||2007 2001||universitÃ¤tsstraÃ 5||2006 94 619 628 10.1111,0.049||0.041||0.035||0.035||0.034||0.028||0.017||0.016||0.016||0.014||0.012||0.011||0.011||0.011||0.01,0.0,0.0,0.0
147,Rev_Endocr_Metab_Disord-3-1-1894829.txt,type||diabet||children||patient||young age||clinic featur||gck||present||test||guidanc||insulin||sulfonylurea||featur||treatment||low dose||gene||glucos||age||young adult||kir6.2||neonat diabet||famili||resist||monogen diabet||lower part||pndm||diagnosi||modi||syndrom||result,diabet||2 diabet||diabet patient||type 2 diabet||neonat diabet||type 1 diabet||monogen diabet||famili diabet||diabet mellitu||diabet phenotyp||maturity-onset diabet||diabet autoimmun||early-onset diabet||diabet rang||type-ii diabet,0.04||0.029||0.023||0.023||0.023||0.023||0.023||0.022||0.022||0.021||0.02||0.02||0.02||0.02||0.02,0.4,0.3,0.2
148,Breast_Cancer_Res_Treat-3-1-2096637.txt,ilc||morpholog||author||calcul||find||case||mammographi||lesion size||convent imag||mri||data||studi||seri||valu||addit lesion||patient||dynam curv analysi||non-mass-lik lesion||small studi||correl||sensit||enhanc||lesion||magnet reson imag||mass||surgic manag||treatment||underestim||invas lobular carcinoma||meta-analysi||ultrasound||high variabl||foci||domin mass||addit find||chang||literatur||tumor||size||breast||irregular||detect||result,1||1 denot 1||2 2 3 1||2||2 2||1 patient||1 2 2 0||2 2 1 0||20 1||1 denot||2 2 2 0||2 0 0 1||1 characterist||refer 1||1 5 6 1 5 7,0.034||0.024||0.022||0.022||0.022||0.022||0.022||0.022||0.019||0.019||0.019||0.018||0.018||0.017||0.016,0.0,0.0,0.0
149,Hernia-4-1-2231409.txt,ta||time||method||mesh fixat techniqu||complic||insert||studi||recurr||standard techniqu||crown||laparoscop repair||incision hernia||oper||straightforward repair||oper time||fixat techniqu||puh||studi group||tacker||group||hernia||differ||fixat||lrvih||techniqu,1 min||refer 1||1 day||patient||6||2||springer-verlag 2008 introduct 1||hernia hernia||hernia||studi||138 patient||8 min||6 week||54 patient||84 patient,0.048||0.039||0.039||0.037||0.037||0.032||0.029||0.027||0.027||0.025||0.024||0.024||0.022||0.022||0.022,0.0,0.2,0.13333333333333333
150,Ann_Biomed_Eng-4-1-2239251.txt,shear load||muscl||joint||spinal load||sij stabil||sij||model||sij compress||pelvic floor||increas||slouch||pelvic region||gluteu mediu||present studi||simul model||pelvic floor muscl||sacroiliac joint||vertic sij shear||load||trunk||leg||biomechan analysi||pain||coxal bone||simul||direct||activ||pelvi||bone||pelvic muscl||ligament||postur||trunk load||sij compress forc||maximum muscl stress||sacrum||result,M.||1 1||1||muscl||1 22 M.||1 30 M.||muscl forc||1 3 M. adductor||2||2 2||M. coccygeu||M. psoa||gurp M.||M. multifidu||M. nordin,0.034||0.025||0.025||0.025||0.021||0.02||0.019||0.018||0.018||0.018||0.018||0.017||0.017||0.017||0.017,0.2,0.1,0.06666666666666667
151,Eur_Arch_Otorhinolaryngol-3-1-2099162.txt,tumour||adenocarcinoma||case||neck region||metastas||head||metastat tumour||palatin tonsil||rout||common origin||metastasi||primari adenocarcinoma||patient||oesophagu||tonsil||tumour cell,1 1 depart||netherland 2 depart||refer 1||2 mooi wolter||ulcer fig. 2 biopsi||9 2 10 6 6 9||discuss 4||netherland 3 depart||10||3 renÃ© leeman||springer-verlag 2007||6||oesophag adenocarcinoma struij bram 1||31-20-4443688 r.bree@vumc.nl 1 van groeningen corn||case report,0.05||0.037||0.036||0.03||0.028||0.028||0.027||0.027||0.022||0.02||0.018||0.017||0.017||0.015||0.014,0.0,0.0,0.0
152,Pediatr_Nephrol-3-1-1805049.txt,calcif||sodium thiosulf||hu||acut renal failur||week||soft tissu||calcif urem arteriolopathi||hemolyt urem syndrom||patient||calcium,refer 1||ipna 2007 introduct 1 2||1 month show||radiotrac activ fig. 2||type 2 diabet||84101 israel 2 depart||case report 3 4 5||ipna 2006 99 tc-mdp||patient||endotheli cell||dialysis-depend patient||2006 21 484 490 10.1359||report transient||8 9 10||abnorm find discuss 6 7,0.032||0.029||0.024||0.021||0.021||0.018||0.016||0.016||0.016||0.015||0.014||0.012||0.012||0.011||0.011,0.0,0.1,0.06666666666666667
153,Immunol_Lett-2-1-2430030.txt,murin||present||respons||antigen present||apc||cytokin product||rel pauciti||sampl||express||class II||neutrophil||macrophag||antigen||cell,fig. 2 fig. 3||fig. 3 fig. 2 3 323||fig. 2 323||339 fig. 2||3||2||339 fig. 3 323||fig. 4 323||cell||339 fig. 4 fig. 4 323||339 fig. 4||neutrophil||1||339 fig. 4 323||murin neutrophil,0.035||0.03||0.028||0.028||0.026||0.025||0.025||0.025||0.025||0.024||0.024||0.024||0.023||0.022||0.017,0.0,0.1,0.13333333333333333
154,J_Gastrointest_Surg-3-1-1852374.txt,follow-up||perman fecal divers||case||surgic treatment||rate||patient||year||perian abscess||risk||rectal advanc flap||temporari stoma||stoma||perman stoma||fecal divers||fistula||multivari analysi||rectal resect||abscess format||surgeri||factor||abdomin procedur||temporari fecal divers||small bowel resect||fecal incontin,2||1||patient||crohn âs diseas||tabl 2||perian crohn âs diseas||incontin 2||perian crohn âs||CI 2||23||tabl 1||2 jehl||perian crohn âs diseas surgeri||12 patient||2 kasparek,0.025||0.021||0.019||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
155,Cardiovasc_Intervent_Radiol-3-1-1914265.txt,endovascular treatment||occlus||abi||complic||procedur||sfa||occlud stent||option||endovascular stent||superfici femor arteri||angiograph result||pier||intervent radiolog||patient||side,1 2||refer 1||conclus 3 1 2||case report 1 2||4 cm||case report||2007||patient||4 cm proxim||case||s00270-006-0032-9 case report||patient âs||stent||2005||11 cm,0.065||0.046||0.043||0.043||0.022||0.021||0.018||0.017||0.017||0.016||0.015||0.014||0.013||0.012||0.012,0.0,0.1,0.06666666666666667
156,Dig_Dis_Sci-4-1-2292501.txt,pathophysiolog mechan||rate||median age 40 year||studi||patient||maximum toler volum||effect||upper abdomin sensat||test||earli satieti||total||nutrient drink||gastric empti||gastric||daili life||relationship||upper abdomin symptom||upper abdomen||pathophysiolog disord||maximum satieti||age||proxim||stomach||drink test||symptom||nutrient drink test||sever||function dyspepsia,1||2||0 1||gastric||1 year||2 test||test 2||1 ml||pain 1||refer 1||3||1 frequenc||2 min||fig. 2||method patient 1,0.033||0.025||0.02||0.02||0.019||0.018||0.018||0.018||0.018||0.018||0.017||0.017||0.017||0.016||0.016,0.2,0.1,0.06666666666666667
157,Naunyn_Schmiedebergs_Arch_Pharmacol-2-2-1705472.txt,cardiac inotropi||low level||blockad||ang II||flow||mineralocorticoid receptor||aldosteron||effect||eplerenon||blood pressur||heart failur||glucocorticoid||chai||rat||aldosteron level||oxid stress||cardiac tissu||activ||synthesi||arrhythmia||inotropi||cardiac level||antagonist||cortisol,2004 2005 2004||1||2||2005 2003 2004 2003 2003||endotheli dysfunct 2005 2004 2004 2004||2005b 2005 2004 3||3 2||aldosteron||heart||receptor||hypertens||2005a 2006||cardiac aldosteron||rat heart||circul,0.024||0.022||0.021||0.019||0.017||0.016||0.015||0.015||0.015||0.014||0.013||0.012||0.012||0.012||0.012,0.0,0.1,0.06666666666666667
158,Eur_J_Pediatr-4-1-2413082.txt,tubercul pericard||tuberculosi||pericardi fluid||diagnosi||pericard,1 1||4||1 year||g.vanwell@vumc.nl 4 1 depart||netherland 4 depart||4 month||refer 1||mycobacterium tuberculosi 2 6||addit 4 month||netherland 3 depart||netherland||31-503-612478 r.bolt@sfg.nl 1 2 rammeloo luka||3||tuberculosi||discuss 6 5,0.055||0.051||0.037||0.034||0.033||0.032||0.032||0.026||0.024||0.024||0.023||0.023||0.023||0.022||0.019,0.0,0.0,0.06666666666666667
159,Pediatr_Radiol-3-1-1805044.txt,find||pretext||siopel||patient||involv||pretext system||risk||pretext stage||criteria||metastas||high risk||current siopel studi||tumour||portal vein||risk stratif||ascit||extrahepat diseas||liver||origin pretext system||biopsi||major branch||hepatoblastoma||medial section||risk factor||hepat vein||revis||diseas||diagnosi||primari malign liver tumour||extrahepat abdomin diseas||children,2||2 fig. 2||pretext||3||7 2 3||pretext stage 1 1||tumour||segment 2||pretext II 1 3 fig. 3||2 2005 pretext stage||pretext stage||3 4 5||hepatoblastoma 3||pretext group||pretext iii tumour,0.027||0.023||0.021||0.02||0.019||0.019||0.018||0.017||0.017||0.016||0.015||0.014||0.014||0.014||0.014,0.2,0.2,0.2
160,Skeletal_Radiol-4-1-2424184.txt,chart review||follow-up||find||time||follow-up period||studi||patient||clinic outcom||bone marrow edema||age differ||review||total||edema||statist analysi||lesion||pattern||cartilag||tka||age||total knee arthroplasti||pain||subject||bandwidth rang||bme||group||function loss||bone||osteoarthrosi||knee||sever||cartilag loss,1||2||4||4 4||4 7||3||7||2 5||1 pattern||fig. 2||2 9||2 8||2 cartilag loss||2 13||3 year,0.025||0.022||0.021||0.021||0.019||0.018||0.017||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.013,0.0,0.0,0.0
161,Clin_Rev_Allergy_Immunol-4-1-2243253.txt,antibodi||RA patient||sensit||ccp2 test||test||studi||rheumatoid factor||arthriti||autoantibodi||data||diseas||patient||specif,2006||1||RA 1 2 3 4 5||4 year||arthriti||patient||refer 1||RA patient||predict potenti 2||2006 patient group number ccp2||RA patient group||2007||rheumatoid arthriti||RA||ther 2006 8 r119 10.1186,0.029||0.026||0.022||0.02||0.018||0.018||0.016||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.011,0.2,0.3,0.2
162,Clin_Oral_Investig-4-1-2238785.txt,condit||level||system||indic||sextant||basic structur||studi||eros wear||level score||eros||develop||epidemiolog||bew score sum||tooth wear||manag||examin||basic eros wear examin||research||highest score||bew||surfac||gener dental practition||eros tooth wear||sever||gdp||diagnosi||index||score,2||score 2||3||3 1 depart||score||1 11 12||1 criteria||refer 1||eros tooth wear 1||eros||dental eros||eros wear||level score||highest score||2 risk level,0.025||0.023||0.023||0.022||0.022||0.022||0.02||0.019||0.019||0.017||0.017||0.016||0.016||0.015||0.015,0.2,0.2,0.3333333333333333
163,Placenta-1-5-1895600.txt,human pregnanc||gestat age||tunel-posit||sampl||apoptot index||individu cell||increas||express||immunoreact||signific increas||placenta||cell type||cell||stress||murin placenta||hne||oxid stress||gc||apoptosi||ihc||fetal endotheli cell||cyclooxygenas||dual-label||co-localis||mous||glycogen cell||primari antibodi||syncytiotrophoblast,"fig. 1||fig. 1 fig. 1 fig. 1||1||fig. 3||fig. 4||fig. 4 fig. 4||fig. 1 a,b||fig. 5||2||2 2 2 2 2 2||fig. 2 a,b||fig. 2 immunoreact||fig. 3 a,b||fig. 3 immunoreact||3 2",0.028||0.028||0.025||0.024||0.021||0.021||0.021||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018,0.0,0.0,0.0
164,Diabetologia-3-1-1820754.txt,type 2 diabet||respir||muscl||studi||patient||parallel electron input||complex iii||oxid phosphoryl||healthi subject||increas||skelet muscl||insulin||content||evid||present studi||control||uncoupl state||oxid capac||electron transport capac||electron transport||mitochondria||subject||biopsi||citrat synthas activ||result,2||2 2 2 2||2 2||1 2 2 2 2||2 fig. 2 2 2||2max 2 2 2||2 10 2 2 2 4||2 2 flux||1 2||type 2||type 2 diabet||1 2 2 flux||2 flux||result 2||2 3 36 2 3,0.081||0.081||0.081||0.069||0.066||0.061||0.056||0.056||0.052||0.051||0.048||0.048||0.044||0.042||0.042,0.0,0.0,0.06666666666666667
165,Biochem_Pharmacol-1-5-1920586.txt,blockad||protocol||concentr||long QT syndrom||data||studi||mutat||effect||current||herg channel||herg||inhibit||fit||control||potenti||short QT syndrom||inactiv||imipramin||extern solut||doxepin||channel pore||mutant||drug,fig. 1||herg fig. 1 fig. 1||herg fig. 1||fig. 2||fig. 3||fig. 3 fig. 3||herg fig. 1 fig. 6||herg fig. 3||fig. 5 fig. 5 fig. 5||herg fig. 4||fig. 6||fig. 8||herg fig. 5||herg herg fig. 4||fig. 7,0.042||0.04||0.039||0.039||0.039||0.039||0.037||0.036||0.035||0.035||0.034||0.034||0.034||0.034||0.034,0.0,0.0,0.0
166,Int_J_Biochem_Cell_Biol-2-1-2267855.txt,pH depend||mutant||substrat transport||substrat||one-way anova||residu||oocyt||peptid||transport||proton||model||charg pair||substrat bind||wild-typ,fig. 3||fig. 3 3||fig. 2||fig. 2 3||fig. 5||fig. 5 fig. 5 fig. 5||3||2004 fig. 3||fig. 4 3||fig. 7 3||fig. 9||xenopu fig. 3||fig. 6||fig. 8||3 oocyt,0.037||0.035||0.03||0.03||0.03||0.03||0.03||0.029||0.028||0.027||0.026||0.026||0.026||0.025||0.021,0.0,0.0,0.0
167,Int_J_Colorectal_Dis-3-1-2077921.txt,dgp||anal manometri||follow-up||case||system||placement||result||artifici bowel sphincter||anal sphincter defect||problem||procedur||data||faecal incontin||studi||implant||treatment||patient||infect||institut,1||2||2 fig. 1||result 1 2||anal repair||ruptur anal repair||refer 1||1 aetiolog||anal sphincter||hysterectomi anal repair||31-43-3875473 c.baeten@surgery.azm.nl 1 1 depart||radiotherapi 2||ruptur anal repair 15||ruptur anal repair 20||total ruptur anal repair,0.035||0.029||0.026||0.024||0.022||0.019||0.019||0.018||0.018||0.016||0.016||0.016||0.016||0.015||0.015,0.0,0.0,0.0
168,Immunogenetics-2-2-1592254.txt,iplitr||detail sequenc analys||molecul||fcrl||domain||cyt||receptor||evid||content||polymorph differ||cell||gene||lrc||genom segment||chir||product||function signific||ident||analysi||catfish||common origin||member||famili||teleost||sequenc analysi||immun receptor||evolut||iplitr sequenc||uniqu composit||inhibitori||lrc-encod receptor||support||lilr||igsf receptor||zflitr||Ig domain||sequenc||membran||kir,receptor||receptor gene||immun receptor||cell||receptor complex||mammalian receptor||Fc receptor||immunoregulatori receptor||individu receptor||teleost receptor||affin receptor||superfamili receptor||regulatori receptor||2004 1997 2001||immunoglobulin-lik receptor,0.021||0.014||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.011||0.01,0.6,0.3,0.2
169,J_Med_Internet_Res-7-1-1550637.txt,gener theme||mesh||system||databas||patient||concept||consum||clinic||inform||major||broader literatur||servic manag||alli health literatur||scientif||definit||patient care||telemedicin||journal||medic informat||potenti||term||broad rang||applic||ehealth||research||research literatur||commun technolog||analysi||taxonomi||care||internet||medic informat literatur||literatur||clinic data||medic subject head||topic||medlin||order||scientif abstract||field||public||hand||organiz factor||articl,health||1||health inform||health informat||health care||feb 1 2005||system health||health system||manag health||health inform system||health servic||health care inform technolog||health commun||health improv||health care research,0.028||0.023||0.021||0.021||0.02||0.018||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.016||0.016,0.0,0.0,0.0
170,Dig_Dis_Sci-3-1-1914242.txt,chapter||central databas||endoscopi||system||code system||find||endobas iii system||complic||databas||descript||comput system||therapeut procedur||structur||investig||get-c||diagnos||text-block||classif||minim standard terminolog||code||intern classif||item||hospit inform system||terminolog||endoscop term||group||report||import||field||comprehens code system||procedur||diseas||endoscop find,2||1||2 3 4||chapter 2||code||netherland 2||chapter 1||code system||6 1 depart||2 comparison||method 2 5||netherland 3 depart||refer 1||result 1||netherland 4 depart,0.031||0.025||0.024||0.023||0.023||0.023||0.02||0.019||0.017||0.017||0.017||0.017||0.017||0.016||0.016,0.2,0.2,0.13333333333333333
171,Ann_Biomed_Eng-2-2-1705520.txt,condit||actin cytoskeleton||time||respons||mechan condit||load curv||studi||cell stiff||mechan properti||effect||hold period||frequenc||strain||baselin length||increas||amplitud||forc||cytod||matrix mechan||cell||day||load||collagen||tissu||drop||curv||bioartifici tissu||cell mechan||decreas||incub||matrix||step||larger rang,forc||cell forc||cell||stretch||tissu forc||1||5 cell stretch||cell mechan||matrix forc||peak cell forc||mechan stretch||tissu||2||figur 2||5 tissu stretch,0.024||0.024||0.024||0.023||0.021||0.021||0.019||0.019||0.018||0.018||0.018||0.018||0.018||0.018||0.018,0.4,0.3,0.26666666666666666
172,J_Fluoresc-3-1-1915606.txt,measur||time||experiment setup||protein aggreg||sec||dye fluoresc||sampl||irrevers denatur||focal volum||data analysi||aggreg||sensit||increas||temperatur||fluoresc correl spectroscopi||fluoresc intens||denatur protein aggreg||nile red||fluoresc spectroscopi||solut||experiment autocorrel function||protein||experi||normal||light||buffer||sensit detect||analyt detect||fluoresc||room temperatur||peak||heat||size exclus chromatographi,2||2 2||1 2||2 Ï||6 2||1||7 2||8 2||2 25||1 2 37||2 tabl 2 coeffici||2 19 Ï||Ï 2 1 Ï Ï||Ï 1||1 Ï,0.035||0.035||0.028||0.023||0.022||0.02||0.02||0.019||0.019||0.019||0.018||0.017||0.017||0.016||0.016,0.0,0.0,0.0
173,Matern_Child_Health_J-2-2-1592247.txt,nation map||program||measur||preconcept risk assess||preconcept||clinic practic strategi||unpublish data||indic||servic provid||public health||project||birth||jurisdict||pregnanc||matern||state||strategi||folic acid||patient||reproduct health||clinic||risk||unit state||perform measur||provid||intervent||preconcept care program||health||preconcept care||educ||health care||women||summit||effort||public polici||father||age||public health practition||popul||abstract||servic||prenat care||ppor||innov strategi||issu||state perform measur||famili plan||prioriti||preconcept health promot||nation summit,health||health care||preconcept health||preconcept health care||2||health servic||preconcept health servic||care||preconcept care||preconcept||health care provid||preconcept health indic||health educ||public health||preconcept health activ,0.036||0.029||0.029||0.026||0.024||0.023||0.022||0.022||0.022||0.021||0.021||0.021||0.02||0.02||0.02,0.4,0.4,0.3333333333333333
174,Breast_Cancer_Res-5-6-314403.txt,upregul||role||emt||epitheli cell||insert||data||studi||cell cycl control||growth inhibit||total rna||express||treatment||cell||gene||cell growth||analysi||experi||regul||rhob||cdna microarray||hybrid||nmumg cell||data analys||signal intens||pathway||origin data file||time point||gene express||result,gene||1||2||cell||1 hour||factor 1||tgf-Î²1-regul gene 1 2||tgf-Î² 1||3 1||tabl 1 gene||tabl 2 gene||gene express||1 regul||cell growth||2 1 16 17 2,0.027||0.026||0.024||0.023||0.022||0.02||0.019||0.019||0.019||0.018||0.018||0.017||0.016||0.016||0.016,0.4,0.2,0.26666666666666666
175,Biochem_Pharmacol-2-1-2279149.txt,activ site||breast cancer||arylamin||studi||tamoxifen||model||inter-domain loop||assay||steroid||structur||recombin protein||compound||express||reaction||protein||nat||spectrum||activ||three-dimension structur||mous||substrat||peak||inhibitor,1||fig. 1||fig. 2||fig. 2 2||2||fig. 1 50 supplementari fig. 1||fig. 6 1||fig. 8 1||tabl 1||15 1||fig. 5 1 15||tabl 2 supplementari fig. 1 50||cancer||fig. 4||n-acetyltransferas 2,0.022||0.021||0.019||0.019||0.019||0.016||0.015||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013,0.0,0.0,0.0
176,Cancer_Immunol_Immunother-3-1-2150627.txt,technolog||respons||protocol||panel||assay||frequenc||cimt||pbmc sampl||present||abil||clinic trial||reactiv||cell||elispot reader||percentag||pbmc||phase||analysi||standard||function assay||group||order||cmv||elispot||tetram||intracellular cytokin||posit||number||requir||donor,1||1 1||2||2 2||fig. 1||3||cancer||13 2||method||cell||4||4 4||13 3||1 ml||refer 1,0.016||0.016||0.012||0.012||0.01||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.009,0.0,0.1,0.06666666666666667
177,Qual_Life_Res-3-1-2039846.txt,person||follow-up||measur||respons||questionnair||practic||util score||hear||studi||patient||standard deviat||dutch tariff||effect||distinct group||follow-up visit||test||life score||econom analys||qali||util||quality-adjust life year||icer||hui||cost||health||aid user||hear aid fit||popul||chang||aid fit||respond||dutch||group||differ||non-applic||visit||attribut||hear complaint||hear loss||score||hrqol||result,2||util||1||health||3||3 3 3||health util index||health util index mark 2||health state util||util score||health util index mark 3||util measur||mark 3 util score||agreement 2 3||health care,0.019||0.019||0.018||0.017||0.015||0.015||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.4,0.3,0.2
178,Matern_Child_Health_J-2-2-1592143.txt,social market||time||behavior||pregnanc||patient||pcc||consum||healthi pregnanc||promot||provid||cost||health||preconcept care||product||women||research||health behavior theori||babi||servic||care||market||demand||benefit||outcom,1||health||health care||care||preconcept health care||preconcept care||health care servic||1 theori||health care provid||2||preconcept||refer 1||preconcept care servic||health care organ||preconcept health promot,0.033||0.028||0.026||0.024||0.024||0.022||0.021||0.02||0.02||0.019||0.019||0.018||0.018||0.018||0.018,0.4,0.3,0.2
179,Apoptosis-4-1-2311383.txt,role||protein kinas||respons||studi||transcript factor||increas||sirna||phosphoryl||cell||oxid stress||apoptosi||alveolar type II cell||protein||creb||activ||nuclear accumul||pka||import||exposur||creb activ||egfr||oxid||camp||result,2 2 2 2 2 2||2||2 2||2 2 2 2||2008 2 2 2||2 2 2 4 3||experi 2 2||2 2 2 2 16 17||result 2 2||2 2 stimul||c10 cell 2 2||2 2 2 hydrogen peroxid||2 2 6 14||3 3 2 2||2 phosphoryl,0.058||0.058||0.058||0.058||0.045||0.04||0.04||0.04||0.04||0.04||0.036||0.035||0.035||0.035||0.032,0.0,0.0,0.0
180,Surg_Endosc-3-1-2077356.txt,follow-up||enuresi||hospit stay||time||higher enterocol rate||laparoscop procedur||studi||patient||march 1994||adhes obstruct||duhamel procedur||rectum||end point||laparoscop duhamel||open||bowel||postop complic||cosmet result||group||differ||duhamel||adhes bowel obstruct||enuresi rate||signific differ||period||aganglionosi,1||result 1||3||2||C. 1 1 depart||1 2 stenosi 0 2||refer 1||llc 2007 1 3||tabl 2||group||7||patient||result||postop fever 3 1 leakag||4,0.045||0.03||0.027||0.026||0.025||0.024||0.024||0.023||0.02||0.019||0.019||0.018||0.016||0.016||0.015,0.0,0.1,0.13333333333333333
181,Mol_Genet_Genomics-3-1-2129107.txt,carbon sourc||gene||sucros||inulin||strain||bind||mutant||invertas||unpublish result||transcript||domain||protein||inulinolyt gene||inulinolyt enzym||data||express||extracellular enzym||inur||growth||result,A.||inur||inur inur||A. niger inur inur||A. niger||niger||1 A.||fumigatu A. niger A. niger inur||A. niger 2004 A.||niger inur A. nidulan||inur 1 A. niger 2007||transfer A. niger A.||inur sucb A. niger A. nidulan||A. fumigatu A.||pyrg inur inur,0.029||0.029||0.029||0.028||0.027||0.025||0.024||0.024||0.023||0.022||0.022||0.021||0.021||0.021||0.02,0.2,0.1,0.06666666666666667
182,Appl_Microbiol_Biotechnol-3-1-1914294.txt,terpenoid||gene||emiss||iptg||strain||product||isopren||enzym||function||concentr||pathway||express||studi||methylerythritol phosphat pathway||biosynthesi||amount||cell||growth||isopren emiss,subtili||B. subtili||B.||2 B. subtili B.||bacillu subtili||1||fig. 3 B. subtili||B. subtili 1999 2001||tabl 1 B. subtili E. coli||2||enzym E. coli B. subtili||strain B.||1996 bacillu subtili||2 bacillu subtili 600 nm||ypga B.,0.045||0.04||0.035||0.035||0.031||0.028||0.027||0.025||0.024||0.024||0.023||0.022||0.022||0.021||0.021,0.0,0.0,0.0
183,Cancer_Causes_Control-3-1-2039842.txt,type||subcohort||cancer||case||fat||mutat||studi||patient||colon||risk||total fat||epidemiolog||linol acid||intak||netherland cohort studi||express||polyunsatur fat||day||rectal tumor||lack||tumor||subcohort member||tabl||rectal cancer||addit||colon tumor||result,apc||apc apc||apc apc 1||cancer||colorect cancer 1 apc apc apc||2 apc apc||apc kra||2 apc apc apc 2||apc apc apc gene||apc 2||kra apc kra apc 25 apc||colorect cancer cancer||1||colorect cancer||kra,0.023||0.023||0.021||0.02||0.019||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.017||0.015||0.015,0.2,0.1,0.06666666666666667
184,Matern_Child_Health_J-2-2-1592151.txt,respons||questionnair||practic||rate||pregnanc||studi||patient||folic acid||pcc||respons rate||carn||major||counsel||routin care||folic acid supplement||preconcept care||women||posit effect||care||routin exam||factor||group||topic||import||issu||survey||obstetrician-gynecologist||physician,2 2||2||1||pcc 2||3||11 2||5||tabl 2 percent||2 6.83||care||pcc 3||preconcept care||tabl 5 patient||pcc 5||tabl 3 percent,0.031||0.031||0.024||0.021||0.02||0.02||0.018||0.018||0.017||0.016||0.016||0.015||0.015||0.014||0.014,0.0,0.1,0.13333333333333333
185,J_Med_Internet_Res-7-3-1550662.txt,type||portal||cancer||categori||health-rel inform||onlin inform||redesign||patient||question||inform||form||search log||clinic trial||onlin||guidelin||cancer inform||health profession||page||websit||cancer patient||averag||result||onlin survey||free-text search||basic search form||feedback||abstract||nci||usabl test||summari||bet||user input||tabl||usabl||specif trial||survey||cancer inform product||internet,inform||cancer inform||cancer||trial inform||clinic trial inform||1||trial||cancer inform servic||cancer inform specialist||cancer inform product||patient-ori cancer inform||cancer trial result||nci cancer inform product||latest cancer inform||user inform,0.028||0.027||0.026||0.024||0.021||0.02||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.018,0.6,0.4,0.26666666666666666
186,Exp_Brain_Res-4-1-2214825.txt,visual illus||illus||target||time||initi postur||grip select||model||studi||strategi||orient||effect||grip plan||end||percept||present||motor plan||grip type||target object||visual inform||grasp||sequenti object manipul task||frame||visual context||result||rod orient||task||experi||action||clockwis||start postur||rod||postur||end postur||trial||particip||movement||grip||object||plan||switch point,1||2||3||grip type 1||type 2||type 3||grip type 2||type||grip type 3||grip type||color 1 2||apparatu 1 fig. 1||grip||2000 1992 2 fig. 2||2004,0.022||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.013||0.013||0.013||0.012||0.011,0.0,0.1,0.13333333333333333
187,Int_J_Cardiovasc_Imaging-3-1-2048828.txt,tricuspid annulu||measur||RV function||tad||assess||analysi||mri||tad measur||magnet reson imag||taf||studi||patient||TA function||real-tim three-dimension echocardiographi,1||2||refer 1||1 2D 3D 3D||1 2 soliman osama||I. 1 2 neme||31-10-4635498 f.j.tencate@erasmusmc.nl 1 1 depart||patient||result 1 3D mri 3D||2 line||9.2 2||8.2 2||studi||3||tabl 1 comparison,0.05||0.039||0.026||0.024||0.024||0.024||0.023||0.022||0.022||0.021||0.021||0.021||0.02||0.019||0.019,0.0,0.1,0.13333333333333333
188,Eur_Biophys_J-3-1-2082062.txt,array||chromatin condens||alpha-satellit dna||measur||centromer||repeat number||liquid||gel||chromatin||nucleosom posit||site||internucleosom distanc||dna||nucleosom||afm||atom forc microscopi||nucleosom array||reconstitut||largest fragment||afm measur||distribut||histon||main phase||fraction||posit||agm||number||fragment||peak||kinetochor protein bind||sequenc||result,2||3 2||1||1 lane 2||lane 2||1 fig. 1||cc cc 1998 cc 2||nucleosom||4||eco lane 1 lane 2 eco||2 Î¼m||2 Hz||cc 4 cc 4 cc||3||cc cc cc cc,0.032||0.024||0.023||0.021||0.02||0.019||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015,0.0,0.1,0.06666666666666667
189,Ann_Surg_Oncol-4-1-2373867.txt,success nerve-preserv surgeri||time||ipss||pelvic autonom nerv||superior hypogastr plexu||studi||patient||preoper baselin data||preserv||femal||nerv||specif sexual problem||erectil function||point likert scale||oper||present studi||femal sexual dysfunct||evalu||inferior mesenter plexu||autonom nerv||intern prostat symptom score||surgeri||sigmoid colon cancer||surgic procedur||item score||rectal cancer||procedur||good||dissect||genitourinari function||function,0||1||2||0 2 poor||discuss 1 2 2||23 1 1||0 1 iief score||function||0 1 ipss score||0 4 poor||54 2 2||0 2 fsfi score||4||refer 1||0 5 poor,0.037||0.032||0.027||0.023||0.022||0.022||0.02||0.02||0.02||0.02||0.019||0.019||0.018||0.017||0.017,0.0,0.1,0.06666666666666667
190,Arch_Dermatol_Res-3-1-1914293.txt,skin cell||plasmacytoid dendrit cell||studi||patient||relaps||lichen planu symptom||lesion biopsi||lichen planu lesion||reactiv||treatment||cell||lichen planu||lesion skin||protein||remiss||diseas activ||lymphocyt||skin diseas||biopsi||skin||number||diseas,1||2 1||2||fig. 1 2||1 month||3||1 year||result 1||refer 1||normal 2||10 1 3 7 2 19||2 patient||5 11 2||1 treatment characterist||5 16 18 1,0.038||0.033||0.028||0.023||0.021||0.021||0.02||0.02||0.02||0.018||0.018||0.018||0.017||0.016||0.016,0.0,0.0,0.0
191,Clin_Oral_Investig-2-2-1705496.txt,level||neurosensori dysfunct||oral implant||regard||questionnair||object evalu||trigemin nerv injuri||patient||studi||light touch sensat||placement||impress||nerv||complaint||region||sensat||psychophys test||orofaci region||lower jaw||load||age||month||popul||surgeri||test group||physic dysfunct||mental nerv||implant||group||symphysi||procedur||neurosensori disturb||oral caviti||object||area||age 56 year||lower lip,1||__||2||patient||2 4||4 patient||__ swallow __||__ speak __||__ numb __||12 patient||refer 1||oral||1 year||1 13||19 patient,0.021||0.019||0.018||0.017||0.015||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.012,0.2,0.1,0.06666666666666667
192,Neurosci_Lett-2-1-2271123.txt,habitu||increas||hippocampu||app||stress||brain||elev platform,2||fig. 2||fig. 1||1||15||1 day||fig. 2 app protein express||c.a.stewart@dundee.ac.uk 1||3||protein||neurosci||3 stewart carolin||stress||app||2007 elsevi ireland,0.028||0.025||0.022||0.021||0.019||0.015||0.015||0.012||0.012||0.012||0.011||0.011||0.011||0.009||0.009,0.0,0.0,0.13333333333333333
193,Mod_Rheumatol-4-1-2275302.txt,rheumatoid arthriti||vector||inflamm||transgen||joint||system deliveri||efficaci||anim model||patient||gene therapi||strategi||gene transfer||effect||angiogenesi||increas||system administr||deliveri||retrovir vector||express||plasmid dna||treatment||cell||therapi||gene transfer vector||success||mice||cytokin||destruct||adenoviru||pannu format||arthriti||inject||deliveri strategi||aav||fibroblast||vivo,gene||1||gene therapi||arthriti||gene transfer||effect gene||gene transfer vector gene||gene deliveri||gene scalpelâ arthriti||interleukin-10 gene||candid gene||gene transfer vector||gene therapi trial||adenovir gene therapi||gene transfer strategi,0.026||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.012,0.6,0.3,0.26666666666666666
194,Histochem_Cell_Biol-4-1-2386534.txt,squamou metaplasia||hair||langbein||diagnost applic||suprabas layer||moll||case||epitheli cell||simpl||mutat||hair follicl||adenocarcinoma||basal||express pattern||marker||pattern||express||schweizer||differenti||cell type||specif||diagnost marker||cell||type II||typic intermedi filament protein||tissu||protein||epitheli type||function signific||tumor||keratin||layer||diseas,keratin||cell||keratin express||keratin 1||human keratin||keratin 3||keratin exp cell||epitheli keratin||keratin gene||hair keratin||keratin 6||keratin 5||cell basal cell||keratin protein||keratin gene express,0.026||0.023||0.02||0.02||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.015,0.4,0.2,0.13333333333333333
195,Int_J_Colorectal_Dis-4-1-2386752.txt,tumour||post-op complic||fisi||score||studi||contin||function outcom||tem||procedur||qualiti||local excis||patient||seri||signific||life||rectal tumour||faecal contin||result,1||2||result 2 2 1 2||1 patient||refer 1||tabl 2||4||3 4||J. R. 2 1 depart||3||9||0.12 2||0.43 2||2 neijenhui||R. 1 tollenaar,0.051||0.039||0.035||0.029||0.027||0.025||0.023||0.022||0.021||0.021||0.021||0.02||0.02||0.02||0.02,0.0,0.0,0.0
196,Virchows_Arch-3-1-2063564.txt,type||grade||intraduct papillari mucin neoplasm||tumor||pancrea||ipmn subtyp||case||intraduct tumor||recent year||ductal adenocarcinoma||prognosi||posit margin||invas||carcinoma||patient||intraduct papillary-mucin neoplasm||recurr||outcom||ipmn,1||2||3 1 4||3||suppl 1||2007||4||1 incid data||3 year||patient||49-431-5973462 guenterkloeppel@path.uni-kiel.d 3 1 institut||intraduct||incid period 2 number||1 23 51 52||springer-verlag 2007,0.033||0.029||0.023||0.021||0.019||0.016||0.014||0.014||0.013||0.012||0.012||0.011||0.01||0.01||0.01,0.0,0.1,0.06666666666666667
197,In_Vitro_Cell_Dev_Biol_Anim-4-1-2277440.txt,control group||doxorubicin concentr||hair follicl||effect||assay||signific||temperatur||viabil||cell||damag||human epiderm keratinocyt||doxorubicin exposur||hair loss||group||keratinocyt||scalp cool||differ||decreas||scalp||doxorubicin||signific differ||medium||drug uptak||result,1||1 2||1 figur 1||1 2003 2||result 1||2||cell||0.001 1||method 2 2 6 cell||11||figur 2||2003||2007||temperatur||cell viabil,0.048||0.038||0.036||0.032||0.029||0.028||0.027||0.026||0.023||0.021||0.02||0.02||0.019||0.018||0.017,0.0,0.1,0.13333333333333333
198,Bioprocess_Biosyst_Eng-2-2-1705532.txt,cool hex||steril inlet feed||pressur drop||flow||lower flowrat||rate||locat||valu||process side||spiral heat exchang||water||air||recycl||effect||process||continu heat treatment||volum||steril||abil||point||pressur||switch||util||temperatur||control||degre||steam||continu steril||ferment||hex||fluid||non-steril side||hot medium||heat treatment||media type||alkalin||acid||loop||resid time||min||fluid densiti||gap||outlet||valv||system outlet||pipe||inlet||steril medium||cooler||media compon||heat transfer||design||heat||media||side,2||2 1||1 1||1||2 3||1 3||temperatur||steril temperatur||steril||18 2 2||1 2 15||system||hex 2||temperatur control||3,0.013||0.013||0.012||0.012||0.01||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.008||0.008||0.008,0.0,0.2,0.13333333333333333
199,Biochim_Biophys_Acta-2-1-2396231.txt,upregul||respons||klf express||data||endothelin-1||studi||transcript factor||effect||multipl klf famili member||increas||total rna||gene promot||express||cell type||cell||signific role||cardiac myocyt||gene||krÃ¼ppel-lik factor||klf||oxid stress||apoptosi||protein||famili||cardiac myocyt hypertrophi||polysom||mrna||pathway||gene express,fig. 2||fig. 1 fig. 2||fig. 2 fig. 3||fig. 5 fig. 1||fig. 4||fig. 3||2||2 2||2 2 fig. 5 2 2||fig. 6 fig. 3 fig. 6||fig. 6||tabl 2 fig. 1||et-1 fig. 2||1||abstract 2 2 2 2,0.033||0.033||0.03||0.028||0.028||0.027||0.026||0.026||0.025||0.024||0.023||0.023||0.023||0.022||0.021,0.0,0.0,0.0
200,Matern_Child_Health_J-2-2-1592159.txt,infant||birth outcom||mother||birth||pregnanc||data||matern||state||cari||oral health||risk||case-control studi||deliveri||intervent||treatment||dental servic||infect||dental||matern oral health||health||potenti||women||preterm birth||age||care||matern periodont diseas||oral||factor||import||diseas||tooth||children,health||oral health||oral||1||oral health care||periodont health||oral diseas||oral health servic||infant oral health||oral care||matern oral health||improv oral health||oral health condit||oral health educ||2 1 depart,0.022||0.02||0.019||0.019||0.017||0.017||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.6,0.3,0.26666666666666666
201,J_Gastrointest_Surg-3-1-1852382.txt,tetanu||case||gastrointestin procedur||complic||procedur||surgeri||diffus muscl spasm||patient||clinic present||vulner patient,1||2||1 17 1 18||1 jerk||patient||refer 1||hemorrhoid 4 result 1 2||tetanu||2 month||2 summari||at-risk patient||male||4||vulner patient||trismu,0.045||0.032||0.026||0.025||0.025||0.024||0.021||0.018||0.017||0.017||0.017||0.016||0.015||0.015||0.015,0.2,0.2,0.2
202,Ann_Biomed_Eng-2-2-1705506.txt,scaffold||ecm||si||bioreactor||leaflet||anim model||studi||molecular imag||heart valv||remodel||heart valv tissu||mechan environ||human||polym||bone marrow||extracellular matrix||fibrin gel||decellular||adult||epc||evid||cell||growth factor||properti||applic||matrix protein||tissu||collagen||endotheli||mechan stimul||implant||myofibroblast||valv||field||biodegrad polym||heart||tissu engin||biomark||function||result,valv||cell||valv tissu||heart valv||heart valv tissu||tissu heart valv||tissu||heart valv tissu engin||in-vivo||in-vivo in-vivo in-vitro 2||1||E. tissu engin heart valv||endotheli cell||in-vivo 2 2||tissu engin,0.02||0.02||0.017||0.015||0.015||0.015||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012,0.8,0.5,0.4
203,Pediatr_Nephrol-3-1-1915616.txt,antibodi||hu||shiga-lik toxin||stx||hemolyt urem syndrom||effect||huvec||specif receptor||coincub||toxin||receptor||protein synthesi||temperatur||cell||cytotox effect||experi||temperatur shift||chang||supernat||renal endothelium||target cell||transfer||monocyt||vero cell,3||2||cell||target cell 1 2 fig. 1||toxin 2||1 125||3 125||shiga toxin 1||toxin||monocyt||6 3 6 5||target cell||refer 1||vero cell||23 3,0.027||0.024||0.024||0.022||0.02||0.02||0.019||0.017||0.017||0.017||0.017||0.016||0.016||0.015||0.015,0.2,0.3,0.3333333333333333
204,Ann_Biomed_Eng-2-2-1705509.txt,stereoscop movi||infrar rang||blood withdraw||blood vessel||imag||vi||nir||visual rang||inform||percept||depth||shadow||user||enhanc||shutter glass||depth percept||superfici artifact||tissu surfac||tissu||result||devic||wavelength rang||camera||surfac||pixel||crt||contrast||light sourc||mode||reflect||techniqu,imag||2 figur 2||2||3 figur 3||nir imag||1 nir||enhanc imag||vi imag||1 vi||imag process||1 12||imag cycl||imag inform||1 cycl||color imag,0.022||0.018||0.018||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
205,Pediatr_Nephrol-4-1-2275772.txt,prevent||proteinuria||measur||antiproteinur||chronic kidney diseas||ra||hypertens||ckd||reduct||efficaci||renal failur||studi||normal rang||patient||effect||risk||therapeut strategi||increas||ckd patient||blood pressur||addit role||chronic inflamm||low-protein diet||adult||ace inhibitor||treatment||oxid stress||antihypertens agent||anemia||renal function||factor||renal replac therapi||kidney function||trial||renal diseas progress||progress||children,kidney||kidney diseas||renal diseas||2||diseas||pediatr renal diseas||hypertens kidney diseas||chronic kidney diseas||chronic kidney diseas 1 2||chronic renal diseas||renal diseas progress||progress renal diseas||studi||renal failur||end-stag renal diseas,0.019||0.017||0.017||0.017||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012,0.0,0.1,0.26666666666666666
206,Ann_Surg_Oncol-4-1-2234448.txt,level||method||sln biopsi procedur||oper procedur||patholog assess||melanoma||sampl||fnb sampl||antimoni concentr||studi||true sln||antimoni||fine-needl biopsi||node||icp-m||fnb specimen||ppb||result||lymph node||ident||analysi||standard||sentinel lymph node||primari cutan melanoma||sln||hydrochlor acid||procedur||patholog||region lymph node||antimoni level||techniqu,2||melanoma||2 3||1||lod 2||lod 3||melanoma patient||1 tabl 2||2 3 24||3 4 5||cutan melanoma||lod 4||metastat melanoma||tabl 3||lod 6,0.027||0.026||0.025||0.022||0.021||0.02||0.018||0.018||0.018||0.016||0.015||0.015||0.015||0.014||0.014,0.2,0.1,0.06666666666666667
207,Mod_Rheumatol-4-1-2279153.txt,rheumatoid arthriti||younger age||clinic respons||respons||retrospect studi||demograph factor||infliximab||low activ||studi||patient||notabl efficaci||diseas durat||secondari insuffici||discontinu||dose||treatment||advers event||therapi||advers reaction||RA manag group||retrospect clinic studi||diseas activ||remiss||age||respons criteria||factor||crp||japan||eular criteria||clinic efficaci||diseas||infliximab therapi||mtx,2||3||studi||infliximab therapi 3 4||clinic studi||2 result||refer 1||clinic characterist 1||therapi||3 result||infliximab therapi||54 week||week 54||retrospect clinic studi||14 week,0.023||0.019||0.018||0.015||0.015||0.014||0.014||0.014||0.014||0.012||0.012||0.012||0.012||0.011||0.011,0.2,0.2,0.26666666666666666
208,Pediatr_Nephrol-3-1-2100430.txt,author||inflamm||chronic kidney diseas||import observ||hypertens||ckd||high preval||abnorm||data||renal failur||studi||transplant patient||hyperphosphatemia||patient||gener popul||calcif||cardiac risk factor||mortal||risk||process||diastol dysfunct||increas||ischem heart diseas||chronic inflamm||cardiac morbid||cardiac arrest||adult||treatment||esrd||renal transplant||lvh||young adult||coronari arteri diseas||anemia||valvular diseas||dyslipidemia||death||cvd||transplant||arteri||gener pediatr popul||high rate||doqi||dialysi||chronic hemodialysi||stiff||children||cardiovascular diseas,pediatr||pediatr renal diseas||1||renal transplant||pediatr patient||pediatr nephrol pediatr nephrolog||kidney diseas||kidney transplant||diseas||cardiovascular diseas 1||chronic renal diseas||pediatr dialysi||suppl 1||transplant||3,0.019||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012,0.2,0.1,0.13333333333333333
209,Pediatr_Radiol-4-1-2292495.txt,cathet||peripher cannula||line||complic||contrast studi||tip posit||cathet tip||central venou cathet||studi||patient||tip||central venou access devic||thrombu||neck||lumen||contrast jet||contrast medium||site||oper||manag||subsequ manag||tunnel||central||clinic team||malfunct||fibrin sheath||access||initi examin||posit||cvc||inject||children||techniqu,fig. 10||cathet||fig. 22||fig. 18||1 2 fig. 1 inset||venou||central venou cathet||suppl 1||cathet 19 fig. 19||infus cathet venou||central venou cathet placement||cathet malfunct||cathet complic||cathet tip||percutan central venou cathet,0.028||0.027||0.023||0.021||0.021||0.021||0.02||0.019||0.018||0.016||0.016||0.016||0.016||0.016||0.016,0.2,0.2,0.2
210,Med_Biol_Eng_Comput-3-1-2039845.txt,measur||cathet||respons||sampl rate||system||time||valu||tip||thermocoupl||vivo measur||air||frequenc||overshoot||leakag test||increas||transport||temperatur||calibr||signal||airway climat explor||sampl cathet||respons characterist||characterist||order||decreas||humid||sensor hous||central canal||intratrach climat||respons time||heat||step||total assembl||hme,2||1||humid||6 2 2||2 3 fig. 2||2 3||humid sensor||4||humid measur||2 cm||1 cm||sensor||3||6||heat humid,0.022||0.022||0.021||0.019||0.018||0.018||0.017||0.016||0.016||0.015||0.015||0.013||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
211,Arch_Microbiol-4-1-2270922.txt,biolog||time||system||rel abund||bioreactor||steadi state||sampl||acet concentr||laboratori||comparison||flask||control cultiv||variabl||pattern||mass||electron donor||cell||growth||optic densiti||protein||proteom||analysi||chemostat cultur||cultiv||acid||shake flask||experi||shake flask cultur||cultur||system biolog||batch||peptid||organ acid||result,2||2 1 2 2 2 1||1 2||1||2 2 2 2 600||control batch 1 2 2 1||1 4||flask 2||2 dark||triangl 2||2 defici||2 3.9||2005||flask 1||1 46,0.03||0.028||0.027||0.025||0.024||0.02||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.013,0.0,0.0,0.0
212,Pflugers_Arch-3-1-1915652.txt,ino||sampl||effect||increas||express||aminoguanidin||rat||renal proxim tubul||gene||product||renal drug transport||lp||proxim tubul||proxim tubular damag||supplementari materi||nephrotox||endotoxemia||tubul cell||renal abc transport||up-regul||gene express||kidney||import efflux pump,1||2||1 1 fig. 1||2 fig. 2||1 1 4 1 fig. 4||1 renal||3||2 fig. 6||2 3 4||3 3 fig. 3||5 2||refer 1||M. 2||pb 1||6,0.025||0.023||0.022||0.02||0.018||0.018||0.017||0.016||0.016||0.016||0.016||0.013||0.013||0.013||0.013,0.0,0.0,0.0
213,Matern_Child_Health_J-2-2-1592251.txt,incom||program||commun health center||preconcept||uninsur||center||public health||pregnanc||state||prevent care||medicaid||major||usual sourc||sourc||health||health coverag||preconcept care||approach||women||health clinic||servic||coverag||feder||fund||opportun||access||famili plan||profession guidelin||waiver||children,health||health care||1||women health||women health care||health polici||2||nation health||care||health care coverag||health center||health coverag||primari health care||public health||health promot,0.039||0.03||0.027||0.025||0.024||0.023||0.022||0.022||0.022||0.021||0.021||0.021||0.021||0.021||0.021,0.2,0.1,0.2
214,Arch_Orthop_Trauma_Surg-4-1-2324129.txt,upper ankl joint||follow-up||case||surgic techniqu||lower ankl joint||soft tissu||complic||wire||posterior facet||reduct||joint deviat||disturb||studi||patient||osteiti||clinic||view||lower leg||statist analysi||fractur||close reduct||treatment||intern fixat||calcaneu||intern fixat techniqu||averag||follow-up evalu||surgeri||normal shoe||disloc calcan fractur||good condit||rang||averag follow-up time||zwipp score||compar result||result,2||2 2||1||1 1||2 20||1 patient||2 1 depart||2 clinic||18 2||2 17 23||patient||minimum 2||2 degreif||fractur||15,0.039||0.039||0.027||0.027||0.024||0.024||0.024||0.022||0.022||0.021||0.021||0.02||0.02||0.02||0.017,0.0,0.0,0.13333333333333333
215,Sleep_Breath-4-1-2270921.txt,apnea||initi treatment option||linear regress||oral applianc||sleep medicin physician||level||sleep medicin||measur||time||reduct||success treatment outcom||data||model||studi||dental sleep medicin specialist||patient||rdi||upper airway||sleep disord breath||investig||recoveri||posttreat||valid||osa||titrat endpoint||clinic cut-off||sleep||mad||sleep apnea||dentist||obstruct sleep apnea||small sampl size||devic||algorithm||group||correl analysi||cpap therapi||mandibular advanc devic||outcom,sleep||1||2 fig. 2||sleep breath sleep||sleep apnea||2||18 1 fig. 1 patient||4 fig. 4||sleep 29||keyword sleep apnea sleep||sleep medicin||sleep qualiti||obstruct sleep apnea||sleep center||sever sleep apnea,0.026||0.023||0.018||0.018||0.018||0.018||0.016||0.016||0.016||0.016||0.015||0.014||0.014||0.013||0.013,0.4,0.2,0.26666666666666666
216,Clin_Oral_Investig-4-1-2238780.txt,level||data||abras||eros||wear||teeth||smith||tooth wear||dentin||adult||evid||term||patholog tooth wear||research||age||popul||attrit||group||adolesc||clinic experi||small proport||hypothesi||progress||children,1||2||tooth||refer 1||8 1 2 10 fig. 1||part 1||tooth wear||wear||25 17 3 1 7||3||3 17 25||patholog tooth wear||3 17 20 25 25||patholog eros tooth wear||palat tooth wear,0.043||0.027||0.024||0.023||0.023||0.023||0.023||0.022||0.021||0.019||0.018||0.017||0.016||0.016||0.016,0.0,0.2,0.2
217,Appl_Microbiol_Biotechnol-3-1-1914249.txt,wastewat||ethanol||reactor||strain||srb||dna||electron donor||specif||cell||gram||oligonucleotid probe||electron acceptor||sulfat||acet||genet divers||singl energi sourc||micro-divers||presenc||substrat||full-scal sulfidogen bioreactor||sulfate-reduc bacteria,2||1 2 2 1985||3||4||1 2 fig. 1||1||2 Î¼m||2 desulfovibrio popul||2 2 1959 1962||1 3 1992||reactor 3 4||analysi desulfovibrio desulfovibrio||cell||electron donor 2||2007 fig. 4,0.025||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011,0.0,0.0,0.06666666666666667
218,Skeletal_Radiol-3-1-2042033.txt,skelet system||diagnost sensit||muscl||case||system||system muscl diseas||fat||high resolut||scanner||mri||imag||muscl diseas||patient||malign diseas||bone marrow||pet-ct||sensit||diagnost accuraci||lesion||magnet reson imag||skelet metastas||multislic CT||muscl dystrophi||patient posit||bone scintigraphi||ms-ct||excel soft tissu contrast||examin||multipl cartilagin exostos||multipl||result||assess||spatial resolut||bodi||multipl myeloma||tumor||destruct||scintigraphi||radiographi||diseas||whole-bodi imag||introduct,1||bone||suppl 1||bone imag||3 fig. 3||whole-bodi imag||whole-bodi mri||3||refer 1||imag||mri||2 3 4 5||bone marrow imag||bone marrow||eur radiol 2005,0.022||0.015||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.01,0.0,0.2,0.26666666666666666
219,Crit_Care-8-6-1065076.txt,metabol||effect||control||cardiac surgeri||intens care unit||hyperglycemia||studi||critic ill||hyperglycaemia||intens insulin therapi||ill patient||insulin||tight glucos control||patient,2||4||1 resid||critic care 7 2 4 5||tabl figur 1||5||tabl 1 featur||intens care||devo philipp 1 preiser jean-charl 2||crit care critic care||3 day||intens care unit||studi||ill patient||intens care unit patient,0.036||0.031||0.026||0.023||0.023||0.022||0.021||0.021||0.019||0.018||0.017||0.016||0.016||0.016||0.016,0.0,0.0,0.2
220,J_Neurooncol-3-1-1915654.txt,von hippel-lindau diseas||hemangioblastoma,1||2||J. 1 1||2 refer 1||2 van||netherland 2 depart||netherland 3 depart||3 month||31-402-465512 monique.hanse@cze.nl 1 3 vincent||C. J.||llc 2007 case present figur||neuro-oncolog||8 mg||ho cancer centr||clinic complaint,0.075||0.069||0.058||0.057||0.043||0.042||0.041||0.04||0.035||0.018||0.018||0.017||0.016||0.012||0.012,0.0,0.0,0.0
221,Mol_Genet_Genomics-4-1-2413074.txt,cell wall||phylogenet analysi||studi||homologu||present||strain||fungi||express||aspergilli||similar||gene||glucoamylas||alpha-amylas||glucan||starch||enzym||protein||analysi||starch-bind domain||member||group||famili||amyr||maltos||presenc||transfer||agdb||sequenc||function||result,A.||A. niger A.||A. niger A. niger||A. niger||A. niger aspergillu A. niger||2 A. niger aspergillu A. niger||1 A.||A. oryza A. niger||A. niger 2007 aspergillu A. niger||4 A. niger||A. fumigatu A.||3 A.||A. nidulan 2007 A. niger||aspergillu niger||A. niger amya,0.032||0.031||0.03||0.03||0.027||0.025||0.024||0.024||0.024||0.023||0.022||0.022||0.021||0.021||0.02,0.0,0.0,0.0
222,Bioinformation-2-2-2174422.txt,teck databas||telomer||entri||inform||centromer||chromosom||protein||databas||data||sequenc||cell,1 2 3 4 5||2007 biomed informat publish group 2007||refer 1 hiyama||10||8 9||1988 16 1201 3344208 4 kwon||methodolog 6 7||cell||cancer||protein||origin data||origin author||protein databas||centromer||inform,0.052||0.043||0.039||0.023||0.022||0.018||0.018||0.015||0.013||0.012||0.011||0.01||0.01||0.009||0.009,0.0,0.2,0.26666666666666666
223,Dev_Genes_Evol-4-1-2292473.txt,insight||insect||constraint||artifact||element||data||organ||breakpoint||region||complex||cluster||express||hox||gene||transcript||beeman||analysi||hox gene||homc||hox cluster||regulatori element||embryon develop||singl imag||sequenc||function||result,tribolium||tribolium 2005 tribolium||transcript tribolium tribolium||gene||tribolium 2003 2001 2007 tribolium||tribolium hox cluster||tribolium 2002 2006||tc-ftz tribolium||hox gene||api anophel tribolium tribolium tribolium homc||ptl tc-antp||tribolium tca-mir-iab-4||tribolium ortholog||1987 2002 tribolium tribolium 2008||keyword tribolium,0.029||0.023||0.021||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015||0.015,0.2,0.2,0.13333333333333333
224,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-2020506.txt,phosphoinositid||actin cytoskeleton||ra||gtpase||isoform||actin remodel||direct interact||actin organ||receptor||arf||pld||schmidt||stimul||enzym||protein||regul||rho||activ||synthesi||small gtpase||phosphatid acid||plasma membran||membran,2||springer-verlag 2007 2 2 2 2||2 2000 2 2005 2 2006||cell||2003 2 2001||2 phosphoinositid||1||biol chem 4:2474||2003||2001 1 2002 2001 2000 2002||mattei MA 2||2001||2 pool biochem||cell type||miller RT 2,0.038||0.027||0.025||0.024||0.023||0.02||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.013,0.0,0.0,0.0
225,Eur_J_Appl_Physiol-4-1-2374881.txt,person||muscl||mmc||ambulatori statu||non-domin side||joint||major muscl group||health-rel fit compon||studi||valu||ankl joint||relat||test||larg group||skin-fold||strength||result||mobil||young adult||joint mobil||physic fit||exercis||activ||maxim exercis test||hydrocephalu||differ||muscl strength||adolesc||particip||health-rel physic fit||aerob capac||spina bifida||compon,2||2 2||2008 2 2 2 2 2||2 2 pet 2 2||result 2 2||2 2 Î²||2 2001||2 3 2 Î²||2 2006||studi 2 1992 2 1978 2||variabl 2||2 tabl 2 descript result||1||ambulatori statu 2 3 2 Î²||netherland 2 depart,0.038||0.038||0.032||0.031||0.027||0.026||0.022||0.022||0.022||0.021||0.02||0.017||0.017||0.016||0.014,0.0,0.0,0.0
226,Eur_Arch_Otorhinolaryngol-4-1-2254466.txt,type||follow-up||case||surgic complic||surgic treatment||facial nerv||studi||recurr||rpa||patient||clinic featur||risk||nerv||multinodular||total||lesion||intervent||signific||multipl lesion||postop radiotherapi||pleomorph adenoma||tumor recurr rate||surgeri||prognost factor||tumor||parotidectomi||malign||previou oper||period,1||2||patient||2 3||4 1 5 5||4||2 cm||result 1||33.3 1||refer 1||5 year||1 summari||30.0 1||23 patient||5,0.028||0.025||0.019||0.018||0.018||0.018||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.2,0.1,0.06666666666666667
227,Arch_Sex_Behav-3-1-2042031.txt,sexual behavior||unprotect sex||men||previou std diagnos||past 3 month||studi||oral sex||patient||abus characterist||std||effect||risk||forc||sex||adult||sexual risk behavior||analys||outcom||coercion||demograph||research||penetr||gender||characterist||experi||sexual partner||group||sexual abus||episod||number||abus||limit||partner||addit||hiv||sexual act,sexual abus||adolesc sexual abus sexual||sexual health||sexual behavior||abus||sexual risk||child sexual abus||childhood sexual abus||sexual abus characterist||sever sexual abus||sexual abus sever||adolesc sexual abus||sexual abus group||sexual abus influenc||sexual abus experi,0.039||0.032||0.03||0.03||0.029||0.029||0.028||0.028||0.027||0.027||0.027||0.027||0.027||0.027||0.027,0.6,0.3,0.2
228,Virchows_Arch-4-1-2329727.txt,normal colon||epitheli cell||sdf-1||normal mucosa||carcinoma||adenoma||express||cell||hypoxia||hypox cell||mammalian target||tissu||mtor||surfac epithelium||activ||cytoplasm||pimonidazol||surfac||hif-1||presenc||sdf1||area||colorect carcinogenesi||CA IX||antigen retriev||akt||normal colon tissu||colorect mucosa,1||1 2||2||factor 1||immunohistochemistri 1 2 3||4 2||ga.meijer@vumc.nl 1 1 depart||system 1||refer 1||transport 1||1 detail||hypoxia-induc factor 1||cell||3||colorect cancer,0.027||0.025||0.023||0.018||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.013||0.013,0.0,0.0,0.06666666666666667
229,Osteoporos_Int-4-1-2277453.txt,placebo||vertebr fractur||data||studi||bone microarchitectur||osteopenia||patient||effect||risk||risk reduct||femor neck||fractur||postmenopaus women||treatment||advers event||bmd||women||nonvertebr fractur||low bone mass||analysi||popul||risedron||preval vertebr fractur||osteoporosi||fragil fractur||trial||trabecular architectur||fractur risk,fractur||1||2||fractur risk||vertebr fractur||2 13||studi||1 year||1 SD||fractur 1 fig. 1 reduct||fragil fractur fragil fractur||fragil fractur||risedron||vertebr fractur risk||1 month,0.024||0.022||0.021||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014,0.6,0.4,0.4
230,Histochem_Cell_Biol-4-1-2413111.txt,mutant form||cancer||inflamm||endotheli cell||tj||ion select||role||TJ assembl||breast cancer develop||data||tight junction strand||patient||occludin||permeabl||observ||increas||toxin||diabet retinopathi||barrier||express||evid||cell||transmembran protein||integr membran protein||barrier dysfunct||tight junction||protein||brb||factor||paracellular pathway||diseas||claudin||molecular composit||cell polar||function||TJ strand,cell||cell junction||junction||2001 2001||tight junction||cancer||endotheli cell||tight junction protein||1999||1999 2||2||tight junction barrier||epitheli cell||2001 2005||3 2001 2 2,0.019||0.017||0.016||0.015||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012,0.4,0.4,0.26666666666666666
231,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292474.txt,measur||endogen insulin level||baselin||studi||somatostatin||healthi subject||ere||optic coher tomographi||hyperglycemia||peripher area||retina||glucos||blood retina barrier||maxim hyperglycemia||subject||chang||retin thick||blood glucos level||refract error||procedur||area||fovea||diabet retinopathi||result,2||diabet||3 3 3 fig. 2||method 2 2||type 2 diabet||1 mm||30 2||diabet retinopathi||type 1||type 2 diabet mellitu||diabet patient||3 mm||1 2 polak bettin||refer 1||studi,0.038||0.029||0.028||0.027||0.025||0.022||0.022||0.021||0.021||0.02||0.02||0.019||0.019||0.019||0.018,0.0,0.1,0.13333333333333333
232,Matern_Child_Health_J-2-2-1592139.txt,program||case||preconcept||diabet||birth||individu||pregnanc||data||studi||effect||birth defect||invest||investig||intervent||perspect||analys||cost||evalu||preconcept care||women||preconcept visit||servic||care||advers pregnanc outcom||prenat care||public health program||econom evalu||health care provid||case studi||econom burden||financi return||busi case||cost-benefit analysi||health outcom||benefit||health plan||outcom||result,care||health care||health||preconcept care||1||health care provid||health care organ||health care system||health care servic||prenat care||care program||care organ||health cost||comprehens care||preconcept care group,0.034||0.029||0.024||0.024||0.021||0.02||0.02||0.02||0.02||0.019||0.019||0.018||0.018||0.018||0.017,0.4,0.4,0.26666666666666666
233,J_Chem_Ecol-4-1-2292484.txt,mechan damag||level||jasmon acid||terpenoid aldehyd||induct||total foliag||data||studi||comparison||young leav||effect||increas||gland number||higher concentr||signific||herbivori||leav||analys||individu leaf||treatment||damag||control||mechan injuri||leaf||cotton||simul herbivori||accumul||monoterpen||true leav||differ||total terpenoid||anova||number||gland||sesquiterpen||terpenoid||plant,1||2||2 2||1 4||1 4 4 1 2 3||2 4||J.||4||2 2 section||leav 2||3 4||1 4 1978a 2 G. hirsutum||plant||3||vol. 1,0.022||0.021||0.021||0.018||0.018||0.018||0.016||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.012,0.0,0.0,0.06666666666666667
234,Breast_Cancer_Res_Treat-3-1-2137942.txt,independ predictor||case||mast cell||surviv curv||core||breast cancer||studi||patient||ER score||statist analysi||MC infiltr||tma||invas breast cancer||cell||immun cell||train||prognosi||mc||total number||group||tumor||surviv||presenc||number||good prognosi||stroma||result,2||2 2||1||cell||breast cancer||analysi 2||mast cell||grade 2||2 cm||cancer patient||grade 1||breast cancer patient||tumor cell||invas breast cancer||fig. 2,0.023||0.023||0.022||0.022||0.017||0.017||0.017||0.015||0.015||0.015||0.015||0.015||0.014||0.013||0.013,0.4,0.3,0.26666666666666666
235,Matern_Child_Health_J-2-2-1592152.txt,prevent||condit||preconcept||dime birth defect foundat||profession practic guidelin||reproduct awar||health care profession||perinat period||medic condit||pregnanc||histori||patient||folic acid||perinat outcom||health statu||risk||organ||reproduct||specif type||preconcept assess||medic||nurs||unit state||profession||counsel||guidelin||health||health care||women||american colleg||effort||preconcept health||famili physician||standard||main perinat prevent strategi||servic||care||commit||poor pregnanc outcom||genet||committe||import||medicin||screen||preconcept health servic||decad||acog||diseas||nation organ||object||preconcept screen||current statu||fetal alcohol syndrom||outcom,health||health care||care||preconcept health care||preconcept health||preconcept care||1||health care profession||women âs health care||health care provid||primari health care||health care commun||health care system||preconcept||prevent care,0.025||0.025||0.025||0.022||0.021||0.021||0.019||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.016,0.8,0.5,0.4
236,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292470.txt,condit||measur||line||asthenopia||fixat cross||prism||artifici view condit||comfort||interv||session||valu||fusion vergenc||observ||test||fixat dispar||heterophoria||stimuli||eye||fusion contour||paramet||natur view condit||phoria paramet||comfort prism||deviat||noniu line||differ||eso||phoria||feedback loop||trial,1||2||2 2 2 2 fig. 2||2 9||9||4||2 3 4||prism||refer 1||19||comfort prism 2||phoria||fig. 3||patient||fig. 5,0.03||0.02||0.019||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.014||0.014,0.0,0.1,0.13333333333333333
237,Doc_Ophthalmol-4-1-2235911.txt,array||measur||commerci system||time||iscev guidelin||artifact||element||data||patient||stimulu||mferg respons||reliabl mferg record||region||clinic electrophysiolog||signal||mferg trace||retina||frame||frame frequenc||display||normal||light||report||mferg||electr nois||trace||record||fixat||size||clinic multifoc electroretinographi||procedur||local amplitud||area||waveform||record time||result,1||1 3||2||3||3 3 4 fig. 3||fig. 4||multifoc electroretinographi 1 fig. 1||contrast 2 2||ground electrod 1 3||5 3 5 5 fig. 5||stimulu||7 1 depart||1 3 fig. A4 weak signal||springer-verlag 2008 introduct 1 2||103 element 2 fig. 2 diagram,0.028||0.024||0.022||0.02||0.018||0.016||0.016||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.012,0.0,0.0,0.06666666666666667
238,Ann_Surg_Oncol-3-1-1914276.txt,van nuy classif||mammographi||tissu microarray||PR express||biolog marker express||studi||patient||van nuy||interv group||PR neg||dci||immunohistochemistri||nonattend||neu express||express||two-year interv||suffici paraffin-embed tissu||screen-detect||multivari analysi||group||differ||woman||interv dci||screen round||screen||patholog||tma group||score||chi-squar analysi,1||2||1 4||2 tabl 2||2 24||1 grade||immunohistochemistri 1 tabl 1||3 1 depart||3||1 0.2||phd 1||hanzeplein 1||1 0.1||1 ER||refer 1,0.028||0.025||0.021||0.019||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015,0.0,0.0,0.0
239,Exp_Brain_Res-4-1-2335293.txt,condit||target||measur||color||time||respons||line||veloc||attribut color||latenc||visual process||lumin||orient||basi||finger||averag||shape||curv||subject||chang||systemat differ||differ||order||refer||posit||attribut||conspicu||particip||movement||hand movement||slope,2||2 2 1||2 2 fig. 2||1 1 1||3||4 4 2 4||3 2 materi||respons 1 1 1 1||5||5 5||fig. 3||4||4 4 4 4||target||conspicu 3 4 4 4 4,0.041||0.035||0.034||0.024||0.024||0.023||0.022||0.022||0.019||0.019||0.018||0.017||0.017||0.016||0.016,0.0,0.0,0.06666666666666667
240,Int_Arch_Occup_Environ_Health-4-1-2254471.txt,elderli employe||depress symptom||men||return||studi||depress||year||social legisl||median||occup health depart||durat||compani||depress episod||compani size||dutch situat||sector||absenc||day||educ||health care||psychiatr disord||sick-leav||age||popul||employe||group||differ||part-tim return||episod||industri sector||number||symptom||work||higher risk||period,2||1||health||2 1 depart||1 year||absenc||1 day||absenc durat 1||age 2||2003||2003 2003||depress||absenc day||tabl 1 number||result 1 2 df,0.022||0.021||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.013||0.013||0.013||0.013||0.012||0.012,0.0,0.1,0.13333333333333333
241,Breast_Cancer_Res_Treat-3-1-2001220.txt,cancer||target||letrozol||ER overexpress||breast cancer||combin||studi||tamoxifen||patient||clinic||effect||microarray gene||agent||aromatas inhibitor||express||tool||treatment||cell||growth||therapi||growth factor||gene||adjuv therapi||tumor biolog||trastuzumab||recent advanc||breast tumor||combin therapi||estrogen||resist||tumor||trial||pathway||biomark,cancer||breast cancer||breast cancer breast cancer||breast cancer cell cancer||breast cancer clin cancer||human breast cancer breast cancer||metastat breast cancer breast cancer||cancer 4||breast cancer cell||letrozol breast cancer||human breast cancer cell breast cancer||breast cancer patient||trastuzumab-tr breast cancer cell cancer||breast cancer treatment||cancer patient,0.033||0.028||0.028||0.025||0.024||0.023||0.023||0.022||0.022||0.022||0.021||0.021||0.02||0.02||0.02,0.4,0.2,0.13333333333333333
242,Exp_Appl_Acarol-3-1-2039815.txt,variat||dna sequenc||host plant associ||coi||host plant||tetranychid mite||base frequenc homogen||phylogenet analysi||sampl||studi||genu||parasit||dataset||mitochondri coi phylogeni||pattern||dna||gene||phylogeograph pattern||speci delin||analysi||barcod||tetranychida||identif||reproduct parasit||taxa||select sweep||access||spider mite||posit||evolutionari relationship||speci||paup||mite||sequenc||genbank||nuclear||result,T.||2007 T.||T. kanzawai T.||1998 T.||T. cinnabarinu T.||tetranychu T. kanzawai T.||T. kanzawai T. truncatu T. urtica||2007 T. truncatu T.||T. urtica 1998 1998 2001 T.||5 T.||tetranychu urtica||1998 1998 T.||2005||tetranychu||T. urtica strain,0.021||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.012||0.012||0.012,0.0,0.0,0.0
243,Calcif_Tissue_Int-3-1-2151961.txt,lifestyl||men||spine||studi popul||data||studi||genotyp||gene||bmd||bodi||analysi||age||associ||polymorph||subject||activ men||popul||low-dens lipoprotein receptor-rel protein 5||peak bone mass||differ||bone||fat mass||signific differ||particip||bodi height||bone miner densiti||bodi mass,1||NS||NS 3||3 NS||1 4 1 depart||0.07 NS NS||fig. 1||1 subject||refer 1||58 1||1 bathum||2||bone marker 1||covari 1 3||bone,0.03||0.025||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.014,0.0,0.0,0.06666666666666667
244,Matern_Child_Health_J-2-2-1592146.txt,public health concern||risk||obes||women||postpartum||birth outcom||age||prevent studi||activ||pregnanc||intervent||bmi||weight trend||nutrit||overweight,1||health||refer 1||anna-maria am_siegariz@unc.edu 1 3||health 2003||health outcom||north carolina||women health 2003||NC north carolina 2 depart||weight gain||public health||gestat weight||pregnanc weight gain||individu health||poorer health,0.033||0.02||0.019||0.016||0.016||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011,0.0,0.0,0.0
245,Pediatr_Nephrol-4-1-2413093.txt,podocyt||slit diaphragm||lmx1b,lmx1b||lmx1b lmx1b||lmx1b gene||patella syndrom||refer 1||lmx1b lox||johnson RL lmx1b lmx1b||30||patella syndrom kidney||patella syndrom patient||lim-homeodomain transcript factor lmx1b||lmx1b ldb1 e2a||lmx1b cre nphs2 bar||gene||podocyt,0.051||0.051||0.033||0.03||0.029||0.029||0.028||0.027||0.026||0.024||0.019||0.019||0.018||0.016||0.015,0.2,0.1,0.13333333333333333
246,Ann_Surg_Oncol-3-1-2039827.txt,delay||dlt||week||maximum-toler dose||phase II studi||studi||patient||endopelv fascia||total||radiotherapi||dose||local recurr rate||day||chemoradi||surgeri||capecitabin||tumor||oxaliplatin||resect||pcr||rectal cancer||treatment cycl||result,2||2 2||1||5 2 2||2 patient||cancer||toxic 2 2 2 tabl 2||1 patient||3||38 2 2||cancer patient||day 1||4||rectal cancer||rectal cancer patient,0.024||0.024||0.021||0.019||0.018||0.018||0.017||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014,0.0,0.0,0.06666666666666667
247,Ann_Surg_Oncol-4-1-2277454.txt,grade||fasciotomi||normal tissu||ilp||radiat||surgic resect||studi||patient||perfus||st||major therapeut intervent||medic intervent||treatment procedur||long-term morbid||manag||item||irrevers function damag||extrem||tissu||sever symptom||late effect||tumor||neg impact||limb||sever||ebrt||object||soft tissu sarcoma||daili activ,1 1||1||1 3||3||3 3||2 3||2||1 4||1 1 axillari||fibrosi 1 3||2 7||2 3 poplit||toxic 0 1 2 3 4||3 patient||2 3 femor,0.037||0.037||0.037||0.037||0.037||0.034||0.031||0.03||0.025||0.025||0.024||0.023||0.023||0.023||0.023,0.0,0.0,0.0
248,Anal_Bioanal_Chem-4-1-2287205.txt,FP detect||measur||gradient hplc system||system||affin||hr||concentr||optim||wavelength||assay||coumestrol||on-lin||phytoestrogen||compound||mixtur||meoh||hr system||experi||min||organ modifi||decreas||fia||fluoresc||competit bind curv||test compound||hplc||mode||fluoresc polar||result,2||1||2 fig. 2||1 6||hplc 14 2 2||microsom incub 2 4 2||7||erÎ± affin 2||3||refer 1||2 mL 5||fig. 1 experiment||2 50 valu||50 fig. 3||7 19,0.038||0.035||0.031||0.028||0.022||0.021||0.021||0.019||0.019||0.019||0.018||0.018||0.018||0.016||0.015,0.0,0.0,0.0
249,Photosynth_Res-4-1-2173912.txt,array||structur||red alga||width||phycobilisom||cyanobacteria||project||pbss||psii||pb||electron microscopi||membran,2||3 3||3||2 1988||1 1 depart||25 nm 3 3 fig. 3||P. cruentum 3||1987 1992 3 1999 1996 2||pbs-thylakoid membran porphyridium cruentum 2||2005||aartsma@physics.leidenuniv.nl 2 zhang||netherland 2 biophys depart||2 1992 2000 2000||50 nm 3 3 thermosynechococcu||2005 85 3 13 10.1007,0.039||0.026||0.026||0.021||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.011,0.0,0.0,0.0
250,Int_J_Cardiovasc_Imaging-3-1-2121121.txt,heart failur,2007||2007 1 2 3||refer 1||2007 keyword left||4||5 6||atrial function||left atrial size||left atrial perform||left atrial volum||age group||atrial contribut||atrial function increas||atrial systol function||left atrial function eur heart,0.088||0.071||0.055||0.043||0.032||0.028||0.025||0.022||0.021||0.021||0.019||0.019||0.019||0.018||0.018,0.0,0.0,0.0
251,J_Magn_Reson-2-1-2323944.txt,equat||human brain||magnet transfer||duti cycl||optim||CW approxim||data||model||acquisit sequenc||excit puls||valu||standard deviat||two-pool model||effect||sensit||test||signal||similar||sled||paramet||solut||estim||experi||simul||flip angl||consist||ramani||CW variant||nois||excit flip angl||magnet||result,1||0 1 1||1 2||2 1||fig. 1||1 RM 0||tabl 1 fig. 1||Ï 1||Ï 1 2||2||1 tabl 2||tabl 1||1 cwpe 2||experi 1||RM,0.04||0.033||0.033||0.033||0.028||0.027||0.026||0.026||0.025||0.025||0.025||0.025||0.023||0.022||0.022,0.0,0.0,0.0
252,J_Med_Internet_Res-4-2-1761933.txt,web site qualiti||time||url||search engin||qualiti||locat||studi||medic topic||internet archiv||specif health-rel topic||site locat||inform||temporari server problem||health claim||site||health inform||address field||content||page||web||web page||uncertain period||item||web content||previou studi||attrit||topic||access||refer||issu||world wide web||viewer||health-rel web site||medic knowledg||result,1||1 2 1 0 1||2||5 1 0 1 0||1 1 1 6 0 travel||2002||1 scher||17 2 1 5 1 expert||8 6 3 2 1||0 0 0 1 0 total||tabl tabl 1||3||2 qualiti||june 2002||web,0.061||0.051||0.042||0.039||0.039||0.035||0.031||0.031||0.031||0.031||0.029||0.027||0.027||0.026||0.022,0.0,0.0,0.06666666666666667
253,Behav_Genet-4-1-2226020.txt,social interact effect||measur||find||phenotyp correl||attent problem||instrument||rate||problem||data||model||dsm||zygos||effect||correl||missing||test||variabl||cbcl||present paper||sex||environment influenc||present studi||specif||fit||item||varianc||twin||age||dsm-iv interview||cprs-r||age 12||genet||matern rate||clinic diagnos||factor||statist analys||influenc||statist power||adhd||score||children||result,1||genet||cbcl||genet effect||cbcl age 7 1||behavior genet||1 year||genet factor||genet studi||genet model||5 genet||1 edn||d.i.boomsma@psy.vu.nl 1 1 depart||1 month||72 1,0.028||0.024||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015,0.4,0.2,0.13333333333333333
254,Eur_J_Pediatr-4-1-2292482.txt,epp||photosensit||girl||erythropoiet protoporphyria||symptom||nose||children||cutan manifest||age||porphyria||sever||sun exposur||liver enzym||diagnosi||patient||skin lesion||skin symptom||protoporphyrin,1 year||2 22 13 18 23||porphyria||refer 1||netherland 2 depart||M. A. 1 1 depart||6 13 13 28||erythropoiet protoporphyria||protoporphyria||4||histochem studi||erythrocyt 2 17||porphyria patient||netherland 3 depart||cutan porphyria,0.017||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.01,0.2,0.2,0.13333333333333333
255,J_Mol_Biol-2-1-2279256.txt,bind pocket||dtdp||activ site||case||wbmf||cofactor||studi||mutat||protein function||structur||site||gmer||wbmg||antigen||gene||reaction||potenti||triad||product||wbmh||catalyt site||residu||protein||side chain||sdr||blast||phosphat||2||pdb||bind||present time||mutant||posit||substrat||function||ump||deoxythymidin diphosph||lipopolysaccharid,2 fig. 2||2||2 2 2||35 fig. 2 2||1||2 fig. 5||1 B. bronchiseptica||fig. 3 6 6 6||fig. 7||tabl 2||fig. 8||wbmf||jking01@uoguelph.ca 1 2||1 1 depart||1 E. coli,0.019||0.018||0.018||0.015||0.015||0.014||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011,0.2,0.1,0.13333333333333333
256,Childs_Nerv_Syst-3-1-1849423.txt,capillari||intracrani complianc||puls pressur||csf||subarachnoid space||chronic hydrocephalu||ventriculostomi||theori||normal-pressur hydrocephalu||hydrodynam concept||view||etv||systol pressur||systol pressur transmiss||acut hydrocephalu||treatment||etiolog||dandi||cerebrospin fluid||csf pressur||pathophysiolog||hydrocephalu||brain parenchyma||narrow capacit vessel||patent aqueduct||complianc,hydrocephalu||1 year||refer 1||studi||hydrocephalu commun hydrocephalu||19 1 5 9 14||springer-verlag 2007 object||patholog studi||chronic hydrocephalu||hydrocephalu 9 14 14||treatment||hydrocephalu research||random clinic studi||intern hydrocephalu||acut hydrocephalu,0.033||0.031||0.031||0.026||0.025||0.024||0.021||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.017,0.2,0.2,0.26666666666666666
257,Eur_J_Pediatr-4-1-2254655.txt,mechan ventil||stay||week||case||respiratori distress syndrom||air leak||patient||cpap||air||pneumomediastinum||subcutan emphysema||infect||tissu||age||spontan PM||pneumopericardium||group||intens care unit||neonat||sever||diseas||lung||children,PM||4 PM||2 PM||1 1||1||2||2 2||3 PM||5 PM||neonat PM||3 1||CT 2 PM||spontan PM||6 PM||4 week,0.038||0.036||0.034||0.034||0.034||0.03||0.03||0.03||0.029||0.029||0.028||0.026||0.025||0.024||0.024,0.0,0.0,0.06666666666666667
258,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914271.txt,effect||contrast agent||field||studi||imag||clinic arena||promis applic||specif inform||vessel wall||total plaqu burden||molecular imag||cardiovascular molecular imag||patient||therapi||cardiovascular diseas,1||2||imag||J. 2 1 depart||1 bax||refer 1||molecular imag||cardiovascular imag||fig. 7||molecular imag agent||cardiovascular molecular imag||netherland 2 depart||review 31 23 1||6 7 fig. 6||cardiac imag,0.048||0.046||0.028||0.027||0.026||0.026||0.022||0.021||0.021||0.02||0.02||0.02||0.019||0.019||0.017,0.2,0.2,0.2
259,J_Autism_Dev_Disord-4-1-2226079.txt,permeabl||autism||ratio||hyperserotonemia||blood sampl||platelet||serotonin||test||sat||studi||pdd||urin||intestin permeabl||patient||children,2||2005||1||patient||9||result patient 1||2005 2003 2005 2005 2003 1988||studi||J. 1 1 depart||2 indic||method patient||2005 washington||1 characterist||netherland 2 depart||24 patient,0.024||0.022||0.022||0.02||0.015||0.015||0.015||0.015||0.015||0.013||0.013||0.012||0.012||0.012||0.012,0.2,0.2,0.13333333333333333
260,Skeletal_Radiol-3-1-2042032.txt,prospect studi||find||week||radiograph||incident find||abnorm||non-acut knee symptom||histori||studi||year||patient||bone marrow edema||articular surfac lesion||diagnos||radiologist||convent radiograph||magnet reson imag||non-acut knee problem||knee radiograph||loos bodi||young adult||group||osteoarthr||symptom||enchondroma||knee||signific differ,1||1 1||1 1 depart||patient||7 1||fig. 1||2 1 3 2 2 2||grade 1||4||4 3||5 patient||3||2||1 osteoarthr||refer 1,0.034||0.034||0.025||0.024||0.023||0.022||0.022||0.022||0.021||0.02||0.019||0.019||0.019||0.019||0.018,0.2,0.1,0.06666666666666667
261,Breast_Cancer_Res_Treat-3-1-2137941.txt,tumour||age 50||cancer||breast tumour||cbc||missens variant||women||spectrum||studi||carrier||analysi||variant||age||atm||radiotherapi||ubc||breast cancer||mutat||treatment||patient,atm||atm 2 atm atm||cancer||atm atm atm tabl 2 atm||1 2 1 divis||llc 2007 atm atm atm atm||atm mutat||atm atm missens variant||mutat 3 2 1||refer 1||p884 1||a1309t 1 1 16||breast cancer||s377g 1||r1039x 1,0.049||0.045||0.039||0.039||0.038||0.034||0.034||0.033||0.033||0.031||0.031||0.031||0.03||0.03||0.03,0.4,0.2,0.2
262,Pediatr_Radiol-3-1-1915603.txt,oper find||find||boy||children||viabl abdomin test||studi||patient||test||abdomen||re-examin||testi||npt||testicular posit||udt||laparoscopi||surgeri||surgic procedur||posit||physician||paediatr surgeon||result,1||refer 1||2||J. 1 1 depart||1 fig. 1 ultrasound find||springer-verlag 2007 introduct 1 2||3||test||3 4||1 leyman paul||1 madern gerard||2 3 5 6 7||4||21||61 88 38 1,0.037||0.025||0.021||0.02||0.018||0.016||0.015||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.012,0.0,0.1,0.06666666666666667
263,Virchows_Arch-3-1-1888715.txt,respons||partial cribriform prolifer||chi-squar test||reexcis||flat epitheli atypia||studi||patient||question||pathologist||interobserv variabl||criteria||atyp hyperplasia||lesion||adh||ductal intraepitheli neoplasia||signific||high proport||manag||resect margin||respond||number||invas carcinoma||duct||survey||diagnosi||breast||hyperplasia,breast||1||2||question 1||breast lesion||question 2||3||5||breast patholog||cancer||1 mm||2 mm||earli invas breast cancer breast cancer||earli breast cancer evolut breast cancer||5 year,0.023||0.02||0.019||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
264,Soc_Sci_Med-2-1-2430159.txt,institut consult||find||depart||global economi||salari||practic||research consult||individu||problem||health-rel research||africa||govern depart||limit research capac||academ research||research programm||low univers salari||sub-saharan africa||northern||east africa||overhead||social scientist||research capac||global econom inequ||consult||institut||staff||health||ngo||research||social scienc capac||senior social scientist||contract||senior||report||uganda||agenc||local capac||interviewe||univers staff||donor,research||develop research||research consult||consult research||research capac||health research||senior research||medic research||research programm||junior research||individu research||academ research||research centr||northern research||research contract,0.053||0.032||0.032||0.032||0.032||0.031||0.03||0.03||0.029||0.028||0.028||0.028||0.028||0.028||0.027,0.6,0.4,0.3333333333333333
265,Int_J_Hematol-4-1-2330061.txt,cdna||cocultur||gene||cfc assay||defect||increas||stromal cell||mice||microarray||analysi||express||anim experi||hematopoiet stem cell||cell||hsc,cell||1||4 cell||pa6 cell||2||stem cell||10 cell||stromal cell||subclon cell||ksl cell||progenitor cell||op9 cell||expand cell||cell fate||colony-form cell,0.037||0.026||0.025||0.024||0.023||0.022||0.022||0.022||0.02||0.019||0.019||0.019||0.019||0.019||0.019,0.2,0.2,0.13333333333333333
266,Clin_Auton_Res-3-1-1858602.txt,attent||deficit||sampl||duschek||recent research||studi||hypotens individu||blood pressur||test||memori||clinic practic||hypotens||brain||cortic activ||cognit||brain perfus||relationship||eeg studi||lower limit||group||perform||limit||cognit test||cognit deficit||tonic brain perfus||cerebr blood flow||cognit perform||strong evid||addit,1||1 studi||hypotens||constitut hypotens 1||blood||refer 1||constitut hypotens 4 1 6||hypotens 17||studi||hypotens 26||1 7 3 8 9||3 fig. 3||blood pressur||40 hypotens||hypotens 25,0.022||0.016||0.014||0.013||0.012||0.012||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.009,0.2,0.2,0.2
267,Immunogenetics-3-1-1914291.txt,gene||rhesu macaqu||indian rhesu macaqu||clone||macaqu||evolut||loci||cynomolgu macaqu||vertebr speci||chines origin||polymorph||region configur||haplotyp||sequenc||allel,A1||2||1||3001 2 A1||7001 3 2 A1||0515 3 3 A1||0515 3 A1||0513 3 A1||0511 3 A1||051201 3 A1||81 A1||77 A1||1301 2 4 A1||80 A1||3 3 4 1,0.031||0.021||0.019||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.016,0.0,0.0,0.0
268,Eur_J_Pediatr-4-1-2292480.txt,colchicin||fmf||amyloidosi||attack||famili mediterranean fever||month||patient||treatment||chest pain||anakinra,1||1 5 1||2 mg||1 mg||2 4||refer 1||3 5||5||itali 2 depart||3 month||fever||5 suppl 42||famili mediterranean fever||month||famili mediterranean fever patient,0.068||0.057||0.047||0.047||0.041||0.038||0.036||0.036||0.031||0.027||0.023||0.018||0.016||0.016||0.016,0.0,0.0,0.13333333333333333
269,Intensive_Care_Med-3-1-2092441.txt,mechan||mortal||control||acut respiratori distress syndrom||criteria||ali||children||studi||ard||acut lung injuri||incid||diseas||cd||patient||unit||admiss||high morbid||syndrom||result,2||1||result 2||R. 2||8||refer 1||netherland 2 depart||1 van woensel||ventil patient||patient||pediatr patient||1 baselin patient characterist||B. 1 van rijn||sepsi 3||2005,0.039||0.033||0.022||0.022||0.021||0.018||0.017||0.017||0.015||0.014||0.014||0.013||0.013||0.012||0.012,0.0,0.1,0.06666666666666667
270,Diabetologia-4-1-2292423.txt,paee||type 2 diabet||follow-up||measur||level||triacylglycerol||diabet||reduct||individu||bodi size||total bodi movement||baselin||data||year||bmi||risk||hdl-cholesterol||increas||systol blood pressur||metabol subcompon||metabol syndrom||variabl||analys||fit||zm||glucos||accelerometri||metabol risk||associ||chang||activ||aerob fit||differ||score||height||physic activ||waist circumfer||particip||statist signific,1||1 1 fig. 1||1 2||1 proactiv||1 year||refer 1||result 1||2||metabol||1 7 9||1 year outcom||1 year follow-up||19 1 20||metabol risk||diabet,0.048||0.037||0.036||0.034||0.031||0.026||0.026||0.023||0.023||0.022||0.022||0.021||0.018||0.018||0.018,0.0,0.0,0.13333333333333333
271,Breast_Cancer_Res_Treat-4-1-2217623.txt,effect||risk||gene||entri||differ||case||age||variant||polymorph||popul||meta-analys||data||breast cancer||studi||estrogen receptor||result,2||1||cancer||pvuii||2 pvuii xbai pvuii||xbai 1||breast cancer||1 2 hofman||2 20||breast cancer risk breast cancer||breast cancer prevent breast cancer||2 siem||breast cancer risk||breast cancer case||tabl 2 pvuii xbai genotyp,0.042||0.036||0.032||0.031||0.031||0.027||0.027||0.027||0.025||0.024||0.022||0.022||0.021||0.021||0.02,0.0,0.1,0.06666666666666667
272,Cancer_Immunol_Immunother-4-1-2253649.txt,cancer||clinic impact||studi||patient||hla||colon||stromal cell||immunohistochemistri||low||analys||impact||prognosi||local recurr||group||tumor||surviv||differ||low express||number||total absenc||rectal cancer||irradi||msi||hla express||result,cancer||1||rectal cancer 1 1||cancer patient||tumor||colorect cancer cancer||cancer clin cancer||rectal cancer||tumor cell||colorect cancer||rectal cancer patient||1 1 1 II 2.2||0.001 1||2||2 2,0.028||0.026||0.022||0.022||0.021||0.021||0.02||0.018||0.018||0.018||0.017||0.016||0.015||0.015||0.015,0.4,0.3,0.2
273,Virchows_Arch-3-1-1888720.txt,cancer||case||icc||data||studi||seri||valu||clinic outcom||patient||neg control||high homogen||immunohistochemistri||express||cell||multivari analysi||liver cirrhosi||immunohistochem||apoptosi||surviv||antibodi demonstr||cholangiocarcinoma||liver fluke infest||tumour cell,1||2||3||cox-2||1 21 2||5 1||6 1||tumour cell||cox-2 express||cell||refer 1||2 analysi||fig. 3||IV 5 1||23 3,0.024||0.02||0.019||0.018||0.018||0.017||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012,0.0,0.2,0.13333333333333333
274,Matern_Child_Health_J-2-2-1592246.txt,infant||behavior||birth||pregnanc||matern||state||perinat outcom||effect||risk||medicaid||primari care provid||profession organ||matern mortal||unit state||deliveri||intervent||evid||primari care||health||preconcept care||women||age||matern complic||servic||prenat care||american academi||pregnanc outcom,1||health||2||health care||preconcept health||care||refer 1||women health care||preconcept care||women health||matern health||health care system||preconcept period 1||2002||health unit state,0.021||0.018||0.017||0.016||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011,0.2,0.2,0.13333333333333333
275,J_Mol_Med-4-1-2374880.txt,effect||renin level||tissu angiotensin gener||bind||blockad||prorenin||activ site||renin receptor||renin inhibitor||renin inhibit||enzymat activ||tissu||receptor||site||function||renin||low pH||vitro studi||activ||gener,2||prorenin||prorenin receptor||type 1||receptor||2 activ||renin receptor||prorenin activ||renin||renin receptor activ||2008||activ||refer 1||prorenin 1 3 8 9||2 diabet,0.023||0.022||0.021||0.021||0.021||0.021||0.02||0.02||0.02||0.02||0.019||0.018||0.018||0.018||0.017,0.4,0.4,0.3333333333333333
276,Graefes_Arch_Clin_Exp_Ophthalmol-3-1-2082068.txt,eog channel||glaucoma||preval||ocular blood flow||high preval||visual field defect||studi||patient||nerv fiber layer thick||polysomnographi||ahi||apnea-hypopnea index||posit correl||optic nerv perfus defect||control||systol blood veloc||iop||obstruct sleep apnea syndrom||RI increas||factor||group||intracrani pressur increas||ophthalm arteri||sever osa group||oari||risk factor||sever||crari||result,1||patient||glaucoma patient||4 fig. 1||4 glaucoma patient||osa patient||refer 1||glaucoma||1 comparison||2||11 patient||4||31 patient||sleep||fig. 2,0.029||0.022||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014,0.2,0.2,0.13333333333333333
277,Crit_Care-6-3-137445.txt,cathet||case||complic||femor arteri||pseudoaneurysm||rate||studi||haemodynam monitor||patient||radial arteri||arteri cathet||sepsi||risk||site||radial||infect||axillari arteri||ischaem damag||paper||dorsal pedi||incid||present review||brachial||arteri||temporari occlus||report||arteri cannul||factor||patient popul||risk factor,0||0 0||113 0 0 0 0||85 0 0 0||0 1||25 0 3 0 0||arteri||118 0 18 0 0||62 0 16 0 0||50 0 1 0||245 0 1 0||200 0 60 0 0||42 0 1 0 1||0 54||64 0 3 1 0,0.05||0.05||0.04||0.038||0.036||0.034||0.033||0.031||0.031||0.031||0.031||0.031||0.029||0.028||0.028,0.0,0.1,0.06666666666666667
278,Cancer_Causes_Control-2-2-1764594.txt,program||method||feder poverti level||mammographi screen||grante||breast cancer||data||state||breast cancer screen||year||screen rate||mammogram||provid||cervic cancer earli detect program||health insur||ethnic background||percentag||women||estim||poverti level||hispan origin||popul||poverti||servic||famili incom||prevent servic task forc||uninsur women||nation level||number||nation breast||race||elig||ethnic,1||250||2||cancer||1 state||women||1 1 divis||1 number||3||result 1||appendix 1||breast cancer screen||2 number||refer 1||1 fig. 1 note,0.02||0.019||0.017||0.014||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011,0.0,0.1,0.13333333333333333
279,Matern_Child_Health_J-2-2-1592147.txt,pregnanc||smoke,1||1 2 3||patient||4 5 4 6||6||3 1 offic||patient consent||health||suppl. 2||2004 6 suppl||2004||http://www.ntrjournal.org/pregnancy.html. refer 1||diseas control||2 barker diann||8 7,0.035||0.028||0.02||0.019||0.019||0.019||0.018||0.017||0.017||0.017||0.016||0.015||0.014||0.014||0.014,0.0,0.0,0.0
280,Histochem_Cell_Biol-3-1-2137940.txt,antibodi||morpholog||method||dna break||sentinel||apoptot cascad||staurosporin||probe||marker||cytochem techniqu||apoptot cell||tissu section||tunel assay result||light microscopi||necrosi||specif||cell||ssdna antibodi||wide varieti||transmiss electron microscopi||apoptosi||tunel assay||cell death||tissu||protein||electron microscopi||activ||import||caspas||mode||varieti||detect,cell||apoptot cell||cell death||cell detect||cell biolog||apoptot cell death||1||cell interact||cell cultur||total cell||necrot cell||cell prepar||cell death 2007 2007||cell surfac||cell death modal,0.034||0.023||0.022||0.02||0.019||0.018||0.018||0.018||0.018||0.018||0.018||0.018||0.018||0.018||0.015,0.6,0.3,0.2
281,Diabetologia-3-1-1781097.txt,pten||key regul||studi||insulin sensit||glucos toler test||primari myocyt||insulin signal||pancreat area||insulin||cell||insulin hypersensit||blood sampl||blood||glucos||insulin inject||mice||protein||activ||blood glucos level||glucos uptak||incub||haploinsuffici||inject||vivo,pten||2 pten pten||1 pten||2 2 pten||3 pten||method pten pten||interpret pten pten||18 pten||3 pten 9 11 pten pten||5 pten||2||pten gene||6 12 pten pten||tabl 2 pten||pten activ,0.042||0.036||0.031||0.03||0.03||0.029||0.028||0.026||0.025||0.025||0.024||0.024||0.024||0.023||0.023,0.2,0.1,0.06666666666666667
282,Environ_Health_Perspect-115-3-1849945.txt,author||level||lead||measur||occup||higher level||effect||current||worker||review||relat||stronger predictor||increas||acut effect||test||cognit function||health effect||adult||blood lead||dose||evid||sourc||blood||cognit||analysi||age||associ||current exposur||psychiatr symptom||cumul exposur||report||bone||exposur||consist||symptom||manual dexter||past||chronic effect||neurobehavior test score||cumul lead dose||function||outcom,lead||lead lead||lead exposur||blood lead||lead dose||lead level||tibia lead||bone lead||patella lead||lead worker||lead oxid||lead biomark||lead smelter||lead toxic||inorgan lead,0.035||0.035||0.022||0.022||0.021||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.018,0.4,0.2,0.13333333333333333
283,Appl_Microbiol_Biotechnol-4-1-2266783.txt,metabolit||biodegrad||monooxygenas||final volum||hydroxymucon semialdehyd||strain||organ||carbon||degrad||hydroquinon||batch cultur||energi||solid MM||cell||reaction||enzym||hydroxyquinol||sole sourc||growth substrat||reaction mixtur||activ||high-perform liquid chromatographi||fluorid||cultur||phenol||catechol||benzoquinon||substrat||pathway||tree||peak||cell-fre extract||intermedi||result,2||1||2 2 fig. 2||1 mM||1 mM 3||1 ml||3||2 uptak||2 consumpt||d.b.janssen@rug.nl 1 1 depart||lc-m analysi 1 4||netherland 2 depart||ml||fluorid concentr 1||2 janssen dick,0.031||0.029||0.026||0.023||0.021||0.021||0.018||0.017||0.017||0.016||0.014||0.012||0.012||0.012||0.012,0.0,0.0,0.0
284,Plant_Mol_Biol-4-1-2238787.txt,type||seed||stress toler||level||atipk2Î²||transgen||relat||increas||test||inositol polyphosph kinas||continu white light||express||treatment||stress||gene||tobacco||transcript level||higher plant||alpha level||wild type||activ||abiot stress||toler||replic||western blot analys||salt||medium||plant||result,atipk2Î²||atipk2Î² 2||1 atipk2Î² arabidopsi atipk2Î² atipk2Î²||arabidopsi atipk2Î²||3||atipk2Î² atipk2Î² arabidopsi 2 fig. 2||plant||ipk2 atipk2Î² atipk2Î²||2||2 2 2 2||2 2 2||2 2||protein atipk2Î²||atipk2Î² protein||arabidopsi,0.038||0.032||0.03||0.03||0.028||0.027||0.026||0.026||0.026||0.026||0.026||0.026||0.024||0.024||0.022,0.2,0.2,0.13333333333333333
285,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2190783.txt,condit||contour articular prosthet||osteochondr defect||data||studi||contact pressur||experiment studi||test||cartilag||articular compon||flush implant||implant result||sensor||medial femor condyl||ground||devic||implant||test condit||specimen||peak contact pressur||posit||full extens||stanc posit||knee||trial||articular cartilag defect||prosthesi||result,1||NS||3 NS 1||4 NS 1||3 1||2||8 NS 1||9 NS 1||29 NS 1||23 NS 1||2 NS 30||2 fig. 2||1 year||3 1 fig. 3||refer 1,0.028||0.025||0.022||0.021||0.02||0.02||0.019||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.015,0.0,0.0,0.0
286,J_Interv_Card_Electrophysiol-4-1-2262917.txt,cathet||time||system||sheath||accessori pathway||cathet tip||data||studi||patient||tip||artisan control cathet||ablat||human||magnet navig||forc||ablat cathet||cathet ablat||outer sheath||left femor vein||artisan||oper||robot ablat||steerabl guid cathet||map||cardiac arrhythmia||left atrium||radiat exposur||posit||remot cathet ablat||robot navig||procedur||effect remot navig||result twenti patient||laboratori,1||1 fig. 1||2||1 5||cathet||cathet ablat||ablat cathet||1 year||ablat||method 1||refer 1||1 cm||cathet ablat procedur||remot cathet ablat||4,0.032||0.026||0.021||0.02||0.02||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.016||0.015||0.015,0.2,0.4,0.3333333333333333
287,Microbes_Infect-2-1-2426737.txt,gene||sequenc||rab||express profil||parasit||apicomplexa||transcript||protein||rab gtpase||function||analysi||intracellular parasit||cluster||upstream region||motif||specif||vesicular traffic||famili,1||rab||12||2||T.||T. parva rab fig. 1||P. falciparum rab rab||rab T. parva P. falciparum rab||tabl 1 P. falciparum rab||tabl 2 T. parva rab||T. annulata T. parva rab T.||T. parva T.||P. falciparum rab fig. 3||2 P. falciparum||fig. 4,0.021||0.02||0.02||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014,0.2,0.1,0.06666666666666667
288,Clin_Rheumatol-3-1-1847465.txt,rheumatoid arthriti||disabl||fibromyalgia,health||arthriti||2 1 centr||refer 1||2006||rheumatoid arthriti||arthriti disabl||mental health||arthriti australia||chronic health condit||popul health||function health statu||health statu measur||arthriti care||19 20,0.029||0.024||0.023||0.021||0.02||0.017||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.013||0.012,0.0,0.1,0.06666666666666667
289,Pflugers_Arch-4-1-2226063.txt,level||integrin stimul||integrin function||ldh||releas||studi||intact ctni||viabl cardiomyocyt||integrin||assay||necrosi||cell||day||ldh activ||control||activ||ctni||incub||cultur||control cardiomyocyt||propidium iodid||chemiluminesc||cardiomyocyt||medium,2||2 2||grgd||3 2 grgd grgd||ctni 1 2 grgd grgd||1||grgd sdgrg grgd||fig. 2||grgd sdgrg||4||3||sdgrg||32 grgd grgd 25 sdgrg||discuss grgd||necrot cardiomyocyt grgd,0.031||0.031||0.025||0.024||0.022||0.021||0.021||0.021||0.019||0.017||0.017||0.014||0.014||0.013||0.013,0.0,0.0,0.0
290,J_Muscle_Res_Cell_Motil-3-1-2045119.txt,iso-osmot ringer||find||increas||nerv fibr||diamet||conduct||osmolar||waveform||skelet muscl||local circuit current||earli surfac||membran potenti||conduct veloc||valu||constant||extracellular osmolar,2||2 1 2 2 2||1||2 osm 2||2 2 1969 2||1 osm 1 2||osm _ 2||2007||1972 2||2 vol||2006 fig. 2||extracellular osmolar 2||cell motil||2001 fig. 1||chapter 1,0.037||0.035||0.031||0.029||0.029||0.028||0.025||0.022||0.022||0.021||0.02||0.02||0.018||0.017||0.016,0.0,0.0,0.0
291,Pediatr_Nephrol-3-1-1805045.txt,plasmapheresi||allograft surviv rate||nativ kidney nephrectomi||rate||patient||LD graft||recurr||induct therapi||regimen||risk||subsequ report||cyclosporin||recurr rate||pre-op PP||esrd||remiss||nativ kidney||graft||incid||transplant||factor||report||recipi||fsg||graft surviv||clinic recurr||diseas||pediatr renal allograft recipi,transplant||1||refer 1||pediatr renal transplant||renal transplant||pediatr kidney transplant||transplant kidney||kidney transplant||pediatr kidney transplant recipi||LD transplant||pediatr recipi||pediatr transplant suppl 6:59||transplant impact||live-rel renal transplant||pediatr patient,0.027||0.027||0.026||0.02||0.02||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014,0.2,0.1,0.06666666666666667
292,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292476.txt,prism||vergenc adapt,2||2008||12 1 5||refer 1||springer-verlag 2008||clinic||8 9 8 8 9 10||binocular vision clinic||clinic aspect||16 8 9||vergenc||clinic literatur||binocular vision||clinic benefit||clinic manag,0.039||0.038||0.032||0.032||0.027||0.026||0.023||0.019||0.019||0.018||0.018||0.017||0.015||0.015||0.014,0.0,0.0,0.0
293,Eur_J_Appl_Physiol-3-1-2039775.txt,muscl||level||time||veloc||rate||upper arm-forearm||prolong test||standard deviat||ipl method||lower||effect||mup||lowest forc level||posit task||increas||forc||variabl||motor unit||within-subject standard deviat||dynam||MU activ||present studi||pv||mvc||sd-pv||motor unit potenti||load||dynam contract||paramet||declin||task||higher valu||experi||subject||skew||activ||mup frequenc||lower valu||initi phase||order||prolong dynam test||motor unit discharg||muscl fibr conduct veloc||posit||peak||peak frequenc||shift||load torqu,1||1 2||2 1||2 1 3||2||1 2005||4||1 2004||result 1||3 4||3||3 3||mvc 4 4 3 4 4||2 min||mvc 4 3 4,0.031||0.026||0.026||0.023||0.021||0.018||0.018||0.018||0.017||0.017||0.016||0.016||0.015||0.014||0.014,0.0,0.0,0.0
294,Int_Arch_Occup_Environ_Health-4-1-2413126.txt,level||case||atherosclerosi||chd||individu||studi||offic worker||carotid arteri||global stress level||correl||risk||scale||imt||stress||smoke||neg correl||work-rel stress||earli atherosclerosi||ldl||employe||healthi lifestyl||factor||sera||low decis latitud||presenc||work||plaqu||result,stress||2||1||3||studi||work-rel stress||2005||job stress||2002||2001||stress work||work stress||stress respons||perceiv stress||relat stress,0.019||0.016||0.016||0.015||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011,0.4,0.3,0.2
295,BMC_Genomics-5-_-375527.txt,match||set||measur||concentr||human promot||bind site||refseq||transcript factor||tfb||gene express||correl||human||threshold||z-transform||promot sequenc||regulatori region||promot||statist analysi||chromosom||cluster||signific||gene||cgi||approach||analysi||list||pwm||score||statist signific||matrix||sequenc||result,2||1 2||1||sequenc||1 2 3||2 3||4 2||23 1 1||genom sequenc||promot sequenc||tabl 2||3||3 3 3||figur 1||tabl 1,0.019||0.018||0.018||0.016||0.016||0.015||0.015||0.014||0.014||0.012||0.012||0.012||0.012||0.011||0.011,0.2,0.2,0.13333333333333333
296,Bioprocess_Biosyst_Eng-2-2-1705473.txt,condit||lower level||lactat overflow||level||case||lactat product||maxim glutam concentr||ldh||final stoppag||gdh||strategi||step chang||constant control||ferment process||metabol balanc||glutam product||metabol flux||enzym||ferment||glutam ferment||metabol flux analysi||activ||tca metabol flux||lactat||bmc||agit rate||tca cycl||glutam||balanc metabol control||oxygen concentr||result,2||4 2 2 4||1 2 4||1||4 2 2 2 2 5||4 2 1 4 5||4||3 4||5 2||3||constant control 1 2 2||6 1 4||control level 1 fig. 1||control level 1 3||metabol,0.035||0.03||0.03||0.03||0.03||0.026||0.026||0.025||0.025||0.024||0.024||0.022||0.021||0.02||0.019,0.0,0.0,0.0
297,Ann_Gen_Hosp_Psychiatry-2-_-162166.txt,attent deficit disord||auditori cortex||respons||auditori deficit||psychoacoust||electrophysiolog test||patient||dyslexia||speech stimulu||test||capd||disord||central auditori deficit||evalu||mental retard||paper||great varieti||central auditori process disord||disabl||mental disord||central auditori system,auditori||2003||central auditori||auditori test||auditori process disord||central auditori disord||central auditori process||1||auditori deficit||central auditori process disord||central auditori test||auditori dysfunct||auditori cortex||auditori pattern||auditori inform,0.036||0.026||0.024||0.024||0.023||0.022||0.021||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.019,0.0,0.2,0.2
298,Int_J_Colorectal_Dis-3-1-2039795.txt,sln procedur||sln||case||number||colon carcinoma||multi-centr studi||studi||ihc||lymph node||aberr lymphat drainag||micrometastas||procedur||result||sentinel lymph node||posit node||patient||multi-centr set||lymph node metastas||tumour cell||group,patient||node||cancer||2 result||colorect cancer patient||netherland 2 depart||15 patient||colon cancer||refer 1||lymph node||5 5||hanzeplein 1||20||colorect cancer||4,0.021||0.02||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015,0.2,0.2,0.13333333333333333
299,Obes_Surg-4-1-2226018.txt,person||vertic||follow-up||time||questionnair||neurotic||self-esteem||studi||year||patient||psychopatholog||psycholog variabl||follow-up assess point||bodi imag||norm group||relev norm group||respect||psychosoci function||psychosoci||gastroplasti||surgeri||weight||social anxieti||bariatr surgeri||morbid obes||extrem obes||signific differ||mix result||addit||score||signific improv||gener popul,1||2||2 year||2 1 depart||2 tabl 2 postop||25 1||patient||refer 1||year||psychosoci||psychosoci function||patient group||13||obe 2003||6,0.028||0.025||0.019||0.018||0.016||0.016||0.016||0.015||0.013||0.012||0.012||0.012||0.012||0.012||0.012,0.0,0.3,0.26666666666666666
300,Invest_New_Drugs-3-1-2039853.txt,cancer||administr||studi||patient||mtd||atp||effect||infus||nurs||disord||side effect||dose||pre-termin cancer||chest discomfort||dyspnea||pre-termin cancer patient||medic supervis||cardiac ischemia||maximum dose||reason||home||presenc||lower mtd||day care center||cardiac disord||lung cancer||deep breath,1||1 infus||1 3||2||1 4||2 side effect||1 1 depart||1 5||side effect||side effect side effect||effect||infus||0||ctc 2 side effect||3,0.035||0.028||0.028||0.027||0.025||0.025||0.025||0.024||0.024||0.024||0.023||0.022||0.021||0.02||0.02,0.0,0.1,0.2
301,Osteoporos_Int-3-1-1820757.txt,vertebr fractur||independ correl||apo polymorph||spine||vertebr bodi||lipid profil||studi||multipl regress model||wrist fractur||risk||observ||fractur||postmenopaus women||acut cardiovascular event||serum triglycerid||lipid||osteoporot fractur||total cholesterol||bmd||bodi composit||women||observ studi||hip||aorta calcif||associ||factor||independ contributor||differ||bone||serum lipid||osteoporosi||signific differ||sever||cardiovascular event||triglycerid||bone loss||apob||bone miner densiti||cardiovascular diseas,2||1||AC 2||1 year||2 christiansen||2 cohort||0.1 2||studi||5.0 2||fractur||bone||AC 2 tabl 2 independ correl||fractur 4||refer 1||1 werg,0.024||0.02||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.01,0.0,0.2,0.2
302,Diabetologia-4-1-2170456.txt,follow-up||case||diabet||birth||baselin||studi||year||middle-ag women||bmi||baselin recruit||durat||risk||whr||type 2 diabet mellitu||analys||glucos||trend||dietari intak||age||month||associ||breast-feed||weight||parou women||number||physic activ||particip||diabet mellitu||children||in-person interview,2||model 2||type 2 diabet||diabet||type 2 diabet mellitu||0.001 2||hypertens 2||type 2 diabet case||2 yang||studi||1||tabl 2 associ||2 5 6||shanghai diabet studi||diabet mellitu,0.036||0.025||0.024||0.022||0.02||0.02||0.019||0.019||0.019||0.018||0.017||0.016||0.016||0.015||0.015,0.4,0.3,0.26666666666666666
303,Infect_Genet_Evol-1-5-2080692.txt,malaria||south asia||egg||hookworm infect||human hookworm infect||locu||analysi||individu||popul||associ||chitin||data||chitotriosidas||studi||evid||infect||tropic diseas||allel,chit1||2||chit1 chit1 tabl 2||chit1 tabl 1||chit1 chit1 genotyp||2001 chit1||abstract chit1 chit1||tabl 2 chit1 genotyp||1997 chit1 chit1 chit1 locu||1 chit1 mutat||popul genotyp chit1||chit1 brooker||st chit1||2003 chit1 genotyp||popul,0.023||0.02||0.019||0.018||0.017||0.016||0.015||0.015||0.015||0.014||0.013||0.012||0.012||0.012||0.012,0.0,0.0,0.06666666666666667
304,Ann_Biomed_Eng-2-2-1705544.txt,mpa||breakdown||level||system||stress level||bioreactor||sampl||studi||densiti||linear bear||PG breakdown||mechanotransduct||compress||displac||strain||test||abil||tissu engin bioreactor||menisc tissu||pressur||cycl||stress||mechan stimuli||load||physiolog load||meniscu||gag||greater PG breakdown||cell death||standard||pressur film||deep zone||displac control||usa||differ||explant||dynam compress||incub||load cell||larg load||actuat||film||meniscectomi||media||result,3||2||2 2 figur 2||1||system 3 figur 3||9 2 10 3 figur 9||figur 10||figur 8||18 3 4 2 figur 4||compress||compress rod||load||bioreactor 1 Î¼ figur 1||3 mm||tabl 3,0.023||0.021||0.021||0.02||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014,0.0,0.1,0.13333333333333333
305,Purinergic_Signal-3-4-2072912.txt,adenin receptor,3||3 3 3||3 3 12 3 11 12||3 A. xylosoxidan 3||3 3 A. xylosoxidan||3 50||1||result 3||3 20 12 3 21||2||7 2||7||1 achromobact achromobact 1 1||4 3 achromobact xylosoxidan||A.,0.051||0.051||0.034||0.034||0.034||0.031||0.03||0.028||0.026||0.024||0.023||0.023||0.022||0.021||0.02,0.0,0.0,0.0
306,Environ_Health_Perspect-114-9-1570082.txt,particul air pollut||measur||method||spe||cross-valid||concentr||kriging-bas estim approach||locat||data||studi||valu||model||geocod address||geograph inform system||spatial correl||se||population-bas studi||unit state||site||krige||daili ambient PM||semivariogram paramet||day||averag PE||approach||estim||rmss||rang||location-specif PM||cross-valid paramet||weight least-squar method||address||PM estim||semivariogram||result,10||10 10 3 10 3 3||tabl 1 10||1||10 10 concentr||tabl 3 10 3||10 2.5||tabl 4 10 10||10 10 distribut||4 10 3||10 2.5 tabl 1 2||3 10 concentr||10 2.5 data||ordinari krige 10||10 year,0.023||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.013,0.0,0.0,0.0
307,Histochem_Cell_Biol-4-1-2413109.txt,actin cytoskeleton||patj||membran asymmetri||junction format||molecul||recent evid||apico-bas polar||par3||complex||jam||aj||signal||adheren junction||specif||cell||protein complex||afadin||local||tight junction||protein||associ||lgl||format||bind||small gtpase||par protein||apkc||interact||major multiprotein complex||claudin||cell polar||membran||function,cell||cell junction||epitheli cell||cell adhes||cell polar||epitheli cell exp cell||cell adhes protein||cell contact||cell polar protein||cell type||cell biolog||cell prolifer||endotheli cell||schwann cell||cell surfac,0.051||0.033||0.032||0.031||0.03||0.029||0.029||0.028||0.028||0.026||0.026||0.026||0.026||0.026||0.026,0.4,0.2,0.13333333333333333
308,Exp_Appl_Acarol-3-1-2039800.txt,eriophyida||dgt||slt||infest||phytoseiida||data||predatori mite||densiti||space||coconut||perianth||bulb||coconut palm||adult femal||cultivar||surfac||gap||coconut fruit||size||coconut mite||mite||sri lanka||narrow space,N.||2||N. baraki||N. baraki N. baraki N. baraki||1 cm||3 4 N. baraki||fig. 3||tabl 1 analysi||N. baraki N. paspalivoru N. paspalivoru||1 2 sabe mauric||5 N. baraki||2007||studi||statist analysi N. baraki||1 cm Ã,0.025||0.023||0.021||0.021||0.021||0.018||0.018||0.017||0.016||0.016||0.016||0.016||0.015||0.014||0.014,0.0,0.0,0.0
309,Eur_Radiol-3-1-2039780.txt,case||fat||renal arteri stenosi||mri||imag||higher sensit||studi||patient||renal cell carcinoma||adc||enhanc||lesion||magnet reson imag||renal arteri||renal imag||potenti kidney donor||pseudocapsul||angiomyolipoma||tumor||renal lesion||signal intens||oncocytoma||malign lesion||opposed-phas imag||function||kidney,1||renal cell||renal imag||renal tumor||renal cell carcinoma||renal lesion||renal donor||10 1 11 fig. 1||malign renal lesion renal cell||renal diseas||TE 1||renal angiomyolipoma||renal arteri||renal neoplasm||1 30,0.022||0.018||0.018||0.015||0.015||0.015||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013,0.4,0.3,0.26666666666666666
310,Diabetologia-4-1-2170455.txt,retin haemodynam||blood flow||level||measur||diabet particip||paramet||good glycaem control||diabet||retin vessel||retinopathi||type 1 diabet||blood glucos||diabet retinopathi||individu||abnorm||retin circul||studi||year||patient||haemodynam measur,diabet||type 1 diabet||type 1||diabet retinopathi||type 1 diabet research||diabet control||diabet individu||diabet particip||insulin-depend diabet||keyword diabet||diabet 8.8||applic 1||refer 1||1 characterist||1 schaumberg,0.052||0.04||0.034||0.033||0.032||0.031||0.029||0.029||0.027||0.027||0.026||0.026||0.025||0.025||0.025,0.6,0.4,0.26666666666666666
311,J_Headache_Pain-4-1-2386850.txt,european countri||tth||chronic headach||interest||burden||preval||direct cost||data||studi||year||europ||life||patient||neurolog disord||qol||countri||impact||cost||day||headach||estim||public health perspect||social function||popul||methodolog||differ||headach patient||work||migrain||disabl||partner||children,headach||headach headach||studi||1||cost studi||migrain headach||headach impact||headach patient||cost||headach disord||econom cost||population-bas cost studi||compar studi||headach pain||control studi,0.019||0.019||0.018||0.017||0.015||0.015||0.014||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.4,0.4,0.26666666666666666
312,Exp_Neurol-2-1-2288636.txt,effect||variat||frequenc||tap||stimul||anova||excess synchron||db||perform||side||synchron||variabl||movement||rate||precis frequenc||normal limit||patient||stn||parkinsonian patient||updr motor score,1 mg||3 mg||day 1||day||400 mg||2||800 mg||0.5 mg||dopa 300 mg 1||dopa 600 mg 1||dopa 500 mg 1||dopa 750 mg 1||dopa 800 mg 1||dopa 450 mg 1||cabergolin 3 mg,0.026||0.019||0.019||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015||0.014,0.0,0.0,0.0
313,Eur_J_Epidemiol-3-1-2071962.txt,hypertens||data||model||stroke||potassium||mortal||risk||volum||blood pressur||potassium intak||intak||event||posit relationship||creatinin||cohort||all-caus mortal||relationship||sodium||analysi||associ||subject||lower quartil||cvd||dietari data||myocardi infarct||dietari potassium||urinari sodium||salt||cardiovascular event||standard deviat increas||cardiovascular diseas,1||2||model 1||model 2||3 2||model||model 3||3||studi||result 1||3 1 divis||1 0.99||refer 1||1 1.09||2 0.99,0.03||0.03||0.027||0.027||0.025||0.024||0.023||0.021||0.018||0.018||0.017||0.016||0.016||0.016||0.016,0.0,0.1,0.06666666666666667
314,Int_J_Cardiovasc_Imaging-4-1-2373860.txt,volum score||method||cms-index||bpm||scanner||artifici arteri||dual sourc CT||suscept||motion curv||motion||densiti||calcif||effect||electron beam CT||ca-scor||equival mass||agatston score||phantom||heart rate||calcium||slice thick||cardiac motion||mdct||dsct||smaller slice thick||calcium score||triangl||ebt||arteri||physic mass||differ||decreas||circl||64-slice mdct||calcif densiti||score||equival mass score||result,1||2 2||2||3||3 3 3||1 1 depart||arteri 3||score||1 4 4 fig. 4||calcium score||11||2 phase||refer 1||1 suess||coronari calcium score,0.028||0.028||0.028||0.022||0.022||0.02||0.018||0.018||0.018||0.016||0.016||0.015||0.015||0.015||0.015,0.0,0.2,0.13333333333333333
315,Diabetologia-3-1-2063563.txt,type 2 diabet||insulin secret||insulin sensit||risk||hyperglycaem clamp||gene||glucos||pancreat beta cell||beta cell||glp-1||result||carrier||variant||polymorph||particip||insulin||data||plasma glucos||ogtt||clamp,2||tcf7l2||2 1||2 diabet||1||tcf7l2 gene 1 1||diabet||tcf7l2 tcf7l2 15||tcf7l2 tcf7l2 14||tcf7l2 tcf7l2 variant||result tcf7l2 tcf7l2||type 2 diabet||tcf7l2 gene||4 1 tcf7l2 4||tcf7l2 1 23,0.031||0.03||0.029||0.027||0.027||0.023||0.023||0.022||0.022||0.021||0.021||0.02||0.02||0.02||0.019,0.0,0.0,0.06666666666666667
316,Eur_J_Epidemiol-4-1-2226058.txt,effect||mortal||risk||chd mortal||hdl-cholesterol||lower risk||hr||relat||analys||rotterdam studi||normal weight individu||age||individu||particip||genotyp||studi||year||normal weight||overweight,apo apo apo||apo||apo apo||1 apo apo||apo apo apo genotyp||2 apo||20 apo apo||1 apo||2 apo 2||3 apo||20 apo||apo 20 22 apo||20 22 apo apo||6 apo||5 apo,0.042||0.042||0.042||0.034||0.033||0.033||0.03||0.03||0.03||0.029||0.024||0.024||0.024||0.024||0.024,0.0,0.0,0.0
317,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2082652.txt,vascular repair||literatur review||embolectomi||occlus||case||arteri embol||aclr||complic||knee||anterior cruciat ligament reconstruct||pseudoaneurysm||graft||poplit arteri occlus||reconstruct||sensori loss||foot||poplit arteri||vascular complic,1||1 fig. 1 4||1 3 6 9||2007||refer 1||4 week||3||discuss 4 5 4||A. G. M. 2 1 depart||conclus 4||6 7 7 6||springer-verlag 2007||31-40-8888609 r.janssen@mmc.nl 1 sala||copyright 2007||9,0.059||0.043||0.034||0.034||0.033||0.028||0.028||0.027||0.024||0.023||0.021||0.021||0.02||0.019||0.019,0.0,0.0,0.0
318,Pediatr_Nephrol-2-2-1764601.txt,proteinuria||case||preval||patient||year||seri||risk||epidemiolog||increas||nephrot syndrom||naprtc||focal segment glomerulosclerosi||renal biopsi||adult||esrd||age||popul||incid||fsg||diagnosi||children,1||2 3||2 mutat||children 4 5 6 6 2||5 7 10 5 9 11||refer 1||histologi 1||4 11 12 11||patient||10||question patient||pediatr||AZ 85013 usa 2 depart||nephrot syndrom||report,0.031||0.027||0.02||0.02||0.018||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.013||0.013||0.012,0.0,0.1,0.13333333333333333
319,Osteoporos_Int-3-1-1766476.txt,prevent||comprehens geriatr assess||convent care||control group||studi||individu care plan||intervent||fractur||treatment||day||fall||multifactori intervent||activ prevent||control||rehabilit||hospit||fall risk factor||multifactori intervent program||surgeri||intervent group||injuri||delirium||group||differ||number||fewer injuri||orthoped||systemat assess||intervent ward||hip fractur||intervent program,1||2||3 2||1 1 depart||fall||1 2 lundstrÃ¶m||studi||fall prevent studi||fall prevent||fall risk||1 englund||1 borssÃ©n||refer 1||2 test||geriatr patient,0.019||0.018||0.014||0.014||0.013||0.013||0.012||0.011||0.011||0.011||0.01||0.01||0.01||0.01||0.01,0.2,0.2,0.13333333333333333
320,Arch_Orthop_Trauma_Surg-3-1-2092411.txt,anim||drill time||time||daili practic||rabbit||studi||long time||hind limb||osteocyt||vivo studi||drill||aim||signific||absenc||posit correl||insert forc||tibia||distanc||experi||femur||surgeri||insert time||bone||base plate||kirschner wire||result,1||2 2||2||2 mg||1 kon mosh 1 1 depart||bone||refer 1||4||fig. 2 dot||3||3 fig. 3||netherland 2 depart||bone tissu||osteocyt||4 week,0.031||0.026||0.026||0.019||0.018||0.017||0.017||0.015||0.014||0.014||0.014||0.012||0.012||0.012||0.012,0.0,0.1,0.13333333333333333
321,Eur_J_Clin_Pharmacol-3-1-1914266.txt,measur||time||co-trimoxazol||data||studi||patient||pdr||risk||clinic||coumarin||user||antibiot||signific||anticoagul clinic||inr||day||dose adjust||sever overanticoagul||consent||acenocoumarol||overanticoagul||differ||dose reduct||interact||follow-up time||therapeut rang||initi||phenprocoumon||result,1||1 1||2||2 3||refer 1||3||0 1||2 4||5||1 13||patient 2 3||3 day||5 day||6||0 0 1,0.033||0.033||0.025||0.023||0.022||0.021||0.021||0.021||0.02||0.02||0.019||0.017||0.017||0.017||0.017,0.0,0.0,0.0
322,J_Med_Internet_Res-7-2-1550646.txt,mass media||mesh||author||notic||ihca||press releas||lexisnexi academ databas||databas||studi||patient||clinic outcom||cochran retract||review||articl||al paper||medic||scientist||page||web||princip conclus||health||retract||citat||pubm||conclus||internet||press report||search||cochran collabor||refer||case studi||public||systemat review||media||queri||result,1||review||review 2005||review 1 2 3||1 cochran review||2005||2004||2||cochran review||ihca review||review public||1 articl||3||octob 2004 cochran review||6,0.023||0.023||0.021||0.02||0.019||0.019||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.014||0.014,0.2,0.1,0.06666666666666667
323,Biochim_Biophys_Acta-2-1-2258316.txt,tau||tyrosin phosphoryl||tauopathi||syk,fig. 3 fig. 3 fig. 3||fig. 4 fig. 1||fig. 2 phosphoryl||fig. 4||2||2 2||vitro fig. 1||fig. 3 tyr-18||3||1||tau||kinas||tau phosphoryl||phosphoryl||tau protein,0.038||0.034||0.033||0.032||0.031||0.031||0.027||0.026||0.022||0.02||0.017||0.016||0.015||0.013||0.013,0.0,0.0,0.06666666666666667
324,Clin_Oral_Investig-3-1-1797073.txt,applianc||volunt||sampl||studi||seri||varnish||site||saliva||acquisit||present studi||detect limit||day||applic||enamel sampl||deminer enamel||duraphat||uptak||fluorid||specimen||opposit buccal aspect||transfer||oral caviti||enamel||tooth||respect tooth,1||fluorid||2||0||day 1||1 day||1 tabl 1||1 2 1 depart||1 2 attin||day 0||1 2 buchalla||1 cm||2 3||fluorid sampl||1 week,0.049||0.042||0.04||0.037||0.037||0.037||0.035||0.035||0.031||0.031||0.031||0.03||0.03||0.026||0.026,0.2,0.1,0.06666666666666667
325,J_Biol_Inorg_Chem-3-1-1915625.txt,activ site||sampl||model||spectroscop data||wild-typ||water||water molecul||structur||t309v||cytochrom p450 2d6||dft calcul||enzym||experiment observ||heme moieti||supplementari materi||experiment structur||heme||substrat||spin equilibrium||experiment data||rel destabil||result,1||1 1||1 5||3||1 Î½ Fe||2||1 7||posit 1||Î½ Fe||2 fig. 2||1 6 27 Î½ Fe||1 Ï||dft calcul 1 1||refer 1||1 fig. 5 WT t309v,0.027||0.027||0.022||0.021||0.02||0.018||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.013,0.0,0.0,0.0
326,Clin_Rheumatol-3-1-2071969.txt,large-vessel vascul||test||patholog uptak||pet||wall||cogan||hear loss||involv||white cell||ear pain||syndrom,1 fig. 1||refer 1||2 3||A. W. 2 1 depart||clinic rheumatolog 2007 introduct 1||netherland 2 depart||hans.balink@znb.nl 1 bruyn||clinic rheumatolog 2007 18||patient||thirteen patient||18||9||6||4 5||18 case,0.04||0.03||0.029||0.026||0.024||0.023||0.021||0.018||0.017||0.016||0.014||0.014||0.014||0.014||0.014,0.0,0.0,0.0
327,Behav_Genet-4-1-2226021.txt,quantit genet analysi||behavior||linkag analysi||golden retriev||control group||anim model||aggress||studi||allel||effect||frequenc||non-aggress golden retriev||microsatellit marker||loci||dog||genotyp||dna||gene||power||serotonin||dna sampl||estim||analysi||associ||behavior inform||aggress dog||molecular genet studi||strong effect||snp||candid gene||major role||haplotyp||aggress behavior||owner impress,1||genet||1 htr1a||htr1a||1 htr1b htr2a slc6a4 htr1b htr2a||htr1b||2 htr1a||2||slc6a4||htr1a htr1b htr2a slc6a4||htr1a htr2a htr1b slc6a4||htr1a htr1b htr2a||htr1b htr2a slc6a4||4 htr1a htr1b||haplotyp 1,0.018||0.016||0.016||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.012,0.0,0.0,0.0
328,J_Comput_Aided_Mol_Des-4-1-2270916.txt,metric||measur||target||enrich||comput||data||model||studi||comparison||properti bia||ligand-bas tool||atom posit||structur||virtual screen||resolut||dataset||compound||purpos||nomin resolut||decoy||simpl molecular properti||properti||applic||paper||crystallograph||atom||decoy set||dpi||predict||rmsd||number||perform||coordin error||robust comparison||area||error||conform reproduct||ligand||engin||pose predict||result,2||1||3 2||4 2||3 3||3||4 3 3 fig. 3 4||2 18||model 1 fig. 1 fit atom||model||1 comparison||free 1||2 resolut||1 homolog model||refer 1,0.022||0.021||0.02||0.018||0.018||0.018||0.016||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.0,0.1,0.06666666666666667
329,Diabetologia-3-1-2039833.txt,muscl||triacylglycerol||diabet||releas||haart||thiazolidinedion||rate||adipocyt||studi||patient||beta cell damag||atp||insulin secret||develop||risk||organ||adipos tissu||metabol syndrom||lipotox||type 2 diabet mellitu||cell||circul||mitochondria||fatti acid||genet factor||pancreat beta cell||ectop triacylglycerol deposit||insulin resist||result,2 2||2 diabet||diabet||type 2 diabet||type 2||type 2 diabet mellitu||obesity-associ type 2 diabet||mitochondri diabet||diabet centr||netherland 2 depart||J. 2 1 depart||5 6 8 2||2 30 33||j.a.maassen@lumc.nl 1 2 romijn||fatti acid,0.043||0.039||0.036||0.032||0.03||0.026||0.024||0.024||0.019||0.017||0.017||0.017||0.017||0.016||0.014,0.2,0.2,0.2
330,Histochem_Cell_Biol-3-1-1779629.txt,vector||high level||system||homolog recombin||embryo||primer||element||lacz activ||transgen mice||probe||hypertroph zone||bac||enhanc||offspr||founder||event||newborn||express||transgen copi||cartilag||dna||report gene mous||downstream||specif||cell||chondrocyt||growth factor||gene||bac dna||hypertroph chondrocyt||hypertroph cartilag||activ||long bone||genom context||growth plate||integr site||fvb mice||construct,1||2||1 1 materi||fig. 1||1 3 1 fig. 3||nco 1||1 ml||lacz||2001||4||4 4 4 4||fig. 5||lacz 2004 lacz transgen||1 1515 F1||2000,0.026||0.02||0.019||0.018||0.018||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.011||0.011,0.0,0.0,0.0
331,Eur_J_Appl_Physiol-3-1-2039810.txt,blood flow||condit||time trial perform||valu||perform decrement||effect||increas||muscl temperatur||bodi temperatur||energi flow model||temperatur||present studi||ambient temperatur||power output||higher cardiac output||climat||exercis||differ||decreas||skin||perform||trial||extra blood||hot condit||heat||time trial exercis,2||1 2||1||3 2||1 3||2 tabl 2||1 fig. 1||2 tabl 3||3||2 2001||1 2005||2 1987||jaeger 2||2004 1999 2004 1999 2004 2001||1999,0.04||0.04||0.04||0.033||0.033||0.031||0.03||0.026||0.026||0.024||0.024||0.021||0.021||0.018||0.017,0.0,0.0,0.0
332,Exp_Brain_Res-3-1-2039806.txt,condit||cue||prior||surfac slant||combin||stimulu||orient||head||textur||textur cue||conflict||slant||inform||probe||binocular dispar||motion parallax||cue conflict||weight||surfac||binocular||monocular||posit||trial||rotat screen||particip||movement,2 fig. 2||2||6 fig. 6||1||10 14 fig. 7||visibl fig. 3||3||2007||2004||analysi 5 5 fig. 5||7 2004||cue||7||cue weight 8 fig. 8||5 6 6 7,0.022||0.019||0.018||0.018||0.016||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013,0.0,0.0,0.06666666666666667
333,Diabetologia-4-1-2235909.txt,type 2 diabet||hypoglycaemia||target||week||fast plasma glucos||insulin detemir||studi||patient||insulin||event||glycaem control||dose||fpg||analys||present studi||treatment||advers event||basal insulin analogu||ten-point PG profil||glargin||oral glucose-low drug||meal-tim insulin||bodi weight||detemir||oral glucose-low agent||oral agent||insulin glargin||trial||particip||weight gain,2||2 diabet||diabet||1||1c 2||2 1c||type 2 diabet||insulin||type 2||type 1 diabet||type 2 diabet rosenstock||type 2 diabet mellitu||result particip 1 1 2 1c||particip 2 1c 1c||3,0.032||0.03||0.028||0.025||0.024||0.024||0.024||0.022||0.021||0.021||0.018||0.018||0.017||0.017||0.017,0.0,0.2,0.13333333333333333
334,J_Chem_Ecol-3-1-2039843.txt,time||endogen glucosinol||leaf tissu||sampl||amount||gener linear model||extract||growth rate||instar||infloresc||genotyp||herbivori||natur enemi||glucosinol concentr||leaf||mechan homogen||result||caterpillar||glucosinol||access||flower||lepidoptera||intern standard||pierida||plant||myrosinas,plant||plant P.||1||plant 2||brassica||P. brassica||10 plant||B.||P.||J. P.||J.||plant tissu||P. brassica B. nigra B.||control plant||plant sampl,0.025||0.02||0.018||0.018||0.017||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.014||0.014,0.2,0.1,0.06666666666666667
335,Histochem_Cell_Biol-3-1-2137947.txt,cancer cell||pnb||cancer||author||mitot phosphoryl||ribosom biogenesi||depend||nucleolar protein||nuclear receptor||norc||studi||process||complex||rdna transcript machineri||nucleolar compon||rdna||dynam||biogenesi||cell||nuclear bodi||nucleolar structur||ribosom||dfc||local||transcript||protein||ribosom protein||nucleolu||upstream bind factor||nuclear export||nucleolar assembl||cell cycl||activ||rrna||bind||factor||nuclear function compartment||compon||nucleolar machineri||assembl||viru||molecul||sequenc||rdna transcript,cell||cell factor||cell function||cell cycl||human cell||cancer cell||cell biolog||mammalian cell||cell nucleu||live cell||cell microbiol||stem cell||cell growth||cell prolifer||giant cell,0.032||0.019||0.019||0.018||0.018||0.018||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.016,0.4,0.3,0.2
336,Eur_Arch_Otorhinolaryngol-4-1-2358940.txt,posterior part||ventromediocaud part||arytenoid cartilag||level||unilater vocal fold paralysi||arytenoid||cricoarytenoid joint||healthi side||posit||paralysi||movement||procedur||surgeri||patient||phonat||three-dimension comput tomographi||techniqu,1 fig. 1||2||fig. 5||evalu case 1 4 fig. 4||patient||3 8 9 10 fig. 3||refer 1||live patient||vocal fold||springer-verlag 2008 introduct 1 2||3dct 3 6||tension case 2 5||neck vol. 1||vocal fold level||paralyz vocal fold,0.048||0.036||0.034||0.03||0.028||0.026||0.025||0.025||0.023||0.022||0.021||0.02||0.019||0.018||0.017,0.2,0.1,0.06666666666666667
337,Neurosurg_Rev-2-2-1705527.txt,dural arterioven fistula||pulsatil tinnitu||complet obliter||transcondylar approach||patholog vessel||posterior condylar emissari vein||patient||occipit condyl||region||treatment||fistula||pulsatil bruit||occipit arteri||approach||surgeri||hypogloss canal||foramen magnum||intraoss davf||obliter||jugular bulb||transoss arteri feeder||extens boni drill||davf||arteri feeder,1||2||case 1 1 1 fig. 1||1 1 depart||case 2 2 2 fig. 2||patient 2||2 5||patient 3||refer 1||1 year||method patient 1||1 month||1 summari||1 bien||1 kappu,0.031||0.026||0.025||0.022||0.022||0.021||0.019||0.019||0.018||0.017||0.017||0.017||0.016||0.016||0.016,0.0,0.0,0.0
338,Neurochem_Res-4-1-2270371.txt,antibodi||anim||level||stain||gdnf protein||transect injuri||western blot||spinal cord||rostral stump||dpo||caudal stump||gdnf||present studi||cell||rat||hindlimb||injuri site||neuron||adult rat||rostral||white matter||cord||ventral horn||incub,2||3 3 2 2 fig. 2||4 2 4 4 2||1||2 day||2 mm||2 week||tabl 2 gdnf||3||1 tabl 1||4||2 Li yong-mei 2 wang||3 day||cell||43 44 2,0.033||0.023||0.022||0.021||0.021||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.012||0.012||0.012,0.0,0.0,0.06666666666666667
339,Pathol_Oncol_Res-4-1-2413131.txt,oscc||egfr inhibitor||concentr||cisplatin sensit||combin||studi||effect||sensit||oral cancer||cell line||inhibit||treatment||cell||growth||higher express||oscc cell growth||protein||cisplatin resist||cisplatin||egfr||pathway||addit||cancer therapi||oral squamou cell carcinoma,1||cell||1 1 fig. 1||1 min||cell line||2||1 cisplatin||cell carcinoma||2 fig. 2||refer 1||3||oscc cell||method cell||cell growth analysi||oscc cell growth,0.036||0.035||0.031||0.025||0.024||0.023||0.023||0.021||0.021||0.02||0.02||0.02||0.019||0.019||0.018,0.4,0.2,0.2
340,Arthritis_Res_Ther-5-3-165040.txt,mechan||type||connect tissu||nutrient||vertebr bodi||studi||disc||patient||nucleu||human||nerv||articular cartilag||back pain||low||cell||therapi||growth||gene||disc degener||spinal canal||tissu||collagen||pain||intervertebr disc||exercis||cartilag end-plat||factor||nutrient suppli||major role||proteoglycan||matrix||loss||annulu||degener,disc||1||intervertebr disc||disc herniat 1||disc degener||degener disc||lumbar disc||disc cell||intervertebr disc degener||lumbar intervertebr disc||disc matrix||intervertebr disc cell||human intervertebr disc||disc biolog||disc herniat,0.028||0.022||0.021||0.017||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.015,0.6,0.3,0.2
341,J_Mol_Med-3-1-1820751.txt,noonan syndrom||gene||costello syndrom||clinic phenotyp||ra||result||protein||ns-like featur||k-ra||ra pathway||disord||jmml||pathway||short statur||mutat||gtp||human cancer||patient||syndrom||germlin,genet||med genet||syndrom||nat genet||cell||2006||human genet||genet evid||type 1 neurofibromatosi||refer 1||noonan syndrom||mathildenstrass 1||neurofibromatosi type 1 ra||genet heterogen||med genet 140:1681,0.026||0.019||0.019||0.018||0.018||0.017||0.016||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.013,0.2,0.1,0.13333333333333333
342,J_Mol_Model-3-1-2039870.txt,dft||classic electrostat attract||data||combin||lda||densiti||homo-bas stack||refer data||interact energi||base||ccsd||larg basi set||densiti function||Ï-Ï stack interact||dna||energi||term||vertic separ||twist angl||hydrogen bond||densiti function theori||function||result,1||1 1||1 2||2||1 2 3 1||1 3||3||1 2 12||1 4||36 1 1||phi chem||1 5||1 fig. 3||refer 1||1 scheme 1 TW,0.032||0.032||0.031||0.029||0.029||0.028||0.024||0.023||0.023||0.022||0.022||0.021||0.02||0.019||0.018,0.0,0.0,0.0
343,Cardiovasc_Eng-3-1-2137944.txt,myocardi energet output||cardiovascular system||system||myocardi oxygen consumpt||data||patient||valu||stroke||ventricl dysfunct||blood pressur||heart failur||numer simul||myocardi energet||numer model||paramet||cardiac rhythm pace||pulmonari pressur||echocardiographi examin||work||ventricular pace||heart||mode||vvi||aai,2||2 2 2 1992 2||2 2 1990 2 2 3||2 4||3 1||http://www.lidco-ir.co.uk/html/clinical/nhp.asp 1 1||1 5||3||mathemat model 2 fig. 2 scheme||pace||fig. 1 ventricular pressur||ventricular pace||420-286-584695 marsik@it.cas.cz 2 1 cardiocent||2004||czech republ 2 institut,0.032||0.027||0.025||0.024||0.021||0.019||0.017||0.016||0.015||0.013||0.013||0.013||0.013||0.012||0.011,0.0,0.0,0.06666666666666667
344,Plant_Mol_Biol-3-1-1805041.txt,seed||line||databas||insert||rice gene||import gene||gene function||correl||function analysi||phenotyp data||insert line||gene||mutant panel databas||natur condit||field||mutant||number||phenotyp||experiment data||long leaf||retrotransposon||sequenc||nipponbar||function,2||1||1 1 1 1 1||1 1 1 1||tos17||2 tos17 tos17 tos17 tos17 insert||refer 2 2||phenotyp analysi 2 2 plant||2 tos17 tos17 insert point||1 1 2004 2005||tos17 tos17 1998||fig. 1||discuss 2 tos17 retrotransposit||1995 2 2004 2006||1 mg,0.033||0.026||0.026||0.026||0.025||0.024||0.022||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.015,0.0,0.0,0.0
345,Biochim_Biophys_Acta-2-1-2225445.txt,antibodi||thymu||phd||panel||mutat||nuclear extract||chromatin||kinas||air||domain||Ku 80||site||phd finger||express||phosphoryl||cell||thymic epitheli cell||gene||protein||activ||posit control||whole-cel extract||apec||immunoprecipit||dna-pk,fig. 3||fig. 2||fig. 4||vivo fig. 2 fig. 2||fig. 6||1||3||2 2||2 2 2||2||5A fig. 5 fig. 5||fig. 6 dna-pk||32 fig. 3 32||cell||protein,0.027||0.027||0.025||0.022||0.021||0.02||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.015||0.015,0.0,0.0,0.13333333333333333
346,Ann_Biomed_Eng-2-2-1705476.txt,antibodi||level||pathogen||time||simpl bar code system||reaction chamber||strain||pathogen detect||test||region||filament||classif||specif||fara||solut||captur||fluoresc||chamber||posit||captur antibodi||laser||peak||viru||decis tree||detect,1||1 1 1 1||1 2||2||level 1||1 figur 2||antibodi 2||3||1 11||level 2||type 1||10 2||1 block||13 1||refer 1,0.036||0.036||0.033||0.03||0.025||0.024||0.024||0.023||0.023||0.022||0.021||0.02||0.019||0.019||0.019,0.0,0.0,0.0
347,Ann_Biomed_Eng-2-2-1705503.txt,type||cell cycl analysi||silicon sheet||concentr||studi||effect||pdgf-ab||increas||cultur substrat||cell prolifer||collagen synthesi||express||cell||gelatin||growth factor||two-dimension substrat||prolifer||collagen||ligament tissu engin||tissu regener||synthesi||cultur||substrat||franc||fibroblast||result,1||cell||1 figur 1||3 2||1 tabl 1||growth||cultur cell||A. cell||10||cell cycl||2 day||growth factor||figur 3||cell prolifer||1 Î²,0.021||0.02||0.017||0.016||0.015||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012,0.2,0.1,0.2
348,J_Gastrointest_Surg-3-1-1852383.txt,case||arteri thrombosi||group||abo-incompat blood group||result||risk factor||chi-squar test||biliari||graft||incid||bc||biliari complic||studi||BC risk factor||neg liver graft||patient||liver transplant||Rh nonident||donor,1||transplant||liver transplant||liver||1 tabl 1 demograph||etiolog 1||refer 1||tumor 1||2||figur 1||4 1 depart||group||6||biliari transplant||conclus liver transplant,0.03||0.021||0.021||0.02||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.014||0.014,0.2,0.1,0.13333333333333333
349,Bioinformation-1-3-1891659.txt,program||time||posit||repeat||microsatellit||ssrscanner||motif||ssr||genom||perl,1||1 2||3||2||1 2 3 4 5||2006||bioinform 1||tabl figur 1||refer 1 levinson||6||2000 10 62 10645951 3 toth||2006 biomed informat publish group 2006||1993 3 175 8401603 6 benson||6 7 8||repeat,0.076||0.068||0.063||0.06||0.05||0.044||0.041||0.034||0.03||0.025||0.023||0.022||0.02||0.019||0.018,0.0,0.0,0.06666666666666667
350,J_Mol_Med-4-1-2374882.txt,proteinuria||level||nephropathi||glomerulosclerosi||renal angiotensin level||renin receptor||nonproteolyt activ||hypertens||import role||anim model||develop||increas||region||recent||receptor||express||renin receptor express||rat||mitogen-activ protein kinas||intracellular||angiotensin||activ||part||bind||podocyt||prorenin||mrna express||angiotensin II||hypertens condit||addit||kidney||result,renin||renin receptor||receptor||2008||prorenin receptor||studi||prorenin||2 activ||vivo studi||kidney||renin receptor express||rat prorenin||hypertens rat kidney||human renin receptor||kinas 1,0.021||0.021||0.02||0.019||0.019||0.019||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015,0.4,0.4,0.3333333333333333
351,Anal_Bioanal_Chem-4-1-2359830.txt,biota||calcul||methylmercuri biothiol||figur||mehgci||cy||detect condit||extract||direct inject||plant extract||inform||form||organ molecul||electrospray mass spectrometri||complex||methylmercuri||compound||icp-m||mass||signal||ion trap||molecular ion||ammonia group||electrospray mass spectromet||biothiol||solut||es-m paramet||in-sourc fragment||standard||group||analyt method||order||hplc eluent||es-m||fragment||mercuri||fragment pattern||nitrogen atom||proton||molecul||plant,2||2 2||2 2 2||2 1 1||2 6 2||2 2 5||3 2||fig. 7 1 2 2 2||1||1 fig. 2||6 2 2 6||5 2 2 5||7 2||fig. 6 2 2||min 2,0.043||0.043||0.043||0.034||0.032||0.032||0.03||0.029||0.029||0.027||0.026||0.026||0.026||0.026||0.025,0.0,0.0,0.0
352,Urol_Res-3-1-2082064.txt,eswl||va||effect||air||inhal entonox||extracorpor shock wave lithotripsi||pethidin||va score||group||stone||statist analysi||pain||signific differ||procedur||pain relief||entonox||studi||patient||analgesia,1||2||2 2||refer 1||result 1||1 mg||1 fig. 1 va score||0 2 1 number||1 demograph data||3||2 78||2 min||10||patient||2 height,0.043||0.028||0.028||0.025||0.024||0.023||0.021||0.02||0.017||0.017||0.017||0.017||0.016||0.016||0.016,0.0,0.0,0.06666666666666667
353,J_Abnorm_Child_Psychol-3-1-1915632.txt,find||social maladjust||boy||behavior||problem||aggress||school||peer||problemat social behavior||depend variabl||behavior pattern||social adjust||stabil||bulli||class||pattern||featur||similar||analys||girl||item||social function||gender||nomin||victim||group||report||adjust||dislik||transient||adolesc||score,2||1||childhood 1||psycholog||social behavior||social develop||peer||result 2||social adjust||T. 2 1 institut||child psycholog||childhood social adjust||school psycholog||psycholog adjust||J.,0.021||0.021||0.015||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.0,0.2,0.13333333333333333
354,Pharm_World_Sci-3-1-1915627.txt,atyp||combin||data||studi||patient||europ||frequenc||medic||clinic practic||polypharmaci||countri||anticholinerg||antipsychot polypharmaci||common practic||belgium||antipsychot agent||number||antipsychot||hospit pharmacist||larg number||daili clinic practic||result,1||2||1 number||1 1 symfora group||part 1||refer 1||germani 1||3||2007 introduct 1 2 3 7||31-33-4609553 wj.broekema@symfora.nl 1 2||antipsychot||6||psychiatr hospit||2 12 14 3 7||1 van harten,0.04||0.032||0.023||0.023||0.022||0.022||0.021||0.02||0.02||0.019||0.017||0.017||0.016||0.016||0.016,0.0,0.0,0.06666666666666667
355,Qual_Life_Res-4-1-2248606.txt,nurs home||qualiti||depress complaint||life||question||alpha||correl||pgcm||scale||oqol||resid||cognit impair||gip-||pilot studi||self-report||gd||valid||na||cognit||item||pa||research||intern consist||group||depress list||posit||neg||cognit test||cognit group||neg affect,3||2||1||scale 1||scale||cognit||inter-relationship 3 2||3 14||pp. 3||3 month||1995 2||01 3||1 36||4||4 4,0.02||0.017||0.015||0.014||0.014||0.013||0.013||0.012||0.011||0.01||0.01||0.01||0.01||0.01||0.01,0.2,0.2,0.13333333333333333
356,J_Digit_Imaging-3-1-2039858.txt,method||system||scp emul||net librari||command line version||project||storag||core||imag||session||definit file||valu||dicom||scu||view||dicom file viewer||exampl||test||servic class user||detail||dataset||tool||valid||dicom file||file||class definit file||applic||scp||script||modal||associ||standard||framework||pac||stand-alon tool||import||sut||attribut||sop class||emul||addit||philip||send||messag||dvt||result,1 fig 1||2 fig 2||dicom||1||2||test||dicom file||dicom valid||fig 5||fig 4||dicom test imag||test session||type 1||7 fig 7||test session file,0.025||0.024||0.024||0.024||0.022||0.02||0.02||0.019||0.019||0.018||0.018||0.018||0.017||0.017||0.017,0.2,0.3,0.2
357,J_Mol_Med-4-1-2359832.txt,human tumorigenesi||level||variant||sampl||data||studi||mdm4 variant||comparison||ptc||correl||form||western blot||express||signific||tumor properti||thyroid carcinoma||ratio||protein||analysi||p53||papillari thyroid carcinoma||human cancer||group||tumor||method tissu sampl||presenc||histopatholog featur||mdm2||mdm4||mrna||ctrl||addit,1||1 1||1 2||1 3||3 1||1 fig. 1||1 4||2||1 n.d||2 4||3||1 mM||1 27||2 fig. 2||13 2 13 3 1,0.043||0.043||0.037||0.033||0.033||0.031||0.03||0.03||0.025||0.024||0.023||0.023||0.022||0.022||0.022,0.0,0.0,0.0
358,Eur_J_Epidemiol-3-1-2071967.txt,glaucoma||measur||anxieti disord||method||endocrin diseas||protocol||atherosclerosi||imag||determin||macular degener||studi||depress||stroke||risk||optic disc||heart failur||high risk||disord||updat||dementia||examin||parkinson diseas||gene||amd||blood sampl||blood||research||grief||assess||age||associ||subject||genet factor||myocardi infarct||factor||alzheim diseas||rotterdam studi||osteoporosi||elderli||candid gene||drug||import inform||risk factor||particip||area||urin||diseas||object||larg number,studi||rotterdam studi||1||genet studi||associ studi||studi 74||follow-up studi||pharmaco-epidemiolog studi||1 3||studi particip||studi district||population-bas studi||studi coordin||PI rotterdam studi||longitudin studi,0.022||0.016||0.015||0.013||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.011||0.011||0.011,0.4,0.2,0.13333333333333333
359,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2413123.txt,hartmann-shack aberrometri||measur||endogen insulin level||studi||ocular paramet||increas||equival refract index||hyperglycemia||hyperop shift||refract properti||higher order aberr||eye||glucos||shape||blood glucos||len||subject||chang||ogtt||order||refract error||ocular refract||procedur||precis||healthi human eye||refract index,2||subject 1||2 len 3 fig. 2 len||result 1 fig. 1||refer 1||refract||1 2 polak bettin||len||3 30 len 4||glucos||2 3 ringen peter||netherland 2 institut||diabet||refract chang||human len,0.036||0.025||0.024||0.022||0.02||0.019||0.019||0.018||0.018||0.018||0.015||0.015||0.015||0.014||0.014,0.0,0.2,0.13333333333333333
360,Ann_Biomed_Eng-2-2-1705519.txt,respons||center||cat type IV unit||paramet estim||rate||model||sensit analysi||frequenc||gerbil||rm||notch nois respons||spectral notch detector||inhibit||notch||unit||cell||NN stimuli||connect paramet||type iii||physiolog data||paramet||princip cell||sound pressur level||good fit||simul||type IV unit||cat||inhibitori||center frequenc||spontan rate||nois stimuli||experiment data||dcn||nois||sound local,6||6 2 figur 6||2 2||2||model||1 1 1 1||1||15 1 1||model cell||18 1 1||6 18 2 17 2||6 8 6 8||model respons||min 6||15 6 5,0.022||0.018||0.018||0.018||0.018||0.018||0.018||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
361,Eur_J_Nutr-2-2-1705483.txt,cereal fraction||author||diet supplement||week||microbicid activ||protect effect||studi||effect||immun function||healthi subject||health promot||cereal||periton leukocyt||gssg||macrophag||leukocyt function||healthi mice||immun cell||health||control||antioxid||chronic diseas||oxid stress||mice||total polyphenol||diet||activ||import||redox state||natur product||immun respons||catechin||diseas||supplement||lipid oxid damag||function||polyphenol||result,2||extract 2 2||17 2||1 week||diet 1 1||fig. 2||6 14||2 week sampl||fig. 1||leukocyt function 14 14 2||redox state 2||2005||antioxid||refer 1||week,0.021||0.014||0.013||0.013||0.013||0.012||0.012||0.01||0.01||0.01||0.01||0.01||0.009||0.009||0.009,0.0,0.0,0.13333333333333333
362,Behav_Genet-3-1-1914301.txt,measur||sum||attent problem||respons||varianc decomposit||handl||individu||sum score||data||model||ceil effect||herit||effect||irt||correl||trait||mcmc||underestim||non-shar environment varianc||varianc compon||paramet||item||estim||approach||varianc||twin||latent variabl||analysi||simul||framework||distribut||genet||item respons theori||classic test theori||number||normal distribut||measur error||score||result,2||Î²||1||model||score||item score||genet model||item||genet||genet model twin||Ï 2||2004||sum score||1998 2004 2004 1 1||item data,0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012,0.4,0.4,0.3333333333333333
363,Sci_Eng_Ethics-4-1-2413105.txt,engin ethic||system||implicit contract||problem||feel||model||self-esteem||pride||view||notion||special oblig||countri||high moral standard||code||virtu||profession integr||approach||social statu||societi||membership-requir view||implicit social contract||contract||occup capac||profess||ethic||sens||high incom||japan||student||social-contract view||posit feel||engin,1||2||1 10||profession||2 11||profession engin||11 2 10||2008 1 2||1 4||engin||10 6 1 7||11||10||6||5 1 6 7 2,0.03||0.025||0.025||0.022||0.022||0.021||0.021||0.021||0.02||0.02||0.019||0.019||0.019||0.018||0.018,0.0,0.1,0.06666666666666667
364,Eur_J_Pediatr-3-1-2042511.txt,metabol diseas||studi||mutat||patient||platelet||defect||platelet-bas bleed disord||dmd||disord||adhes||adp||gene||gray platelet syndrom||protein||broader clinic phenotyp||platelet function||secret||epstein syndrom||human patholog||pathway||diseas||platelet research||function||result,platelet||1||platelet defect||platelet function||platelet research||platelet activ||platelet adhes||1 syndrom||blood platelet||platelet secret||platelet test||morpholog platelet||platelet format||giant platelet||platelet defect disord,0.041||0.035||0.026||0.025||0.024||0.024||0.023||0.023||0.023||0.022||0.022||0.022||0.022||0.021||0.021,0.6,0.3,0.2
365,Crit_Care-9-3-1175868.txt,cardiac surgeri||author||dopexamin group||enoximon||tachycardia||amrinon||vital organ perfus||signific reduct||data||pulmonari hypertens||studi||patient||clinic outcom||effect||agent||investig||cardiovascular drug||increas||cpb||cowork||dose||signific||levosimendan||signific increas||cabg||low dose||low cardiac output syndrom||map||advers cardiac event||paper||cardiac output||catecholamin||epinephrin||cardiac surgeri patient||min||dobutamin||group||milrinon||clinic research||low cardiac output||literatur search||report||pdi||lco||signific differ||trial||pulmonari arteri pressur||function,1||2||2 2||haemodynam||2 2 3||cardiac surgeri||studi||cardiac surgeri patient||4 1||patient||surgeri patient||2 HV 2||surgeri||haemodynam effect||recommend 1,0.016||0.015||0.015||0.014||0.014||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.01,0.0,0.4,0.26666666666666666
366,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998889.txt,locoregion rit||surviv time||resect caviti||mri||high radiat dose||baselin||studi||valu||recurr||patient||tumour-fre statu||fet||fet uptak||effect||sensit tool||intracavitari radioimmunotherapi||clinic deterior||threshold||highest uptak||blood-brain barrier||criterion||normal brain tissu||present studi||treatment||malign glioma||tumour recurr||tumour||ratio||post-therapeut phase||analysi||reliabl indic||residu tumour||initi surgeri||uptak||radiat therapi||pet||peak||contrast||addit||serial fet pet||rit||result,2||2 patient||patient||3||1 max max||131||04 2 131||02 1 131||03 1 131||04 3 131||01 1 131||00 1 131||02 2 131||03 2 131||tumour,0.022||0.021||0.021||0.02||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014,0.2,0.1,0.13333333333333333
367,Bioinformation-1-6-1891690.txt,databas,1 2||1 figur 1 5||bioinform 1||2 depart||refer 1 kÃ¶hler||tabl tabl 1 list||databas||categori figur 1 screen-shot||3 4||biosilico 2004 2 61 2 merali||india 3 depart||2006||6||databas categori||molecular biolog databas,0.094||0.069||0.062||0.047||0.043||0.041||0.039||0.038||0.036||0.034||0.028||0.028||0.028||0.024||0.024,0.0,0.1,0.06666666666666667
368,Skeletal_Radiol-4-1-2257990.txt,high intens||advanc imag||case||radiograph||entir marrow space||mri||imag||vertebr bodi||patient||lumbar vertebra||chordoma||bnct||lesion||adipocyte-lik vacuol chordoid cell||metastat diseas||soft tissu mass||pain||benign notochord cell tumor||progress diseas||bone scintigram||tumor||biopsi||surgic procedur||notochord vestig||bone||low signal intens||diagnosi||giant notochord rest,2||1 2||1||1 2 3||1 3 1||3||5||2 patient||fig. 2||1 antibodi||13 3 3||method 1||3 imag||refer 1||2 summari,0.04||0.04||0.04||0.037||0.037||0.031||0.028||0.026||0.025||0.022||0.022||0.022||0.021||0.021||0.021,0.0,0.0,0.0
369,Histochem_Cell_Biol-4-1-2323029.txt,subsequ studi||type||mechan||organel||viral transmiss||thin||tnt||data||intercellular transfer||tunnel nanotub||membran continu||cell||direct transfer||tissu||virus||similar structur||mitochondria||format||tnt-like structur||nanotub||transfer||bridg||connect||plasma membran,cell||1||2004 1||2004||1 2008||2004 2007||2006 2006 1 2004||2 2004||2004 2007 2008||2005||cell type||cultur cell||connect cell||cell protrus||cell surfac,0.038||0.037||0.034||0.031||0.027||0.026||0.024||0.024||0.023||0.021||0.021||0.021||0.02||0.02||0.02,0.2,0.1,0.06666666666666667
370,Eur_Arch_Otorhinolaryngol-3-1-2042030.txt,imdd||biopsi||midlin facial structur||complaint||case||local||progress ulcer||lesion||palat||radiotherapi||diseas||radiat ulcer||patient||year||rare diseas||physic examin||treatment||re-irradi||total dose,1||1 3 3 1||1 3 1 4 1 3||1 erythema||refer 1||2 1 3 4 5||5 1 depart||case report 1 fig. 1||grade 1 mucos||grade 1 erythema||springer-verlag 2007 introduct 1||netherland 2 depart||netherland 3 depart||netherland 4 depart||2 mucos,0.093||0.066||0.066||0.05||0.049||0.047||0.045||0.043||0.039||0.039||0.033||0.027||0.026||0.026||0.024,0.0,0.0,0.0
371,Purinergic_Signal-3-1-2096766.txt,role||respons||cd39||vascular inflammatori||cellular immun respons||data||adenosin||effect||treg||atp||platelet||major defect||dendrit cell||receptor||express||cell||immunoregulatori function||lymphocyt||ecto-enzym||ecto-nucleotidas||function||ecto-atpas||vasculatur||immun respons,cell||2||cd39||cd39 cd39||cd39 cd39 3 cd39 3||3 3 3||1||immun cell||2007 cd39||cd39 function||2007 introduct 1 2 3||2 14||15 16 2 17 2 2||cd39 express||cd39 28 cd39 28,0.024||0.024||0.023||0.023||0.022||0.021||0.02||0.017||0.015||0.015||0.015||0.015||0.014||0.014||0.013,0.4,0.2,0.13333333333333333
372,J_Med_Internet_Res-5-4-1550572.txt,person||attempt||time||behavior||studi||adolesc searcher||question||school||observ||inform||correct||site||qualit data||adult||content||similar||health educ||page||web||success||result||factor||topic||issu||comput literaci||adolesc||survey||link||answer||internet,search||2||4 search||search engin||health||1||search result||search question||health inform search result||health inform||7 search||success search||search behavior||search 13||search strategi,0.036||0.025||0.024||0.023||0.023||0.023||0.022||0.022||0.022||0.021||0.021||0.021||0.02||0.02||0.019,0.0,0.0,0.0
373,Support_Care_Cancer-3-1-2092408.txt,sr||cancer||measur||level||time||measur time||distress||studi||year||patient||physic function||chemotherapi||refer group||start||qol||testicular cancer||mental health||spous||coupl||treatment||relationship||social function||stress respons symptom||correspond||differ||partner||diagnosi||function||children,cancer||cancer patient cancer||1||cancer patient||testicular cancer||3||testicular cancer patient||testicular cancer treatment||cancer diagnosi||lung cancer||colorect cancer||testicular cancer survivor||1 year||2||refer 1,0.03||0.024||0.023||0.021||0.02||0.019||0.018||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014,0.4,0.2,0.13333333333333333
374,J_Mol_Med-3-1-2121656.txt,hypoxia||hif||therapeut||brain||stroke,2 2||2||1||factor 2||factor 1||2 3||cell death fig. 2 1||4 1 5||7 2||cell||refer 1||hypoxia-induc factor 1||3 4 5 6 2||springer-verlag 2007 1||cell death,0.031||0.031||0.031||0.022||0.021||0.021||0.02||0.02||0.019||0.018||0.016||0.016||0.015||0.014||0.013,0.0,0.0,0.0
375,J_Gastrointest_Surg-3-1-1915638.txt,follow-up||center||complic||data||studi||year||eea||long-term result||leakag||stent||patient||stent therapi||stenosi||endoscop||treatment||present studi||addit therapi||reconstruct surgeri||bdi||strictur||end-to-end anastomosi||surgeri||injuri||cholecystectomi||bile duct injuri||bile duct||surviv||long-term stricture-fre surviv||data analys||percutan transhepat catheter||duct||procedur||present seri||referr||outcom,1 1||1||2||2 2||patient||3||refer 1||2 4||figur 1 refer patient||refer patient||18 patient||eea patient||d.j.gouma@amc.uva.nl 1 1 depart||tabl 1 patient characterist||5,0.029||0.029||0.025||0.025||0.025||0.02||0.02||0.02||0.018||0.018||0.017||0.016||0.016||0.015||0.015,0.2,0.1,0.06666666666666667
376,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764204.txt,popul center||servic util||alcohol abus||rate||tarapaca||data||socio-demograph differ||studi||substanc abus disord||bio bio||region||mental health||disord||countri||interview||chile||drug abus||psychiatr disord||major depress disord||conclus region differ||analysi||lifetim||popul||servic||major depress||region differ||differ||drug||household||mental health servic||span wide geograph area||district,2||disord||health||result 1 2||mental disord||tabl 1||mental health||region disord||psychiatr disord||2 df||SE 2||3||mental||refer 1||volum 1,0.026||0.021||0.018||0.018||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014,0.2,0.3,0.2
377,Arch_Orthop_Trauma_Surg-4-1-2225998.txt,measur||reproduc||tradit measur techniqu||radiu fractur||studi||patient||radial length||distal radiu fractur||x-ray||direct measur||observ||AO fractur type||improv||classif||reduct result||techniqu||volar angul||radiu||normal valu||radial inclin||templat||distal radiu||distal radial fractur||side||result,1||3||2||observ||1 fig. 1 anatom||observ 7||C. 3 1 depart||refer 1||lidstrÃ¶m 2 fig. 2 normal||4||netherland 2 depart||8 observ||experienc observ||840 observ||observ agreement,0.037||0.035||0.033||0.028||0.023||0.021||0.021||0.02||0.018||0.017||0.016||0.016||0.016||0.016||0.015,0.2,0.1,0.06666666666666667
378,Eur_J_Appl_Physiol-3-1-1914221.txt,level||deficit||studi||patient||year||life||liver transplant||complaint||test||neuromuscular fit||liver transplant recipi||cross-sect studi||norm valu||present studi||fit||ltx||relationship||bodi composit||percentag||rehabilit program||sedentari person||sever||fatigu||isokinet strength||gener popul,2 2||2||2 3||1||1 2 3 agent||transplant||2 2 1979 1999||liver transplant||1 1 depart||2 peak||2 ffm||physic fit||2001||2 1974||transplant liver patient,0.022||0.022||0.019||0.019||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012,0.0,0.1,0.06666666666666667
379,Diabetologia-3-1-1914285.txt,upregul||lipid content||level||matur adipocyt||thiazolidinedion||adipokin||adipocyt||tzd||prostaglandin metabol||secret protein||lipolysi||rosiglitazon||rosi||adipos tissu||increas||low insulin||insulin||adipos||cell type||treatment||cell||gene||protein||lipid accumul||analysi||fatti acid||chang||metabol||decreas||secret||pathway||result,1||2||fig. 1||glucos 1||metalloproteinas 1||1 fig. 1 oro||1 2 rene||dehydrogenas 1||member 1||beta 1||desaturas 1||refer 1||acyltransferas 1||oxidas 1||1 Î¼mol,0.027||0.018||0.017||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.013,0.0,0.0,0.0
380,Ann_Hematol-4-1-2413090.txt,md||case||ipss||studi||patient||cytogenet find||clinic manag||therapeut strategi||complex abnorm||cell||gene||delet||result||prognosi||month||cytogenet||multicentr studi||group||genet materi||profound||median surviv||prognost relev||monosomi 7||karyotyp||deleteri cytogenet alter||anomali||monosomi,1||1 2 3 1 1||2 1||3||2||2 cytogenet||cytogenet||3 1 fig. 3||1 24 2 1 fig. 2||3 1 15 fig. 1||1 3 10 11||7||refer 1||1 incid||cytogenet studi,0.027||0.025||0.024||0.021||0.021||0.02||0.02||0.019||0.017||0.017||0.016||0.015||0.014||0.014||0.014,0.0,0.1,0.06666666666666667
381,Mol_Genet_Genomics-4-1-2329726.txt,condit||gene||human||strain||absent||gene pool||abu||genom||number||transcript||microarray||hypothet protein||urinari tract infect||urinari tract||environment condit||analysi||upec||up-regul||gene express||asymptomat bacteriuria,escherichia coli E. coli||E.||escherichia coli||E. coli transcript||E. coli 2006b||strain 83972 E. coli||escherichia coli strain||1||escherichia coli isol||escherichia coli bacteriuria||3 E. coli tabl 3 distribut||2008 escherichia coli strain||hycacd tauabcd E. coli||upec gene E. coli 2006 agai||2003 E.,0.031||0.028||0.027||0.024||0.024||0.023||0.021||0.02||0.019||0.018||0.018||0.018||0.018||0.017||0.017,0.0,0.0,0.0
382,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-4-1-2259253.txt,measur||pregnanc||data||studi||pad test||stress urinari incontin||test||women||self-report symptom||curv||diagnost strength||urinari incontin||group||symptom||clinic relev||sever||childbirth||incontin||weight gain||pad||result,1||2||test||pad test||2 fig. 2||pad test 1 fig. 1 distribut||1 1 depart||pad||pad test 3||refer 1||4 fig. 4||pad test result||incontin||24-h pad test||4,0.034||0.026||0.025||0.024||0.024||0.024||0.023||0.023||0.022||0.018||0.018||0.018||0.017||0.017||0.017,0.4,0.3,0.26666666666666666
383,Health_Care_Anal-4-1-2362137.txt,polici develop process||target group||interact polici develop||databas||problem||pam||data||theori||patient||effect||neurologist||develop||criteria||central pre-utilis approv||central committe||nation databas||clinic practic||variabl||clinic trial||guidelin||medic advisor||intervent||hcib||treatment||argument polici analysi||cost||health||workshop||polici||nation registri||clear protocol||interferon-beta||actor||specif recommend||target popul||order||reimburs||long-term effect||multipl sclerosi||drug||interact process||ministri||reimburs request||particip||drug interferon-beta,polici||2||polici measur||1||polici problem||polici develop||polici analysi||public polici||propos polici||polici implement||polici scienc||polici make||polici maker||polici object||polici institut,0.026||0.018||0.017||0.017||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
384,Eur_J_Clin_Pharmacol-4-1-2254473.txt,find||beta-lactam antibiot||outpati antimicrobi treatment||model||studi||patient||admiss||cap||mortal||pneumonia||antibiot||caus pathogen||treatment||antimicrobi therapi||atyp pathogen||hospit||microbi aetiolog||diagnost workup||antimicrobi drug||predictor||co-morbid||potenti predictor||initi treatment||aetiolog||hospit admiss||diagnosi||bacteria,1||pneumonia||2||3||3 1 depart||1 5 6||octob 1||august 1||refer 1||streptococcu pneumonia||community-acquir pneumonia||viral pneumonia||1 demograph||pneumonia sever||1 voorn,0.028||0.026||0.022||0.019||0.018||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015,0.2,0.1,0.06666666666666667
385,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2413121.txt,placebo||inflamm||nsaid||cartilag lesion||anterior cruciat ligament||intern knee document committe||studi||patient||joint preserv||function recoveri||effect||chondroprotect||follow-up visit||form||increas||recoveri||articular cartilag||knee pain||cartilag||treatment||i-on||day||control||joint reaction||studi design||sport activ||pemf||arthroscop reconstruct||pain||placebo group||activ||group||ikdc knee examin form||biophys stimul||recoveri time||signific differ||procedur||score||puls electromagnet field||result,1||1 2||2||2 fig. 2||4||patient||2 tabl||2 tabl 2 gener||result 1||fig. 4||refer 1||1 characterist||2 week||effect||knee,0.022||0.022||0.021||0.017||0.015||0.015||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.011,0.0,0.1,0.13333333333333333
386,Neurogenetics-4-1-2238789.txt,gene||SI _ figur _||probe||link||biolog associ||lewi bodi||number||drug||interact||microarray||iter analysi||substantia nigra||data||express||studi||neurodegener||complet list||diseas||cell,SI _ figur _||SI _ figur _ 2||SI _ figur _ 1||diseas||2||SI _ figur||SI _ tabl||gene||1||gene 2 fig. 2||2007||2 http://www.morphonom.net/ng/esm/t/si_table_2.xl SI _ tabl||parkinson diseas||parkinson âs diseas||3 http://www.morphonom.net/ng/esm/t/si_table_3.xl SI _ figur,0.02||0.019||0.019||0.017||0.017||0.016||0.016||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012,0.4,0.3,0.2
387,Eur_J_Health_Econ-3-1-1913175.txt,copd||cost effect||data||model||patient||valu||year||effect||tiotropium||ipratropium group||ipratropium||spain||qali||util||clinic trial||prefer option||analys||perspect||treatment||cost||diseas state||spanish nation health system||similar declin||month||life year||salmeterol||scenario||gener practition||econom evalu||chronic obstruct pulmonari diseas||differ||scenario analys||trial||sever||probabl||bronchodil||spanish healthcar utilis||ce-plan,1||1 1 17||2||1 fig. 1||year 1||tabl 1||health||year 2||2 year||refer 1||1 month||4.98 1||cost||scenario 2||3 1 institut,0.03||0.023||0.022||0.021||0.02||0.017||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.014||0.014,0.0,0.0,0.06666666666666667
388,Ann_Surg_Oncol-4-1-2244700.txt,cancer||studi||prolif activ||prognost signific||correl||section||apoptot cell||perimembran||postop surviv||poor prognosi||overexpress||present studi||nsclc||neg control slide||signific factor||prognosi||surgeri||tumor||cell mitosi||aurora-a||lung cancer||non-small-cel lung cancer||clinic studi||result,cancer||1||1 1||aurora-a||lung cancer||aurora-a express||2||2 2||3 2||express||cell carcinoma cancer||3||cell||carcinogenesi cancer||surviv cancer,0.022||0.018||0.018||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013,0.6,0.3,0.2
389,J_Med_Internet_Res-7-3-1550657.txt,cancer||method||interest||search activ||internet user||common cancer||search engin||onlin inform||studi||media coverag||cancer search activ||test||user||health inform||news||buzz index||news media||health||term||month||popul||incid||neoplasm||yahoo||specif cancer type||time period||news coverag||breast||score||internet,cancer||cancer cancer||cancer search||search||cancer search activ||cancer cancer yahoo||search activ||1||cancer search activ tabl 2||cancer inform||19 cancer||breast cancer||cancer incid||cancer mortal||nation cancer,0.041||0.041||0.037||0.034||0.032||0.03||0.027||0.027||0.024||0.024||0.023||0.023||0.022||0.022||0.022,0.4,0.3,0.2
390,Exp_Brain_Res-3-1-2080346.txt,musculoskelet factor||maxim flexion||target||find||present experi||visuo-motor track||extens excurs||flexion||effect||feedback signal||organ||form||region||variabl||point||coordin dynam||harmon||maxim extens||cycl||dynam||present studi||wrist postur||phase space||phase||analysi||direct||musculoskelet underpin||execut||veloc profil||trial||global kinemat||shorter||particip||wrist||stroke patient||experiment trial||movement trajectori||endpoint variabl||global track behavior||anchor||extens||full track trajectori||peak veloc,1||tempor 1||5 1||7 1||anchor||tempor 4 1||fig. 5||1994 1994 1995 1 fig. 1||2 2||2||spatial anchor||tempor anchor||1 result||fig. 4||fig. 7,0.023||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
391,Bioprocess_Biosyst_Eng-2-2-1705497.txt,optim valu||set||individu||problem||design variabl||amount||bit||multi-object experiment optim||process||mop||multi-object optim||variabl||softwar tool||experiment effort||small popul size||experi||popul||algorithm||experiment design||genet algorithm||gener||object||result,1 1||1||1 fig. 1||2 1||_{ 1||1 4||1 time||refer 1||0||le 1||2||2 2||_{||4 1 5 6||2 3,0.079||0.079||0.057||0.056||0.054||0.048||0.041||0.04||0.04||0.04||0.033||0.033||0.03||0.03||0.028,0.0,0.0,0.0
392,Apoptosis-4-1-2423418.txt,st||effect||control||hicc||process||electron cell||regulatori volum increas||apoptosi||hela cell||experi||shrunken cell||rvi||avd||hyperton stress||cation channel||cell shrinkag||activ||channel||cell||hypertonicity-induc cation channel,2 2||2||2 2 2 2||2 2 2 2 2||2 2 3 3||2 1||cell||discuss 2 2||1||3 5||3 3 fig. 3||2 18||1 1 fig. 1||5 5||5 fig. 5,0.043||0.043||0.043||0.043||0.035||0.034||0.029||0.029||0.025||0.025||0.025||0.024||0.023||0.023||0.021,0.0,0.1,0.06666666666666667
393,Transgenic_Res-3-1-1829418.txt,tumor latenc||mammari tumor phenotyp||latenc||breast cancer||model||studi||data||fvb||effect||strain||increas||background||metastasi||mice||ino defici||analysi||mammari tumorigenesi||tumor||differ||mous||pymt||phenotyp||molecular pathway||gland||ino||result,1||1 gland||1 fig. 4||mammari tumor||tumor||breast cancer||tabl 1||mammari gland||cancer model||2003||human cancer||1 6 201||cancer progress||cancer 2003 106 1 7 10.1002||human breast cancer,0.033||0.023||0.02||0.019||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014,0.2,0.2,0.13333333333333333
394,Eur_J_Pediatr-3-1-2039787.txt,neuro-cognit sequela||aspect||intens care treatment||measur tool||psycholog sequela||qualiti||studi||patient||life||effect||health statu||review||qol||outcom||treatment||sequela||health||paediatr intens care unit||lung function||parent||origin ill||post-traumat stress disord||famili||survivor||follow-up research||support||function||children,1||picu 1||1 2||picu||intens care||health care||studi 1 2 3||1 1 paediatr intens care unit||studi||pediatr intens care||diseas parent 1||18 1 NA picu||diseas picu||pulmonari function 1||1 mild,0.019||0.016||0.015||0.013||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.01,0.0,0.1,0.06666666666666667
395,J_Gastrointest_Surg-3-1-1915599.txt,anim||reproduc||immun system||laboratori anim||treatment strategi||organ sampl||mucos barrier function||rout||pancreat||model||studi||anim model||biliopancreat duct||effect||experiment studi||human||intestin flora||anim speci||treatment||duoden content||rat||infect||sever acut pancreat||bacteri transloc||fals posit result||earli mortal||sever||acut pancreat||diseas||intestin motil||bacteria||bacteriolog result||immun respons||result,2||acut pancreat 1 2||pancreat||12 15 2 2||acut pancreat||2 aspect||refer 1||1 characterist||31-30-2531944 l.m.a.akkermans@umcutrecht.nl 1 2 1 depart||h.timmerman@chir.azu.nl 1 2 visser||drs.m.blom@gmail.com 1 2 timmerman||lpvminnen@gmail.com 1 2 blom||h.gooszen@umcutrecht.nl 1 2 akkerman||acut||acut pancreat pancreatolog 2005 5 2,0.032||0.025||0.021||0.019||0.018||0.017||0.017||0.017||0.017||0.017||0.017||0.017||0.017||0.015||0.014,0.4,0.2,0.13333333333333333
396,Cardiovasc_Intervent_Radiol-3-1-2062488.txt,esophag varic||cathet||transjugular intrahepat portosystem shunt||patient||tip||intervent radiolog||placement||varic||collater vein||portal vein||avp||varic bleed||devic||liver||closur||portal vein collater||avp devic||amplatz vascular plug||procedur||embol||large-diamet vessel||creation||emerg procedur,2||1||1 2 fig. 1 portal||llc 2007 1 2||1 1 depart||3||2 cm||refer 1||netherland 2 depart||3 4||3 day||tip occlus 3 fig. 3||liver transplant 2 day||singl coronari vein fig. 2||llc 2007,0.064||0.048||0.04||0.039||0.036||0.035||0.035||0.028||0.028||0.025||0.024||0.024||0.023||0.023||0.022,0.0,0.0,0.0
397,Cancer_Causes_Control-4-1-2323031.txt,program||cancer||categori||mammographi||gp||women||repres sampl||screen||fear||result||rate||subject||nationwid opinion poll||franc||evid||gener practition||reason||crc||gener popul||cancer screen,1||1 1||franc||1 2 5||2||refer 1||1 reason||screen||result 1 fig. 1 adher||cancer screen||cancer||2008 introduct 1 2 3||franc 2 inserm u599||cancer screen test||edific committe 1 depart,0.059||0.059||0.039||0.039||0.034||0.032||0.032||0.028||0.028||0.027||0.025||0.025||0.022||0.02||0.019,0.2,0.3,0.26666666666666666
398,Naturwissenschaften-4-1-2270361.txt,condit||anim||hair||infant||mother||bodi angl||problem||primat||gorilla||valu||cling||densiti||mechan properti||bodi hair||human||forc||friction||african ape||infant carri||load||gibbon||human hair||orangutan||result||bodi||curv||biped||adult bodi||scenario||chang||weight||young modulu||skin||ape||posit||limit||area||safeti,2||1 2||1||2 1968 2||2 Î¼||2 line 2||hair||Î¼ 1||1 Î¼||2 1994 2004||2 1968||1931 1968 2 2||2 appendix||1 2 1987 2004 2 1982||2 squar 2 triangl 2 line,0.025||0.022||0.019||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013,0.0,0.1,0.06666666666666667
399,Breast_Cancer_Res_Treat-3-1-2092407.txt,shape factor form _ AR||case||nuclear morphometr featur||benign tissu||nuclear size||histori||breast cancer||patient||bbd||multivari analys||risk||breast tumor tissu||case-control studi||nuclear area||famili histori||featur||analys||control||women||form _ AR||associ||longest axi||subject||perimet||nuclear perimet||risk factor||subsequ develop||shape factor||area||benign breast diseas||form _ nci||longest nuclear axi||diagnosi||hyperplasia||morphometri,breast||breast cancer||1||2||3 2 2||breast cancer patient||breast cancer case||breast cancer risk||subsequ breast cancer||breast cancer cell||breast cancer develop||invas breast cancer||breast cancer detect||breast cancer microsc||3,0.033||0.03||0.03||0.024||0.023||0.022||0.022||0.022||0.022||0.022||0.021||0.021||0.02||0.02||0.02,0.2,0.1,0.06666666666666667
400,Int_J_Cardiovasc_Imaging-3-1-2121119.txt,LA contractil||ventricular||measur||lav||eject fraction||studi||left atrial volum||patient||aei||la-k||wall thick||aa-sv||mass||lad||control||hypertroph cardiomyopathi||LA size||group||differ||LA conduit||hcm||atrial volum||function,2||1||2 1 2 3||1 fig. 1||13 3 3 2 fig. 2||3||mitral regurgit 2 2 2 12||result 1||I. 1 2 neme||1 2 soliman osama||tabl 2 left||atrial diamet 1||left||31104635498 f.j.tencate@erasmusc.nl 1 1 depart||2007 method 3 3,0.038||0.037||0.033||0.028||0.022||0.021||0.02||0.02||0.019||0.019||0.019||0.018||0.016||0.016||0.015,0.0,0.0,0.0
401,Support_Care_Cancer-4-1-2206248.txt,type||cancer||time||total problem||problem||studi||patient||recurr||physic problem||health statu||qol||spous||aim||treatment||cancer patient||relationship||signific relationship||male partner||psychosoci||age||parent||parent cancer||report||group||ill||adolesc||treatment intens||diagnosi||norm||score||function||children,cancer||cancer 1||1||cancer patient cancer||cancer patient||2||patient||cancer patientsâ qol 1||cancer patientsâ||breast cancer||parent cancer||function||patient âs function||patient âs||parent âs cancer,0.025||0.024||0.022||0.022||0.02||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014,0.4,0.3,0.3333333333333333
402,Intensive_Care_Med-3-1-2039828.txt,serum||GM assay||combin||patient||diagnost process||high tropism||breakthrough infect||ipa||relat||human studi||sign||clinic trial||antifung therapi||treatment||invas diseas||voriconazol||fungal infect||non-invas diagnost test||combin therapi||chronic obstruct pulmonari diseas||invas pulmonari aspergillosi||drug||pcr||risk factor||oral administr||diagnosi,aspergillu||2||1||aspergillu aspergillu pcr||aspergillu niger aspergillu||patient||conclus aspergillu aspergillu aspergillu pcr||aspergillu antigen||aspergillu speci||J. 2||43 aspergillu||springer-verlag 2007 aspergillu aspergillu pcr||89 aspergillu||scedosporium aspergillu||ill patient,0.022||0.018||0.017||0.016||0.015||0.014||0.014||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.0,0.1,0.06666666666666667
403,Bioinformation-1-7-1891696.txt,web databas||inform||enzym||protein interact||cell signal||databas||dcse||hyperlink||tool||blast||biolog commun||sequenc||cell,1||access figur 2 figur 3 4||figur 1 5 6 7||bioinform 1||methodolog 2 3 4||refer 1 persidi||1997 25 3389 9254694 figur||cell signal||7||blast||cell||cell signal enzym||2006||blast search||cellular signal,0.081||0.05||0.047||0.044||0.034||0.033||0.024||0.023||0.022||0.02||0.02||0.019||0.018||0.015||0.015,0.0,0.2,0.2
404,Behav_Genet-4-1-2257998.txt,case||suffici statist||exact simul||time||effect size||method||mont carlo||data||model||studi||genet design||transform||effect||fals hypothesi||raw data||power||paramet||summari statist||varianc||analysi||qtl||simul||power studi||power calcul||distribut||genotyp valu||group||DZ twin||number||sampl size||probabl||suffici summari statist||design,1||1 1||2 1||2||1 2 1 2 0 2||1 3 2||1 2 3 2002||0 0 1 1||1 0||2 0 2 0||2 0||2 1 0 1988||3||size 2||illustr 1,0.042||0.042||0.042||0.042||0.038||0.037||0.031||0.03||0.03||0.03||0.03||0.026||0.025||0.025||0.025,0.0,0.0,0.0
405,Breast_Cancer_Res_Treat-4-1-2244694.txt,irregular categori||testosteron||menstrual cycl||cancer||level||find||breast cancer||studi||year||lifetim exposur||risk||menopaus||cycl||breast cancer risk||androgen||androstenedion||menarch||fftp||cumul number||dhea||women||trend||age||characterist||lifetim||sex hormon level||number||physic activ||risk factor||particip||shbg||reproduct characterist||hormon||children||sex hormon,1||2||cancer||result 1 2 17 2||2 week||breast cancer cancer||1 17.5||refer 1||1 16.14||breast cancer||breast cancer breast cancer||3||cancer risk||2 185||breast cancer risk breast cancer,0.029||0.025||0.019||0.018||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.013||0.013,0.2,0.2,0.13333333333333333
406,J_Neurol-3-1-1915650.txt,follow-up||method||db||reduct||studi||intent tremor||patient||effect||advers effect||tremor amplitud||scale||ataxia||intent||tremor reduct||treatment||function improv||case report||thalamotomi||tremor||isoniazid||limb||multipl sclerosi||trial||placement site||movement||disabl||superior cerebellar peduncl||articl,tremor||clinic tremor||tremor sever||sever tremor||tremor patient||intent tremor||bilater tremor||cerebellar tremor||arm tremor||tremor assess||improv tremor||postur tremor||tremor preval||action tremor||tremor reduct,0.038||0.028||0.026||0.026||0.023||0.023||0.022||0.022||0.021||0.021||0.021||0.02||0.02||0.02||0.02,0.2,0.2,0.2
407,J_Struct_Funct_Genomics-3-1-2140095.txt,crystal||dehydrogenas||target||protein kinas||case||method||structur determin||wide scientif audienc||drug develop||target area||scientif commun||determin||data||sgc||pdz||develop||inform||human||structur||domain||class||reductas||compound||specif||protein structur||inhibitor||approach||enzym||protein||success||metabol enzym||data collect||ligand screen||nmr||oxford||wide structur rang||protein character||gener||famili member||import||number||diseas||purifi protein sampl||ligand,protein||protein structur||structur||1||target protein||protein target||annot protein structur||human protein||protein structur univers||protein famili||2 protein kinas structur||structur data||crystal structur||1 3||protein construct,0.022||0.02||0.018||0.017||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013,0.6,0.3,0.2
408,Skeletal_Radiol-4-1-2335296.txt,find||mri||calcan edema||logist regress||studi||patient||pearson chi-squar analys||calcan spur format||nerv||marker||inferior calcan nerv||achil tendinosi||plantar enthesophyt||abductor digiti minimi atrophi||plantar fasciiti||ptt dysfunct||initi report||analysi||age||calcan spur||format||posterior tibial tendinosi||atrophi||adma||foot||order||presenc,1||1 7||2||refer 1||3||tabl 1 comparison||tabl 2||patient||7||studi||muscl fig. 2 adm||mri||pediatr patient||atrophi patient||5 7 14 15 7,0.046||0.031||0.03||0.024||0.019||0.018||0.018||0.017||0.015||0.014||0.013||0.012||0.011||0.011||0.011,0.0,0.2,0.2
409,Eur_J_Appl_Physiol-4-1-2267484.txt,muscl||find||modul||data||studi||motor cortex||walk||healthi subject||test||central fatigu||contractil properti||muscl damag||spinal modul||signific recoveri||evok potenti||day||dom||voluntari contract||subject||exercis||intens||mvt||decreas||maxim voluntari torqu||muscl sore||plantar flexor muscl||result,"1||2||2 2||1 2005||fig. 2||potenti 3 1||test 1||1 1 motor effici||1 year||1 noak||1 puchaux||4,36 1 fig. 3||exercis||974-413-2020 contact@sebastienracinais.com 1 2||muscl",0.03||0.026||0.026||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.015,0.0,0.0,0.13333333333333333
410,Eur_Radiol-3-1-1779628.txt,cancer||neoadjuv therapi||mri||imag||studi||patient||coil system||crm||mesorect fascia||rectal carcinoma||local excis||local stage||fov||import anatom landmark||rectal tumor||import criterion||recent year||accuraci||imag modal||power gradient system||local recurr||mesorect fatti tissu||tumor||eu||rectal cancer||sequenc||stage,cancer||rectal cancer||rectal cancer stage||7 1 8 fig. 1||2||rectal cancer eur||resect rectal cancer||rectal tumor||rectal cancer surgeri||rectal cancer Br||advanc rectal cancer||T4 rectal cancer||keyword rectal cancer||refer 1||rectal cancer fig. 11 arrow,0.021||0.021||0.018||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014,0.4,0.3,0.2
411,Pediatr_Nephrol-3-1-1915619.txt,gene||role||marker||vur||result||linkag||locu||sampl||linkag studi||children||famili,1 1 depart||7 1||2||1 gdnf||3||chromosom 1||result 1||1 onlin||famili 1||refer 1||7 7 8 1 onlin||genet||C. 1 van||8||linkag,0.026||0.025||0.024||0.023||0.023||0.021||0.021||0.021||0.021||0.02||0.017||0.014||0.014||0.013||0.013,0.0,0.0,0.06666666666666667
412,Pharm_World_Sci-3-1-2039831.txt,week||questionnair||melatonin||qualiti||patient||year||effect||medic||user||pdd||intervent||discontinu||low dose||daili dose||discontinu rate||gp||bd||gener practic||group||hypnot||differ||trial||particip||placebo control group||primari care||benzodiazepin||period,1||1 year||3||2||1 21||80 1||refer 1||year||1 characterist||result 1 fig. 1 select||5 year 6||6||5 year 7||5 year 8||50 3,0.033||0.026||0.022||0.02||0.019||0.018||0.018||0.018||0.018||0.017||0.015||0.014||0.013||0.013||0.013,0.0,0.1,0.06666666666666667
413,Clin_Oral_Investig-4-1-2238781.txt,case||indic||problem||studi||eros||wear||teeth||forc||depth||tooth wear||dentin||lesion||dental cari||relev||paramet||tissu||primari||acid||factor||exposur||sever||area||enamel||loss||diagnosi||dentit||score,1||2||eros||dentin eros 2||tooth||1 slight eros||dental eros||30 6 1||eros tooth wear||1 loss||involv 2 eros||refer 1||keyword tooth eros tooth||tooth wear||dental clinic,0.025||0.019||0.019||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012,0.2,0.1,0.13333333333333333
414,Appl_Microbiol_Biotechnol-3-1-2043089.txt,biorefineri||calcul||n-function||advantag||econom||year||agricultur wast stream||arginin||plant compon||polym||amino acid||protamylass||bulk chemic||technic process||cost||raw materi||cyanophycin product||potenti||applic||ton||product||cyanobacteria||protein||ferment||paper||import group||cyanophycin||materi||larg scale||fossil raw materi||amino acid arginin||chemic||biomass||potato||large-scal ferment||organ acid||plant,2||2 2007||product||cyanophycin product||cyanophycin||2007||chemic 2 2||1||plant 2 fig. 2||2 2006||2 econom||ferment cyanophycin product||2004 1 2005 2007||product cost||3,0.02||0.018||0.017||0.016||0.016||0.016||0.016||0.015||0.013||0.013||0.012||0.012||0.012||0.012||0.012,0.6,0.3,0.2
415,Ann_Surg_Oncol-4-1-2266786.txt,biolog||deceas donor liver graft||liver graft||studi||patient||year||dropout rate||patient surviv||liver transplant||ldlt||criteria||morphology-bas stage system||select bia||favor preliminari surviv result||graft||hcc||olt||past 10 year||transplant||tumor||milan criteria||size||tumor morpholog||ucsf group||ddlt||outcom||result,1||liver transplant||5||patient||transplant||donor liver transplant||tumor||2||5 7 1 fig||suppl 1||pancreat tumor liver transplant||liver transplant recipi||conclus liver transplant||living-donor liver transplant||liver graft,0.025||0.021||0.02||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014,0.6,0.4,0.3333333333333333
416,Int_Arch_Occup_Environ_Health-4-1-2413125.txt,measur||regard||determin||studi||year||life||lower regress coeffici||life style||stress life event||multivari model||older age||increas||abil||variabl||mental health||work-rel factor||event||white-collar worker||health||studi popul health promot||higher score||psychosoci factor||lack||age||stress handl||associ||dimens||factor||wai||influenc||work abil||physic activ||work||demand||score||oldest age group||self-develop||result,1||health||1 2||2||physic health||work||work abil||1 characterist||mental health||result 1||abil||occup health||1 min||gener health||health statu,0.028||0.026||0.024||0.021||0.02||0.019||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014,0.2,0.4,0.3333333333333333
417,Cogn_Process-4-1-2254470.txt,mechan||attent||role||level||retent||find||time||behavior||modul||represent||pfc||episod buffer||inform||process||sensit||abil||complex||memori||integr||pattern||cognit control||evid||unit||stimuli||cell||neural model||brain||posterior part||control||posterior cortex||task||simul||neuron||neural pattern||recurr loop||mainten||coher||cell assembl||instanc||activ||recurr connect||order||cortex||activ state||relev inform||synchron||input||interact||interdepend function||prefront cortex||area||assembl||automat process||function,2001||2003 2001||2001 2002||brain 2001||integr 2001||integr 2000 2001||2003||2000||2003 2000 2000 2001 2003 2004||1996 2001 1999 2003 2001||2005 2001||memori||2||pfc 2001 2003||2003 2003 1,0.026||0.021||0.019||0.017||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.015,0.0,0.0,0.06666666666666667
418,Neurochem_Res-4-1-2413118.txt,vector||level||DA level||data||studi||Î±-synuclein||gene express||ds oligo||express||cell||normal function||specif primer||DA biosynthesi||protein||activ||specif monoclon antibodi||dopamin||min||rna interfer||pcr||PD patholog,cell||lane 1 lane 2 lane 3||2||2 2||lane||3||fig. 1||cell viabil 2||2 fig. 2||2 min||mn9d cell||con cell||dopaminerg cell||cell line||1 Î¼l,0.028||0.022||0.022||0.022||0.021||0.02||0.018||0.018||0.017||0.016||0.016||0.016||0.016||0.015||0.015,0.2,0.1,0.06666666666666667
419,Diabetologia-3-1-2039867.txt,genet varianc||type 2 diabet||variat||principl||total variat||lipid metabol||metabol characterist||model||studi||chorion||herit||effect||correl||hdl-cholesterol||environment factor||leptin level||east flander prospect twin survey||sex||trait||insulin||random intercept model||young healthi twin popul||varianc compon||total cholesterol||hdl-cholesterol ratio||varianc||twin||high rang||pair||metabol risk factor||genet factor||genet||MZ MC||quantit sex differ||fat mass||covari||MZ DC pair||insulin resist||twin studi,1||1 2||2||2 2 2||2 2 2 2 2||2 3 2||genet||twin||twin twin||2 5||analysi 1 1||1 2 beunen||model sex 2 2||1 5 fig. 1||2 diabet,0.023||0.023||0.023||0.023||0.023||0.018||0.018||0.017||0.017||0.017||0.016||0.015||0.015||0.015||0.014,0.0,0.2,0.13333333333333333
420,J_Med_Internet_Res-5-4-1550579.txt,pharmaceut compani||method||common convers||studi||consum||difficulti||inform||criteria||process||site||consum search||web site||sourc||variabl qualiti||standard||internet||group||search||medicin||health public||issu||drug||particip||apprais skill||focu group||result,inform||particip||group||particip 1||group 1||particip 2||group 2||1||particip 6||group 6||health inform||2||particip 3||group 3||particip 4,0.027||0.026||0.026||0.024||0.024||0.023||0.023||0.022||0.021||0.021||0.02||0.02||0.02||0.02||0.019,0.6,0.3,0.2
421,Calcif_Tissue_Int-3-1-1914224.txt,vertebr fractur||follow-up||baselin||studi||year||allel||risk||promot||fractur||bmd||women||analysi||associ||independ effect||chang||osteoporosi||colia1||pcr cycl||femor neck bmd||haplotyp||bone miner densiti||result,2||2 2 2||colia1||colia1 colia1||haplotyp 2||2 colia1 genotyp||1||baselin colia1 genotyp 2 colia1 2||llc 2007 colia1 colia1 colia1 colia1||3||0.14 2||2 ng||91 2||55 2||colia1 polymorph,0.033||0.033||0.026||0.026||0.022||0.022||0.022||0.021||0.019||0.018||0.018||0.018||0.017||0.017||0.017,0.2,0.1,0.06666666666666667
422,Photosynth_Res-3-1-1769344.txt,aps-ito||OG micel||effici energi transfer||photosynthesi||electrod||IR spectra,R. rubrum R.||R. rubrum||2 R.||1 R. rubrum R. rubrum rp||2004 R. rubrum R. rubrum rp||2003 R.||R. rubrum R. rubrum 1991 Î»||4 R. rubrum rp||palustri R. rubrum rp||discuss 1 R. rubrum rp||2002 R. rubrum rp||method R. rubrum rp||palustri 2003 R. rubrum rp||palustri 2000 R.||palustri bacterium R. rubrum rp,0.054||0.052||0.045||0.043||0.039||0.038||0.036||0.034||0.032||0.031||0.031||0.03||0.029||0.026||0.026,0.0,0.0,0.0
423,Eur_Radiol-4-1-2373858.txt,follow-up||high tempor resolut imag||time||method||case||tempor resolut||mri||imag||studi||valu||morpholog characterist||clinic inform||malign group||benign||diagnost accuraci||total||reader||lesion||magnet reson imag||breast||imag protocol||initi enhanc||multivari analysi||local imag||evalu||analysi||min||order||auc||divers histolog distribut||perform||pharmacokinet paramet||signific differ||wash-out||lesion size 14 mm||malign lesion||diagnost perform||result,1||2||breast||1 tran||2 tran||breast lesion||fig. 2||reader 1||breast cancer||reader 2||imag||tran||dynam breast mri||ep tran 2 tran||4,0.023||0.022||0.02||0.019||0.018||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.2,0.1,0.13333333333333333
424,Ann_Surg_Oncol-4-1-2190337.txt,cancer||center||data||studi||patient||hospit volum||mortal||high-volum center||risk adjust||volum||comorbid||treatment||in-hospit mortal||multivari analysi||hospit||case-mix||import determin||lvh||ptnm stage||clinic data||hvh||group||surviv||origin patient file||differ||esophag resect||adjust||resect||tumor stage||procedur||neoadjuv treatment||diseas||high-volum hospit||stage||outcom||result,2||1||4 1 2 1 complic||2 1 14 3||4 1 6 1||mortal 2||2 1 6 1 stage||phd 1 1||5 2 1 0||8 2||3||cancer||3 4 tabl 2||hospit||surviv 2,0.021||0.021||0.015||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.012,0.0,0.0,0.13333333333333333
425,Eur_J_Appl_Physiol-4-1-2225999.txt,food intak||measur||full||respons||cortisol level||level||session||lf-to-hf ratio||sensori rate||human||relat||increas||blood pressur||desir||heart rate||eat||food intak regul||amylas||food||subject||satieti||min||hunger||orosensori stimul||waist-to-hip ratio||hip circumfer||cortisol||oral activ,2||fig. 2||result 2 1 1||63 2||fig. 3||saliva biochemistri 2||Î± Î±||Î±||1 kg||263 fig. 1||saliva biochemistri 3 Î± 3 Î±||2000||min||1 anthropometr valu||1997,0.031||0.023||0.02||0.018||0.016||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011,0.0,0.0,0.06666666666666667
426,Glycoconj_J-4-1-2234449.txt,antibodi||lmwh||gag||biolog characterist||nadroparin||anticoagul||enzymat digest||danaparoid||domain||chemic||sulodexid||enoxaparin||reactiv||heparinas||immunoprofil||sulfat||heparinoid||specif immunoprofil||heparin-induc thrombocytopenia,2 2||2||3||1||1 1||2 fig. 2||2 8||2 4||1 2 van||5 3||3 5||3 10||3 38||2 23||6 3,0.028||0.028||0.028||0.026||0.026||0.02||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.017||0.017,0.0,0.0,0.0
427,J_Med_Internet_Res-9-2-1913941.txt,medic research||nlm||interest||inform manag||session||studi||inform||open access||domain||altern medicin practition||user||profession||clinic practic||tool||chiropractor||specif||health||degre||research||pubm||inform retriev||full text||profession develop||abstract||servic||literatur||practition||medicin||access||full-text articl||limit||public||cam||particip||life scienc||articl,2||1||search||research||pubm search||research articl||3||integr 1 2||tabl 2||figur 2||âs||articl figur 2||2006||pubm âs||research access pubm,0.021||0.02||0.019||0.017||0.016||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.012,0.2,0.1,0.06666666666666667
428,Ann_Surg_Oncol-3-1-1914247.txt,follow-up||level||complic||ilp||object measur||patient||amput||year||median follow-up||perfus||st||femor PI||treatment||limb salvag treatment strategi||vascular complic||lower limb||ultrasonographi||month||arteri occlus diseas||critic leg ischemia||late vascular morbid||rang||limb||arteri occlus||vascular reconstruct||resect||poplit PI||ebrt||sarcoma||long-term vascular side effect,3||3 4||1||2||3 3 axillari||2 3 poplit||2 3 iliac||3 year||1 1 iliac||2 tabl 2||pnet 3 3 iliac||patient||3 4 axillari||synovi sarcoma 3 3 iliac||4,0.026||0.02||0.02||0.02||0.019||0.018||0.018||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015,0.0,0.0,0.06666666666666667
429,Osteoporos_Int-2-2-1705543.txt,method||bisphosphon||data||model||patient||conclus patient||effect||clinic practic||fractur||therapi||cohort||alendron||hip||nonvertebr fractur||month||incid||risedron||differ||osteoporosi||primari analysi||date||risk factor||trial||baselin characterist||hip fractur||health plan||result,1||2||3||12 1||5 1||fractur||1 year||analys 2||CI 2||1 identif||refer 1||2 comparison||3 3 fig. 3 cumul incid||26 2 3 4 12 14||observ studi,0.024||0.024||0.018||0.018||0.017||0.016||0.014||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.012,0.0,0.1,0.06666666666666667
430,Clin_Oral_Investig-3-1-2099161.txt,rate||perman molar||studi||year||cari||effect||oral health||altern treatment strategi||teeth||perman dentit||failur||caviti||art||primari dentit||treatment||gross margin defect||oper effect||evalu||restor||dentist||result||primari||high-cari popul||analysi||cox regress analysi||three-year surviv||materi||secondari cari||dental treatment||two-surfac restor||dutch dentist||signific differ||basic oral health care||children||restor treatment,1||restor||1 2 fig. 1||2||art restor||restor treatment||3||restor level||1 44||restor present||refer 1||E. 1||22 restor||louwesweg 1||2 26,0.03||0.028||0.022||0.021||0.021||0.019||0.018||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015,0.2,0.2,0.13333333333333333
431,Childs_Nerv_Syst-3-1-2092440.txt,level||case||mmc||protocol||modern palli care||groningen protocol||prospect||ethic debat||qualiti||studi||deliber termin||life||sever form||decis||criteria||lesion||newborn||palli care||countri||hopeless||treatment||sever physic disabl||intern medic recommend||end-of-lif decis||dutch associ||medic care||pain||babi||experi||parent||care||termin||hydrocephalu||intern legisl||ethic||sever||meningomyelocel||physician||suffer||spina bifida||result,1||refer 1||1 month||4||3||2||medic||2005||medic care||73 4 5 fig. 4||child||care||bifida||child âs life||sever brain damag 3 1 5,0.018||0.01||0.01||0.01||0.009||0.009||0.009||0.008||0.008||0.008||0.008||0.007||0.007||0.007||0.007,0.0,0.1,0.13333333333333333
432,Childs_Nerv_Syst-4-1-2413122.txt,tumour||meningioma||marker||analysi||mutat||dna||loh||patient||year||radiat therapi||myoepithelioma,ini1||C. 2||refer 1||10 12 1||31-20-5669312 t.j.hulsebos@amc.uva.nl 1 1 depart||1 loh region||ini1 mutat||netherland 2 depart||histolog find 2||C. J. 1 houben||year||analysi||conclus ini1||case report histori 2||children 3 year,0.036||0.03||0.03||0.026||0.026||0.024||0.024||0.023||0.021||0.02||0.02||0.019||0.019||0.018||0.018,0.0,0.0,0.13333333333333333
433,Neuropsychologia-2-1-2265793.txt,condit||categori||level||effect size||recognit||individu||data||environment support||studi||comparison||asd||difficulti||process||inform||abil||recal||memori||pattern||evid||relat inform||item||hippocampu||task||list||asd particip||group||word||autism spectrum disord||asd group||perform||relat memori||particip||support,2||1||categori||tabl 2||fig. 2||2 show||memori||small 2||2 error||categori size||asd categori||psycholog||comparison categori||8 item categori||2 comparison individu,0.021||0.018||0.016||0.014||0.013||0.012||0.012||0.012||0.012||0.011||0.01||0.01||0.01||0.01||0.01,0.2,0.2,0.13333333333333333
434,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-4-1-2248214.txt,case||diagram||reflect spectra||wavelength||angular reflect||pattern||butterfli||kinoshita||transmiss electron microscopi||scatter||singl scale||singl butterfli scale||butterfli speci||light||structur colour||angular distribut||colour||wing||multilay structur||backscatt light||reflect,2 2 2||2||2 1 2 P. rapa||2 4 2 4||fig. 2||2 D.||2 min||2 stavenga||present studi||1 min||column 1||G. 1 1 depart||scale||P.||4 4 6,0.039||0.039||0.028||0.028||0.026||0.023||0.022||0.022||0.02||0.018||0.017||0.017||0.017||0.017||0.016,0.0,0.0,0.0
435,Eur_J_Pediatr-3-1-1820762.txt,condit||antibodi||hu||method||plasma||vwf||sampl||mutat||studi||ttp||patient||assay||immunoblot||heterozyg carrier||congenit||thrombot thrombocytopen purpura||polyclon antibodi||normal phenotyp||proteas||normal plasma||von willebrand factor||parent||activ||sds-page||adamts13||normal individu||result,adamts13||1||patient 1||ttp patient adamts13 1||2||4||adamts13 activ||patient 4||3||adamts13 present||patient 3||adamts13 mutat||patient||adamts13 method||adamts13 antigen,0.023||0.021||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014,0.2,0.1,0.13333333333333333
436,Int_J_Colorectal_Dis-3-1-2134973.txt,abdomin cramp||questionnair||irrig||dynam graciloplasti||defec disord||qualiti||studi||patient||life||amount||water||colon irrig||treatment||addit therapi||dgp||success rate||defec||colostomi||contin||constip||appendico-cecostomi||fecal incontin||result,1||1 1||2||1 2 fig. 1 biotrol||3||colon irrig||patient||2 success||28 32 1 5 1 5||refer 1||rectum||8||3 fig. 3 success||irrig||2004,0.029||0.029||0.022||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.014||0.014||0.013||0.013,0.0,0.2,0.2
437,J_Gastrointest_Surg-3-1-1852386.txt,linear regress||author||respons||week||time||signific growth inhibit||rate||interv||studi||valu||patient||brdurd-label cell||schedul II||treatment time||clinic down-stag||clinic assess||radiotherapi||spf||signific||treatment||cell||prolifer rate||schedul||earli tumor respons||ratio||brdurdli||prolifer||complet respons||cell death||surgeri||local recurr||tumor||preoper radiotherapi||regress||resect||rectal cancer||cancer cell prolifer,tumor||3||1||1 1||3 2 1||rectal tumor||2||patient 1 1 1||tumor cell||tumor respons 2||prolifer tumor||cancer||respons tumor||tumor respons||tumor cell prolifer,0.027||0.023||0.022||0.022||0.022||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.019||0.019||0.017,0.2,0.1,0.06666666666666667
438,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-4-1-2323032.txt,mechan||ear||caudal region||tonotop axi||tympan membran||frequenc||spontan otoacoust emiss||organ||anuran||similar||tonotop organ||narin||round window||tectori curtain||auditori system||s-shape extens||characterist||amphibian||contact membran||mammalian cochlea||nerv fiber||frog||basilar papilla||sacculu||emiss||frequenc select||amphibian auditori system||otoacoust emiss||vertebr||endolymphat space||amphibian papilla||hair cell||speci||spontan emiss||hair bundl||membran||function||singl auditori filter,1||1 2006||2006||3 2006||2006 2003 2004 2006||2||papilla||2003||1 2000b fig. 1 1985||auditori hair cell||2001 2004 2006 2003 1996 2006||amphibian papilla||auditori mechan||auditori research 2003||auditori organ,0.015||0.014||0.013||0.012||0.011||0.011||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.008||0.008,0.0,0.0,0.06666666666666667
439,J_Headache_Pain-4-1-2276243.txt,autosom domin||mechan||chronic headach||epigenet||model||studi||mutat||genet repertoir||cluster headach||clinic featur||risk||genet variat||chromosom||typic migrain||headach pathogenesi||disord||featur||behaviour||primari||attack||suscept loci||primari headach||fhm||genet||famili||infanc||migrain||diseas||epigenet mechan,genet||headach||migrain headach||migrain||migrain gene||gene||typic migrain genet gene||migrain genet research||typic migrain genet||genet studi||med genet||1||famili migrain||migrain candid gene||cluster headach,0.022||0.02||0.02||0.019||0.019||0.019||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013,0.4,0.2,0.2
440,Ann_Surg_Oncol-3-1-2039838.txt,anim||mmc||cytoreduct surgeri||model||studi||physic condit||perfus||heat intraperiton chemotherapi||clinic trial||dose||temperatur||treatment||rat||day||adjuv therapi||periton carcinomatosi||result||macroscop tumor||surgeri||group||surviv||surgic procedur||median surviv||rit administr||hipec||procedur||toxic||preclin studi||radioimmunotherapi,1||2||follow-up 2 2||phd 1 1 depart||oper procedur 2 2 11||1 boerman||tabl 1||refer 1||2 year||3 2 2 treatment group characterist||phd 1 oyen||6||phd 2 bleichrodt||intraperiton||hipec procedur 1 fig,0.026||0.026||0.018||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.012||0.012||0.012||0.012||0.012,0.0,0.0,0.0
441,Eur_Radiol-4-1-2220024.txt,data||patient||solid residu||regimen||effect||diagnost accuraci||colonoscopi||total||barium||dose||magnesium citrat||ctc||polyp||residu||fluid||bowel prepar||reason||group||proxim colon||differ||score||statu||patient accept||addit||prone||prepar||diagnost perform,1||3 1||1 2||1 fig. 1||patient||3||2||5 patient||1 3 19||inconveni 1||18 1 2||refer 1||institut 1||5||patient experi 1 16,0.028||0.023||0.023||0.022||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014,0.2,0.1,0.06666666666666667
442,Behav_Genet-4-1-2292426.txt,questionnair||homophobia score||homophobia||individu||sampl||data||model||studi||herit||effect||femal||twin pair correl||threshold||hlq||total||sex||environment influenc||signific||gay men||homosexu||item||estim||varianc||twin||non-heterosexu||pair||genet||differ||contribut||homophobia categori||attitud||influenc||item score||twin studi||score||result,2||2 2||1 2||1||3 2||6 score 2||genet||score||5 1 fig. 1||2 number||2 Î´d.f||genet model||twin pair correl 3 1 2||genet studi||homophobia score,0.028||0.028||0.026||0.024||0.02||0.016||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.013,0.0,0.2,0.2
443,Mol_Imaging_Biol-3-1-1915656.txt,elig studi||imag||data||studi||patient||rel lesion detect||review||sensit||articl||lesion||positron emiss tomographi||attenu correct||AC imag||fdg||specif||nac imag||meta-analysi||fr-pet||index test||oncolog patient||dual-head coincid pet||methodolog qualiti||test accuraci||transmiss||elig||lesion detect||systemat review||tomographi||refer test||result,imag||2||1||pet imag||1 1 depart||2 tabl||lesion||1 cm||3||AC imag||nac imag||imag interpret||lesion detect||conting 2||CT imag,0.026||0.024||0.024||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.2,0.3,0.3333333333333333
444,Mol_Biochem_Parasitol-1-5-1885993.txt,rdgc||myristoyl||data||motif||phosphatas||ef-hand domain||parasit||amino acid||ef-hand||ppef||specif||gene||conserv||protein phosphatas||protein||analysi||high confid||tbppef||s-gfp||lmppef||result,fig. 1||fig. 2||fig. 3 fig. 3||fig. 1 L.||fig. 1 3||protein||fig. 3 L.||fig. 6 fig. 1 fig. 7||1||fig. 2 fig. S1||1 1 2||fig. 7 fig. 7||fig. 7 fig. 5||fig. 5||fig. 5 2,0.027||0.026||0.025||0.024||0.024||0.023||0.023||0.022||0.022||0.021||0.021||0.021||0.021||0.02||0.02,0.0,0.1,0.06666666666666667
445,Osteoporos_Int-4-1-2277446.txt,placebo||level||administr||calcium intak||nurs home||baselin||studi||serum 25||effect||secondari hyperparathyroid||increas||bone turnov marker||serum pth||dose||calcium||day||calcium supplement||month||phosphat||pth||nurs staff||home||group||decreas||monthli administr||random clinic trial||particip||daili administr||result,2 2||2||0 1 2||calcium 2||3 tabl 2 0 1 2||1||1 2 wijnhoven||2 lip||2 week||Ca 2||tabl 1 0 0 2||discuss 2 3 4||0||4 month||measur 2 21,0.043||0.043||0.029||0.026||0.025||0.025||0.023||0.023||0.022||0.022||0.022||0.021||0.018||0.017||0.016,0.0,0.0,0.0
446,Histochem_Cell_Biol-4-1-2228381.txt,patholog gain-of-funct mechan||edem1||earli secretori pathway||ER stress||gl II||golgi apparatu||pathogenesi||nuclear envelop||exampl||complex||edem||chaperon||degrad||oligosaccharid||cell||copii coat||erad||glucosidas II||protein qualiti control||protein||qualiti control||endomannosidas||zuber||chemic chaperon||myocilin-caus open-angl glaucoma||synthet chaperon||protein fold diseas||work||mammalian cell||diseas||result,cell||protein||2006||histochem cell biol||2002||1||cell regul||secretori cell||2005||pancreat cell||2005 1999 2005 2006 2005 2006||cell biolog||2006 2001 2001 2002 1996 2006||cell death||mammalian cell,0.024||0.019||0.016||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.012||0.012,0.4,0.2,0.2
447,Neurosci_Lett-1-5-1885995.txt,notch||sub-nuclear bodi||cbf-1,icd||icd icd||icd icd icd||fig. 2 icd icd icd||fig. 3 icd icd||abstract icd icd icd||1||2||3||4||cell||21||2000 260 1 8 11010805||cell biol||8,0.043||0.043||0.043||0.042||0.041||0.032||0.032||0.027||0.021||0.016||0.016||0.011||0.011||0.01||0.01,0.0,0.0,0.0
448,J_Chem_Ecol-4-1-2239250.txt,insect||level||time||induct||concentr||individu||studi||GS concentr||dri mass determin||effect||femal||parasit||pieri rapa||parasitoid||sex||compound||natur enemi||defens||generalist||caterpillar||mithen||popul||oviposit||glucobrassicin||herbivor||direct defens||surviv||glucosinol||artifici select||speci||total GS concentr||specialist||plant,2||plant||P.||2 P. xylostella||P. J.||P. xylostella||brassica||P. xylostella B.||1 P. xylostella||2 B. oleracea brassica||brassica B.||J. brassica||3 fig. 2||B.||J.,0.018||0.018||0.018||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.012,0.2,0.1,0.06666666666666667
449,Eur_J_Pediatr-3-1-2151775.txt,breastf infant||netherland paediatr surveil unit||case||week||administr||infant||birth||data||current dutch guidelin||studi||effect||cholestat liver diseas||netherland||surveil||newborn||dose||late vkdb||age||prophylaxi||incid||current incid||oral||paediatr||report||order||secondari case||vkdb,1 1||1||1 1 1||1 1 1 3||1 1 1 29||1 1 depart||1 1 1 9 1 daili||springer-verlag 2007 1 1 1||1 year||refer 1||1 januari||1 mg p.o.||2||3||1 confirm case,0.052||0.052||0.052||0.044||0.04||0.036||0.036||0.035||0.028||0.027||0.027||0.026||0.024||0.022||0.02,0.0,0.0,0.0
450,Ann_Surg_Oncol-3-1-1914273.txt,follow-up||adjuv radiotherapi||respons||ilp||radiat||patient||year||amput||distant metastas||perfus||radiotherapi||necrosi||patholog examin||treatment||tumor necrosi factor alpha||late morbid||recurr diseas||month||critic leg ischemia||resect margin||isol limb perfus||limb salvag||tumor||surviv||melphalan||limb||skin||time period||resect||diseas||sarcoma||patholog fractur||result,2||1||tumor||month||limb salvag 2 2 tabl 2||limb||patient||rang 2||necrosi||tumor necrosi factor||4 4 fig||tumor respons||21 patient||patient 21||limb perfus,0.022||0.02||0.017||0.016||0.015||0.014||0.014||0.012||0.012||0.011||0.011||0.01||0.01||0.01||0.01,0.4,0.5,0.3333333333333333
451,J_Biol_Inorg_Chem-4-1-2359831.txt,condit||polyacrylamid gel electrophoresi||odn||gel||sampl||copper complex||platinum||copper||close proxim||dna||dna cleavag||odn II||adduct||major groov||sequence-select cleavag||solut||clear sequenc select||band||cleavag||fragment||strand cleavag||nucleobas||smear||result,2||1 2 2||1 2||1 2 1 1||1 4 2 1 2||1||1 2 3 2 2 27||1 2 7 2 4 2||3â²-phosphat end 2 2 2 2||6 1 2 6 1 2||1 2 2 3 15 1||cleavag 1 2 1||2 4||method 1 2||cytotox 1 2,0.087||0.08||0.076||0.07||0.065||0.065||0.061||0.06||0.059||0.058||0.058||0.055||0.055||0.051||0.051,0.0,0.0,0.0
452,Diabetologia-3-1-2039826.txt,type 2 diabet||insulin level||vascular event||chronic hyperglycaemia||white matter lesion||diabet||mri||histori||data||vascular risk factor||patient||multivari model||cerebr complic||pwml||brain infarct||test||infarct||insulin||type 2 diabet mellitu||macrovascular diseas||present studi||brain||vascular factor||control||regress analys||cognit||sever wml||retinopathi||sever mri abnorm||associ||atrophi||brain mri||group||factor||perform||neuropathi||risk factor||cognit domain||neuropsycholog examin||cognit perform||larg number||score,diabet||2 diabet||2||type 2 diabet||2 diabet mellitu||type 2||type 2 diabet group||diabet patient||type 1 diabet||type 2 diabet mellitu||type 2 diabet manschot||interpret type 2 diabet||diabet characterist||diabet mellitu||diabet encephalopathyâ,0.039||0.037||0.035||0.03||0.025||0.025||0.024||0.023||0.023||0.023||0.023||0.022||0.021||0.021||0.02,0.4,0.3,0.2
453,J_Mol_Model-4-1-2386531.txt,crystal||type||method||solid||eid||unit cell||higher accuraci||bond length||bond||pm6||artifact||optim||model||valu||distort||ion||densiti||strong bond||partial charg||form||forc||silic||compound||period boundari condit||paramet optim||dabco||fault||unit||energi||net charg||geometri||distanc||train||good accuraci||organ compound||unpair electron||atom||polymorph||gradient||sulfur||ice||turn||charg||hydrogen bond||inter-r distanc||carbon group||solid state||electrostat potenti||miner||survey||speci||error||weak interact||proton||good approxim||organ solid||acet group||molecul||result,2||2 2||2 2 3 2 2 2||2 4 2 2||3 2 2 2||82.8 2 2 2 2 2||2 2 7 2 2||2 4 2||2 2 4||2 3 2||1 2 2||2 2 5||2 4||4 2||2 2 6,0.047||0.047||0.042||0.041||0.04||0.039||0.039||0.039||0.039||0.038||0.036||0.035||0.035||0.035||0.034,0.0,0.0,0.0
454,Neurosurg_Rev-3-1-2077911.txt,occipit bone||case||dura||rate||fmm||import vascular structur||studi||patient||craniocerv junction||head||difficulti||nerv||occipit condyl||surgic strategi||spinal cord||drill||lesion||point||FM area||skull base surgeon||lower cranial nerv||anatomi||VA damag||surgic approach||nerv root||approach||atla||complet resect||VA transposit||literatur||foramen magnum||FM meningioma||tumor||arteri||exposur||meningioma||resect||lower part||branch||vertebr arteri||bone resect,2||1||2 fig. 2||100 1||3||1 3 5 55||5||2 15||surgic approach||3 7||suppl 2||1 review||2 0 86.0||refer 1||vol 2,0.018||0.018||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.01||0.01||0.01||0.01||0.009,0.0,0.1,0.06666666666666667
455,Neuroimage-2-1-2225446.txt,method||scanner||imag||data||studi||grey matter||effect||medial tempor lobe||upgrad||test||region volum||multi-scann data-set||signific||calibr||brain||control||varianc||analysi||subject||qualiti control||group||differ||interact||error||diseas||imag intens||thalamu||result,scanner||scanner 1||scanner differ||scanner 2||6 scanner||scanner effect||scanner 4||scanner 3||5 scanner||scanner 5||fig. 1||differ||scanner group||multipl scanner||1 normal,0.032||0.028||0.025||0.024||0.023||0.022||0.021||0.021||0.019||0.019||0.019||0.018||0.018||0.018||0.016,0.2,0.1,0.13333333333333333
456,Intensive_Care_Med-3-1-1915613.txt,case||respons||medic condit||disturb||studi||clinic observ||patient||effect||present||criteria||anxieti||hypoact||antipsychot medic||disord||patient descript studi||adult||treatment||picu||diagnost||acut||ill children||approach||pediatr intensivist||haloperidol||parent||routin clinic practic||incid||psychiatr consult||delirium||explan||clinic present||risperidon||intens care unit||design||treatment respons||dsm-iv criteria||pediatr intens care unit||children,year||3 year||1||2 year||4 year||haloperidol||1 year sepsi||1 year pneumonia||15 year||18 year||16 year||9 year||17 year||haloperidol 2||3,0.029||0.022||0.021||0.02||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.014||0.014,0.0,0.1,0.06666666666666667
457,Cell_Calcium-1-5-1885971.txt,steady-st level||tip||extrus||effect||casm||depth||recoveri||larg snail neuron||diffus coeffici||sequestr||cell||calcium||intracellular calcium||solut||experi||mobil||neuron||cell membran||buffer||time constant||depolaris||appar paramet||diffus||respons time||transient||size||influx||peak||membran||microelectrod||result,2||2 2||fig. 2||1 2||fig. 1 2||fig. 2 fig. 1||Ca 2||fig. 4 2||Ca fig. 2||fig. 3 2||fig. 7 2||app 2||fig. 1 fig. 4 2||Ca fig. 1 2||fig. 6 2,0.047||0.047||0.038||0.035||0.033||0.032||0.029||0.029||0.029||0.029||0.028||0.028||0.028||0.027||0.026,0.0,0.0,0.0
458,Matern_Child_Health_J-2-2-1592158.txt,embryo||assist reproduct technolog||birth||fertil||pregnanc||patient||risk||art||cycl||ivf||treatment||lower birth weight||embryo cultur condit||multipl gestat||women||multipl||twin||infertil||factor||addit counsel||singleton||fertil problem,1 3||4 4||1 1 depart||4 4 5 6 7||1 2 3 frazier linda||refer 1||2006||4 13||kansa usa 4 depart||kansa usa 3 depart||8 9 10 2||hum reprod 2004||patient||4 14 14||patient inform,0.028||0.028||0.023||0.019||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.014||0.013||0.012||0.011,0.0,0.0,0.06666666666666667
459,Behav_Genet-4-1-2226023.txt,time||week||gestat age||birth||insert||studi||chorion||herit||effect||environment factor||covari matrix||increas||placenta||growth||cord insert||matern factor||varianc||twin||qtl||umbil cord||weight||birth weight||gestat||regress||order||separ placenta||influenc||covari||placent factor||unadjust model||chanc,1||1 2||2||1 2 3 3 2002||3||1 model||delta _{ 1||upsigma _{ 1||1 2 time||twin||delta _{ 2||1 3 2000||time 1||gestat 1||genet studi,0.029||0.027||0.025||0.022||0.022||0.022||0.021||0.021||0.021||0.02||0.02||0.019||0.018||0.018||0.016,0.0,0.1,0.06666666666666667
460,Clin_Oral_Investig-4-1-2238777.txt,condit||consumpt||dental eros||time||soft tissu||protect effect||salivari flow||studi||eros||effect||wear||sport||miner content||clinic examin||increas||dentin||saliva||calcium||enamel surfac||acid drink||eros potenti||eros agent||fluorid||surfac||factor||chemic factor||behaviour factor||phosphat content||import||drink||chemic||enamel||tooth||tooth surfac||progress,eros||1||dental eros||enamel eros||eros tooth||dental eros cari||eros effect||eros potenti||eros Br dent||dental eros Br dent||dental eros eur||enamel eros cari||facial eros||vitro eros||eros condit,0.027||0.022||0.021||0.019||0.018||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015||0.015,0.4,0.3,0.2
461,J_Med_Internet_Res-4-3-1761945.txt,nation||system||parti||commun||conduct||user guid||relev profession associ||european council||state||criteria||inform||specif tool||medic||user||unit state||provid||guidelin||label||tool||content||avid consum||websit||code||health||eeurop||hon||site provid||bodi||standard||action||rate system||site develop||european||possibl||high qualiti servic||privaci||qualiti initi||order||core set||european union||specif aim||organis||member state||eeurop 2002 action||qualiti criteria||initi||sixti||internet,health||qualiti||health relat||health inform||health relat inform||health data||2||health relat websit||qualiti criteria||specif health||health relat content||relat||health site provid||public health||health servic,0.024||0.021||0.019||0.019||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.2,0.2,0.13333333333333333
462,Eur_J_Epidemiol-4-1-2249618.txt,indic drug||discharg||full multivari model||studi||patient||year||admiss||prescript||non-acut care hospit||medic||intervent||ace inhibitor||day||arb||hospit||health care system||statin||odd||popul||secondari prevent||care||myocardi infarct||acut MI||MI admiss||copay||aspirin||beta-block||sick fund||absolut contraind,1||1 1||2||3||studi||2 3 3 4||2 3 4||refer 1||studi medic||studi drug||myocardi infarct 1||myocardi infarct 2||7||patient||2008 introduct 1 3 4,0.015||0.015||0.014||0.013||0.012||0.012||0.011||0.011||0.01||0.01||0.009||0.009||0.009||0.008||0.008,0.2,0.1,0.13333333333333333
463,Chiropr_Osteopat-13-_-1151650.txt,method||search engin||problem||data||studi||year||patient||question||overweight||bmi||risk||obes||review||bodi mass index||evid||evidence-bas practic||research||causal factor||paper||pain||associ||definit answer||literatur||osteoarthr||search||date||risk factor||link,4||2||tabl 2||4 calcul||step||1 4 6 7||1||tabl 1 step||answer question step 2||back pain||search strategi step 4||tabl 5||tabl 3 clinic||pain||studi,0.031||0.024||0.018||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.013||0.012||0.011||0.011||0.011,0.0,0.0,0.13333333333333333
464,Appl_Microbiol_Biotechnol-4-1-2243254.txt,petrochem process||metabol pathway||immobil||studi||yield||process||ferment process||organ||agent||fungi||cell||fumar acid||glucos||product||ferment||acid||maleic anhydrid||carboxyl acid||fumar||product recoveri||organ acid,1||1 1||http://tonto.eia.doe.gov/dnav/pet/xls/pet_pri_wco_k_w.xl 1 2 2||2 2 fixat||3 1997 1||acid||2006 2||1990 2 fig. 2||1 3 1986||1999 3||fumar acid product 1990 2 3||fumar acid 1||1 2000||2 comparison||1 1999,0.023||0.023||0.021||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.017||0.016||0.016||0.015,0.0,0.1,0.06666666666666667
465,Pflugers_Arch-3-1-2082651.txt,condit||quinidin||data||studi||bcl||arrhythmogenesi||arrhythm activ||flecainid||effect||parallel||point||treatment||heart rate||solut||analysi||ventricl||restitut curv||full agreement||critic DI||br||repolar||drug||pharmacolog condit||extrasystol stimul||heart||arrhythmogen||murin heart,2||2 1 2||1 2 2 scn5a||1||1 2 scn5a||2 scn5a||1 2 6 2||3 2 3 2 3 2||1 2 1 2 fig. 1||heart||2 6||scn5a||1 Î¼M||3 4 2||3,0.031||0.029||0.027||0.027||0.026||0.025||0.025||0.025||0.024||0.022||0.021||0.02||0.02||0.02||0.019,0.0,0.1,0.06666666666666667
466,Dig_Dis_Sci-4-1-2413116.txt,questionnair||sexual offenc||histori||studi||depress||total score||GI symptom||ssf||childhood||anxieti||definit||signific||valid||non-consult||odd ratio||rape||function gastrointestin disord||kind||ib||adulthood||women||sweden||popul||subject||assault||group||hrql||fgid||dyspepsia||abus||signific differ||irrit bowel syndrom||function dyspepsia||gener popul,1||1 1 1 1||abus 1 1 1 1||abus||emot abus 1 1 1 1||abus 1 1 1 1 childhood||physic abus 1 1 1 1||abus 1 1 1 1 adult||sexual abus 1 1 1||2||abus 1 1 1 adult||abus 1 1 childhood||abus 1 1 adult||emot abus 1||3,0.025||0.025||0.024||0.022||0.021||0.021||0.021||0.021||0.021||0.02||0.02||0.019||0.019||0.018||0.016,0.2,0.1,0.06666666666666667
467,Environ_Manage-2-2-1705511.txt,forag||anim||studi area||meadow||conflict||region||kiang||pastor||war||livestock||nomad||product||changthang||estim||eastern ladakh||kiang densiti||ladakh||hanl valley||livestock popul||survey||herder||area||import habitat||habitat,2||2 2||2 1 1||1||2 3||1 mishra 2001 2 2||livestock 2 2 chundawat||1 1 2 fig. 1 chundawat||3||kiang||livestock||conserv||1 ha||equu kiang kiang||method studi area 2 2 changpa,0.026||0.026||0.023||0.022||0.021||0.018||0.017||0.017||0.016||0.016||0.014||0.013||0.013||0.012||0.012,0.0,0.1,0.13333333333333333
468,Int_J_Cardiovasc_Imaging-3-1-2121118.txt,blood pressur data||control||systol||studi||aortic distens||aortic stiff||nccm patient||gender-match control||conclus||noncompact||aortic diamet||wall||diastol heart failur||patient||aortic elast||nccm||result,1||3||2||nccm 3||7||3 4 fig. 3||3 1 fig. 1 SD DD||3 4||2007 introduct 1 2 3 4||refer 1||group 2||patient||nccm patient||6||result patient popul 1,0.037||0.03||0.029||0.023||0.023||0.023||0.021||0.021||0.021||0.02||0.018||0.018||0.017||0.017||0.017,0.0,0.0,0.13333333333333333
469,Bioinformation-1-1-1891626.txt,gene||est||inform||eukaryot||mrna sequenc||databas||mrna||avatar||gene locat||altern splice||genom,1||1 2 3||figur 1||step 1||2||bioinform 1||3||step 2||taiwan 2 depart||2005||mrna figur 1 panel||tabl figur 1 process||refer 1 breitbart||depart||taiwan 3 depart,0.07||0.048||0.046||0.042||0.042||0.037||0.032||0.028||0.028||0.027||0.027||0.026||0.026||0.025||0.025,0.0,0.0,0.0
470,Photosynth_Res-3-1-1779625.txt,metabolit||time||rate||valu||extract||water||present||incorpor||carbon||mixtur||chloroplast||oxygen electrod||label||dephosphoryl step||glucos||solut||sugar||cylind||analysi||experi||mox-tm deriv||filter membran||intern standard||work-up||apparatu||octulos||photosynthesi||dri nitrogen||membran||sugar phosphat,2||13 2 2||13 2||13 2 2 13||13 2 13 2 13||13||1 2 2 2||13 2 2 2 2001||4 13 13 2||13 13 2 1989||2 2 2001||13 2 1989||2 3||method chemic 13 2 2||3 3 13 3 13 2,0.073||0.07||0.069||0.069||0.068||0.065||0.06||0.058||0.054||0.052||0.051||0.048||0.046||0.044||0.043,0.0,0.0,0.0
471,Eur_J_Pediatr-3-1-1829442.txt,case||flow||hilar portion||lrv||gross hematuria||data||studi||patient||renal vein||PV ratio||screen examin||renal doppler ultrasound||doppler ultrasound||nutcrack group||asymptomat microscop hematuria||adult||nutcrack syndrom||examin||ratio||doppler angl||hematuria||hypercalciuria||detect||children,1||2||NS 2||result 1 fig. 1||glomerulonephr 1||2 SD||5 10||refer 1||5||1 renal doppler find||deaf 2||2 renal doppler find||3||renal doppler||10 10 12,0.03||0.029||0.019||0.018||0.017||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.014,0.0,0.0,0.0
472,Ann_Surg_Oncol-3-1-1914261.txt,primari melanoma site||type||melanoma||re-excis specimen||diagnost biopsi type||import confound||re-excis||studi||patient||incis biopsi||primari melanoma||SN statu||site||posit margin||df||wide excis biopsi group||age||tumor cell||narrow excis biopsi||group||surviv||unknown||influenc||melanoma patient surviv||lymphat invas||breslow thick||invas,patient||1 patient||melanoma patient||1||2||1 4||melanoma patient surviv||5 patient||11 patient||4||melanoma||31 patient||52 patient||471 patient||25 patient,0.038||0.032||0.029||0.026||0.025||0.024||0.024||0.023||0.022||0.022||0.021||0.021||0.02||0.02||0.02,0.2,0.2,0.2
473,Eur_J_Nucl_Med_Mol_Imaging-4-1-2100432.txt,condit||femal group||men||sex differ||auditori||baselin||data||studi||rcbf||region||sex||spm||contrast||male||stimuli||brain||prefront region||auditori process||analysi||gender||subject||auditori stimul||primari auditori cortex||activ||pac||differ||pet||prefront cortex||attent result||music||nois||white nois||result,1 1||1||2||2 2||3||2 fig. 3||4||auditori||brain||2 region||refer 1||auditori cortex||auditori brain studi||differ||M. 3 1 depart,0.024||0.024||0.023||0.023||0.02||0.017||0.016||0.016||0.015||0.014||0.013||0.013||0.013||0.013||0.013,0.0,0.2,0.2
474,Purinergic_Signal-2-3-2096647.txt,atp||fura-2 microfluorometri||ach||concentr,2||2 4 2||atp 2||1 2||2006 2||30 2||1 fig. 2||1C 2||2 28 1C 2||electrophysiolog record 2 2||increas 2||Na 2||nitrendipin 2||29 2||50 2,0.06||0.044||0.041||0.041||0.035||0.034||0.032||0.032||0.031||0.031||0.031||0.031||0.031||0.031||0.031,0.0,0.0,0.0
475,Pediatr_Cardiol-4-1-2267487.txt,subgroup||hla-b locu||ethnic group||taq dna polymeras||studi||comparison||hla||patient||allel||frequenc||increas||dna||signific increas||gene||healthi control group||hla-b||kawasaki diseas||polymorph||associ||korean children||healthi korean adult||diseas||amplif||intern control primer||children,2||1||diseas||kawasaki diseas||1 3||1 min||25 1||kawasaki diseas patient||1 Î¼mol||7 2 8||39 2||08 2||75 2||2 hour||57 2,0.024||0.023||0.022||0.019||0.018||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.014,0.4,0.2,0.13333333333333333
476,BMC_Med_Educ-4-_-328087.txt,inform explos||educ activ||knowledg||core||problem||knowledg base||inform manag||medic school||doctor||develop||graduat||learn||knowledg manag||pbl||today||train||trend||factual||web-bas resourc||teach||teacher||challeng||faculti time||opportun cost||student||medic educ,educ||medic educ||1 repstein@hku.hk 1 depart||medic educ practic||educ activ||educ risk||educ reform||educ program||educ strategi||educ util||dental educ||educ output||in-hous educ||figur 1 comparison||medic school,0.032||0.027||0.023||0.019||0.018||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.015,0.4,0.2,0.2
477,Clin_Rheumatol-3-1-2092406.txt,follow-up||situat||studi||profession guidanc||year||patient||durat||sick leav||proport||guidanc||eac||vocat guidanc||aim||tool||chronic arthriti||health profession||workplac adapt||earli arthriti||work disabl||job||gener practition||symptom durat||group||adapt||number||symptom||statu||arthriti||work||studi entri||disabl||diagnosi||diseas||period||gener popul,1||patient||arthriti||1 year||2 1 3 1 3 4||work||demand 1||rheumatoid arthriti patient||3 month||studi||2||work disabl studi||6 patient||3 month sick||12 month,0.027||0.023||0.019||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015,0.4,0.4,0.26666666666666666
478,Diabetologia-3-1-1794136.txt,type 2 diabet||independ predictor||follow-up||baselin||patient||year||incomplet covari adjust||risk||end||annual assess||variabl||independ contribut||macrovascular diseas||cardiac death||present studi||all-caus mortal||western australian data linkag system||smbg||community-bas cohort||rosso||full adjust||outcom||result,"2||model 2||diabet||type 2 diabet||type 2||1||2 patient||model 3||diabet patient||1,280 type 2 diabet patient||stroke model 1||blood glucos type 2 diabet||microalbuminuria model 1||retinopathi model 1||neuropathi model 1",0.053||0.048||0.042||0.039||0.037||0.036||0.035||0.03||0.03||0.027||0.027||0.027||0.027||0.027||0.027,0.2,0.1,0.06666666666666667
479,Mar_Drugs-5-4-2365694.txt,person||system||center||educ materi||studi||marin||inform||major||organ||toxin||public health personnel||pilot studi||caller||blue green alga||health profession||evalu||coastal manag||interview||red tide||cyanobacteria||educ outreach materi||futur hab outreach||hotlin||hab||florida red tide||florida||ciguatera fish poison||brevetoxin||outreach||particip||poison inform specialist||ciguatoxin||healthcar provid,1||health||toxin||inform||tabl 1||florida||2||studi||human health||florida health depart||florida poison inform center||florida aquat toxin hotlin||tabl 2||hab inform||3,0.019||0.018||0.016||0.014||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.01,0.4,0.4,0.26666666666666666
480,Surg_Radiol_Anat-3-1-1820760.txt,scapula visibl||muscl||deform||intern||patient||contralater side||superior trunk outlet||view||scapula||rotat||ratio||clavicl||paramet||shoulder||width||sublux||obstetr brachial plexu palsi||brachial plexu||extern rotat||height||acromion||area||angl||children,1||2||2 2||3||2 fig. 2||shear grade 1 2||3 fig. 3||result 1||refer 1||2 2 16 16||0.51 2||shear grade 2 3.6||shear grade 3 20||11||shear grade 4,0.031||0.029||0.029||0.024||0.024||0.023||0.02||0.019||0.017||0.016||0.016||0.015||0.015||0.014||0.014,0.0,0.0,0.0
481,Dig_Dis_Sci-3-1-1914298.txt,superior mesenter arteri||optim diagnost accuraci||measur||target||exercis intens||low level||low cost||studi||patient||consecut period||test||anaerob threshold||optim exercis test||exercis level||exercis tonometri||paramet||roch diagnost||chronic gastrointestin ischemia||tonometri||exercis||rapid serial lactat||lactat||false-neg test||decreas||target HR||exercis test||gastric exercis tonometri||gastric ischemia||diagnosi||period,exercis||1||exercis test||2||3 2||3||1 test||exercis tonometri||tonometri exercis||exercis level||1 max||clinic exercis||exercis intens||clinic exercis test||method 3 1,0.046||0.04||0.035||0.034||0.034||0.033||0.032||0.029||0.029||0.029||0.028||0.028||0.027||0.026||0.026,0.4,0.4,0.3333333333333333
482,Neurogenetics-2-2-1513515.txt,caucasian dataset||ethnic group||autism patient||sampl||data||studi||seizur||allel||autism||subunit||dataset||disord||caucasian popul||autism risk||gene||gaba receptor subunit||analysi||associ||popul||signific associ||candid||gaba||group||snp||differ||potenti regulatori region||largest differ||interact||addit||result,gabra4||gabra4 gabra4 gabra4||1||genet||autism||gabra4 gabrb1||gabra4 gabrb1 gabra4 gabrb1 gabrb1 gabra4||gabrb1 gabra4 4 gabra4 gabrb1 gabrb1||gabrb1 tabl 1 gabra4 gabrb1||gabrb1||gene||2 2||2||human genet||2 2 gabra4 snp,0.016||0.016||0.016||0.016||0.015||0.014||0.014||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.2,0.1,0.13333333333333333
483,Plant_Mol_Biol-4-1-2295252.txt,line||rosett||plastochron||juvenil||singl mutant||apic domin||abaxi trichom||day||gene||phase chang||leaf||veget phase chang||averag||arabidopsi||success||leaf initi||light||order||flower||mutant||number||t-dna||signific differ||shoot develop||plant,spl9||spl9 spl15||spl15 spl9 spl15 spl9 spl15 spl9||spl15 spl9||spl15 spl15 spl9||spl15 spl9 spl15||spl15 spl15 spl15 spl15 spl15||spl15||spl9 spl15 spl9 spl15 mir156b||spl9 spl15 spl9 spl15 spl2 spl9||spl9 spl15 spl9 spl15 2003||spl15 1 spl15 spl15||spl9 spl15 pp2a spl9||2008 spl9 spl15 mir156b spl9 spl15||spl9 spl15 mutant,0.054||0.054||0.054||0.054||0.053||0.053||0.053||0.053||0.047||0.045||0.044||0.044||0.041||0.04||0.037,0.0,0.0,0.0
484,Purinergic_Signal-4-2-2377324.txt,atp||membran||jnk||Na||nkcc||usa||cotransport||Cl||intercal cell||purinerg receptor||inhibit||activ||cell||medium||stress-activ protein kinas||kinas,1||1 2||cell||2||2 2||1 3 3||3 2||2007 1||1 13 1 6 fig. 6||1 Î¼g||13 17 1 2 44 1||refer 1||1 agonist||4 2||epitheli cell,0.04||0.034||0.033||0.029||0.029||0.026||0.024||0.023||0.022||0.021||0.021||0.021||0.021||0.02||0.02,0.2,0.1,0.06666666666666667
485,Int_J_Hematol-4-1-2276242.txt,c-kit gene||find||case||nasal lymphoma||mutat||studi||patient||malign lymphoma||frequenc||develop||korea||epidemiolog||lymphoma||epidemiolog studi||lmp1||pesticid||cell||gene||nktcl||tumor suppressor gene||china||p53 gene||gene mutat||japan||risk factor||ebv||diseas||latin american countri||western countri,1||2||3||lymphoma||3 1 depart||1 ebv||cancer||hematolog 2008 1 2 3 4||nasal lymphoma||refer 1||tap 1||cell lymphoma||t-cell lymphoma||1 14 15 16 fig. 1||subtyp 2,0.019||0.016||0.014||0.013||0.012||0.012||0.011||0.011||0.01||0.01||0.01||0.01||0.01||0.01||0.009,0.2,0.2,0.13333333333333333
486,Intensive_Care_Med-3-1-2040486.txt,condit||muscl||scherer||lactic acid||patient||demonstr||patholog condit||observ||autopsi||articl||shock||puerper fever||blood||research||johann joseph scherer||carl folwarczni||death||lactat||human blood||leukaemia||result,patient||refer 1||live patient||11||springer-verlag 2007||februari 11||15 17||acid||35 15||die milchsÃ¤ur||lactic acid||birth||6 februari 1843||1843||sever diseas,0.018||0.017||0.015||0.015||0.013||0.012||0.011||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.009,0.2,0.1,0.13333333333333333
487,Ann_Surg_Oncol-4-1-2190340.txt,follow-up||case||aspir||false-neg result||melanoma||sampl||locat||studi||patient||cytolog||clinic||difficulti||histopatholog evalu||sensit||diseas statu||needl||test||diagnost accuraci||failur||site||lesion||cell||verif||cytopathologist||fnb||axillari node||lymph node||accuraci||clinic follow-up||malign cell||materi||metastat melanoma||factor||posit||number||primari lesion||fine needl biopsi||clinic materi||procedur||needl pass||patholog||diagnosi||larg number||result,1||2||4||1 4 6||melanoma||4 2 tabl 4||metastat melanoma||melanoma metastat||6||fnb procedur 2 2||melanoma patient||refer 1||4 22||method patient 1 tabl 1||1 fig,0.028||0.025||0.023||0.023||0.02||0.019||0.017||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014,0.2,0.2,0.13333333333333333
488,Pain-2-1-2258319.txt,method||respons||questionnair||line||practic||return||studi||vignett||patient||clinic practic||recommend||health care practition||pt||UK gp||behaviour||guidelin recommend||treatment||hcp||advic||gp||clinic behaviour||clinic guidelin||pain||associ||subscal||activ||practition||attitud||lbp||belief||work||random sampl||survey||practic behaviour||score,pain pain||pain||1||back pain||3||pain guidelin||pain spine||tabl 3||care||clinic behaviour||behaviour tabl 3||clinic behaviour fig. 1||pain manag||back pain belief||pain survey 1 introduct,0.022||0.022||0.02||0.018||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.012,0.2,0.2,0.13333333333333333
489,Exp_Brain_Res-3-1-1914235.txt,condit||muscl||measur||afference-bas interact||time||error correct||peak flexion||bilater muscl activ||kinemat||method||bimanu coordin||left||depend||electromyographi||rel phase||valu||flexion||effect||neural control signal||correct||rhythmic bimanu coordin||pattern||cycl||emg activ||signal||effer signal||control||tempor relat||coordin pattern||instruct||half-cycl||ecr||phase||analysi||emg||phase entrain||activ||coher||rhythmic movement||differ||kinesthet track||limb||time error||antiphas coordin||time correct||emg amplitud||trial||movement||extens||coordin||cycl durat||hand||success half-cycl||result,2||FC 3 2005b 2 2||fig. 2||2 7||1||3||HC 3 2||1 2 7 2 fig. 7||2005b||phase||emg 2||3 trial||2 cm||movement||FC 1,0.021||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.013||0.011||0.011||0.011||0.011,0.0,0.1,0.13333333333333333
490,J_Med_Internet_Res-6-2-1550592.txt,health servic research||technolog||qualiti expert||project||accur||rate instrument||conduct||search engin||qualiti||studi||patient||common reason||consum||inform||criteria||organ||review||abil||eysenbach||user||site||consum search||health inform||web site||recommend||onlin search||content||tool||code||health||educ||ehealth||research||result||popul||algorithm||stakehold meet||search engin expert||pew||factor||search||access||import variabl||human mediat||particip||health-rel web site||engin||internet,health||health search||health inform||search||consum health||health web||consum health inform||health inform site||health qualiti||qualiti health inform||internet health inform||inform||health search educ||onlin health search||health search strategi,0.036||0.031||0.029||0.026||0.025||0.025||0.024||0.024||0.023||0.023||0.023||0.023||0.022||0.021||0.021,0.6,0.3,0.26666666666666666
491,Plant_Cell_Rep-4-1-2413081.txt,ornament||transgen||line||ornament plant||root induct||somat embryo||transform||millenium||current studi||poinsettia||pnmv-deriv hprna construct||infect||genet engin||non-fe plant||pnmv||pcp||co-cultiv||somat embryogenesi||resist||explant||poinsettia genom||t-dna||transgen line||area||poinsettia plant||medium||rna,plant||plant plant||1||1 1||3||2||poinsettia plant||transgen plant||1 1 1994 1||plant viru||3 1994 3 3||plant tissu||regener plant||plant regener||ornament plant,0.026||0.026||0.02||0.02||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015,0.0,0.1,0.13333333333333333
492,BMC_Bioinformatics-4-_-166134.txt,mesh||method||figur||introduct||data||text mine||keyword content||question||section||full text articl||inform||mesh term||articl||context||content||cell||biolog inform||gene||term||relev||inform extract||analysi||subject||abstract||natur text||word||order||number||keyword||biolog concept||scientif articl||result,2||1||1 3||tabl 2||2 protein||1 2 3 andrade@embl.d 1 biocomput||figur 3 2 19||figur 1||figur 2 6||text||germani 2 depart||section||keyword||tabl 1 keyword select||section 4,0.047||0.034||0.032||0.028||0.027||0.025||0.023||0.022||0.022||0.019||0.018||0.017||0.016||0.016||0.015,0.0,0.0,0.13333333333333333
493,Biotechnol_Lett-3-1-1914260.txt,dextran||gene||starch||result||class||starch granul||kd-ut||foreign polym||asr||alternan||express||tuber juic||potato||starch content||tuber||transform||plant||glucansucras,1||1 2||1 tabl 1 50||3||1 2001 2003||asr||1 asr transcript level||1 2005a 2006 streptococcu||2003||2000||agpas gbssi gene||2002||plant||starch||4 4 2000,0.034||0.03||0.02||0.019||0.019||0.017||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.0,0.1,0.2
494,Cell_Tissue_Res-4-1-2386754.txt,medium||alp activ||studi||surface-mark express profil||assay||frequenc||chondrogen differenti potenti||human||adipos tissu||abdomen||rel target gene express||variabl||fat depot||cell||svf||day||gene||asc||protein||chondrogen differenti||differenti capac||osteogen differenti||differ||order||osteogen lineag||chondrogen||cultur||signific differ||tissue-harvest site||homogen popul||stem cell||gene express||donor,1||2 1||2||cell||1 2 2006 2006||2006 6 1 1 2||asc 2006 1 1||3 cell||2006||2006 2007 2007 1 3||1 min||stem cell||cell tissu||2004 2003 2002 2006 2006 2006||3 3 fig. 3,0.025||0.023||0.022||0.021||0.021||0.02||0.019||0.018||0.018||0.015||0.014||0.014||0.014||0.014||0.013,0.2,0.1,0.13333333333333333
495,World_J_Urol-3-1-1913171.txt,inflamm||bladder tumour||mmc||studi thermo-chemotherapi||transit cell carcinoma||sampl||studi||patient||local microwav||human||chemotherapi||high-grad urotheli cell carcinoma||increas||prolifer activ||temperatur||bladder||treatment||cell||haemorrhag||day||tumour||thermo-chemotherapi||tumour sampl||p53||activ||superfici bladder cancer||group||decreas||hyperthermia||posit||bladder cancer||cystectomi||result,2||group 2||1||group 1||group||11 2 2 2 2||7 2 2||group 3||treatment 1||group patient||group 4 patient||hyperthermia 2||group 3 patient||2 day||4,0.031||0.028||0.027||0.026||0.026||0.025||0.022||0.021||0.02||0.019||0.019||0.018||0.018||0.018||0.017,0.2,0.1,0.06666666666666667
496,Nutr_J-2-_-293472.txt,low densiti lipoprotein cholesterol||tablet||isoflavon||studi||cholesterol||effect||form||daidzein||serum TC||phytoestrogen||intervent||mixtur||treatment||lipid||soy protein||meta-analysi||subject||diet||serum cholesterol||serum lipid||genistein||soy||trial||isp,2||1||2 trial||soy||1 trial||1 1 2 2 6 31||soy isoflavon||women 2002 2||soy protein||8||femal 2 20||11||11 trial||trial||12 soy protein,0.021||0.017||0.016||0.015||0.014||0.014||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011,0.2,0.2,0.2
497,Int_J_Colorectal_Dis-4-1-2386753.txt,follow-up||perian fistula||previou fistula surgeri||seri||recurr||patient||anal fistula plug||rectal advanc flap||cryptoglandular origin||high transsphincter fistula||high success rate||recurr rate||treatment||fistula||sphincter||advanc||anal canal||sphincter complex||surgeri||fibrin glue||group||high transsphincter perian fistula||intern open||consecut seri||altern treatment||closur||advanc flap||procedur||outcom||result,2||1 2||patient||3||2 characterist||1 characterist||4||fistula||26 patient||37 patient||39 patient||refer 1||13 patient||vicryl 2||80 patient,0.029||0.028||0.028||0.022||0.02||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.015,0.2,0.2,0.13333333333333333
498,Cancer_Causes_Control-2-2-1764867.txt,alcohol consumpt||consumpt||cancer||drink pattern||time||wine intak||ovarian cancer||baselin||breast cancer||year||risk||rel||california||daili glass||alcohol beverag||intak||analys||median famili incom||day||cohort||women||cohort studi||alcohol||decil||age||associ||estrogen||report||liquor||drink||non-drink||wine||censu block group||beer||california teacher studi cohort||daili intak,cancer||cancer alcohol||1||1.00||ovarian cancer||2||cancer risk||ovarian cancer alcohol||control cancer||ovarian cancer risk||breast cancer||cancer research||cancer develop||1997 cancer||cancer prevent,0.028||0.02||0.02||0.02||0.019||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.014||0.014||0.014,0.4,0.2,0.2
499,Histochem_Cell_Biol-4-1-2228382.txt,type||morpholog||cargo||fission||post-golgi transport||process||structur||cisterna||complex||domain||golgi||transport||tubular subdomain||molecular motor||protein||carrier||clem||golgi complex||tgn||format||motor||precursor||tubular network||cell surfac||apic surfac||post-golgi carrier||plasma membran||pgc||target membran||membran||molecular machineri,2003||2003 2003 2003 2003 2004 2004||live cell||cell type||cell surfac||mdck cell||cell biolog||epitheli cell||2003 1995 2003 2003 2001||cell peripheri||hela cell||2003 2003 2005 2004 2005||histochem cell biol histochemistri||1998 2001 2003 2003 1998||1998 2003 2004 2006,0.031||0.027||0.024||0.024||0.024||0.023||0.023||0.023||0.023||0.023||0.023||0.023||0.022||0.02||0.02,0.2,0.1,0.06666666666666667
500,Pediatr_Radiol-3-1-1950216.txt,dwi||time||protocol||spine||mri||imag||abnorm||patient||year||diffusion-weight imag||plane||fat satur||addit sequenc||manufactur||imag protocol||brain||tumour||slice thick||signal-to-nois||age||injuri||contrast||axial||sequenc||children,year||2 year||2||imag||3 month||1 year||6 month||brain||4 month 3||5 year||1||12 month 6 month 6||1st year 6 month||5th year 6 month 6||imag protocol,0.024||0.024||0.024||0.021||0.021||0.02||0.02||0.018||0.018||0.017||0.017||0.017||0.016||0.016||0.016,0.4,0.3,0.26666666666666666
501,J_Membr_Biol-2-2-1764598.txt,mechan||vesicl||synapt bodi||find||system||ribbon||releas||rate||studi||channel||immumoact||exocytosi||synapt transmiss||molecular dissect||increas||evid||auditori nerv fiber||activ zone||cell||calcium||hair cell synaps||protein||synapt ribbon||ribbon synaps||pool||synaps||mous||number||synapt relev||hair cell exocytosi||hair cell||function pool||neurotransmitt||capacit measur||larg number||sound||compon,cell||2||2005 2||1||2005||hair cell||2004 2||2004 1||2005 2 figur 2||hair cell synaps||hair cell ribbon||synapt vesicl||synapt ribbon||hair cell ribbon synaps||2000 2,0.017||0.015||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011,0.2,0.3,0.26666666666666666
502,Plant_Cell_Rep-4-1-2413084.txt,respons||anthocyanin accumul||red color||metabol pathway||studi||red pigment||transcript factor||lettuc plant||leaf color||anthocyanin||anthocyanin biosynthesi||express||rt-pcr||repressor||gene||structur protein||myb transcript factor||analysi||regul||atmyb||accumul||factor||lettuc||secondari metabol||plant||result,plant||atmyb60||arabidopsi plant||lettuc plant||4 atmyb60 atmyb60 atmyb60 atmyb60 1994||plant protein||transgen plant||plant cell rep plant cell report||import plant||model plant||plant tissu||atmyb60 2005 atmyb60 2005 atmyb60 result||atmyb60 protein||plant speci||jinjachuckmyun plant,0.039||0.032||0.031||0.026||0.024||0.023||0.023||0.021||0.021||0.021||0.02||0.02||0.02||0.02||0.02,0.4,0.2,0.13333333333333333
503,Pediatr_Nephrol-3-1-1805050.txt,standard method||case||hypertens||kidney||serum creatinin level||diastol BP||studi||patient||blood pressur||daytim||uak||control||renal mass||renal size sd||renal function||compensatori hypertrophi||abpm||report||ufsk||renal size||group||unp||patient group||solitari kidney||creatinin concentr||size||ura||BP profil||urin microalbumin||renal agenesi||children,1||2||group 2||group||refer 1||result 1||type 1||control group||patient group||control group 3||0.06 2 1 121.95||10 10||2 22||0.001 2||11,0.039||0.03||0.029||0.027||0.022||0.022||0.021||0.021||0.02||0.019||0.018||0.018||0.018||0.017||0.016,0.2,0.2,0.13333333333333333
504,J_Mol_Med-4-1-2262918.txt,hsf1||transfect||yfp||protect effect||studi||hsp||aggreg||effect||western blot||polyglutamin toxic||therapeut agent||treatment||cell||protect||protein||hsp70||hsp gene||experi||polyglutamin||polyglutamin aggreg||number||celastrol||drug||diseas||toxic||result,1||cell||1 protein||6 cell||refer 1||cell cultur||protein||pc12 cell||stain cell||cell death||transfect cell||cell exhibit||cell phenotyp||hela cell||mef cell,0.028||0.025||0.021||0.017||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013,0.2,0.2,0.13333333333333333
505,Biogerontology-4-1-2367389.txt,calor restrict||anim||phd||hif-1Î±||data||diet protocol||restrict||prolyl-4-hydroxylas domain||diet-specif||skelet muscl||express||rat||hypoxia||gene||hif||tissu||protein||age||chang||liver||mif||mous||calor intak||heart,1||2||3||1 mmol||1 Î¼g||3 express||2006 2005 2007||hypoxia-induc factor 1||express||49-551-395895 katschinski@physiol.med.uni-goettingen.d 2 1 institut||2006 2006 2006||germani 2 depart||effect||real time pcr fig. 2 effect||6 month,0.031||0.03||0.021||0.019||0.018||0.017||0.017||0.017||0.014||0.014||0.013||0.013||0.013||0.013||0.013,0.0,0.1,0.06666666666666667
506,Arch_Orthop_Trauma_Surg-3-1-1914284.txt,antevers||inaccuraci||safe zone||data||patient||placement||freehand placement||acetabular cup posit||resid||total hip arthroplasti||present studi||free hand||acetabular compon||surgic approach||approach||estim||hip||accuraci||abduct||perop||factor||differ||cup||posit||surgeon||posterolater approach||signific differ||result,1||2 3||tabl 2 result||studi||refer 1||3||springer-verlag 2007 introduct 1 6 7||springer-verlag 2007||present studi||prospect studi||11 13||signific differ||cup||orthop||patient,0.032||0.024||0.02||0.019||0.019||0.017||0.016||0.015||0.013||0.013||0.013||0.013||0.013||0.013||0.013,0.0,0.1,0.26666666666666666
507,Osteoporos_Int-3-1-1820756.txt,follow-up||measur||men||elderli men||spine||roi||larg cohort||rate||baselin||age-rel appar net||studi||periost apposit||periost expans||individu slope||abmd||increas||bone miner content||morpholog basi||femor neck||site||signific||mass||prospect follow-up||hip||bodi||age||chang||areal bone miner densiti||distal forearm||bmc||decreas||bone||periost expans rate||osteoporosi||cross-sect data||distal radiu||area||distal ulna||loss||bone loss,bone||bone loss 2 2||age bone||bone loss||baselin 2 2 fig. 2||bone miner||bone size||7 0.21 2||bone mass||0.001 bone size 2||densiti 2||bone width||0.05 2||1 comparison||0.001 bone,0.032||0.026||0.021||0.021||0.021||0.018||0.017||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016,0.4,0.2,0.13333333333333333
508,Purinergic_Signal-4-1-2245997.txt,ligand-bas homolog model||molecular model studi||ligand bind||affin||molecular model||structure-act relationship||receptor||side chain||adenosin receptor||deriv||antagonist||ligand||select,3||3 3 receptor||3 5 3 3 3 model||3 1||3 AR 3 3 3 36||3 model||3 adenosin receptor||1||3 16||3 2A receptor||3 3 36 37||3 receptor antagonist||5||5 5 5 2||5 2,0.058||0.047||0.046||0.046||0.04||0.037||0.034||0.033||0.03||0.03||0.03||0.029||0.029||0.029||0.029,0.0,0.0,0.0
509,Exp_Cell_Res-1-5-2131725.txt,centromer||polo||polo kinas||anaphas||phosphatas treatment||chromatin||histon modif||kinas||aurora||region||nhk-1||mitosi||phosphoryl||chromosom arm||cell cycl||cyclin||chromosom segreg||histon||loss||centromer region||function,fig. 1 fig. 1||fig. 2 fig. 2||fig. 2||fig. 3||fig. 4||supplementari fig. 1 supplementari fig. 1||fig. 2 supplementari fig. 5||supplementari fig. 4||fig. 5||supplementari fig. 5||cell||supplementari fig. 2A||supplementari fig. 2B||supplementari data supplementari fig. 1||nhk-1 fig. 2,0.046||0.045||0.045||0.042||0.041||0.041||0.039||0.038||0.037||0.035||0.035||0.033||0.032||0.032||0.032,0.0,0.0,0.0
510,Intensive_Care_Med-2-2-1315314.txt,hospit stay||icu admiss||sap II||system||project||origin counterpart||northern europ||data||model||studi||patient||europ||sap 3 databas||admiss||sap II paramet||risk adjust||region||variabl||sap 3 studi||intens care||countri||cohort||hospit||chronic condit||intens care unit||vital statu||esm||perform||risk adjust system||icu||outcom,3||1||intens care||patient 1 1||intens care med||2 3||intens care patient||icu||icu patient||2 1||1 2||patient||sap 3||patient data||intens care med intens care medicin,0.018||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013,0.2,0.2,0.2
511,Antonie_Van_Leeuwenhoek-3-1-2140096.txt,array||complet genom sequenc||studi||present||strain||chromosom||region||dataset||dna||signal||gene||conserv||protein||termin region||analysi||core region||group||linear genom||secondari metabol||speci||sco||sequenc||result,protein||streptomyc||S.||S. coelicolor streptomyc||put sporulation-rel protein||S. maritimu streptomyc S.||S. avermitili streptomyc S. coelicolor||ribosom protein||S. coelicolor S. maritimu S.||S. avermitili streptomyc maritimu streptomyc||S. maritimu S.||protein region||S. avermitili||microarray streptomyc||put regul,0.028||0.024||0.023||0.02||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.016,0.2,0.1,0.06666666666666667
512,Abdom_Imaging-4-1-2386533.txt,follow-up||regard||fat||accur||cross-sect imag||inflammatori bowel diseas||patient prepar||colon||bowel wall enhanc||CD patient||contrast medium||CT enterographi||magnet reson imag||termin ileum||bowel wall||vce||ultrasonographi||accuraci||bowel||contrast administr||specif valu||activ||small bowel||diseas||optim bowel prepar||ibd||sequenc||detect||diagnost perform||techniqu,bowel||diseas bowel||imag||small bowel||1||bowel prepar||inflammatori bowel diseas||diseas||2005||bowel wall||bowel assess||small bowel crohn diseas||bowel ultrasonographi||bowel ultrasound||bowel sonographi,0.024||0.019||0.017||0.016||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013,0.4,0.5,0.3333333333333333
513,Anal_Bioanal_Chem-3-1-1802726.txt,vibrat band||current experi||dmso||corneocyt||molecular structur inform||secondari structur||imag||sampl||solvent||studi||current work||spectra||structur||spectral data||treatment||cell||protein structur||lipid||human SC||relationship||strong band||tissu||factor analysi||II band intens||patholog state||factor||singl cell||band||keratin||skin||epidermi||raman||imag plane||intact tissu||compon,1||1 1||1 2||2||2 4||1 12||1 tran 2||1 13||1 region||1 11||1 11 fig. 2||1 tran||5 3 5||refer 1||1 min,0.036||0.036||0.031||0.025||0.022||0.022||0.022||0.022||0.021||0.02||0.02||0.02||0.019||0.019||0.019,0.0,0.0,0.0
514,Behav_Brain_Res-1-5-2148464.txt,muscimol||cannula||dorsal||place||guid cannula||ap5||studi||ventral hippocampu||effect||infus||food reward||altern||correct||ventral hpc||lesion||dose||present studi||rat||spatial memori||goal arm||hippocampu||result||task||experi||arm||perform||drug||trial||side,"2||1||2 fig. 1||fig. 2||1 fig. 1||experi 2||fig. 2 2 5||experi 1||2 5||2 mm||4||3||fig. 3||4,18 fig. 2||experi",0.034||0.03||0.027||0.026||0.026||0.026||0.024||0.023||0.021||0.019||0.018||0.018||0.018||0.018||0.017,0.0,0.0,0.06666666666666667
515,J_Neurol-3-1-1915612.txt,va||placebo||botulinum toxin||muscl||whiplash||week||baselin||studi||total pain||patient||central nervou system||effect||neck||btx||total||improv||cervic rang||treatment||day||whiplash syndrom||va intens||pain||placebo group||intens||chronic pain||differ||number||central mechan||trial||signific differ||chronic whiplash syndrom||neck pain||placebo-control clinic trial,1||1 1 1 3||pain||2 1||3||3 2||2 3||2||2 2||2 4 1 4 2 3||1 2 3 7||week||neck pain||week 4||4 week,0.031||0.029||0.029||0.028||0.026||0.026||0.026||0.025||0.025||0.024||0.024||0.022||0.021||0.02||0.02,0.2,0.1,0.2
516,Plant_Cell_Rep-3-1-1824786.txt,seed||level||transgen||respons||line||signific reduct||studi||fhb||fusarium head blight||parent materi||inocul||transgen plant||analys||rt-pcr||fhb sever||percent fhb sever||field condit||greenhous||wheat||chitinas||resist||field||screen||transgen wheat||sever||diseas||transgen wheat line||plant||result,plant||1||wheat plant||2 2||2||transgen wheat plant 1||transgen plant||transgen wheat plant||transgen plant 2 fig. 2||wheat||protein 1||2 1 0 1 2 seed||3||plant genet||2 3 2 3 screen,0.023||0.022||0.019||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013,0.2,0.3,0.2
517,FEBS_Lett-1-5-1942071.txt,s6k1||cell develop||embryon stem cell||pkc||mice||pkd||phosphoryl||pdk1||lymphocyt||depend||pathway||agc kinas||loss||activ||present studi||cell||p90rsk||kinas,cell||1||kinas 1||fig. 1||kinas||ES cell fig. 1||fig. 2 fig. 2||fig. 2||6 cell||protein kinas||pdk1-null cell||fig. 1 fig. 1 Î±||2||pre-t cell||cell develop,0.033||0.025||0.025||0.025||0.025||0.022||0.022||0.022||0.022||0.02||0.02||0.02||0.02||0.019||0.019,0.4,0.2,0.2
518,Int_Ophthalmol-4-1-2359829.txt,donor cornea||method||time||storag||endothelium||studi||risk||hypotherm storag||inspect||antibiot||evalu||corneoscler button||tissu||solut||storag time||donor||cornea||eye bank||mandatori||microbiolog safeti||preserv techniqu||addit||organ cultur||bank||medium||techniqu,storag||corneal storag||2||cornea||corneal||cultur||donor cornea||hypotherm storag||hypotherm storag 2 fig. 2 evalu||organ cultur corneal||corneal organ cultur||donor||storag techniqu||organ cultur||storag time,0.019||0.017||0.017||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.4,0.4,0.4666666666666667
519,Ann_Hematol-3-1-1914243.txt,CR rate||surviv||secondari aml||level||elderli aml patient||aml||studi||wbc count||drug resist||age||mrna||major vault protein||breast cancer resist protein||express||patient||cell||event-fre surviv||ef||result,bcrp||mdr1 bcrp bcrp bcrp mdr1||mdr1 bcrp||mdr1 bcrp mdr1 bcrp||mdr1 mdr1 bcrp mdr1||mdr1||1 bcrp mdr1||mdr1 bcrp 3 2||1||2 mdr1||mdr1 3 2||mrp1 lrp bcrp 1 mdr1 mdr1||1 bcrp mrp1 bcrp lrp||analysi mdr1 bcrp||mdr1 mrp1 lrp bcrp 1,0.03||0.029||0.029||0.029||0.028||0.028||0.027||0.024||0.023||0.023||0.022||0.021||0.021||0.02||0.02,0.0,0.0,0.0
520,J_Mol_Med-3-1-2121654.txt,effect||tat cpp||actin||cpp||protein||primari cell||terminu||concentr||peptid||tat||phase-contrast imag||myosin motor domain||cardiomyocyt||cell||primari adult cardiomyocyt,1||2||1 1 waf||1 3 3||4 fig. 1||control 1 3 2||1 mW||refer 1||4 4 2||fig. 2||3 3 3 3 fig. 3||4||springer-verlag 2007 2||4 fig. 4||cell,0.04||0.028||0.028||0.027||0.024||0.023||0.022||0.021||0.021||0.021||0.019||0.018||0.017||0.017||0.016,0.0,0.0,0.06666666666666667
521,Virchows_Arch-3-1-1888719.txt,grade||ki-67 index||clinic behavior||system||stage iiib||confer||prognost assess||session||patient||digest tumor||foregut||propos||consensu||guidelin||classif||net||neuroendocrin tumor||consensu confer||tumor||tnm||mitot index||particip||pancrea||endocrin||stage||enet guidelin,tumor||2||1||4 2 2 2||1 2 3||endocrin tumor||neuroendocrin tumor||2 G2 2||digest tumor||primari tumor||carcinoid tumor||primari tumor T1 tumor||T2 tumor||2 cm T2 tumor||T1 tumor,0.025||0.021||0.019||0.018||0.017||0.017||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013,0.2,0.3,0.2
522,Theory_Biosci-4-1-2254468.txt,attent||biolog||find||essenti||graduat student||earlier paradigm||evolutionari tree||singl student||question||phylogenet||cladogram||phylogenet relationship||region univers colleg||relationship||remaind||evolutionari biolog||popul||respond||taxon||group||order||import||taxa||text book||stem group||correct answer||linnean categori||speci||tree||systemat||modern evolutionari biolog||draw,1 1||1||2||3 3||fig. 1||fig. 3||question 2||400 1||discuss 1997 1||2 fig. 2 phylogenet tree drawn||2008||univers||detail 1 1974||norway 2 avdel||2008 tree,0.035||0.035||0.03||0.025||0.024||0.019||0.019||0.018||0.016||0.015||0.015||0.015||0.015||0.013||0.013,0.0,0.0,0.0
523,Diabetologia-4-1-2170457.txt,adipos vein||abdomin subcutan adipos tissu||time||sat||vivo whole-bodi||releas||lipolysi||lipolyt respons||obes||infus||adipos tissu||net uptak||tag||unit||present studi||blood||isotop enrich||insulin concentr||glycerol||glycerol uptak||mainten||abdomin sat||min||obes particip||import||obes individu||beta-adrenerg stimul||particip||neg net flux||result,2||2 2 5||2 5||2 5 2 5||1 2||3 2||2 5 fig. 1 2 5||9 10 2 5 2 5||method 2 5||1||ratio 2 5||fig. 2||metabolit 2||2 circul||type 2,0.06||0.052||0.048||0.048||0.047||0.039||0.038||0.035||0.034||0.033||0.032||0.032||0.031||0.031||0.031,0.0,0.0,0.0
524,Diabetologia-3-1-1914282.txt,insulin sensit||high molecular weight||adiponectin||men||alcohol||concentr||oxid capac||moder alcohol consumpt||studi||activ||hmw||hmw adiponectin||result,2||1 2||method 2 2||method 2||type 2 diabet||15 2||netherland 2 depart||J. 2 pelser||4 5||refer 1||tabl 2 1c||type 1 0.022||type 1 0.084||type 1 0.027||type 1 0.086,0.048||0.042||0.033||0.026||0.026||0.025||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.018,0.0,0.0,0.0
525,Clin_Oral_Investig-2-2-1544376.txt,titanium||anim||mandibl||week||osseointegr||experiment studi||direct bone||bone format||pilot studi||dog||histolog data||bmp-a||tibia||present studi||rhbmp-2||distanc||BD valu||implant||surfac||differ||germani||biocoat||titanium implant||respect site,1||bone||1 mm||bmp-b 3 1 2 fig. 3||implant||springer-verlag 2006 2 2||3||refer 1||studi||1 mg||protein 4||bone-morphogenet protein 2||2 2 40 18 21 40||1996 30 1 4 10.1002||implant surfac,0.027||0.019||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.011||0.011,0.2,0.1,0.06666666666666667
526,J_Neurooncol-4-1-2174520.txt,effect||report||agent||dna fragment||apoptosi||non-chemotherapeut agent||lovastatin||trail||dna-depend protein kinas||glioblastoma||combin||synergist effect||studi||strategi||activ||medium||cell||flow cytometri,cell||1 1 fig. 1||glioblastoma cell||cancer cell||cell death||cell viabil 4 cell||apoptot cell||cell cultur||receptor cell||cell line||cell regul||healthi cell||viabl cell||osteosarcoma cell||fix cell,0.045||0.029||0.027||0.027||0.026||0.025||0.024||0.024||0.024||0.024||0.023||0.023||0.023||0.023||0.023,0.2,0.1,0.06666666666666667
527,Histochem_Cell_Biol-4-1-2413112.txt,morpholog||day 1||uuo||data||control group||studi||Le hir||interstiti space||uranyl acet||cortic interstitium||fibrosi||fibrot kidney||s100a4||cell||rat||day||control||proxim tubul||uret||tubul||resid fibroblast||rer||mitot activ||tubular cell||distal tubul||fsp1||myofibroblast||cortex||interstitium||ligatur||larg popul||uret obstruct||fibroblast||kidney,1||1 Î¼m||1 2 fig. 1||cell||day 1||1 day||tubular cell||1 list||interstiti cell||kidney||renal tubular cell||3 1 4 4||10 Î¼m fig. 2||2 Î¼m fig. 6||epitheli cell,0.032||0.026||0.025||0.024||0.022||0.022||0.017||0.017||0.017||0.016||0.016||0.015||0.015||0.014||0.014,0.4,0.4,0.26666666666666666
528,Eur_Arch_Psychiatry_Clin_Neurosci-2-2-1705499.txt,current knowledg||pyromania||behavior||preval||rate||intermitt explos disord||posit result||efficaci||studi||psychiatr||patient||impuls||effect||internet addict||comorbid||evid||icd||treatment||pharmacolog option||specif subtyp||internet||impuls control disord||report||kleptomania||double-blind||skin||double-blind trial||impuls disord||compuls buy||addit||patholog gambl||result,psychiatri||1||adolesc psychiatri||practic psychiatri||2||psychiatri neurobiolog||clin psychiatri 55||disord||1 1 compuls||impuls aggress psychiatri||clin psychiatri 1995 55||3||compuls disord||control disord||studi,0.027||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.011||0.01||0.01||0.009||0.009,0.0,0.0,0.06666666666666667
529,J_Gastrointest_Surg-3-1-1852372.txt,measur||time||biliari reflux||esophagu||upper gastrointestin diseas||studi||valu||refer valu||data||patient||acid reflux||bilirubin absorb||ambulatori pH||bile||age 51 year||reflux||simultan bile||lower esophag sphincter||age||gender-match control||acid||barrett||stomach||meal||group||bile reflux||healthi volunt||intragastr pH||healthi control||esophag manometri||period||result,1||2||result 1||refer 1||patient||1 week||3||bile monitor 3 3 2||reflux||2 tabl 2 median||14 17 1 figur 1 posit||control patient||bile reflux||control||4,0.025||0.02||0.015||0.015||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.011||0.011,0.2,0.2,0.2
530,J_Gastrointest_Surg-3-1-1852384.txt,pulmonari embol||complic||logist regress||leak||data||patient||year||bmi||roux-en-i gastric bypass||mortal||risk||obes||morbid||comorbid||msof||signific||male||oper||women||age||obstruct sleep apnea||coronari arteri diseas||incid||surgeri||death||cad||bariatr surgeri||report||periop risk||major complic||morbid obes||surgeon||rygb||procedur||postop small bowel obstruct||syndrom,1||2||2 3 11 2 2||result 1 2||2 3 11 2||1 year||http://www.asbs.org 1 2 3||unknown 1 1 0 0||2 year||refer 1||0.01 2||patient||3||PE 0 1 0 0 0||0 2 0 0 pulmonari,0.031||0.028||0.022||0.021||0.021||0.019||0.019||0.019||0.018||0.017||0.016||0.016||0.016||0.015||0.015,0.0,0.0,0.06666666666666667
531,Virchows_Arch-3-1-1888721.txt,cutan melanoma||morpholog spectrum||case||male breast||carcinoma||data||studi||seri||larg tertiari center||patient||frequenc||femal counterpart||metastas||site||slide||male||lobular||histolog subtyp||distribut||invas carcinoma||breast||period,carcinoma||breast carcinoma||breast||breast cancer||male breast carcinoma||male breast cancer breast cancer||2 carcinoma||1||male breast cancer||male breast||invas carcinoma||femal breast cancer||duct carcinoma||lobular carcinoma||male breast cancer diseas,0.04||0.038||0.036||0.033||0.03||0.029||0.029||0.029||0.027||0.025||0.025||0.023||0.022||0.022||0.021,0.4,0.3,0.26666666666666666
532,Biogerontology-4-1-2174522.txt,glycolysi||condit||level||nad avail||dietari restrict||nadh level||mitochondri||increas||sirtuin activ||cell||sirtuin||control||product||protein||nad||age||format||accumul||activ||dhap||genet||gener||metabol||AL condit||alter protein||lifespan||nadh||pathway||methylglyox||oxid||benefici effect||function,2006||2007||2003 2007 2006 2007 2006||cell||age 2007 2007 2007 2007a||1||nad regener 2007 2006 2007||age||2005 2007 2003||2006a 2007 2007 2007 2006a||protein age||suscept 2005 2006||2005||neuron cell||cell death,0.026||0.024||0.022||0.021||0.018||0.017||0.017||0.016||0.016||0.016||0.013||0.013||0.013||0.012||0.012,0.2,0.2,0.13333333333333333
533,Crit_Care-8-1-420054.txt,measur||capac||cardiopulmonari resuscit||earlier applic||suboptim care||patient||admiss||risk||develop||team||process||chain||increas||medic||clinic practic||cardiac arrest||acut pain team||intervent||evid||treatment limit decis||treatment||advers event||staff||ward||medic emerg team||hospit||approach||outreach care||earlier recognit||care||servic||literatur||group||report||import||opportun||emerg||outreach||critic ill||error||critic care||icu,care||critic care||hospit care||clinic care||health care||intens care||crit care critic care||collabor care||outreach care||care unit||suboptim care||care resourc||prevent care||safe care||end-of-lif care,0.039||0.024||0.024||0.024||0.023||0.023||0.023||0.021||0.02||0.02||0.02||0.02||0.02||0.02||0.02,0.4,0.3,0.26666666666666666
534,Med_Biol_Eng_Comput-3-1-1820753.txt,random nois||period signal||modul||sampl||thorax||electrocardiogram||ecg||inform||scale||amplitud||sourc||scale transform||signal||potenti||term||sft||random||multi-modul sourc||phase||spectral analysi||standard||algorithm||heart rate variabl||waveform||compon,1||1 2||1 Ï||1 2 Ï||1 4||2||2 2||_{ 1||Ï||appendix 1||1 Îµ||1 5||2 4 Ï||4 Ï||method 1 fig. 1,0.049||0.041||0.04||0.038||0.037||0.034||0.034||0.033||0.031||0.031||0.031||0.031||0.03||0.029||0.028,0.0,0.0,0.0
535,Ann_Hematol-4-1-2324127.txt,multipot adult progenitor cell||multi-lineag differenti||protocol||germ layer||differenti capabl||differenti potenti||circumst||marker||isol||mapc||adult||express||msc||differenti||present studi||cell||gene||adult stem cell||basal medium||cultur||passag||stem cell||pluripot||medium,2||1 2 1||1 2 3||4 3 2||cell||1||mapc 6 2 2||mapc 4 2||3||2 week||4||stem cell||1 2 3 immunofluoresc analysi||3 fig. 3||10,0.036||0.029||0.027||0.025||0.025||0.025||0.024||0.023||0.021||0.019||0.018||0.018||0.018||0.018||0.016,0.2,0.1,0.13333333333333333
536,J_Gastrointest_Surg-4-1-2231408.txt,biopsi||correl||strain||specif type||pud||lavag fluid||result||studi||analysi||strip||popul||determin||sampl||genotyp||allel type||patient||ppu||perop lavag fluid,H. pylori H. pylori H. pylori||H. pylori H. pylori||H. pylori||2 H. pylori H.||1||H.||caga H. pylori||vaca 1 2||helicobact pylori||5 H. pylori H.||vaca||2||H. pylori statu||H. pylori infect||keyword H. pylori,0.035||0.035||0.035||0.031||0.029||0.028||0.028||0.027||0.027||0.027||0.026||0.026||0.025||0.024||0.024,0.0,0.0,0.0
537,Mar_Biotechnol_(NY)-3-1-2100433.txt,adhes test||anim||find||studi||marin||tyrosinas||marin mussel||recombin protein||domain||similar||marin mussel adhes||freshwat mussel||plant||cell||adhes||strength||dopa||product||quinon||research||collagen||protein||repetit motif||larg quantiti||byssu||surfac||specif identif||spider silk||natur adhes||adhes research||substrat||repeat||plaqu||marin polychaet||foot organ||attach||mussel||varieti||durabl||thread,adhes||adhes protein||protein||mussel adhes protein||eduli adhes protein||mussel adhes||mussel protein||adhes protein mefp-1||relat adhes protein||individu adhes protein||cell adhes||adhes plaqu protein||adhes protein compon||mussel adhes protein numer||recombin protein,0.021||0.021||0.021||0.018||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013,0.4,0.2,0.2
538,Cardiovasc_Intervent_Radiol-4-1-2367387.txt,measur||person dosimet||data||studi||lead apron||special holder||intervent procedur||relat||dosimet||radiologist||protect apron||statist analysi||dose||william||present studi||occup exposur||effect dose||singl year||holder||addit dosimet||linear relat||differ||exposur||transmiss||addit inform||procedur||physician||result,1||2||dose||1 2 3 4||radiologist 1||method 1 2 fig. 1||fig. 2||tabl 1||msv||refer 1||effect dose||present studi dose||dose report||dose measur||3,0.04||0.032||0.032||0.028||0.028||0.027||0.025||0.023||0.022||0.021||0.021||0.021||0.021||0.021||0.02,0.2,0.1,0.13333333333333333
539,Sleep_Breath-4-1-2194800.txt,placebo||armodafinil||hypertens||episod secondari memori||residu ES||baselin||clinic global impress||studi||patient||effect||long-term memori||test||cognit function||sleepi||adjunct treatment||treatment||advers event||therapi||day||obstruct sleep apnea syndrom||daili live||wake test||analysi||placebo group||ncpap||wake||visit||fatigu||final visit||signific amount||score||ncpap-adher patient,1||2||stage 1||0 1||activ 1||refer 1||1 month||1 patient demograph||sleep||patient||fig. 2||2 week||wake 2||stage 2||sleep disord 1 29 30,0.034||0.022||0.018||0.018||0.018||0.018||0.017||0.017||0.016||0.015||0.014||0.014||0.013||0.013||0.013,0.0,0.1,0.06666666666666667
540,Pediatr_Radiol-3-1-1891641.txt,vesicoureter junction||uti||veloc||doppler||studi||durat||observ||sphincter muscl||function sphincter||ureter jet||pattern||bladder||physiolog||pregnant women||vur||dual compon||uret||age||action||subject||gener anaesthesia||chang||healthi uret||vuj||neural compon||activ sphincter||group||physiolog condit||signific differ||jet||initi slope||normal subject||children,jet||2||ureter jet||1 2||1||jet pattern||ureter jet pattern||ureter jet 18||1 2 3||jet waveform||ureter jet 11||ureter jet effect||monophas jet||ureter jet multispik||ureter jet direct,0.039||0.033||0.031||0.03||0.026||0.026||0.025||0.024||0.024||0.023||0.022||0.022||0.022||0.021||0.021,0.4,0.2,0.13333333333333333
541,Eur_J_Appl_Physiol-4-1-2226001.txt,measur||obstacl||capac||account||risk||correl||push-off||jump height||abil||high risk||grip strength||lower limb strength||classif||leg press apparatu||strength||daili life||leg||age||subject||faller||muscl strength measur||fall risk||leg extens strength||non-fal||healthi older adult||muscl strength||knee||trial||particip||hand grip strength||result,1||3||2||2004||2005||1 jump||older adult||legpress max 2 2 3 jump||trip||muscl strength||strength||studi||1 0.69||risk||knee max 1 0.72,0.019||0.015||0.014||0.013||0.012||0.012||0.011||0.011||0.01||0.01||0.01||0.01||0.01||0.01||0.009,0.0,0.1,0.2
542,Calcif_Tissue_Int-4-1-2268729.txt,anim||measur||time||ovx||bisphosphon||structur paramet||studi||valu||standard deviat||mechan properti||ultim displac||effect||bone structur||test||late zol||singl inject||cortic thick profil||rat||mechan adapt||control||zol||age||late treatment||group||percentag chang||differ||bone||anova||osteoporosi||earli||time point||cortic thick||absolut valu||result,bone||2||trabecular bone||bone structur||bone tissu||bone 17||bone miner||cortic bone||1 1 2||bone loss||1||bone mass||bone microstructur||metaphys bone||bone architectur,0.038||0.023||0.022||0.022||0.021||0.021||0.021||0.021||0.021||0.021||0.02||0.02||0.02||0.02||0.02,0.4,0.2,0.13333333333333333
543,Virchows_Arch-3-1-1888718.txt,case||tcrbcl||infiltr pattern||studi||hepat lymphoma involv||malign lymphoma||frequenc||diagnost algorithm||immunohistochemistri||liver biopsi||infiltr||lymphoma||site||pattern||classif||extranod lymphoma||margin zone lymphoma||lymphoma cell||anaplast larg cell lymphoma||entiti||liver||extranod site||biopsi||differenti diagnosi||pcr||molecular analys||diagnosi||dlbcl||addit biopsi,2||1 1 2||1||3 2||1 1 3 1 3 0||0 3 3 2 2 3||3||1 1 0 0 1 0||lymphoma||1 2 7 0 6 1||0 2 0 0 2 0||1 8 1 6||1 11||1 2 4 mzl||4 2 6,0.033||0.033||0.032||0.029||0.027||0.026||0.025||0.025||0.025||0.023||0.023||0.021||0.021||0.02||0.02,0.0,0.1,0.06666666666666667
544,Auton_Neurosci-2-1-2428072.txt,antibodi||import role||somat motoneuron||studi||chat-ir cytoplasm||chat||sympathet preganglion||electroton transmiss||lower cell surfac||spinal cord||rhythmic||slice||express||gap junction||lamina viii||coupl||cell||motoneuron||adult anim||dendrit process||cell bodi||neuron||adult rat||cytoplasm||import||connexin||optic section||room temperatur||vitro studi||close apposit||electr synaps,fig. 3 fig. 2||2||fig. 1||fig. 3||2005 fig. 2||1||fig. 2A||fig. 2 repres exampl||somat motoneuron fig. 3||2 materi||cell||spinal cord figs. 2||4||1 i.p.||3 cabot,0.024||0.024||0.023||0.022||0.021||0.017||0.016||0.014||0.013||0.013||0.012||0.011||0.01||0.009||0.009,0.0,0.0,0.06666666666666667
545,Pediatr_Nephrol-3-1-1794138.txt,podocyt||nephrin||podocin||nephrot syndrom||anim model||tubulointerstiti||injuri||pathophysiolog,1 1 1 7 8||9||6||1 5||9 10||6 10||fkaskel@aecom.yu.edu 2 1 divis||9 26 9||7 9 10||10 6 9 11||plo biol 2||1 27 28 9 29||2006||protein||24 24 9 29,0.032||0.03||0.026||0.026||0.024||0.023||0.022||0.022||0.021||0.019||0.018||0.017||0.016||0.014||0.013,0.0,0.0,0.0
546,Calcif_Tissue_Int-3-1-1914289.txt,endocort osteocyt||shaft||periosteum||studi||rat tibia||endost surfac||section||probe||bone format||increas||express||singl period||tibia||cell||rat||brain||control||bone marrow cell||load||igfbp-2 mrna express||endost side||sham-load tibia||sham||group||hybrid||bone||four-point bend system||mechan load||lamella,2||1||1 1 depart||1 2 7 25||1 7||vivo 1||fig. 2||bone||chapter 2||n.bravenboer@vumc.nl 1 2 holzmann||refer 1||1 unit||1 blankenstein||vivo 26 27 2 2 15||netherland 2 depart,0.034||0.032||0.022||0.02||0.02||0.019||0.019||0.019||0.018||0.017||0.017||0.017||0.017||0.014||0.014,0.0,0.1,0.06666666666666667
547,Sex_Abuse-2-2-1764595.txt,affin self-report rate||categori||affin||VT approach||interest||ppg||femal children||sexual arous||rate||individu||data||offend||studi||devianc index||sexual attract||self-report sexual arous||correl||femal toddler||self-report||adult||view time||male||letourneau||research||assess||age||prepubesc children||intern consist||adult femal||experi||male child victim||victim||group||photograph||auc||sexual interest||intern consist estim||sexual offend||adolesc||procedur||particip||children,2||sexual offend||1||sexual arous||sexual abus||sexual interest||self-report sexual arous||sexual recidiv||sexual offens||sexual histori||sexual assault||sexual thing||sexual prefer||sexual attract||sexual interact,0.019||0.019||0.019||0.018||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015||0.015,0.4,0.4,0.3333333333333333
548,Bioinformation-1-10-1896059.txt,array||aspect||import aspect||level||method||copi number alter||data||valu||effect||boundari||gene express analysi||region||chromosom||gene||term||copi number||analysi||alter||cgh array||group||hybridis||diseas||profil||step||gene express||detect||function,1||2||1 2 3||tabl 1||1 depart||bioinform 1||fÃ¡tima 1 dopazo joaquÃ­n 1 2||function||copi number||refer 1 kallioniemi||copi number alter||alter copi number||2007||tabl tabl 1 percentag||function profil,0.064||0.04||0.038||0.035||0.034||0.033||0.03||0.028||0.025||0.024||0.021||0.021||0.02||0.02||0.019,0.0,0.2,0.2
549,Theor_Appl_Genet-2-2-1544375.txt,seed||match||set||coffe||databas||pericarp||librari||gene famili||similar chromosom architectur||est||annot||tissu||solanacea||protein||blast||famili||cdna||uniqu||tomato||number||speci||stage||unigen set||highli||unigen||sequenc||seed develop||function||result,arabidopsi||arabidopsi arabidopsi arabidopsi||4 arabidopsi arabidopsi arabidopsi arabidopsi||arabidopsi arabidopsi 3||1||springer-verlag 2005 arabidopsi arabidopsi arabidopsi arabidopsi||5 arabidopsi 5 1||6 arabidopsi||8 arabidopsi||method arabidopsi||arabidopsi arabidopsi 6 6 remain||arabidopsi thaliana||seed develop 5 arabidopsi||arabidopsi wrki gene||7 arabidopsi gene famili,0.028||0.028||0.023||0.022||0.021||0.02||0.019||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.013,0.0,0.0,0.0
550,Apoptosis-3-1-1914234.txt,antibodi||concentr||nuclear ro product||sampl||studi||effect||atp||heart failur||express||cell||apoptosi||experi||usa||decreas||incub||nuclear nitrotyrosin residu||cardiomyocyt||sah||pb||hci||result,1||1 1||2||fig. 1||9||1 fig. 3||cell||fig. 2||2 3 5||M. 1 8 9 1 depart||3||5||5 5 fig. 5||2 2 act||tabl 1,0.024||0.024||0.018||0.018||0.017||0.017||0.016||0.015||0.015||0.014||0.013||0.013||0.013||0.013||0.013,0.0,0.1,0.06666666666666667
551,Eur_J_Epidemiol-3-1-1914270.txt,level||measur||find||method||reproduc||cac||studi||cholesterol||technic variabl||epidemiolog||relat||coronari calcium measur||volum||agatston||measur protocol||mass||ebct||calcium||slice thick||mdct||absolut||calcium score||coronari arteri calcif||subject||scan||differ||cardiovascular risk factor||random select||coronari arteri||risk factor||particip||error||score||result,1||2||2 2||result 1||2007 introduct 1 2 3 4||refer 1||1 grobbe||2 1 juliu center||2 2 13 14||2 characterist||2 bartelink||sabour siamak 1 3||score||calcium score||E. 1 mali,0.035||0.03||0.03||0.019||0.018||0.018||0.018||0.017||0.017||0.016||0.015||0.014||0.013||0.013||0.013,0.0,0.0,0.13333333333333333
552,Breast_Cancer_Res_Treat-3-1-2001224.txt,placebo||posit immunohistochem analysi||letrozol||efficaci||breast cancer||data||patient||tamoxifen||median follow-up||year||recurr||post-unblind analysi||risk||placebo-control trial||HR statu||nation cancer institut||tamoxifen therapi||aromatas inhibitor||df||treatment||therapi||adjuv therapi||women||result||analysi||tumor||continu hormon treatment||hormon therapi||clinic benefit||adjuv tamoxifen therapi||trial||ma.17||benefit||hazard ratio||outcom||safeti,breast cancer||cancer||breast cancer patient||1||earli breast cancer||breast cancer recurr||human breast cancer cell breast cancer||primari breast cancer||receptor-posit breast cancer||breast cancer model||advanc breast cancer||node-neg breast cancer||early-stag breast cancer||her2-posit breast cancer||1 suppl,0.027||0.027||0.021||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.018||0.018||0.017,0.2,0.1,0.06666666666666667
553,Sleep_Breath-3-1-1794626.txt,apnea||daytim function||follow-up||oral applianc||measur||author||airway||applianc||reduct||overbit||rate||efficaci||data||studi||patient||benefici respons||upper airway||ess||respons rate||cpap||effect||clinic||abnorm anatomi||polysomnographi||sleep studi||inform||present||investig||common featur||bed partner||continu posit airway pressur||clinic trial||treatment||upper airway resist syndrom||sleep||random||sleep apnea||success||assess||mandibular advanc||group||loud||symptom||subject percept||signific differ||success rate||signific improv||outcom||result,maa||sleep||12 maa||1 maa||applianc||sleep studi||25 maa||sleep apnea||22 maa||23 maa||75 maa||44 maa||26 maa||sleep breath sleep||33 maa,0.026||0.02||0.017||0.017||0.015||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014,0.4,0.4,0.26666666666666666
554,Eur_Arch_Otorhinolaryngol-4-1-2279159.txt,subglott||time||peakflow||dilat tracheoscopi||patient||upper airway||femal||present||progress complaint||refer group||tracheal stenosi||stenosi||intervent||treatment||institut||age||number||subglott stenosi||sg||diagnosi||local diseas||tracheoscop,2||1||2 16||2 21||2 19||2 24||rang 2||patient||1 26||4 trachea 2 14||refer 1||tabl 2 patient characterist||6 2 7 8||fig. 3 patient||1 54,0.044||0.032||0.023||0.023||0.023||0.023||0.022||0.02||0.018||0.018||0.018||0.018||0.017||0.017||0.017,0.0,0.1,0.06666666666666667
555,J_Biomol_NMR-4-1-2268728.txt,structur restraint||residu||nmr structur||nmr data||protein data bank,nmr||nmr structur||structur||nmr data||data||nmr structur deposit||2008||structur 2005||experiment nmr data||biomolecular nmr data||3||macromolecular structur data||protein||structur model||nmr restraint,0.039||0.038||0.037||0.036||0.032||0.03||0.026||0.026||0.025||0.024||0.023||0.023||0.022||0.022||0.022,0.4,0.2,0.13333333333333333
556,Breast_Cancer_Res_Treat-3-1-2001222.txt,cardioprotect effect||placebo||exemestan||joint symptom||signific decreas||letrozol||breast cancer||studi||year||tamoxifen||patient||endometri cancer||effect||risk||vagin dryness||disadvantag||increas||aromatas inhibitor||ai||life-threaten event||event||fractur||postmenopaus women||treatment||advers event||adjuv therapi||women||result||incid||co-morbid||heart diseas||anastrozol||bone||earli breast cancer||lower incid||trial||signific differ||nation surgic adjuv breast||hot flash||bone loss||safeti,cancer||breast cancer||breast cancer clin cancer||breast cancer patient||breast cancer trial||tamoxifen breast cancer||earli breast cancer||breast cancer treatment||breast cancer cell||receptor-posit breast cancer||breast cancer Br||primari breast cancer||breast cancer survivor||breast cancer eur||posit breast cancer,0.033||0.028||0.024||0.021||0.021||0.02||0.02||0.02||0.02||0.019||0.019||0.019||0.019||0.019||0.019,0.2,0.2,0.13333333333333333
557,J_Med_Internet_Res-8-2-1550696.txt,electron health inform||document||level||skill||journal articl||case||measur||behavior||understand plagiar||data||studi||question||research librari||higher educ||consum||procedur knowledg||inform||health inform compet||studi particip||articl||actual perform||health inform||consum health inform||idea||sourc||rrsa||one-keyword search||health profession||health educ||secondari sourc||websit||multipl choic||health||nutrit supplement||item||research skill||librarian||assess||health topic||import marker||plagiar||respond||search||compet||particip||area||self-report skill level||score||inform age student||internet,health||health inform||inform||health inform compet||health inform evalu||evalu health inform||health inform tabl 1||health inform consum||consum health inform||health inform journal||health inform literaci||health inform web||health inform sourc||electron health inform||trustworthi health inform,0.03||0.029||0.028||0.022||0.022||0.022||0.021||0.021||0.021||0.02||0.02||0.02||0.02||0.02||0.02,0.8,0.5,0.4
558,Diabetologia-3-1-1871609.txt,prevent||type 2 diabet||follow-up||level||diabet||weight loss||signific reduct||individu||control group||studi||effect||risk||impair glucos toler||review||cardiovascular fit||multi-compon lifestyl intervent||exercis intervent||moder increas||glucos||analysi||independ effect||physic fit||incid||exercis||igt||plasma glucos||chang||group||physic activ||trial||particip||ifg||relev clinic measur||prediabet||outcom measur,2 2||2 year||diabet||year||1 year||1||diet 2 2||type 2 diabet||2 exercis||exercis 2||2 year chang||type 2||3 year||prevent type 2 diabet||type 2 diabet mellitu,0.03||0.026||0.025||0.022||0.022||0.021||0.021||0.021||0.021||0.021||0.02||0.019||0.018||0.017||0.017,0.2,0.2,0.13333333333333333
559,Anal_Bioanal_Chem-4-1-2324126.txt,peptid vpp||method||hydrophil fraction||amino acid||compound||complex mixtur||hilic||analys||at-lin assay||separ||column||identif||activ||min||formic acid||fraction||peptid||ace-inhibit||milk hydrolys||larg number||total activ||total run time,1||1 fig. 1||1 peptid||1 1 1 1 lactobacillu||3||peptid||6 1||refer 1||fraction||4 1 5 7 4||7 8 fig. 7 1||hydrophil peptid||1 tran 15||springer-verlag 2008 introduct 1 3||4,0.035||0.03||0.028||0.028||0.023||0.022||0.021||0.021||0.019||0.018||0.017||0.017||0.016||0.016||0.016,0.0,0.2,0.13333333333333333
560,Pediatr_Radiol-3-1-2077923.txt,week||project tract||gestat age||infant||anisotropi||roi||imag||refer valu||studi||valu||patient||fraction anisotropi||adc||correl||diffus tensor||brain||white-matt tract||age||standard||direct||white matter||scan||diffus||signific correl||pyramid tract||dti||diffus tensor imag,2||tract 2||3||2 year||method 2||2 35||age 1||2 tract statist||fig. 2 confirm||netherland 2 divis||age||refer 1||imag||3 year||tract,0.03||0.021||0.018||0.017||0.017||0.016||0.016||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011,0.0,0.0,0.13333333333333333
561,Surg_Endosc-4-1-2292804.txt,path length||motion analysi||expert||studi||resid||plane||point||normal path length||object assess||shortest path||method particip||goal-ori movement||train||retract||cylind||mi perform||assess||phase||analysi||experi||task||group||differ||import||basic mi skill||mi||perform||import measur||signific differ||movement||novic||result,2||1||3||task 2 fig. 2||fig. 3 abp||mekelweg 2||netherland 2 depart||experi 6 6 5 fig. 6||AB fig. 4 abp AB||phase 5 fig. 5 abp AB||refer 1||abp||netherland 3 depart||abp AB abp||phase 4,0.028||0.023||0.022||0.02||0.018||0.016||0.015||0.013||0.013||0.013||0.013||0.013||0.013||0.012||0.012,0.0,0.0,0.0
562,Ann_Biomed_Eng-2-2-1705493.txt,outflow decreas||coronari bed||limit number||flow||low ventricular volum||model||isobar beat||strain||cardiac wall||coronari inflow||volum||increas||pressur||radial wall stress||ventricular wall||cycl||stress||bottom||paramet||fiber||nfa||experiment observ||primari interact||chang||resist||ventricular pressur||intramyocardi pump||decreas||normal physiolog condit||minimum||vessel||intramyocardi pressur||primari relat||paramet sensit analysi,1||6||6 3||3 6||2||1 1 depart||19 1 1 1 figur 2||3||6 15 6 15 6||1 8||coronari pressur||6 figur 6||model 9 1 2 6 22||coronari flow||pressur,0.025||0.02||0.019||0.019||0.019||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.014||0.014,0.0,0.0,0.06666666666666667
563,Environ_Health_Perspect-115-3-1849909.txt,mechan||anim||document||set||similar inhal exposur||case||occup||respons||asthma||subsequ inhal challeng||protect cloth||potenti risk||dermal exposur||studi||polyurethan product||clinic||develop||worker||human||sensit||skin absorpt||childhood||import chemic||health administr||workplac||person protect equip||isocyan||health||potenti||respiratori exposur||product||research||host factor||mdi-ig||isocyan asthma||factor||absorpt||import||exposur||skin||mdi||subsequ develop||occup safeti||immun respons||result,isocyan||isocyan exposur||exposur||isocyan skin exposur||skin exposur||skin||2||human isocyan skin exposur||isocyan respiratori exposur||assess isocyan skin exposur||human isocyan exposur||sensit skin isocyan||isocyan skin exposur quantif||environment isocyan exposur||isocyan exposur assess,0.025||0.024||0.024||0.023||0.022||0.021||0.019||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.017,0.4,0.3,0.2
564,Pediatr_Nephrol-3-1-1994209.txt,anatom defect||ureter bud||children||structur variat||urinari tract||linkag analysi||kidney||studi||mutat||larg multicentr collabor group||clinic classif||develop||human||defect||form||renal||trait||disord||malform||classif||clinic diagnosi||gene||approach||gene map||clinician||congenit anomali||dysplasia||development disord||diseas||renal agenesi||discoveri||signific discoveri||renal parenchyma||syndrom,kidney||1||genet||2||renal||gene||kidney develop||genet studi||kidney agenesi||3||small kidney||kidney hypoplasia||kidney dysplasia||kidney anomali||renal development gene,0.018||0.016||0.015||0.014||0.014||0.013||0.012||0.012||0.011||0.011||0.011||0.01||0.01||0.01||0.01,0.4,0.3,0.2
565,Pediatr_Nephrol-3-1-2064942.txt,mechan||proteinuria||angiotensin type 1 receptor||glomerulosclerosi||ckd||kidney||low nephron number||mutat||renal diseas||patient||glomerulu||aldosteron||effect||human||increas||spironolacton||abil||receptor||macrophag||key role||cell||therapi||growth factor||mice||result||angiotensin||tubulointerstiti fibrosi||action||low birth weight||interstiti fibrosi||angiotensin receptor blocker||injuri||activ||genet factor||experiment model||sclerosi||podocyt||regress||initi injuri||fsg||function||glomerular hypertens||diseas||acei||progress||fibrosi||cardiovascular diseas,kidney||kidney diseas||1||diabet kidney||2||renal diseas||kidney int 39||kidney fibrosi||type 1||kidney function||chronic kidney diseas||kidney model||2 suppl 2||2 receptor||proteinur kidney diseas,0.022||0.016||0.015||0.015||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.011||0.011,0.2,0.2,0.13333333333333333
566,Purinergic_Signal-2-2-2096640.txt,oxid stress||cd39||e-ntpdas||bacteri clearanc,2||2 2||ntpdase 1||3||1 2 45 P.||22 2 4 5 2||cell||phase 1||refer 1||2 receptor agonist||fig. 1 impact||fig. 6 2B 2 4||receptor||68 fig. 2||vitro 69 2 2 70,0.022||0.022||0.014||0.013||0.013||0.013||0.013||0.013||0.012||0.011||0.01||0.01||0.01||0.01||0.01,0.0,0.0,0.0
567,Clin_Rev_Allergy_Immunol-3-1-2071970.txt,antibodi||infliximab||patient||rituximab||effect||salivari flow rate||infus||va score||improv||biolog agent||clinic trial||treatment||cell||therapi||autoimmun diseas||promis result||baff||pss patient||pss||II studi||trial||score||result,2||2 6||1||2 15||2005||2 16||2 12||6||patient||2 3 5 6 7||M. 2 1 depart||autoimmun diseas arthriti||14 15 2||cell||activ diseas,0.023||0.018||0.017||0.015||0.014||0.014||0.014||0.013||0.012||0.011||0.011||0.011||0.011||0.01||0.01,0.0,0.1,0.13333333333333333
568,Oecologia-4-1-2270366.txt,anim||seed||author||bodi size||model||studi||adult size||intercept||correl||mammal||present||reproduct||egg||scale||empir evid||cold-blood vertebr||variabl||fecund||offspr||present paper||mass||reproduct event||averag||annual cycl||heterotherm||reproduct paramet||weight||terrestri habitat||regress||number||allometr scale||speci||expon||plant||slope,1||2 1||1 2||2||2 2||4 1 1||4 1||1 4||1 1 2007||3||4 3||1 3 5||3 2 5||4||1 1 Îº,0.022||0.021||0.021||0.021||0.021||0.02||0.019||0.019||0.017||0.016||0.016||0.016||0.016||0.015||0.015,0.0,0.0,0.0
569,Ann_Surg_Oncol-4-1-2190341.txt,case||center||neoadjuv therapi||re-explor||studi||patient||pancreat cancer||unresect||initi find||oper||day||analysi||surgeri||reoper||group||tumor||resect||initi oper||distal pancreatectomi||diseas||pancreat surgeri||result,1||3 2 1||2||patient||3||3 3 3||1 0 resect||1 fig||refer 1||1 durat||0 1 mortal 0 1 length||infiltr 1 4||resect patient||3 fig 2||grade 1 tumor,0.042||0.032||0.028||0.025||0.025||0.025||0.023||0.022||0.022||0.022||0.02||0.02||0.019||0.018||0.018,0.2,0.1,0.06666666666666667
570,Neuroradiology-2-2-1592467.txt,respons||intraobserv variabl||astrocyt glioma||mri||glioma||oligodendroglioma||data||studi||seri||patient||oligodendrogli tumour||prognost signific||chemotherapi||volum||grade II oligoastrocytoma||genotyp||tumour||rcbv||pcv chemosensit||pcv||pf||primari tumour||factor||chemosensit||loss||outcom,1||2||8 2||1 rcbv||8||0.238 1 1||4 23 4 1 4 2||4||14 2||11 2||2 5 5||test 1 4 p53 1||dcs-mri 1 fig. 1 8 9||rcbv||refer 1,0.025||0.021||0.019||0.019||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.013||0.013,0.0,0.0,0.06666666666666667
571,Matern_Child_Health_J-4-1-2335294.txt,lead||occup||commun||pregnanc||reproduct toxic||patient||water||worker||reproduct risk||wast site||exampl||site||workplac||health||women||fish||clinician||food||diet||home||hobbi||medicin||exposur||chemic||toxic||environment exposur,1||1 2||refer 1||qualitativeâ 1||4 1 5||9||2||2001 120 1||health||12 13 fig. 1||environment health||3||2006||8||fig. 2,0.034||0.024||0.019||0.018||0.017||0.015||0.014||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.01,0.0,0.1,0.06666666666666667
572,Pflugers_Arch-3-1-1839769.txt,condit||action potenti||hypokalemia correl||critic interv||membran potenti||clinic observ||stimulu||hypokalem heart||neg shift||effect||criteria||refractori||experiment result||tdr||hypokalemia||conduct time||map||arrhythmia||repolar||refractori period||verp||heart||arrhythmogen,1||1 1||90||90 90||90 90 90||2||clh11@cam.ac.uk 1 1||fig. 1||3 4 90 90||90 5||25 90 90||refractori 2 2 2||1 11||refer 1||3 4 3 4 90,0.025||0.025||0.021||0.021||0.021||0.018||0.017||0.017||0.016||0.015||0.015||0.014||0.013||0.013||0.013,0.0,0.0,0.0
573,Purinergic_Signal-4-1-2245999.txt,adenylyl cyclas||level||terminu||intern||studi||adenosin||effect||human||amino acid||receptor||arrestin||adenosin receptor||grk||specif||phosphoryl||cell||gpcr||desensit||stimul||protein||lipid raft||agonist exposur||caveola||addit||function||result,1||1 1||1 1 2A receptor||1 1 1 1 41||1 1 1 1 58||2A 1 receptor||1 1 42 1||44 1 1 1||receptor||2A receptor||1 1 depart||2A||1 3 3 3||5 1||1 1 9 1 57,0.045||0.045||0.038||0.037||0.036||0.036||0.034||0.034||0.033||0.031||0.031||0.03||0.029||0.029||0.028,0.0,0.1,0.06666666666666667
574,J_Chem_Ecol-4-1-2266969.txt,multi-speci herbivori||volatil||predatori mite||effect||test||plant speci||compound||gc-m||herbivori||natur enemi||treatment||feed||cucumb||volatil blend||min||lima bean||emiss||cold trap||spider mite||speci||thermodesorpt cold trap setup,plant||T. plant||S.||S. exigua S.||S. exigua||S. exigua T.||1 S.||T.||S. exigua T. urtica S. exigua||1 T.||S. M.||T. urtica S.||2 S.||1||2 T.,0.023||0.021||0.02||0.019||0.019||0.019||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.017||0.016,0.0,0.0,0.0
575,Mol_Biochem_Parasitol-1-5-1906845.txt,polv,1||fig. 1||fig. 2||fig. 2 var var||2||group 1||var||var var var var||var var var||fig. 1 var supplementari inform var||fig. 1 supplementari inform||var gene||1 dbl||group 2||gene,0.051||0.047||0.038||0.035||0.034||0.032||0.031||0.031||0.031||0.028||0.027||0.027||0.026||0.024||0.022,0.0,0.0,0.0
576,Pflugers_Arch-3-1-2040175.txt,fiaf||inflamm||level||vegf||adipokin||adipocyt||effect||glut||obes||adipos tissu||normox condit||hypox condit||white adipos tissu||express||differenti||present studi||cell||hypoxia||gene||product||protein||inflammatori respons||mif||leptin||mrna||adiponectin||result,2 2||2||2 2 2||2 2 2 4||32 2 2 2 2||2 1||5 2||6 2 2 6||6 2||control 2||2 38||2 min||control 2 5 2 5||2 2 40 2 stabilis hif-1Î±||control 7 2 7,0.045||0.045||0.045||0.037||0.036||0.029||0.028||0.027||0.027||0.026||0.025||0.024||0.024||0.024||0.018,0.0,0.0,0.0
577,Doc_Ophthalmol-3-1-1784540.txt,time||grey hexagon||studi||valu||xlr||patient||femal||situ inversu||amplitud||test||retin dysfunct||eye||control||stimulu array||carrier||subject||averag control subject||mferg||hexagon||x-link retinoschisi||implicit time||segment||area,3||1||2||1 3 1 depart||16 2 2 2 2||fig. 3||2 20||result 1 1 18||3 SD||refer 1||OU||20 normal OU 3 23 20||1 normal OU 4 53 20||20 20||20,0.036||0.033||0.031||0.027||0.026||0.023||0.022||0.02||0.019||0.018||0.017||0.015||0.014||0.013||0.013,0.0,0.0,0.0
578,J_Comput_Aided_Mol_Des-4-1-2311385.txt,report||evalu||inform||set||goal||method||binding-mod predict||field||test||paper||requir||practic applic||result||recommend||area||special issu||data||prepar||statist evalu||statist report,7 8||5 7||2||7 7 9 8 9 7||4 7 9||10 1 7 8 10||1 3 7 10 10||2 4 5 8 10||gener 1 5 7 10||8||7 9 11||1 11||5 8 10||3 4 9||2 8 11,0.031||0.03||0.03||0.029||0.028||0.027||0.027||0.024||0.024||0.023||0.022||0.022||0.022||0.022||0.021,0.0,0.0,0.0
579,Curr_Genet-4-1-2413079.txt,report||luciferas imag||cultur||bioluminesc||luminesc imag||vivo||express||signal||activ||cell||luminesc||arginin||assay sensit,g-luc chlamydomona||g-luc g-luc chlamydomona 5 g-luc||chlamydomona||chlamydomona chlamydomona||g-luc chlamydomona gaussia chlamydomona chlamydomona chlamydomona||hsp70a g-luc hsp70a g-luc||g-luc chlamydomona strain||g-luc C.||chlamydomona g-luc gaussia C.||chlamydomona reinhardtii||hse g-luc g-luc hsp70a 2007||g-luc WT hsp70a r-luc hsp70a g-luc||chlamydomona gaussia||g-luc 4 4||g-luc r-luc g-luc dark grey,0.053||0.047||0.045||0.045||0.043||0.041||0.036||0.035||0.033||0.033||0.032||0.032||0.031||0.031||0.03,0.0,0.0,0.0
580,Pharm_World_Sci-3-1-2082656.txt,treatment regimen||attempt||psycholog reactanc||respons||intervent strategi||freedom||studi||physician behaviour||patient||reactanc theori||reactanc||decis support system||recommend||intervent||evid||behaviour||treatment||clinic care recommend||pharmacist||care||action||factor||sens||medic regimen||medic review||medic practition||physician||decis,1||2008 1 2||refer 1||2||2007||reactanc||medic||5||psycholog reactanc||23||3 4 5||6||clinic care||care||30,0.036||0.02||0.02||0.016||0.016||0.016||0.015||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011,0.0,0.2,0.2
581,Ann_Surg_Oncol-4-1-2277449.txt,retrograd outflow||ihhp||respons||time||isol hepat perfus||hepat toxic||concentr||perfus circuit||hepat arteri||retrograd||studi||simpl procedur||median||leakag||patient||perfus||tumor respons||treatment||oper time||partial respons||portal vein||pharmacokinet||heart-lung machin||progress diseas||month||liver||system melphalan concentr||blood loss||surviv||melphalan||hepat metastas||bile duct necrosi||present seri||stabl diseas||circuit||progress||ihpp procedur,1||0||2||phd 1 1 depart||1 mg||ihhp 1||tabl 1||refer 1||PR||phd 1 vermaa maarten MD 1||11 15 1 21||hepat perfus||tumor respons 19 result 1||2 mg||perfus,0.034||0.027||0.021||0.018||0.018||0.018||0.018||0.017||0.014||0.013||0.013||0.012||0.012||0.011||0.011,0.0,0.0,0.06666666666666667
582,Virchows_Arch-3-1-1888717.txt,colorect carcinoma||case||tissu microarray||reactiv cell||core||metastat site||studi||patient||correl||concord egfr statu||section||metastas||tissu section||site||egfr-posit cell||slide||express||tma||epiderm growth factor receptor||egfr statu||crc||tumor||number||primari crc||egfr||result,1||1 1||2||1 1 1 fig. 1||3||1 1 1 19 22 27||refer 1||4||specimen 2||egfr egfr immunohistochemistri 1||franc 3 depart||6||tma 2 tabl 2 comparison||5||cedex 5 franc 2 depart,0.029||0.029||0.025||0.024||0.02||0.016||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.011,0.0,0.0,0.0
583,J_Chem_Ecol-4-1-2239252.txt,specialist herbivor||insect||plant defens||bar-typ plant||effect||amino acid level||egg||amino acid||bar-typ||leav||glucosinol concentr||leaf||sugar||generalist||chemotyp||experi||oviposit||herbivor||glucosinol||perform||prefer||larva||plant,M.||M. brassica||brassica||M. brassica P.||2 M. brassica||1 M. brassica||3 M. brassica||M. J.||J. brassica||P. M.||1 M.||M. brassica P. rapa P.||3 M.||M. pieri brassica||oviposit P. rapa M. brassica brassica,0.025||0.025||0.024||0.021||0.021||0.021||0.02||0.02||0.02||0.019||0.019||0.018||0.018||0.018||0.018,0.0,0.0,0.0
584,Photosynth_Res-3-1-1779624.txt,method||enzym prepar||reduct PP||rate||octulos phosphat||assay||carbon||phosphotransferas reaction||photosynthet carbon reduct cycl||chloroplast||label||leav||calvin cycl||reaction||reaction sequenc||pga||enzym||PT enzym||phosphat||activ||intact||sep||spinach chloroplast||mg chl||octulos||spinach||sugar phosphat||non-oxid segment||result,2 2||2||2 14 2||2 2 14||14 2 2 2 2 3||2 2 1||2 1 2||2 14||2 14 2 14||2 14 14 2||14 2||3 2 2||2 2 3||2 14 14 14 14 2||2 1 2 14 14,0.061||0.061||0.053||0.053||0.049||0.049||0.049||0.049||0.049||0.049||0.049||0.046||0.046||0.045||0.044,0.0,0.0,0.0
585,Pediatr_Nephrol-3-1-1989764.txt,attent||chronic kidney diseas||group deficit||infant||deficit||ckd||mri||data||studi||norm popul||effect||develop||frequenc||cognit function||nervou system||kidney diseas||esrd||kidney transplant||control||cognit||age||popul||literatur||transplant||cognit deficit||dialysi||diseas||function||children,1||1 year||2||11||4 year||6 year||8 year||9 children 1 year||3||5 year||children||12 year||3 1 divis||2003||16,0.021||0.021||0.018||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.013||0.012||0.012||0.012||0.012,0.0,0.0,0.06666666666666667
586,Osteoporos_Int-3-1-1915640.txt,femor neck width||placebo||synergist effect||studi||year||fractur risk||total||femor neck||clinic trial||dxa-bmd||intak||dose||postmenopaus women||treatment||osteocalcin||non-osteoporot women||day||strength||clinic endpoint||women||age||fnw||menaquinon||bmc||group||bone||osteoporosi||bone loss||vitamin||result,2||2 2||2 1||1||follow-up 1 2 1 2||2 2 2 intak||result 2 2||2 year||0.05 discuss 2 2 2||1 5 1 1 6||method 2||0.03 2||conclus 2||2 38||acknowledg 2,0.04||0.04||0.039||0.037||0.031||0.031||0.028||0.026||0.025||0.024||0.022||0.021||0.021||0.02||0.02,0.0,0.0,0.0
587,Transgenic_Res-4-1-2268725.txt,gene||skin||mice||periton lavag||bac||mast cell||eyfp||transgen mice||cre||cell,cell||mast cell||mcpt5-cre||skin mast cell||mast cell biolog||mast cell develop||mast cell lineag||mast cell involv||periton mast cell||mast cell gate||mucos mast cell||1||cell factor||2007 mast cell proteas||cell number,0.041||0.034||0.03||0.024||0.023||0.023||0.023||0.023||0.023||0.023||0.023||0.023||0.022||0.021||0.021,0.4,0.2,0.13333333333333333
588,Arch_Dermatol_Res-3-1-2064945.txt,role||find||eosinophil||pathogen effect||mast cell degranul||model||neutrophil||develop||human||neutrophil infiltr||cell||autoimmun diseas||hemidesmosom||mice||lesion skin||extracellular matrix protein||blister fluid||experiment BP||human BP||autoantibodi||diseas||pathogen epitop||inflammatori cell,pemphigoid||bullou pemphigoid||human bullou pemphigoid||bullou pemphigoid antigen||1||bullou pemphigoid autoantibodi||pemphigoid antigen||cell||bullou pemphigoid patient||experiment bullou pemphigoid||bullou pemphigoid antigen 2||autoimmun bullou pemphigoid||bullou pemphigoid arch dermatol||bullou pemphigoid 180||bullou pemphigoid Br,0.025||0.022||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.015||0.015,0.0,0.1,0.06666666666666667
589,J_Biol_Inorg_Chem-3-1-2099461.txt,formaldehyd oxidoreductas||reaction||high concentr||pre-steady-st data||substrat||ferredoxin||benzyl viologen||visibl spectrum||enzym||concentr||singl broad line||substituted-enzym mechan||data||electron acceptor||valu||wavelength||formaldehyd||pre-steady-st kinet,1||2||1 10 1||2 1 2 3||2 5 2||1 21 2||1 10||1 6||1 13||2 21||tabl 1||1 20||refer 1||pre-steady-st kinet 2||fluoresc 2,0.043||0.041||0.035||0.034||0.033||0.031||0.03||0.029||0.024||0.024||0.024||0.023||0.023||0.023||0.023,0.0,0.0,0.0
590,Eur_J_Nucl_Med_Mol_Imaging-3-1-2121116.txt,phase histogram||cardiac cycl||substanti LV dyssynchroni||studi||patient||histogram bandwidth||interventricular dyssynchroni||LV dyssynchroni||correl||inform||heart failur||gmp||tdi||gate spect||phase analysi||assess||gate myocardi perfus spect||analysi||higher valu||LV segment||tri-plan tissu doppler imag||crt implant||kurtosi||crt||good correl,1||2||5 1 2||LV||LV dyssynchroni||studi LV dyssynchroni||studi||refer 1||patient||dyssynchroni||NS||3.79 NS 1||substanti LV dyssynchroni 7 8 2||3 fig. 3 correl||LV dyssynchroni assess,0.028||0.023||0.021||0.019||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.013||0.013,0.2,0.3,0.2
591,J_Affect_Disord-1-5-1894757.txt,prospect studi||children||infant||mother||birth||pregnanc||studi||depress||year||earli identif||rural sub-district||life event||difficulti||persist||debt||prolong depress||preval rate||event||countri||psycholog symptom||social support||postnat period||item||women||trimest||persist depress||maximum score||month||subject||depress women||factor||famili||pakistan||infant growth||ladi health worker||depress disord||postnat depress||postnat year||outcom,1||month||depress||tabl 1||2 month||6 month||2||studi||3 month||postnat month||tabl 2||6||postnat depress||4 month||fig. 1,0.02||0.017||0.016||0.016||0.015||0.015||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.011,0.4,0.3,0.26666666666666666
592,Oecologia-3-1-2039789.txt,total biomass product||main stolon||main effect||defens induct||respons||time||measur anova||induct||competit||petiol||competit tray||leaf tissu||studi||effect||leaf area||rel biomass alloc||stolon||adapt plastic hypothesi||dri mass||trait||express||leav||clonal plant||cost||damag||defens||leaf||asymmetr competit||experi||resist||herbivor||leaf area loss||tray||perform||phenotyp||area||leaf dri mass||petiol dri mass||benefit||ramet||plant||result,plant||1||1 1 depart||2||2 2||induc plant||clonal plant||1 day||sir 1 2||benefit plant||plant perform||plant popul||signific 1||induc plant defens||uninduc plant,0.021||0.02||0.014||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.2,0.2,0.13333333333333333
593,J_Med_Internet_Res-5-4-1550575.txt,search rank||search engin||search term||studi||correl||search effici||user||site||health inform||web site||page||web||smoke cessat||direct relev||result||link densiti||characterist||internet||teen||search||presenc||posit||number||web-sit characterist checklist||popular search site||googl||posit rank||link||simpl web search||teenag,search||1||1 search site||search site||1 site||site||2||4 search site||3 site||3 1 5 3 4||3||web search||1 4 2 1 0||5||2003,0.031||0.031||0.03||0.029||0.029||0.027||0.027||0.026||0.026||0.025||0.024||0.024||0.023||0.022||0.022,0.2,0.2,0.13333333333333333
594,Int_J_Colorectal_Dis-4-1-2386750.txt,colon cancer||oscc||time||case||radial margin||bloc resect||studi||patient||hemicolectomi||colon||laparoscop surgeri||middl colic vessel||altern||convers||transvers colon||laparoscop resect||middl colic arteri||statist differ||anterior resect||local||lymph node||oncolog qualiti||laparoscopi||proxim resect margin||surgeri||group||tumor||differ||long-term analysi||number||laparoscop approach||splenic flexur||patholog outcom||tcc,1||outcom 1||K. 1||H. 1 1 depart||refer 1||colon cancer||colon||colon cancer laparoscop||cancer patient||2||K. 1 cho||K. 1 kang||transvers colon cancer||T. 1 kim||G. 1 kim,0.052||0.036||0.029||0.028||0.028||0.025||0.024||0.021||0.021||0.02||0.02||0.02||0.02||0.02||0.02,0.0,0.2,0.13333333333333333
595,Plant_Foods_Hum_Nutr-4-1-2413119.txt,ast activ||placebo||anim||liver damag||noni||placebo pretreat||noni juic||alt||protect effect||experi||liver||rat||group,4||4 4||1||2008 4 4 4 4||4 4 4 exposur||4 tabl 1 4||4 4 arrow||vitro 5 4 4 4 4||4 arrow||experi 1||ast activ 1 4||conclus 4||0.01 4||fig. 1||1 mL,0.065||0.065||0.059||0.054||0.05||0.049||0.046||0.046||0.037||0.035||0.034||0.034||0.034||0.033||0.032,0.0,0.0,0.0
596,J_Med_Internet_Res-4-2-1761932.txt,type||survey research||questionnair||commun||inform consent||databas||studi||patient||site visitor||qualit research||inform||electron public||electron one-to-on interview||exampl||clinic trial||technic issu||web||select bia||research||result||confidenti||data collect||materi||type 2 public||due emphasi||ethic||issu||trial databas||public||survey||particip||peopl||newsgroup||e-mail||internet,1||research||survey research||internet survey research||type 1||1 eysenbach||1 public||health survey research||research particip||medic research||web survey research||survey||research issu||medic internet research||research result,0.026||0.024||0.02||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.014,0.4,0.2,0.2
597,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914225.txt,non-invas detect||target||case||imag||model||patient||strategi||molecular imag||annexin A5||process||vulner plaqu||necrot cell||lesion||apoptot program||apoptot macrophag||cell||apoptosi||environ||death||cell suicid||atherosclerot lesion||cardiovascular diseas||caspas cascad||non-invas imag||pet||caspas||plaqu||clinic studi||detect||vivo||result,imag||apoptosi imag||cell||molecular imag||fig. 3||molecular imag apoptosi||vivo imag||99m||99m 5 99m fig. 5||biolog imag||apoptosi||noninvas imag||function imag||annexin-v imag||cell death,0.02||0.015||0.015||0.015||0.014||0.013||0.011||0.011||0.011||0.011||0.011||0.011||0.011||0.011||0.01,0.6,0.3,0.26666666666666666
598,Skeletal_Radiol-3-1-1934928.txt,mechan||fat signal||radiograph||spine||CT imag||low signal||imag||mri||vertebr bodi||patient||disc||neural dysfunct||periost apposit||epidur fat||increas||osteoclast activ||signal||cord compress||pain||intervertebr disc||signal characterist||facet||activ||clinic symptom||spinal stenosi||bone||neural||spinal involv||diseas||vertebra,1||2||enlarg fig. 2 1||3||fig. 4 3||âs diseas||paget âs diseas||5 8 4||paget||bone||paget diseas||refer 1||diseas||fig. 3 orang||paget âs diseas periost,0.025||0.022||0.017||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.012||0.012,0.0,0.1,0.13333333333333333
599,Environ_Manage-3-1-2094719.txt,swc||project withdraw||soil manag practic||project||knowledg||practic||farmer-bas extens||bolivia||strategi||solid foundat||develop||farmer contest||wide-scal impact||rural develop||rural poverti||sustain||tool||farmer||impact||cl||widespread sustain result||local institut||swc practic||rural villag||approach||train||sustain develop||paper||zimbabw||conserv leader||villag||stone line||mainten||activ||natur resourc manag||famili||group||bolivian mountain valley||contest||ex-post evalu||order||train activ||particip rate||particip||extens||experiment||institut level||farmer group||farmer-to-farm train,2||2005 2005||2005||swc||swc extens||extens||1||swc practic||2005 2005 2005 2004 2005||develop||2005 1991 2||2 year||practic||2005 2001||2 show,0.019||0.017||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.012,0.2,0.4,0.3333333333333333
600,J_Plant_Res-3-1-2039807.txt,consequ||cell wall||carbohydrate-bind modul||modul||sampl||wall||cellulos||high express||cell wall modif||acid hydrolysi||express||plant develop||cell type||plant||tobacco||control||tobacco cell wall||tissu||cell wall structur||primari||prolong juvenil||polysaccharid||wall loosen||singl cbm||xylem cell||layer||stem||membran||cbm||result,plant||plant cell||cell||plant cell wall||1||cell wall||1 4||plant cell wall modif||2||1 plant height||1 3||control plant||4||transgen plant||1 6,0.028||0.027||0.026||0.023||0.022||0.02||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016,0.2,0.2,0.13333333333333333
601,Exp_Eye_Res-2-1-2394572.txt,anim||onl||intravitr inject||administr||find||time||outer||retin transplant||greater number||studi||photoreceptor||disrupt||effect||section||olm||integr||dose||signific increas||eye||cell||retina||control||adult mous||mice||normal||transplant||subretin space||aaa administr||mous||recipi||number||segment layer||layer||subretin inject||mÃ¼ller cell||cell integr||photoreceptor cell,fig. 2||fig. 1 fig. 3||cell||retin cell||fig. 5||1||supplementari fig. 1||2 week||fig. 1 uga||1 week||photoreceptor cell||2001 fig. 3||1979 fig. 3||2006 fig. 5||retin progenitor cell,0.021||0.019||0.018||0.016||0.016||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.012,0.2,0.1,0.13333333333333333
602,Int_J_Hematol-4-1-2276240.txt,multi-centr survey||case||indic||efficaci||favor respons||patient||criteria||investig||clinic evid||clinic trial||treatment||advers event||invas fungal infect||malign hematolog diseas||voriconazol||fungal infect||prophylaxi||activ||diseas||toxic||ifi||antifung,1||1 tabl 1||3||2||4||caspofungin 1||2 tabl 2||refer 1||surgeri 1||cn 1||treatment||2 diarrhea 1 drug fever 1||2005||a. 4||16,0.026||0.022||0.02||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.012||0.011||0.011,0.0,0.0,0.06666666666666667
603,J_Abnorm_Child_Psychol-3-1-1915590.txt,co-occurr||hostil reactiv parent||parent psychopatholog||high level||children||behavior||mother||problem||sampl||physic aggress||model||studi||prenat smoke||impuls||scale||comorbid||matern depress||signific||low||analys||smoke||hyperact||item||age||trajectori||associ||parent||earli childhood||group||famili||tremblay||high||neg parent||adhd||contrast||control variabl,1||2006||2005||2004 2005 2006||2||2004||2006 2001 2002||1 fig. 1||1994 2004 2006 2006 2003||2003||1999 2005 2001 2005||2002||1 qlscd 2||trajectori 1 2004||2 matern prenat smoke,0.017||0.017||0.015||0.015||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.01,0.0,0.0,0.0
604,Matern_Child_Health_J-2-2-1592150.txt,pregnanc||preconcept care||hiv,1||2006||refer 1||llc 2006 1 2||4 4||4||1 15 cdc||1 20 cdc||3||hiv||transmiss||5 6 7||utero 4 4||hiv infect||perinat hiv transmiss,0.042||0.026||0.024||0.021||0.021||0.021||0.02||0.02||0.019||0.017||0.016||0.016||0.016||0.016||0.015,0.0,0.1,0.06666666666666667
605,Histochem_Cell_Biol-4-1-2248607.txt,vesicl||role||earli biochem approach||granul||isoform||neuroendocrin tissu||data||hypothesi||msg||molecular tool||isg||prohormon convertas||assay||observ||chromogranin||process||constitutive-lik secret||matur||import issu||secretori granul||cell type||cell||zymogen granul||biochem||neuroendocrin cell||homotyp fusion||protein||mice||golgi complex||experi||tgn||secretori pathway||biochem approach||ph||pc||immatur secretori granul||secret||size||phenotyp||special cell||pathway||addit||hormon process||membran||physiolog pH,cell||secretori cell||cell biol||neuroendocrin cell||secretori||secretori cell rab3d||cell system||exocrin cell||secretori granul||cell type||cell biolog||fat cell||pc12 cell||cell fraction||special cell,0.033||0.026||0.025||0.019||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.017||0.017||0.017||0.017,0.4,0.4,0.3333333333333333
606,Bioinformation-1-2-1891631.txt,medicin||aromat plant||india||databas||folklor||plant,figur||bioinform 1||tabl figur 1||search result figur 1||2||2005||2005 biomed informat publish group 2005||bioinform bioinform bioinform||plant||inform||biomed informat publish group 1891631 17597854||medicin plant||databas||origin author||aromat plant,0.088||0.087||0.086||0.074||0.057||0.054||0.033||0.025||0.023||0.022||0.017||0.017||0.017||0.016||0.016,0.0,0.1,0.2
607,Int_J_Legal_Med-3-1-2039830.txt,age interv||socioeconom statu||method||complet fusion||CT scan||individu||data||model||studi||hdi||medial epiphysi||year||effect||femal||variabl||sex||signific||examin||clavicl||slice thick||fusion||age||dri bone specimen||fusion statu||differ||probabl||ethnic||result,2||1||model 2||model 1||age||6||1 1 fig. 1 age distribut||result 2||tabl 2||1 number||refer 1||model||age 0.000||12 14 2||R. 2 schulz ronald 3,0.03||0.028||0.022||0.021||0.021||0.019||0.019||0.019||0.017||0.017||0.015||0.015||0.013||0.013||0.013,0.2,0.1,0.13333333333333333
608,Biochim_Biophys_Acta-1-5-2212780.txt,mechan||cx43||IP||glycogen synthas kinas 3||pten||measur||role||diazoxid||connexin43||data||ischaemia||mediat||reactiv oxygen speci||mitochondri permeabl transit pore||kinas||effect||atp||ro format||sensit||mct1||increas||volum||pkc||complex||reperfus||recoveri||abil||gsk3||evid||channel open||phosphoryl||pharmacolog agent||calcium||csa||ro level||cardiac myocyt||cyp||respiratori chain||open||pkg||mitochondri atp-depend potassium channel||apoptosi||product||pore||oxid stress||protein||techniqu||adenin nucleotid||surviv kinas cascad||vdac||cyclophilin||sfa||ant||experi||mitochondria||calcium overload||activ||light||respiratori chain inhibitor||ro product||membran||ampk||decreas||mitok||note||adenin nucleotid translocas||sur||ro||pathway||pharmacolog||heart||mitochondri protein||mptp||ischaem precondit||monocarboxyl transport 1||protect,1||2||mitochondri||fig. 1||fig. 2 fig. 1||fig. 2||fig. 3||mitochondri protein||3||fig. 3 atp||mitochondri permeabl||3 2 14||fig. 4||mitochondri target||mitochondri membran,0.01||0.01||0.009||0.009||0.009||0.009||0.007||0.007||0.007||0.006||0.006||0.006||0.006||0.006||0.006,0.0,0.1,0.06666666666666667
609,Anal_Bioanal_Chem-4-1-2413088.txt,flow cell||flow||concentr||solut composit||bife||electrochem detect||electrod||increas||maximum respons||signal||adsorpt||potenti||solut||flow system||sensor||analysi||injection-mould electrochem micro-flow cell||cadsv||height||carbon fibr||dimethylglyoxim||film||peak||mercuri film||sampl solut||in-lin,2||3||1||4 2||3 mV||flow||1 1 school||4||1 mm||accumul stage 2 fig. 2||procedur 3||5||4 mV||refer 1||rang 1,0.023||0.023||0.02||0.019||0.017||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012,0.0,0.1,0.06666666666666667
610,Mol_Immunol-1-5-1994210.txt,role||thymu||real-tim pcr||mtec||epitheli cell||air protein||data||studi||thymocyt||microarray data||air||effect||develop||express||signal||antigen||tra||cell||thymic epitheli cell||gene||normal develop||lymph node||autoimmun regul||autoimmun||mous||central toler||result,express||air express||fig. 2 express||tra express||thymic express||fig. 2 fig. 2||fig. 3 tra express||air||2005 fig. 1 air fig. 1||fig. 4 air||gene express||tra gene express||tra||cell||1,0.024||0.021||0.02||0.02||0.018||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.015,0.2,0.2,0.26666666666666666
611,Plant_Mol_Biol-3-1-1805039.txt,respons||flag||microarray||high-salin stress||cold||studi||rice||motif||full-length cdna sequenc||flag leaf||express pattern||organ||express profil||high-salin||promot||express||leav||rehydr||stress||promot region||gene||salin||genom express||analysi||experi||shoot||panicl||group||regulatori element||drought||bind protein||plant||result,gene||1 gene||1||2 gene||2||3||3 3 1 fig. 3||plant||gene express||2 kb||fig. 2||arabidopsi gene||rice gene||t-p 1 2 fig. 1||stress,0.019||0.019||0.018||0.018||0.018||0.017||0.016||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013,0.2,0.2,0.2
612,Matern_Child_Health_J-2-2-1592157.txt,alcohol consumpt||major health risk||preconcept||behavior||indic||infant health||birth||pregnanc||data||state||folic acid||effect||preconcept period||risk||hiv test||inform||hiv transmiss||brfss||unit state||intervent||health||preconcept care||percentag||women||alcohol||insur||advers pregnanc outcom||factor||opportun||risk factor||current smoke||birth defect||hiv||outcom,2||health||risk||result 1 2||2 8||2 health risk indic||health statist||statist method 1||women||refer 1||1 comparison||1 serv||health behavior||risk factor||major health risk,0.03||0.025||0.024||0.024||0.022||0.021||0.02||0.019||0.019||0.019||0.019||0.018||0.017||0.017||0.017,0.4,0.3,0.3333333333333333
613,Exp_Brain_Res-3-1-1914290.txt,attent||visual depriv||postur sway||cop||valu||local stabil||amount||effect||sagitt plane||depend variabl||largest lyapunov expon||increas||correl dimens||plane||variabl||surrog data||sampl entropi||analys||dimension||regular cop trajectori||eye||postur control||control||center-of-pressur||cognit dual task||task||dual task||task difficulti||postur stabil||cognit invest||order||decreas||regular||postur||sway-path length||particip||intern focu||expon||dynam structur||result,1||postur||2 2 2||2||2 2||2 2006||postur control||postur task||2002 2002 2000||2 Ï||2 2005 2005 2002||postur sway||postur control brain||postur variabl||Ï 2006 1 present,0.023||0.022||0.022||0.022||0.022||0.019||0.017||0.017||0.017||0.014||0.014||0.013||0.013||0.013||0.013,0.2,0.2,0.2
614,Virchows_Arch-3-1-1888722.txt,cancer||case||microsatellit analysi||residu cancer||figur||block||rp||atyp foci||prostat tissu||biopsi core||core||posit biopsi||studi||patient||section||RP specimen||slide||paraffin block||dna||dna specimen analysi||ident||incid||deeper section||specimen||biopsi||vanish cancer||residu prostat cancer||prostatectomi||dna analysi||number||prostat cancer||radic prostatectomi||addit||step,1||3||6 3||3 3 fig. 3||cancer||2||apex 3 1||mid-zon 6 1||6||apex 2 1||suppl 1||prostat cancer||12 3||mid-zon 4 1||10 3,0.032||0.027||0.023||0.023||0.021||0.021||0.02||0.019||0.018||0.018||0.018||0.018||0.018||0.018||0.017,0.2,0.1,0.13333333333333333
615,Neuroradiology-3-1-2082067.txt,avm||onyx||embol agent||flow||pial fistula||detach coil||venou side||shunt||liquid embol agent||high flow||AV shunt,case 1 1 fig. 1||shunt case 2 2 fig. 2||patient 1||refer 1||3 2 4||springer-verlag 2007 introduct 1 3||41 case||6 month||patient||springer-verlag 2007||coil||shunt||detach coil||2005 147 17 31 10.1007||AV shunt,0.086||0.063||0.062||0.058||0.056||0.046||0.029||0.027||0.022||0.021||0.016||0.015||0.014||0.013||0.013,0.0,0.0,0.2
616,J_Comput_Aided_Mol_Des-3-1-2039848.txt,aldosteron synthesi||backbon atom||method||cyp11b1||activ site||isoform||model||cyp11b2||aldosteron||select||substrat bind||helix||hydroxyl||steroid||natur substrat||structur||amino acid||region||similar||protein-inhibitor interact||cell||templat structur||hydroxyl group||protein||inhibitor potenc||molecular dynam||metyrapon||steric fit||carbon atom||fadrazol||crystal structur||substrat||interact||molecular dock||hydroxyl distanc||inhibitor||result,1||18 18 18 18 18||4||3||11 18 3||2||1 mL 1||model||1 65 2||1 amino||protein 18 11||1 mL||3 21||ligand 11 18||refer 1,0.018||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.011||0.011||0.01||0.01||0.01||0.01||0.009,0.0,0.1,0.06666666666666667
617,Virchows_Arch-4-1-2335297.txt,type||cancer||follow-up||case||contralater breast||flat epitheli atypia||carcinoma||studi||atypia||patient||dci||epitheli atypia||descript criteria||lesion||tubular carcinoma||adh||subsequ cancer||classif||fea||ductal carcinoma||median follow-up 160 month||lobular neoplasia||atyp ductal hyperplasia||biopsi||initi diagnosi||high slide rate||microcalcif||diagnosi||malign||breast,1||breast||breast cancer||cancer breast||cancer||1 fig. 1||2||lesion 1||breast cancer risk||breast biopsi||subsequ breast cancer||breast cancer histopatholog||breast cancer screen||breast cancer progress||breast patholog,0.024||0.024||0.023||0.023||0.021||0.019||0.018||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.015,0.4,0.2,0.13333333333333333
618,Eur_Arch_Otorhinolaryngol-4-1-2279158.txt,vocal emiss||qualiti||voic||studi||perceptu analysi||patient||life||laser surgeri||inform||radiotherapi||dysphonia||signific||treatment||maximum phonat time||vocal||grab||spectrogram||voic qualiti||fundament frequenc||surgeri||group||laser cordectomi||voic handicap index||differ||laser||score,2 2||2||2 2 3||tabl 2 2||2 laser||voic||result 2 laser||1||2 2 10 11 12||0 1 2 3 total||laser||3||voic qualiti||29 2 laser surgeri||20 2 laser surgeri patient,0.043||0.043||0.035||0.033||0.031||0.025||0.024||0.022||0.022||0.02||0.019||0.019||0.019||0.019||0.018,0.0,0.1,0.2
619,Environ_Health_Perspect-113-12-1314901.txt,document||case||ethylen bisdithiocarbam||meet||compani||human||phosphin||review||mrl||commod industri coalit||pesticid regul||pesticid||methopren||ebdc||coalit||world health organ||tobacco pesticid||public interest||regul||standard||member||note||agenc||epa||industri||case studi||public||philip morri||vettorazzi||regulatori agenc||tobacco industri,access||1||2004||13 april 2004||studi||industri||7 decemb 2004||tobacco industri||6 decemb 2004||30 march 2004||tabl tabl 1 number||case studi||tobacco||13 apr 2004||4 1 center,0.032||0.022||0.02||0.015||0.015||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.012,0.0,0.2,0.2
620,Extremophiles-4-1-2175526.txt,major peak||coval bond||glycerol dibiphytanyl glycerol tetraeth||core lipid||fraction||dcm layer||group||analysi||compound||intact polar lipid analysi||cell||thermoacidophil||gdgt,2||2 2||1||2 2 3 4||4||A. boonei||2000 2||1998||A. boonei 1998 2007 1998||2002 4 1998||aciduliprofundum boonei||water 1||1 1988 1998 2004 aciduliprofundum||fig. 2 candidatu||analysi A. boonei,0.034||0.034||0.032||0.027||0.024||0.023||0.021||0.021||0.02||0.019||0.019||0.018||0.018||0.017||0.017,0.0,0.0,0.0
621,Diabetologia-4-1-2292422.txt,atp||type 2 diabet||current||function effect||insulin secret||effect||subunit||beta cell||diabet||neurolog examin||block||sulfonylurea therapi||sur||kir6.2||mutat||channel||patient||mgatp||neonat diabet||atp sensit,atp||atp 1||1 1 2 atp 2||1||1 1||2||2 2||atp channel||3 atp 2||29 1 1 fig. 1 atp||kcnj11 atp||atp sensit||atp 50||4 2||channel atp sensit,0.035||0.031||0.029||0.027||0.027||0.027||0.027||0.025||0.024||0.021||0.021||0.021||0.02||0.019||0.019,0.2,0.1,0.13333333333333333
622,J_Med_Internet_Res-5-4-1550578.txt,type||cancer||internet user||search engin||cancer type||individu||sampl||cancer queri||data||studi||question||difficulti||inform||nation cancer institut||exampl||natur languag process||user||site||health inform||web site||cancer inform||gener public||treatment||specif||web||term||user question||internet||subcategori||topic||methodolog||search||issu||vocabulari||symptom||specif type||breast||queri||gener inform,cancer||cancer queri||cancer esophag cancer||cancer inform||cancer type||cancer categori||specif cancer||cancer treatment||breast cancer||cancer patient||cancer type queri||queri cancer type||cancer subcategori||bone cancer||cancer site,0.058||0.042||0.039||0.036||0.035||0.034||0.033||0.033||0.032||0.032||0.032||0.032||0.032||0.031||0.031,0.8,0.4,0.26666666666666666
623,Clin_Auton_Res-3-1-1914255.txt,blood flow||measur||method||reproduc||vop||venou occlus pressur||head-up tilt||studi||venou occlus||increas||doppler ultrasound||DU measur||supin posit||leg||superfici femor blood flow||subject||hut||cbf||agreement||posit||strain gaug plethysmographi||superfici femor arteri||venou occlus plethysmographi||angl||blood flow measur||tilt angl||techniqu,1||2||2 3 fig. 2 blood flow||blood flow||fig. 1||test||flow||blood flow measur||2 minut||refer 1||leg blood flow||flow measur||limb blood flow||leg blood flow measur||skin blood flow,0.037||0.035||0.027||0.027||0.026||0.026||0.024||0.023||0.02||0.02||0.02||0.02||0.019||0.019||0.018,0.2,0.2,0.13333333333333333
624,Pediatr_Nephrol-3-1-2064946.txt,ccd||Na||capillari||endotheli cell||proteinuria||sodium retent||nephrot patient||renal retent||hydrostat pressur||patient||aldosteron||high blood pressur||effect||increas||nephrot syndrom||edema||glucocorticoid||fluid leakag||cortic collect duct||rat||oncot pressur||pan||sodium||edema format||chang||alter||distal nephron||factor||interstitium||trans-capillari gradient,1||2||sodium||2 fig. 2||13 11 13 13 1||4||refer 1||nephrot syndrom||syndrom||2 mg||sodium retent||nephrot rat||nephrot patient||experiment nephrot syndrom||11 13,0.032||0.022||0.017||0.017||0.017||0.017||0.017||0.017||0.015||0.014||0.014||0.012||0.012||0.012||0.012,0.2,0.2,0.26666666666666666
625,Skeletal_Radiol-3-1-2141652.txt,blood flow||rheumatoid arthriti||connect tissu||author||measur||ray||small quantiti||flow||joint||mri||imag||studi||patient||eros||disadvantag||space||view||sensit||increas||synov||finger||proxim phalanx||small joint||contrast agent||small field||tendon||ultrasound||proxim recess||fluid||normal||neovascularis||bone||subcutan tissu||dorsal aspect||hand||detect||tendon insert,1||techniqu 1 fig. 1||joint||2 1 fig. 2 arrowhead arrow||2||1 2 1 3 4||6 fig. 6 arrow||phalanx 1||ultrasound||interphalang joint 1||arthriti||7 fig. 7 arrow arrowhead||phalanx fig. 10 arrowhead||1 mm||small joint,0.018||0.016||0.016||0.015||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.2,0.2,0.2
626,Cell_Tissue_Res-3-1-2071963.txt,antibodi||cone||outer plexiform layer||goldfish||electron micrograph||cone triad||rod triad||section||process||spinul||pkc||structur||receptor||arrow||cell||retina||rod-driven hc||horizont cell||similar posit||result||dendrit||protein||metabotrop glutam receptor||BC marker||bc||synapt ribbon||electron microscopi||light||rod||posit||mglur||BC dendrit||mglur antibodi||bipolar cell,"1||2||2 2||1 2 2 1986||cell||antibodi 2 2005||3||immunochem 1||1 1983 1985 1 d,e||bipolar cell||neurosci||horizont cell||cell dendrit||cell tissu||glial cell",0.018||0.017||0.017||0.014||0.013||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.008||0.008||0.007,0.2,0.2,0.2
627,Dev_Genes_Evol-4-1-2292471.txt,cuticl||gene circuit||class iii||gene||conserv||short germ insect||embryo||normal number||segment polar gene||segment||rnai||express||segment groov||cell,tribolium||tribolium drosophila drosophila tribolium||drosophila tribolium drosophila||drosophila||tc-hh||1||1 1||1 1 1||tc-hh tc-smo tribolium 2 drosophila tribolium||gene||tc-ci 1||tc-hh tc-smo||2006 tribolium drosophila||tc-ci tc-smo tribolium||tc-ci tc-hh tc-smo tc-ci tc-ptc tribolium,0.03||0.03||0.03||0.03||0.028||0.026||0.026||0.026||0.026||0.024||0.023||0.023||0.023||0.023||0.022,0.0,0.1,0.06666666666666667
628,Intensive_Care_Med-4-1-2244699.txt,effect||sepsi intervent strategi||level||lp inject||increas||pct||ct-proavp||intervent||prednisolon||human endotoxemia||dose||mr-proanp||studi||patient stratif method||biomark||mr-proadm||corticosteroid||sepsi,2||4||2 4 5 7||fig. 1||refer 1||fig. 2||netherland 3 center||5 7 7 15||2007||netherland 2 depart||result pharmacokinet data 1||springer-verlag 2008 introduct 1||netherland 4 research depart||assay 5 7 14||2 giebelen ida,0.028||0.026||0.023||0.022||0.02||0.018||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.012,0.0,0.0,0.0
629,Eur_Radiol-4-1-2270358.txt,invas angiographi||find||pulmonari embol||protocol||imag||dose length product||studi||patient||chest pain||simultan evalu||recent CT technolog||respect valu||diagnost accuraci||aortic diseas||neg predict valu||contrast materi||coronari cta||coronari find||diagnost evalu||examin||heart rate||acut chest pain||analysi||diagnost workup||chest pain assess||coronari arteri diseas||coronari arteri segment||cta find||stenos||cta||cardiologist||dual-sourc CT||coronari atherosclerosi||equival dose||heart||insuffici contrast opacif,1||2||patient||1 1 depart||1 13||3||refer 1||patient popul||coronari arteri||4||examin 5 1||2 diagnos||coronari angiographi||patient protocol||coronari CT angiographi,0.026||0.022||0.019||0.019||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.2,0.1,0.06666666666666667
630,Histochem_Cell_Biol-4-1-2228376.txt,plc||bax||smooth domain||data||studi||reticulon||subcompart||transit endoplasm reticulum||smooth ER||marker||ER fraction||domain||chaperon||protein complex||cell||lipid||rough||enzym||protein||proteom||analysi||associ||molecular machin||metabol||fraction||ER subcompart||microtubul||membran traffic||rough endoplasm reticulum||pathway||smooth endoplasm reticulum||ER protein||plasma membran||ser||membran||function,protein||cell||2006 2006 2006 2006 2006 2001||2005 2006 2006 2002 2006||2006 2005||2006 2006 2005 2003||2006 2006 2005 2006 1998||membran protein||ER protein||2003 2006 2||2006 1998 2005 2006||protein complex||2006 2004 2005||ribosom protein||reticulum protein local protein,0.034||0.029||0.026||0.025||0.024||0.024||0.023||0.021||0.021||0.021||0.02||0.02||0.02||0.02||0.019,0.4,0.3,0.26666666666666666
631,Virchows_Arch-3-1-2151131.txt,cancer||author||target||mirna express||normal tissu||dna sequenc||case||human protein||role||oligonucleotid||pathogenesi||develop||malign transform||cell prolifer||express||human genom||differenti||cell||gene||human diseas||approach||apoptosi||protein||group||mirna||antisens therapi||microrna||function,cell||cancer cell||cancer||human cancer cell cancer||rna||1 1||human cancer||microrna||rna gene||human cancer cell line cancer||microrna express||cultur human cancer cell||gene||gene express||express,0.021||0.02||0.018||0.017||0.016||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.012,0.4,0.3,0.3333333333333333
632,Purinergic_Signal-3-4-2072928.txt,mechan||atp||bbg||immunofluoresc||process||posit cell||microglia||gfap||microgli cell||receptor||activ||nac||data||studi||injuri||pakt||agonist||cell||rat||P2 receptor,7 7||7||7 receptor||7 1 1||2||1||7 7 25 7 7||receptor||2 4 receptor||4 receptor||59 7 7 receptor||7 1 receptor antibodi||7 receptor activ||3 7 3 3 7||7 receptor express,0.03||0.03||0.027||0.027||0.026||0.025||0.025||0.024||0.023||0.022||0.021||0.021||0.02||0.02||0.02,0.0,0.1,0.06666666666666667
633,J_Neurol-2-2-1705488.txt,correct descript||medic emerg||measur||questionnair||knowledg||St john ambul||heart attack||session||studi||stroke awar||stroke||brain attack||inform||sign||acut stroke||brain||educ||train||action||lesson||hands-on measur||teach||topic||healtheduc||symptom||number||aid train||particip||cours||peopl,stroke||1||stroke symptom||stroke lesson||stroke patient||acut stroke||stroke care||stroke knowledg||stroke awar||2 1 depart||1 symptom||stroke initi||stroke manag||stroke progress||stroke 78.7,0.047||0.04||0.03||0.028||0.027||0.027||0.026||0.026||0.026||0.026||0.026||0.024||0.024||0.024||0.024,0.2,0.3,0.2
634,Pflugers_Arch-3-1-1915642.txt,find||fat||plasma||glycogen||studi||fat oxid||carbohydr ingest||effect||infus||fiber type||muscl glycogen||lipid-droplet densiti||total||con trial||insulin||imtg||con||plasma ffa oxid||carbohydr||muscl biopsi||glucos||averag||skelet muscl glycogen||insulin concentr||subject||exercis||oxid rate||carbohydr supplement||cho||adipos tissu lipolysi||oxid||cho trial||rest,2||2 2||1 2 2||13 2 2||1 13 2 2||2 2 3||1 13 2 13 2||1||2 2 34||13 2 2 18||1 13||fig. 2||type 2||2 44||1 13 13,0.053||0.053||0.048||0.044||0.042||0.039||0.039||0.038||0.036||0.033||0.031||0.03||0.03||0.029||0.029,0.0,0.0,0.0
635,Int_J_Cardiovasc_Imaging-3-1-2048829.txt,measur||method||aortic stenosi||studi||patient||left ventricl||tte||aortic regurgit||ava||signific||axial view||avc||contrast allergi||mild||non-invas method||result||moder||tte measur||cardiac catheter||ebt||valv||aortic valv area||aortic valv||sever||area||signific correl||contrast||aortic valv stenosi||function||techniqu,2||2 2 2 2 2||2 2||1||2 patient||3 2 2||1 1 1 1 fig. 1||18 2 2||patient||24 2 25 2 2||fig. 2||aortic valv area 2 2||2 plane||6 patient||17 patient,0.041||0.041||0.041||0.034||0.034||0.031||0.03||0.029||0.027||0.026||0.024||0.023||0.021||0.02||0.018,0.0,0.1,0.06666666666666667
636,Diabetologia-3-1-1998885.txt,type 2 diabet||level||gfr||plasma||diabet||hyperglycaemia||concentr||microvascular complic||studi||patient||urinari albumin excret||metabol control||renal dysfunct||marker||type 1 diabet||metabol dysfunct||thiamin||microalbuminuria||adhes molecul||plasma thiamin concentr||erythrocyt||urinari excret||link||diabet complic||vascular dysfunct,diabet||2 diabet||thiamin||thiamin thiamin||thiamin thiamin thiamin||type 2 diabet||type 1 diabet||diabet patient||2||2 2||1 2||diabet complic||1||diabet control||clinic diabet,0.046||0.037||0.034||0.034||0.034||0.031||0.031||0.029||0.028||0.028||0.027||0.027||0.027||0.026||0.026,0.4,0.4,0.3333333333333333
637,Neuroradiology-3-1-1786189.txt,mechan||anim||find||secondari deterior||complement||cerebr ischemia||mri||studi||strategi||clinic outcom||rat model||brain damag||patient||disrupt||stroke||effect||temporari mcao||reperfus||platelet||increas||vasogen edema||magnet reson imag||ischem stroke||rat||blood||tissu||reperfus injuri||hypothermia||leukocyt||brain cool||leukocyt infiltr||infarct volum||ischemia||injuri||hyperperfus||bbb||group||blood reperfus||result,1||stroke||6 2||ischem stroke||stroke patient||stroke group||refer 1||2 pile-spellman john 1 1 depart||acut stroke||1 week||2 day||6 2 20||ischem stroke patient||springer-verlag 2007 introduct 1 2||stroke studi group,0.022||0.019||0.015||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.011,0.4,0.2,0.13333333333333333
638,J_Mol_Biol-1-5-1950483.txt,atom forc microscopi||mechan stabil||tnfn3||fibronectin type iii||simul||fnfn10||afm,1||figur 2||6||figur 2 5||figur 3||10 figur 1 10||1 13||refer 1||1 18||jc162@cam.ac.uk 1||20 21 5 4 4||unfold extracellular matrix 1 2 3||8 6 4 9||6 11||17 6,0.046||0.037||0.033||0.031||0.03||0.028||0.028||0.028||0.026||0.025||0.021||0.021||0.02||0.019||0.019,0.0,0.0,0.0
639,Histochem_Cell_Biol-4-1-2386530.txt,mechan||flow||ciliari membran||studi||mutat||cilia||ciliopathi||cell biologist||structur||defect||signal||basal bodi||human diseas||tissu||primari cilia||protein||motil||mous||electron microscop studi||diseas||function||ciliogenesi,cell||cell signal||cell biolog||cell divis||mammalian cell||differenti cell||cell line||cell surfac||schwann cell||stem cell||mdck cell||cell biologist||1||2 motil||2007,0.036||0.022||0.021||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.018||0.018||0.017||0.016||0.015,0.0,0.0,0.06666666666666667
640,Neuroimage-2-1-2330063.txt,left||studi||patient||seizur||tle||white matter tract||correl||medial tempor lobe||volum||test||memori||tractographi analysi||signific interact||memori function||epilepsi||control||voxel||tractographi||parahippocamp gyru||age||hippocamp atrophi||visual cue||hippocamp volum||connect||signific correl||structur connect||side,left||1||left tle||cp||2||left tle patient||3||tle 3||fig. 3 fig. 2||2004 fig. 2 fig. 3||13 34 cp 1 2||fig. 4||tle||14 30 cp 4 1||14 27 cp 4 1,0.023||0.017||0.016||0.015||0.014||0.014||0.013||0.012||0.011||0.01||0.01||0.01||0.01||0.01||0.01,0.2,0.1,0.13333333333333333
641,Appl_Microbiol_Biotechnol-3-1-1914237.txt,transcriptom||gene||high-dens oligonucleotid microarray||absent||strain||fragment dna||relationship||discrimin phylogenet relationship||genomotyp||solvent-toler bacteria||microarray||pseudomonad||orf||cog||studi||aflp||absenc||function categori||function||intergen region,P. putida||P.||discuss P. putida P. putida P.||pseudomona putida||pseudomona monteilii putida P. putida P.||P. putida pseudomona pseudomona||P. putida 2002||pseudomona P. monteilii P. putida||P. putida s12||P. putida 1977||700801 P. putida||2 pseudomona P.||P. putida pseudomona strain||proteom pseudomona putida P.||P. putida pseudomona 1 materi,0.038||0.036||0.032||0.031||0.03||0.03||0.03||0.028||0.026||0.026||0.026||0.025||0.025||0.025||0.024,0.0,0.0,0.0
642,Purinergic_Signal-4-2-2377318.txt,mechan||filter||flow||epitheli cell||releas||perfus||atp||assay||signal||cell||stimuli||hypoton challeng||volum addit control||ionomycin||mechan stimul||fluid||atp secret||pool||purinerg||apic surfac||atp releas||transient||monocilium||medium||monolay,2||2 2 2||cell||10 2||signal 2||1||cell monolay||9 2||38 2||33 2||2 mg||fig. 6 2||68 2||fig. 10 2||2 Î¼M,0.031||0.031||0.027||0.02||0.02||0.02||0.018||0.018||0.018||0.017||0.017||0.017||0.016||0.016||0.016,0.2,0.1,0.06666666666666667
643,J_Gastrointest_Surg-3-1-1852380.txt,cha||hepat inflow||major surgeri||major hepatectomi||gastroduoden arteri||hemostasi||case||complet hemostasi||hepat failur||pseudoaneurysm||hepat arteri||patient||pha||tae proxim||angiographi||success outcom||superselect tae distal||rha||hemorrhag||ligat||re-laparotomi||tae||massiv arteri hemorrhag||subphren arteri||surgeri||spa||vascular reconstruct||sma||pancreat head||gda||hilar bile duct cancer||outcom,1||patient 1||1 2 3||patient||patient 2||6||patient 3||2||1 2 figur 1 arrow||result 1||refer 1||1 detail||patient 11||4||13 patient,0.037||0.03||0.027||0.023||0.023||0.022||0.022||0.022||0.022||0.02||0.02||0.019||0.019||0.017||0.017,0.2,0.1,0.06666666666666667
644,Support_Care_Cancer-3-1-2092409.txt,attent||cancer||pleasur intens||preval||tempera dimens||problem||studi||analys factor analys||year||question||concept||eatq-r||pearson correl analys||effect||life event||variabl||frustrat||adolesc children||control||relationship||tempera||recurr diseas||age||parent||educ level||dutch||factor||parent cancer||group||report||inter-item correl||socio-demograph||number||daughter||adolesc||illness-rel variabl||children,1||2||2 4||2 5||2 tabl 2||cancer||studi||problem||4||5||children âs||children||children 3||children âs tempera||3,0.018||0.017||0.015||0.015||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.0,0.3,0.26666666666666666
645,Pharm_World_Sci-3-1-1805038.txt,pharmaci||health care centr||case||system||questionnair||databas||determin||studi||patient||risk||correl||validation-set||netherland||dutch commun pharmaci||drug interact||ratio||analysi||medic surveil system||advers patient outcom||medic surveil||dispens||import||number||drug||euron system||drug combin,1||1 1||drug||2||1 number||number 1||drug interact||1 erythromycin||result 1||drug interact number||refer 1||keyword drug interact drug||dispens drug||4||drug combin,0.04||0.04||0.032||0.027||0.027||0.027||0.025||0.025||0.023||0.022||0.021||0.021||0.02||0.02||0.02,0.2,0.2,0.2
646,J_Chem_Ecol-3-1-1915630.txt,plant defens||van loon||leaf tissu||effect||gl||egg||van poeck||test||total||leaf surfac||leav||natur enemi||butterfli||treatment||pupal weight||cabbag||sixth leav||control||paper||experi||butterfli speci||oviposit||surfac||herbivor||glucosinol||number||perform||leaf surfac extract||plant,P.||P. A.||P. brassica P. rapa||1 P.||J. P.||P. brassica||P. rapa 2003 P.||plant||2||2 2||JA P. brassica P.||A.||1 2 1||JA P. rapa||3 fig. 3 P. rapa,0.022||0.018||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.013||0.013||0.013||0.013,0.0,0.1,0.06666666666666667
647,Int_Arch_Occup_Environ_Health-3-1-1915587.txt,pharmaci||level||method||concentr||cytotox drug||hospit pharmaci||sampl||locat||solvent||data||analyt run||effect||variabl physic characterist||threshold||sensit||wipe||platinum||compound||initi amount||icp-m||valid||laf hood||hcl||hospit||dutch hospit pharmaci||clean room||materi||facil||surfac||import||contamin||intern standard||cytotox agent||drug||desorpt solvent||nebulis||procedur||surfac contamin||complianc||result,1||1 3||1 platinum||3||3 3||1 2002||2||2 2||1 week||site 1||platinum||result 1||day 3 3 3||1 amount||3 4,0.031||0.026||0.024||0.022||0.022||0.022||0.018||0.018||0.018||0.018||0.018||0.018||0.017||0.017||0.017,0.0,0.0,0.06666666666666667
648,Mol_Genet_Genomics-4-1-2270915.txt,tobacco||defens||fourth leav||level||respons||jasmon acid||pathogen||transcript||acc||express||studi||valu||rice||plant||infect,ospr1||ospr1 ospr1 2 ospr1||ospr1 ospr1 8 ospr1||ospr1 gene ospr1||051 ospr1 ospr1||rice plant pr1 ospr1 ospr1||ospr1 gene||ospr1 protein||5 ospr1||074 ospr1||gu ospr1||young rice plant ospr1 ospr1||pr1 pr1 arabidopsi pr1 ospr1||012 ospr1||101 ospr1,0.055||0.047||0.042||0.042||0.038||0.035||0.035||0.033||0.032||0.031||0.031||0.03||0.03||0.029||0.029,0.0,0.0,0.0
649,Diabetologia-3-1-2039861.txt,contractil dysfunct||basal phosphoryl||triacylglycerol||fat||lcfa uptak||data||substrat uptak||diabetes-rel heart diseas||cd36||basal||high-fat feed||cardiac dysfunct||increas||insulin||hfd||phosphoryl||rat||high-fat diet||vivo cardiac function||diabet cardiomyopathi||diet||lcfa||group||glucos uptak||myocardi triacylglycerol accumul||utilis||sso||lfd||insulin-resist rat||insulin resist||heart||cardiomyocyt,2||2 2||2 2 15||1 2 5||1 1 1||1||9 2 13 2||fig. 2||cd36 2 24 23 2 2||morpholog 2||9 13 2 23 2||2 fodor||3 3||3||salin 4 2 5,0.033||0.033||0.023||0.023||0.022||0.022||0.02||0.02||0.018||0.017||0.017||0.017||0.015||0.015||0.015,0.0,0.0,0.0
650,Pediatr_Nephrol-4-1-2335295.txt,appar diseas onset||follow-up||proteinuria||time||children||studi||year||end-stag renal diseas||patient||corticosteroid||mesangi prolifer degre||late group||signific||focal mesangi prolifer||outcom||treatment||long-term outcom||present studi||multivari analysi||iga-n||studi period||signific factor||sever mesangi cell prolifer||renal surviv||mild iga-n||analysi||japanes children||sever iga-n||group||differ||mesangi prolifer||time period||initi renal biopsi||diseas||diagnosi||baselin characterist||rct||result,2 2||2||1||4 1 2 1 2||2 4||1 4||1 1 depart||group 1||2 day||4||1 treatment||4 week 2 mg||4 week 1 mg||0.67 2||treatment 5 6 1,0.033||0.033||0.029||0.029||0.027||0.024||0.021||0.02||0.02||0.02||0.019||0.018||0.017||0.017||0.016,0.0,0.0,0.0
651,Qual_Life_Res-4-1-2358934.txt,level||method||global qualiti||index score||individu||qualiti||patient||life||correl||conjoint analysi||aca||domain||util||valid||iqol||altern method||cancer patient||averag||feasibl||worst option||task||pair||social judgment theori||seiqol||scenario||direct weight||weight||respond||import||largest benefit||agreement||number||individu qualiti||life domain||score||global individu qualiti,domain||domain 3||1||3||2||life domain||import domain||tabl 3||5||domain function||iqol domain||life domain qualiti||pair 1||inconsist 1||M. 2,0.025||0.025||0.024||0.024||0.022||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.2,0.2,0.13333333333333333
652,Neuropsychol_Rev-3-1-2039835.txt,block||practic motor skill||practic||studi||patient||amount||procedur learn||effect||review||abil||motor-skil learn||cognit function||clinic practic||recommend||dick||train program||control||schmidt||rehabilit||train||research||task||non-pharmacolog intervent||feedback||motor||compon||implicit motor-skil learn||implicit learn||implicit||AD patient||perform||movement||result,AD||AD patient||patient||learn||AD patient 1995 1999 1995||17 AD||1995 4 AD||motor learn||AD group||1995 20 AD||1995 12 AD||AD mild||mild AD||1997 20 AD||2,0.024||0.022||0.021||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013,0.4,0.2,0.13333333333333333
653,J_Behav_Med-4-1-2346512.txt,psycholog treatment||condit||time||therapist time||problem||control group||studi||patient||effect||review||disord||intervent||adult||treatment||headach||health condit||chronic diseas||research||cognit behavior therapi||pain||health problem||popul||internet||trial||therapist||systemat review||tradit form||cbt||result,2006||control||control studi||studi||2007 2006 2006 2006||studi 1||1||intervent 2||studi 2006 2004||2007 2006||control trial||2 2003||control group||studi patient||psycholog,0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.01||0.01||0.01,0.2,0.1,0.13333333333333333
654,Clin_Oral_Investig-3-1-2134843.txt,surgic periodont therapi||statist unit||ral-v gain||baselin||studi||patient||greater bone loss||effect||clinic||teeth||aggress periodont||site||baselin ppd||therapi||smoke||single-root teeth||baselin data||paramet||ppd reduct||recent statist method||analysi||nonsurg||ral-v||pli||oral||interproxim groov||srp||factor||influenc||clinic paramet||periodont therapi||doubl contour||bone loss||treatment result||ppd,1||2||4||clinic||3 4||studi||tabl 1 studi popul||4 5||3||periodont||result 1||6||8||5||3 month,0.02||0.017||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.2,0.2,0.13333333333333333
655,Eur_J_Epidemiol-3-1-2039783.txt,effect intervent||theori||studi||disadvantag||risk||epidemiolog||child||intervent||earli disabl pension||administr databas||evid||countri||health||educ||norway||polici||low parent educ||death||gener||disabl||parent disabl||social polici||low educ,2007||2007 1||bioethic 3 4 4 5||health||patient||studi||follow||epidemiol 2007||refer 1||10||evalu intervent studi||good health||intervent||studi design||observ studi,0.03||0.029||0.025||0.023||0.023||0.022||0.019||0.019||0.017||0.016||0.016||0.016||0.016||0.015||0.014,0.2,0.2,0.2
656,Pediatr_Radiol-3-1-1891645.txt,tracheobronchi tree||airway||case||time||protocol||high-resolut imag||imag||mpr||compress||low-dos protocol||inform||CT protocol||congenit||dose||anatom relationship||tracheal||scan||radiat dose||clinic case||lung||children||techniqu,3||2 3 3||1 1 1||1 1 1 1 1||1||2||1 2 1 2 5||1 2 3 4 5||1 6 1 3 4 5||fig. 3||5 3||4||10 3 7 3 6||fig. 4||3 year,0.031||0.03||0.029||0.029||0.029||0.029||0.025||0.024||0.023||0.023||0.021||0.02||0.019||0.017||0.016,0.0,0.0,0.0
657,Arch_Dermatol_Res-3-1-1950585.txt,pre-analyt sampl prepar||background intens level||ratio||intens||amplif||array cgh studi||genom dna||fresh tissu||skin dna||tissu||clinic practic||sampl||qualiti||signal||agaros gel||fix||molecular fix||result,2||1 2||1||1 1||2 fig. 2||1 2 3 24||1 6||3||fig. 1||38.73 1 2 3 24||refer 1||dna||1 week||genom dna||2 repres data,0.034||0.034||0.034||0.034||0.025||0.024||0.024||0.023||0.02||0.019||0.019||0.018||0.018||0.017||0.014,0.0,0.0,0.06666666666666667
658,Surg_Endosc-4-1-2262145.txt,curriculum||level||endoscop surgeri||skill||mandatori part||time||competit element||studi||traine||resid||pgi||train program||train time||surgic resid||train||paramet||task||opinion||virtual realiti||month||simul||endoscop procedur||possibl||perform||particip||virtual realiti simul||surgic curriculum||virtual realiti train||score||result,1||pgi 1||pgi||pgi 2||pgi 5||pgi 6||pgi 3||1 11||refer 1||pgi 4||1 broeder||pgi 6 level||train||5||1 august 2000,0.048||0.046||0.044||0.044||0.032||0.032||0.03||0.026||0.026||0.026||0.026||0.024||0.021||0.02||0.02,0.2,0.1,0.13333333333333333
659,Cancer_Immunol_Immunother-3-1-2150634.txt,respons||figur||serum||protocol||immun monitor||panel||valid practic||cell recoveri||studi||strategi||low background||panel particip||assay||dri ice shipment||criteria||intern site||immun assay||abil||plate||recoveri||harmon||common sourc||guidelin||valid||antigen||cell||intern locat||elispot assay||result||pbmc||immun||central lab||protocol choic||spot||donor||assay outcom||choic||group||report||cmv||elispot||profici panel||perform||repeat||survey||particip||weak respond||laboratori,1||panel 1||panel||2 1||panel 2||cancer||panel assay||cell||2||panel particip||1 cell recoveri||cancer vaccin||profici panel||elispot profici panel||assay,0.019||0.018||0.018||0.016||0.015||0.015||0.014||0.014||0.013||0.012||0.011||0.011||0.011||0.011||0.011,0.2,0.3,0.3333333333333333
660,Arch_Sex_Behav-3-1-1914258.txt,person||self-efficaci||person norm||measur||find||hiv-posit statu||men||casual sex encount||behavior||subject norm||consequ||import role||msm||determin||neg influenc||unprotect anal intercours||theori||effect||antivir therapi||prosoci behavior||intent||context||sex||variabl||plan behavior||signific||sexual risk behavior||signific increas||present studi||condom||norm-activ theori||moral concern||person characterist||riski sexual behavior||item||varianc||prosoci tendenc||predictor||steadi||predict||neg impact||particip||partner||sexual motiv||peopl||addit||step||emot,2||1||behavior 2||sexual||2000||sexual behavior||sex||model||sex behavior||2005 2000 2005||2000 1999 1 2000 2005 2004||behavior||sex partner||2005||norm,0.016||0.016||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.01||0.01,0.0,0.1,0.13333333333333333
661,Eur_J_Pediatr-3-1-2151778.txt,antibodi||follow-up period||data||studi||year||patient||liver biopsi||fibrosi||low rate||natur histori||adult||hematolog diseas||infect||minim necrosi||nosa||hcv||liver||hgv||group||biopsi||diseas||children,1||2||patient||antibodi 1 0||0 2||group 1||antibodi 0 2||2 year||group 2||0 0||antibodi||2 6 3||0 4||3||3 year,0.024||0.022||0.021||0.02||0.02||0.019||0.019||0.019||0.018||0.017||0.017||0.016||0.016||0.016||0.015,0.2,0.1,0.13333333333333333
662,Rev_Endocr_Metab_Disord-3-1-1894828.txt,syndrom||respons||children||cfc||birth||growth hormon||mutat||year||normal rang||patient||short neck||costello syndrom||adult||cardio-facio-cutan syndrom||high incid||treatment||growth||gene||age||hypertroph cardiomyopathi||cytokin||similar cardiac defect||noonan syndrom||height||factor XI||function||leopard syndrom||clinic studi||hormon||short statur,ptpn11||syndrom||ptpn11 mutat||growth||1||1994 ptpn11 nat genet||ptpn11 gene mutat||mutat||noonan syndrom||growth hormon||med genet||2006 nat genet||nat genet 2006||2003 nat genet||genet disord,0.024||0.02||0.019||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013,0.4,0.5,0.3333333333333333
663,Anal_Bioanal_Chem-4-1-2287204.txt,anim||gross||concentr||model||studi||sexual differenti||water||develop||effect||femal||observ||neg control||increas||test||exampl||gonad||metamorphosi||tank||treatment||acclim||complet||daili||dilut water||analysi||experi||treatment group||terminolog||biolog variabl||light||water qualiti||frog||group||statist analys||order||exposur||mix sex||procedur||dpf||environment chamber||tadpol||flow-through system||result,1||1 1||1 1 fig. 1||1 2||1 X. laevi||1 2 2 2||1 2 2 2 2||1 3||1 water||1 2 fig. 2||2||2 2 2 2||1 4||X.||X. laevi X.,0.026||0.026||0.021||0.021||0.019||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.015,0.0,0.0,0.0
664,Biodegradation-3-1-2151777.txt,oxygen consumpt||long-chain alkylamin||nitrogen||depend||micro-organ||octylamin||ammonium||strain||carbon||silica gel||substrat specif||growth||enzym assay||dodecylamin||enzym||strain bert||fatti acid||activ||cell suspens||cultur||substrat||oxid||cell-fre extract||biodegrad pathway||prepar||alkylamin,2||2 2||1 2 2||1 2||1||1 fig. 1||pseudomona||1 protein||activ 1||2 oxid||1 agar||1 pseudomona 1992 1999||1 pseudomona strain bert||4||pseudomona pseudomona 12 18,0.042||0.042||0.042||0.041||0.041||0.03||0.029||0.027||0.025||0.023||0.022||0.02||0.02||0.018||0.018,0.0,0.0,0.0
665,Plant_Mol_Biol-4-1-2268730.txt,rice||Zn defici||zn-defici shoot||barley||nicotianamin||transport||iron||ma secret||dma||dma synthesi||analysi||experi||zn-defici rice||shoot||absorpt||Fe defici||secret||zinc||root||dma secret||ma||plant,62||62 62 62 2||62 62 2||62 2||plant||2||62 62 1 62 2||62 5 62 62 62 2||62 5 62 62 2||5 62 62 62 2||3 62 62 62 2||62 5 62 5 62 2||62 5 2||6 62 62 2||5 2 2,0.041||0.04||0.04||0.04||0.038||0.038||0.038||0.037||0.036||0.036||0.036||0.033||0.033||0.032||0.032,0.2,0.1,0.06666666666666667
666,J_Behav_Health_Serv_Res-4-1-2214828.txt,case||subclassif||individu||data||studi||state||idb||state agenc||IP SA||medicaid||inform||medicaid enrol||washington state||unit state||opiat||co-occur||mh-onli||day||coeffici||analysi||popul||MH servic||servic||care||group||mental health servic administr||residenti SA servic||window||record||client||addit||diagnosi,servic||SA servic||agenc servic||1||medicaid servic agenc servic||medicaid servic 2 agenc servic||servic data||MH servic agenc servic||medicaid servic||3 agenc servic||medicaid servic 2||treatment servic||2||SA agenc servic||MH servic,0.036||0.026||0.025||0.025||0.024||0.024||0.023||0.023||0.023||0.023||0.023||0.022||0.022||0.022||0.021,0.2,0.1,0.13333333333333333
667,Bioprocess_Biosyst_Eng-2-2-1705514.txt,total biomass||batch-to-batch reproduc||concentr||valu||distort||growth rate||process||recombin protein||pat||manufactur||rel deviat||biomass concentr||cell||control||product||predefin profil||result||ferment||experi||deviat||feedback control||cultur||procedur||biomass||profil||reproduc,2||2 2 2||1 2||2 4 14.60 2||0.74 2 4 2.00 2 2||4||_{ 2||0.18 4 2||0.21 4 2||1.20 4 2||1||edta 20.10 2 4 2||47 2||low 2 1||1 fig. 1,0.049||0.049||0.038||0.032||0.03||0.029||0.027||0.027||0.027||0.027||0.026||0.026||0.026||0.026||0.025,0.0,0.0,0.0
668,Biochim_Biophys_Acta-2-1-2323027.txt,oocyt||nano||element||data||translat activ||deadenyl||meiotic matur||translat repress||complex||symplekin||parn||signal||tail||phosphoryl||polyadenyl||cpsf||regul||associ||translat control||activ||cytoplasm||cpeb||bind||factor||synthesi||maskin||polymeras||mrna||gld2||addit||cytoplasm polyadenyl||function,cell||1||2 1||2||polyadenyl||polyadenyl mrna||3||5 1||cytoplasm polyadenyl||mrna cytoplasm polyadenyl||mrna||5 2||cell dev||cytoplasm polyadenyl xenopu||protein,0.016||0.015||0.014||0.013||0.013||0.011||0.011||0.011||0.01||0.01||0.01||0.01||0.01||0.01||0.01,0.2,0.2,0.2
669,Anal_Bioanal_Chem-4-1-2324128.txt,stationari phase||larg rang||post-transl modif||proteom level||hydrophil interact liquid chromatographi||retent||scx||separ||chromatographi||proteom||analysi||column||enrich||hydrophil compound||sampl||hilic||neg charg,2||2007||11 2 11 fig. 2 11||11 12 12||10 12 12 12||12||9 11||refer 1||proteom 2002 2 3 10 10.1002||3||proteom||4 23 4 23||separ||commun 2003 308 1 11 10.1016||chem commun,0.025||0.019||0.017||0.014||0.013||0.013||0.011||0.011||0.011||0.011||0.01||0.01||0.01||0.009||0.009,0.0,0.0,0.13333333333333333
670,Evid_Based_Complement_Alternat_Med-4-2-1876616.txt,condit||non-malign pain||robust support||headach pain||find||week||tension-typ headach||discret pain condit||futur work||patient||depress||rigor studi design||chronic||acupunctur||chronic pain condit||effect||craniosacr therapi||neck||superior||review||colleagu||waitlist control||broad overview||improv||evid||moyer||massag||treatment||therapi||headach||spinal manipul||meta-analysi||broad array||relax||futur studi||pain||follow-up assess||assess||conclus||posit group||chronic pain||group||cochran collabor||fibromyalgia||massag therapi||relev studi||limit||trial||date||preliminari support||support||usual care||migrain||futur clinic trial||outcom||result,pain||pain studi||pain condit||chronic pain||pain 30||pain 3 MT||headach pain||pain intens||pain number||shoulder pain||neck pain||fibromyalgia pain||tabl||pain complaint||non-malign pain,0.042||0.028||0.025||0.025||0.024||0.024||0.023||0.022||0.022||0.022||0.022||0.022||0.022||0.022||0.022,0.4,0.3,0.26666666666666666
671,Ann_Biomed_Eng-2-2-1705516.txt,bioreactor||mechan forc||leaflet||valv leaflet||cyclic stretch||cell morpholog||imag||elastin||studi||valv failur||effect||section||nativ structur||forc||tissu section||current studi||express||stretch||contractil phenotyp||valv interstiti cell||circumferenti stretch||fiber||dmem||tissu||collagen||cell phenotyp||elastin content||analysi||circumferenti cyclic stretch||sgag||sgag content||aortic valv leaflet||valv||rel motion||aortic valv||stretch bioreactor||avl,2||1 2||1||valv||1 figur 1||valv leaflet||1 2 25||4 2 5||aortic valv||10 2||aortic valv leaflet||leaflet||red 2||1 10||valid 2,0.024||0.023||0.022||0.019||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014,0.2,0.3,0.3333333333333333
672,Anal_Bioanal_Chem-4-1-2262919.txt,antibodi||target||recognit||nanoscal sensor||fet||sensit||high sensit||nacl solut||signal||small size||electrochem aptam sensor||detect limit||carbon nanotub||recognit element||deby screen length||protein||sensor||electr signal||bind||electr doubl layer||aptam,1||1 2||2||1 fig. 1 mip||3||1 16||1 nm||refer 1||1 Î¼m||3 1 Î¼M sandwich||tabl 2||2 80||2006||6 6 fig. 6||aptam,0.039||0.033||0.027||0.024||0.023||0.022||0.021||0.021||0.02||0.016||0.016||0.015||0.014||0.013||0.012,0.0,0.0,0.06666666666666667
673,Arch_Dermatol_Res-3-1-1950346.txt,placebo||chronic plaqu psoriasi||psoriasi||ccr5||baselin||data||patient||pasi||pathogenesi||receptor||lesion||express||treatment||cell||day||pasi 50 respond||analysi||psoriasi patient||placebo group||total number||non-lesion skin||skin||single-stain section||result,1||1 1 depart||number 1||type 1||2||site 1||psoriat skin 1||refer 1||1 cm||ccr5 inhibitor 3 1||number 2||express||type 1 cytokin||3||skin,0.022||0.015||0.015||0.014||0.013||0.013||0.012||0.012||0.011||0.01||0.01||0.01||0.01||0.01||0.01,0.0,0.0,0.13333333333333333
674,Sleep_Breath-3-1-1794625.txt,satisfact||night||studi||patient||c-flex||cpap||effect||va score||pressur||ahi||treatment||therapi||patient prefer||apap||potenti||standard cpap||sleep||expir||airflow||technician||subject||devic||convent cpap||score||central apnea||central event||prefer||complianc,1||2||2 2||sleep||c-flex 1 fig. 1||3||patient||result 2 2 0. 1||1 3 ryan||question 1||1 outcom||sleep apnea patient||refer 1||springer-verlag 2006 2 2||studi,0.037||0.032||0.032||0.026||0.024||0.024||0.023||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.019,0.2,0.2,0.2
675,Mol_Cell_Biochem-4-1-2226060.txt,growth medium||level||vascular calcif||atherosclerosi||concentr||amlodipin||combin||studi||atorvastatin||calcif||effect||vitro||ascorb acid||ca||vascular smooth muscl cell||vsmc||dexamethason||cell||calcium||day||calcium deposit||calcif medium||prolifer||apoptosi||statin||immunofluoresc imag||incub||cultur||highest concentr||plaqu||vsmc cultur||calcium antagonist||medium||result,2||fig. 2||1||concentr 2||2 concentr||cell||calcif||vsmc 21 2 2||result 1 fig. 1||albinusdreef 2||vascular smooth muscl cell 2||muscl cell||3 4 cell||vsmc calcif||vascular cell,0.027||0.021||0.019||0.018||0.018||0.017||0.017||0.016||0.015||0.014||0.013||0.013||0.013||0.013||0.012,0.0,0.2,0.13333333333333333
676,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-1915621.txt,respons||kcl||olcegep||interest||vehicl||concentr||model||studi||channel||capsaicin||distal coronari arteri||cgrp||relax||concentr respons curv||arteri||bath fluid||porcin||segment||antagonist||human coronari arteri||relax respons,1||1 2 1 2||2||2 2||3 1||1 Î¼M||37 1 1 1||2 3||4 2||1 1 fig. 1 effect||3 3||3||1 mM||1 0||3 4,0.038||0.036||0.034||0.034||0.031||0.029||0.029||0.029||0.028||0.025||0.023||0.023||0.023||0.023||0.022,0.0,0.0,0.0
677,Int_J_Biochem_Cell_Biol-1-5-1906734.txt,cytosol||hsj1||bind surfac||system||vivo assay||substitut||western analysi||data||mutat||conserv qkraa motif||structur||abil||region||domain||loop region||similar||conserv||helix IV||leu||protein||residu||dnaj||bind||bip||iii||interact||basic residu||prj-b vector||function||result,E.||E. coli E. coli genevaux||chimera E. coli E. coli||E. coli E. coli prÃ¶l||1997 E. coli E. coli hennessi||2003 E. coli E. coli genevaux||2002 E. coli E. coli chevali||1996 E. coli E. coli delano||E. coli od259||E. coli huang||E. coli hill||E. coli brodski||1||2000 E. coli hennessi||coli genevaux,0.027||0.024||0.023||0.023||0.021||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.018||0.018||0.018,0.0,0.0,0.0
678,Community_Ment_Health_J-2-2-1705498.txt,level||measur||commun||tradit servic||formal servic||model||substanc abus servic prefer||reserv||effect||SU problem||american indian||mental health||adult||substanc abus||social support||health||higher score||current medic model||research||statement||servic||care||respond||import||cultur||novin||prefer,servic||health servic||health||mental health servic||indian health servic||mental health||health servic provid||health servic system||J. mental health servic||mental health servic util||mental health servic administr||mental health servic improv||mental health servic whitbeck||tradit servic||american indian health,0.03||0.029||0.028||0.024||0.023||0.021||0.02||0.02||0.019||0.019||0.019||0.018||0.018||0.018||0.018,0.4,0.3,0.26666666666666666
679,Breast_Cancer_Res_Treat-3-1-2001216.txt,treatment strategi||letrozol||breast cancer||model||studi||tamoxifen||patient||effect||human||peripher tissu||ai||aminoglutethimid||aromatas||complet inhibit||postmenopaus women||select inhibit||vivo model||estrogen||anastrozol||tumor||random clinic trial||trial||breast||clinic signific||vivo,cancer||breast cancer||breast cancer breast cancer||breast||breast cancer patient breast cancer||breast cancer clin cancer||advanc breast cancer cancer||postmenopaus breast cancer||human breast cancer||breast cancer model||breast cancer risk||mcf-7 breast cancer cell breast cancer||advanc breast cancer||postmenopaus breast cancer model cancer||receptor-posit breast cancer,0.032||0.032||0.032||0.031||0.026||0.026||0.024||0.024||0.023||0.022||0.022||0.022||0.022||0.022||0.021,0.4,0.2,0.13333333333333333
680,Eur_J_Pediatr-4-1-2190787.txt,prematur children||school outcom||problem||data||studi||year||school||norm score||test||development outcom||neurolog||special assist||follow-up programm||motor skill||development domain||standard test||mild||perinat data||problemat follow-up outcom||school perform||development disturb||development follow-up||age||follow-up assess||assess||parent||low birth weight||group||differ||school outcom group||score||children||result,1||problemat development outcom||development outcom||1 year||school outcom normal problemat||2 2||problemat school outcom||normal development score||1 30||1 0||development follow-up||outcom||problemat follow-up outcom||school outcom||school outcom school outcom,0.022||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013,0.2,0.1,0.26666666666666666
681,Diabetologia-3-1-1914300.txt,type 2 diabet||csf||hypercholesterolaemia||white matter lesion||diabet||wml volum||studi||patient||grey matter||effect||leukoaraiosi||volum||total csf volum||sex||smaller volum||magnet reson imag||control particip||intracrani volum||analys||brain||wml||control||women||cerebrospin fluid||age||associ||cerebr tissu||atrophi||white matter||larger wml volum||segment||particip||white matter volum,2||2 diabet||diabet||type 2 diabet||type 2||2 diabet patient||2 volum||type 2 diabet patient||fig. 2||result 1 2 3||1 2 kappel||diabet patient||hypothesi type 2 diabet mellitu||type 2 diabet 1c 1c||diabet subject,0.038||0.033||0.029||0.027||0.027||0.025||0.024||0.022||0.02||0.02||0.019||0.018||0.017||0.017||0.017,0.4,0.2,0.13333333333333333
682,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2206250.txt,suicid bomb||senior surgeon||type||ophthalmologist||ED stay||patient||urgent primari closur||head||lacer||primari repair||eye||open globe||ocular trauma||hospit||terror||attack||ocular injuri||surgeri||emerg facil||medic treatment||injuri||ocular procedur||victim||bomb||primari closur||special attent||surgic procedur||intra-lenticular foreign bodi||mass casualti||surgeon||trauma||vitrectomi,trauma||1||1 1||2||ocular trauma||trauma patient||trauma 2 16||1 mm||trauma surgeri||7||2 mm||trauma center||trauma surgeon||springer-verlag 2008 1 2 3||refer 1,0.025||0.024||0.024||0.022||0.019||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014,0.4,0.2,0.13333333333333333
683,Invest_New_Drugs-3-1-1915607.txt,mass balanc studi||pseudopharmacokinet paramet||faecal excret||administr||plasma||sampl||studi||patient||radioact||termin elimin phase||typic radio-trac studi||recoveri||long half-lif||dose||tra||epothilon||pharmacokinet||ixabepilon||bile duct||metabol||high concentr||auc||acceler mass spectrometri||total volum||drug||mobil phase||total radioact||urin,1||2||2 14||14 14 14||14||patient 1 14 14 1||14 14 14 1 2 blocker||4 5 14 14 2 14||patient 1||result 14 2 fig. 2 14||patient 2||2 3 max tabl 1 14||fig. 3 14||refer 1||patient fig. 5 14,0.031||0.03||0.029||0.029||0.029||0.026||0.025||0.024||0.022||0.021||0.021||0.019||0.018||0.017||0.016,0.0,0.0,0.0
684,Pediatr_Radiol-4-1-2292494.txt,nephrogen system fibrosi||previou gadolinium exposur||time||chronic kidney diseas||nsf||ckd||gadolinium||patient||year||develop||renal dysfunct||proinflammatori condit||dose||day||renal impair||contrast agent||renal transplant||end-stag renal failur||bodi||age||gadolinium-bas contrast agent||kidney failur||gadodiamid exposur||group||report||contrast-enhanc mri||gadodiamid||risk factor||diseas||children,2||2 year||1 year||2007||year||renal patient||patient||1 case||26 2||2 month||nsf 2||2 day||2006||refer 1||18 year,0.018||0.016||0.015||0.014||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.01||0.01||0.01||0.009,0.2,0.2,0.13333333333333333
685,Arch_Orthop_Trauma_Surg-3-1-2111040.txt,time||proxim femor nail||arthroplasti||complic||revis rate||hip screw||multipl regress analysi||total hip replac||studi||year||patient||full weight bear||mortal||risk||comorbid||fractur||primari arthroplasti||outcom||treatment||intern fixat||rel risk||hip||primari||age||treatment group||mortal risk||complic rate||trochanter femor fractur||group||minimum age||influenc||dh||dynam hip screw,1||2||1 year||treatment 1 2||1 refer||refer 1||patient||2 10||mortal 2||24 19 1 fig. 1||2 tabl 3||3||fig. 2||49-69-6705220 f.geiger@friedrichsheim.d 1 2||tabl 1 descript,0.033||0.023||0.021||0.021||0.02||0.02||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.014,0.0,0.1,0.06666666666666667
686,Ann_Hematol-4-1-2324130.txt,gammopathi||follow-up||level||ert||clinic respons||studi||normal rang||patient||mgu||risk||increas||prednison||free light chain||cell||flc||growth factor||gaucher diseas||cohort||protein||age||cytokin||parc||multipl myeloma||rang||decreas||immunoglobulin||serum level||diseas sever||monoclon gammopathi||risk factor||diseas||result,diseas||gaucher diseas||patient||gaucher âs diseas||gaucher||2||1||gaucher âs||4||gaucher diseas type||3||mgu patient||adult gaucher diseas||gaucher diseas Br||gaucher âs diseas scand,0.018||0.016||0.015||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011,0.6,0.3,0.2
687,J_Gastrointest_Surg-3-1-1852388.txt,case||middl pancreatectomi||patient||mortal||neck||risk||exocrin function||benign||exocrin pancreat function||oper||main pancreat duct||long-term endocrin||tumor||distal transect||surgeon||middl segment pancreatectomi||procedur||low-grad malign tumor||segment||gland||median pancreatectomi,1 3||1 6 10 1 3||refer 1||1 6 1 21 32 34||1 3 27 31||patient||2 3 10 12||13 patient||pancreat surgeri||well-select patient||pancreat neck||pancreat fistula||scuro 10||53 patient||older patient,0.04||0.036||0.028||0.025||0.023||0.022||0.018||0.016||0.015||0.014||0.013||0.013||0.013||0.013||0.013,0.0,0.1,0.06666666666666667
688,Purinergic_Signal-3-4-2072915.txt,adenin deriv||affin||adenosin receptor subtyp||adenosin receptor antagonist||adenosin receptor||deriv||result,3||2 3 3||3 1||2||2 2||3 CH 2 3||3 3 receptor||1||3 5||1 2B 3||6 1 3||2 CH 3 CH 2 3||6 3||1 5||5 1,0.063||0.059||0.056||0.051||0.051||0.05||0.049||0.049||0.047||0.046||0.046||0.046||0.044||0.04||0.04,0.0,0.0,0.0
689,Mol_Neurobiol-3-1-2039784.txt,neurotox||cell interact||role||cn injuri||releas||model||studi||patholog condit||central nervou system||effect||vitro||synapt transmiss||abil||cn||electrophysiolog properti||receptor||astrocyt||express||cell||brain||microglia||protein||neuron||death||neuroprotect activ||injuri||activ||report||cell function||cultur||interact||cn cell||pathway||chemokin||chemokin express,chemokin||neuron chemokin||chemokin express||chemokin receptor||cell||neuron chemokin express||neuron cell||chemokin receptor express||neuron||neuron express||chemokin stromal cell||function chemokin receptor||cxcr4 chemokin||neuron chemokin co-receptor express||chemokin receptor cxcr4,0.028||0.023||0.022||0.021||0.021||0.021||0.02||0.019||0.019||0.017||0.017||0.016||0.016||0.016||0.016,0.6,0.4,0.26666666666666666
690,J_Struct_Funct_Genomics-3-1-1769342.txt,interfac||genom sequenc||time||figur||databas||year||structur||region||domain||domain interfac||structur genom||amino acid sequenc||famsbas||hydrophob||orf||homolog model||genom||surfac||famili||sequenc ident||solubl protein||templat||number||p-loop||eukaryot protein||function,2||1||2003||2005 2005 2003||2004 2005 2003 2004 2004 2005||2004||2000||protein||protein structur||model structur 2003||structur||2000 2002||5||protein 3D structur||model structur,0.025||0.022||0.022||0.02||0.02||0.019||0.018||0.018||0.017||0.016||0.016||0.016||0.015||0.014||0.013,0.0,0.0,0.06666666666666667
691,Diabetologia-3-1-1914292.txt,ccn famili member||diabet retina||diabet||connect tissu growth factor||protein level||studi||advanc glycat end product||increas||streptozotocin-induc diabet||extracellular matrix||aminoguanidin treatment||express||aminoguanidin||rat||retina||ctgf||ace inhibit||gene express regul||mice||protein||diabet milieu||age||cystein-rich protein 61||microvascular basement membran||famili||differ||extracellular matrix compon||ccn famili||mrna||diabet retinopathi||mrna level,diabet||1||2||3 2||diabet rat 1 fig. 1||3||r.schlingemann@amc.uva.nl 1 1||diabet rat||diabet retina||diabet retinopathi||group 1||diabet nephropathi||growth||ctgf||refer 1,0.02||0.019||0.017||0.016||0.015||0.014||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011,0.2,0.3,0.26666666666666666
692,Histochem_Cell_Biol-4-1-2323030.txt,mechan||antibodi||cancer||role||target||ligand bind||concentr||intern||studi||endosom||year||erbb||cbl||review||complex||receptor||degrad||evid||epiderm growth factor receptor||cell||endosom sort||lysosom degrad||protein||activ||bind||import||ubiquitin||caveola||egfr||pathway||anti-canc therapi||plasma membran||ligand||erbb2||endocytosi,receptor||cell||cancer cell||erbb receptor||2007 2007 2007 2006 2006||receptor ubiquitin||receptor activ||activ receptor||receptor degrad||2004 2003 2004||growth factor receptor||2004||receptor downregul||2005 2004 2004 2005 2005||egf receptor,0.03||0.026||0.021||0.019||0.018||0.018||0.018||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.017,0.4,0.2,0.13333333333333333
693,Eur_J_Epidemiol-3-1-2071965.txt,discharg||doubl count||hospit mortal||time||case||men||data||studi||patient||admiss||recurr case||mortal||epidemiolog||linkag||acut myocardi infarct||hospit regist||recurr event||event||regist||cohort||ratio||hospit||hospit morbid data||trend||declin||postal code||gender||incid||differ||date||hospit admiss||nation hospit discharg regist||ami||result,1||2||30 2 1 1||1 1 0||hospit||hospit regist||regist hospit regist||2 1 0||1 incid||regist||2 hospit mortal||1 year||4||refer 1||hospit regist 7,0.028||0.024||0.022||0.021||0.021||0.02||0.02||0.02||0.019||0.019||0.018||0.017||0.015||0.015||0.015,0.2,0.3,0.2
694,Eur_Child_Adolesc_Psychiatry-2-2-1705537.txt,attent||fwit||tmt||indic||schizophren patient||interfer task||patient||studi||cognit flexibl||young person||select||first-degre rel||effect||risk||correl||rel||test||correct||cognit function||cognit impair||variabl||control||execut function||cognit adjust||genet risk||task||analysi||correct trial||genet vulner||subject||genet influenc||group||differ||proband||sibl||perform||impair||wcst||speed||schizophrenia||score||gener alert||children||result,1||3||2||school 1 1||psychiatri||3 4||secondari school 3 1||3 13||cognit||risk||refer 1||1998 30 1 1 9 10.1016||3 comparison||section 3||2000 46 2,0.018||0.017||0.016||0.014||0.013||0.012||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.009,0.0,0.1,0.06666666666666667
695,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2206251.txt,delay||time||case||tertiari care eye hospit||studi||endophthalm||patient||visual loss||remov||nlp||risk||clinic evid||antibiot||treatment||repair||eye||foreign bodi||vision||visual outcom||ocular trauma||iofb||age||associ||final VA||ocular injuri||king khale eye specialist hospit||injuri||factor||eye trauma||risk factor||visual acuiti||decad||trauma||vitrectomi,eye||1 1||2 eye||2 3||4 1||5 eye||result 1 2 1||6 eye||21 eye||20 eye||10 eye||eye trauma||17 eye||eye injuri||11 eye,0.039||0.038||0.035||0.029||0.029||0.028||0.028||0.024||0.024||0.023||0.023||0.023||0.023||0.023||0.023,0.2,0.1,0.13333333333333333
696,J_Biol_Inorg_Chem-3-1-1915633.txt,crystal||ecftna||data||channel||outer entranc||chain ferritin||structur||electron-dens map||Fe atom||site||fourfold channel||side-chain atom||huhf||iron||similar||main-chain||glu||high number||protein||residu||bfr||phase||side chain||ferroxidas center||FC epr signal||monom||refin||afftn||hyperthermophil microorgan||ferritin||hydrogen bond||crystal structur||factor||pfftn||symmetri||result,2||1 2||1||afftn 2||2 month||2 2 2 P. furiosu escherichia||6 9 2 3 2||vol 2||4 2 fig. 4||30 1 fig. 1||FC 1||7 7 7 2 1||refer 1||1 day||351-21-4463644 matias@itqb.unl.pt 2 1 depart,0.03||0.027||0.024||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.014||0.013||0.013||0.013||0.011,0.0,0.0,0.0
697,Osteoporos_Int-4-1-2267483.txt,follow-up||poorer complianc||categori||bisphosphon therapi||bisphosphon||data||interv||patient||year||mpr||risk||treatment benefit||medic||user||fractur||low complianc||osteoporot fractur||studi period||women||treatment complianc||analysi||pharmo-rl||osteoporosi||hormon replac therapi||drug||maxim treatment benefit||femal user||complianc||result,1||2||1 fig. 1 complianc||fractur||patient||result 1||refer 1||treatment fractur patient||studi patient||fractur risk||2 time||2 fig. 2 half||1 januari 1999||osteoporot fractur||1 gener characterist,0.031||0.021||0.02||0.019||0.018||0.018||0.017||0.015||0.015||0.013||0.013||0.013||0.013||0.012||0.012,0.4,0.2,0.2
698,J_Gastrointest_Surg-3-1-1852373.txt,cohort||surviv||tumor||node||nodal involv||number||dismal prognosi||studi||lymph node||analysi||patient||impact||lymphadenectomi||patholog stage||stage||outcom,1||1 2||0 0 1||node 1 1 2||0 0 0||0||0 0 0 0 0 0||0 0||0 0 0 0 2||0 0 2||0 2||0.001 1||0.001 1 2||2||stage 4 0 0 1,0.038||0.03||0.028||0.028||0.024||0.024||0.024||0.024||0.024||0.024||0.023||0.023||0.023||0.023||0.022,0.0,0.0,0.0
699,Planta-4-1-2270913.txt,report||SA treatment||author||defens||final extens||induct||pathogen||salicyl acid||promot||element||luc||region iii||ethephon||rice||salicyl acid induct||activ||gfp||plant,ospr10a||ospr10a promot ospr10a ospr10a||ospr10a ospr10a promot||ospr10a ci ospr10a promot||ospr10a promot||plant||result ospr10a||1||ospr10a http://www.dna.affrc.go.jp/cdna/plac||ospr10a osactin||ospr10a cis-bold||ospr10a Os materi||rt-pcr analysi 16 ospr10a ospr10a||plant gene||promoter-luc construct ospr10a ospr10a pr10a Os,0.06||0.047||0.043||0.037||0.035||0.035||0.032||0.031||0.031||0.03||0.03||0.028||0.026||0.025||0.024,0.0,0.1,0.06666666666666667
700,World_J_Urol-4-1-2413091.txt,independ predictor||follow-up||diamet||median||studi||patient||median follow-up||mtd||patholog stage||risk||tumor volum||total TV||correl||independ prognost factor||short follow-up||high risk||total||largest diamet||index TV||largest tumor||signific||maximum tumor diamet||month||bcr||prostat||prognost factor||tumor||gleason score||psa failur||high-risk group,1||2 1||2||3||3 3||result 1||refer 1||A. 3 1 depart||1 301 22.3 22.0 1||springer-verlag 2008 introduct 1 2 3||1 241 27.3 26.0 1||A. 1 kok||patient||4||3 11,0.042||0.034||0.025||0.025||0.025||0.023||0.022||0.019||0.018||0.018||0.018||0.016||0.015||0.015||0.015,0.0,0.0,0.06666666666666667
701,Ann_Hematol-4-1-2275303.txt,md||risk||order||myelodysplast syndrom||lenalidomid||respons||time||drug||recommend||panel||abnorm||clinic trial||vte||nhae||diseas||patient||neutropenia||treatment||advers event||therapi,5 5||1 3||8 8 8 8||8||1 2||1 2 3||3||8 9||2||md 8 9 8||5 recommend||8 10||hematolog 8 9 9||1 intern||patient,0.025||0.023||0.022||0.022||0.022||0.022||0.021||0.018||0.018||0.016||0.016||0.016||0.015||0.015||0.014,0.0,0.0,0.06666666666666667
702,Mol_Immunol-1-5-2080686.txt,igg||level||Tg||sle||increas||light chain||endogen light chain||mice||genet background||activ||FO||ab||model||autoab||MZ||cell||margin zone,1||fig. 1||tabl 1||fig. 2||tabl 1 fig. 3||fig. 3||2||cell||3||1 Li||tabl 1 splenic||l.fossati@imperial.ac.uk 1||4 discuss||apoptot cell||cell express,0.023||0.021||0.018||0.018||0.017||0.017||0.016||0.015||0.014||0.013||0.012||0.012||0.01||0.01||0.01,0.0,0.1,0.06666666666666667
703,Appl_Microbiol_Biotechnol-4-1-2279157.txt,imag analysi||method||time||larg number||imag||gel||sampl||data||valu||larg amount||express level||quantiti||express profil||test||background||statist||proteom map||pattern||label||calibr||approach||techniqu||protein||analysi||experi||biolog system||biolog interpret||spot||intens||imag process method||differ||show||express analysi||statist method||softwar||statist test||step||detect||vivo||result,spot||gel spot||gel||electrophoresi||gel imag||protein spot||imag||protein||1||gel analysi||proteom||electrophoresi analysi||two-dimension electrophoresi gel imag||two-dimension gel electrophoresi||two-dimension electrophoresi gel,0.016||0.016||0.016||0.016||0.015||0.015||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.013,0.4,0.4,0.26666666666666666
704,Doc_Ophthalmol-3-1-1896293.txt,clinic perg record||measur||frame rate||respons||amplitud measur||time||amplif system||baselin||patient||lumin||stimulu||electrod||frequenc||pattern electroretinogram||amplitud||clinic electrophysiolog||macula||surfac electrod||perg||perg record||ground||peak time||standard||steady-st perg||compon||transient perg||tempor frequenc||field||refer||checkerboard||implicit time||small signal||waveform||equip||peak||activ electrod||techniqu,perg||1||1 2||2||standard perg||perg record||2007||transient perg 1 fig. 1||perg amplitud||field perg||perg measur||normal perg||standard clinic perg||electrod||clinic perg record,0.03||0.029||0.027||0.025||0.021||0.021||0.019||0.019||0.018||0.018||0.018||0.018||0.017||0.017||0.017,0.2,0.2,0.26666666666666666
705,J_Autism_Dev_Disord-4-1-2268726.txt,wai iii factor scale||asperg syndrom||wais-iii||level||piq||process speed||problem||studi||hfa group||inform||intellig profil||adult||comprehens||subtest||subtest level||group||differ||hfa||wais-iii profil||perform||diagnost group||speed||peopl||factor scale,1||2||tabl 4||tabl 6||3||1 characterist||studi||subject 1||tabl 2 viq||1 2.3||4||6||2 1 ggz eindhoven||development disord||autist disord,0.024||0.019||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.0,0.1,0.06666666666666667
706,Pediatr_Nephrol-3-1-1766479.txt,administr||sever side effect||noncompli||concentr||studi||adult patient||increas||guidelin||pediatr periton dialysi patient||iron||adult||erythropoietin||treatment||carnitin supplement||dosag||anemia||iron prepar||carnitin||report||periton dialysi||drug||children,2||1||ipna 2003 1 2 3||iron 2 evid opinion||250 2||600 2||2 month 100||suppl 1||100 1||month||opinion||refer 1||2001||suppl 3||200 1 month 200,0.034||0.028||0.02||0.018||0.018||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.014||0.014||0.014,0.0,0.0,0.0
707,Plant_Mol_Biol-4-1-2295253.txt,seed||role||aba insensit||stratif||arrest||germin||studi||seed germin||develop||glucose-arrest seedl||treatment||day||gene||control||sugar||result||analysi||experi||compon||import||abscis acid||mutant||similar time window||phenotyp||seedl develop||media||aba,abi3||plant||abi3 abi5||1||abi4 plant||1 gin||abi3 gene||abi4 abi5 rab18 abi3 abi3||gin||2001 abi3 abi5||3 abi3||abi5 plant||gin abi4||er abi3||plant cell,0.03||0.024||0.022||0.021||0.02||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.017,0.0,0.0,0.0
708,Matern_Child_Health_J-2-2-1592249.txt,time||knowledg||pregnanc||data||studi||patient||risk||inform||deliveri||famili medicin practic||annual exam||preconcept care||vast major||women||annual well-woman exam||preconcept health||popul||import||primari care practic||risk factor||survey||preconcept healthcar||physician||primari care,1||result 1 2 2 1||3 1||2 9||fig. 1||refer 1||health||type 1 diabet||2 year 13.5||patient||preconcept health||health care||3||2006||45 year,0.049||0.034||0.034||0.027||0.027||0.027||0.022||0.022||0.021||0.02||0.019||0.018||0.018||0.017||0.017,0.0,0.1,0.13333333333333333
709,Anal_Bioanal_Chem-3-1-1839866.txt,signal enhanc||method||seira||immobil||gold||function studi||studi||metal||electrod||enhanc||potenti||properti||approach||protein||acid||surfac||metal electrod||substrat||interact||self-assembl monolay||film||enhanc factor||membran||techniqu,1||1 2 3||1 2 2 3||2||1 2 4||1 4||1 min||substrat 2 2 2||refer 1||1 2 11 12 13||1 4 Cl||6 12 1 3 5||2006||protein||phi chem,0.037||0.026||0.026||0.025||0.025||0.024||0.021||0.02||0.02||0.017||0.017||0.015||0.015||0.014||0.014,0.0,0.0,0.06666666666666667
710,Biotechnol_Lett-4-1-2248218.txt,bioactiv||recombin protein||exendin-4||protein determin protein||express||purif||min||vivo||result,1||1 2 fig. 2||protein||fusion protein 1||type 2 diabet||3||P. pastori||detect 1 fig. 1||3 fig. 3||summari P. pastori P. pastori||1 summari||fusion protein||protein determin protein||min||P.,0.034||0.032||0.026||0.024||0.024||0.023||0.023||0.023||0.022||0.019||0.019||0.018||0.018||0.018||0.017,0.0,0.0,0.13333333333333333
711,Arch_Orthop_Trauma_Surg-4-1-2413128.txt,calcaneu||report||conserv treatment||subtalar arthrodesi||case||subtalar joint||bone graft||complic||pain||nonunion||month||calcan nonunion||fractur||patient||pseudarthrosi||trauma,1 5 6 4 2 1||6||refer 1||1 summari||3||patient||nonunion 1 year||bone graft 2 6||subtalar arthrodesi 6||6 month||case||subtalar arthrodesi 3||subtalar||subtalar arthrodesi||bone graft 8 12,0.036||0.034||0.031||0.031||0.026||0.025||0.024||0.024||0.024||0.023||0.022||0.021||0.02||0.019||0.019,0.0,0.1,0.2
712,Curr_Eye_Res-1-1-2430176.txt,visual prognosi||venou thrombosi||laser treatment||case||follow-up period||macular thick||studi||patient||effect||pathogenesi||neovascular||brvo||improv||sheathotomi||signific||ilm||macula||treatment||eye||abnorm hematolog factor||blood||branch retin vein occlus||occlus||hemodilut||month||final VA||small sampl size||group||grid laser photocoagul||random clinic trial||laser photocoagul||risk factor||inject||visual acuiti||short follow-up period||initi VA||hematolog disord||diseas||initi,eye||2 eye||1 eye||studi eye||3 eye||4 eye||6 eye||12 eye||5 eye||20 eye||10 eye||7 eye||21 eye||16 eye||8 eye,0.028||0.021||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016,0.2,0.1,0.06666666666666667
713,Photosynth_Res-3-1-1769343.txt,absorpt spectra||band||structur||chl||reconstitut||fluoresc excit||complex||protein||pcp||nativ pcp||room temperatur||peridinin||molecular detail||energi transfer||high effici||energi transfer effici||spectroscop studi||chlorophyl||spectra||fluoresc excit spectra,1||1 2||2||5 1||ic2 2 1||line 2 1||et1 2 1||ic1 2 1 1 0||line 2 1 1 0||1 2005||2 4||fig. 2||1 530||1 546||R1 1,0.045||0.041||0.037||0.028||0.028||0.028||0.028||0.027||0.027||0.027||0.024||0.024||0.024||0.024||0.024,0.0,0.0,0.0
714,Ann_Hematol-3-1-2040174.txt,follow-up||refractori itp||time||week||respons||long-term complic||studi||patient||rituximab||chronic||rituximab therapi||platelet||immun thrombocytopen purpura||dose||itp||treatment||cell||median time||month||chronic itp||rang||splenectomi||diseas||result,2||9 9 9 9||9 9||9||8 9 2||fig. 2 9||respons 1||result 1 9||2 1 6 18||2 studi||2 month||1 year||4||4 8 9 3 15 9||refer 1,0.027||0.025||0.025||0.025||0.022||0.021||0.02||0.02||0.019||0.018||0.018||0.018||0.017||0.017||0.017,0.0,0.0,0.0
715,Eur_J_Clin_Pharmacol-3-1-1779627.txt,categori||system antibiot||respons||questionnair||alspac||databas||data||studi||medicin product||medic||avon longitudin studi||antibiot||cohort||health||product||age||babi||parent||tick box respons option||paracetamol||medicin||number||drug||children,1||1 2||1 4||0||1 9||2||1 17||1 0 treatment||214 0 1||1 39||result 1||refer 1||1 64||1 170||2 month,0.029||0.024||0.019||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014,0.0,0.0,0.0
716,Qual_Life_Res-4-1-2238779.txt,follow-up||measur||respons||time||gener health statu measur||clinic condit||studi||patient||similar symptom||health statu||kccq score||empir evid||heart failur||nyha||clinic trial||valid||analys||similar clinic manifest||assess||intern consist||anemia||kccq||clinic chang||symptom||psychometr properti||statu||reliabl||disease-specif measur||baselin assess||diseas||follow-up interview,2||heart||heart failur||heart failur journal||heart failur patient journal||patient||3||fig. 2||heart failur popul||part 2||chronic heart failur||heart failur questionnair||A. identifi heart failur patient||congest heart failur||advanc heart failur,0.025||0.021||0.021||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014,0.2,0.2,0.13333333333333333
717,Cancer_Metastasis_Rev-4-1-2362138.txt,mef||dna damag||cancer||role||target||level||respons||oncogen||depend||target protein||wip1||intrins activ||phosphatas||effect||dna damag respons||tumor suppressor||increas||dephosphoryl||compound||overexpress||cell||phosphoryl||major compon||apoptosi||mice||ppm1d||atm||p53||activ||human cancer||tumor||import||homeostat regul||cancer cell line||amplif||function||result,wip1||49 wip1 wip1 wip1 wip1 wip1||wip1 wip1 wip1 71 wip1||wip1 phosphatas||human wip1||12 wip1||wip1 gene||E. wip1||wip1 journal||wip1 pathway||wip1 target||overexpress wip1||wip1 overexpress||wip1 dephosphoryl||wip1 express,0.035||0.03||0.029||0.024||0.021||0.021||0.02||0.02||0.019||0.019||0.019||0.019||0.019||0.019||0.019,0.2,0.1,0.06666666666666667
718,Skeletal_Radiol-4-1-2226078.txt,cancer||nsaid||method||week||complic||spinal metastas||ideal treatment||tumour ablat||combin||studi||patient||electrod||CT guidanc||effect||ablat||opioid||metastas||lesion||pain relief||treatment||cancer patient||net ablat time||pain interfer||local anaesthesia||bpi score||pain||deploy||radiopharmaceut therapi||radiat therapi||radiofrequ ablat||bone metastas||procedur||osseou metastas,1||1 3||3||1 3 5||1 tibia 1||3 patient||2 3 4 fig. 1||1 week||2||34 1||3 week||1 cm||4||method 1||fig. 3,0.043||0.039||0.036||0.032||0.029||0.028||0.027||0.026||0.025||0.024||0.023||0.023||0.023||0.023||0.022,0.0,0.0,0.0
719,Mol_Genet_Metab-2-1-2279742.txt,find||dmso||nativ gel||data||mutat||state||chemic chaperon rescu||amount||rescu||effect||catalyt domain||increas||amino acid||chaperon||compound||osmolyt||mixtur||tmao||growth||yeast||homocystinuria||enzym||protein||enzym activ||mutant cb protein||glycerol||activ||chemic chaperon||tetram||mutant||diseas||addit||missens mutat||cb||media||result,1||chaperon||fig. 2||fig. 3 fig. 2||fig. 4||chaperon set 1||chemic chaperon||2||fig. 4 chemic chaperon effect||chaperon effect||3||fig. 5||chaperon set 2||4||chaperon set 3,0.017||0.016||0.015||0.015||0.015||0.013||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.2,0.2,0.13333333333333333
720,J_Med_Internet_Res-2-2-1761853.txt,health||ethic||product||health inform||care||servic||peopl||internet,health||1||health care||2000||health care provid||health internet||health inform||patient||health servic||2003 1||onlin health care||educ patient||health care profession||care||feb 2,0.033||0.033||0.026||0.026||0.023||0.022||0.022||0.022||0.021||0.021||0.021||0.02||0.02||0.02||0.019,0.2,0.2,0.2
721,Anal_Bioanal_Chem-3-1-1764596.txt,author||molecular fragment||method||instrument||injector||higher bromin congen||hrm||studi||review||sensit||on-column inject||pbde||octabd congen||increas||compound||degrad||detector||polybromin diphenyl ether||temperatur||analyt||environment sampl||human sampl||bromin flame retard||HR instrument||instrument method||analyt techniqu||ptv injector||paper||higher bromin compound||analysi||column||standard||mass resolut||min||isobutan||congen||work||molecular weight||inject||inject techniqu||commerci standard||multipl inject||result,1||2||2006||2005||1 pbde 25||5||springer-verlag 2006 introduct 1 2||refer 1||25 1 25||2004||2 Î¼l||pbde||environ sci technol 33:26||4||method,0.02||0.017||0.013||0.012||0.011||0.011||0.011||0.011||0.01||0.01||0.009||0.009||0.008||0.008||0.008,0.0,0.0,0.13333333333333333
722,Purinergic_Signal-3-4-2072917.txt,time||concentr||protect effect||experiment condit||effect||caspase-3||guanosin||treatment||cell||mpp||dna fragment||apoptosi||cell death||protein||dopaminerg neuron||activ||bind||cell surviv||molecular mechan||addit||result,1||cell||1 fig. 1||post-treat 1||3 6 1||3||protein||cell death||2||2 2||neuroblastoma cell||cell surviv||kinas 1||4||4 4,0.02||0.019||0.015||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.011,0.2,0.3,0.26666666666666666
723,Clin_Rheumatol-4-1-2367388.txt,rheumatoid arthriti||non-signific increas||studi||patient||clinic characterist||open pilot studi||effect||da||marker||intervent||benefici effect||antioxid intervent||treatment||blood||antioxid||oxid stress||stabl non-steroid anti-inflammatori drug||diseas activ score||clinic symptom||number||clinic paramet||step||period,1 2 fig. 1 clinic condit||studi||antioxid||2 dijkman||4||C. 1 1 depart||pilot studi||refer 1||diseas activ score fig. 2||netherland 2 depart||patient 4 fig. 4 marker||2003 2 5 10.1186||patient||open studi||intervent studi,0.028||0.026||0.025||0.023||0.023||0.021||0.02||0.02||0.019||0.018||0.018||0.018||0.017||0.017||0.017,0.4,0.2,0.2
724,Ann_Surg_Oncol-3-1-1914254.txt,cancer||univers hospit||expertis||oper procedur||center||studi||year||patient||univers||hospit volum||effect||mortal||esophag cancer||select referr||outcom||treatment||oper mortal||hospit||data collect||surgeri||death||surviv||tumor||esophag carcinoma||esophag resect||surgeon||diagnosi||referr||stage||region cancer registri,hospit||2 hospit||cancer||3 hospit||1||2||9 hospit||univers hospit||esophag cancer||2002 hospit||esophag cancer patient||10 hospit||7 hospit||hospit outcom||nonteach hospit,0.028||0.024||0.023||0.021||0.021||0.02||0.019||0.018||0.018||0.018||0.017||0.016||0.016||0.016||0.016,0.4,0.4,0.26666666666666666
725,Eur_J_Clin_Pharmacol-4-1-2235908.txt,curriculum||medic student||skill||knowledg||practic||core||patient||valid inform||inform||process||nierenberg||clinic practic||lectur||analyt reason||context-learn||undergradu medic curriculum||treatment||consult||essenti skill||educ||term||approach||effect approach||diagnost reason||script||experi||clinic clerkship||therapeut||teach||reason||current theori||clinic pharmacolog||import||undergradu student||pharmacotherapi||compet||student||drug||diseas||futur doctor||object||undergradu teach,1||1 18||1 24 fig. 1 24||refer 1||suppl 1||clinic pharmacolog||box 1||2||patient||medic student||compet 4 1||practic 1 fig. 3||clinic practic||medic educ||clinic skill,0.03||0.018||0.017||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.0,0.3,0.26666666666666666
726,Behav_Genet-3-1-2039802.txt,variat||origin||complex phenotyp||epigenet background||rat model||apo-su||epigenet factor||apomorphin suscept||low gnaw score||ap-pcr product||complex disord||topoisomeras II bind site||dna||unsu rat genom||rat||product||hippocampu||genet||wistar rat||unsu genom||genom||differ||high gnaw score||locu||epigenet variat||ap-pcr analysi||thalamu,2 2||rsa hpa||aph-1b aph-1b aph-1b aph-1b gene||aph-1b aph-1b 2005 2002||aph-1b aph-1b gene||aph-1b aph-1b copi||genet||rat||1||rat model aph-1b||wistar rat aph-1b||fig. 3||2005||aph-1b express||apo-unsu rat genom rsa hpa 3,0.025||0.023||0.022||0.021||0.019||0.018||0.017||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.014,0.0,0.2,0.13333333333333333
727,Neuroradiology-3-1-2151779.txt,aneurysm||intracrani aneurysm||hour||time||logist regress analysi||diagnost angiograph run||procedur time||vessel||support devic||logist||anterior cerebr arteri||procedur||predictor||angiograph run||devic||patient||occurr||coil||min,1||1 procedur time||procedur||2 1 depart||result 1 fig. 1 procedur time||refer 1||procedur time||aneurysm procedur time||patient||coil procedur||aneurysm||15-min time period 1 2||6||time||procedur ruptur,0.044||0.028||0.025||0.025||0.023||0.023||0.02||0.019||0.018||0.017||0.017||0.017||0.016||0.015||0.015,0.2,0.3,0.3333333333333333
728,Appl_Microbiol_Biotechnol-4-1-2271084.txt,rel abund||concentr||methanogen popul||acetogen bacteria||studi||sulfat ratio||reactor||srb||probe||dgge||anaerob commun||methanogen||propion||divers||ratio||fish||oligonucleotid probe||complet oxid||sulfat||acet||activ||methanogen archaea||lactat||effluent||total bacteria||mix anaerob commun||acetogen||domin microbi commun||sulfate-reduc bacteria||percentag abund||bacteria||microbi commun||result,2||2 2||2 2 2||1 2 2||2 2 2 5||1 2||1 2 2 D.||1||1 1||2 1986 2 2 2002 2005||fig. 2 2 strip||5 2 D.||1 5||2 stoichiometri||128.5 2,0.042||0.042||0.042||0.036||0.035||0.034||0.029||0.026||0.026||0.023||0.023||0.022||0.021||0.021||0.021,0.0,0.0,0.0
729,Matern_Child_Health_J-2-2-1592142.txt,consumpt||awar||knowledg||birth||pregnanc||year||folic acid||vitamin supplement||increas||folic acid daili||fortif||recommend||dietari supplement||educ||ntd||women||age||folic acid consumpt||health care provid||number||survey||supplement||birth defect,1||2||acid||7||folic acid||3||folic||u.s. depart||health||folic acid daili||refer 1||result 1||folic acid awar||folic acid supplement||age,0.023||0.021||0.021||0.019||0.018||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013,0.2,0.2,0.2
730,Exp_Brain_Res-3-1-2048826.txt,condit||surfac orient||author||cue||surfac slant||slant trapezoid||data||studi||stimulu||orient||depth cue||percept||slant||altern||depth||depth percept||vergenc||perspect||slant rectangl||signal||present studi||eye||saccad||monocular arrow||slant rivalri stimulu||dispar||ambigu||conclus||display||direct||onset||surfac||ambigu stimulu||influenc||perceptu condit||trial||hypothesi||show||result,1||1 2||2||stimuli 2 fig. 2||2003 2003 1||3||experi 1||5||vergenc||experi 2||1 fig. 1 wheatston stereoscop||stimulu 3 fig. 3||2007||1 knapen||experi 1 show,0.028||0.027||0.025||0.018||0.017||0.017||0.017||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014,0.0,0.1,0.06666666666666667
731,Int_J_Biol_Sci-3-3-1802012.txt,transcriptom||broad-coverag array||author||respons||method||microarray||databas||data||gene express||inform||review||serial analysi||increas||filament conceptu||abil||express||porcin sequenc||cell type||cell||infect||gene||pig gene express||est||annot||pig||porcin tissu||transcript||paper||tissu||protein||immun||analysi||qpcr||bioinformat||group||report||differ||snp||number||porcin||pathway||unpublish project||sequenc||librari||result,gene||gene express||express||1||1 1||2||2 2 2 2||2 2||pig gene express||gene express data||differenti gene express||gene express analysi||immunolog gene express||porcin gene express data||gene express pattern,0.023||0.023||0.023||0.021||0.021||0.019||0.019||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016,0.6,0.4,0.26666666666666666
732,Mech_Dev-2-1-2428104.txt,embryo||shh||breakpoint||region||human disord||site||pattern||express||dna||gene||delet||mice||ihh||limb||mous chromosom 1||anterior||mutant||polydactyli||limb bud||sequenc||posterior||result,dbf||dbf dbf||ihh dbf||ihh ihh dbf||fig. 3 ihh dbf||fig. 2 dbf||shh dbf||2.6 dbf ihh dbf ihh dbf||shh ihh dbf||ihh shh ihh ihh dbf||fig. 3||ihh fig. 3||ihh||fig. 1 gli3 fig. 1 dbf||fig. 5 dbf,0.04||0.04||0.034||0.032||0.031||0.031||0.03||0.029||0.029||0.029||0.029||0.029||0.029||0.028||0.028,0.0,0.0,0.06666666666666667
733,Qual_Life_Res-4-1-2238788.txt,futur||questionnair||satisfact||control group||experiment condit||data||studi||patient||liver transplant||effect||inform||chronic liver diseas||clinic practic||mental hrqol||cld||consult||univari analys||control||chronic diseas||hepatolog||age||gener practic||experiment group||implement||group||hrqol measur||differ||checklist||computer measur||physician||diseas||experiment||score||hrqol||gener popul||result,1||2 1 2 2||2||1 fig. 1||3 4 1 1 2||patient||1 differ||patient hrqol||1 year||refer 1||fig. 2 patient||liver patient||1 2 darlington anne-sophi||2 characterist||hrqol,0.03||0.026||0.024||0.021||0.021||0.02||0.017||0.017||0.017||0.016||0.016||0.015||0.014||0.014||0.014,0.0,0.1,0.13333333333333333
734,Eur_J_Epidemiol-3-1-2071968.txt,signific risk factor||case||socioeconom statu||independ variabl||data||model||studi||year||patient||water||inform||variabl||proport||sourc||signific||impact||agricultur||cryptosporidiosi||analysi||popul||associ||water suppli||postcod||water treatment||ill||speci||result,C.||cryptosporidium C. homini C. parvum C.||C. parvum cryptosporidium cryptosporidium C. parvum||C. homini C. parvum||C. parvum C. homini||cryptosporidium C. homini C. parvum||C. homini||cryptosporidium||3 C. parvum C.||cryptosporidium parvum||background C. homini C.||6 2 C.||2||result cryptosporidium 1 cryptosporidium||1,0.044||0.035||0.034||0.034||0.034||0.033||0.032||0.032||0.031||0.029||0.027||0.024||0.021||0.021||0.019,0.0,0.0,0.0
735,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2413124.txt,case||ppv||complic||studi||endophthalm||patient||pdr||anti-glaucoma eye drop||retin detach||event||prolif vitreoretinopathi||eye||advers event||final examin||hospit||intra-op complic||analysi||incid||convent ppv group||surgeri||intravitr TA inject||group||factor||differ||order||retin break||sampl size||signific differ||visual acuiti||diseas||diagnosi||addit surgeri,1||3||1 year||1 month||3 tabl 3||tabl 1 diseas||refer 1||1 week||studi||2||eye 1 fig. 1 TA ppv||2 tabl 2 factor||3 month||2 13 13||5,0.032||0.02||0.02||0.017||0.017||0.017||0.017||0.016||0.015||0.014||0.014||0.012||0.012||0.011||0.011,0.0,0.1,0.06666666666666667
736,J_Fluoresc-3-1-2064943.txt,short-liv unwrap state||data||time resolut||valu||blink||process||bulk experi||excit||total||acceptor||event||dna||label||intact nucleosom||dynam||fret pair||nucleosom||fluoresc intens||fret||immobil nucleosom||fret effici||lifetim||experi||fluorophor||spfret measur||trace||fluoresc||subpopul||nois||averag fret effici||donor,2||1||2 2 14 2 2||3||mononucleosom 2 2 16 fig. 2||1 12||nucleosom 3 3 fig. 3||0 2 4||13 2||0 fig. 1||2 set||dot line 2 1||refer 1||2 logi||3 4 5,0.03||0.03||0.025||0.02||0.018||0.018||0.018||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.015,0.0,0.0,0.0
737,Pediatr_Radiol-4-1-2292492.txt,delay||tumor||neuroendocrin tumor||present||function imag||carcinoid||pancrea||carcinoid crisi||children||anatom||imag||diseas||diagnosi||patient||imag find||detect||gep-net,1||imag||tumor||pediatr||net||hepat net 1||refer 1||1 cm||function imag||2 year||imag featur||neuroendocrin tumor||anatom imag||springer-verlag 2008 introduct 1 2||pulmonari net tumor,0.03||0.026||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014,0.4,0.3,0.26666666666666666
738,J_Gastrointest_Surg-3-1-1852387.txt,anim||inflammatori tissu infiltr||method||veloc||endothelium interact||model||studi||platelet||intravit microscopi||mild||sever AP||mild AP||microcircul||inflammatori respons||leukocyt||activ||perfus failur||platelet function||thromboxan||platelet activ||sever||acut pancreat||pancrea||tissu damag||inflammatori cell||function||result,1||2 2 1 2 1 2||1 9||1 werner jen 1 1 depart||histopatholog 1||refer 1||2 result||1 serum paramet||figur 2||pancreat||2 cycl||mild acut pancreat figur 1||platelet||3||acut pancreat,0.042||0.033||0.026||0.023||0.023||0.022||0.018||0.018||0.016||0.016||0.015||0.015||0.015||0.013||0.012,0.0,0.0,0.13333333333333333
739,J_Mol_Biol-1-5-2291452.txt,role||parent protein||depend||core||side-chain dynam||mutat||tnfn3||stabil||region||domain||exchang||dynam||fold||properti||protein||residu||chimer protein||parent||strand||backbon||loop||surfac||rate constant||fnfn10||fnotnc||fniii||intermedi,1||fig. 2 fig. 2||fig. 2||2||tabl 1||fig. 4||2 fig. 6||protein||supplementari tabl 1||fig. 5||supplementari tabl 2||fig. 7||fnotnc fig. 4 fig. 4||fig. 6||2 1 15 22,0.031||0.031||0.031||0.028||0.023||0.023||0.022||0.022||0.022||0.021||0.021||0.02||0.019||0.019||0.019,0.0,0.1,0.06666666666666667
740,Intensive_Care_Med-2-2-1315315.txt,equat||icu admiss||hospit mortal||time||refer databas||prognost model||databas||logist regress||comput||sampl||data||model||patient||icu level||circumst||sap 3 score||mortal||develop||hospit discharg||variabl||sap 3 system||maximum valu||physiolog data||approach||hospit||region differ||goodness-of-fit||predict||intens care unit||score||refer||ill||check||icu||final estim||outcom||result,3||sap 3||4 3||sap 3 score||2||3 perform||sap 3 admiss score||3 neurolog||sap 3 studi||sap 3 databas 2||admiss||sap 3 system||intens care||1||sap 3 probabl,0.029||0.021||0.02||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.2,0.1,0.13333333333333333
741,Liver_Int-1-_-2156150.txt,respons||rate||combin||studi||patient||lamivudin||hbeag clearanc||quantit meta-analys||intent||hbeag-posit patient||treatment||meta-analysi||biochem respons||heterogen||analysi||nonadult popul||treatment safeti||primari efficaci measur||group||monotherapi||interferon||trial||addit,2||1||2 NL 1||3||3 3 3||4||studi||discuss 2 2||2 NL||fig. 2||fig. 1||4 1 depart||adult 2||definit 2||random 3 3 3 alt,0.03||0.029||0.023||0.022||0.022||0.022||0.021||0.021||0.02||0.019||0.018||0.018||0.016||0.016||0.015,0.0,0.1,0.06666666666666667
742,J_Neurooncol-4-1-2295256.txt,meg||low-grad glioma||lgg||studi||state||patient||hemispher||correl||higher cognit function||special brain area||increas||rel||region||state brain activ||lower alpha||rel power||neurocognit deficit||delta||gamma band||brain||bilater frontocentr meg region||control||power||frequenc band||neurocognit function||analysi||theta||left pariet region||brain tumor patient||group||differ||tumor||diffus||healthi control||lower alpha band||diseas||left hemispher||result,patient||1||brain tumor patient||3 patient||brain||patient âs brain||patient âs||brain tumor||patient left||tumor||16 patient||patient group||lgg patient||patient popul||2 tumor,0.024||0.023||0.018||0.018||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014,0.6,0.4,0.26666666666666666
743,Bioprocess_Biosyst_Eng-4-1-2214824.txt,envirocam||condit||measur||imag analysi softwar||imag analysi||shroud||system||broth||diamet||liquid||imag||larger number||ferment broth||scale||increas||abil||resolut||frame||modular camera system||bubbl size||ferment||situ measur devic||standard||agit||ccd camera||led light sourc||distribut||sauter||light||rang||camera||pixel||photograph||number||limit||size||bubbl||agit rate||result,bubbl||2||bubbl measur||measur||1||bubbl size measur||2 3 3 2 3||bubbl measur system||bubbl size||bubbl imag||bubbl measur data||measur 5||1.2 2 2||bubbl diamet measur||system 2 2 fig. 2 environcam,0.02||0.019||0.019||0.018||0.017||0.016||0.015||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013,0.4,0.3,0.2
744,Neuropsychologia-2-1-2394569.txt,addit activ||condit||non-sign||skill||BA 37||superior tempor cortex||hear adult||nativ signer||hear||gyru||individu differ||BA 21||experiment condit||model||studi||deaf nativ signer||perisylvian region||hemispher||deaf||languag||fmri||correl||speech||posterior portion||region||cluster||posit correl||sign languag||stimuli||brain||voxel||hear non-sign||BA 46||frontal cortex||analysi||task||associ||speechread||identif||activ||deaf children||group||deaf peopl||word||score||particip||experiment||middl||deaf particip,1||tabl 1||2||tabl 3||hear||2006 tabl 1||3||fig. 2||skill tabl 1||baselin tabl 2 fig. 1||deaf||6||fig. 2 calvert||hear group||hear particip,0.016||0.015||0.015||0.013||0.013||0.013||0.012||0.011||0.011||0.011||0.011||0.01||0.01||0.01||0.009,0.2,0.1,0.13333333333333333
745,Neuropharmacology-2-1-2194164.txt,effect||glutamaterg transmiss||excitatori postsynapt current||applic||endocannabinoid||solut||hippocampu||glutamaterg synaps||high dose||cannabinoid||concentr||transmitt releas||experi||slice||data||glutam||channel,1||1 1||abstract 1 1 1 1 1||1 1 2||1 1 1 hÃ¡jo||2006 1 1||1 2||2002 1 1||1 1 fig. 2||2002 1 1 2||fig. 1||4 discuss 1 1 1 2||2006 1||2001 1||2007 1,0.083||0.083||0.069||0.068||0.066||0.061||0.06||0.059||0.056||0.054||0.052||0.05||0.049||0.048||0.048,0.0,0.0,0.0
746,Intensive_Care_Med-4-1-2271085.txt,bioimped||measur||svi||stroke volumeindex||studi||bioimped svi||cardiac output||coronari arteri bypass graft||error||data||algorithm||patient||tpco||transpulmonari thermodilut,1||2||result 2 1 TD||1 1 divis||1 loa svi TD||svi||TD 17 15 TD||result TD||method 2||refer 1||intervent TD||bioimped svi||patient||studi||2008 object TD,0.03||0.029||0.024||0.021||0.02||0.018||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.014,0.0,0.1,0.26666666666666666
747,Bioinformation-2-4-2255066.txt,gene||neurolog disord||entri||dnd||drug||databas||disord||diseas||neurodegen disord||sequenc,1 2 3 4 5||refer 1 http://en.wikipedia.org/wiki/neurodegenerative_diseas 2 copped||india 2 depart||content 6 7 figur 1||cell||neurodegen disord gowthaman ragul 1||nerv cell||diseas||neurodegen diseas||neurodegen disord||relat neurodegen diseas||disord||neurodegen disord databas||neurolog disord||requir data,0.048||0.037||0.036||0.028||0.025||0.024||0.023||0.019||0.019||0.018||0.017||0.017||0.017||0.015||0.014,0.0,0.2,0.26666666666666666
748,BMC_Struct_Biol-4-_-331416.txt,program||method||figur||mlv||murin leukaemia viru||model||structur||probe||eia||region||domain||quest||loop region||sequenc similar||helic||gene||paramet||multipl||protein||molecular model||ident||residu||sequenc align||loop||agreement||signific sequenc similar||viru||sequenc||fv1||result,1||model||fv1 model||fv1||fv1 sequenc||sequenc||3||structur model||tabl 1||mlv model||fv1 align||2||12 sequenc||sequenc align||control model,0.029||0.027||0.027||0.027||0.026||0.025||0.022||0.022||0.02||0.018||0.018||0.017||0.017||0.017||0.017,0.4,0.3,0.26666666666666666
749,Arch_Dermatol_Res-3-1-1800369.txt,prognost classif||cancer||tumour entiti||serum||melanoma||skin cancer pathogenesi||patient||skin cancer||primari melanoma||immunohistochemistri||malign melanoma||express||classif||metastasi||cell||squamou cell carcinoma||molecular marker||prognosi||vascular invas||prognost factor||cancer entiti||primari tumour||cutan malign||tumour size||classif system||invas||diseas||molecul||biomark||gene express,express||melanoma||melanoma melanoma||express 3||cancer||immunohistochem express||express 13||express profil||malign melanoma cancer||express 5||gene express||melanoma marker melanoma||malign melanoma||malign melanoma 1 1||1,0.029||0.021||0.021||0.018||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016,0.6,0.3,0.3333333333333333
750,Angiogenesis-4-1-2268731.txt,cancer||role||endotheli cell||nf-Îºb||mediat||effect||agent||angiogenesi||express||inhibit||treatment||cell||growth||growth factor||direct effect||apoptosi||angiogenesi inhibitor||activ||report||pathway||addit||inhibitor,cell||1||endotheli cell||2||tumor cell||2006||human endotheli cell||vascular endotheli cell||endotheli cell int||endotheli cell function||endotheli cell anergi||tumor cell nf-Îºb||endotheli cell surviv||endotheli cell integr||activ,0.027||0.024||0.021||0.018||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.4,0.2,0.2
751,BMC_Fam_Pract-4-_-169167.txt,elect appoint||measur||time||method||questionnair||compat system||practic||appoint data||data||patient||numer data||primari care organis||develop||appoint||day||routin||term||approach||clinician||survey techniqu||care||literatur||definit problem||search||access||number||organis||broad approach||primari care||demand||mind||articl,1||practic||care||patient care||patient||patient access||access||gener practic care||care appoint||gener practic||practic system||primari care||day 1||1 2 3 5||appoint,0.028||0.027||0.024||0.024||0.023||0.023||0.022||0.021||0.021||0.02||0.019||0.019||0.019||0.018||0.017,0.6,0.4,0.4
752,J_Chem_Ecol-4-1-2373416.txt,hydrocarbon||type||ppg||individu||strohm||extract||femal||postpharyng gland||sphecida||compound||proport||chemic composit||alken||unsatur||hymenoptera||gc-ftir||femal european beewolv||group||european beewolf||keton||secret||herzner||crabronida||function||polar fraction,1||1 1||2||2 fig. 2||ppg 1 1||2001 1998 1||J.||2003||E.||chemic dimorph 2 2||valu 1||2 P. triangulum||2 df||2007 2001 2007a 2007 2007||A.,0.016||0.016||0.016||0.012||0.011||0.01||0.01||0.01||0.009||0.009||0.009||0.008||0.008||0.008||0.008,0.0,0.0,0.0
753,Environ_Manage-4-1-2242854.txt,total nitrogen||watersh manag||downstream reach||spatial scale||stream size||nutrient||concentr||sampl||data||studi||effect||correl||ecoregion||total phosphoru||scale||land||total||site||watersh||downstream water qualiti||land cover||analys||relationship||riparian zone||varianc||previou studi||water chemistri||first-ord||high flow||water qualiti||differ||signific predictor||riparian||influenc||stream||annual water volum||surfac water chemistri||entir watersh||result,2||3 2||2 3||3||1 3||1||2 2000 2001 fig. 2||4 3||water||1 2 1 divis||chemistri relationship 1 3 3||2007 3||2 valu||riparian land cover 2||2 month,0.025||0.024||0.024||0.022||0.02||0.018||0.017||0.017||0.017||0.016||0.015||0.014||0.014||0.014||0.014,0.0,0.0,0.0
754,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1779626.txt,membran||type II collagen||method||number||tissu||phenotyp express||cell viabil||articular cartilag||sampl||maci procedur||matrix||tissu engin||implant||distribut||chondrocyt||cell||ultrastructur analys||maci,3||1||6 3 2||knee||2||6 3 3 knee 50||6 3 2 knee 22||6 3 6 knee 43||6 3 4 knee 23||1 knee 54||tabl 1 2||6 3 12 knee 13||6 3 5 knee 29||6 3 10 knee 35||6 3 9 knee 19,0.044||0.04||0.035||0.034||0.031||0.031||0.028||0.028||0.026||0.025||0.025||0.024||0.024||0.024||0.024,0.0,0.0,0.0
755,Pituitary-3-1-2045692.txt,larg bronchial carcinoid||pancreat polypeptid||ectop ghrh-syndrom||glucos load||case||approxim entropi||ghrh concentr||ghrh||mri||concentr||studi||valu||patient||serum ghrh concentr||remov||increas||test||octreotid||pituitari gland||repeat CT||GH secret||treatment||secretori regular||examin||primari tumor||igf-i||acromegali||normal valu||long-term follow-up||medic therapi||surgeri||normal||report||tumor||decreas||carcinoid||secret||primari pituitari somatotropinoma||clinic find,patient||patient 2||patient 1||patient 3||2||patient ghrh||patient 3 3||1||femal patient||acromegal patient||patient seri||GH||male patient||3||patient 3 ghrh level,0.024||0.021||0.019||0.018||0.017||0.017||0.016||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.012,0.2,0.1,0.06666666666666667
756,Virus_Res-2-1-2194287.txt,bcl-2||vector||replicon vector||alphavirus||protect effect||releas||data||studi||effect||semliki forest viru||high-level express||similar result||vlp||express||cell||infect||egfp||apoptosi||cell death||protein||death||sfv||ire||replicon||viru replic||viru||construct||rna||result,fig. 2 fig. 2||fig. 2||cell||fig. 2 fig. 2 fig. 3||fig. 3 fig. 4||fig. 4 fig. 4||fig. 4 fig. 4 fig. 4||fig. 2 5 cell||fig. 6||fig. 6 fig. 5||fig. 5||fig. 8 fig. 8||fig. 8||fig. 7||fig. 9 fig. 9,0.041||0.041||0.04||0.038||0.033||0.033||0.033||0.033||0.032||0.032||0.032||0.031||0.031||0.031||0.03,0.2,0.1,0.06666666666666667
757,Med_Oncol-4-1-2386844.txt,cancer cell||cancer||level||low level||tumor growth||patient||basal express level||hsp||effect||sirna||express||present studi||cell||growth||fir||gene||reaction||heat shock protein||prolifer||protein||brdu incorpor||medic treatment||incub||result,2||cell||2 2 11 2 2||1 4 2 2||cell cultur 2||cancer cell||2 day||4||cell line||1||hsc3 cell||6 2 3 4 13||cell carcinoma||a431 cell||fir incub 2,0.033||0.031||0.028||0.026||0.023||0.021||0.02||0.02||0.019||0.018||0.017||0.017||0.017||0.017||0.017,0.2,0.2,0.13333333333333333
758,Biochim_Biophys_Acta-2-1-2428106.txt,Na||drug transport||studi||small intestin||effect||amino acid||nhe3||caffein||electrochem gradient||exchang||inhibit||cell||phosphodiesteras||uptak||activ||brush-bord membran||pde||incub||small intestin epithelium||function||monolay,fig. 2||fig. 1||2||fig. 2 14||4 2 4 2 4 2||2 4||fig. 5||fig. 6||1||fig. 6 3||fig. 3 14||fig. 4 14||1 3||3||fig. 3 50,0.029||0.027||0.026||0.022||0.022||0.022||0.021||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.018,0.0,0.0,0.0
759,J_Occup_Rehabil-3-1-1915628.txt,follow-up||femal comput worker||week||muscl activ||myofeedback train||pain intens||baselin||model||studi||myofeedback||muscl relax||effect||work-rel neck-should complaint||complaint||EC group||va score||netherland||improv||intervent||signific||odd ratio||neck-should region||shoulder||pain||analysi||mfb||subject||factor||group||work-rel musculoskelet complaint||work||cinderella-bas myofeedback train||disabl||result,1||pain||2||3||group||studi group||studi||pain intens||pain 2006||pictur 1||refer 1||work||intervent group||occup pain||intervent studi,0.02||0.017||0.016||0.014||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.01||0.01||0.01||0.01,0.4,0.4,0.3333333333333333
760,Osteoporos_Int-4-1-2358936.txt,grade||measur||low-norm bmd||method||deform||follow-up period||bone resorpt||baselin||data||vertebr deform||studi||year||patient||lumbar spine||risk||increas||sarcoidosi||fractur||suggest||bone turnov||bmd||GC therapi||gc||progress vertebr deform||women||hip||age||popul||subject||multivari logist regress analysi||group||preval deform||bone||ictp||progress deform||diseas||bone miner densiti,1||bone||1 5||2||ns||refer 1||1 baselin||1 fig. 1 arrow||vertebr fractur||bone miner||17||3 17 3||S. P. 1 1 depart||fractur||5,0.023||0.017||0.016||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.01,0.2,0.1,0.13333333333333333
761,J_Gastrointest_Surg-3-1-1852378.txt,follow-up||case||imag||hepat aml||hepatocellular carcinoma||surgic resect||studi||year||seri||recurr||patient||hepat angiomyolipoma||conserv treatment||oper||treatment||month||angiomyolipoma||report||tumor||fine needl aspir biopsi||conserv manag||diagnosi,"1||2||10 1||1 1 2 c,d||studi 1||follow-up 2 1 2 figur 1||tumor||10||patholog studi 1 2||10 patient||month 1||patient||clinic data 1 2||refer 1||acknowledg 1",0.035||0.029||0.028||0.025||0.024||0.024||0.022||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.018,0.0,0.1,0.13333333333333333
762,J_Abnorm_Child_Psychol-4-1-1915634.txt,type||self-report questionnair||homotyp||rcad data||sad||futur soph||gener anxieti disord||sampl||studi||correl||continu||scale||anxieti||disord||ocd||anxieti dimens||soph||girl||varianc||previou studi||taxonomi||social phobia||anxieti construct||gad||obsess compuls disord||commun sampl||symptom||previou work||item score||adolesc||panic disord||young adolesc,1||2||wave 1||wave 2||anxieti||1 1 depart||anxieti disord||1 rcad scale||wave 1 anxieti scale score||1 soph||anxieti 2001||1 sad||1 gad||wave 2 score||1 scale score,0.027||0.022||0.022||0.019||0.019||0.019||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015,0.2,0.1,0.06666666666666667
763,Ann_Biomed_Eng-3-1-2040176.txt,atd||rollov||measur||acceler||time||crash mode||vehicl||roof deform||roof crush||data||studi||contact||head||far-sid||driver||test||rollov crash||dynam||present studi||human spine||atd neck||probabl column injuri||hybrid iii dummi||load||passeng||spinal injuri||local peak neck forc||dynam rollov test||seat belt||sensor||residu forc magnitud||injuri||camera||onboard clock||lap belt||cervic spine||cadav||load cell||suv||passeng atd||neck load||peak||passeng car||result,1||1 1 figur 1||2||sae||test||3||figur 2||load||2 11 2||method 1||2 4||neck load||atd instrument 2 2 1||rollov test||1 problem,0.023||0.02||0.016||0.016||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.012,0.2,0.2,0.2
764,Ann_Hematol-4-1-2226003.txt,risk||thrombosi||studi||atherosclerosi||genet marker||serum ferritin concentr||carrier||associ||anemia||coronari heart diseas||coronari arteri diseas||iron||cardiovascular event||patient||thrombocytosi||cardiovascular diseas,1||iron||studi||heart diseas||1 7||iron defici||refer 1||heart||1 summari||coronari heart diseas||1 3 8 10.1046||coronari heart diseas patient||2 patient||patient||cardiovascular diseas,0.021||0.017||0.015||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.01,0.4,0.3,0.3333333333333333
765,Ann_Surg_Oncol-4-1-2234441.txt,condit||cancer cell||cancer||level||case||line||import role||hypoxia-resist hcc line||studi||patient||differenti hcc||immunohistochemistri||tumor differenti||hypox condit||statist analysi||express||differenti||liver cirrhosi||result||analysi||immunoblot analysi||hcc||tumor||import||rage||hepat||normal liver||noncancer tissu,cell||1||2||cancer cell||rage||tumor cell||3||rage express||immunohistochemistri 2 2||phd 1 1 depart||cell surviv||100 cell||hcc 1 fig||cell cultur 2 condit||differenti,0.018||0.018||0.015||0.014||0.013||0.013||0.012||0.011||0.011||0.01||0.01||0.01||0.01||0.01||0.01,0.4,0.2,0.2
766,Ann_Surg_Oncol-3-1-2077910.txt,follow-up||risk carrier||cancer||prophylact surgeri||find||complic||ovarian cancer||histori||microscop examin||breast cancer||hereditari BC||studi||year||mutat||pbso||data||risk||care histolog examin||fnac||relev data||pm||institut||examin||metastat diseas||standard procedur||women||mastectomi specimen||age||addit investig||prophylact mastectomi||group||famili||hereditari breast cancer||number||malign find||signific differ||primari BC||reconstruct||decis||breast||mastectomi,cancer||breast cancer||breast||breast cancer risk||PM breast cancer 1||breast cancer famili||cancer risk||2 patient breast cancer||hereditari breast cancer||contralater breast cancer||1||primari breast cancer||breast cancer recurr||occult breast cancer||brca-associ breast cancer,0.026||0.024||0.022||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016,0.6,0.4,0.26666666666666666
767,Eur_Radiol-3-1-2077918.txt,peripher vascular diseas||level||time||scanner||contrast arriv||imag||data||patient||peripher arteri||review||extens calcif||imag qualiti||enhanc||resolut||peripher CT angiographi||contrast media||acquisit||vessel wall calcif||CT angiographi||bolu||import||diagnost cost||tabl||tomographi||pad||techniqu,2||4||paramet 1 fig. 1||1 total tree||G. 1 2 3 1 depart||refer 1||1 84||imag||3||4 1 5 fig. 4a||arteri diseas CT||angiographi||peripher arteri||CT angiographi||CT,0.015||0.015||0.013||0.012||0.012||0.012||0.012||0.011||0.01||0.01||0.01||0.009||0.009||0.009||0.009,0.0,0.1,0.2
768,Diabetologia-4-1-2270360.txt,diabet||children||hyperglycaemia||mutat||patient||test||site||guidelin||featur||molecular genet diagnosi||treatment||genet diagnosi||molecular genet||gene||maturity-onset diabet||blood glucos||analysi||report||monogen diabet||diagnosi||modi||interpret||syndrom||result,diabet||2 diabet||1||diabet patient||maturity-onset diabet||type 2 diabet||famili diabet||monogen diabet||2||gestat diabet||diabet rang||late-onset diabet||maturity-onset type diabet||hnf1a mutat hnf1a hnf1a young-onset diabet||young-onset type 2 diabet,0.035||0.027||0.023||0.023||0.022||0.021||0.02||0.019||0.019||0.018||0.018||0.018||0.018||0.016||0.016,0.4,0.3,0.2
769,Childs_Nerv_Syst-2-2-1705512.txt,mirna express||method||array result||microarray||sampl||oma||oligonucleotid microarray||human||probe||express profil||organ||human chromosom 13||nervou system develop||express||cluster||signal||nervou system||specif||analysi||cdna||hybrid||mirna||northern blot||microrna||profil,2||1||1 1 1 1 fig. 1||1 2 4||human develop 2 fig. 2||1 min||nucleotid 2||spinal cord 2 2||microrna 3 fig. 3 2 left||86-10-62179059 genetic@263.net.cn 1 2 1 depart||microarray fabric 2||refer 1||5||mirna||1 kb,0.035||0.027||0.025||0.025||0.021||0.02||0.019||0.019||0.017||0.016||0.016||0.015||0.015||0.014||0.014,0.0,0.0,0.06666666666666667
770,Int_J_Med_Sci-4-2-1796947.txt,larg||dna damag||cancer||function effect||method||individu||studi||nucleotid excis repair pathway||allel||effect||risk||drc||human||abil||dna repair||multipl gene||dna repair gene||dna||genotyp||epidemiolog studi||dna repair capac||damag||gene||meta-analysi||heterogen||polymorph||popul||associ||ner pathway||genet polymorph||nucleotid excis repair||lung cancer risk||lung cancer||pathway||statist signific||function,cancer||popul||caucasian popul||lung cancer cancer||caucasian||lung cancer||cancer risk||studi popul||lung cancer patient cancer||dna repair||lung cancer risk||1||caucasian studi||dna repair polymorph||lung cancer risk ercc2,0.025||0.023||0.021||0.021||0.019||0.019||0.017||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.014,0.4,0.4,0.3333333333333333
771,Fam_Cancer-3-1-1914241.txt,cancer||method||multipl tumour||fifti year||carcinoma||data||patient||young age||lynch syndrom||criteria||inform||bethesda-guidelin||colorect cancer||famili histori||guidelin||tumour||hospit||clinic genet centr||age||microsatellit instabl||crc||msi-analysi||famili||group||medic specialist||physician||diagnosi||hnpcc,1||2||cancer||1 11||colorect cancer||refer 1||2007 introduct 1 2 3||patient||3||colorect||hereditari colorect cancer||patient group||fam cancer famili cancer||6||A. 1 oostindiÃ«r,0.039||0.027||0.027||0.024||0.023||0.021||0.021||0.021||0.019||0.019||0.019||0.017||0.017||0.016||0.016,0.4,0.3,0.2
772,Eur_J_Appl_Physiol-4-1-2358938.txt,muscl||time||exercis countermeasur||individu||rate||torqu develop||studi||resist exercis||inact control group||bed rest||frequenc||effect||increas||forc||abil||intrins contractil properti||knee extensor||maxim||vibrat train||day||mvc||stimul||foa||torqu||resist vibrat exercis||characterist||subject||exercis||contract||group||rve||isometr knee extens||isometr contract||train session||rest,2||1||muscl||1 2 4 1 institut||4||F. 1 2 3||2 week||2 min||day||3 day||3||skelet muscl||2 khz||1 min||e.mulder@neuro.umcn.nl 1 2 3 gerrit,0.023||0.021||0.02||0.016||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.2,0.2,0.13333333333333333
773,J_Biomol_NMR-3-1-1892527.txt,tensor||case||order paramet||system||dipolar coupl||constraint||bond||sampl||data||deriv||valu||princip axi||cholesterol||molecular re-orient||nmr interact||orient||inform||similar result||exampl||site||high degre||experiment error||dynam behaviour||pseudo-forc||quadrupolar interact||averag||molecular properti||nmr investig||nmr interact tensor||analysi||simul||molecular dynam||molecular align||solid state nmr||pgla||segment orient||pyren||membran||order||MD approach||peptid||heat||nmr data||molecul||molecular dynam simul||axi||time averag||compon,2||2 2||3 2 2 2 2 2||2 1 2||2 2 1||2 4 2||3 2||2 2 20||pyren 2 2005 2 2||2 2005||2 7||1 zz 2 yy 2 2||2 4||2 8||fig. 8 2 3 2,0.055||0.055||0.049||0.044||0.044||0.04||0.038||0.037||0.035||0.033||0.032||0.032||0.032||0.031||0.03,0.0,0.0,0.0
774,J_Abnorm_Child_Psychol-3-1-1915644.txt,longitudin model||lower level||high level||questionnair||children||behavior||infant||parent-child attach||problem||qualiti||model||studi||year||caregiv||mediat||complet longitudin model||life||strang situat||extern behavior||stress life event||develop||low se||risk||test||se||domain||variabl||signific||cognit abil||present studi||earlier find||tempera||primari caregiv||research||contextu characterist||toddlerhood||assess||high-risk sampl||characterist||parent||path analysi||predictor||effect guidanc||teacher||factor||famili||predict||influenc||interact||earli predictor||ego-resili||score||parent-child interact||attach||result,child||2||2 2||1||child psycholog||child develop||psycholog||develop||fig. 1 child||child behavior problem||child âs develop||2 2 df||child develop journal||child develop research||behavior,0.016||0.015||0.015||0.015||0.014||0.014||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.01||0.01,0.0,0.1,0.13333333333333333
775,BMC_Bioinformatics-4-_-521197.txt,model paramet||linear regress||cumul normal distribut||set||method||real gene||random sequenc||hidden markov model||emiss probabl||model||state||glimmer||hmm||fals posit||organ||test||start||signific||similar||gene||stop||train||protein||orf||rb||put gene||distribut||raw genom||challeng||order||score||number||perform||markov model||tabl||codon||length||probabl||statist signific||order markov chain||background state||sequenc,2||1||1 1||gene||3 2||order 2||order 1||2 E. coli||order 2 1479 2||3||figur 1||order 1 336 2||gene score||equat 2||predict gene,0.024||0.022||0.022||0.022||0.02||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.2,0.1,0.06666666666666667
776,Calcif_Tissue_Int-3-1-2039811.txt,placebo||follow-up||method||raloxifen||baselin||studi||year||postmenopaus osteoporosi||total trabecular bone area||osteocyt||effect||correl||section||immunohistochemistri||test||follow-up biopsi||osteocyt apoptosi||cell||bone remodel||empti lacuna||percentag||women||apoptosi||apoptot osteocyt||placebo group||chang||group||biopsi||differ||number||raloxifen treatment||signific differ||posit osteocyt||averag standard deviat,2||4 2 2 2||2 fig. 2||1||bone||2 year||1 1 1 1 fig. 1||2 3 tabl 2 associ||1.91 2||4.67 2||2 year postmenopaus||previou 2 year||1 result||1 month||osteocyt,0.032||0.026||0.023||0.023||0.022||0.021||0.02||0.018||0.016||0.016||0.016||0.015||0.015||0.014||0.014,0.0,0.0,0.06666666666666667
777,FEBS_Lett-1-5-1964784.txt,thymu||thymocyt||transcript factor||develop||egr||express||notch||cell||rhoa||transcript||mice||protein||enzym||pre-tcr||ap-1||wild type||cell develop||affymetrix gene||divers biolog function||loss||function,cell||fig. 1 fig. 1||fig. 2||fig. 2 supplementari fig. 1||1||fig. 3||supplementari fig. 1||2||supplementari fig. 2||fig. 2 fig. 2 cd2||fig. 4||supplementari fig. 3 supplementari fig. 3||figs. 1 fig. 1||dn3 cell||cell develop,0.024||0.023||0.023||0.021||0.02||0.02||0.019||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.016,0.2,0.1,0.13333333333333333
778,Oecologia-3-1-1915600.txt,pot||top-down control||studi||soil microorgan||microarthropod||effect||inocul||steril||soil biota||hodgkin||microorgan||growth||control||multipl||multitroph interact||plant perform||cook||factor||natur ecosystem||plant commun composit||influenc||biomass||rooij van der||root||nematod||microbi enemi||soil||result,T. ventrali||T. ventrali T. ventrali T.||T. ventrali T.||T.||1 T. ventrali||2 T. ventrali||1 T.||1 2 T. ventrali||T. ventrali T. ventrali A.||2 T.||1||T. ventrali A. arenaria T. ventrali||experi T. ventrali||3 T.||soil T. ventrali 1998 T.,0.039||0.039||0.039||0.038||0.036||0.035||0.034||0.034||0.033||0.032||0.03||0.03||0.029||0.028||0.027,0.0,0.0,0.0
779,J_Interv_Card_Electrophysiol-4-1-2292475.txt,time||line||block||conduct||radiofrequ||pain score||isthmu length||studi||recurr||patient||atrial fibril||ecg||ablat||cathet ablat||atrial flutter||flutter||signific||cryo group||lower requir||bidirect block||recurr rate||cryothermi||applic||cathet curv||success||pain||similar rate||bidirect isthmu block||group||recurr flutter||arrhythmia||isthmu||cryotherapi||procedur||isthmu line||fibril||acut success||isthmu conduct,1||patient||atrial flutter||atrial flutter ablat||ablat||atrial cathet||flutter||6 patient||atrial isthmu||atrial flutter journal||J. atrial flutter||cathet ablat||success 1||3||3 3,0.017||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.011,0.6,0.4,0.3333333333333333
780,Eur_Arch_Otorhinolaryngol-4-1-2217621.txt,adult form||year||cidofovir||rrp||form||vaccin||papilloma||lesion||treatment||hpv||infect||laryng papilloma||infect host cell||suffici clinic follow-up data||recurr respiratori papillomatosi||prophylact hpv vaccin||low incid||larg multi-centr collabor clinic trial||adequ airway||risk factor||diseas||juvenil onset form,refer 1||studi||human papillomaviru||human papillomaviru type||type||human||human papillomaviru type 16||human papillomaviru type 11||UK 2 depart||16||human papillomaviru 6||44-1223-217559 holger.sudhoff@rub.d 3 1 depart||human papillomaviru type embo||human papillomaviru type 31b||human papillomaviru E6,0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.01||0.01||0.01||0.009||0.009||0.009,0.0,0.0,0.0
781,Clin_Oral_Investig-4-1-2238784.txt,measur||dental eros||method||system||indic||data||age group||amount||eros||wear||criteria||epidemiolog||teeth||tooth wear||dentin||epidemiolog studi||occlus||partial record system||hard tissu loss||literatur||surfac||aetiolog||sever||loss||score,2||1||3||4 2||1 10||2 mm||tooth||tooth wear||30 2||2 30||wear||involv 2||1 mm||dentin 1 dentin||2 30 4,0.024||0.022||0.018||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.013,0.0,0.1,0.13333333333333333
782,J_Biol_Inorg_Chem-4-1-2359827.txt,reson||zero-field paramet||iii||electron supplementari materi||line||quadrupol split||citrat||site||fe-protein||superreduc||pattern||cluster||state||epr||activ,2||0||0 0||2 2 1||0 1||5 2||1||2 fig. 2||2 3||0 0 31||0 7 2 5||0 0 cluster||0 51 0||3:1 0 5 0||5,0.029||0.028||0.028||0.027||0.026||0.024||0.024||0.023||0.022||0.021||0.021||0.02||0.019||0.019||0.019,0.0,0.0,0.0
783,Ann_Biomed_Eng-2-2-1705490.txt,clinic situat||respons||hypertens||model||anim studi||averag error||increas||heart failur||adapt control||hemodynam||anim experi||dbt||drug interact||acut heart failur||acut||cardiac output||acut disturb||physiolog variat||part||snp-map loop||snp||snp infus||drug||input||setpoint||hemodynam variabl||actual hemodynam,NN||1 NN NN NN||2 NN NN||2 NN||NN mod NN||1||1 1||1 mod NN||mod NN||NN mod||NN mod mod NN||2 1||2||2 2||control NN,0.035||0.033||0.032||0.031||0.029||0.027||0.027||0.027||0.027||0.027||0.027||0.026||0.026||0.026||0.025,0.0,0.0,0.0
784,Ann_Biomed_Eng-2-2-1705524.txt,capillari||consumpt||hepatocyt layer||case||simul result||model||strategi||mat||intern oxygen||hepatocyt distribut||inform||increas||doubl number||mmhg||intern geometri||cell||oxygen||flow field||shear stress||percentag||zone||flow rate||micro model||extern oxygen||flow veloc||cell distribut||shear stress distribut||hepatocyt||maxim shear stress||fraction||fluid flow||outflow zone||ga capillari||effect hepatocyt util ratio||amc-bal||clinic set||medium||result,2 2||2||2 2 2 5 2||1 2||2 2 2 penetr||2 2 3||2 2 2 cell 2 avail||2 ga 2||9 2 2||2 3 2 2 3||2 distribut||distribut 2||case 2||2 4||1 1,0.05||0.05||0.041||0.04||0.037||0.036||0.036||0.036||0.034||0.034||0.033||0.033||0.031||0.031||0.029,0.0,0.0,0.0
785,J_Gastrointest_Surg-3-1-1852394.txt,greater omentum||tumor||hemangiopericytoma||case||resect||patient||english literatur||literatur,figur 3||discuss 3 11 12 3 11||refer 1||figur 2||omentum||tumor||12 case||greater omentum||case||alimentari tract 2007||addit treatment||report||heterogen enhanc tumor||omentum present||greater omentum eur,0.062||0.047||0.046||0.045||0.024||0.023||0.021||0.02||0.02||0.017||0.017||0.017||0.017||0.014||0.014,0.0,0.3,0.2
786,Behav_Genet-3-1-1824713.txt,model test||time||marijuana||problem||abnorm||model||year||normal rang||risk||frequenc||inform||present||environment influenc||analys||present studi||twin||age||liabil||parent||longitudin studi||conduct problem||genet||factor||presenc||influenc||substanc||england twin||risk factor||adolesc||initi||progress||environment risk factor||result,1||2||2 2 2||model 2||time 1||initi progress 2 2 2||time 2||genet||2 marijuana||2 df||1 2001 2003 2003||model||conduct problem 2 df||2 fig. 2 note||bracket 2 2 df,0.026||0.024||0.024||0.019||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013,0.0,0.1,0.13333333333333333
787,J_Mol_Evol-3-1-1894752.txt,mechan||translat system||nuclear genom||case||origin trna-il||reassign||modif||cau||stramenopil||mutat||argument||aaa||present||base||cun||abil||amino acid||fungi||ambigu translat||mitochondri genom||uag||trna||code||ucu||gene||aua||delet||met||absent||stop||estim||wobbl posit||gau||pair||codon reassign||ambigu||simul||chang||releas factor||asn||trna gene||small number||uga||fact||posit||disappear||codon||ambigu intermedi mechan||speci||mitochondri genet code||base frequenc||length||origin posit||show,codon||1||2||0||3||codon reassign||reassign codon||stop cca 1 2||stop codon||stop 1||codon disappear 3 3||3 4||2 S.||trna||mitochondri codon reassign,0.017||0.017||0.015||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.01||0.01,0.2,0.2,0.2
788,DNA_Repair_(Amst)-1-5-2077361.txt,telomer||yeast||role||non-permiss temperatur||strain||defect||checkpoint activ||mrc1||telomer dna||dna repair||protein||experi||depend||nucleas||checkpoint pathway||temperatur||accumul||ssdna||activ||dna replic,cdc13-1 cdc13-1 mrc1Î´||cdc13-1 mrc1Î´||cdc13-1 cdc13-1 mrc1Î´ yku70Î´ mrc1Î´||cdc13-1 cdc13-1 rad9Î´||cdc13-1 2||rad9Î´ cdc13-1 cdc13-1 mrc1Î´||uncap cdc13-1 cdc13-1 cdc13-1 fig. 5||cdc13-1 mrc1Î´ fig. 5||mrc1Î´||mrc1Î´ mrc1Î´||cdc13-1 mrc1Î´ yku70Î´||cdc13-1 yku70Î´||mrc1Î´ cell||cdc13-1 mrc1Î´ exo1||cdc13-1 mutant,0.036||0.034||0.029||0.029||0.028||0.028||0.027||0.026||0.026||0.026||0.025||0.025||0.024||0.023||0.023,0.0,0.0,0.0
789,Cell_Tissue_Res-4-1-2295254.txt,ecm||fibronectin||studi||ami phase 2||section||border-zon||adipos tissu||increas||infarct||cell||adhes||asc||prolifer||posit effect||stem cell therapi||ami||myocardi infarct||incub||posit||number||infarct area||area||stem cell||heart||cardiomyocyt||attach,cell||2 2||2||1||2 2 fig. 2 2||2 2 fig. 1||asc 2 2 2 2||stem cell||cell cultur 5 2 2||1 day||5||infarct phase 2||asc 2 2||cell tissu||fibronectin 1,0.028||0.024||0.024||0.022||0.021||0.02||0.02||0.02||0.019||0.019||0.018||0.017||0.017||0.017||0.017,0.2,0.2,0.13333333333333333
790,J_Behav_Med-4-1-2413087.txt,alcohol consumpt||level||find||higher level||time||wave||regard||mother||problem||parent problem drink||effect||genet suscept||environment factor||test||present studi||control||van der vorst||item||alcohol||father||parent||parent alcohol||longitudin studi||problem drink||famili||factor||drink||behavior control||adolesc||support||addit||children||result,1||parent||alcohol parent||parent alcohol||alcohol||2||adolesc alcohol||parent model||time 1||M.||behavior||alcohol problem||alcohol psycholog||adolesc||problem drink 1,0.019||0.017||0.017||0.017||0.016||0.015||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.011,0.6,0.3,0.26666666666666666
791,Dev_Genes_Evol-4-1-2292478.txt,insect||genom sequenc||embryo||head||develop||observ||region||paralog||tiptop||teashirt||express||gene||conserv||trunk||leg||protein||ident||rnai||hox gene||member||famili member||dsrna||milkwe bug||pcr||segment||ectop express||addit||larval rnai||function||tsh||result,tsh||tc-tiotsh||tc-tiotsh tc-tiotsh tc-tiotsh||tc-tiotsh tc-tiotsh||tsh drosophila||drosophila tsh 2005 tsh tsh||tc-tiotsh tsh tio tsh||tribolium tc-tiotsh tribolium tc-tiotsh tsh drosophila||tsh tsh tsh trichoplax||tc-tiotsh tsh tio||tc-tiotsh tc-tiotsh tc-tiotsh tc-tiotsh prothoraxless||tribolium tio tsh||tribolium||drosophila||tc-tiotsh 2000 tc-tiotsh,0.041||0.035||0.035||0.035||0.033||0.033||0.032||0.031||0.03||0.03||0.028||0.027||0.025||0.025||0.025,0.2,0.1,0.06666666666666667
792,Mol_Syst_Biol-3-_-1800356.txt,set||method||enrich||modul||data||bind site||motif||top||inform||human||test||promot sequenc||background||signific conserv||promot||site||sourc||proxim promot||express||tcat||catalog||cis-regulatori modul||random||tissu||transcript||analysi||liver||balanced-error rate||order||mous||tissue-specif regul||vote||genbank||result,factor||NM||factor 1||1||2 NM||factor 3||3 NM||2||tissue-specif||factor 4||promot||transcript factor||3||NM _ 004533 NM||factor 6,0.017||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.011,0.0,0.0,0.06666666666666667
793,Behav_Genet-4-1-2226022.txt,uniqu environment factor||sex differ||phobia||twin correl||individu||sampl||data||model||studi||herit||effect||femal||blood-injuri||sex||spous||women||estim||varianc||twin||herit estim||age||genet||ade model||famili member||famili||factor||differ||domin||sibl||influenc||fear||assort mate||broad-sens herit estim||particip||non-addit genet effect||oldest age group||result,twin||2 twin||australian twin twin||twin pair||twin studi||2||famili twin||twin correl||genet model twin||1||genet||sibl twin||twin sibl||DZ twin||netherland twin regist twin,0.029||0.023||0.019||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016,0.2,0.2,0.2
794,Breast_Cancer_Res_Treat-3-1-2001218.txt,time||letrozol||signific benefit||hormone-sensit breast cancer||breast cancer||patient||tamoxifen||year||recurr||clinic||risk||prior cancer event||event||df||treatment||upfront therapi||distant site||system df||adjuv therapi||big 1-98||women||primari||analysi||monotherapi||trial||addit||primari core analysi||result,cancer||breast cancer||postmenopaus breast cancer patient breast cancer||1||earli breast cancer||breast cancer recurr||primari breast cancer||advanc breast cancer||breast cancer model||receptor-posit breast cancer||outcom breast cancer||breast cancer eur||early-stag breast cancer||endocrine-respons breast cancer||contralater breast cancer,0.025||0.025||0.018||0.018||0.017||0.017||0.017||0.017||0.017||0.017||0.017||0.017||0.016||0.016||0.016,0.2,0.1,0.06666666666666667
795,J_Insect_Sci-1-_-355886.txt,lepidopteran||condit||immunodiffus||cecropia||concentr||v-mth||m-mth||sampl||fat bodi||extract||reserv||femal||present||egg||femal pupa||pupa||metamorphosi||yolk format||hemolymph||day||arh||short day condit||protein||whole-bodi extract||long day condit||hexamerin||monarch||mth||support||adult develop||post-eclos egg format,figur 1||1||figur 3||figur 2||figur 4||tabl figur 1||figur 7||figur 5||figur 6||figur 4A||figur 5B||figur 5B figur 5A||figur 6B||adult figur 4A||1992 figur 2 pan,0.046||0.038||0.037||0.037||0.033||0.031||0.031||0.03||0.029||0.028||0.028||0.028||0.028||0.023||0.021,0.0,0.0,0.0
796,Domest_Anim_Endocrinol-2-1-2428105.txt,mechan||de||caruncular stroma||involut||caruncular tissu||studi||uterin involut||uteru||uterin horn||uterin igf system||myometrium||deep endometri stroma||se||region||dairi cow||express||similar||postpartum uteru||tissu||igf-ii||sub-epitheli stroma||horn||igf-i mrna||postpartum||mrna||bovin||igf,2||1||tabl 2||tabl 1||fig. 3 tabl 2 fig. 3||3||2 figs. 3||figs. 1||4||fig. 3||fig. 4||1 receptor figs. 1||fig. 2 photograph||2 materi||growth,0.022||0.021||0.02||0.02||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.012||0.012||0.012,0.0,0.0,0.0
797,Breast_Cancer_Res_Treat-4-1-2217620.txt,grade||follow-up||role||cancer||socioeconom statu||time||statist probabl valu||breast cancer||adjuv treatment||studi||year||excess mortal||brca||patient||risk||mortal||node||breast cancer patient||obes||larger tumour||classif||treatment||tumour||women||clinic behaviour||nodal statu||lymph node||age||prognosi||prognost factor||factor||surviv||tumour size||probabl||diagnosi||BC diagnosi||BC patient,cancer||breast cancer||breast cancer breast cancer||breast||breast cancer surviv||primari breast cancer breast cancer||breast cancer patient||patient breast cancer||age breast cancer||cancer patient||breast cancer mortal||breast cancer diagnosi||breast cancer recurr||primari breast cancer||earli breast cancer,0.033||0.03||0.03||0.028||0.025||0.025||0.024||0.024||0.022||0.022||0.021||0.021||0.021||0.021||0.021,0.4,0.3,0.2
798,Health_Care_Anal-4-1-2226192.txt,level||bioethic principl||principl||bioethic||commun||univers principl||intern||social||univers||african countri||social respons||context||guidelin||ethic committe||countri||health||interview||relev||research||paper||polici||south africa||declar||research project||nation level||kenya||ethic||biomed research ethic||nation law||unesco,1||5 20 1||2 5 1||20||ethic||3||research ethic||4||5 6||univers||research||limit 2 3 4||9 13||13||articl 9 20 9 13 11,0.024||0.021||0.021||0.02||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014,0.2,0.2,0.2
799,Appl_Microbiol_Biotechnol-4-1-2270352.txt,lime-tr wheat straw||lactic acid||amount||lime||process||ssf||total||ltw||hydrolysi||wheat straw||monomer sugar||product||glucan||enzym||ferment||phase||supernat||polysaccharid||pretreat||lactic acid product||fed-batch phase||pH control||hydrochlor acid||biomass||addit||mol||medium||calcium hydroxid||organ acid||result,2||1||1 1||2 3 3 3||1 B. coagulan||2 suspens||acid||3||3 3||coagulan||B. coagulan||A. 2 visser diana 2||lactic acid||B.||tabl 1,0.04||0.032||0.032||0.025||0.023||0.021||0.021||0.021||0.021||0.019||0.019||0.018||0.018||0.018||0.017,0.0,0.0,0.06666666666666667
800,Int_J_Legal_Med-4-1-2226061.txt,stabl mrna marker||time||method||genom express analysi||rna marker||sampl||stain||vagin secret||test||forens||saliva||express||rna degrad||tissue-specif mrna marker||gene||blood||tissu||analysi||experi||cotton swab||candid||identif||saliva stain||signal intens||mrna||gene express||candid marker,1||2||4||3||express||forens||tissue-specif marker 1 fig. 1||5||refer 1||gene express||31-10-4089300 m.kayser@erasmusmc.nl 1 1 depart||netherland 2 depart||marker||gene||2 27 28 29 fig. 2,0.022||0.019||0.016||0.016||0.014||0.014||0.013||0.012||0.012||0.012||0.01||0.01||0.009||0.009||0.009,0.2,0.3,0.26666666666666666
801,Apoptosis-4-1-2217618.txt,therapeut protein||rgdpeg-avidin||integrin||huvec||subunit||tumor tissu||complex||angiogen endothelium||cell||tumor vasculatur||jurkat cell||approach||product||apoptosi||proapoptot effect||protein||antitumor activ||rgdpeg group||experi||promega||tumor cell||activ||primari amino group||bind||incub||trail||ligand||result,1||3||2||3 3 cell||3 fig. 1||3 4||rgdpeg-avidin 2 2 2 fig. 2||cell||3 24 125 2 2 2||1 ng||3 18||trail||tumor cell||trail activ||lane 1,0.024||0.022||0.021||0.02||0.019||0.017||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014,0.0,0.1,0.2
802,Bioinformation-2-2-2174421.txt,year 2005||entri||categori||molecular biolog||javascript||access||global search||molecular biolog databas||number||categori list||user||databas||keyword||data||link||list||page,1 2 3 4||figur 2||databas||530016 2 depart||biolog databas babu padavala ajay 1||4 depart||genom databas||databas link||databas entri||molecular biolog databas||1082 databas||databas scan||209 databas||patent databas||databas segreg,0.049||0.045||0.045||0.03||0.026||0.025||0.025||0.025||0.024||0.024||0.023||0.023||0.023||0.023||0.023,0.2,0.2,0.13333333333333333
803,Breast_Cancer_Res_Treat-4-1-2190785.txt,cancer||time||se indic||breast cancer||studi||patient||year||se||socio-econom strata||proport||high particip rate||women||eindhoven cancer registri||social class||socio-econom statu||distribut||group||surviv||vital statu||differ||adequ treatment||multivari rate||screen||diseas||screen programm||period||stage||introduct,cancer||breast cancer||cancer surviv||breast cancer screen||breast cancer surviv||netherland breast cancer||breast cancer patient||1||breast cancer treatment||breast cancer mortal||cancer diagnosi||lung cancer||itali cancer||massachusett cancer||invas breast cancer,0.033||0.024||0.021||0.019||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016,0.4,0.2,0.13333333333333333
804,Clin_Rheumatol-4-1-2367392.txt,amyloidosi||tracheobronchomalacia||kidney||patient,1||1 1 depart||netherland 2 depart||refer 1||netherland 4 depart||case report 1 fig. 1 amyloidosi||discuss 2 4 5||netherland 5 depart||netherland 3 depart||clinic rheumatolog 2008 introduct 1||31-20-4442138 f.turkstra@janvanbreemen.nl 1 2 rinkel rico||patient||prospect cohort studi||rheumatoid patient||RA patient,0.067||0.057||0.04||0.037||0.034||0.032||0.031||0.03||0.029||0.025||0.024||0.024||0.023||0.02||0.019,0.0,0.0,0.06666666666666667
805,Clin_Auton_Res-3-1-1797060.txt,hrr||coronari arteri calcium||relationship||presenc||atherosclerosi||slow hrr||cac||young adult||particip||exercis||middl age||heart rate recoveri||year||cac score||heart rate||gxt,2||1||2 3||1 1 dept.||3||refer 1||2 1.20||2 minut||1 2 carnethon merced||result 1||studi||hrr tertil 1||5 12 2 3 10 9||type 2 diabet||IL usa 2 dept.,0.048||0.042||0.038||0.03||0.027||0.026||0.025||0.025||0.024||0.023||0.021||0.02||0.02||0.019||0.017,0.0,0.0,0.0
806,Purinergic_Signal-1-3-2096543.txt,atp||respons||corneal epithelium||imag||migrat||wound repair||cell,2||2 2||7 2||1 2||figur 2 2||2 3 3 2||3 2||4 2||5 2||2 3 25 2||2 2 7e figur 7 2||2 4 receptor||3 6 2||50 2||3 4 3 2,0.065||0.065||0.048||0.048||0.047||0.046||0.046||0.043||0.041||0.04||0.04||0.035||0.035||0.035||0.035,0.0,0.0,0.0
807,J_Autism_Dev_Disord-4-1-2175022.txt,diagnost protocol||social domain||aq-d||studi||patient||mild asd||asd||diagnos||domain||comorbid||atn||adult||II disord||present studi||high function autism||item||gener outpati clinic||dutch||group||differ||autism spectrum disord||symptom||pddno||clinic experi||score||autism spectrum quotient||result,disord||disord 1||1||1 patient||patient||anxieti disord 1||2||development disord||asd patient||autism spectrum disord||disord 7||comorbid disord||patient group||psychot disord||II disord,0.033||0.033||0.033||0.027||0.022||0.022||0.02||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.018,0.2,0.2,0.2
808,J_Mol_Biol-2-1-2267215.txt,fn3||previou peptid studi||Ig||neural cell adhes molecul||bind site||spr||fibroblast growth factor receptor||tris-buff salin||fgfr||structur||tb||domain||fibronectin type 3||cell||conform||protein||ncam||acid box||dissoci constant||immunoglobulin||cell surfac||interact||cam||peptid||weak interact||mammalian cell||pb,"2||1 2||1||1 1 1||1 2 1 2 37||4 2||1 1 1 unit cell dimens||fgfr1 interact 1 2||fig. 4 1 2 fn3||1 2 2vkw 2vkx||9,10,12 1||47 6 1 2 fn3||2 2 28 Î± atom||purif 2 4||put fgfr1 bind site 1 2",0.058||0.058||0.058||0.058||0.047||0.033||0.032||0.032||0.031||0.029||0.029||0.027||0.025||0.022||0.022,0.0,0.0,0.0
809,Diabetologia-4-1-2292425.txt,type 2 diabet||variat||insulin secret||gene||snp||childhood||genet variat||region||type 1 diabet||age||birth||variant||associ||popul||genotyp||studi||materi||growth||children,1||igf1 igf1||igf1 igf1 igf1 igf1||1 diabet igf1||1 diabet||result igf1 1 1||1 igf1 3||type 1||1 igf1 10||1 igf1 tag-snp||result igf1 igf1 igf1||igf1 8 igf1||type 1 diabet||method igf1 igf1||hypothesi igf1 igf1,0.056||0.046||0.046||0.043||0.042||0.04||0.039||0.037||0.035||0.035||0.035||0.034||0.034||0.031||0.031,0.0,0.0,0.06666666666666667
810,Intensive_Care_Med-4-1-2271079.txt,bdi-ii||posttraumat stress disord||follow-up||younger age||ies-r||stay||final model||questionnair||instrument||abdomin sepsi||secondari periton||model||studi||depress||patient||sepsi||multivari model||major comorbid||develop||risk||memori||intens care||event||ptss-10||traumat event||initi emerg laparotomi||previou 3 year||hospit||age||hospit ward||median apache-ii score||factor||predict||nomogram||symptom||ptsd||diseas||icu||periton,1||2||3||stress||intens care||studi||intens care patient||ptsd symptom 1||1 month||stress disord||respons 1 tabl 1 associ||refer 1||j.reitsma@amc.nl 1||4||patient,0.018||0.014||0.013||0.013||0.011||0.011||0.011||0.01||0.01||0.01||0.01||0.01||0.01||0.009||0.009,0.2,0.2,0.2
811,Sleep_Breath-4-1-2211364.txt,srbd||oral applianc||sleep-rel breath disord||posit||dgz||posit paper||snore||mandibular advanc devic||obstruct sleep apnea||effect treatment option||treatment||dental sleep medicin||upper airway resist syndrom,sleep||1||sleep breath sleep||sleep medicin||sleep apnea||patient||treatment||sleep research||germani 2 offenburg||sleep physician||individu patient||dental sleep medicin||sleep medicin report||germani 3 hern||intern sleep societi,0.041||0.032||0.029||0.027||0.023||0.023||0.022||0.022||0.021||0.021||0.021||0.02||0.019||0.018||0.018,0.0,0.1,0.13333333333333333
812,Neurochem_Int-2-1-2194163.txt,effect||control||synapt transmiss||applic||amplitud||capsazepin||drug||glutam releas||data||glutam||studi||wild type||spontan epsc||capsaicin||epsc,1 1||1||fig. 2 1 1 1||2006 1 1 1||fig. 3 1 1 1||fig. 4 1 1||1 1 ac||fig. 2 1||2||2000 1 2 fig. 1||2006 1||fig. 4 1||1 caterina||2002 1 1 sasamura||1 Rs,0.056||0.056||0.045||0.045||0.042||0.039||0.039||0.038||0.035||0.035||0.033||0.033||0.032||0.03||0.03,0.0,0.0,0.0
813,Purinergic_Signal-3-4-2072924.txt,singl channel||model||kinet,2||7 receptor||7 7 receptor||1 receptor||7 7||7||4 2||2007 2 4 7 receptor||4 receptor channel||1 3 receptor||1||channel||p2x receptor||2007 1 2 3||7 receptor embo,0.04||0.037||0.036||0.035||0.032||0.032||0.032||0.032||0.031||0.03||0.028||0.027||0.027||0.026||0.025,0.0,0.0,0.0
814,Eur_Arch_Otorhinolaryngol-3-1-1914238.txt,cancer||troubl||qlq-h||qualiti||studi||patient||tongu||neck cancer||speech||teeth||comorbid||classif||tumor site||function deficit||impact||present studi||treatment||tongu mobil||pain||wors score||function statu||ill||major impact||singl item||oral caviti||oral tumor||score||hrqol||function||gener popul||result,1||2||cancer||function||3 2||1 16||refer 1||neck cancer||function statu||springer-verlag 2007 introduct 1 2||neck cancer patient||2 35||oral function||2a 2||result sampl descript 1 2,0.03||0.025||0.02||0.019||0.017||0.017||0.017||0.016||0.014||0.014||0.014||0.014||0.014||0.013||0.013,0.4,0.4,0.26666666666666666
815,Eur_J_Pediatr-3-1-1802727.txt,placebo||respons||infant||efficaci||baselin||good clinic practic||studi||data||patient||bodi temperatur||gener state||probiot||trial medic||ecn||treatment||day||health||stool||treatment group||placebo group||nissl 1917||group||present trial||differ||acut diarrhoea||bodi weight||diarrhoea||number||trial||toddler||acut gastroenter||children,1||2||2 2||patient||4||3||4 year 1||3 year 1||4 fig. 4||3 fig. 3||1 year 1 ml||4 year||treatment 2||studi 3||2 2 fig. 2 diagram,0.021||0.018||0.018||0.017||0.017||0.017||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
816,Purinergic_Signal-3-4-2072925.txt,mechan||subtyp||role||neural stem cell||releas||patholog condit||central nervou system||atp||biolog function||develop||process||synapt transmiss||embryogenesi||cn||astrocyt||cell prolifer||express||calcium wave||differenti||cell||rat||physiolog||prolifer||approach||antisens oligonucleotid||glial cell||hippocampu||neuron||specif agonist||activ||rat hippocampu||earli stage||import||purinerg||knockout anim||purinerg receptor express||pathway||glutam||antagonist||purinerg receptor||result,2||2 1 2||1 2||receptor||1||cell||3 2 receptor||3 receptor||2 56 2||purinerg receptor||7 receptor||purinerg receptor cell membran receptor||cell membran receptor||atp receptor||receptor activ,0.026||0.026||0.025||0.024||0.024||0.024||0.022||0.019||0.018||0.017||0.017||0.017||0.016||0.016||0.015,0.0,0.2,0.13333333333333333
817,Exp_Brain_Res-4-1-2257995.txt,measur||lowest intens||studi||motor cortex||effect||correl||mep||variabl||interhemispher inhibit||activ condit||motor hotspot||tm||inhibit||transcrani magnet stimul||sici||motor system||corticospin output||age||corticospin excit||subject||chang||fdi||activ||intens||older individu||function imag studi||ihi||pathway||hand,1||2||2 chang||2007||2006 2003 2006 2007||chang 2 chang||2007 chang||chang 2006 2002 2003 2006 2007||chang||motor||2002 2006 2006 2006 2005 2003||chang chang chang ihi||2007 2004||result 1||1 reflect,0.025||0.021||0.019||0.019||0.018||0.018||0.018||0.017||0.017||0.017||0.016||0.014||0.014||0.014||0.014,0.0,0.1,0.06666666666666667
818,Dig_Dis_Sci-3-1-1914226.txt,tumor||rectal examin||signific medic histori||rectal gist||constip||calculu||gastrointestin stromal tumor||gist||abdomin pain||rectal tumor,2||1||3||eur radiol 2 2||conclus 1 3||2007 1 3 4 9||fig. 2 arrow||5||refer 1||5 low risk 2||fig. 3 arrow||10 5||3 oâclock||4 cm||13,0.053||0.047||0.038||0.032||0.03||0.029||0.028||0.026||0.026||0.025||0.023||0.021||0.021||0.02||0.018,0.0,0.0,0.0
819,Crit_Care-9-1-1065098.txt,attent||oper manag||role||regard||protocol||icu director||icu physician||ethic challeng||nurs manag||ethic topic||decis||review||articl||nurs||profession||intens care||manag||paper||polici||clinician||literatur||director||intens care unit||search||ethic||issu||difficult decis||physician||resourc alloc||dilemma||ethic dilemma||critic care||icu||clinic issu,result 1 1||2 0 1 0 3||ethic||3 1 0 0 4||care||8 1||critic care ethic||1 critic care medicin||manag ethic||ethic role||icu ethic||2 3||ethic issu||gener 10 0 3 0 13||tabl 1 distribut,0.043||0.04||0.04||0.037||0.032||0.032||0.028||0.027||0.027||0.025||0.025||0.025||0.024||0.024||0.023,0.2,0.1,0.06666666666666667
820,Crit_Care-9-1-1065088.txt,administr||case||eh||core temperatur||rate||studi||patient||dantrolen||effect||convent cool||sever case||heat stroke||bodi temperatur||dose||temperatur||treatment||cool||group||hyperthermia||relev studi||exert heat stroke||heat||convent method||result,2||cool||dantrolen||2 mg||dantrolen 3 mg||3||1 2 3 15 22||3 mg||heat||heat stroke||studi||cool rate||dantrolen sodium||dantrolen exert heat||dantrolen treatment,0.025||0.021||0.02||0.019||0.017||0.016||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.4,0.4,0.3333333333333333
821,J_Mol_Evol-3-1-1915622.txt,method||immun system||hypervari domain||secondari structur||select pressur||model||slr method||select||structur||vaccin||amino acid||region||domain||site||phylogenet relationship||analys||stretch||nonsynonym substitut||potenti||local||protein||recombin||outer membran protein||immun studi||posit||codon||sequenc||immun respons||align,2 2||2003 1 2||influenza||tabl 1||2005 2||1 M8||yalelaan 1||2 1 fig. 2. H. influenza||2000 2 2 yang||H. influenza||2 chong||2005||M. 2 1 netherland institut||H. influenza H. influenza bolduc||select,0.025||0.024||0.021||0.02||0.02||0.019||0.019||0.017||0.017||0.017||0.016||0.014||0.014||0.014||0.014,0.0,0.0,0.06666666666666667
822,Eur_J_Epidemiol-4-1-2270357.txt,signific level||set||method||case||scientif find||microarray||problem||data||model||studi||valu||variabl||confound||statist||signific||marit statu||smoke||independ data set||data split||research||analysi||pain||predictor||part||hypothesi fish||independ parti||two-stag analysi||number||epidemiolog hypothes||epidemiolog survey||case studi||hypothes||procedur||statist signific||population-bas survey,1||2 1||part 1||2||part 2||2 site||part||data||pain site||smaller part 1||pain site 3||pain||0.012 1||refer 1||2 pain site 2.292,0.03||0.028||0.026||0.025||0.023||0.023||0.022||0.021||0.018||0.017||0.017||0.016||0.016||0.016||0.016,0.0,0.2,0.2
823,Pediatr_Radiol-3-1-1950215.txt,cowperian duct||mullerian duct cyst||embryolog||urethr strictur||patient||intern sphincter||male urethra||present||vcug||congenit||bladder||diverticulum||male||urethra||urogenit diaphragm||anterior urethr diverticula||valv||anterior||dorsal aspect||urorect septum||anomali,1 1 2 fig. 1 2||fig. 2 4||1||fig. 4 4||8 fig. 8||1 7||urethr anatomi fig. 6||present fig. 20 arrow||9 18 fig. 9||urethra||arrow||21 22 fig. 21 arrow||refer 1||5 6 fig. 5 normal||configur fig. 22 anorect malform,0.031||0.029||0.029||0.027||0.022||0.022||0.02||0.02||0.019||0.017||0.017||0.017||0.016||0.016||0.012,0.0,0.1,0.06666666666666667
824,Cancer_Immunol_Immunother-4-1-2335290.txt,anim||cancer||case||immun system||respons||complic||carcinoma||studi||high altitud||patient||human patient||effect||massiv liber||section||sensit||system immun||metastas||necrot materi||human cancer patient||local edema||dose||therapeut effect||bladder||local treatment||immunotherapi||cell||therapi||treatment||boscc||day||applic||complet regress||sarcoid||local||mice||immun||month||conclus||nasopharyng carcinoma||interleukin-2||tumor||regress||order||cure||function||inject||sarcoma||immun reaction||median surviv time||result,tumor||il-2||tumor cancer||cancer||local tumor||tumor cell||il-2 tumor treatment||1||local il-2||1 2||treat tumor||12 tumor||il-2 therapi||tumor regress||local tumor treatment,0.02||0.018||0.018||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.012,0.4,0.2,0.13333333333333333
825,Childs_Nerv_Syst-4-1-2367395.txt,small ventricl||case||tv||small supraorbit craniotomi||patient||altern||etv||routin procedur||shunt||treatment||slit ventricl||headach||mtv||ventricl||supraorbit craniotomi||hydrocephalu||lamina terminali||report||multipl shunt revis||procedur||supraorbit approach,1||2||case 1||1 year||2 3||refer 1||eyebrow incis case 2 2||3 fig. 3||10 1 23 25||case||follow-up studi 14||shunt||patient shunt||lamina terminali fig. 2 postop photograph||3 day,0.052||0.04||0.035||0.03||0.03||0.028||0.02||0.02||0.018||0.018||0.017||0.016||0.014||0.013||0.012,0.0,0.1,0.13333333333333333
826,Protein_Expr_Purif-1-5-1885977.txt,gene||vector||tap||yellow fluoresc protein||yfp||tandem affin purif||protein||site||gfp||mc||tag||purif||cell,1||2||2 2||protein||dictyostelium||fig. 1||protein complex||protein complex dictyostelium discoideum dictyostelium||complex||4 2 4||3 complex||p.schaap@dundee.ac.uk 1||2 abbrevi||3||protein express,0.032||0.031||0.031||0.027||0.025||0.023||0.023||0.021||0.019||0.018||0.018||0.017||0.016||0.016||0.016,0.2,0.1,0.06666666666666667
827,Biotechnol_Lett-3-1-2045120.txt,crystal||cross-link protein crystal||ara||time||transport phenomena||studi||channel||motion||water||pore wall||amino acid||diffus coeffici||transport||lysozym||protein crystal||solut||protein||residu||analysi||orthorhomb lysozym crystal||simul||molecular dynam||order||diffus||free lysozym||molecul||result,2||1||discuss 2 2||1 2004||13 2||10 2||14 2||2004 2005||2005||fig. 5||1996||2004 2005 2005 3||2000||2004 2002||3 fig. 3,0.027||0.02||0.019||0.019||0.018||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013,0.0,0.0,0.0
828,Pediatr_Radiol-4-1-2292498.txt,grade||administr||urinari tract||imag||kidney||studi||uca||durat||fundament imag||vcug||increas||fundament mode||harmon||vu||cycl||bladder||urethra||advers event||examin||reflux||intraves administr||evalu||contrast agent||vur||renal pelvi||normal salin||levovist||modal||microbubbl||posterior urethr valv||ultrasound contrast agent||grade II||low diagnost accuraci||reflux diagnosi||procedur||vesicoureter reflux||precontrast||children||result,1||1 fig. 1||1 reflux||2||2 3||4||imag||suppl 1||reflux||2007||contrast imag||pediatr radiol 33||pediatr radiol 35||void||pediatr radiol pediatr radiolog,0.019||0.017||0.015||0.015||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.01,0.0,0.2,0.13333333333333333
829,Bioinformation-2-1-2139994.txt,gene||approach||polar side chain||protein||hypothet protein||databas||sequenc||amino acid residu||function||network,protein||2 3 4||materi 1||hypothet protein||refer 1||2007 biomed informat publish group 2007||gene||protein famili||supplementari materi data 1||human hypothet protein||8 5||disord protein||potenti protein||order protein||protein data bank,0.039||0.034||0.03||0.029||0.026||0.024||0.023||0.022||0.022||0.022||0.021||0.021||0.021||0.021||0.02,0.4,0.3,0.2
830,Diabetologia-4-1-2292424.txt,follow-up||diabet foot diseas||diabet||heal||individu||rate||data||model||studi||end-stag renal diseas||year||patient||older age||prospect data||variabl||analys||sensat||eurodial studi||treatment||outcom||infect||esrd||foot ulcer||ulcer||diabet foot ulcer||predict model||characterist||popul||predictor||co-morbid||major amput||peripher arteri diseas||foot||non-heal||presenc||neuropathi||pad||daili clinic practic||result,diabet||1||diabet foot||2||diabet foot ulcer||diabet patient||diabet foot diabet metab||foot||1 year||diabet foot diseas||diabet foot ulcer patient||diabet foot wound||studi||diabet foot infect||1 1 divis,0.022||0.02||0.019||0.017||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013,0.4,0.4,0.3333333333333333
831,Ann_Surg_Oncol-3-1-2077912.txt,time||seer||preval||data||locat||studi||year||patient||distant metastas||head||durat||seer 17 registri||pancreat cancer||epidemiolog||duoden gastrinoma||seer databas||tumor site||small insulinoma||multivari analysi||uncertain malign potenti||seer stage||age||pancreat endocrin tumor||prognost factor||group||islet cell||surviv||seer 9 registri||tumor||neoplasm||registri||islet cell carcinoma||seer program||diseas||diagnosi||pancrea||malign,1||2||seer||islet cell||cancer||islet cell tumor||tumor||4||4 4||2007||refer 1||seer 9||tumor stage 2||seer registri||patient,0.021||0.015||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.011||0.011,0.4,0.3,0.26666666666666666
832,Eur_Radiol-3-1-1914219.txt,filter||measur||coronari angiographi||msct||imag||studi||valu||standard deviat||lumen||increas||vivo studi||cnr||contrast media||contrast materi||smooth||evalu||tissu compon||coronari plaqu||result||vivo model||oil||intracoronari attenu||specimen||snr||attenu valu||germani||coronari arteri||noncalcifi plaqu||plaqu||attenu||convolut||vivo||plaqu attenu valu,2||1||nico 1 2 1 depart||6.4 2 fig. 2||1 mm||2 summari||similar 2||refer 1||eur radiol 1||netherland 2 depart||coronari plaqu||plaqu||1 fig. 1 CX lad LM||tabl 1 summari||solut 3 fig. 3,0.037||0.035||0.024||0.022||0.021||0.02||0.019||0.019||0.018||0.017||0.016||0.016||0.015||0.014||0.014,0.0,0.0,0.13333333333333333
833,Addiction-1-_-2253702.txt,target||measur||effect size||subject norm||tpb||determin||model||studi||expect||ecstasi||review||intent||test||variabl||behaviour||evidence-bas intervent||ancestri approach||control||neg expect||research||associ||theoret framework||attitud||belief||social facilit||drug||posit outcom||public||compound construct,1||1 2||2||1 5||1 4||1 8||1 2 intens||4 2||1 9||2 0.01 2||2 7||tabl 1||1 5 behaviour||2 8||1 0.05,0.042||0.038||0.035||0.028||0.028||0.026||0.026||0.025||0.024||0.024||0.024||0.023||0.023||0.023||0.022,0.0,0.0,0.0
834,Ann_Hematol-4-1-2174523.txt,long travel||author||case||anteced||data||studi||patient||travel||venou thromboembol||vted||relat||plane||variabl||transport||potenti bias||control||meta-analysi||heterogen||associ||bia||factor||episod||methodolog qualiti||hospit patient||systemat review||dvt||result,2||1||studi||3||12 7||11 7 10 13 7||8 11 9 11||8||control||12 12 11||7 10 13||12||4||9||9 14,0.024||0.022||0.022||0.019||0.018||0.017||0.017||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.013,0.2,0.2,0.13333333333333333
835,Arch_Dermatol_Res-3-1-1910890.txt,therapeut option||evidence-bas guidelin||unsystemat literatur search||evalu||aspect||psoriasi||psoriasi vulgari||expert||drug||recommend||guidelin||evid||patient||literatur||treatment||therapi||induct therapi||drug interact,1||2||2 week||week 2||week||dermatol treat 2||5 1||3 week||week 3||1 2 evid||psoriasi||4 week||6 week||LE 1||8 week,0.015||0.014||0.013||0.013||0.013||0.011||0.011||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.009,0.0,0.0,0.06666666666666667
836,Neuroimage-1-5-1971136.txt,quantit histopatholog||measur||visual inspect||protocol||mri||imag||roi||data||studi||valu||patient||volumetr mri data||correl||mtr||patholog block||region||neun||signal||resect tempor lobe||epilepsi||focal epilepsi||paramet||anterior tempor lobe resect||tissu||neuron loss||gray matter||vivo mri||quantit mri||field fraction||analysi||middl tempor gyru||subject||normal||quantit neuropatholog||white matter||neuron tissu||field||neuron densiti||mtr valu||patholog||histopatholog measur,1||1 2 2 1||1 2||2||2 3||1 4||fig. 2||3||tabl 2||fig. 3||2006 fig. 1||tabl 3||4||1 6||registr 1,0.022||0.022||0.022||0.022||0.02||0.018||0.018||0.017||0.017||0.016||0.015||0.015||0.014||0.014||0.014,0.0,0.0,0.0
837,Biochim_Biophys_Acta-2-1-2258317.txt,cytosol||calmodulin||neuron calcium sensor||sampl||CN||data||studi||assay||dephosphoryl||nfat||analys||specif||cell||CN activ||calcium||nfat-gfp||control||pierc||gst||bovin brain cytosol||protein||nc||vitro evid||calcineurin activ||activ||bind||sd dissoci buffer||interact||cam||sd||calcineurin||bind buffer||detect||result,1||2||2 2||fig. 1 2||fig. 1 fig. 1 2||fig. 2 2||fig. 1 fig. 1 fig. 1||fig. 1||fig. 2 fig. 2 2||fig. 2 fig. 2||fig. 2||fig. 3 2||assay 2 2||3 2||1 minut,0.032||0.03||0.03||0.028||0.028||0.028||0.027||0.027||0.027||0.026||0.026||0.021||0.02||0.02||0.02,0.0,0.0,0.0
838,Ann_Biomed_Eng-2-2-1705526.txt,tempor variat||variat||straight tube model||dynam model||time||oxygen transport||flow||veloc||import role||outer||wall||coronari arteri motion||studi||model||gradual increas||wss||motion||dynam curvatur effect||effect||pulsatil flow effect||region||ldl transport||lad||oxygen||pulsatil||ldl||flux||futur studi||factor||speci transport||medial region||arteri||mass transport pattern||curvatur||wall motion||instantan variat||coronari arteri||mass transport||wss pattern||speci||distal region||result,1||2||5 2 1||8 figur 8||8||flow||8 2 39||arteri||9 15 16 2 figur 1||1 27||7 figur 3||15 2 3||1 4 32||Îº figur 2||arteri wall,0.02||0.019||0.017||0.015||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012,0.0,0.2,0.13333333333333333
839,Ann_Biomed_Eng-2-2-1705491.txt,flow condit||system||method||flow||studi||ldv||averag number||view||leukocyt adhes||specif||cell||shear stress||averag||hydrogel||leukocyt||surfac||firm adhes||field||number||interact||molecul,1||1 1 1||1 2||2||2 figur 2||cell||1 2 environ||4 1 3 figur 3||1 min||A. cell||cell adhes||2 integrin||vivo figur 1||refer 1||IL 1,0.027||0.027||0.027||0.027||0.022||0.019||0.019||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.014,0.0,0.1,0.06666666666666667
840,Eur_Radiol-2-2-1766021.txt,level||case||spatial compound||mammography-dens breast||CM enhanc||mri||imag||combin||studi||patient||harmon imag||calcif||tumour vascularis||breast tumour||speckl reduct imag||fundament mode||lesion||focal breast lesion||breast ultrasound||vascularis||thi||tumour||tissu||small tumour||vacuum biopsi||sri||bolu inject||biopsi||chi||digit imag||malign tumour||malign||contrast||breast||detect||tissu harmon imag,1||breast||breast imag||2 1 fig. 2||2||level 1||group 1||breast ultrasound||breast lesion||1 0||imag||3||refer 1||1 cm||breast tissu,0.029||0.021||0.019||0.018||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.015,0.2,0.2,0.2
841,Eur_J_Appl_Physiol-3-1-1914240.txt,surfac emg signal||muscl||high level||knee angl||experiment day||data||studi||voluntari activ||neural drive||muscl length||maxim VA||increas||forc||high contract intens||present studi||twitch interpol||mvc||minor influenc||relationship||voluntari torqu||torqu||contract intens||conclus||subject||emg||herzog||contract||differ||triplet||rsemg||subject popul||angl||rest,1||1 1||1 2 2||2||2001 1 2 3 1997||2 3 fig. 2||fig. 1||subject 1||1997 2004 2||3||2004 1997 2003 2003 2001||torqu||2 3 2001 1994 2003 1997||fig. 3||2 valu,0.026||0.026||0.025||0.025||0.02||0.02||0.02||0.019||0.018||0.017||0.017||0.017||0.016||0.015||0.015,0.0,0.0,0.06666666666666667
842,Biochim_Biophys_Acta-1-5-1906864.txt,cmr||find||particl||lrp||atherosclerosi||studi||cholesterol||effect||increas||receptor||oxid state||top fraction||macrophag||foam cell||lipid||cell||crlp||lactoferrin||ldl||lipid accumul||uptak||apo||accumul||excess ldl||import||decreas||incub||chylomicron remnant||pathway||oxid||phagocytosi||foam cell format||result,fig. 2 fig. 2||fig. 2||fig. 1 fig. 1||fig. 3||fig. 5||fig. 4||fig. 2 fig. 3 tabl 2||fig. 7||fig. 7 fig. 7||fig. 7 fig. 6 fig. 7||fig. 6||macrophag fig. 3 fig. 3||macrophag fig. 2||2||5 fig. 5,0.033||0.033||0.029||0.029||0.027||0.027||0.026||0.026||0.026||0.025||0.025||0.025||0.025||0.023||0.022,0.0,0.0,0.0
843,Matern_Child_Health_J-2-2-1592145.txt,pregnanc||disabl,9||1||6 7 6||8 6||7||3||llc 2006 1 3 4 5||health||refer 1||disabl||13 6 8 11||2||2006 keyword disabl pregnanc women health||2 9 28 10.1300||decemb 7,0.032||0.03||0.026||0.026||0.025||0.023||0.021||0.019||0.019||0.019||0.018||0.017||0.016||0.016||0.014,0.0,0.1,0.06666666666666667
844,Invert_Neurosci-4-1-2413115.txt,crystal||insect||import role||bind site||achbp||subunit||structur||backbon carbonyl||molecular basi||ion channel||neonicotinoid||ctd||vertebr nachr||protein||residu||nitro group||ligand-bind site||hydrogen bond||crystal structur||interact||nicotin acetylcholin receptor||imi||insect nachr,Ls||1 Ls||3 Ls||neonicotinoid Ls 1 2002||Ls 4||neonicotinoid Ls||1 Ls Ls 5 fig. 5||2004 3 2003 1||2004||2||2006||0 Ls||posit 1||2007||black 2007 Ls,0.024||0.024||0.018||0.017||0.017||0.017||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013,0.0,0.0,0.0
845,Pediatr_Nephrol-3-1-1784542.txt,long-term cohort studi||proteinuria||respons||children||rate||studi||renal diseas||cholesterol||patient||lower respons rate||corticosteroid||effect||risk||agent||medic||nephrot syndrom||adult||dose||treatment||therapi||sirolimu||esrd||resist||report||urinari protein excret||kidney function||fsg||diseas||kidney||cardiovascular diseas,3||2||pediatr nephrol pediatr nephrolog||kidney||studi||pediatr patient||refer 1||syndrom||kidney diseas||pediatr renal allograft||nephrot syndrom||renal diseas||angiotensin type 1 receptor||ipna 2006 therapi||nephrot syndrom treatment,0.015||0.013||0.013||0.012||0.011||0.011||0.011||0.01||0.009||0.009||0.009||0.008||0.008||0.008||0.008,0.4,0.2,0.26666666666666666
846,Dysphagia-3-1-1914227.txt,pharyng residu||volunt||data||studi||amount||head||water||viscos||increas||marker||temperatur||percentag||solut||data collect||analysi||bolu||xanthan||deglutit disord||pharyng||differ||refer||substanc||healthi volunt||oral caviti,1||2||2 2||3||llc 2007 1 2||MD 2 1 depart||refer 1||1 millisievert||3 4 14 11 1 12||3 4 5||6 Pt 1||MD 1 bennink||2 male||11||11 11,0.045||0.033||0.033||0.026||0.025||0.024||0.024||0.023||0.022||0.02||0.02||0.018||0.018||0.017||0.017,0.0,0.0,0.0
847,Eur_J_Pediatr-4-1-2234440.txt,hypogonadotrop hypogonad||hypogonad||moebiu syndrom||patient,refer 1||2||2 ml||ml||patient||8 ml||final testicular volum 6||present patient||patient âs famili||testicular volum||15 year||hospit 12||med genet 123:107||case report||newborn âs face,0.054||0.05||0.044||0.038||0.033||0.029||0.022||0.022||0.022||0.017||0.015||0.014||0.013||0.012||0.011,0.2,0.1,0.06666666666666667
848,FEBS_Lett-1-5-1942070.txt,class II histon deacetylas||cell surviv||surviv||role||prolifer||respons||pkc||oxid stress||pkd||regul||pathway||data||express||bcr||present report||activ||cell antigen receptor||cell||essenti role||stress stimuli,cell||fig. 1||1||fig. 2||fig. 3 fig. 3||fig. 3||fig. 4||kinas||fig. 2 2 2||protein kinas||cell activ||protein||cell biol||cell surviv||cell prolifer,0.032||0.031||0.026||0.026||0.025||0.025||0.023||0.021||0.021||0.02||0.02||0.019||0.019||0.018||0.018,0.2,0.1,0.13333333333333333
849,Pediatr_Nephrol-3-1-1805047.txt,crystal||calcium ion||risk||kidney stone||bri||healthi subject||kidney stone diseas||healthi children||statist analysi||age||adolesc||urin||adult||subject||studi||valu||ammonium oxal||bonn risk index||children||result,1||1 2 2 2 2 2||2||9 2||refer 1||3||age||2.66 1||0.02 1||3.1 1||0.13 1||fig. 2||3 fig. 3||children||y-axi 2,0.04||0.032||0.031||0.022||0.022||0.022||0.022||0.021||0.021||0.021||0.021||0.019||0.017||0.017||0.016,0.0,0.1,0.13333333333333333
850,Pediatr_Nephrol-4-1-2335288.txt,gfr||chronic kidney diseas||case||hypertens||ckd||studi||end-stag renal diseas||year||patient||renal diseas||liver transplant||renal insuffici||risk||develop||epidemiolog||cyclosporin||lung transplant||esrd||serum creatinin||hematopoiet stem cell transplant||renal function||liver||transplant||hsct||calcineurin inhibitor||risk factor||diseas||cardiac||cardiac transplant||children,transplant||renal transplant||marrow transplant||liver transplant||heart transplant||lung transplant||renal transplant patient||cardiac transplant||transplant pretranspl||transplant type||age transplant||transplant physician||transplant vari||bone marrow transplant||marrow transplant patient,0.049||0.037||0.031||0.03||0.029||0.028||0.027||0.026||0.026||0.026||0.026||0.025||0.025||0.024||0.024,0.4,0.4,0.26666666666666666
851,Eur_Radiol-2-2-1766022.txt,earli post-op period||time||case||complic||joint||high resolut||mri||aci||imag||high signal-to-nois ratio||cartilage-cartilag interfac||cartilag defect||smooth contour||studi||patient||autolog chondrocyt implant||cartilag repair surgeri||structur||defect||cartilag repair tissu||complet fill||synov||variabl||articular cartilag||delamin||cartilag||signal||defect fill||repair||evalu||paramet||tissu||cylind||graft||adjac cartilag||joint effus||normal||surfac||earli stage||bone||cartilag repair||osteochondr autograft||signal intens||biomechan statu||sequenc||nativ cartilag||techniqu,2||2 1||1||cartilag||2 year||1 year||imag||cartilag repair||3||2 3 4||reson imag||articular cartilag||patient 2 year||articular cartilag repair||1 marlovit,0.019||0.019||0.019||0.017||0.014||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011||0.01,0.2,0.3,0.26666666666666666
852,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2358931.txt,measur||intact joint surfac||tekscan sensor||cartilag defect||contact||motion||effect||defect||forc||pressur||cartilag||stress||bottom||plug||surfac measur||osteochondr transplant||earli osteoarthr||flush level||sensor||weight bear motion||stress elev||weight||condyl||transplant||group||mosaicplasti||bone||border contact pressur||surfac congruenc||full-thick cartilag defect||knee||signific differ||articular cartilag defect,1||2 2||region 1||1 pixel||statist 1||1 result||region 2||1 5 fig. 5||2 statist||refer 1||2 techniqu||3 9 4 2 16||3 3 fig. 3||netherland 2 depart||1 smolder josÃ©,0.038||0.034||0.024||0.023||0.023||0.022||0.022||0.021||0.02||0.02||0.019||0.017||0.017||0.014||0.014,0.0,0.0,0.0
853,J_Mol_Biol-1-5-2098880.txt,muscl||fast||muscl contract||concentr||isoform||rate||releas||S1||data||studi||rabbit||amount||equilibrium||muscl fibr||actin bind||actin||amplitud||elc||adp||fast phase||essenti light chain||reaction||tca||pig||phase||lifetim||actomyosin complex||mhc||regulatori light chain||light chain||fluoresc||presenc||myosin heavi chain||constant||rlc||myosin||bovin,1||1 2||1 BM||1 tabl 1||1 figur 2||2||2 2||figur 1 BM||2 BM||1 BM scheme 1||BM||BM BM||tabl 1||figur 2 BM BM||figur 2,0.039||0.035||0.034||0.032||0.031||0.03||0.03||0.03||0.029||0.029||0.028||0.028||0.028||0.028||0.027,0.0,0.0,0.0
854,J_Neurol-2-2-1705504.txt,genet studi||csf||molecular etiolog||anim model||model||studi||multifactori disord||pathogenesi||human||major||form||congenit||cellular signal pathway||brain||growth factor||molecular genet||gene||molecular||htx rat||genet diseas||cerebrospin fluid||genet loci||cytokin||genet factor||development mechan||hydrocephalu||locu||aqueduct||diseas||cellular prolifer||function,hydrocephalu||1||genet||human hydrocephalu||congenit hydrocephalu||hydrocephalu gene||acknowledg 1 1||hydrocephalu express||hereditari hydrocephalu||hydrocephalu associ||famili hydrocephalu||inherit hydrocephalu||experiment hydrocephalu||x-link hydrocephalu||prenat hydrocephalu,0.027||0.023||0.018||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.2,0.1,0.06666666666666667
855,Plant_Mol_Biol-3-1-1805040.txt,respons||microarray||data||comparison||valu||rice||floral transit||jasmon||express||genotyp||main shoot||present studi||stress||gene||control||salin||tissu||transcript||protein||growth stage||shoot||salt stress||report||toler||salt||agami||root||auxin||stage||plant,1||1 2||2||2 2 2||2 2||1 2002 2 1||plant||1 fig. 1||1 japonica||rice plant||2005 1||1 1 depart||3||plant gene||rice,0.021||0.02||0.018||0.018||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.012,0.0,0.1,0.13333333333333333
856,Immunogenetics-3-1-1914303.txt,host||data||studi||host respons||express profil||express||signific||cell||pmn||infect||gene||mice||transcript||immun||analysi||group||rna qualiti||number||locu||pathway||lung||immun respons,pertussi||B. pertussi||B. pertussi B. pertussi||B.||3 B. pertussi B. pertussi||2 B. pertussi||pertussi 3||1||1 1||B. pertussi infect||1 fig. 1 B. pertussi||2004 bps-3 B. pertussi B. pertussi||B. pertussi inocul||B. pertussi 1949||3 B. pertussi infect,0.035||0.033||0.033||0.031||0.03||0.028||0.026||0.023||0.023||0.023||0.023||0.023||0.023||0.022||0.022,0.0,0.0,0.0
857,Matern_Child_Health_J-2-2-1592140.txt,condit||embryo||asthma||mother||individu||pregnanc||studi||folic acid||concept||effect||risk||advers effect||inform||medic||dose||treatment||therapi||health||preconcept care||women||chronic condit||medic supervis||exposur||health care provid||isotretinoin||drug||drug administr||addit inform||fetu||plan,1||care||effect||refer 1||2 week||studi||pregnanc||drug||1 7 cdc||matern||7||matern medic||pregnanc matern effect 6||medic||4,0.016||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.009||0.009||0.009||0.009||0.009||0.008||0.008,0.2,0.4,0.3333333333333333
858,J_Gastrointest_Surg-3-1-1852390.txt,time||stay||complic||persist dysphagia||studi||dysphagia||seri||patient||convers rate||convers||postop dilat rate||short gastric vessel divis||oper||oper time||cohort||fundopl||short gastric vessel||hospit||dilat||wrap||month||curv||reoper||decreas||laparoscop||seventh cohort||number||surgeon||learn curv||open fundopl||procedur||length||lnf||singl surgeon||laparoscop nissen fundopl||result,1||month||patient||2 month||result 1 1||3 month||2||1 1 dysphagia||12 month||11 month||6 month||10 month||reoper 1 2||9 month||patient underw,0.027||0.025||0.025||0.022||0.02||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.017||0.016||0.016,0.4,0.2,0.13333333333333333
859,Exp_Brain_Res-4-1-2315690.txt,sensorimotor impair||target||obstacl||visual monitor||hemiparet CP||individu||begin||lah||data||studi||prospect control||hypothesi||intermedi fixat||effect||end||visual inform||statist analysi||visuomotor control||respect||control||cerebr palsi||saccad||hemiparesi||task||action||affect hand||experiment group||saccad initi||group||grasp time||number||hand||healthi control||trial||signific differ||particip||movement||object||landmark region||experiment||peak veloc,2||1||control||procedur 1 1 fig. 1||control particip||3||particip||2 3 moa eye||hand||1 particip inform||moa||hand movement||moa 4||fig. 3||section 1,0.02||0.019||0.015||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011,0.2,0.3,0.2
860,Evid_Based_Complement_Alternat_Med-5-1-2249747.txt,mechan||condit||chronic smoker||method||emphysema patient||potenti applic||gsh inhal||studi||patient||sulfit||effect||respiratori diseas||review||potenti concern||antioxid protect||minor side effect||side effect||respiratory-rel condit||dose||inhal gsh||treatment||defens||antioxid||gsh||oxid stress||clinic effect||sulfit sensit||report||optim dose||glutathion||inhal||upper||urin||diseas||lung||lower respiratori tract||pulmonari diseas||articl,1||1 2||gsh||2||inhal gsh||gsh inhal||patient||inhal gsh effect||2 year||3||gsh introduct 1||studi||inhal||2 week gsh||lung,0.02||0.019||0.019||0.018||0.016||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012,0.4,0.4,0.4666666666666667
861,Eur_J_Clin_Pharmacol-3-1-2039832.txt,regress analysi||limit sampl strategi||auc||time||satisfactori predict||ape||lss||popul||tacrolimu||renal transplant recipi||studi||strategi||pharmacokinet profil||literatur||patient||tacrolimu concentr,0||2 0||0 4||0 2 4||2||0 1 4||2 4||1 2 4||21. 0 2 0||20. 0 2 4 0||4||1 4||1||12 0||12 0 12 0,0.057||0.053||0.049||0.049||0.048||0.046||0.044||0.043||0.041||0.041||0.04||0.04||0.04||0.039||0.039,0.0,0.0,0.0
862,Pflugers_Arch-3-1-2137943.txt,respir||anim||cathet||time||trans-diaphragm approach||trans-thorac approach||studi||increas||small amount||netherland||recoveri||mmhg||diaphragm||pressur||mct-induc PH||echocardiographi||rat||control||studi period||pulmonari arteri||cardiac output||ventricl||surgeri||pulmonari circul||respiratori rate||procedur||small burst||heart,2||1||1 1||hypertens 2 2||2 1 depart||anaesthesia 2 2||ventricl 1 1 fig. 1||2 week||1 week||4 4||4||1 23||2 kramer||surgeri 1||autopsi 1,0.029||0.028||0.028||0.021||0.021||0.02||0.018||0.018||0.018||0.016||0.016||0.015||0.015||0.015||0.015,0.0,0.0,0.0
863,Qual_Life_Res-3-1-2039864.txt,program||group differ||measur||rate||baselin||session||studi||attend||effect||vitamin supplement||mci||cognit declin||qol||intervent||community-dwel adult||signific interact||analys||outcom||day||percentag||item||random||daili live||age||subject||exercis||pap||physic health||possibl||activ||intens||group||differ||mild cognit impair||random control trial||trial||particip||supplement||moder intens||vitamin||result,1||2||1 2 3||Z. 1 2 3||1 year||particip 15 1 1||1 inclus||3||refer 1||7||1 week||scienc||4||physic activ||14 25 16 2,0.021||0.019||0.017||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011||0.009||0.009||0.009||0.008,0.0,0.0,0.0
864,Environ_Manage-2-2-1705480.txt,variat||lake||spatial scale||boreal lake||deposit variabl||independ variabl||studi||amount||water movement||effect||stepwis rda||water chemic variabl||total phosphoru||water resid time||process||region||variabl||site||alpin||veget||analys||alpin treeless area||largest amount||variat partit||rda||varianc||treeless land cover||toc||arabl land||natur variabl||water chemistri||stream chemistri||local-scal variabl||partial redund analysi||ecosystem||factor||differ||import||geograph posit||uniqu varianc||stream||anc||aquat ecosystem||interact||landscap posit||lake chemistri||total organ carbon||catchment,2||1||2 2 borcard||combin 2 2 3||factor 2 3||water||2 2 fig. 3 sourc||3||variabl||lake area 2||2 valu||lake 3||stream||water chemistri variabl||2003 1 2 wiland,0.023||0.018||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.011,0.0,0.1,0.13333333333333333
865,J_Gastrointest_Surg-3-1-1852376.txt,origin imag find||metastat site||patient||recurr||patholog find||chemotherapi||sensit||metastas||high risk||extens extrahepat diseas||lesion||nonresect diseas||treatment||neoadjuv chemotherapi||bevacizumab||hepat resect||extrahepat diseas||liver||longer follow-up||tumor||colorect liver metastas||resect||neoadjuv treatment||abdomin CT||fdg-pet||detect||result,2||2 2||1 2||1||group 2||group 2 patient||group 1||0 2 group 1||1 cm 1||group 2 sensit||2 month||2 week||patient||1 cm||1 month,0.035||0.035||0.031||0.028||0.027||0.024||0.023||0.022||0.021||0.02||0.02||0.018||0.018||0.017||0.016,0.0,0.0,0.06666666666666667
866,Neuroradiology-3-1-2039855.txt,follow-up||superior cerebellar arteri||sca||cranial nerv||complic||clinic condit||patient||aneurysm||nerv||treatment||institut||circul||basilar arteri||endovascular treatment||initi angiograph result||complet||occlus||incid||good angiograph||addit||coil||outcom||result,patient||1 patient||3||2 aneurysm||2 fig. 2||aneurysm||method patient 1 fig. 1||2 1 depart||3 month||31 patient||22 patient||33 patient||35 patient||27 patient||angiograph follow-up patient,0.04||0.038||0.032||0.032||0.03||0.028||0.027||0.026||0.025||0.025||0.024||0.023||0.023||0.023||0.022,0.2,0.2,0.13333333333333333
867,Oecologia-4-1-2270359.txt,forag||tarangir||low nutrient||constraint||nutrient||larg tree||sampl||qualiti||domin grass speci||studi||savanna tree||savanna||gener linear model||effect||grass||high fibr content||canopi||veget||lower fibr concentr||ludwig||open grassland||energi||bush||dom||protein concentr||percentag||season||posit effect||nutrient requir||protein||veget zone||wildebeest||herbivor||open field||forag qualiti||requir||linear program model||african savanna||canopi edg||speci||tree||eleph||larg herbivor||maximum fibr intak||result,2||1||1 acacia acacia 1||tree||1999||savanna tree||acacia tortili tree||T. 1 1 depart||part 1||1999 3||2008 acacia tortili tree||1 cynodon cynodon dactylon||1994 2 ithaca||larg tree||1995 1994 1969 2,0.019||0.017||0.013||0.013||0.011||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.009||0.009,0.2,0.2,0.2
868,Naturwissenschaften-3-1-2039849.txt,time||pratt||social carri||model||emigr||strategi||recruit||frank||paramet||late recruit||paper||experi||ant||nest||scout||activ||mallon||rang||revers tandem||fraction||number||tandem||coloni||tandem run,2||1 2||1||model 2||model 1||1 2002 2006||2002 2005 1||2002||3||model||result 2||2 frank||2002 2006||2 fig. 2 top figur||3 2001,0.038||0.035||0.032||0.031||0.028||0.024||0.024||0.024||0.024||0.023||0.021||0.021||0.02||0.019||0.018,0.0,0.1,0.06666666666666667
869,Eur_J_Pediatr-3-1-1876255.txt,middl ear||acut otiti media||studi||patient||year||aom||effect||tympanostomi tube insert||poor long-term prognosi||vaccin||tympanostomi tube||eustachian tube||antibiot||treatment||infect||day||acut inflamm||recent prospect studi||virus||result||age||month||dysfunct||viral infect||amoxicillin||tube||antibiot treatment||ome||episod||nasopharyng aspir cultur||viral test||bacteria||eustachian tube dysfunct,2||2 year||pediatr||1||2 month||2 fig. 2 NP||2 week||2 50||2 43||pediatr 2005 164 1 2 10.1007||year||3 year||3||pediatr otolaryngolog||1 54 fig. 1,0.027||0.02||0.02||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.011||0.01,0.0,0.0,0.06666666666666667
870,Virchows_Arch-3-1-2039817.txt,tumor||mix inflammatori cell||pancrea||cystic mass||case||mural nodul||primari retroperiton||borderlin malign||foci||mucin cystadenoma||mass||cyst||retroperitoneum,1||2 2 1||2||2 case||clinic histori 1 1 fig. 1||refer 1||12 month 2||2 merku||patholog find 2 fig. 2||31-70-3126657 j.merkus@hagaziekenhuis.nl 1 1 depart||10||netherland 2 depart||TR UD 1||2007||cytokeratin 10,0.042||0.04||0.04||0.027||0.025||0.023||0.021||0.021||0.021||0.019||0.018||0.017||0.016||0.016||0.016,0.0,0.0,0.0
871,Eur_Radiol-3-1-2077913.txt,time||thorac aorta||bpm||artifact||roi||imag||studi||patient||chest||acut coronari syndrom||ecg-gating-rel artifact||imag qualiti||ecg-gat chest examin||heart rate||excel inter-observ agreement||evalu||contrast media protocol||slice thick||acut chest pain||data acquisit||ventricl||pulmonari trunk||contrast attenu||attenu valu||dual-sourc CT||coronari arteri||independ reader||attenu||heart||nois||lung||aorta||score,2||1||patient||1 6||imag||3||13 patient||2 mm||patient popul||1 mm||2 imag find||find 2 3 4 5||5||rca 1||imag qualiti,0.017||0.017||0.016||0.014||0.014||0.013||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.01||0.01,0.4,0.2,0.2
872,Purinergic_Signal-3-4-2072910.txt,gene||yeast||pseudogen||posit||evolut||nucleotid||orphan gpcr||receptor||intron||key residu||express||ortholog||specif||analys||agonist||adp||group,12||2007 12 12 12 12 12||12 12 12 12 12 56||1 12||receptor 12||12 3 12||1 2 12||conclus 12 12||1 10 1 12 1 12||12 33 12 2||3 12||12 18 21 12 12||12 4||1 1||1,0.046||0.039||0.038||0.037||0.036||0.034||0.032||0.031||0.03||0.03||0.029||0.028||0.028||0.028||0.028,0.0,0.0,0.0
873,Eur_Radiol-4-1-2270369.txt,signific cad||coronari angiographi||three-dimension imag||origin||variant||intermedi branch||preval||data||studi||patient||anomali||visual||cca||msct-ca||coronari anomali||complex anatomi||popul||anatom variant||diagon branch||number||coronari arteri||variabl number||segment||conu branch arteri,2||1||2 3||2 1 depart||2 18||2 24||fig. 1||2 segment||coronari arteri||2 49.7||2 99.3||2 46.2||3||2 cm 7||1 25,0.03||0.023||0.023||0.019||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.014,0.0,0.1,0.06666666666666667
874,Virchows_Arch-3-1-1888716.txt,common variant||role||find||microarray||variant||sampl||data||studi||ptc||potenti biomark||lesion||express||cluster||gene||tumour||benign thyroid tissu||metallothionein||transcript||molecular patholog||papillari thyroid carcinoma||express microarray studi||group||follicular variant||rna qualiti||function||biomark||classic morpholog||result,1||protein 1||protein||2||thyroid carcinoma||result 1||transcript 1||thyroid cancer||2 gene||refer 1||metalloproteinas 1||1 smyth||1 cahil||1 sherlock||1 streck,0.023||0.019||0.016||0.015||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012,0.0,0.0,0.0
875,Matern_Child_Health_J-2-2-1592248.txt,ecolog model||program||strateg plan||level||commun||behavior||children||knowledg||panel||pregnanc||individu||focu||model||preconcept period||high risk||action step||clinic practic||recommend||provid||intervent||purpos||sector||health||preconcept care||goal||preconcept intervent||women||research||public polici||preconcept health||action||care||member||famili||lifespan||partner||select panel||step||outcom,health||preconcept health||preconcept health care||health risk||care||women health care||women health||preconcept care||health promot||preconcept health promot||preconcept health program||public health||preconcept||preconcept health recommend 9||health outcom,0.046||0.036||0.033||0.029||0.028||0.027||0.027||0.027||0.027||0.027||0.026||0.026||0.026||0.026||0.026,0.6,0.4,0.26666666666666666
876,Mol_Biochem_Parasitol-1-5-1964783.txt,effect||dextran||rna interfer||parasit||defect||pcf||major defect||protein||degrad||rnai||express||arf||lysosom||knockdown||endocytosi,fig. 2||fig. 2 fig. 2||2||fig. 1 fig. 1||fluid-phas endocytosi fig. 2 fig. 2||fig. 2 35||1||fig. 1 T. brucei||2 materi||2007||cell||result||4||lysosom||4 discuss,0.044||0.044||0.042||0.036||0.03||0.03||0.026||0.023||0.023||0.023||0.019||0.018||0.017||0.016||0.016,0.0,0.0,0.06666666666666667
877,Eur_J_Clin_Pharmacol-3-1-2071959.txt,level||method||time||haart||histori||data||studi||patient||bottl||antiretrovir medic||regimen||period||form||failur||mem cap||thirti patient||self-report||hiv patient||treatment||therapi||feasibl||viral replic||low resourc||pilot-studi||reason||pill intak||monitor||botswana||adher||electron monitor||pill,1||2||patient||3 2||1 lamivudin||1 month||refer 1||1 death||100||data 100 100 3 21 1||3||springer-verlag 2007 introduct 1 2||hiv patient||2 week||2 lamivudin,0.038||0.026||0.024||0.021||0.021||0.02||0.02||0.02||0.02||0.018||0.017||0.016||0.015||0.015||0.015,0.2,0.1,0.13333333333333333
878,Histochem_Cell_Biol-4-1-2386529.txt,type||denk||steatohepat||apoptot protein||unpublish data||variant||zatlouk||cytoplasm inclus||omari||mallory-denk bodi||mdb format||studi||patient||aggreg||human||inclus||mdb||degrad||p62||phosphoryl||type II||oxid stress||alcohol||mice||protein||format||liver||hepatocyt||import||ubiquitin||keratin||major constitu||diseas||toxic memori||function,2004||2004 2007 2007||2007||2004 2004 1998 2004 2004 2007||cell||2005 2007||liver cell||1999 2004 2004 2004 2008||2007 2002 2006||2001 2004 2007 2005 2006||2002 2007 1999 2006 2004 2006||liver||1992 2007 2007||liver diseas||2006,0.021||0.02||0.02||0.018||0.018||0.016||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014,0.0,0.0,0.06666666666666667
879,Pflugers_Arch-3-1-1915585.txt,role||endotheli cell||glycosaminoglycan chain||endothelium||dermatan sulfat||delic layer||permeabl||mechanotransduct||glycoprotein||plasma-deriv protein||two-photon microscopi||chondroitin sulfat||hyaluronan||vascular diseas||specif||heparan sulfat||endotheli surfac layer||cell||endotheli glycocalyx||glycocalyx||blood||shear stress||vascular endothelium||specif protein bind||part||number||layer||interact||proteoglycan||patholog||molecul||membran||function||compon,cell||endotheli cell||2||proteoglycan 1||refer 1||1 characterist||endotheli cell glycocalyx||vascular endotheli cell||3||endotheli cell circ||endotheli glycocalyx||decorin 40 1 1 CS||type 1 diabet||endotheli cell interact||endotheli cell membran,0.018||0.018||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.4,0.2,0.2
880,Mol_Syst_Biol-3-_-2174632.txt,biolog||set||ra||block||databas||data||quantit analysi||mutat||motif||oncogene-sign block||mutat frequenc||node||oncogene-sign collabor||tumorigenesi||event||pattern||regulatori relat||downstream||cell||gene||map||protein||analysi||regulatori loop||neutral hub||alter||cancer signal||tumor||oncogene-sign rout||surviv||gene mutat||number||oncogen stimuli||sequenc||function||network||result,signal||tabl||gene||cancer signal||cancer gene||supplementari figur 2||signal gene mutat||supplementari tabl 3 supplementari tabl 4||cancer||figur 1||gene mutat||mutat gene||supplementari tabl 10 supplementari tabl 10||supplementari tabl 7||2005 supplementari figur 3,0.026||0.026||0.025||0.024||0.024||0.024||0.023||0.023||0.022||0.021||0.021||0.021||0.021||0.021||0.02,0.4,0.2,0.2
881,Obes_Surg-4-1-2367390.txt,band||case||morbid obes||gastric band||paraesophag hernia||perfor||complic||sever complic||patient||stomach||gastric perfor,2 3 1 depart||2 day||discuss 1 2 4||2 fig. 2 complet atelectasi||refer 1||netherland 2 depart||simon smitweg 2||1 schutteva herman||netherland 3 depart||2008||31-71-5828903 j.vogelaar@rijnland.nl 1 adhin santosh||5 day||thirteen day||6 month||intrathorac,0.065||0.064||0.054||0.051||0.048||0.047||0.045||0.034||0.028||0.025||0.023||0.021||0.017||0.017||0.016,0.0,0.0,0.0
882,Mol_Biochem_Parasitol-1-5-1906846.txt,sdx||low level||higher level||intern pH||nutrient||depend||pH gradient||exogen folat transport||effect||pyr||assay||parasit||proton gradient||transport||cell||glucos||2â²||npp||uptak||2||folin acid||erythrocyt||buffer||paba||drug||folat||stage||profil||plasma membran||pb||membran||dnp,fig. 1||fig. 3 3||fig. 2||fig. 1 fig. 1 P.||3||1 3||fig. 4 3||1||fig. 7 3||fig. 6 3||fig. 5 3||fig. 6||fig. 5 fig. 5 fig. 5||folat||fig. 4 P. falciparum,0.023||0.022||0.021||0.02||0.02||0.019||0.019||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016,0.0,0.0,0.06666666666666667
883,Purinergic_Signal-3-1-2096771.txt,inflamm||human neutrophil||dc||eosinophil||import role||releas||cell damag||studi||neutrophil||atp||receptor||dendrit cell||migrat||recruit||evid||cell||immun cell||intracellular calcium||nucleotid||chemotact activ||lymphocyt||human immun cell||earli recruit||activ||monocyt||function||immatur||chemotaxin||chemokin||immun respons||purinerg receptor,2||cell||3 4||receptor||45 2||dendrit cell||2007 introduct 3 3 1 2||immun cell||type 1||human dendrit cell||human immun cell||refer 1||mast cell||cell tissu||cell respons,0.034||0.029||0.02||0.019||0.018||0.017||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016,0.4,0.4,0.3333333333333333
884,Eur_J_Nutr-2-2-1705489.txt,digest residu||method||sampl||dsc||experiment condit||studi||model||digest||amount||x-ray||small intestin||experiment paramet||digest product||dynam||lower crystallin||glucos||starch||experi||mechan stress||ham||fraction||substrat||batch||crystallin||lower amount||prepar||vivo,2||1||digest residu 2 1||3||diffract 2 fig. 2||1 fig. 1||starch type 2||digest||starch digest||starch||RS type 2||starch type 3||prepar 1 1 16||1 ml||1 averag,0.031||0.024||0.02||0.02||0.019||0.019||0.019||0.019||0.018||0.017||0.015||0.015||0.014||0.013||0.013,0.0,0.2,0.13333333333333333
885,springeropen-4-1-2200676.txt,mechan||biolog||upregul||find||respons||unigen number||studi||hypertrophi||express level||section||increas||hypox condit||differenti||independ experi||oxygen||cardiac myocyt||hypoxia||gene||zebrafish||normox||oxygen level||chronic hypoxia||group||molecular function||decreas||import||adapt||cch||heart||hyperplasia||gene express||chronic constant hypoxia,2||1||2 2 2 2 concentr||heart 2||2 heart||gene||2005 2005 2||factor 1||growth factor 2||protein||gene express||metabol 2||gene function||2 concentr||section 2,0.023||0.019||0.019||0.017||0.017||0.017||0.015||0.015||0.014||0.013||0.013||0.013||0.012||0.012||0.012,0.0,0.1,0.13333333333333333
886,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1950586.txt,follow-up||time||week||return||studi||labral tear||patient||hockey player||fai||joint motion||sport||femor neck||open surgic approach||treatment||adhes||arthroscop approach||structur abnorm||revis arthroscopi||techniqu||hip||microfractur||averag time||profession athlet||imping||femoroacetabular imping||activ||soft tissu patholog||osseou abnorm||order||acetabular rim||arthroscopi||extens OA||atraumat hip injuri||athlet||cam||hip arthroscopi||pincer||patholog||procedur||debrid procedur||proxim femor neck||acetabular retrovers,1 1||1||1 1 2 2 fig. 1||patient||2 patient||2||1 29||art 1 tenni 1 jockey 1||refer 1||1 golfer||3 patient||1 basebal player||1 footbal player||1 hockey player||7 2,0.033||0.033||0.024||0.02||0.02||0.02||0.019||0.018||0.017||0.017||0.017||0.016||0.015||0.015||0.014,0.2,0.1,0.06666666666666667
887,J_Mol_Biol-2-1-2279226.txt,nativ page||bromodomain||rsc complex||modif||rsc||depend||rate||mutat||studi||atp-depend chromatin||chromatin||effect||increas||lysin acetyl||complex||amino acid||octam transfer||dna||result gener||tail||nucleosom||hydrolysi||histon acetyl||reaction||control||full-length||acetyl||enzym||protein||activ||octam||snf2||histon||transfer||histon tail||effici||atp hydrolysi||addit||purif,figur 1||figur 2||figur 2 figur 2 figur 2||figur 3 figur 3||figur 3||figur 4||figur 5 figur 4||figur 6 figur 4||figur 5||figur 7 figur 7 figur 7||figur 7||figur 6||figur 6 figur 6||figur 1 figur 1 24||1 figur 6 figur 6,0.036||0.035||0.035||0.033||0.033||0.032||0.031||0.031||0.031||0.031||0.031||0.03||0.03||0.03||0.028,0.0,0.0,0.0
888,Int_Urol_Nephrol-4-1-2268719.txt,phosphat control||level||valu||phosphate-bind||serum phosphat level||serum||sever hypermagnesemia||end-stag renal diseas||rang||serum magnesium level||serum phosphat||studi||magnesium||magnesium carbon||patient||hemodialysi||calcium||group,3||3 3||3 3 3||3 3 3 3 3 3||3 3 3 3 2||2 3 3 3||3 3 3 2||2 3 3||3 3 3 group||result 3 3 3||4 3 3||3 2||2 3 3 2||3 3 group||3 1,0.069||0.069||0.069||0.069||0.062||0.06||0.06||0.058||0.055||0.053||0.052||0.052||0.052||0.05||0.049,0.0,0.0,0.0
889,Eur_J_Pediatr-4-1-2413080.txt,syndrom||closur defect||wh||boy||dutch||delet size||age||birth||growth chart||data||studi||weight||sever growth||patient||growth||children,growth||4||growth chart||wh growth growth chart||4 1 depart||growth retard||girl fig. 3 growth chart||sever growth||catch-up growth||specif growth chart||girl fig. 5 growth chart||standard growth chart||4 year||boy fig. 6 growth chart||girl discuss 1 1,0.061||0.047||0.043||0.038||0.036||0.033||0.032||0.032||0.031||0.031||0.031||0.03||0.029||0.029||0.028,0.4,0.3,0.2
890,Eur_J_Pediatr-3-1-1829443.txt,age 3 year||episod||symptom||insulinoma||confusion state||month||gtc||diagnosi||state||seizur||patient,2||5||refer 1||1 fig. 1 ictal eeg||4 year||4 day||10 month||age 3 year||5 month||armenia 2 medic center||diagnosi 5 9 menin gene||child neurolog||beta-islet cell tumor||neurolog manifest||joint medic center,0.034||0.031||0.031||0.028||0.026||0.023||0.021||0.021||0.021||0.018||0.015||0.012||0.011||0.011||0.011,0.0,0.1,0.06666666666666667
891,Qual_Life_Res-3-1-2039822.txt,fsq specif||follow-up||life questionnair||respons||method||questionnair||regard||acut otiti media||poor sensit||paediatr condit||caregiv||year||gener questionnair||mcid||aom||effect||clinic||correl||sensit||nr||valid||function health statu||health||estim||om6||function limit||assess||moder||disease-specif||popul||fh||subscal||chang||sem||gener||nr caregiv||taiqol||fsq||otiti media||episod||inter-item correl||clinic relev||reliabl||frequent episod||chang score||sever diseas||hand||construct||score||hrqol||children,2||1||M.||M. gener||clinic||M. 3||clinic chang||score 1||health||1 graph 1||chang||2 episod||A. M.||L. M.||M. 1 2 schilder ann,0.015||0.013||0.013||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.009||0.009||0.008,0.2,0.2,0.2
892,Neurochem_Res-4-1-2226019.txt,effect||rat cerebr cortex||vesicular glutam transport||vglut||normal morpholog||incub||cultur||cell cultur||amino acid||peptid||transport||quantit analysi||neuron||glutam||cell||rat,1||cell||1 15 1 1 1||neuron cell||2||cell cultur||neuron cell cultur||2 fig. 2||neuron||4 5 5 5||3||3 4 5||immunoreact 1 fig. 1||4||neuron cultur,0.027||0.026||0.024||0.022||0.022||0.02||0.02||0.02||0.019||0.018||0.018||0.018||0.018||0.017||0.017,0.2,0.3,0.2
893,Histochem_Cell_Biol-4-1-2413110.txt,mechan||desmosom||stratifi epithelia||PV pathogenesi||acantholysi||pathogen||desmoglein||specif epiderm layer||desmoglein compens||dsc||cadherin||cell biologist||present||human||desmosom format||rho gtpase||desmoplakin||receptor||dsg||event||adheren junction||cell||junction||intercellular adhes||adhes||gene||pemphigu||plakoglobin||mice||protein||steric hindranc||experi||PV patient||extracellular||tyrosin kinas||bind||keratinocyt||skin||epidermi||PV serum||epiderm split||plakophilin||egfr||desmosom compon||junction complex||autoantibodi||pv-igg||intermedi filament||molecul||compon,cell||cell biol||1||desmosom cell||2006||2007||2007 2007||2 cell||pemphigu||desmoglein 1||cell adhes||desmosom||epiderm cell||2 2006||2007 2,0.016||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.01||0.01||0.01,0.2,0.2,0.2
894,Eur_J_Pediatr-3-1-1914296.txt,robot surgeri||convent laparoscopi||robot||case||techniqu||vur||children||surgic treatment||complic||laparoscopi||experi||treatment||laparoscop techniqu||vesicoureter reflux||patient||open surgeri||submucos tunnel||patient laparoscopist||reflux||group,3||pediatr urolog 1||2||3 23 24 1 fig. 1||refer 1||pediatr urolog 2||2006||urolog||pediatr||3 18 24||22 3 24||fig. 3 extraves approach||patient||reflux patient||reflux,0.033||0.025||0.023||0.023||0.02||0.02||0.019||0.018||0.018||0.017||0.016||0.015||0.015||0.014||0.014,0.0,0.0,0.13333333333333333
895,Pediatr_Nephrol-3-1-1766475.txt,renal osteodystrophi||level||sever lesion||growth hormon||patient||normal rang||parathyroidectomi||recommend||hypercalcemia||intak||normal level||dose||growth||calcium||parathyroid hormon||pth level||phosphat||pth||chronic renal failur||group||pediatr patient||dialysi||upper limit||children,2||2 3 3||1||pth 6 3 1 2||ipna 2005 2 2||recommend 3||2 mmol||2 rÃ¶nnholm||56 57 2 3||3 19 2 24||3 time||36 2 5||3 4 5 6||3 schaefer||ipna 2006 introduct 1 2,0.045||0.039||0.031||0.026||0.025||0.024||0.024||0.023||0.022||0.021||0.02||0.019||0.019||0.018||0.017,0.0,0.0,0.0
896,Matern_Child_Health_J-2-2-1592243.txt,prevent||prepregn plan||preconcept||practic pattern||knowledg||practic||nation recommend||pregnanc||key word||studi||patient||folic acid||risk||behavior pattern||medic||counsel||recommend||provid||intervent||preconcept survey||guidelin||specif preconcept recommend||preconcept care||ntd||effort||women||approach||age||preconcept counsel||prepregn survey||famili||health care provid||survey||physician||pregnanc outcom||nation summit,preconcept||1||preconcept care||preconcept care practic||2||keyword preconcept care preconcept||preconcept care knowledg||health care provid||preconcept care trial||preconcept care innov||preconcept health promot||preconcept health teach||preconcept health curriculum||comprehens preconcept care||preconcept risk,0.024||0.023||0.022||0.019||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015,0.4,0.3,0.2
897,Pharm_World_Sci-4-1-2253652.txt,cancer||complementari treatment option||system||support medic||health care profession||consequ||medic error||system cancer therapi||problem||care process||patient||risk||cancer chemotherapi||oncolog||drug-rel problem||chemotherapi||advers effect||process||specif contribut||prescript||medic||drug regimen||clinic trial||treatment||cancer patient||pharmaceut care||drp||research||analysi||pharmacist||oncolog pharmaci||order||pharmaceut care concept||drug||adr||interact||physician||adher||error||cochran librari,cancer||cancer patient||patient||cancer patient pharm||1||pharmaceut care||cancer care process||2||health care||drug||cancer therapi||cancer chemotherapi||pharm||result 1 3||system cancer therapi,0.02||0.018||0.017||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.012,0.6,0.5,0.4666666666666667
898,Eur_Arch_Otorhinolaryngol-2-2-1705529.txt,flap||periosteum||volum||mastoidectomi caviti||studi||caviti||open caviti problem||cmof||small meatoplasti||eac||eac volum||neo-osteogenesi||fascioperiost flap||patient||year||meatoplasti||radic mastoidectomi||mastoid obliter,1||2 3 fig. 2||3||patient||2||3 4 fig. 4||10 1 8||refer 1||1 week||2 year||3 6 fig. 6 calcif foci||4||patient epithel||springer-verlag 2006||24 patient,0.041||0.033||0.031||0.031||0.029||0.028||0.026||0.023||0.023||0.022||0.021||0.021||0.02||0.019||0.018,0.2,0.1,0.06666666666666667
899,Matern_Child_Health_J-2-2-1592250.txt,report||risk||health||alcohol consumpt||level||women||high rate||alcohol||screen||assess||alcohol-expos pregnanc||age||individu||pregnanc||intervent||fa||effect contracept||fetal alcohol syndrom||bing drink,refer 1||2||4||pregnanc||llc 2006 introduct 1||alcohol||1 consult visit||alcohol-expos pregnanc||studi find||5 drink||health||7 drink||2006 keyword alcohol pregnanc preconcept care||utero 4 5 6 4 www.cdc.gov||studi,0.022||0.022||0.019||0.018||0.017||0.016||0.015||0.013||0.012||0.012||0.012||0.012||0.012||0.011||0.011,0.2,0.3,0.26666666666666666
900,Int_J_Hematol-4-1-2330060.txt,gene||respons||express||activ||cell type||cell,hox||hox gene||hox gene express||gene||keyword hox||rel express hox hoxa2 hox||cell||hox hox hoxd10 hoxd11 hoxd12||method 2 11 3 3||cell activ||s12185-008-0057-8 origin articl hox gene||triplic experi fig. 2||3||homeobox gene||express,0.057||0.043||0.035||0.03||0.03||0.028||0.026||0.024||0.02||0.019||0.019||0.018||0.018||0.018||0.017,0.2,0.2,0.2
901,Gene-2-1-2270349.txt,respir||rate||oligomycin||bioenerget capac||effect||haplogroup||oxid phosphoryl||human popul||cybrid||cell||ident nuclear dna||bioenerget differ||nuclear gene||analysi||mitochondria||differ||intact cybrid||proton leak||atp synthesi||triphenylmethylphosphonium||result,fig. 1||fig. 4 fig. 4||fig. 4||2005 fig. 1 fig. 1||1||fig. 1. fig. 2 Ï||1 Ï||fig. 2. fig. 3 Ï||2||cell||2007 2 4 2||intact cybrid cell fig. 4||1 Ï Ï Ï brand||fig. 4 6 Wu||1990 fig. 4 figs. 2,0.03||0.026||0.026||0.025||0.025||0.02||0.019||0.019||0.017||0.016||0.016||0.015||0.015||0.015||0.015,0.0,0.1,0.06666666666666667
902,Pediatr_Radiol-4-1-2292491.txt,pituitari siderosi||method||mri||place||studi||patient||correl||liver biopsi||myocardium||pituitari gland||iron||time domain||signal intens ratio||relax||iron elimin||age||relaxometri||iron overload||organ dysfunct||liver||relaxometri method||ferritin||order||thalassaemia||tissu iron||chelat therapi||multipl echo||liver siderosi,iron||iron overload||liver iron||iron chelat||1||tissu iron||myocardi iron||iron content||iron store||iron metabol||iron deposit||individu iron||cellular iron||iron load||liver iron overload,0.034||0.022||0.021||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.018||0.018||0.018||0.017||0.017,0.4,0.3,0.2
903,Int_J_Cardiovasc_Imaging-3-1-2048827.txt,TV leaflet shape||measur||TV anatomi||cross-sect view||TV leaflet||leaflet||imag||studi||patient||normal TV||TV annulu diamet||commissur width||assess||analysi||agreement||commissur||tricuspid annulu shape||qualit assess||area||standard two-dimension echocardiographi||suffici||inadequ,2||2 2||1||4 2||area 2||2 normal||1 score||1 2 geleijns marcel||tricuspid valv||valv tricuspid||3||tricuspid||refer 1||31-10-4635498 f.j.tencate@erasmusmc.nl 1 1||patient,0.041||0.041||0.036||0.028||0.025||0.024||0.021||0.02||0.02||0.02||0.02||0.019||0.019||0.019||0.019,0.0,0.0,0.06666666666666667
904,Evid_Based_Complement_Alternat_Med-4-1-1810371.txt,dna damag||anim||consumpt||high level||tobacco smoke||year||regular intak||effect||risk||period||latent period||epidemiolog studi||dose||evid||non-smok||cell||tea||smoke||day||tobacco||carcinogen||mice||long durat||human trial||exposur||cup||smoker||lung cancer||trial||chemoprevent effect||green tea,cancer||1||2||tea 2||tea||studi||lung cancer||cancer chemoprevent cancer||green tea||1 cup||tabl 1||tabl 2||jphc studi cancer||cancer risk||2 50,0.03||0.027||0.027||0.027||0.026||0.025||0.022||0.021||0.02||0.019||0.019||0.019||0.018||0.018||0.017,0.2,0.3,0.2
905,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2226194.txt,studi||patient||flexion||postop knee kinemat||rotat||stair ascent||signific||dynam stair activ||knee arthroplasti||posterior cruciat||control||stair activ||activ||tibial rotat||group||differ||ligament||knee||knee kinemat||previou report||condylar contact||static knee flexion||averag center||spreader||posterior||anterior femor translat||techniqu,knee||1||knee arthroplasti||knee kinemat||4||2||total knee||knee arthroplasti kinemat||method 1 2 fig. 1||total knee arthroplasti||knee joint||knee motion||4 fig. 4 knee motion||knee societi||5 4,0.036||0.033||0.026||0.023||0.023||0.022||0.022||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.019,0.6,0.3,0.2
906,Trans_R_Soc_Trop_Med_Hyg-1-5-1950430.txt,unpublish data||preval||pregnanc||aor||sampl||studi||effect||malaria||stool sampl||hiv infect||infect||hookworm infect intens||hookworm||women||estim||analysi||anaemia||associ||moder||intens||import||uganda||epg||helminth||trial||hiv||result,1||1 1||women||tabl 1 associ||1 0.0002 1 0.014 2||1 month||figur 1||1 319||1 0.025||1 0.049||1 0.060||1 0.127||1 0.966||1 0.980||pregnanc tabl 1,0.023||0.023||0.014||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.012,0.2,0.1,0.06666666666666667
907,J_Gastrointest_Surg-3-1-1852375.txt,gastrointestin symptom||case||genit ulcer||ileocec resect||surgic resect||patient||year||seri||intestin perfor||lesion||reperfor||ocular lesion||ulcer||intestin ulcer||age||intestin involv||oral ulcer||symptom||resect||diseas||diagnosi,2||1||resect||3 4||3||ileocec resect 4||method 1 1 2 2||ileocec resect||3 case||case||ileum 3||1 termin ileum 4||ileocec resect 11||ileocec resect 5 4 figur 5||colon 4,0.033||0.031||0.03||0.027||0.027||0.026||0.026||0.025||0.025||0.023||0.023||0.021||0.02||0.02||0.02,0.2,0.3,0.2
908,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998890.txt,gep tumour||tumour||follow-up||administr||fsh concentr||chi-squar test||side-effect||progress diseas||final dose||dose||uptak||patient||treatment||therapi||octreot,3||1||result 177 3 0 3||3 month||follow-up 3||1 1 2||7 gastrinoma 3||patient||grade 1||177||177 177 177||mri 3 month||springer-verlag 2003 introduct 1 2 3||2||refer 1,0.064||0.04||0.038||0.037||0.035||0.034||0.027||0.027||0.026||0.026||0.026||0.026||0.026||0.022||0.022,0.0,0.1,0.06666666666666667
909,Int_J_Colorectal_Dis-4-1-2225995.txt,placebo||certolizumab pegol 400 mg||placebo respons rate||infliximab||efficaci||baselin||studi||patient||life||inflammatori bowel diseas||effect||domain||improv||analys||treatment||certolizumab pegol||offici||crp||symptom||clinic benefit||clinic efficaci||phase iii studi||diseas||hrqol||ibdq||cdai score,diseas||1||2||crohn âs diseas||1 patient||crohn diseas||crohn âs diseas patient||patient||activ crohn âs diseas||4 suppl 1||studi||moderate-to-sever crohn âs diseas||cdp870 crohn âs diseas studi group||3||3 3,0.019||0.018||0.016||0.015||0.015||0.015||0.015||0.013||0.012||0.012||0.012||0.012||0.012||0.011||0.011,0.2,0.2,0.2
910,Naturwissenschaften-3-1-1829419.txt,behavior||ii||studi||ci||serotonin receptor||bee||marker||region||defens respons||receptor||trait||express||ortholog||pollen||analys||defens behavior||gene||clone||map||qtl||ovariol number||cdna||natur variat||influenc||number||candid gene||coloni||behavior genet||step||sequenc,2004||2005||behavior||2003||behavior genet||genet||1||behavior 2006 1 4||2006||1989 2005 2003 2003 2004 2005||4||2||genet map||4 2001 drosophila 2005 4||2 3,0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.012||0.011||0.011||0.011||0.011||0.01,0.4,0.2,0.13333333333333333
911,Neuroradiology-3-1-2082066.txt,axial imag||find||rate||studi||patient||aneurysm||middl cerebr arteri||angiographi||risk||inconclus find||unenhanc CT||treatment||rebleed||intern carotid arteri||endovascular treatment||raw date imag||subarachnoid haemorrhag||surgeri||distribut||ia-dsa||cta||diagnost modal||neg||neuroradiologist||sah||vessel loop||posterior||result,1||1 aneurysm||1 patient||aneurysm||patient||1 2||aneurysm 2||2||1 1 depart||24 1 1||4 aneurysm||4 patient||1 2 3 4||intracrani aneurysm||5 aneurysm,0.029||0.028||0.028||0.027||0.027||0.025||0.024||0.021||0.02||0.02||0.02||0.02||0.018||0.018||0.017,0.4,0.2,0.13333333333333333
912,Purinergic_Signal-3-4-2072913.txt,atp||ntpdase||swelling-inhibitori effect||A1 receptor||extracellular degrad||enzym||retina||receptor||rat retina||releas||neuron||retin parenchyma||ectonucleotidas||nuclear layer||retin slice||glutam||activ||agonist||cell||extracellular metabol,1||3||2007 1 1||1 receptor||4||cell||refer 1||1 31 32 4||2 2||2||16 17 1||glial cell||mÃ¼ller cell||5 5 5||5,0.03||0.027||0.023||0.019||0.018||0.016||0.016||0.015||0.015||0.015||0.014||0.012||0.011||0.011||0.011,0.0,0.1,0.06666666666666667
913,Exp_Brain_Res-4-1-2190788.txt,asynchron AV stimulu pair||respons||tempor ventriloqu||vroomen||locat||spatial dispar||effect||stimulu gener||short exposur phase||visual task||present studi||gelder||spatial separ||jnd||test stimuli||task||pss||exposur||tempor order judgment||keetel||trial||particip||shift||tempor recalibr||sound||result,1||2||stimuli 2 1 fig. 1||2 1 fig. 2 v-first||tabl 1||1 show||2003||3 min||warandelaan 2||test sound||2005||2006||sound||2004||2003 2003 2003a,0.043||0.033||0.03||0.027||0.025||0.025||0.019||0.019||0.019||0.016||0.015||0.015||0.014||0.014||0.013,0.0,0.0,0.06666666666666667
914,Eur_J_Clin_Pharmacol-3-1-1914304.txt,intern databas||case||databas||studi||apd||patient||ror||risk||bodi temperatur||case report||hypothermia||associ||factor||report||literatur search||hypotherm effect||number||drug||adr||risk factor||antipsychot||advers drug reaction||schizophrenia,2||1||2 patient||2 case report||report||2 characterist||case report||case||report 3 34 2||43 2||1 antipsychot drug||result 1||refer 1||1 72||1 1514,0.045||0.043||0.032||0.032||0.025||0.025||0.025||0.025||0.024||0.024||0.023||0.023||0.022||0.022||0.022,0.2,0.3,0.2
915,Int_J_Cardiovasc_Imaging-4-1-2233707.txt,control||LV dysfunct||mad||mitral annulu||studi||nccm patient||laef||noncompact||subject||maa||patient||noncompact cardiomyopathi||LA function||present studi||control subject||nccm||result,1||3||2 3||3D 3||2||data 1 2||3D||3D 3D||refer 1||1 demograph||2007||31-10-4635498 f.j.tencate@erasmusmc.nl 1 1 depart||2de examin 2 2 2||1 2 anwar ashraf||discuss 1 6 9,0.041||0.034||0.031||0.029||0.028||0.027||0.023||0.023||0.022||0.022||0.021||0.018||0.018||0.018||0.018,0.0,0.0,0.0
916,J_Headache_Pain-4-1-2245994.txt,level||olcegep||studi||cgrp receptor blocker||effect||human||increas||cgrp||migrain attack||receptor||relief||side effect||treatment||advers event||headach||trigemino-cerebrovascular system||pain||action||arteri||acut attack||trigemin ganglion||cardiovascular side effect||migrain||triptan||addit||mk-0974||coronari blood flow,1||2||1 67||refer 1||3||pharmacol 2002 434 1||8||2001 909 1||migrain||pharmacol 2000 397 2||pharmacol 2003 481 2||2 49 53 10.1016||2007||migrain headach||ramp pharmacol ther 2006 109 1,0.027||0.023||0.015||0.014||0.013||0.012||0.012||0.011||0.011||0.01||0.009||0.009||0.009||0.009||0.008,0.0,0.1,0.06666666666666667
917,Neurosci_Lett-2-1-2330064.txt,p2i||adp||spinal cord,1||1 fig. 1 1||1 1 fig. 2 1 1||13 1 1 1 1 receptor||2||2 2||fig. 3 1 1||fig. 2 2||1 receptor||4 1||1 12 13||2 2 atmospher||12 13 2 12 13||3||2 Î¼l,0.063||0.056||0.056||0.05||0.049||0.049||0.047||0.044||0.043||0.038||0.035||0.033||0.027||0.027||0.026,0.0,0.0,0.0
918,J_Abnorm_Child_Psychol-3-1-1915626.txt,depress symptom||boy||behavior||good learner||problem||data||studi||earli adolesc||depress||school||peer||effect||human||sport||scale||domain||social hierarchi||relev||girl||research||gender||associ||gender differ||nomin||social group||classroom social statu||differ||high||statu||trail||adolesc||achievement-rel domain||area||depress problem||intermedi||children||result,1||statu||2||peer statu||social statu||statist 1||social psycholog||low statu||high statu||child psycholog||peer statu journal||low peer statu||high peer statu||statu area||depress,0.016||0.016||0.015||0.013||0.012||0.012||0.012||0.011||0.011||0.01||0.01||0.01||0.01||0.01||0.01,0.2,0.1,0.13333333333333333
919,Immunogenetics-4-1-2206249.txt,variat||major indel||dbb||databas||data||studi||gene annot||mann||annot data||loci||region||human genom||cluster||haplotyp sequenc||gene||pgf||annot||analysi||popul||popul level||mhc||cox||qbl||european popul||major histocompat complex||popul genet||segment||mcf||founder haplotyp||diseas||haplotyp||sequenc||mhc refer sequenc,1||2004||method 1 1 1 or2j1 1||haplotyp||haplotyp 2004 2006||haplotyp sequenc||sequenc haplotyp||2006||3||intron 1||suppl 1||sequenc||sequenc hla haplotyp||hla haplotyp||1 hart elizabeth 1,0.019||0.015||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.01||0.01||0.01||0.01||0.01,0.2,0.2,0.2
920,Neurosurg_Rev-2-2-1564192.txt,time||logist regress analysi||radiolog featur||patient||recurr||correl||volum||edema||mib-1||low densiti area||male||cell||growth||potenti||multipl||age||characterist||higher growth rate||tumor||growth potenti||meningioma||independ risk factor||high prolif potenti||index||skull base,1 1 2||1 0 1||3||2||refer 1||mib 1||1 characterist||1 11 19||1 4 4 15||result 1 3 11||13 2 15||0 15 15 1 17 18||15||meningioma||springer-verlag 2006 3,0.032||0.031||0.021||0.021||0.02||0.02||0.02||0.018||0.018||0.018||0.017||0.016||0.013||0.013||0.013,0.0,0.0,0.06666666666666667
921,Purinergic_Signal-4-2-2377323.txt,chlorid channel||releas||data||channel||atp||effect||current||apic solut||treatment||cell||solut||enac||experi||apic||amilorid||activ||atp releas||addit||camp||cftr||monolay,2||2 2||sc||2 3||fig. 2||6 2||10 2||point 2||line 2||physiol cell physiol 275||physiol cell physiol 277||physiol cell physiol 269||physiol cell physiol 272||physiol cell physiol 276||physiol cell physiol 264,0.045||0.045||0.042||0.032||0.03||0.029||0.027||0.025||0.025||0.024||0.024||0.024||0.024||0.024||0.024,0.0,0.0,0.0
922,Histochem_Cell_Biol-4-1-2386528.txt,cancer||role||centriol||studi||centrosom cycl||katanin||complex||cell divis||mtoc||centrosom||mitosi||cell||sperm||cell cycl regul||aurora kinas||numa||research||protein||duplic||associ||spindl||schatten||cell cycl||accumul||centrosom protein||microtubul||number||scnt||centrosom function||formamid||diseas||plk||result,cell||centrosom||cell cycl||cell cancer||cancer cell||cell function||donor cell centrosom||centrosom protein||human cell||cell type||exp cell||mammalian cell||cell system||multipl cell||cell number,0.039||0.027||0.023||0.023||0.023||0.022||0.022||0.022||0.022||0.021||0.021||0.02||0.02||0.02||0.02,0.6,0.4,0.26666666666666666
923,Pediatr_Surg_Int-4-1-2248216.txt,time||major ccvd||abnorm||studi||patient||congenit malform||IM patient||mortal||risk||congenit defect||correct||morbid||age||associ||popul||ccvd||high morbid rate||intestin malrot||IM diagnosi||risk factor||IM surgeri||post-op morbid||cardiovascular complic||syndrom,2||1||IM||3||IM patient||defect 1||IM surgeri||ccvd||patient||ccvd surgeri||associ 2||IM surgeri morbid||284 IM patient||intestin malrot surgeri 3||defect,0.022||0.021||0.021||0.019||0.018||0.017||0.017||0.016||0.016||0.014||0.014||0.013||0.013||0.012||0.012,0.2,0.4,0.26666666666666666
924,J_Interv_Card_Electrophysiol-4-1-2292477.txt,follow-up||chronic success rate||afl||cryoablat||histori||common type afl||data||patient||year||recurr||atrial fibril||atrial flutter||cti||long term follow-up||month||popul||late recurr||long term outcom||cavotricuspid isthmu||procedur||larg popul||acut success,patient||1||3 patient||14 patient||16 patient||11 patient||13 patient||afl patient||6 patient||23 patient||18 patient||patient popul||57 patient||patient group||39 patient,0.034||0.027||0.023||0.021||0.021||0.021||0.019||0.019||0.019||0.019||0.019||0.019||0.018||0.018||0.018,0.2,0.1,0.06666666666666667
925,Mol_Immunol-1-5-2075531.txt,amino acid differ||antibodi||igg||condit||respons||glycan||pbs-t||equin||glycosyl||half molecul||ehv-1||chain||fcÎ³r||region||pbl||reactiv||strong respiratori burst||nip||subclass||residu||hors||human serum||potent activ||bind||reqigg||human igg||elisa||molecul,1||fig. 2 2||fig. 2 fig. 2 sheoran||fig. 3||fig. 4||fig. 2 reactiv||2 2 2 2 burton||1 Î¼g||2004 fig. 8||1993 2 2||fig. 5 sheoran||fig. 3 reactiv||2000 fig. 8||1992 fig. 7 fig. 7||1987 2 2,0.021||0.021||0.019||0.018||0.017||0.016||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013,0.0,0.0,0.0
926,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2082657.txt,attach area||arthroscop view||tunnel placement||line||anterior cruciat ligament||centr||studi||landmark||anatom posit||amb||bundl||anteromedi bundl||plb||double-bundl acl reconstruct||tibia||notch||distanc||arthroscop procedur||tibial attach||acl||femur||attach geometri||notch roof||posterolater bundl||tunnel posit||refer line||posit||intercondylar notch||shallow||knee||area||attach||result,2||4||3||2 tabl 2||1 6 1 6||3 7 3 7||refer 1||tabl 1||tibia 4 5 fig. 4||1 SD||3 mm||surfac 2||tabl 3||M. 4 1 research||cruciat ligament,0.027||0.026||0.025||0.02||0.019||0.017||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015,0.0,0.0,0.0
927,Eur_J_Clin_Pharmacol-4-1-2329724.txt,train programm||addit train||case||skill||session||classic curriculum||person formulari||studi||patient||univers||gener problem-bas curriculum||effect||posttest||treatment||facilit||train||formulari||ration prescrib||patient case||group||differ||prescrib||student||drug||score||result,1||result 1 1||refer 1||2||1 richir||13 1 depart||1 pre||1 barn||1 groot||1 fig. 1 PF EF||1 2 3 4 case||1 2 fig. 2 PF EF||group||intervent 1 4 8||A. 1 wewerink,0.041||0.029||0.022||0.022||0.022||0.021||0.021||0.021||0.021||0.02||0.019||0.017||0.016||0.016||0.016,0.0,0.0,0.06666666666666667
928,J_Comput_Aided_Mol_Des-4-1-2270923.txt,metric||target||set||method||system||popular measur||measur||individu error bar||simpl||studi||valu||question||extens properti||extens quantiti||correl||virtual screen||exampl||intrins properti||test||compound||evid||cost||decoy||independ||properti||goal||approach||varianc||dud||curv||experi||averag properti||experiment design||activ||gener||auc||true posit rare||field||number||perform||screen||bedroc||procedur||extens||design||earli enrich||score||result,2||1 2||2 1||1||fig. 4||4||method 2||1 1 4 21 fig. 1||virtual screen 4 fig. 4||decoy 2||screen||1 differ||3||model||7 2 fig. 2 auc valu,0.02||0.018||0.018||0.017||0.015||0.015||0.015||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.011,0.0,0.0,0.06666666666666667
929,Semin_Immunopathol-4-1-2315689.txt,endotheli cell||role||inflamm||selectin||endothelium||integrin||inflam venul||local microenviron||bone marrow||leukocyt migrat||site||migrat||recruit||express||cystein molecul||separ anatom site||leukocyt adhes cascad||inflammatori site||rpe||cell||retina||adhes||retin pigment epithelium||inflammatori condit||tissu||tight junction||leukocyt||lymphocyt||brb||immun privileg||bind||monocyt||retin antigen||uveiti||eau||molecul||chemokin||function||barrier,1||cell||forrest JV 2||endotheli cell||cxc chemokin receptor 2||refer 1||chemokin||inflammatori cell||chemokin receptor||2006||9 137 1||vascular cell adhes molecul 1||barrier||cell function||retin barrier,0.018||0.014||0.012||0.012||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.009||0.008,0.4,0.3,0.26666666666666666
930,Matern_Child_Health_J-2-2-1592155.txt,program||safe motherhood||infant||pregnanc||intern||matern||reproduct health||inform||health promot||promot||recommend||intervent||countri||safe motherhood initi||health||child surviv||preconcept care||women||polici||care||declar||preconcept counsel||activ||numer factor||famili plan||pregnanc outcom||children,health||3||care||preconcept health care||preconcept health||women health care||preconcept care||3 5||child health||reproduct health intern health||2||1||women health||public health||reproduct health,0.029||0.026||0.023||0.022||0.022||0.019||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.017||0.016,0.4,0.3,0.26666666666666666
931,Int_J_Parasitol-1-5-1885961.txt,method||subolesin||engorg femal||reduct||control group||studi||bm91||femal||egg||total rna||adult||bm86||day||gene||control||larva||analysi||rnai||rel humid||dsrna||group||oligonucleotid primer||tick||inject||rna||result,subolesin||bm86||bm91 subolesin bm86||bm86 bm91 subolesin bm86 subolesin B.||bm86 bm91||bm91 subolesin bm86 bm91 subolesin gene||dsrna bm86 bm91 subolesin bm86||fig. 1 bm91 bm91 bm91 subolesin||bm91||egg bm86 bm91 subolesin bm86||bm86 bm91 subolesin tabl 1||subolesin gene||fig. 5 bm86 bm91 bm86 bm91||bm86-bm91-subolesin fig. 1 bm86 bm86 bm86||bm86 subolesin 82,0.025||0.023||0.022||0.021||0.021||0.02||0.019||0.018||0.018||0.018||0.018||0.018||0.017||0.017||0.016,0.4,0.3,0.2
932,Plant_Mol_Biol-3-1-1876254.txt,nerolidol synthas||monoterpen synthas||jasmon acid||petiol||linalool||trichom||amino acid||terpen||herbivori||leav||nerolidol||product||transcript||protein||enzym||min||cdna||tomato||emiss||spider mite||linalool emiss||root||plant,lemts1||lemts1 lemts2 lemts1 lemts2 lemts1 lemts1||lemts1 lemts2 lemts1||plant||lemts1 lemts2||plant cell plant||2||2 2||gel lemts1 lemts1 lemts1 9||lemts1 express||discuss 2004 lemts1 lemts2 lemts1||lemts1 function||2 lemts1 5 9||1||result lemts1 lemts2,0.028||0.024||0.024||0.024||0.022||0.019||0.019||0.019||0.018||0.018||0.018||0.016||0.015||0.015||0.015,0.2,0.1,0.06666666666666667
933,Virchows_Arch-4-1-2329729.txt,follow-up||atyp intraduct epitheli prolifer||mammographi||core||carcinoma||studi||risk lesion||patient||excis||classic lobular neoplasia||core biopsi diagnosi||calcif||risk||diagnost surgic excis||pleomorph lci||dci||site||core biopsi||lesion||lci||surgic biopsi||women||fibrocyst chang||lobular neoplasia||literatur||biopsi||columnar cell chang||radiolog||malign||diagnosi||breast,1||2||biopsi||core biopsi||LN 1||1 5 mm||core||refer 1||1 extent||breast core biopsi||lobular||core biopsi forty-nin core biopsi||breast biopsi||breast core||needl core biopsi,0.028||0.018||0.018||0.017||0.017||0.016||0.016||0.014||0.014||0.014||0.014||0.013||0.013||0.012||0.012,0.4,0.3,0.2
934,Int_J_Colorectal_Dis-4-1-2225996.txt,respect cytokin||role||respons||real-tim pcr||induct||import role||nuclear factor||strong synergist effect||combin||synergist effect||studi||data||inflammatori bowel diseas||effect||express||cell||protein secret||iec||protein||intestin epitheli cell||cytokin||secret||mrna||chemokin,cell||1||inflammatori cell||5||cell line||immun cell||cytokin 5 5 5 fig. 5||2||transcript 1||caco-2 cell||cell cultur||1 Î¼l||colon epitheli cell||intestin epitheli cell||cell suspens,0.024||0.021||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.2,0.1,0.13333333333333333
935,J_Biol_Inorg_Chem-3-1-2099460.txt,serr||activ site||activ form||studi||state||amount||electrod||spectra||heme iron||electrod surfac||interfaci electr field||Ag electrod||cell||activ enzym||potenti||cyp||solut||enzym||protein||coat electrod||imidazol||potassium phosphat buffer||supplementari materi||intens||buffer||heme||band||presenc||substrat||experiment data||detail structur inform,1||1 2 1||2 1||2 1 2||2||2 2||1 4||1 37||1 3 1 3 22||34 2 2 2||Î½ 4||3||1 37 33 37 1 3||1 materi||1 5 fig. 5 Î½ 4,0.028||0.027||0.026||0.026||0.024||0.024||0.02||0.02||0.019||0.019||0.019||0.019||0.017||0.016||0.016,0.0,0.0,0.0
936,Environ_Manage-4-1-2359833.txt,water sector||government regul||provis||infrastructur||capit shortag||financi risk||servic qualiti||water||develop||maanshan||invest||tariff reform||current landscap||energi||public-priv partnership||water govern||urban water govern||manag||bot project||govern||public util||china||mwsl||servic||joint ventur||wastewat treatment||polici paper||contract||local offici||legal system||bcg||capit||macau||environment state||access||privat sector involv||privat||privat sector||public||particip||maswsc||local resid||construct,water||water sector||water manag||water suppli sector||water suppli||water servic||water govern||2||water sector reform||chines water sector||water util||china water||1||privat sector||water project,0.034||0.028||0.021||0.021||0.021||0.021||0.02||0.02||0.02||0.02||0.019||0.019||0.019||0.019||0.019,0.4,0.3,0.26666666666666666
937,Exp_Brain_Res-3-1-1914263.txt,condit||muscl||trial block||magnitud||orient||effect||space||inform||percept||rel||test||limb orient||forearm||mass||line segment 1||pattern||joint angl||signal||kinesthesi||gravit torqu||mass vector||elbow||effort||static torqu||manipul||torqu||line segment||experi||propriocept||vertic plane||upper arm||limb||inerti eigenvector||trial||particip||error||angl||result,CM||CM CM||CM CM CM CM||3 CM CM||2 CM||3 CM||3 CM 2005 CM CM CM||3 CM 2 1||2||1||3||3 CM 1 fig. 1||7 CM 2||arm CM||3 CM CM fig. 6,0.036||0.036||0.036||0.033||0.032||0.032||0.03||0.03||0.028||0.028||0.027||0.026||0.024||0.023||0.023,0.0,0.0,0.0
938,Plant_Mol_Biol-4-1-2268718.txt,anim||categori||system||depend||environment situat||secondari activ transport||rice||membran transport||nucleosid||channel||ion||transport system||biolog activ||organ||increas||amino acid||diverg||transport||transport gene||specif||cell||gene||divers||control||arabidopsi||protein||environment condit||biolog system||prokaryot||pump||gradient||number||substanc||osmot pressur||bacteria||plasma membran||membran||plant,1||2||2 3||3 2||4 2||1 2 2005||2003 2 2||2 1 1 fig. 1 number||1 2 2001 2003||1 2 1999 2002||3||3 3||system 1 2 E.||4||rice 2 6 6 2,0.041||0.04||0.031||0.031||0.031||0.029||0.029||0.028||0.024||0.024||0.023||0.023||0.023||0.022||0.022,0.0,0.0,0.0
939,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-3-1-1915583.txt,respons||feed respons||host plant||host||concentr||leaf disc||cold receptor||sensit||receptor||compound||behaviour||cell||stimuli||palp||group||rosacea||record||lepidoptera||evolutionari relict||speci||sensilla||adapt speciat||benzaldehyd||larva,2||1 2||Y.||isol 2 2 2||Y. cagnagellu Y.||Y. cagnagellu Y. cagnagellu Y.||Y. cagnagellu||2 Y. cagnagellu 2 1996||yponomeuta Y. cagnagellu||1||2 8 9 2 2||yponomeuta cagnagellu||cell 1||yponomeuta||cell,0.023||0.019||0.018||0.017||0.017||0.017||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.014||0.014,0.0,0.0,0.06666666666666667
940,Eur_J_Nutr-2-2-1705523.txt,anim||week||triglycerid level||model||studi||stanol ester||cholesterol||sesamin||effect||human||atherogen diet||intervent||analys||rat||lignan||mice||serum cholesterol||group||pure sesamin epim||cholesterol reduct||result,1||group 1||2 2||2||1 2 3 4 5||3 fig. 3||tabl 1||refer 1||intervent 1||fig. 2||7||fig. 1 chemic structur||4 group||rat||26 11 11 12 11,0.038||0.024||0.024||0.024||0.022||0.022||0.021||0.021||0.02||0.019||0.017||0.015||0.013||0.013||0.012,0.0,0.0,0.06666666666666667
941,Matern_Child_Health_J-2-2-1592141.txt,risk||cancer||ovarian stimul||chemotherapi||agent||ovarian failur||icsi||women||radiat therapi||ovarian tissu||radiat||fertil||rate||pregnanc||chemotherapi agent||young cancer survivor||treatment,cancer||breast cancer||cancer treatment||refer 1||pediatr cancer||childhood cancer||4||fertil||fertil preserv techniqu 1||breast cancer patient||1 fertil preserv option||young cancer survivor||llc 2006 introduct 1 2||4 5||earli breast cancer,0.033||0.022||0.021||0.02||0.02||0.02||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.016,0.2,0.2,0.2
942,Pediatr_Nephrol-3-1-2100434.txt,igfbp||level||final adult height||ckd||growth hormon||renal failur||patient||end-stag renal diseas||insulin-lik growth factor||effect||ghrelin||rhgh||growth failur||treatment||growth||glomerular filtrat rate||protein||GH resist||renal function||linear growth||transplant||resist||igfbp displac||age 6 year||GH receptor||axi||children,growth||1||growth hormon||2||growth factor||growth failur||insulin-lik growth||growth hormon treatment||insulin-lik growth factor 1||2 3||recombin growth hormon||introduct 1 2 4||normal growth||serum growth hormon||growth hormon resist,0.036||0.03||0.027||0.026||0.024||0.023||0.022||0.022||0.022||0.021||0.019||0.019||0.019||0.019||0.019,0.4,0.3,0.2
943,J_Biomol_NMR-3-1-2039844.txt,variat||order paramet||bond||data||motion||residu dipolar coupl||ensembl||rdc-probe order paramet||addit motion||dynam||rdc||dma||rdc-probe dynam||liquid crystal nmr spectroscopi||protein||molecular align||charg distribut||direct||intern fluctuat||ubiquitin||net electr dipol moment||dispers||bond fluctuat||molecular align fluctuat||molecul||align,2||2 1 2||1||2 4||2 fig. 2||2 NH 2||4 1 2003||protein||LS 2 2 Î± 2006||fig. 1||protein align||LS 2||2 valu||model 5 2||4,0.027||0.026||0.023||0.02||0.02||0.02||0.017||0.017||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.0,0.1,0.06666666666666667
944,Purinergic_Signal-3-4-2072911.txt,antibodi||pma||oocyt||direct pkc-mediat phosphoryl||pkc site||atp||current||final concentr||immunoblot||pkc||receptor||phosphoryl||cell||reaction||p2x receptor||protein||min||sds-page||germani||site-direct elimin||immunoprecipit||result,2||2 3 2||3 2||2 3||3 3 2||3||2 3 2 3 X.||2 fig. 2 2 3 X.||2 3 subunit||2007 3 2||24 2 2||2 3 antibodi||3 2 23||discuss 3 2||2 receptor,0.075||0.074||0.073||0.073||0.073||0.072||0.061||0.052||0.051||0.05||0.05||0.05||0.049||0.049||0.048,0.0,0.0,0.0
945,Pflugers_Arch-4-1-2270919.txt,fluoresc imag||order||sscm||pit||membran||method||caveola||fluoresc||endocytosi||high resolut||topograph imag||microscopi||topographi||imag||flotillin||high resolut imag||cell||endocyt pit||surfac||indent,1||2||sscm 2 2 2 2||3||flotillin 1||5||22 fig. 1||sscm 3 3 3 fig. 3||2 2 16 5||refer 1||sscm 1 6||cell||sscm 5 fig. 5||fluoresc||caveolin-gfp fluoresc 3 3 3,0.034||0.023||0.021||0.02||0.02||0.02||0.019||0.018||0.018||0.018||0.018||0.017||0.017||0.016||0.016,0.0,0.0,0.13333333333333333
946,Int_J_Legal_Med-3-1-1794629.txt,y-str||divers||dys643||dys576||loci||tabl||individu||dys481||studi||dys570||intermedi allel||simpl loci||intermediate-s size,2||1||2 5 2 3||2 10 2 10 4||2 taq 1||5 7 1 1||result 2 3 10 1||3||10||1 min||2 variat||refer 1||multiplex 1||1 Î¼l||1 loci,0.044||0.039||0.035||0.031||0.029||0.029||0.028||0.026||0.025||0.025||0.024||0.023||0.023||0.023||0.023,0.0,0.0,0.0
947,J_Mammary_Gland_Biol_Neoplasia-3-1-1820839.txt,upar||transgen model||cancer cell||cancer||role||person commun||transgen||unpublish data||involut||latent growth factor||breast cancer||mmp||studi||model||defici||heterogen genet background||plasminogen||develop||proteas intervent studi||dci||human||stromal cell||similar express pattern||transgen mous model||express||metastasi||similar||cell||singl transgen||protect role||growth factor||mammari epithelium||mice||proteas||extracellular proteas||gene defici||entir gland||activ||tumor||genet alter||mammari gland||PA system||gland||breast||stroma||mammari cancer,cancer||cancer cell||mammari cancer||breast cancer||cell||breast cancer metastasi breast cancer||transgen mammari cancer||transgen breast cancer||mous breast cancer||1||breast cancer model||human breast cancer||cancer cell prolifer||metastasi cancer||breast,0.02||0.017||0.016||0.016||0.015||0.013||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012,1.0,0.5,0.4
948,Eur_J_Nucl_Med_Mol_Imaging-4-1-2275776.txt,collim||independ predictor||variat||delay||mibg||imag||centr||studi||patient||durat||heart failur||nyha classif||acquisit||present studi||neg correl||ratio||paramet||analysi||prognosi||associ||subject||acquisit paramet||differ||inject||result,123 123||123||123 123 123 123||123 1||1||123 15 123 123||123 123 15 123||tabl 1 123||123 14 123||conclus 123 123||0.0001 1 123||123 15 23 123||analysi 123||heart||3,0.034||0.034||0.034||0.032||0.03||0.028||0.028||0.025||0.024||0.023||0.022||0.02||0.02||0.019||0.019,0.0,0.0,0.0
949,Pituitary-3-1-1915635.txt,cortisol level||week||surgic treatment||data||visual field defect||patient||year||defici||process||defect||pituitari macroadenoma||recoveri||improv||progress improv||non-funct pituitari macroadenoma||nerv compress||treatment||eye||visual outcom||assess||month||surgeri||visual field recoveri||optic chiasm||visual field||initi surgic treatment||visual acuiti||transsphenoid surgeri,1||1 year||1 patient||A. 1||result 1||refer 1||M. 1 1 depart||3||fig. 1||1 cm||A. 1 honkoop||2 year||1 vd klaauw||31-71-5248136 o.m.dekkers@lumc.nl 1||1 year premenopaus women,0.053||0.033||0.033||0.029||0.029||0.028||0.028||0.028||0.028||0.027||0.02||0.02||0.018||0.018||0.018,0.0,0.0,0.0
950,Qual_Life_Res-3-1-2039790.txt,hospit anxieti||cancer||measur||endoscopi||time||level||upper GI endoscopi||burden||distress||baselin||patient||depress||cancer surveil test||potenti determin||potenti adapt||anxieti||surveil||pattern||signific||specif distress||lower distress||specif||sedat||gener distress||barrett esophagu||pain||upper gastrointestin||reason||group||differ||symptom||discomfort||procedur||depress score||time point||score||upper gastrointestin endoscopi,patient||1||CA patient||NS patient||patient group||patient respons||patient 16||CA||result patient||endoscopi||3||patient characterist||82 patient||NS CA||patient request endoscopi,0.025||0.021||0.021||0.018||0.018||0.016||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.013||0.013,0.2,0.2,0.13333333333333333
951,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2042026.txt,follow-up||case||radiograph||bear||studi||year||surviv rate||patient||oper||anteromedi pain||averag||loos femor compon||pain||averag flexion||compon||tibial compon||osteoarthr||surgeon||knee||procedur||revis||score||outcom||result,knee||2||1 year 3||1 oxford||method 1||unicompartment knee||refer 1||3||bear 1 revis||knee arthroplasti||2 mm||bear knee||result knee societi score knee score||4||score,0.028||0.027||0.024||0.022||0.02||0.02||0.02||0.019||0.019||0.018||0.018||0.018||0.017||0.017||0.017,0.2,0.1,0.13333333333333333
952,Pediatr_Nephrol-3-1-1766478.txt,blood flow||acut renal failur||cathet||hypoglycemia||expertis||complic||ultrafiltr||rate||patient||dialysi therapi||glucos solut||multi-organ failur||clinic circumst||volum||blood pressur||continu supervis||guidelin||cvvh||arf||therapi||blood||solut||fluid||free flow||dialysi fluid||care||renal function||standard time||hemodialysi||choic||intens care unit||good practic||renal replac therapi||access||prefer therapi||hemofiltr||periton dialysi||blood flow rate||dialysi||extracorpor circuit||buffer-fre solut||extracorpor techniqu||circuit||renal unit||children||techniqu,2||1||1 2 3||suppl 2||2 40||2003||suppl 1||renal failur||pediatr patient||pediatr nephrol pediatr nephrolog||4||renal 2002 failur||latvia 2 children||renal med||acut renal failur,0.024||0.017||0.016||0.016||0.014||0.013||0.012||0.011||0.011||0.011||0.01||0.01||0.01||0.01||0.01,0.0,0.0,0.06666666666666667
953,Purinergic_Signal-1-2-2096532.txt,guanosine-depend neurit outgrowth||cyclic gmp||neurit outgrowth||heme oxygenas||pc12 cell||nitric oxid synthas||ngf||carbon monoxid||guanosin||PC 12 cell,cell||1||pc12 cell||3||2||figur 3 1||neuron cell||pc12 cell treatment||figur 2 1||pc12 cell cultur||pheochromocytoma cell||glial cell||human cell||synthas pc12 cell||endotheli cell,0.022||0.018||0.016||0.016||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.012||0.011,0.2,0.1,0.06666666666666667
954,Matern_Child_Health_J-2-2-1592153.txt,prevent||set||level||behavior||practic set||knowledg||practic||pregnanc||patient||folic acid||preconcept care visit||nonphysician hcp||variabl||provid||hcp||ntd||women||age||correct amount||care||predictor||multivitamin||health care provid||survey||public health servic||particip||physician,1||provid||health care provid||health||2||1 provid type||care||refer 1||health care provid outreach||health care provid dialogu||provid variabl||provid age||result 1||5||provid group,0.019||0.018||0.015||0.015||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.011,0.4,0.3,0.2
955,Purinergic_Signal-3-3-2096642.txt,wateri diarrhea||larg releas||pathogen||method||uss chamber||host||releas||studi||adenosin||effect||strain||diarrheal diseas||amp||cell||infect||host cell||enzym||experi||phosphat||supernat||activ||host cell death||type iii secret||zinc supplement||revers transcript||secret||cell surfac||minim medium||zinc||addit||inhibitor||rna||epec||phosphat releas,1||3||result 1 1 1||2||cell||4||4 4||fig. 1||3 3 sepz||2 2 2 fig. 2 E.||2 3 2 incub||1 effect||3 lane 4||fig. 3||24 1,0.024||0.021||0.018||0.018||0.018||0.017||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.013,0.2,0.1,0.06666666666666667
956,Extremophiles-4-1-2262144.txt,bacteri enzym||spite||metabol pathway||arginin||enzym gene||dkfp||archaea||prolin||threonin||pyruv||lipid||gene||complet||glucos||enzym||altern enzym||glycerol||phosphat||compar genom||menaquinon||synthesi||lysin||isoprenoid||folat||haloarcha genom||speci||pathway||isoleucin||bacteria||step||haloarchaea,H.||H. salinarum||H. marismortui H. walsbyi H. salinarum||H. salinarum 1989||H. salinarum 1986||mete H. salinarum||N. pharaoni H. salinarum||H. marismortui H. salinarum 1988 2006||haloarchaea H.||halobacterium salinarum||3 N. pharaoni H. salinarum||aspart degrad H. salinarum H. marismortui||green red H. salinarum||lipid metabol H.||2,0.038||0.032||0.025||0.022||0.022||0.021||0.021||0.02||0.02||0.019||0.019||0.019||0.017||0.017||0.017,0.0,0.0,0.0
957,Qual_Life_Res-3-1-2039824.txt,follow-up||high level||measur||time||depress symptom||work absenc||work limit||due||data||return||studi||musculoskelet disord||recurr||baselin||mental||claim statu||health statu||worker||complet recoveri||mental health||disord||rtw||health||wage replac benefit||women||pain||trajectori||intern consist||month||injuri||function statu||multipl outcom measur||rtw statu||limit||statu||particip||disabl||health outcom||score||outcom||result,2||1 2||1||work||month||health||1 month post-injuri||2 item||fig. 2||studi||2 36||6 month||work limit||pain||health statu,0.022||0.021||0.02||0.016||0.016||0.016||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.011||0.011,0.2,0.3,0.4
958,Eur_J_Pediatr-4-1-2234442.txt,joint contractur||clinic phenotyp||ert||earli development mileston||complic||joint||enzym replac therapi||hunter syndrom||studi||idursulfas||patient||life||spleen||placebo-control trial||infus||cn involv||involv result||improv||attenu form||disord||treatment||reaction||gene||gag||mucopolysaccharidosi type II||age||sever airway obstruct||death||challeng||infusion-rel reaction||sever||sever diseas||diseas||diagnosi||mp II||progress,1||2||II||diagnosi 1||therapi||patient||mp II||mp II 2 8 fig. 2||1 mg||3||2 month||refer 1||sever mp II||suppl 1||2007,0.014||0.012||0.01||0.009||0.009||0.009||0.008||0.008||0.008||0.008||0.008||0.008||0.008||0.008||0.007,0.0,0.2,0.13333333333333333
959,Histochem_Cell_Biol-4-1-2248609.txt,mechan||dynamin||role||depend||intern||membran lipid||sandvig||ricin||endocyt mechan||raft||clathrin||actin||complex||toxin||shiga toxin||cell||cholera toxin||rhoa||protein||uptak||flotillin||instanc||caveola||macropinocytosi||plasma membran||membran||endocytosi,cell||2007||2007 2005 2006 2007 2007||2006 2007||2007 1 2007 2001||2006 2007 2005||2007 2005 2007 2005 2005 2006||2005 2005||mdck cell||cell type||2003 2007 2006 2003 2007||cell polar||cell surfac||cell biolog||cell int,0.044||0.041||0.034||0.033||0.03||0.03||0.03||0.024||0.024||0.024||0.024||0.023||0.023||0.023||0.023,0.2,0.1,0.06666666666666667
960,Evid_Based_Complement_Alternat_Med-2-4-1297501.txt,author||men||practic||data||posit result||studi||patient||chronic||acupunctur||chronic prostat||clinic trial||palmetto||treatment||complementari medicin||random||biofeedback||pain||abstract||altern medicin||hyperthermia||symptom||trial||exploratori studi||supplement||pollen extract||herbal||varieti,prostat||prostat 1||1||1 1||chronic prostat||1 3||3 1||prostat categori 2||categori 3 prostat||2||2 2||1 1 hyperthermia||7 1||categori 1||2 3 categori 1,0.028||0.026||0.024||0.024||0.022||0.02||0.02||0.019||0.018||0.017||0.017||0.017||0.017||0.017||0.017,0.2,0.1,0.06666666666666667
961,Eur_Arch_Otorhinolaryngol-4-1-2217619.txt,specimen||valv||closur||bast||structur||open||utriculo-endolymphat valv||duct||3d-reconstruct||object||lip||wall||opfo||utricular side||endolymph,1||3 2 6||system 1 6||refer 1||h.p.wit@med.umcg.nl 1 1 depart||3 1 5 10||3 4 2 20||5||4 5||6||2005 209 1||2002 171 1||2 6 valv lip||7 fig. 7||j.h.segenhout@kno.umcg.nl 1 buytaert,0.045||0.027||0.024||0.024||0.024||0.023||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.017||0.016,0.0,0.0,0.0
962,Purinergic_Signal-3-4-2072914.txt,exocytosi||vesicl exocytosi||clone||camp||nucleotid||pc12 cell||protein||nucleotid releas||noradrenalin||receptor||atp releas||sampl||express||p2i receptor||valu||radioact||cell||cyclic amp synthesi,2||2 2||12 2||3 2||cell||12||3||1 3||12 3 12 receptor||1||12 33 12 2||12 12 receptor||3 12 receptor||2007 2||3 12 14 3,0.03||0.03||0.027||0.027||0.026||0.025||0.025||0.024||0.022||0.022||0.022||0.021||0.021||0.021||0.021,0.2,0.1,0.06666666666666667
963,Photosynth_Res-3-1-2117338.txt,light-harvest complex||posit charg||electron||bond||dipol||water||chl||methylacetamid||complex||oxygenas||electrostat bond||chloroplast develop||backbon carbonyl group||feig||protein||dipol moment||plastid||sidechain||charg||group||specif locat||interact||electron densiti||assembl||lhcp||molecul||ligand||membran||chlorophyl,1||1 2||2||2 2||1 1 fig. 1||2 3 2 3||2002 1||1 3 2 5||3 3 2 3||2 fig. 2||2004||2006||tran 1 2 3||1992 2004 1||3,0.023||0.022||0.02||0.02||0.019||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.0,0.0,0.0
964,Photosynth_Res-3-1-1769345.txt,edg||electron transfer||iron centr||iron geometri||measur||structur||complex||sampl||data||x-ray absorpt spectroscopi||energi||plastocyanin||spectra||cytochrom,1||1 2||2 2 1 2 2 2||2||2 2||iii 1||1 1998||panel 1||3 fig. 2||1999 2||2006||6 2006||1 dÃ­az-quintana antonio 1 1 instituto||3||2 1.97,0.029||0.027||0.026||0.025||0.025||0.02||0.018||0.018||0.017||0.017||0.017||0.016||0.015||0.015||0.015,0.0,0.0,0.0
965,Virchows_Arch-4-1-2329733.txt,valid studi||cancer||case||core||two-class||full section||kappa||marker||slide||paraffin block||express||tma||squamou cell carcinoma||molecular marker||donor block||tissu||escc||analysi||moder||tma core||tumor||agreement||posit,1||0 1 2 3||1 1 0 2 10||2 1 depart||2 1 0 3 10||6. 2 fig. 2||1 4 fig. 1||result 2||2 34||2 overview||5 2 1 8 10||3 fig. 3||7||0 4 0 4||0 11 2 13,0.026||0.023||0.021||0.021||0.02||0.018||0.018||0.018||0.018||0.017||0.017||0.016||0.015||0.014||0.014,0.0,0.0,0.0
966,Purinergic_Signal-3-4-2072920.txt,atp||microglia||role||nerv||spinal glial cell||neuropath pain||receptor||pain||releas||neuron||p2x||evid||phagocytosi||cell||rat,7||4||6 12||12||1||pain||cell||2||neuropath pain||neurosci||neurosci 2004 24 1 7 10.1523||microgli cell||2007 introduct 1 2||refer 1||receptor,0.041||0.034||0.029||0.029||0.028||0.023||0.019||0.019||0.017||0.017||0.017||0.017||0.016||0.016||0.015,0.0,0.3,0.26666666666666666
967,Purinergic_Signal-3-4-2072926.txt,mechan||function consequ||striatum||blockad||bdnf protein||synapt transmiss||hippocampu||bdnf||receptor||bdnf function||bdnf level||hippocamp slice||normal bdnf tone||experiment model,2A 2A 2A||2A||2A KO mice 2A 2A||2A 4 2A Rs||2A 2A 15 16 2A Rs||17 27 28 2A 2A 2A||2A receptor reduc||receptor||2A receptor facilit||refer 1||1 minghetti||exon 1||1 domenici||1 armida||1 pÃ¨zzola,0.037||0.037||0.025||0.022||0.021||0.021||0.02||0.019||0.019||0.016||0.016||0.016||0.016||0.016||0.016,0.0,0.1,0.06666666666666667
968,Semin_Immunopathol-4-1-2315691.txt,crri||creg||inflamm||low level||anim model||studi||transgen mice||inform||mous model||altern||cfh||treatment||eye||complement system||amd||complement regulatori protein||normal tear||protein||vascular endotheli growth factor||rodent eye||activ||cornea||compon||import||age-rel macular degener||uveiti||diseas||result,complement||complement system complement||1||complement system||complement activ||complement factor||ocular complement||keyword complement system complement||complement compon 2||complement compon||complement inhibit||complement inhibitor||mous complement||complement regulatori protein||recombin complement,0.028||0.021||0.02||0.017||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015,0.2,0.1,0.13333333333333333
969,Eur_Radiol-4-1-2292493.txt,match||mammographi||case||sharp margin||brca-mc||rim-enhanc||sporad case||mri||control group||breast cancer||studi||risk||type 3 curv||dci||benign||enhanc kinet||radiologist||lesion||margin||women||carrier||enhanc pattern||age||characterist||brca2||tumor size||group||differ||size||brca1||malign||breast||detect,1||2||breast||breast lesion||breast cancer||1 cm||2 mutat||breast tumor||1 1 430 depart||hereditari breast cancer breast cancer||refer 1||breast malign||1 kok||brca 1||lesion,0.023||0.02||0.019||0.016||0.016||0.015||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012,0.4,0.2,0.2
970,J_Biomol_NMR-3-1-2048825.txt,type||nmr structur ensembl||set||pdb entri||constraint||inter-atom distanc||data||occurr||contact||spectra||inform||sequenc fragment||structur||total||hpc||file||entri||distanc||residu||atom||analysi||distanc inform||nmr||total number||pdb||import||constraint data||number||fragment||noesi spectra||nmr constraint list,2||1||constraint||structur||constraint data||nmr constraint data||data||nmr structur||nmr data||nmr||constraint set||constraint inform||structur inform||data set||nmr analysi,0.022||0.021||0.02||0.02||0.019||0.018||0.018||0.018||0.018||0.017||0.016||0.016||0.016||0.015||0.015,0.6,0.5,0.3333333333333333
971,Neurogenetics-3-1-1820748.txt,myokymia||potassium channel||genet studi||function effect||muscl||clinic||electrophysiolog studi||current||epilepsi||oocyt||episod ataxia||transvers||mutat||mutant crna||famili,3||2||2 2||3 3 fig. 3 xenopu||3 4 7 10 11||type 1||function||electrophysiolog studi||refer 1||kcna1 dde 2 fig. 2||1 day||mutat||genet studi||4 year||express studi,0.031||0.029||0.029||0.022||0.018||0.018||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015,0.0,0.1,0.2
972,Naturwissenschaften-4-1-2270370.txt,non-breed season||coastal||diversif||number||speci diversif||speci||popul||ecolog speciat||sub-speci||non-migr||wader||migratori||studi||environ||area||habitat||migrant||result,1 1 1 1||1||1 fig. 1||1 result||inland||inland boreal 1 19.211||inland wetland||tropic wetland 1 8.547||tropic wetland 1 9.21||migrant inland||wetland||migrant||2||inland stepp 1 5.008 vanellu vanellu||inland stepp 1 5.008 vanellu indicu,0.053||0.053||0.036||0.029||0.023||0.022||0.022||0.021||0.021||0.021||0.02||0.018||0.017||0.017||0.016,0.0,0.0,0.06666666666666667
973,J_Med_Internet_Res-1-suppl1-1761819.txt,visitor||inform||web site||peopl||telemedicin||internet,1 1 univers||sep 1999 19 9 1999 1||1999 introduct||internet||internet work||med internet||internet address||UK||medic internet research||internet search engin||UK health commun||internet hypermedia readership analysi telemedicin||inform||inform resourc||telemedicin,0.077||0.073||0.07||0.047||0.032||0.028||0.027||0.024||0.024||0.021||0.019||0.018||0.017||0.017||0.016,0.2,0.1,0.2
974,J_Digit_Imaging-3-1-2039840.txt,interfac||document||technolog||time||system||phrase||search engin||radiolog report||problem||data||search queri||wildcard||inform||abil||radiologist||user||featur||binari oper||web||queri durat||pac integr||report warehous||solut||medic context||result||user interfac||ri||search interfac||implement||open sourc||report||word||design||index||queri||internet,1||3||3 fig 3||2||2 fig 2||method 1 fig 1||2 5 6||2007||fig 6||report||3 4||index||6||refer 1||3 year,0.022||0.019||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.014||0.014||0.013||0.013||0.012||0.012,0.0,0.1,0.13333333333333333
975,J_Neurooncol-4-1-2174521.txt,transfect||level||data||copi number rel||studi||immunoblot||gain||cell cultur||report plasmid||cell line||overexpress||cell||fish||isochromosom 17q||medulloblastoma||apoptosi||larg cell||chemotherapeut agent||sem||p53||tumor||medulloblastoma growth||amplif||copi gain||result,wip1||wip1 wip1||wip1 2 2 wip1 wip1||24 wip1 wip1 wip1 wip1||wip1 wip1 wip1 wip1 locu||i17q wip1 wip1 wip1||tp53 wip1 tp53 wip1||wild-typ wip1 wip1 5 wip1||wip1 wip1 overexpress||2 2 wip1 2 2||1||2||chromosom 17 wip1 2 2 wip1||wip1 function||wip1 phosphatas,0.034||0.034||0.029||0.028||0.028||0.027||0.025||0.024||0.024||0.024||0.023||0.021||0.021||0.02||0.019,0.0,0.0,0.0
976,Qual_Life_Res-3-1-2039860.txt,demograph characterist||dutch colleg||refer popul||practic||qualiti||studi||depress||earli identif||life||patient||physic function||depress group||complaint||domain||chronic consequ||mental health||descript studi||dutch nation survey||consult||health||unexplain complaint||gp||characterist||popul||gener practic||gener practic popul||group||differ||fatigu,1||patient 1||patient||2||patient group 3||patient group||patient popul||studi group 1||unexplain complaint patient||depress patient||studi||refer 1||gener practic||2007 introduct 1 2||depress patient group,0.024||0.023||0.023||0.018||0.018||0.017||0.017||0.017||0.015||0.014||0.014||0.014||0.014||0.014||0.014,0.2,0.1,0.2
977,Eur_Radiol-3-1-2039819.txt,coronari fly-through||mdct||time||imag qualiti||coronari arteri||dual-sourc CT||high qualiti visualis||post-process||virtual angioscopi||major coronari arteri||major branch||patient||min,1||3||1 fig. 1 larg||3 min||2 3 fig. 2 visibl||patient||2 min||refer 1||hanzeplein 1||twenti patient||6 10 2||bypass graft 1 3||12 13 3||discuss 3||min,0.045||0.036||0.031||0.028||0.027||0.027||0.026||0.025||0.024||0.024||0.022||0.022||0.022||0.02||0.019,0.0,0.1,0.13333333333333333
978,J_Membr_Biol-3-1-1784061.txt,block||ionic strength depend||concentr||data||low affin||studi||channel||gallamin block||amino acid||outer vestibul||electrostat charg||tea||tetraethylammonium||ionic strength sensit||ionic strength||solut||residu||surfac||lysin||surfac electrostat||vestibul||electrostat potenti||interact||gallamin||quaternari ammonium ion||neg charg||result,1||2||figur 2||shaker||shaker shaker channel||shaker shaker 3 figur 3||shaker 1 shaker 5 6||1990 figur 1||channel||1 taglialatela||1991 1 3||2007 shaker shaker||shaker shaker 4 7 figur 7||2 2 guid||figur 4,0.029||0.023||0.023||0.023||0.021||0.02||0.019||0.018||0.018||0.018||0.017||0.017||0.017||0.016||0.016,0.0,0.1,0.06666666666666667
979,Int_J_Biochem_Cell_Biol-2-1-2279807.txt,antibodi||role||stabl cell line||bind partner||rasgap||isoform||eef1a1||protein synthesi function||elut protein||complex||sh3 domain||sh2 domain||cell||phosphoryl||shp2||ciap||protein||bead||non-transl function||incub||interact||codon-depend bind||specif antibodi||eef1a2||function,cell||2005 fig. 2 fig. 2||1||fig. 3||2||protein 2 fig. 2||fig. 4||2003 fig. 1||fig. 3 fig. 3 ann||fig. 2 interact||3||fig. 3 eef1a1||cell signal||vivo fig. 4 fig. 4||total cell,0.022||0.02||0.02||0.02||0.019||0.019||0.018||0.017||0.017||0.016||0.015||0.015||0.015||0.014||0.013,0.2,0.1,0.06666666666666667
980,Eur_J_Pediatr-3-1-2151774.txt,case||alveolar wall ruptur||vomit||patient||chest||alveolar wall||neck||risk||anorexia nervosa||pneumomediastinum||subcutan emphysema||sign||disord||pressur||laryngopharyngoscopi||anorexia patient||literatur||malnutrit||adolesc||spontan pneumomediastinum||secondari pneumomediastinum,2||case 2||1 2 3 4 1 depart||patient 2||2 fig. 2 arrow||2 1 fig. 1 coron||1 2 3 4 heggelman ben||patient 1||1 2 4 5 7 8||netherland 2 depart||refer 1||1 9 8||case report case 1||netherland 3 depart||case,0.089||0.055||0.054||0.053||0.049||0.047||0.043||0.041||0.04||0.036||0.034||0.03||0.029||0.024||0.022,0.0,0.0,0.06666666666666667
981,Soc_Psychiatry_Psychiatr_Epidemiol-3-1-2039804.txt,asylum procedur||lower qualiti||center||preval||qualiti||studi||life||long asylum procedur||psychopatholog||netherland||iraq||physic diseas||iraqi asylum seeker||health||psychiatr disord||post-migr live problem||drug consumpt||servic||care||gener practition||group||factor||visit||import predictor||medic specialist||asylum seeker||physic health problem||disabl||pmlp,health||2||2 health servic||group 2||health servic||2 year||1||mental health||health care||group 1||gener health||physic health||2 month||health problem||mental health servic,0.035||0.031||0.026||0.025||0.023||0.022||0.022||0.022||0.021||0.02||0.02||0.019||0.019||0.019||0.019,0.2,0.1,0.06666666666666667
982,Purinergic_Signal-4-1-2245998.txt,blood flow||vascular tone||similar import||role||respons||hypertens||releas||studi||atp||effect||human||platelet||increas||angiogenesi||heart failur||purin||receptor||p2i||cell prolifer||ectonucleotidas||clinic import||pyrimidin||growth factor||catecholamin||erythrocyt||pathophysiolog||factor||myocardi infarct||purinerg||aspirin||human skelet muscl||heart||sympathet nerv||antagonist||cardiomyocyt||p2x||blood pressur regul,1||1 2||2||1 receptor||2 receptor||receptor||2 6 receptor||1 2 4 6 receptor||1 6||1 2 6 receptor antagonist||4 receptor||cell||6 receptor||antagonist 1||3 receptor,0.028||0.028||0.028||0.026||0.026||0.023||0.022||0.021||0.021||0.02||0.019||0.019||0.019||0.018||0.017,0.0,0.1,0.06666666666666667
983,Eur_Radiol-3-1-1820761.txt,prospect studi||cancer||reoxygen||method||flow||imag||studi||human applic||perfus||develop||hypoxia-direct therapi||abil||radiotherapi||hypoxia imag||treatment||cell||therapi||oxygen||invas techniqu||hypoxia||tumour||cancer patient||blood||tissu||chang||chronic hypoxia||cu-atsm-pet||presenc||vessel||clinic translat||vascular||bold-mri||lead contend||function||tumour cell||techniqu,2||2 2 2 2 18 60||2 2 13 2 14||imag||18||2 15 2 1 16||2 2 40 41||1||2 hour||import 3 4 2||hypoxia imag||4||2 33 64 fig. 4||clinic imag||heterogen 18 18,0.034||0.027||0.022||0.02||0.019||0.019||0.018||0.018||0.017||0.016||0.016||0.015||0.013||0.013||0.013,0.2,0.1,0.13333333333333333
984,Eur_J_Appl_Physiol-3-1-1914232.txt,chronic heart failur||recoveri kinet||method||breath||ventilatori threshold||interv||studi||patient||onset kinet||correl||threshold||test||recoveri||coeffici||chf||paramet||function impair||mono-exponenti model||exercis||onset||differ||clinic purpos||exercis test||respons time||kinet||rest||intra-class correl||reproduc,2 2||2||tabl 2 2||springer-verlag 2007 2 2 2 2||2 2 1987||2 2 2 onset kinet||2 recoveri kinet 2 2||2 2 onset kinet||2 onset||2 2 2005 2001||2 min||2 1996||97 2||2 1995 2 recoveri kinet||2 week,0.042||0.042||0.031||0.03||0.029||0.029||0.029||0.026||0.025||0.024||0.023||0.023||0.022||0.022||0.021,0.0,0.0,0.0
985,Qual_Life_Res-4-1-2275305.txt,level||quantit posit||method||system||instrument||descriptor||isoform||direct quantif||eq-5d||studi||vignett||transform||health statu||mild depress||va scale||health||va continuum||extrem||pain||equidist||mobil||respons scale||untransform equidist||level descriptor||five-level version||respond||health state||dimens||indirect method||respons option||methodolog||sever||score,1||2||health||3||dimens 2||direct method 1 2||1 3 bonsel||indirect method 3 3||refer 1||1 fig. 1 diseas vignett||5||level||health statu||health state||health analysi,0.019||0.017||0.015||0.013||0.012||0.012||0.012||0.01||0.01||0.01||0.01||0.01||0.009||0.009||0.009,0.2,0.1,0.26666666666666666
986,Eur_J_Nutr-3-1-1914246.txt,dutch polici||calcul||level||risk manag||afl||maximum level||public health||model||age group||folic acid||nation survey||risk||vitamin||netherland||fortif||intak||adult||exempt||dietari supplement||energi||msfl||dutch model||toler upper intak level||maximum safe amount||product||micronutri||food||popul||risk-assess model||maximum fortif level||sensit group||dutch commod act||group||european union||safe addit||maximum amount||miner||ul||maximum||rasmussen||children||result,1||children 1||2||1 3 11||1 1 5 6||1 maximum||3||95 1||children||box 1||0.15 children 1||0 children||refer 1||risk||10,0.025||0.02||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013,0.0,0.1,0.13333333333333333
987,World_J_Urol-3-1-1913182.txt,cancer||time||case||men||patient||year||strategi||risk assess||mortal||inform||base||earli age||overdiagnosi||treatment||earli detect||popul||incid||random studi||prostat||possibl||invas treatment||biopsi||nomogram||activ surveil||psa||number||overtreat||screen||procedur||prostat cancer||radic prostatectomi||diseas||detect||result,cancer||prostat cancer||prostat cancer screen||prostat||screen||prostat cancer screen trial||prostat cancer patient||prostat cancer trial||earli prostat cancer||indol prostat cancer||population-bas prostat cancer screen||NS prostat cancer screen||prostat cancer int||prostat cancer diagnosi||prostat cancer case,0.039||0.034||0.032||0.03||0.027||0.025||0.025||0.025||0.024||0.024||0.024||0.024||0.024||0.023||0.023,0.8,0.4,0.26666666666666666
988,Int_Arch_Occup_Environ_Health-3-1-1915641.txt,self-report questionnair||time||larg size||psychosoci risk factor||sick||baselin||model||studi||patient||potenti confound||baselin questionnair||effect||neck||risk||style||upper extrem||sick leav||complaint||increas||sex||effect modif||analys||decis author||regress model||pain||popul||upper extrem complaint||turn||musculoskelet co-morbid||heavi physic work||high||cox regress model||symptom||work||risk factor||long period||wildhagen,1||scale 1||1 month||3||scale 3||3 month||1 week||2||1 year||1 month 36||1 week 5||scale 4||scale 5||pain||1 3 4 bouter lex,0.025||0.02||0.019||0.019||0.017||0.016||0.015||0.015||0.013||0.013||0.013||0.013||0.012||0.012||0.011,0.0,0.0,0.06666666666666667
989,Qual_Life_Res-3-1-1915653.txt,cancer||measur||time||respons||studi||self-present||strategi||question||patient||bit||present||discrep group||chemotherapi||qol||treatment||ann||counter-intuit find||interview||respons shift||small-cel lung cancer||discrep||conflict find||explan||fatigu||respons categori||score||answer||result,2||1||3||4 2||3 patient||box 2||3 3 4||3 femal||3 male||01 femal 42 LD 2 2||patient||refer 1||4 4 3||cancer patient||netherland 2 depart,0.041||0.036||0.028||0.027||0.023||0.022||0.022||0.021||0.019||0.019||0.019||0.018||0.017||0.016||0.016,0.0,0.0,0.06666666666666667
990,J_Mol_Biol-1-5-2082129.txt,condit||time||singl dna-bind cleft||concentr||activ form||plasmid||state||separ molecul||wt||subunit||hexachlorofluorescein||form||sfii||recognit site||complex||site||mixtur||dna||duplex||singl exponenti||fast phase||reaction||enzym||protein||hex||dimer||experi||copi||one-sit plasmid||auc||cleft||substrat||lin||linear product||OC,figur||figur 2||figur 8 figur 1||figur 5 figur 4||figur 4||figur 4 figur 4||figur 8 figur 8 figur 4||figur 8||1 figur 5||1 figur 4||figur 7||figur 6||12 figur 3 figur 3||3 figur 5||36 figur 5 figur 8,0.06||0.043||0.041||0.037||0.036||0.036||0.036||0.036||0.036||0.034||0.034||0.034||0.031||0.031||0.031,0.0,0.0,0.0
991,J_Med_Internet_Res-9-2-1913940.txt,hit||immigr||nation||translat||local languag||url||host||search engin||maiz||rate||human migrat||nutrit||turkish||languag||human health||linguist prefer||sourc||countri||indigen group||page||institut||websit||health||higher rate||tuberculosi||term||food agenc||effort||world||estim||result||english||food||food-rel institut||group||order||avian flu||googl search||world wide web||global agenc||french||onlin health inform||googl||diseas||peopl||schizophrenia||spanish||strong prefer||internet,search||tabl 1||1||tabl 2||2||languag search||search languag||health||onlin search||tabl 3||english search||onlin health search 2006||tabl 5||french search||3 tabl 3,0.026||0.023||0.022||0.022||0.021||0.02||0.02||0.019||0.018||0.018||0.018||0.018||0.017||0.017||0.016,0.0,0.1,0.06666666666666667
992,Purinergic_Signal-3-4-2072916.txt,anim||inflamm||respons||spinal cord injuri||data||studi||effect||section||volum||recoveri||spinal cord||potenti mechan||present studi||treatment||guanosin||rat||day||myelin||microglia||apoptosi||potenti clinic import||inflammatori respons||injuri||cord||secondari patholog event||apoptot cell death||secondari injuri||sci||function,1||cord||spinal cord||spinal cord injuri||3 3||2||fig. 1||injuri||day 1||injuri fig. 3||neurolog function 1 1||spinal cord 8||fig. 2||2 1 depart||secondari spinal cord injuri,0.02||0.019||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.013,0.6,0.4,0.26666666666666666
993,Pflugers_Arch-3-1-1950587.txt,target||respons||epi||stretch-activ channel||endo||wall thick||observ||express||stretch||stimuli||transmur differ||rat||cardiac myocyt||gene||myocyt||protein||mechan stimul||ventricl||region differ||rapid||slow inotrop respons||mrna||heart||gene express,1||1 1 fig. 1||1 2 harrison||1 min||result 1||limit 10 2 1||e.white@leeds.ac.uk 1 1 institut||1 calaghan||2 min||mechanotransduc 12 6 6 1||2 9||12 8 6 2||1 calibr sampl||M. 1 white||tabl 1 comparison,0.057||0.044||0.034||0.032||0.031||0.031||0.03||0.03||0.024||0.023||0.023||0.022||0.022||0.021||0.021,0.0,0.0,0.0
994,Intensive_Care_Med-3-1-1915615.txt,complet recoveri||csf||case||week||differenti diagnosi||lyme diseas||coma||protein||mri||lesion||cell count||diseas||full recoveri||treatment||patient,2||1||case 1||case 1 fig. 1||case||3 1 depart||3||2 week||refer 1||netherland 2 depart||springer-verlag 2007 case 9 6 2||case discuss||brain 2 month||follow-up studi||patient,0.048||0.045||0.038||0.032||0.03||0.028||0.027||0.026||0.025||0.024||0.024||0.022||0.02||0.02||0.019,0.2,0.1,0.13333333333333333
995,J_Med_Internet_Res-6-3-1550604.txt,level||high-school read profici||skill||basic search||grade level||search engin||navig||search term||individu||literaci level||studi||question||effect||read level||difficulti||inform||investig||rectum cancer||abil||site||health inform||web site||method subject||low literaci||health site||health educ||page||health materi||web||health||literaci||term||averag||strong read skill||read abil||experi||subject||text||weak search strategi||materi||group||word||order||search||access||lung cancer||read||particip||think-aloud||googl||answer||health question||internet,health||health question||1||health search||health health care||question 1||health inform||question||health site||question 3||3 question||health literaci||literaci health||question 2||health web,0.031||0.026||0.022||0.022||0.022||0.022||0.021||0.021||0.021||0.02||0.02||0.02||0.02||0.02||0.02,0.4,0.5,0.3333333333333333
996,Intensive_Care_Med-4-1-2249616.txt,antimicrobi resist||grade||mechan ventil||acut respiratori distress syndrom||acut renal failur||children||protocol||mortal benefit||recent trial||rate||patient||studi||clinic outcom||strategi||sepsi||effect||mortal||risk||superior clinic outcom||organ||increas||failur||clinic assess||sever sepsi||recommend||pressur||insulin||sepsi bundl||guidelin||steroid therapi||evid||clinic trial||dobutamin inotrop therapi||infect||renal replac||shock||sedat||day||rct||strong||meta-analysi||blood cultur||random||septic patient||cardiac output||blood glucos||fluid challeng||fluid||popul||blood lactat concentr||peep||death||surviv sepsi campaign||literatur||fluid resuscit||group||mortal rate||committe||decreas||fluid administr||report||grade system||entir group||ali||resuscit||shorter intub time||trial||upper GI||critic ill||stress ulcer prophylaxi||support||tidal volum||earli goal-direct resuscit||septic shock||continu analysi||benefit||icu||ill children||outcom||sepsi syndrom,care||crit care med||clinic care||1||2||2 2||patient||intens care patient||intens care||critic care||intens care med intens care medicin||clinic outcom crit care med||crit care med 20:864||acut care||intens care med 31,0.012||0.01||0.009||0.008||0.008||0.008||0.008||0.008||0.008||0.007||0.007||0.007||0.007||0.007||0.007,0.0,0.1,0.06666666666666667
997,Matern_Child_Health_J-2-2-1592162.txt,prevent||risk||health||control||preconcept care||health insur||educ||import||women||diabet||commun||complic||age||provid||pregnanc||intervent||barrier||chw||gdm||african american,diabet||health||health care||diabet women||diabet care 2003||type 1 diabet||type 2 diabet||diabet prevent||preconcept health care||diabet control||gestat diabet||1||2||influenc diabet||recommend diabet,0.04||0.032||0.03||0.025||0.025||0.024||0.024||0.024||0.024||0.023||0.023||0.022||0.022||0.021||0.021,0.4,0.2,0.13333333333333333
998,J_Gastrointest_Surg-3-1-1852379.txt,type||cancer||case||stage IB||center||gastric surgeri||comp||data||studi||year||patient||medic school||hospit volum||mortal||high-volum center||gastric adenocarcinoma||node||gastrectomi||gastric cancer||signific||medic oncolog unit||treatment||institut||diagnost evalu||oper mortal||hospit||nation cancer data base||curv||stage IV diseas||lymphadenectomi||report||surviv||differ||number||ncdb||chcp||hospit type||outcom,cancer||gastric cancer||cancer case||cancer program||cancer mortal||cancer stage||gastric cancer patient||cancer registri||cancer surgeri||hospit cancer program||cancer research||cancer 1 depart||stomach cancer||1||cancer societi,0.034||0.022||0.02||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.018||0.017||0.017,0.4,0.2,0.13333333333333333
999,Anal_Bioanal_Chem-3-1-2117337.txt,filter||apoglucos oxidas||applic||glucos||system||solut||apogox||enzym||flow system||acid treatment||flavin adenin dinucleotid||microreactor||fad||detector||low flow rate||devic||glucos oxidas||activ||electrochem detect||prepar,1||1 2||2||2 2 1 1 4||1 1 univers||2 4 1||enzym activ 2 2 2||1 squar||1 triangl||refer 1||1 diamond||hanzeplein 1||microreactor 1 12 fig. 1||miniatur enzym reactor 1 1||inject 2,0.049||0.045||0.04||0.038||0.035||0.033||0.029||0.027||0.027||0.026||0.026||0.025||0.024||0.023||0.022,0.0,0.0,0.0
1000,Anal_Bioanal_Chem-3-1-1592252.txt,metabolit||biolog effect||type||method||biolog fate||data||characterist ion||structur inform||sulfat metabolit||compound||site||mass spectrometri||fragment pathway||rule||product||pharmaceut||carcinogen product||hydroxylamin||neg ion mode||relev properti||sulfat||group||allyl alcohol||bioactiv||structur featur||benzyl alcohol||fragment||drug||sulfat product||vivo,1||3||3 3||2||4 2 2 2||rule 1||4 3||3 3 33 scheme 3||3 fig. 2||3 3 carbon||3 3 34||18 5 1||97 3 3||sulfat||tabl 1,0.039||0.031||0.031||0.028||0.025||0.024||0.024||0.024||0.023||0.022||0.022||0.021||0.021||0.021||0.021,0.0,0.0,0.06666666666666667
1001,Anal_Bioanal_Chem-4-1-2228378.txt,adduct||dna sequenc||product||electrospray mass spectrometri||guanin||fragment||gutingimycin||oligom||capillari exit voltag||dna||format||higher temperatur||hplc||oligonucleotid||trioxacarcin,2||1 2 2||1 2||2 4a 2||2 1 1||2 2 1 2 5a||2 2 2 4a 3||conclus 2 2||1 2 2 Î»||1 2 4 2 4||1 fig. 2 4a 2||1||4b 2||5d 2||2 5a,0.091||0.079||0.073||0.069||0.066||0.066||0.063||0.061||0.059||0.056||0.055||0.054||0.051||0.049||0.048,0.0,0.0,0.0
1002,Anal_Bioanal_Chem-4-1-2226000.txt,dynam monitor||gold nanoparticl||concentr||wash solut||chip||studi||ser||cell||rang||spectra,1||1 1||2 2 2||12 23||23||2 6||9 12 23||1 fig. 1 schemat||3||1 27 6 2||1 6 6||1 11 23 fig. 4||1 3 21 fig. 3||2 25||12 23 24,0.036||0.036||0.035||0.028||0.027||0.025||0.024||0.024||0.024||0.023||0.022||0.022||0.022||0.021||0.021,0.0,0.0,0.0
1003,Anal_Bioanal_Chem-3-1-1820759.txt,analyt bias||certif||sampl||standard solut||valu||mbt||extract||organotin compound||water||mae||crm||small amount||degrad||methanol||phenyltin analysi||solut||analyt result||uncertainti||materi||tube||upper toluen layer||between-method varianc||dpht||organotin||butyltin||result,1||1 1||118||1 2||1 4||2||2 2||4||120 118 118||springer-verlag 2006 118 118 118 118||3||valu 1 2||1 20||120 118 4||1 4 solut,0.037||0.037||0.034||0.034||0.032||0.031||0.031||0.027||0.026||0.025||0.025||0.025||0.024||0.024||0.022,0.0,0.0,0.0
1004,Anal_Bioanal_Chem-4-1-2270354.txt,melanin||hair||Cu liver statu||Cu determin||chemometr||princip compon analysi||sampl||studi||inaa||liver biopsi||hepat Cu concentr||dog||nail clip||analysi||Cu concentr||nail||pc||sick dog||thumb nail||hair sampl||Cu liver level||sampl mass||pca||raman||chronic hepat||result,1||1 1 2||2||3 1 8||3 4||1 8||refer 1||1 69m||3 4 fig. 3 pca analysi||1 fig. 6 top||Cu||gender 3 4 5 4||black fig. 4||1 11 12 66 Cu||2 min,0.031||0.028||0.023||0.021||0.02||0.02||0.018||0.016||0.015||0.015||0.015||0.014||0.012||0.012||0.012,0.0,0.0,0.0
1005,Anal_Bioanal_Chem-3-1-1914286.txt,protein identif score||sampl||long-capillari monolith column||digest||mass spectromet||peak capac||increas||squar root||linear flow rate||gradient liquid chromatographi||separ||mascot||protein||flow rate||analysi||column||gradient||extern flow cell||min||bsa||score||long column||length||effici||protein identif||similar gradient slope,3||1||3 fig. 3||2||20 1 1||2 2 fig. 2||4 3 4 3 buffer||10 fig. 1||tabl 1||5 min||reagent 4 3||2 mascot||3 Î¼M||3 kV||10,0.026||0.025||0.021||0.021||0.02||0.019||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.014,0.0,0.0,0.0
1006,Acta_Neuropathol-4-1-2386160.txt,antibodi||role||dysplast cortex||fcd||normal tempor cortex||case||immunocytochemistri||studi||patient||pyramid neuron||vegfb||patholog condit||observ||vegfa||receptor||dysplast neuron||express||immunoreact||cell||epilepsi||hippocampu||tissu||protein||neuron||vascular endotheli growth factor||intract epilepsi||similar pattern||primari antibodi,2||immunocytochemistri 2 2||vegfa 2 2 fig. 2||1||3||2 vegfa||6||4||5||netherland 2 depart||fcd||growth factor||6 Î¼m||endotheli growth factor||vegfb 3 fig. 3,0.022||0.015||0.015||0.014||0.013||0.012||0.011||0.009||0.009||0.009||0.009||0.009||0.009||0.008||0.008,0.0,0.0,0.06666666666666667
1007,Acta_Neuropathol-4-1-2386158.txt,human brain||antibodi||low level||AD patholog||brain tissu||imag||insult||reactiv oxygen speci||specif cellular marker||control tissu||form||increas||region||astrocyt||molecular form||evid||specif||cell||control||diffus plaqu||oxid stress||gray matter||enzym||protein||neuron||gray||dens core||report||mous||number||plaqu||minor form||area||peroxiredoxin 6||patholog||peroxiredoxin||tau||goat,6||MC 6||peroxiredoxin 6||1||2||2 2||AD||2 2 3||MC||peroxiredoxin 6 astrocyt||cell||3||peroxiredoxin 6 30||peroxiredoxin 6 stain||MC 3 5,0.022||0.018||0.018||0.017||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013,0.2,0.1,0.13333333333333333
1008,Anal_Bioanal_Chem-4-1-2259237.txt,regress tree||leutra river||biofilm sampl||Mg content||method||chemometr||predict abil||sampl||data||model||saal river||water||supervis method||node||discrimin||high sensit||variabl||test set||classif||dpl||biofilm||PC 2||percentag||environment condit||pc||order||munich||number||cart||object||river||result,1||1 2||1 1 1 1 10||1 fig. 1||2 2||2||PC 3 1 1||2 fig. 2||PC 1||2 1 depart||biofilm||3||biofilm sampl||sampl biofilm||sampl,0.033||0.03||0.029||0.028||0.026||0.026||0.025||0.023||0.022||0.021||0.021||0.02||0.02||0.02||0.019,0.0,0.0,0.2
1009,AIDS_Behav-3-1-1847541.txt,pilot intervent||MC servic||men||bailey||mother||practic||circumcis||africa||studi||school||effect||region||clinic trial||non-circumcis commun||accept||cost||lukobo||signific impact||south africa||age||infant circumcis||tradit circumcis||sti||foreskin||non-circumcis ethnic group||unpublish report||male circumcis||medic practition||particip||procedur||submit||addit||hiv||ethnic||protect,2003||2003 2005||2005 2003||2005||2005 2006 2005||2006||2002 2003 2003 2003||2006 2003 2002 2006 2003||2002 2005 2003 2003||circumcis 2003 2003||2006 2003 2002 2006||2002 2003 2003||2003 2005 2006 2001 2006 2005||2003 2002 2006||circumcis 2002 2006 2003 2005,0.028||0.027||0.027||0.027||0.027||0.026||0.026||0.026||0.026||0.026||0.025||0.025||0.025||0.025||0.024,0.0,0.0,0.0
1010,Acta_Neuropathol-4-1-2270355.txt,case||clinic sign||ep||account||studi||region distribut||inclus||dlb||high likelihood categori||braak||dementia||mild||cohort||vulner nuclei||transentorhin region||subject||categor||materi||distribut||dmv||sever||diseas||stage||result,0||0 0 0||0 0||0 0 0 0||1 0 0 0||2 0 0 0 0||4 0 0 0||2 0 0 0||1 0||6 0 0 0 0||2 0 0||6 0 0 0||5 0 0 0||3 0 0||1,0.076||0.076||0.076||0.076||0.07||0.067||0.065||0.065||0.064||0.063||0.061||0.059||0.059||0.056||0.053,0.0,0.0,0.0
1011,Anal_Bioanal_Chem-4-1-2175028.txt,signific ree content||ree||method||la-mc-icpm analys||isobar interfer||mass bia correct||problem||sampl||data||studi||spot analysi||Sr isotop||mass spectromet||geolog materi||element fraction||high Sr content||carbon||correct||la-mc-icpm||marin carbon||Sr isotop analys||mc-icpm||ratio||dimer||analysi||accuraci||sampl materi||fraction||interfer||Kr correct||laser||Rb correct||precis||instrument mass discrimin||tim analys||Sr isotop ratio||techniqu,2||86||87||1 2 fig. 2||1||21 87 86 Sr||86 88 87 87 21||84 86||Sr||6 87 86||87 86 84 86 Sr ratio||1 18 88 2||2 Sr isotop mass||1 88 Sr||1 1 27 1,0.026||0.022||0.021||0.019||0.018||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.015||0.015||0.014,0.0,0.0,0.0
1012,Anal_Bioanal_Chem-3-1-1805043.txt,method||primari clarifi||wastewat||concentr||sampl||biotransform||remov||process||compound||elimin||mbr||treatment||membran bioreactor||ca effluent||diclofenac||hydrochlorothiazid||pharmaceut||hydraul retent time||analysi||effluent concentr||ca process||wastewat treatment||effluent||remov effici||sludg||averag daili flow||intern standard||drug||effici||attenu||membran,1||1 2||2||1 3 3||3||parenthes 1 2 3 fig. 1||tabl 2||18 1||fig. 2||1 month||2 3 9 11||2 17||1 5 biotransform||1 mrm transit||2006,0.042||0.039||0.037||0.031||0.026||0.026||0.025||0.025||0.022||0.022||0.022||0.021||0.018||0.018||0.017,0.0,0.0,0.0
1013,Acta_Neuropathol-4-1-2270353.txt,antibodi||lewi neurit||section||control||method tissu sampl||case||lewi bodi||overnight||ampa receptor||cell death||protein||tissu section||sporad PD case||express||synapt plastic||dementia||alpha-synuclein||cell,1||2 1 1 1 fig. 1||2||1 fig. 2||tabl 1||refer 1||1 hour||neuron||4||2 derkac maria 1||log 2||3||case||supplement tabl 1||supplement figur 1,0.028||0.023||0.02||0.019||0.016||0.015||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012,0.0,0.0,0.06666666666666667
1014,Anal_Bioanal_Chem-3-1-2117336.txt,capillari||gold-sensor disk||time||pH optimum||aceton||sampl||surfac modif||immobil||spr||liquid chromatographi||amount||digest||high activ||reactor||water||netherland||on-lin digest||dextran hydrogel||open-tubular reactor||protein||enzym||experi||gentl flow||spr sensor||surfac||order||carry-ov||buffer||high concentr||incub||protein digest||substrat||pda||surfac plasmon reson||fragment||disk||peptid||immobil enzym||complet digest||result,1||1 1||1 2||1 3||protein 1||1 4||fig. 1||method 1||1 solut||refer 1||1 cdi||1 http://www.matrixscience.com||22 1 2||1 5 5||38 1 3,0.046||0.046||0.031||0.029||0.028||0.028||0.028||0.024||0.024||0.024||0.023||0.023||0.022||0.021||0.02,0.0,0.0,0.0
1015,Am_J_Community_Psychol-2-2-1705531.txt,lifestyl||case||secondari victim||respons||self-blam||neg experi||studi||neg reaction||disclosur||silenc||friend||legal||current studi||sourc||commun system personnel||impact||rape||natali||karen||reaction||interview||effort||neg social reaction||result||social reaction||experi||social class||support provid||assault||commun system||reason||religi commun||medic system||famili||legal system||woman||survivor||posit||rape survivor||fear||support||foster care system||mari||decis||shawna||step||polic||in-person interview,support||rape||social support||2001||1||1998||support provid||rape victim||social psycholog||social reaction||neg social reaction||psycholog||rape survivor||commun psycholog||reaction,0.014||0.014||0.012||0.012||0.011||0.011||0.011||0.011||0.01||0.01||0.01||0.009||0.009||0.009||0.009,0.4,0.4,0.4666666666666667
1016,Anal_Bioanal_Chem-3-1-1914274.txt,condit||measur||present pad system||system||off-lin batch format||concentr||optim||data||pro-oxid||effect||ascorb acid||pad system||ros-produc||increas||resolut||compound||mixtur||hplc separ||on-lin pad system||protein concentr||antioxid||harm effect||paper||flow-rat||flow rate||gradient||flow inject analysi||paraquat||min||organ modifi||fia||bioactiv||flow-rat gradient||individu compound||ro||hplc||mode||detect||result,1||2||1 1 fig. 4||2 2 fig. 2||1 mM||1 mg||1 tabl 1 initi||4||refer 1||discuss 1||2 fig. 5||1 ml||31-205987610 npe.vermeulen@few.vu.nl 1 1 lacdr-divis||3||27 29 1,0.044||0.037||0.033||0.033||0.028||0.024||0.024||0.024||0.023||0.023||0.023||0.023||0.019||0.018||0.017,0.0,0.0,0.0
1017,Anal_Bioanal_Chem-3-1-1797063.txt,import||biofilm||quorum||stabil||signal product||system||commun||signal concentr||aip||endoproteas||growth condit||agr cascad||environ||studi||bacteria||biofilm format||signal diffus||quorum sens||molecul,1||2||S. aureu||S. aureu S.||S.||1 2 vibrio||cell||biofilm S. aureu biofilm||3||1 phcb||14 1 P.||refer 1||1 Î´||2 16 P. aeruginosa fig. 1||6 2,0.026||0.021||0.02||0.02||0.019||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.014,0.0,0.0,0.0
1018,Anal_Bioanal_Chem-4-1-2259236.txt,bond||data||marin||ion||spectra||isom||nonrepetit complex materi||meaning molecular-level analysi||complex unknown||current inabl||discret analyt volumetr pixel space||complex mixtur||mass||oxygen||voxel||ratio||properti||separ||chemic structur||structur space||analysi||fticr mass spectra||nmr||complex system||limit bandwidth||materi||chemic bind||number||organ structur spectroscopi||peak||molecul||function,1||2007||5 2||acc chem||5 4||phi chem||6 8||4||9||anal chem 66:3849||anal chem 75:5030||anal chem 70:3853||anal chem 35:2146||3||chem soc 119:7928,0.016||0.015||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.01,0.0,0.0,0.0
1019,Anal_Bioanal_Chem-2-2-1764597.txt,toxic equival quantiti||pcb||sampl type||method||concentr||dioxin-lik pcb||determin||tcdd||sampl||data||seri||toxic effect||pcdd||select||extract||toxic equival factor||discuss||dlpcb||human||review||tempor trend||compound||dioxin||sourc||mixtur||analyt||mass spectrometri||calux||applic||hite||furan||analysi||pcdf||concentr rang||report||order||emiss||number||chemic||congen||polychlorin dibenzofuran||tef||toxic||signific advanc||techniqu,1||1 1 1||1 1 fig. 1||1 4||pcb||2||2005||pcb teq||refer 1||3||method||1 37||teq||5 pg teq||1 151,0.01||0.01||0.008||0.008||0.008||0.008||0.008||0.007||0.007||0.006||0.006||0.006||0.006||0.006||0.006,0.2,0.1,0.13333333333333333
1020,AIDS_Behav-2-2-1544374.txt,prevent||program||sexual behavior||level||time||campaign||africa||strategi||year||multipl channel||effect||inform||review||sexual activ||hiv preval||countri||health educ||condom||behavior chang||ugandan ministri||health||educ||vision||train||world health organ||iec||hiv||global aid crisi||educ campaign||activ||report||aid||uganda||note||ministri||support||major differ||plan||gpa||district,uganda||health||uganda program||uganda aid program||1 uganda||aid||aid program||program||1||uganda hiv||2006 uganda||health educ||uganda aid control program 1989||health uganda aid control programm||nation aid program,0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012,0.4,0.4,0.3333333333333333
1021,Anal_Bioanal_Chem-3-1-2117333.txt,calcul||compil||set||higher level||method||time||sampl||solvent||polar||full-scan acquisit||retent time shift||amount||solid phase||process||toluen||effici extract||fortif||recoveri||calibr standard||degrad||sourc||methanol||valid||pesticid||mix solut||adsorpt||inject speed||solut||residu||analysi||liner||standard||ethyl acet||clean-up||gpc clean-up||minimum||intern standard||gcb||inject||matrix||step||multi-residu analysi||result,1||1 2||1 5||1 1 1 GC||0||4||2 4||2||1 8 2 4||5 2||1 2 fig. 1||5||1 8||1 10||1 2.5 1,0.022||0.019||0.019||0.017||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015,0.0,0.0,0.0
1022,Anal_Bioanal_Chem-3-1-1802725.txt,condit||galleri||non-destruct analysi||instrument||mar virgin||analyt challeng||panel||experiment condit||exhibit galleri||larg dimens||investig||raman spectroscopi||museum object||exampl||mobil spectromet||artefact||pigment||indian kalighat||conserv||paint||analysi||spectrum||museum||antiqu egyptian sarcophagi||varnish layer||renaiss||laser||work||lid||area||mobil raman spectroscopi||earli keyboard instrument||object||textil banner||techniqu,2||2 3 2 2 3||2 3||3 2||3||1 2 3||2 fig. 2||3 4||1||3 4 fig. 3 4||4||mar virgin 3 2||3 mW||1 19 fig. 1||1 accumul,0.047||0.044||0.043||0.043||0.04||0.039||0.036||0.032||0.031||0.028||0.024||0.023||0.022||0.021||0.018,0.0,0.0,0.0
1023,Anal_Bioanal_Chem-4-1-2226005.txt,light mass ratio||variat||plasma||instrument||extern precis||element||sampl||data||mc-icp-m||isotop fraction||silic||ion beam||composit||ratio measur||mass spectrometri||ratio||larg variat||standard||intens||extern normal||isotop||high instabl||fraction||interfer||isotop ratio measur||light element||precis||techniqu,1||2||isotop||26 2 2 2 2 2||chem geol||2 3||refer 1||7 Î´ 25 26||28 1||7||1 35||44 2||Î´ 44 Ca||1 saprolit||1 Li isotop composit,0.017||0.013||0.013||0.012||0.011||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.009||0.009,0.2,0.1,0.06666666666666667
1024,Anal_Bioanal_Chem-3-1-1592466.txt,channel dimens||system||larg molecul||squar capillari||cas-chip||success separ||mix protein sampl||multilay flow||small molecul||capillary-assembl microchip||capillari electrophoresi||solut||protein||squar section channel||CE separ||fluoresc intens profil||microchip||feasibl studi||microchannel||deprotein||pretreat||sampl inject||inject||pdm||molecul||f-bsa||sampl solut,1||1 1||1 molecul||1 fig. 4||7 2||fig. 2 photograph||6 2||refer 1||fig. 3||fig. 5||1 26 27||electrophoret separ 1 28||molecul||studi||3 3 3 3,0.041||0.041||0.028||0.026||0.026||0.025||0.024||0.022||0.022||0.019||0.018||0.016||0.016||0.014||0.014,0.0,0.0,0.06666666666666667
1025,Anal_Bioanal_Chem-3-1-1705481.txt,individu congen||program||pcb||method||routin pop analysi||electron supplementari materi||concentr||sampl||low cost||data||solvent||strategi||pop||extract||low environment impact||water||air||GC column||review||analyt laboratori||abil||recoveri||scientist||pesticid||analyt||countri||lipid||field blank||manag||organochlorin||percentag||evapor||analysi||gpc||routin measur||analyt standard||analyt method||sediment||ocp||congen||limit||stockholm pop convent||lab||blank||step||analyt system||environment monitor||detect||techniqu,1||1 2||environ||2||tabl 1||1 pg||10 1||2 4||tabl 2||sampl||analyt||3||analyt method||method||4,0.01||0.009||0.008||0.008||0.008||0.008||0.007||0.007||0.007||0.007||0.007||0.007||0.007||0.006||0.006,0.0,0.1,0.26666666666666666
1026,Acta_Neuropathol-3-1-2080348.txt,astrocyt hypertrophi||find||case||pvl||pvl case||infant||perinat period||gray matter lesion||data||studi||neg group||cerebr cortex||dwmg||reactiv astrocyt||necrosi||signific||periventricular leukomalacia||cell||brain||gfap||basal ganglia||periventricular necrosi||gray matter||hippocampu||neuron loss||globu pallidu||white matter gliosi||age||frontal cortex||perinat panencephalopathi||incid||injuri||purkinj cell||group||sever||white matter injuri||gliosi||dwmg group||prematur infant||thalamu,1||2||3||deliveri 1 1 1 1||1 3 1 depart||1 dwmg||23 2 2 2||postnat period 1 1 1 1||4||4 pvl||pvl||1 2 3 billiard saraid||refer 1||3 pvl dwmg neg||cerebellar hemispher 1 fig. 1,0.021||0.018||0.017||0.017||0.016||0.016||0.015||0.014||0.013||0.012||0.011||0.011||0.011||0.011||0.011,0.0,0.0,0.06666666666666667
1027,Osteoporos_Int-4-1-2267485.txt,rheumatoid arthriti||clinic fractur||comput||data||model||studi||year||bmi||risk||continu variabl||increas||exampl||prior histori||fractur probabl||fractur||signific interact||signific||valid||absenc||cohort||osteoporot fractur||bmd||women||hip||assess||age||death||death hazard||osteoporosi||cost-effect||hazard function||clinic risk factor||probabl||clinic spine||fractur risk||hip fractur,2||2 2||risk||fractur risk||fractur||2 2 fig. 2 2||3 2||1||hip fractur risk||vertebr fractur risk||fractur risk predict||long-term fractur risk||forearm fractur 2||rel fractur risk||absolut fractur risk,0.021||0.021||0.021||0.02||0.02||0.018||0.016||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.014,0.6,0.3,0.2
1028,Sleep_Breath-4-1-2276561.txt,level||time||week||fat||weight loss||hypoxia group||hypox climat||train period||studi||bmi||effect||air||hypox condit||moder hypoxia||oxygen||hypoxia||mild||train||climat||bodi||subject||weight||min||group||normobar hypoxia||room||low intens physic exercis||simul altitud,2||2 2||1 2 2 2||1 2||springer-verlag 2007 2 2 2 2||1||subject 2 3 fig. 2||period 2||2 month||hypoxia||2 max||sham hypoxia group 2||hypoxia group||hypoxia group fig. 3||studi,0.038||0.038||0.035||0.032||0.027||0.026||0.023||0.02||0.02||0.02||0.02||0.019||0.017||0.016||0.016,0.0,0.1,0.2
1029,Purinergic_Signal-3-4-2072919.txt,subtyp||releas||modul||nerv termin||adenosin||pharmacolog profil||channel||patholog situat||atp||effect||synapt transmiss||spinal cord||receptor||excitatori amino acid||p2i receptor||nervou system||brain||p2x receptor||neurotransmitt releas||nucleotid||hippocampu||neuron||termin||activ||extracellular space||neurotransmitt||ligand-g cation channel||sympathet nerv||glutam||neuron activ,receptor||1 receptor||atp receptor||7 receptor||p2x receptor||P2 receptor||p2i receptor||1||2 1||2||12 receptor||3 3 1 2 4 receptor||atp p2x receptor||purinerg receptor||2 receptor mrna,0.034||0.027||0.023||0.023||0.022||0.022||0.021||0.021||0.021||0.021||0.02||0.02||0.019||0.019||0.018,0.4,0.3,0.2
1030,Intensive_Care_Med-4-1-2228379.txt,refractori shock||septic shock||supplementari materi||product||septic patient||urinari excret||benefici effect||short-term effect||proxim tubul injuri||septic shock patient||kidney damag||clinic paramet||MB treatment||renal tubular injuri marker||renal failur||studi||urin||continu infus||patient||day,1||1 1||3||1 fig. 1||2||format 3 1||1 mg||patient||refer 1||3 year||5||kidney damag 1||septic patient||netherland 2 depart||4,0.036||0.036||0.03||0.026||0.023||0.023||0.02||0.02||0.019||0.016||0.016||0.016||0.015||0.015||0.015,0.0,0.1,0.13333333333333333
1031,Diabetologia-4-1-2362134.txt,vitro techniqu||resorpt||coverslip||control group||rankl||studi||mediat||patient||observ||increas||receptor||opg||diabet control||osteoclast format||osteolysi||excess concentr||osteoclast||m-csf||dentin slice||activ||group||rankl-independ pathway||bone||cultur||presenc||number||healthi control||particip||addit||result,2||1||osteoclast||2 fig. 1||osteoclast activ||activ osteoclast||osteoclast resorpt||human osteoclast||3 fig. 3||1 mol||10 Î¼m fig. 2||1 petrova||1 1 nuffield depart||3||osteoclast format,0.031||0.026||0.025||0.025||0.018||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015,0.2,0.1,0.13333333333333333
1032,BMC_Bioinformatics-4-_-317283.txt,literatur mine||matrix tabl||modifi term||basic pubm search window||simpl||databas||search term||data||larg dataset||keyword term||combin||proteom approach||gene list||tool||term co-occurr||gene||approach||pubm||pair-wis comparison||list||tabl||keyword||queri||pubmatrix||result,1||gene||figur 1 2||3 4 3 4 11 12||figur 2||gene express||search||gene list||figur 3 gene express result||search term||term||individu gene||microarray gene list||human gene||tabl 1 exampl,0.031||0.026||0.024||0.022||0.021||0.019||0.018||0.018||0.018||0.017||0.016||0.016||0.016||0.015||0.015,0.2,0.3,0.2
1033,Dev_Genes_Evol-3-1-1784541.txt,macrostomorpha||anim||organ system||triclad||postembryon develop||polyclad||amput||regener||divers taxa||head||develop||planarian||organ||main function||abil||pharynx||similar||nervou system||ovari||eye||cell||brain||egger||free-liv flatworm||platyhelminth||regener capac||acoela||neoblast||acoel||part||main nerv cord||anterior||flatworm||speci,1||lignano||regener||M. lignano||M. lignano M. lignano||regener M.||M.||cell||2 M.||2||regener 2001 M.||M. lignano fig. 2||macrostomum lignano||regener studi||fig. 4 M. lignano,0.017||0.017||0.016||0.016||0.016||0.015||0.014||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011,0.2,0.2,0.13333333333333333
1034,Int_J_Cardiovasc_Imaging-4-1-2233708.txt,viabl myocardium||cmr||system||flow||artifact||imag||element cardiac||quantit analysi||studi||cardiovascular magnet reson||imag qualiti||acut myocardi infarct||stent posit||repeat intervent||sequenc paramet||day||dark band artifact||patenc||field strength||acut||feasibl||chronic phase||cine||analysi||cine imag||dark band||scan||repeat catheter||puls sequenc||safeti,1||1 1||2||1 2 1 depart||ave 1 1||prokinet 1 2||prokinet 2 1||multi-link vision 1 1||result 1||1 inhomogen||lekton motion 1 1||chronic phase 2 1||imag qualiti 2 3||multi-link vision 1 2||multi-link vision 2 1,0.041||0.041||0.033||0.03||0.028||0.025||0.025||0.023||0.022||0.022||0.022||0.021||0.021||0.021||0.021,0.0,0.0,0.0
1035,Osteoporos_Int-3-1-1894753.txt,bone mass||measur||find||method||narrow age rang||boy||studi||periost growth||longitudin growth||humer AR||avon longitudin studi||fractur||analys||present studi||humer dimens||ratio||humeru||girl||width||humer width||age||gender differ||puberti||tanner stage 2||scan||differ||bone||height||dxa||tanner stage||periost||length||area||humer geometri||bone miner densiti||children||result,1||2||2 2 2 fig. 2||2 tabl 2||children 1||bone||tabl 1||result 1||refer 1||tanner stage 1||emma.clark@bristol.ac.uk 1||age 9.8 year 2 2||2 1 8 9 10||tanner stage 2||age 3,0.037||0.033||0.028||0.024||0.022||0.021||0.021||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.016,0.0,0.1,0.13333333333333333
1036,Virchows_Arch-4-1-2329735.txt,cell adhes||type||intestin||high level||find||case||tissu microarray||liver metastasi||carcinoma||studi||patient||patholog characterist||diffus distribut||diffus compon||high stage||muc2||express||classif||diffus part||present studi||mix type||lymph node||emmprin||analysi||lymph node metastasi||genet||group||MT case||invas||gastric carcinoma||statist signific||venou invas||periton||compon,carcinoma||2||gastric carcinoma||1||gastric carcinoma 3||gastric carcinoma 4||carcinoma cell||gastric||gastric MT carcinoma||carcinoma mixed-typ carcinoma diffuse-typ carcinoma||MT carcinoma||1 fig. 1||gastric cancer||mucin carcinoma||intestinal-typ gastric carcinoma,0.029||0.025||0.024||0.023||0.021||0.021||0.02||0.019||0.018||0.018||0.018||0.018||0.018||0.017||0.017,0.4,0.2,0.13333333333333333
1037,Neuroimage-2-1-2387200.txt,corpu callosum||group differ||method||mri||abnorm||studi||diffus process||patient||white matter pathway||fraction anisotropi||pdf||genu||pico||threshold||region||multipl linear regress||specif cortic region||first-episod psychosi||interhemispher connect||splenium||voxel||FA||control||psychosi||fiber||age||gender||subject||seed region||white matter||group||differ||cortex||tract||probabl||schizophrenia||focal abnorm||dti||result,2||2 patient||patient||1 month 7 patient durat 1||imag||5 month 1 patient||3 month 1 patient durat 3||tabl 1||2 month 6 patient durat 2||2003 tabl 1||2 FE patient||2005||2003||tabl 2||patient group,0.017||0.016||0.015||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.2,0.1,0.06666666666666667
1038,Int_J_Cardiovasc_Imaging-3-1-2121120.txt,follow-up||wall motion abnorm||nwma||mri||imag||studi||patient||dobutamin stress cmr||lbbb||dose||examin||stress||wall motion analysi||perfus abnorm||cine||cardiac event||peak-dos dobutamin||coronari arteri diseas||ischemia||peak stress||perfus sequenc||min||cag||dobutamin||addit inform||segment||perfus imag||rest||normal first-pass perfus||perfus deficit,1||1 oudkerk matthij 1 1 depart||refer 1||bronovolaan 1||1 demograph||hanzeplein 1||1 2 fig. 1 flow chart||patient||perfus||14 patient||ipat 2||myocardi perfus||C. 1 kuijper||1 2 van dijkman paul||perfus imag,0.035||0.019||0.019||0.019||0.018||0.018||0.017||0.017||0.015||0.014||0.014||0.014||0.013||0.013||0.013,0.0,0.1,0.13333333333333333
1039,Virchows_Arch-3-1-2082069.txt,tumor||ectop tissu||neoplasia||structur||case||paratesticular structur||mesotheli hyperplasia||pseudotumor||benign mimick||testicular||lesion||diagnosi||cyst||leydig cell||sertoli cell||testi||true neoplasia,2||fig. 1||2 case||fig. 4||fig. 5||fig. 7||3 case||fig. 11||fig. 3 idiopath||testicular||lesion||case||refer 1||testicular inflammatory-react lesion 2 3 12||1 montironi,0.024||0.021||0.018||0.017||0.017||0.016||0.015||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012,0.0,0.1,0.2
1040,Matern_Child_Health_J-2-2-1592154.txt,preconcept||sara||infant||pregnanc||histori||year postpartum||depress||concept||risk||medic||postpartum period||counsel||mental health||earlier treatment||treatment||melani||women||month||care||famili||perinat||health care provid||episod||mood disord||addit||outcom,depress||postpartum depress||perinat depress||refer 1||1 sara||matern depress||depress episod||2 melani||postnat depress||sever depress||depress symptom||kmounts@pol.net 2 1 wisconsin associ||comorbid depress||antenat depress||1 mount kyle,0.033||0.022||0.022||0.02||0.02||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.017||0.017||0.015,0.2,0.1,0.06666666666666667
1041,Ann_Surg_Oncol-3-1-1914262.txt,intern mammari lymph node||time||surgic treatment||rate||breast cancer||patient||node||visual||metastas||visual IM sln||parastern intercost incis||axillari sln||radiotherapi||primari tumor||IM sln||sentinel node||tumor||sln||stage procedur||surgic explor||patient IM sln||inject||lymphoscintigraphi||radiotherapeut treatment,1||patient||1 tabl 1||2||breast cancer patient||8||breast cancer||RT||2 tabl 2||5||3 patient||4||breast cancer patient eur||tabl 5||patient IM sln,0.02||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013,0.2,0.2,0.2
1042,Support_Care_Cancer-4-1-2413096.txt,day-to-day hands-on caregiv||level||individu||data||model||studi||year||caregiv||patient||concept||inform||abil||proport||valid instrument||palli care||relationship||life-limit ill||south australia||unmet||popul||servic||death||respond||famili member||termin ill||long-term caregiv outcom||survey||health omnibu survey||special palli care servic||support||area||peopl||outcom,care||2||health care||1||2 fig. 2||palli care||2 year||caregiv||hands-on care||medic care||support care cancer support care||death 1 1||physic care||health outcom||futur care,0.019||0.017||0.016||0.014||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.01||0.01,0.0,0.2,0.13333333333333333
1043,J_Gastrointest_Surg-3-1-1852391.txt,logist regress analysi||complic||logist regress||rate||studi||patient||effect||obes||anastomosi||variabl||peripher neuropathi||signific||gastric bypass||strictur||age||analysi||odd||surgeri||gerd||bariatr surgeri||group||factor||rygb||oper techniqu||gastrojejunostomi||obes patient||techniqu,2||2 2 antagonist||1 group 2||1||3||2 antagonist||result 2||20 2||2 26||1 year||infect 2||group 3||strictur||strictur group||alimentari tract 2007 2 2 antagonist,0.031||0.023||0.022||0.021||0.019||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.015||0.014||0.014,0.0,0.0,0.06666666666666667
1044,J_Mol_Model-3-1-2039871.txt,type||attempt||set||emphasi||method||system||level||bond||pm6||molybdenum||incorrect structur||optim||element||data||valu||spin-fre energi level||orbit||effect||refer data||larg formal charg||water||structur||failur||transit metal complex||complex||parameter||compound||high level calcul||fault||electron state||geometri||group iva||core-cor express||potenti||distanc||main group||paramet||rule||atom||accuraci||rare ga atom||potenti sourc||weight||interatom separ||transit metal||group||hydrogen bond||hydrogen||import||core-cor interact||refer||semiempir method||interact||speci||error||heat||chemic bond||function||approxim||result,1||1 1||1 2||1 3||1 5||refer 1||2||2 2||2 3 3||3||2 5||4 4 3||4 4||4||4 5,0.022||0.022||0.019||0.019||0.017||0.016||0.016||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014,0.0,0.0,0.0
1045,Eur_J_Clin_Pharmacol-3-1-2071964.txt,type||aspect||ddd||daili dosag||pharmacotherapi audit meet||ptam||method||agreement||result||associ||pharmacist||meet||data||studi||tool||cost||group,1||level 1||level 2||level||level 3||4 2||ptam level||ptam level descript level 1||ptam 4 5 1 2||tabl 2||type 2||atc 1||guidelin 1||netherland 2||1 21,0.034||0.033||0.032||0.032||0.027||0.026||0.025||0.024||0.024||0.022||0.021||0.02||0.02||0.019||0.019,0.0,0.0,0.0
1046,Purinergic_Signal-3-4-2072921.txt,atp||confoc analysi||striatum||dopamin denerv||rat striatum||presenc||gray matter||rat brain||protein level||protein||receptor||green immunofluoresc||substantia nigra||experiment condit||express||lesion nigro-striat circuit||specif||brain||purinerg receptor,"1||1 1||1 1 1 1 1 1||2 1||2 2 1||2||2 2||3 1||5,6,7 1 1||4 1||2007 1||receptor||4 4 1||1 panel||astrocyt 2 1 3",0.036||0.036||0.036||0.032||0.03||0.027||0.027||0.025||0.024||0.024||0.023||0.021||0.02||0.02||0.019,0.0,0.0,0.06666666666666667
1047,Eur_Arch_Psychiatry_Clin_Neurosci-3-1-1800370.txt,deficit||control group||fals belief||schizophren||mental state||studi||social cognit task||patient||brain damag||cognit profil||tactic strategi||human||abil||stori||tom||lesion||behaviour||damag||brain||social cognit||item||mental retard||frontal lobe lesion||task||statement||subject||ventromedi frontal lobe damag||group||order||lmpfc||differ||perform||healthi control||prefront cortex||signific correl||medial frontal lobe||peopl||schizophrenia||score||social situat,1||1 2||2||lesion||3||fig. 1||frontal lesion||2 fig. 2 perform||3 fig. 3 perform||frontal lobe lesion||refer 1||40 3||social cognit||social brain||4 5 6 7 7 8,0.015||0.014||0.014||0.013||0.013||0.011||0.011||0.01||0.009||0.009||0.008||0.008||0.008||0.008||0.008,0.2,0.2,0.2
1048,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1915597.txt,aitfl imping||fascicl||joint tissu||joint||studi||patient||contact||ankl joint||anterior talofibular ligament||ankl||aitfl||chronic ankl pain||talu||anterior aspect||pain||imping syndrom||imping||dorsiflexion||anterior||arthroscopi||ligament||anterior inferior tibiofibular ligament||talar dome||result,4 4 4||4||1 1 4||2||diagnosi 4 2 4 4 2||24 2 4 4||1||2 2 4 13||2 4 22 22 2 24||1 1 22 22||fascicl 1 4 12 1||24 2||2 24||1 24||1 1 4 30 31,0.053||0.053||0.045||0.045||0.042||0.042||0.042||0.037||0.034||0.032||0.031||0.031||0.031||0.029||0.029,0.0,0.0,0.0
1049,J_Headache_Pain-4-1-2386847.txt,placebo||region cerebr blood flow||time||volunt||studi||patient||effect||infus||increas||cgrp||blood pressur||rcbf||mca||signific||treatment||present studi||heart rate||cerebr arteri||chang||min||arteri||decreas||migrain||cerebr blood flow,1 1||1 2||2||2 2||2 2 2||2 correct 2||12 1||tabl 1||2 20||2 7||2 18||fig. 1||A. 1||refer 1||2 region,0.043||0.042||0.041||0.041||0.041||0.029||0.029||0.026||0.024||0.024||0.023||0.023||0.023||0.023||0.023,0.0,0.0,0.0
1050,Surg_Endosc-4-1-2422865.txt,follow-up||week||questionnair||minim invas||randomis trial||complic||studi||patient||health statu||sic||bodi imag||test||total||small-incis cholecystectomi||preoper data||symptomat cholecystolithiasi||analys||method patient||oper||alloc sequenc||health||giqli||alloc conceal||surgeri||subscal||minim invas procedur||cholecystectomi||gener||group||gener short form||differ||order||trial||procedur||score||secondari outcom measur||techniqu,1||health 1||2||result 1 fig. 1||refer 1||recoveri 1||1 pancreat||bosboomstraat 1||1 epididim||2 week||oper result 1 2||1 patient characterist||H. M. 1 1 depart||3||cbd stone 1,0.029||0.02||0.018||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.015||0.013||0.013||0.013||0.012,0.0,0.0,0.0
1051,Ann_Biomed_Eng-4-1-2413127.txt,csf||time||method||brain tissu||traumat brain injuri||model||studi||brain injuri||cerebr cortex||head||boundari constraint||increas||region||shear modulu||finit element model||injuri criteria||geometri||brain||stress||tbi||numer model||equival stress||gray matter||heterogen||simul||direct||part||cerebrum||injuri||load condit||cortex||influenc||mechan load||comput head model||materi properti||result,1||1 2||1 1 2 4||2||model||4||heterogen model 1||1 5||39 1 2||1 3 3||figur 4||head model||2 4 10||refer 1||brain,0.024||0.022||0.021||0.019||0.018||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.012,0.2,0.1,0.13333333333333333
1052,Health_Care_Anal-3-1-2045690.txt,reflex consumer||type||social commun||non-profit organ||skill||respons||technolog||commun||internet technolog||practic||individu||state||patient||trust mark||consum||prescript||inform||percept||organ||exampl||user||site||tool||health profession||web||user tool||health||term||hon||non-government organ||reflex||care||activ||special toolbar||literatur||choic||actor||search||medic profession||question reliabl||reliabl||citizen||particip||diseas||polit actor||initi||internet,1||health||health inform||inform||2||medic inform||1 4||4 2 3 1||9 1||12 1 fig. 1||1 56 2||journal||health care||onlin health inform||link health inform,0.02||0.017||0.016||0.015||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011,0.4,0.2,0.13333333333333333
1053,Qual_Life_Res-4-1-2238782.txt,isrf||mhm||content domain||lower level||social health||measur||level||case||method||respons||questionnair||msp||polytom item||grade respons model||monoton||locat||model||nonparametr monoton homogen model||valu||monoton homogen model||patient||nonparametr irt analysi||data analysi||scale||parametr model||exampl||domain||point||psycholog well-b||dimension||item||latent variabl||estim||research||paramet||analysi||social limit||mokken model||grm||item respons theori||psycholog||whoqol-bref||patient group||unidimension scale||hrqol||result,item||1||1 2||2||item respons model||item 4||respons||item 3||Î¸ Î¸ 1 Î¸ Î¸||Î¸ Î¸ Î¸ Î¸ 1||measur||respons model||scale 2||Î¸ Î¸ Î¸||Î¸,0.017||0.016||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013,0.2,0.2,0.2
1054,Clin_Rheumatol-4-1-2262146.txt,develop||chemotherapi||r-chop||microbiolog test||joint||arthriti||lymphoma||pain||knee||rheumat diseas||synovi fluid||tumor lysi syndrom||wrist||cours||diagnosi||patient||rituximab||treatment||nhl,1 2||F. 1 1 depart||1 week||M. 1||refer 1||3||2 dijkman||clinic rheumatolog 2008 introduct 1 2||netherland 2 depart||A. C. 1 lem||arthriti||31-20-5124554 f.h.swaneveld@versatel.nl 1 3 van vugt||netherland 3 depart||9 3||develop,0.059||0.038||0.037||0.036||0.036||0.029||0.029||0.028||0.027||0.022||0.02||0.02||0.02||0.018||0.018,0.0,0.0,0.13333333333333333
1055,Pediatr_Nephrol-4-1-2214826.txt,antibodi||proteinuria||sever immunosuppress||clinic respons||patient||year||system lupu erythematosu||rituximab||rituximab therapi||rtx||multipl cours||clinic diseas activ||dose||treatment||therapi||lupu nephriti||age||renal function||hemodialysi||sever sle||sle||clinic remiss||children,2||1||1 year||0.01 1 2 2||year||2 month||clinic protocol 2 2||3 year||2 NS||0.01 2||2 week||8 year||rtx 1||1 month||7 year,0.028||0.022||0.021||0.02||0.02||0.017||0.017||0.016||0.016||0.016||0.015||0.014||0.014||0.014||0.014,0.2,0.1,0.06666666666666667
1056,Intensive_Care_Med-3-1-1915647.txt,prematur neonat||subgroup||high-frequ ventil||time||gestat age||respiratori distress syndrom||infant||ventil||studi||rr||year||patient||effect||risk||depend variabl||lpv||protect ventil strategi||high lung volum strategi||cld||rel risk||analysi||death||meta-regress analysi||convent mechan ventil||factor||differ||cmv||import||chronic lung diseas||import variabl||rrr||sensormed ventil||trial||ventil strategi||public||hfv||explanatori variabl||random trial||public bia||outcom||result,2||3 3 2||4 2 4||fig. 2||3||4||1||2 3 25||4 5||fig. 1||0.06 0.05 2||studi||rel risk 1||ventil||1 covari,0.032||0.024||0.024||0.021||0.02||0.02||0.019||0.019||0.015||0.014||0.013||0.012||0.012||0.012||0.011,0.0,0.0,0.13333333333333333
1057,J_Autism_Dev_Disord-4-1-2254472.txt,plaist||effect search strategi||target||fixat cross||stimulu element||stimulu discrimin||control group||enhanc abil||visuo-spati task||effect||search strategi||test||pdd||reaction time data||present studi||search task||control||fixat time||analysi||enhanc stimulu discrimin||subject||high function adult||group||fixat||number||eye movement||size||signific differ||particip||superior perform,1||2||1 fig. 1||3||2 fig. 2||condit 1 condit 2 1996||netherland 2 depart||4||search||1 adi score||condit||2001||netherland 3 school||1998 2001 2001||eye,0.035||0.03||0.028||0.027||0.025||0.02||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.013||0.013,0.0,0.0,0.0
1058,Mcgill_J_Med-11-1-2322926.txt,scaffold||patellar tendon||anterior cruciat ligament||heal||studi||patient||dacron prosthesi||review||acl reconstruct graft||replac||artifici ligament||biolog tissu autograft reconstruct||lad||cell||strength||techniqu||tissu||tissu engin principl||research||collagen||signific progress||graft||acl||surgeri||prosthet replac||implant||acl replac||carbon fibr||ligament||knee||reconstruct||prosthesi||tissu engin||prosthet,1||1 1||ligament||2 35 2||artifici ligament 1||1 advantag||1 nau||cruciat ligament||patient||anterior cruciat ligament||reconstruct anterior cruciat ligament||anterior cruciat ligament reconstruct||cell||acl||prosthet ligament,0.031||0.031||0.021||0.018||0.018||0.017||0.016||0.016||0.016||0.014||0.013||0.013||0.013||0.013||0.012,0.2,0.3,0.3333333333333333
1059,FEMS_Microbiol_Ecol-1-_-2121141.txt,variat||statist packag||set||measur||method||commun||data matric||princip compon analysi||sampl||data||model||ordin||ordin diagram||multivari analys||distanc matric||observ||inform||scale||specif rule||test||complex||variabl||site||statist||cca||pattern||signific||cluster||origin varianc||nmd||ecolog hypothes||rank||distanc||relationship||approach||rda||varianc||multivari||environment condit||gradient||axe||environment gradient||row||instanc||cluster analysi||group||order||divers pattern||pca||tabl||canon correspond analysi||ecolog studi||speci||constrain ordin||object||microbi ecolog||hypothesi||interpret||techniqu,1||tabl 1||fig. 1||tabl||data tabl||tabl 1 fig. 1 avis||data||fig. 2 tabl 2||speci tabl||2||tabl 1 gower||tabl 1 usag||tabl 1 merril||multivari data tabl||speci data,0.026||0.022||0.02||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015||0.014,0.2,0.2,0.13333333333333333
1060,Behav_Genet-4-1-2257994.txt,person||level||behavior||anxious-depress||discord group||monozygot twin||twin pair||studi||comparison||valu||data||life||psychopatholog||life event||OC symptomatolog||pi-r abbr||environment factor||uniqu life event||OC twin pair||between-pair comparison||ocd||religi obsess||sexual assault||genet similar||alcohol||twin||concord MZ pair||age||pair||futur studi||parent||somat complaint||genet factor||obsessive-compuls symptom||group||factor||differ||uniqu||discord||report||symptom||previou report||concord||concord high pair||score,pair||twin pair||twin||2||MZ twin pair||OC twin pair||MZ pair||discord twin pair||1||5 pair||MZ twin||3 pair||4 pair||adult twin pair||OC twin,0.016||0.015||0.015||0.014||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.01,0.6,0.4,0.26666666666666666
1061,Int_J_Hematol-4-1-2276241.txt,subtyp||categori||aml||data||normal karyotyp||patient||year||clinic featur||advers risk group||cytogenet risk group||classif||mld phenotyp||acut leukemia||mpo||fab||11q23 abnorm||age||analysi||acut myeloid leukemia||prognost factor||genet||mld||surviv||karyotyp||diagnosi||myeloperoxidas||result,3||2||leukemia||5 3||1 2 1 4 mpo||leukemia 1 0.2 acut leukemia||clinic characterist 3 1||acut leukemia||patient||acut myeloid leukemia||leukemia group||refer 1||3 0.5||5 1 0.2||studi,0.024||0.022||0.019||0.018||0.018||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013,0.0,0.3,0.2
1062,Planta-4-1-2249615.txt,total chlorophyl||carbohydr accumul||carbon export||maiz||doubl mutant||data||callos deposit||leaf tip||carbon||anilin blue||leav||carbohydr||chlorophyl level||sucros||leaf||tissu||starch||lack||mesophyl cell||accumul||sucros export||chlorot||mutant||vein||phenotyp||carbon partit||function||plant,tdy1-r||sxd1-1 tdy1-r||sxd1-1 tdy1-r sxd1-1||tdy1-r sxd1-1 sxd1-1||sxd1-1||tdy1-r sxd1-1 2||tdy1-r 1||sxd1-1 2||tdy1-r tdy1-r fig. 2||sxd1-1 1||sxd1-1 tdy1 tdy1||tdy1-r tdy1 sxd1||tdy1-r sxd1-1 arrow||sxd1-1 plant||tdy1-r sxd1-1 4 2 4,0.056||0.053||0.052||0.052||0.05||0.046||0.041||0.04||0.038||0.037||0.037||0.037||0.036||0.035||0.034,0.0,0.0,0.0
1063,Aesthetic_Plast_Surg-4-1-2175019.txt,case||liposuct aspir||convent lipoinject||studi||patient||cal||adipos tissu||volum||increas||cosmet breast augment||aspir fat||cell||augment||asc||tissu||postop atrophi||materi||inject||breast augment||breast||lipoinject||result,1||1 patient||2 fig. 2||2||2 patient||patient||2 month||3 month||breast||discuss 3 1 3||1 21 fig. 1 scheme||9||8 patient||refer 1||12 patient,0.027||0.023||0.02||0.02||0.019||0.019||0.018||0.017||0.017||0.017||0.016||0.016||0.015||0.014||0.014,0.0,0.2,0.13333333333333333
1064,J_Hum_Genet-4-1-2413114.txt,gene||control||japanes||snp||obes||power||test||associ||genotyp rel risk||sever obes||genotyp||sever adult obes||bmi||japanes popul||group,2||2 2 2 2 1 2||2 fto||2 1||fto 2 2 fto gene||fto||1||2007||2007 2007 2007||2 fto fig. 1||2 diabet||type 2||statist analysi 2 2007 2||2 2002 2 1998 fto gene||springer 2008 fto fto fto,0.029||0.028||0.026||0.026||0.023||0.022||0.022||0.021||0.021||0.019||0.019||0.018||0.018||0.017||0.017,0.0,0.0,0.0
1065,Eur_Arch_Otorhinolaryngol-4-1-2217622.txt,ear||dpoae||perilymph||scala tympani||pressur increas||ear fluid volum||effect||cochlear function||CM potenti||pressur||signal||cmdp||acut||ear pressur||chang||2||decreas||cochlea||guinea pig||inject||diseas||artifici perilymph,2||1 2||2 1||1||1 1||1 2 4||2 3||inject 1 1||1 Ï 2 Ï||1 4||2 3 4||fig. 1||2 fig. 4||2 dpoae||2 3 fig. 3,0.045||0.043||0.043||0.04||0.04||0.035||0.034||0.032||0.03||0.03||0.029||0.029||0.027||0.027||0.027,0.2,0.1,0.06666666666666667
1066,Neurochem_Res-3-1-1832150.txt,level||cerebellar ataxia||form||studi||coq10||diseas||patient||defici||skin fibroblast,10||10 1||fig. 1 10 10||1 1||1||2006||10 10 12 26||10 10 coq1 17||ubiquinon 10||10 coq2 10 27 10 biosynthesi||10 20 22 26 22 10||10 17 18 19 10 23||refer 1||defici||lancet 1 368:70,0.058||0.048||0.04||0.037||0.037||0.035||0.033||0.032||0.031||0.031||0.025||0.023||0.02||0.018||0.015,0.0,0.0,0.06666666666666667
1067,Clin_Oral_Investig-4-1-2238790.txt,zinc phosphat cement||type||resin cement||retent||time||questionnair||diamet||core||high preval||stainless steel||resin composit||studi||year||amalgam||patient||clinic crown||restor materi||extent||failur||fractur resist||fractur||treatment||lute||post-retain restor||restor||materi||function time||practition||privat practition||factor||root||cement||survey||length||tooth||post,2||post 2||1||post||1 15 2||1 5 4 6 15 2||4 5||2 distribut||5 distribut||1 1 depart||1 distribut||5 year||5 20 2 11 33 6||2 asmussen||5 50 6,0.022||0.02||0.018||0.018||0.017||0.015||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.011,0.2,0.1,0.06666666666666667
1068,Eur_J_Pediatr-4-1-2413085.txt,type||gene||role||human||rab||defect||bind||protein||function||transport||diseas||patient||rab protein||activ||griscelli syndrom||membran traffick||brain,2 1||rab||rab protein||protein||2 avp||refer 1||rab function||4 5 13 4 5||host cell||2008 conclus||1 human monogen diseas||rab gtpase||rab interact||belgium 2 center||human,0.022||0.018||0.017||0.016||0.013||0.013||0.013||0.012||0.011||0.01||0.01||0.01||0.01||0.01||0.01,0.6,0.3,0.26666666666666666
1069,Neurochem_Res-3-1-1794624.txt,arginyl residu||posit charg||import role||data||studi||amount||deimin||process||structur||increas||dna||brain||myelin||apoptosi||protein||neurolog diseas||myelin protein||mbp||citrullin||white matter||methyl||histon||multipl sclerosi||citrullin mbp||up-regul||demyelin||pad||result,2||pad 2||pad 2 promot||pad 2 enzym||pad 2 gene||pad||pad 2 regul||pad 2 label||pad 2 cluster||2 fig. 2 deimin pathway||pad 4||1 fig. 1||2006||pad enzym||4 5,0.042||0.032||0.024||0.023||0.022||0.022||0.022||0.022||0.022||0.02||0.019||0.018||0.014||0.013||0.013,0.0,0.1,0.06666666666666667
1070,Environ_Health_Perspect-116-2-2235228.txt,endocrin disrupt||de||diethylstilbestrol||summari estim||method||time||uniti||chi-squar test||qualiti||oral contracept||studi||sensit analysi||cryptorchid||risk||prenat exposur||random-effect model||test||testicular cancer||statist||subset||meta-analysi||estim||de exposur||heterogen||associ||hypospadia||environ||estrogen||exposur||pharmaceut estrogen||public||result,studi||2||control studi||1||case-control studi||cohort studi||studi design||risk estim studi||epidemiolog studi||hypospadia||studi popul||individu studi||observ studi||prospect studi||addit studi,0.021||0.014||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.011||0.011||0.011,0.2,0.2,0.13333333333333333
1071,Cancer_Causes_Control-3-1-1914283.txt,prospect cohort studi||follow-up||alcohol consumpt||cancer||data||studi||year||never-smok||bmi||endometri cancer||risk||prospect data||netherland||menopaus||cigarett||smoke||day||cohort||women||cohort studi||alcohol||estim||multivari||age||analysi||associ||endometri cancer risk||exposur||smoker||subcohort member||hrt||cigarett smoke||endometri carcinogenesi,cancer||endometri cancer cancer||1 1||1||endometri cancer||control cancer||endometri cancer risk||2||2 2||women cancer||1 1 depart||postmenopaus breast cancer cancer||cancer registri||endometri cancer case||cancer eur,0.025||0.02||0.02||0.02||0.018||0.015||0.015||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013,0.4,0.3,0.2
1072,Biol_Psychol-1-5-2075532.txt,attent||attent task||individu||individu differ||rate||data||studi||effect||anxieti||amygdala||facial express||manual respons||face||threat-process||emot intens||cognit||research||eye-mov data||task||bia||direct||intens||present find||similar pattern||attent bia||group||fear||signific differ||emot||result,1||face||2||emot face||anxieti||2005||fig. 2||cognit||number 1||data fig. 2||1 tott0006@tc.umn.edu||anxieti group||neutral face||emot||2 ratcliff,0.021||0.017||0.016||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.011||0.011||0.011,0.4,0.3,0.26666666666666666
1073,Virchows_Arch-4-1-2234444.txt,case||rapamycin||aml||tsc||patient||uteru||gynaecolog origin||present||lymphangioleiomyomatosi||actin||site||lesion||featur||sugar tumor||cell||numer case||gene||term||pecoma||angiomyolipoma||mtor||pulmonari lymphangioleiomyomatosi||normal counterpart||tumor||epithelioid||pec||posit||diseas||ccst||clear epithelioid cell||lung||kidney,1 month||year||1 year||1||cell||epithelioid cell||epithelioid||6 month||14 month||12 month||13 month||39 month||1 year hepat||18 month||1 year pulmonari,0.019||0.017||0.017||0.017||0.015||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012,0.2,0.2,0.13333333333333333
1074,Arch_Dermatol_Res-4-1-2254658.txt,psoriasi||moderate-to-sever psoriasi||studi||patient||peripher blood||sever form||mild diseas||increas||lesion||total lymphocyt||subset||present studi||cell||mild||ratio||blood||mild psoriasi||percentag||moderate-to-sever diseas||analysi||lymphocyt||subject||pasi-scor||rel under-represent||differ||skin||diseas||absolut number||normal subject||result,3||fig. 3||1||fig. 1||4 fig. 4||2 3 fig. 2||10||psoriasi||10 11||1 demograph||result 1||5 fig. 5||refer 1||cell||psoriasi patient,0.033||0.029||0.028||0.027||0.025||0.025||0.022||0.02||0.017||0.017||0.017||0.016||0.016||0.016||0.016,0.0,0.1,0.13333333333333333
1075,Clin_Oral_Investig-4-1-2238791.txt,dental eros||case||shallow defect||studi||diagnost process||eros||wear||current criteria||criteria||epidemiolog||defect||risk group||teeth||tooth wear||lesion||current diagnost criteria||valid||epidemiolog studi||incis||occlus||adjac tooth surfac||shape||characterist||acid||subject||diagnost criteria||tissu loss||surfac||group||exposur||cup||clinic experi||diseas||loss||diagnosi,1||2||eros 1||eros||3||grade 2 5||dental eros||grade 1 24||eros tooth||refer 1||moder 1||1 10 8||2 preval||part 2||19 28 2 fig. 2,0.024||0.021||0.02||0.016||0.014||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.011||0.011,0.2,0.2,0.13333333333333333
1076,Virchows_Arch-4-1-2233709.txt,antibodi||line||tissu microarray||gastriti||downregul parafibromin express||studi||surviv rate||patient||pathogenesi||parafibromin||section||gastric tumour||adenoma||independ prognost factor||depth||cell line||express||metastasi||multivari analysi||larg tumour||prognosi||tumour tissu||tumour size||invas||gastric carcinoma||progress||parafibromin express,1||1 2||carcinoma||2||parafibromin||1 parafibromin express||gastric carcinoma||carcinoma cell line 1 2||cell||parafibromin express||tumour cell||5||fig. 1||gastric carcinoma cell line||gastric tumour,0.018||0.018||0.017||0.017||0.017||0.015||0.014||0.014||0.014||0.013||0.012||0.012||0.012||0.011||0.011,0.2,0.3,0.26666666666666666
1077,J_Hum_Genet-2-2-1705471.txt,logist regress analysi||variant||sampl||data||studi||allel||low statist power||region||upstream region||dopamin D4 receptor||gene||control||synergist interact||polymorph||associ||re-sequenc||haplotyp analysi||snp||genom variant||schizophrenia||linkag disequilibrium||result,1||1 1||genet||2||2 2||drd4||result drd4 1||1 drd4 marker||1 fig. 1 drd4 box||2 2 fig. 2 drd4||japan||626065 1||genet variant||drd4 gene||human genet,0.03||0.03||0.021||0.019||0.019||0.019||0.018||0.017||0.017||0.017||0.016||0.016||0.015||0.015||0.013,0.0,0.0,0.0
1078,Atherosclerosis-2-1-2292239.txt,aortic distens||atherosclerosi||mri||imag||baselin||patient||effect||atheroma burden||carotid||magnet reson imag||treatment||therapi||unselect coronari arteri diseas patient||statin||chang||small number||crp||regress||larg arteri stiff||plaqu size||coronari arteri||area||plaqu||time point||earli time point||brachial arteri||aorta||ldl-c||function,1||2||2 2||1 patient||fig. 1||3||tabl 2||fig. 2||3 month||3 tabl 3||tabl 3||patient||2007||robin.choudhury@cardiov.ox.ac.uk 1||3 month treatment,0.022||0.017||0.017||0.017||0.016||0.014||0.014||0.014||0.014||0.014||0.013||0.012||0.012||0.011||0.011,0.0,0.0,0.06666666666666667
1079,J_Headache_Pain-4-1-2386848.txt,week||headach frequenc||reduct||studi||patient||topiram||school||effect||frequenc||follow-up visit||aim||side effect||advers event||day||headach||paper||month||open studi||group||prophylact treatment||drug||prevent treatment||trial||adolesc||pediatr migrain||migrain||disabl||loss||children,2||1||10||2 year||springer-verlag 2008 introduct 1 2 3||3 mg||7||refer 1||migrain||migrain headach||10 10 14||headach||method 1 9||10 12||treat migrain,0.03||0.029||0.022||0.021||0.02||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015,0.0,0.1,0.13333333333333333
1080,Evid_Based_Complement_Alternat_Med-4-1-1810360.txt,multiple-dos effect||condit||measur||immun system||children||behavior||mood||reduct||sampl||data||studi||depress||session||salivari cortisol||effect||MT research||MT session||child||review||pediatr MT||increas||anxieti||blind||statist||adult||treatment||therapi||research||scientif understand||pain||frequent failur||popul||parent||suffici data||trait anxieti||arthriti pain||report||single-dos effect||field||recipi||massag therapi||statist power||outcom||result,tabl 1||20 1||1 20||1 field||15 1||MT||2||MT effect||2 1 2 univers||1 month||1 31||march 1||pediatr MT||effect||MT studi,0.021||0.021||0.021||0.021||0.02||0.019||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016,0.0,0.0,0.13333333333333333
1081,Pediatr_Nephrol-4-1-2275777.txt,type||detrusor muscl||follow-up||irrevers renal damag||renal damag||detrusor overact||oxybutynin||intraves pressur||studi||year||intraves instil||detrusor||patient||effect||risk||secondari damag||bladder||earli diagnosi||intermitt catheter||treatment||safe urinari contin||nbsd||long-term outcom||manag||infect||anticholinerg||therapi||evalu||urodynam||renal function||cic||adequ medic treatment||neurogen bladder||standard therapi||upper||contin||long-term experi||nbsd manag||children,2||bladder||2 fig. 2||neurogen bladder 2 2 2 7||bladder complianc 2||neurogen bladder||bladder dysfunct||dysfunct bladder||bladder function||2 predict||neurogen bladder dysfunct||1 fig. 1||bladder capac||bladder growth||bladder outlet,0.027||0.026||0.02||0.02||0.018||0.017||0.017||0.017||0.015||0.015||0.014||0.014||0.013||0.013||0.013,0.2,0.2,0.13333333333333333
1082,Oecologia-3-1-2039837.txt,thermal toler||measur||acclimat||respons||clam||rate||data||valu||bay||sensit||temperatur||north sea group||ambient condit||physiolog||genet group||metabol rate||popul||season variat||factor||specimen||taxa||limit||speci||data point||respir rate||mussel,mytilu||mytilu M.||mytilu M. balthica mytilu||2 mytilu||10 mytilu||mytilu eduli||5 mytilu||mytilu galloprovinciali||M.||1||respir rate M. balthica mytilu M.||10 M. balthica mytilu 7||10 mytilu M. balthica popul||2 M. balthica mytilu ssp||fig. 1 mytilu M. balthica light,0.027||0.021||0.021||0.019||0.018||0.017||0.017||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.013,0.0,0.0,0.0
1083,Eur_J_Pediatr-3-1-2042510.txt,condit||case||logist regress analysi||children||infant||birth order||birth||rsv infect||studi||patient||higher likelihood||major epidem||rsv||respiratori syncyti viru infect||strong autocorrel||gestat age categori||control||hospit||season||age||young children||social characterist||predictor||famili||factor||bivari analysi||number||risk factor||hospit admiss||control-pati||rsv-induc lrti||sever rsv-induc lrti,3||1||studi||7 month 1||2||refer 3||3 month 25||12 month||refer 1||3 month 60||pediatr||test 1 2||12 month 6||5 month 48||10,0.02||0.019||0.018||0.016||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.013||0.013||0.012||0.012,0.2,0.1,0.06666666666666667
1084,Eur_J_Epidemiol-4-1-2190784.txt,time||men||knot||preval||msm||sexual behaviour||studi||year||hsv transmiss||risk||homosexu contact||calendar year||western blot||increas||amsterdam cohort studi||time trend||blood sampl||age||orogenit contact||associ||sexual partner||sexual activ homosexu men||hsv-2||decreas||independ risk factor||sexual risk behaviour||hsv-1||risk factor||partner||hiv||hsv-infect||result,1||type 1||time 1 2 2||2||2 2||lifetim 1||viru type 1||1 1987||refer 1||1 0.01||1 northern||risk factor 1||1 57||1 461||1 615,0.031||0.021||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.016||0.016,0.0,0.0,0.0
1085,Ann_Surg_Oncol-4-1-2277445.txt,patent blue dye||case||liver metastas||figur||ovarian cancer||studi||patient||adopt immunotherapi||expans procedur||pancreat cancer||preoper lymphoscintigraphi||node||transfus||blue||increas||superior surfac||metastas||tumor homogen||malign melanoma||radioact tracer||immunotherapi||cell||antigen||partial right-sid liver resect||squamou cell carcinoma||squamou cellular cancer||averag||lymph node||lymphocyt||surgeri||local recurr||liver||sentinel node||tumor||lymphat vessel||lymphat||posit||success expans||inject||lymphoscintigraphi||diseas||lymphat map,1||2||cancer||patient 1||patient 2||node||cancer cell||RT 2 2||cell||patient||1 po||recurr PB 2 1||lymph node||t-helper 1 cell||3,0.023||0.022||0.019||0.019||0.018||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013,0.0,0.3,0.26666666666666666
1086,Eur_Radiol-3-1-2077917.txt,week||limit bowel prepar||origin raw data||patient||CT colonographi||low-dos protocol||observ||sensit||imag qualiti||colonoscopi||dose-level||rectum||repeat CC||fecal tag||ctc||stool||polyp||experi||simul||bowel prepar||extens cleans||sixty-on patient||larg false-posit lesion||dose reduct||oral contrast agent||stool soften||moder sensit||segment||contrast||prefer||result,1||2||1 2 1 2 analysi||patient||2 3 fig. 2||studi||5||3||4||radiolog||2 colonoscopi||patient questionnair 1||refer 1||result 2||definit 1,0.022||0.019||0.017||0.016||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012,0.2,0.1,0.06666666666666667
1087,J_Mol_Biol-1-5-1885968.txt,order paramet||ligand bind||data||bind site||hsqc||motion||structur||complex||domain||diffus tensor||free energi||dynam||rdc||abp||conform entropi||paramet||heteronuclear singl quantum coher||residu||protein||flexibl||analysi||simul||chang||bind||favour enthalp contribut||protein dynam||differ||entropi||consist||nmr relax||rotat diffus||interact||optimis||experiment data||entrop cost||molecul||molecular dynam simul||ligand||result,2||2 2||2 1||1||figur 2||2 LZ||tabl 2||2 apoabp||8 2||43 1 15 1||2 valu||tabl 1||2 measur||2 ps||2 abpgal,0.036||0.036||0.033||0.031||0.027||0.022||0.022||0.02||0.02||0.02||0.02||0.019||0.019||0.019||0.019,0.0,0.0,0.0
1088,Pediatr_Nephrol-4-1-2259254.txt,condit||muscl||chronic kidney diseas||complic||ckd||caspase-3||metabol acidosi||glucocorticoid||degrad||insulin||muscl wast||cell||kidney diseas||growth||muscl mass||protein||protein degrad||activ||uremia||muscl atrophi||acidosi||insulin resist||loss||result,muscl||muscl protein||protein||degrad muscl protein||muscl protein degrad||protein protein degrad||kidney||muscl cell||cell protein||skelet muscl protein||2004||muscl degrad||protein degrad||protein metabol||3,0.021||0.021||0.021||0.016||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.4,0.2,0.2
1089,Doc_Ophthalmol-3-1-1820752.txt,type||standard method||minimum amplitud||method||respons||light adapt||data||valu||eog||electr potenti||electrod||refer data||difficulti||present||clinic eog||total dark||amplitud||test||norm data||dilat pupil||light peak||eye||retina||retin pigment epithelium||ratio||potenti||light rise||saccad||dark||standard||subject||chang||pupil||minimum||clinic electro-oculographi||report||record||eog record||peak||arden ratio||pupil dilat||result,light||1||2||2 3||eog 2 fig. 2||standard 1 8 1 2||standard||test||1 min||light lumin 2 3||light phase 2||eog standard||electrod 1 fig. 1||3||eog,0.025||0.023||0.023||0.02||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.017||0.017||0.016,0.0,0.2,0.2
1090,Qual_Life_Res-3-1-2062490.txt,refer point||cancer||measur||method||men||then-test score||studi||vignett||erectil dysfunct||patient||effect||qol||then-test||local prostat cancer||treatment||health||primari treatment||assess||month||respons shift||chang||respond||differ||prostat cancer||diagnosi||origin score||score||result,2||1 1 2 2||1||1 month||2 4||cancer||1 month post-diagnosi||2007 introduct 1 2 3 4||3 3||3||prostat cancer||month||result 1||14 2||health,0.031||0.031||0.031||0.024||0.024||0.021||0.019||0.019||0.019||0.019||0.018||0.018||0.018||0.018||0.018,0.0,0.1,0.26666666666666666
1091,Int_Arch_Occup_Environ_Health-4-1-2175021.txt,conceptu||role||measur||case||sick||emot process||sampl||posit result||strategi||sick absenc measur||durat||avoid||frequenc||effect||present||sick leav||excess risk||ucl||problem-solv||absenc||behaviour||day||social support||item||result||associ||employe||total number||sick absenc||cope||factor||short length||length||health outcom||day absent||stress situat,2||cope||1||absenc||sick absenc||sick||1 year||sick absenc sick absenc length||sick absenc sick absenc data||cancer||sick absenc histori||activ cope||sick absenc measur||sick absenc risk||sick absenc behaviour,0.017||0.015||0.014||0.013||0.013||0.013||0.012||0.011||0.01||0.01||0.01||0.009||0.009||0.009||0.009,0.6,0.4,0.3333333333333333
1092,Eur_J_Pediatr-4-1-2254659.txt,organ||chelat||method||liver biopsi||ferritin serum ferritin||bodi||deferasirox||mri||iron overload||magnet reson imag||lic||liver||patient||therapi||day,3||iron||iron level 1||fig. 3||2 3 12||iron chelat||2 4||liver iron||1 8 fig. 1 blue||refer 1||1 comparison||iron chelat therapi 6 2||iron overload||cardiac iron||iron chelat therapi,0.029||0.029||0.023||0.021||0.021||0.02||0.02||0.018||0.018||0.018||0.018||0.017||0.017||0.017||0.017,0.0,0.0,0.06666666666666667
1093,Behav_Genet-4-1-2257997.txt,motor task||measur||find||time||pac interview||famili vulner||deficit||abnorm||compar problem||studi||effect||tendenc||motor output||variabl||disord||genet underpin||motor speed||control||famili resembl||task||age||endophenotyp||accuraci||subject||motor||group||famili||proband||sibl||genet basi||famili suscept||screen||adhd||extern cue||speed||motor time||addit||non-affect sibl||children,1||2 1 1||2||3 1||1 1 depart||7 1 1 1 24 1||motor||1 115 3 1 2||motor time||time||4 2||2 22 4 1 3||10 1||3||1 distribut,0.031||0.028||0.024||0.024||0.021||0.021||0.021||0.021||0.02||0.02||0.019||0.018||0.017||0.017||0.017,0.0,0.3,0.2
1094,J_Gastrointest_Surg-3-1-1852393.txt,surviv||demograph data||mitogen-activ protein kinas||chemotherapi||radiat therapi||mapk||studi||protein||cd24 express||radiat||month||prognost marker||cholangiocarcinoma||data||express||patient||treatment||cell||patient surviv||multivari analysi,1 1 figur 1||1 figur 2||surviv 2 3||2 2 30||4||2 15 11||11||human cancer cancer||patient||time 1||john.gibbs@roswellpark.org 1 1 depart||time 2||3 8||refer 1||patient surviv,0.021||0.019||0.019||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014,0.0,0.1,0.13333333333333333
1095,Pediatr_Nephrol-3-1-1766474.txt,ultrafiltr rate||ultrafiltr||session||patient||hemodiafiltr||permeabl||risk||volum||dialysi session||needl||blood volum||blood purif||mmhg||guidelin||dialys||blood||fluid||ultrapur dialys||normal||weight||newer machin||hemodialysi||continu blood volum||import||high flux||access||endotoxin||dialysi||urea||adequ||membran||children||high flux membran,1||1 2||2||2 2||dialysi||guidelin 1||guidelin 2||3 4 4 1||1 3 28||guidelin 3||double-needl dialysi 3||dialysi membran||1 Kt||dialysi effici 3 24 3||2 Kt,0.023||0.022||0.022||0.022||0.021||0.016||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.013,0.2,0.1,0.06666666666666667
1096,Cardiovasc_Intervent_Radiol-3-1-2039794.txt,qualiti||baselin||studi||patient||question||bodi imag||sexual||improv||treatment||sexual life||sexual function||women||analysi||fibroid||group||differ||bi||uae||uterin arteri embol||hysterectomi||score,1||2||1 1 depart||5||month 1||4||sexual||1 year||refer 1||2 week||1 58||fig. 2||question 2||part 2||2 year,0.026||0.023||0.018||0.017||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.013||0.013,0.0,0.1,0.06666666666666667
1097,Bioprocess_Biosyst_Eng-2-2-1705492.txt,model paramet||primari human liver cell||system||bioreactor||data||model||valu||asp||amino acid||variabl||cell||amino acid metabol||liver cell bioreactor||oxid deamin||activ||part||liver||ly kinet||high||perform||run||princip compon||kinet||differenti equat system||medium,1 1||1||2||0||0 1 2258 1||0 3||1 8||1 10||cell||tabl 1||2 2 2.1||_{ 0||liver||0 21 0||1 2.1,0.041||0.041||0.033||0.031||0.029||0.026||0.025||0.024||0.023||0.023||0.023||0.023||0.022||0.022||0.022,0.0,0.1,0.13333333333333333
1098,Purinergic_Signal-4-2-2377316.txt,guanylyl cyclas||concentr||data||studi||avoid||pkc||western blot||messeng pathway||cell||calcium||behavior assay||tyrosin phosphoryl||control||enzym||protein||chemorepel||tyrosin kinas||purin metabol||buffer||behavior buffer||pharmacolog inhibitor||gtp||inhibitor,tetrahymena||tetrahymena thermophila||1 2 tetrahymena tetrahymena||tetrahymena tetrahymena tetrahymena 33 tetrahymena||tetrahymena cell||3||T. thermophila tetrahymena||1 1 3||3 3 3 fig. 3 tetrahymena||1||tetrahymena 50||2||tetrahymena thermophila eur||1 3 4 2 2 2||cell,0.042||0.037||0.035||0.034||0.033||0.029||0.029||0.028||0.028||0.028||0.026||0.026||0.025||0.025||0.024,0.0,0.0,0.06666666666666667
1099,J_Autism_Dev_Disord-4-1-2335292.txt,level||time||play||behavior||control group||qualiti||book||studi||account||autism||durat||asd||develop||disord||play behavior||control||relationship||manipul||age||month||group||differ||daili utensil||opportun||agreement||symbol||development disord||toy||object||attach||children,play||2||play behavior||play behavior play behavior||1||play develop||symbol play||child play||H. play||3||play durat||A. play||manipul play function play symbol play||0 2 2 0 2 3||studi play behavior,0.031||0.024||0.022||0.022||0.021||0.019||0.019||0.018||0.018||0.018||0.018||0.018||0.017||0.017||0.017,0.4,0.2,0.13333333333333333
1100,Photosynth_Res-3-1-2117334.txt,photosystem II||effect||electron transfer||photosynthesi||level||fluoresc||uv-b radiat||increas||PS II||acceptor side||uv-b irradi||function||uv-b||irradi||chlorophyl||donor side||light||damag||plant,plant||1||2||fig. 1||1 5||1 2 1 laboratori||1 2 1993||1 fig. 2 effect||1 2 5 5 fig. 4||plant cell||1 2003||2000||5||plant physiolog||higher plant,0.029||0.029||0.027||0.022||0.022||0.022||0.02||0.02||0.019||0.019||0.018||0.017||0.016||0.016||0.016,0.2,0.1,0.06666666666666667
1101,Matern_Child_Health_J-2-2-1592144.txt,attent||commun health center||method||pregnanc||problem||data||state||pregnanc plan||counsel||avail||famili plan servic||preconcept care||healthi infant||percentag||women||care||servic||reason||facil||inadequ attent||famili||visit||access||famili plan||underutil,famili plan||famili||famili plan 1||pregnanc plan||famili plan servic||plan servic||famili plan research||seek famili plan||famili plan practic||state-fund famili plan servic||effect famili plan method||health care||pregnanc||medicaid famili plan demonstr||health plan employ data,0.038||0.033||0.033||0.032||0.03||0.028||0.027||0.027||0.026||0.023||0.022||0.02||0.02||0.02||0.02,0.8,0.4,0.3333333333333333
1102,Pediatr_Nephrol-3-1-2064944.txt,rrt||chronic kidney diseas||children||ckd||preval||kidney||data||patient||end-stag renal diseas||inform||epidemiolog||major||naprtc||preval rate||unit state||adult||countri||kidney diseas||esrd||renal transplant||earli detect||age||popul||incid||care||congenit renal disord||report||renal replac therapi||registri||dialysi||pediatr ckd,2||pediatr||2 8||15 2||22 2||5 21 2 5 fig. 2||age 2||renal diseas||5||5 5 5||Cr 2 19||1 5 fig. 1||pediatr patient||10 2 17 10||pediatr nephrol pediatr nephrolog,0.027||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.0,0.0,0.0
1103,J_Mol_Med-3-1-1820750.txt,dcmi||quantit real-tim pcr analysi||cardiac express profil||microarray analysi||studi||patient||apn||wnt||standard clinic character||biolog function||human||heart failur||dcmi heart||express||molecular virolog analys||human inflammatori cardiomyopathi||cell||gene||local inflamm||dilat cardiomyopathi||gene network||cardiac inflamm||analysi||etiology-rel pathogen pathway||therapeut potenti||genom express profil||heart||cardiac diseas,"1||1 1 2 2 2||cell 1||2||studi group 1 1 1||cell||2 2 16 2||2 2 2 a,b||1 11||2 fig. 2||fig. 1||1 2 5 17||1 character||tabl 1||1 13",0.027||0.023||0.022||0.021||0.019||0.018||0.017||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014,0.0,0.1,0.06666666666666667
1104,Glycoconj_J-4-1-2234451.txt,array||antibodi||mab||epitop||glycan||cell wall||sampl||probe||polym||hybridoma supernat||pectic side chain||plant cell wall||hybridoma line||specif||cell||monoclon antibodi||carbohydr microarray||hierarch cluster||analysi||agp||materi||bind||order||plant,1||2||A.||array 2 2 2 2||cell||A. thaliana||analysi 1 1 2 5||box 1 2 3 4 1||fig. 2||plant cell||3||array 2 4 2 4||8 A. thaliana||2 1 fig. 3 probe||cell wall,0.025||0.024||0.021||0.02||0.019||0.019||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.015,0.2,0.1,0.13333333333333333
1105,Eur_Arch_Otorhinolaryngol-3-1-1914267.txt,split skin graft||questionnair||non-donor site||subject complaint||studi||patient||total score||test||morbid||forearm||lower arm||frff||strength||forearm disabl||subject self-rat||radial forearm flap||donor site morbid||function result||differ||flap||skin||object function test||fasciocutan flap||reconstruct||object||free radial forearm flap||wrist||hand||cosmet||function||donor,2||1 2||1||forearm 1||tabl 2||forearm||3||8||2 cm||door 2||bike 2||7||forearm flap||1 fig. 1 inclinomet||result 1,0.033||0.03||0.027||0.023||0.021||0.019||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016,0.0,0.1,0.06666666666666667
1106,Mar_Biotechnol_(NY)-4-1-2263118.txt,method||microarray||studi||fish chip||gene express||fluoresc signal||probe||dna||cross-hybridis||gene||singl target hybridis||speci identif||oligonucleotid probe||spot||identif||european sea||fish speci||dna chip||dna microarray||fragment||signal intens||speci||suitabl||design||sequenc||oligonucleotid,2||1||3||2 20||1 2 5 2 10 ab108498||2005||2 min||1 1 centr||silico 2||2 weber||4 2 6 ay359673||2 nontarget speci||1999 3||2005 2004||1 plane,0.025||0.019||0.018||0.015||0.014||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.011||0.01,0.0,0.0,0.0
1107,Clin_Rheumatol-3-1-2039777.txt,function abil||measur||level||jafa||questionnair||final score||studi||patient||median diseas durat||perform test||present studi||individu item||chaq||item||jia||diseas activ||rom||childhood health assess questionnair||intern reliabl||rheumat diseas||spearman correl coeffici||children,1||2||1 jafa||1 fig. 1 frequenc||0.01 discuss 1 1||refer 1||3||7 Îº 1||posit 1 0.38||t.p.m.vliet-vlieland@lumc.nl 3 1 depart||0||5 step 1 0.38||head 1 0.38||2 0.52||m.a.vanrossum@amc.uva.nl 2,0.039||0.03||0.024||0.021||0.021||0.021||0.018||0.018||0.016||0.016||0.016||0.016||0.016||0.015||0.015,0.0,0.0,0.0
1108,Dev_Biol-2-1-2279743.txt,gata||bmp||induct||embryo||earli role||combin||earli express||effect||zebrafish correl||marker||myocardium||express||cardiac marker express||absenc||cell||somit||gene||zebrafish||gata factor||nkx||loop||gata activ||mous||vertebr||evolut||requir||feedback loop||phenotyp||zebrafish embryo||heart||function||network,xenopu||2004 xenopu xenopu xenopu fig. 5||xenopu xenopu peterkin||vivo xenopu xenopu||1999 xenopu||2005 xenopu||fig. 3 nkx2.5||xenopu peterkin||pannier nkx2.5 xenopu fig. 7||xenopu gata-4||fig. 3 nkx2.5 fig. 3 nkx2.3||2001 xenopu fig. 7 peterkin||1999 xenopu peterkin||abstract xenopu xenopu gata5 faust||xenopu gata-2,0.026||0.02||0.019||0.018||0.018||0.016||0.016||0.016||0.014||0.014||0.014||0.014||0.014||0.013||0.013,0.0,0.0,0.0
1109,Bioprocess_Biosyst_Eng-2-2-1705518.txt,method||organel||time||nutrient||concentr||steadi state||rate||model||root mass||growth rate||hairi root growth||independ pathway||amino acid||tool||analys||cell build block||growth||cell||metabol regul||glucos||intracellular ammonium||sugar||primari metabol pathway||flux||plant cell||intracellular concentr||literatur||cultur||medium exchang cultur||secondari metabolit||metabol network||batch||minim medium||experiment data||root||metabol model,C. roseu||2||2 2||C.||model||2 4||4 2||1 C.||model calibr||DW C. roseu model calibr||1||DW C. roseu||1 2 3 4 3||plant||3 1,0.021||0.019||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015||0.015||0.014,0.2,0.1,0.06666666666666667
1110,Diabetologia-3-1-1849422.txt,person||futur||diabet||project||preval||individu||burden||data||model||studi||year||II mortal survey||mortal||risk||potenti impact||increas||proport||adult||nhane iii||substanti number||estim||age||popul||total number||nutrit examin survey||decreas||number||older age group||survey||high-risk group||hispan commun||score||result,diabet||diabet diabet burden||diabet risk||1||diabet 5||diabet preval||diabet patient||futur diabet||diabet burden||diabet 20||total diabet||diabet estim||diabet develop||diabet mortal||diabet 1995,0.055||0.039||0.035||0.033||0.032||0.032||0.031||0.031||0.031||0.031||0.031||0.031||0.03||0.03||0.029,0.2,0.1,0.06666666666666667
1111,Tuberculosis_(Edinb)-1-5-1913930.txt,glutamin||ammonia||extra-cellular GS||gene||control||strain||level||delet||nitrogen sourc||glutamin synthetas||mutant||protein||cultur filtrat||glnd||virul||nitrogen metabol||macrophag||activ||cell||growth,"tuberculosi||glnd||glnd M. tuberculosi||4||2||glnd 7 glnd glnd||mycobacterium tuberculosi||1||fig. 1 M. tuberculosi 7||figur 4 glnd mutant||M. tuberculosi 4,5||result glnd||glnd result||glnd mol||streptomyc coelicolor M. tuberculosi 8 glnd",0.039||0.037||0.033||0.033||0.031||0.03||0.025||0.024||0.023||0.021||0.021||0.02||0.02||0.02||0.018,0.2,0.1,0.06666666666666667
1112,Pediatr_Radiol-2-2-1764599.txt,larger bone||databas||roi||low bmd||studi||patient||total bodi bmc||standard deviat||densiti||lumbar spine||norm data||radiologist||clinic pathologist||bmd||bodi composit||bone age||hip||standard deviat score||bodi||age||dxa result||chang||numer result||bmc||factor||import||height||dxa||osteoporosi||pediatr dxa||signific chang||interpret||children||result,2||1 2 2 2 2||bone||1||pediatr bone||1 2 1 depart||1 2 3 4||bone miner||2 43||2 gender||bodi bone||lumbar bone||2 min||bone age||134 2,0.026||0.025||0.021||0.019||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.013||0.013,0.0,0.0,0.06666666666666667
1113,J_Med_Internet_Res-8-3-2018828.txt,time||effect relaps prevent intervent||cessat||individu||search engin||rate||data||studi||year||inform||quitnet||organ||total||time onlin||onlin||internet searcher||treatment||web||smoke||day||estim||result||popul||servic||reason||readi||search||smoker||survey||particip||peopl||queri||internet,1||2 2||2||tabl 1 2 2||1 month 2||cessat||4 2 2||cessat inform||2 4||1 week||7||inform||januari 1||search||smoke,0.028||0.022||0.022||0.021||0.018||0.018||0.018||0.017||0.017||0.016||0.016||0.015||0.015||0.015||0.014,0.0,0.1,0.26666666666666666
1114,Purinergic_Signal-4-2-2377317.txt,mechan||hypoton solut||uridin triphosph||rel abund||concentr||releas mechan||studi||adenosin||perfus||exocytosi||nucleotid speci||udp||uridin nucleotid||nucleotid releas||Ca||cell||intracellular calcium||cell surfac hydrolysi||nucleotid||result||experi||major mechan||fluoresc||hypoton shock||plasma membran||calcium-depend exocytosi,1||2||2 2||1 8 1||nucleotid releas 1 1 fig. 1||fig. 2 2||1 9 10 1||3 1 4 7||10 2||3||2008 introduct 1 3 4 1||4||refer 1||discuss 1||1 pmol,0.045||0.036||0.036||0.032||0.028||0.028||0.027||0.026||0.026||0.025||0.024||0.024||0.024||0.024||0.023,0.0,0.0,0.0
1115,Pediatr_Nephrol-3-1-1805046.txt,attent||level||find||chronic kidney diseas||hypertens||ckd||sampl||gener popul||studi||patient||standard deviat||pediatr ckd popul||test||cognit impair||cognit function||memori||neurocognit deficit||mild||esrd||age||analysi||anemia||attent score||onset||clinic variabl||rang||age-bas standard score||memori score||cognit test||risk factor||sever||particip||diseas||cognit perform||IQ score||standard score||function||children,2||2 1||1 2||1 2 3||1||2 relationship||8 12 2 12 2||2 week||anemia 2||ipna 2006 2||diseas||ipna 2007 introduct 1 2||3||52 2 bodi||4,0.033||0.027||0.027||0.022||0.021||0.02||0.019||0.018||0.017||0.016||0.014||0.013||0.013||0.013||0.012,0.0,0.0,0.06666666666666667
1116,Exp_Brain_Res-3-1-2137946.txt,attent||condit||measur||visual depriv||visual feedback||postur sway||sampl||data||time seri||amount||opposit effect||effect||visual inform||cop trajectori||sampl entropi||concurr visual feedback||present studi||eye||postur control||control||cerebr palsi||posturogram||EC condit||task||analysi||neural control mechan||sway||regular||extern focu||function task||sen||function context||children||result,1||2 1 1||2002||hypothesi 1||TD children 1||tabl 1||2||2000 2002||children||1 1 research institut move||2006 2002 2 2000||postur||2007 2002 2006 2005 2003 2005||postur control||2003,0.036||0.03||0.028||0.019||0.019||0.019||0.019||0.018||0.017||0.017||0.017||0.015||0.015||0.014||0.014,0.0,0.1,0.13333333333333333
1117,Eur_J_Epidemiol-4-1-2190786.txt,mother||birth||young adulthood||urin sampl||pregnanc||fetal life||studi||develop||process||child||plate||genet determin||dna||medic ethic committe||biobank||blood||research||parent||erasmu medic center||tube||biolog specimen||partner||equal dna concentr||biolog sampl||children||laboratori,2 2||2||1||studi||2007 introduct 1 2 1 2||2 fig. 2 distribut||2 14||netherland 2 depart||sampl||2 main determin||7 hofman albert 2 1||3||studi number||refer 1||1 31,0.025||0.025||0.02||0.018||0.017||0.014||0.014||0.013||0.011||0.011||0.011||0.011||0.011||0.011||0.011,0.2,0.1,0.06666666666666667
1118,Diabetologia-4-1-2292420.txt,type 2 diabet||studi||patient||blood pressur||intervent||type 2 diabet mellitu||glycaem control||cardiovascular risk profil||cost||heart rate||exercis intervent||month||physic fit||exercis||medic fit programm||long-term efficaci||min||resist||differ||physic activ||programm||clinic benefit||medic fit||particip||adher||endur type exercis||brisk walk||physic therapist,2||2 diabet||diabet||2 1 2||type 2 diabet||3 1 2||1||type 2||2 2 aggrav||3 1||type 2 diabet mellitu||type 2 diabet patient||type 2 diabet scand||type 2 diabet treatment||elderli type 2 diabet,0.027||0.026||0.025||0.025||0.021||0.02||0.02||0.019||0.018||0.017||0.017||0.017||0.016||0.016||0.016,0.2,0.1,0.13333333333333333
1119,Eur_Arch_Otorhinolaryngol-4-1-2279156.txt,prospect studi||subject symptom||phpt||parathyroidectomi||asymptomat phpt||questionnair||asymptomat primari hyperparathyroid||symptom||forget||concentr||improv||surgeri||success parathyroidectomi||depress||medic observ||treatment||patient||subject neuropsycholog symptom||result,0 1 2||1 5||2||1 year||1 case||refer 1||method 1 fig. 1 pt||patient||patient 25 10 10 5 2||4||25 patient||suppl 2||patient 25 6 17 2||2 comparison||improv gener health 1 year,0.045||0.04||0.038||0.033||0.03||0.029||0.024||0.021||0.021||0.021||0.02||0.02||0.02||0.019||0.019,0.0,0.1,0.06666666666666667
1120,Mar_Biotechnol_(NY)-2-2-1475948.txt,tumor necrosi factor||transgen zebrafish||japanes flounder promot||studi||egg||region||promot||site||adult||pattern||induc promot||express||gene||tissu||zebrafish||tnf||liver||gfp||induc activ||keratin||japanes flounder||tissue-specif promot,1 embryo||2||transgen zebrafish||1 minut||promot||transgen fish||2003 1 fig. 3.||transgen embryo||4 7 1 fig. 4.||express||2 transgen strain||4 promot||transgen japanes flounder||5 1 gong||discuss 1 fig. 1. express,0.024||0.023||0.022||0.021||0.021||0.021||0.02||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.017,0.4,0.3,0.2
1121,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764203.txt,voluntari statu||time||non-convert||individu||legal statu||clinic factor||data||model||studi||treatment engag||patient||inv-inv||medic problem||voluntari||criteria||counti hospit||medic||variabl||compulsori||treatment||polytom logist regress model||psychot symptom||hospit||research||assess||analysi||data collect||commit||group||factor||differ||inv-vol||symptom||diagnost characterist||adher||outpati follow-up,patient||2||1||psychiatr patient||patient 2 17 2||hospit psychiatr patient||discharg patient||discharg 3 2||3||psychiatr hospit||involuntari psychiatr patient||55 2 2||hospit||involuntari patient||psychiatr medic,0.021||0.021||0.02||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.014,0.2,0.1,0.13333333333333333
1122,Ann_Hematol-3-1-2082654.txt,case||molecular character||mutat||cml||peripher blood||allogen hematopoiet stem cell transplant||criteria||bone marrow||cel||disord||cytomorpholog||classif||cimf||diagnost||neg cmpd||cytogenet||chronic myelomonocyt leukemia||tyrosin kinas||cmpd||molecular diagnost||diagnosi||detect,jak2||jak2 mutat||2005||jak2 1 5 10 bcr||jak2 v617f||jak2 35 11 jak2 jak2 bcr||9||jak2 v617f mutat||10||jak2 11 bcr||2||jak2 v617f-posit||molecular mutat||cmpd 1 bcr||2006,0.019||0.013||0.012||0.012||0.012||0.012||0.011||0.01||0.01||0.01||0.01||0.01||0.01||0.01||0.009,0.0,0.0,0.0
1123,Biochem_Biophys_Res_Commun-1-5-1899526.txt,anion||sensit||atrial myocyt||solut||myocyt||experi||drug-contain solut||chlorid current||data||heart||valu||human atrial cardiomyocyt||channel||cell,1||fig. 1 fig. 1||fig. 1||1 2 2||fig. 1 fig. 2||2||2 2 2 2 2||fig. 2||tabl 1 2||tabl 1 tabl 1 tabl 1||1 2 3 4 3||8 1||fig. 3||figs. 1||2 4,0.051||0.043||0.043||0.042||0.039||0.037||0.037||0.036||0.035||0.034||0.03||0.028||0.028||0.026||0.026,0.0,0.0,0.0
1124,Intensive_Care_Med-3-1-1915596.txt,lo||find||case||reduct||demand cxr||abnorm||clinic indic||data||studi||patient||daili routin cxr||elimin||intervent||day||daili routin chest radiograph||chang||chest radiograph||mortal rate||differ||import||daili routin||number||cxr||icu patient||physician||readmiss rate||icu||result,1||phase 1||2||1 month||refer 1||phase 1 lo||phase 2||patient||mortal rate 1||cxr||intens care patient||1 march 2004||1 septemb 2004||31-20-5669111 m.j.schultz@amc.uva.nl 1 6 1 depart||medic patient,0.047||0.033||0.026||0.025||0.025||0.023||0.023||0.023||0.02||0.019||0.019||0.019||0.019||0.019||0.018,0.0,0.2,0.13333333333333333
1125,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998878.txt,type||delay||normal tissu||time||figur||nuclear medicin||cur treatment||studi||effect||dose rate||receptor||narrow rang||analys||exposur time||low dose||cell||therapi||growth||day||radionuclid therapi||growth delay||radionuclid||low dose rate||dish||rang||irradi chamber||order||slower rate||beta particl||exposur||cultur||chamber||intrins radiosensit||cultur dish||exponenti growth||irradi||tumour cell,cell||5 cell||tumour cell||cell line||u-118mg cell||cell surviv||cell type||cell kill||skbr-3 cell||glioma cell||u-373mg cell||cell count||5 5 5 tumour cell||ht-29 cell||cell dish,0.042||0.03||0.027||0.024||0.023||0.023||0.022||0.022||0.022||0.022||0.022||0.022||0.022||0.021||0.021,0.4,0.2,0.13333333333333333
1126,Pediatr_Nephrol-3-1-1805051.txt,inflamm||chronic kidney diseas||children||studi||patient||end-stag renal diseas||erythropoiesis-stimul agent||effect||ascorb acid||esa therapi||increas||erythropoiet respons||esa||guidelin||iron||advers event||therapi||esrd||acut||oxid stress||absolut||iron storag||anemia||hemoglobin level||hemodialysi||iron supplement||ferritin||parenter iron prepar||kidney function||iron statu||vitro studi||intern recommend||intraven iron,iron||intraven iron||iron therapi||iron statu||iron sucros||iron treatment||parenter iron||iron defici||serum iron||iron administr||oral iron||iron supplement||activ iron||iron complex||patient,0.048||0.03||0.029||0.027||0.026||0.026||0.026||0.025||0.025||0.025||0.025||0.025||0.025||0.025||0.025,0.6,0.3,0.3333333333333333
1127,J_Behav_Med-3-1-2080858.txt,person||aspect||type||attempt||neg feel||awar||level||find||restraint||neg emot||divis||individu||feel||distress||studi||concept||posit aspect||style||tendenc||scale||repression-lik concept||memori||self-decept||definit||denial||empir find||traumat event||non-express||repressor||defens||term||gener approach||suppress||repress memori||research||alexithymia||social phobia||self-imag||other-decept||report||differ||act||repress||self-conceal||peopl||emot control||emot||social situat,psycholog||1||repress||repress repress||social psycholog||differ||repress 1990||cancer||1990||1990 1990||emot||clinic psycholog||repress journal||1 fig. 1||cancer journal,0.017||0.015||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012||0.011||0.011,0.2,0.2,0.2
1128,Neurochem_Res-3-1-1832151.txt,role||bind partner||lrp||beta amyloid||secretas||presenilin||studi||aspartyl proteas activ||gamma secretas||nicastrin||intramembran cleavag||substrat competit||interact protein||complex||evid||molecular clamp||calsenilin||enzym||protein||result||insect cell||activ||gener||amyloid precursor protein||cell surfac||interact||fragment||date||pathway||strong evid||transmembran domain||app||function||compon,presenilin||presenilin 1||1||presenilin 1 protein||presenilin protein||protein||1 presenilin interact protein||1 1 2||presenilin 2||1 2||1 interact||presenilin complex||presenilin 1 associ||interact protein||presenilin 1 variant,0.027||0.027||0.027||0.026||0.026||0.025||0.023||0.022||0.021||0.02||0.019||0.019||0.019||0.018||0.018,0.2,0.2,0.2
1129,Breast_Cancer_Res_Treat-3-1-2001217.txt,placebo||adjuv||case||neoadjuv therapi||letrozol||individu||hormone-sensit breast cancer||breast cancer||breast cancer continuum||patient||tamoxifen||year||recurr||combin||effect||risk||regimen||chemotherapi||aromatas inhibitor||ai||sexual health||mbc||event||treatment||advers event||adjuv therapi||detriment effect||women||patient awar||long-term survivorship||anastrozol||tumor||trial||decis||benefit,cancer||breast cancer||breast cancer breast cancer||cancer breast cancer group||receptor-posit breast cancer breast cancer||II breast cancer breast cancer||breast cancer patient||primari breast cancer breast||breast cancer clin||earli breast cancer||outcom breast cancer||metastat breast cancer||primari breast cancer||breast cancer experi||advanc breast cancer,0.034||0.032||0.032||0.026||0.026||0.026||0.024||0.024||0.023||0.022||0.022||0.022||0.022||0.022||0.022,0.2,0.1,0.06666666666666667
1130,J_Neurol-3-1-1915648.txt,rand-36||placebo||measur||myoton dystrophi||hypersomnol||modafinil||patient||effect||percept||test||medic||mental health||sleepi||point||dose||present studi||interview||gener health||action||chang||activ||rang||insuffici effect||partner||double-blind placebo-control crossov studi||period,2||2 point||point||3 point||3||1 point||1||3 patient||2 3 4||patient||0 point||find point||29 point||13 patient||6.8 point,0.042||0.04||0.039||0.038||0.038||0.037||0.035||0.034||0.032||0.03||0.024||0.023||0.022||0.021||0.021,0.2,0.2,0.13333333333333333
1131,Semin_Immunopathol-3-1-2071951.txt,antibodi||level||renal damag||complement||membran attack complex||glomerulonephr||mpgn type II||hemolyt urem syndrom||model||mutat||patient||defici||deposit||risk||mpgn||complex||inhibit||mbl||cell||damag||therapeut intervent||mice||protein||regul||format||cell membran||renal function||activ||bind||factor||membranoprolif glomerulonephr||diseas||fluid phase||immun complex||ligand||kidney||result,complement||complement activ||refer 1||2 2||complement factor||springer-verlag 2007 introduct 1 2||complement activ pathway||complement system||complement deposit||complement scienc||complement studi||1 fig. 1 schemat overview||complement defici||complement regul||complement attack,0.019||0.014||0.013||0.012||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.011||0.01||0.01||0.01,0.2,0.1,0.06666666666666667
1132,Dev_Biol-1-5-2082130.txt,transgen||commun||core||polar||adjac cell||intercellular commun||failur||trichom||complex||polaris||planar polar||rotat||apf||signal||local coordin||cell||localis||clone||tissu||protein||lack||activ||stronger phenotyp||core polar protein||factor||distal cell edg||requir||development||interact||wing||asymmetri||cell polar||function||result,stbm||fz stbm||pk||fz||polar||polar polar||cell polar||cell||2002 fz fz fz fz||vang pk stbm||fig. 2 fz stbm||fz fig. 1||fz stbm 6||dsh fz||dsh 1 dsh fz stbm,0.025||0.024||0.024||0.023||0.023||0.023||0.023||0.023||0.02||0.02||0.02||0.02||0.019||0.019||0.019,0.2,0.3,0.2
1133,Crit_Care-5-4-37409.txt,technolog||system||databas||patient data||comput||data||studi||clinic scenario test||traine||patient||daili note||crossov studi||text entri||inform||process||resid||test||comput commun network||user||staff||palm devic||studi period||care||devic||patient manag||usa||medic refer inform||templat||refer||infrar||pda||handheld devic||physician||handheld comput||softwar||benefit||medic databas,patient||patient data||data||group||care||studi||4||patient inform||2 3 4 5 6 7||patient data manag||patient data applic||softwar||focu group kit 4||patient data entri||patient databas,0.023||0.021||0.019||0.019||0.018||0.018||0.017||0.016||0.016||0.016||0.016||0.016||0.016||0.015||0.015,0.8,0.5,0.4
1134,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-3-1-2062491.txt,questionnair||univari analysi||biomed factor||preval||pregnanc||data||gener popul||studi||depress||year||stress urinari incontin||epidemiolog studi depress scale||urg urinari incontin||ces-d||deliveri||uui||signific increas||analys||over-act bladder syndrom||higher rate||urogenit symptom||women||clinic depress||associ||urinari incontin||oab||factor||sui||healthi nullipar women||symptom||urinari symptom||syndrom,1||2||depress||1 year||1 week||depress symptom||result 2 2||2 tabl 1 incid||studi||refer 1||2 univari||symptom||1 year post-partum||depress disord||postnat depress symptom,0.022||0.019||0.016||0.016||0.015||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.012||0.01||0.01,0.2,0.2,0.2
1135,Pediatr_Nephrol-4-1-2259258.txt,linkag analysi||chromosom 1||individu||npl||studi||patient||genet linkag||loci||region||linkag||pedigre||complex disord||total||evid||reflux||gene||averag||primari vur||vur||total npl||previou studi||addit marker||famili||lod||maximum lod||genet heterogen||haplotyp||score||children||result,1||famili 1||2||famili 2||genet||famili||chromosom 1||refer 1||1 perrotta silverio 2 1 depart||result patient 1||clinic genet||genet linkag||2 1.34||3||genet studi,0.026||0.021||0.02||0.018||0.017||0.016||0.016||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.012,0.0,0.2,0.2
1136,Cell_Tissue_Res-3-1-2039796.txt,soft connect tissu||control group||data||bone regener||section||thrombin peptid||protein express||osteoblast lineag||osteopontin||bsp||adult||osteoblast differenti||bone sialoprotein||cell||osteoblast||tissu sampl||runx2||opn||distract gap||group||gap||bone||distract||area||distract osteogenesi,2||1 fig. 1||2 1998 2||1 day||tabl 1||1 mmol||2000||cell||immunohistochem procedur 2 2||fig. 3||31-20-4448683 a.bronckers@vumc.nl 1 1 depart||bone||3 min||3 day||4 4 3 cell,0.031||0.028||0.022||0.021||0.019||0.018||0.018||0.017||0.017||0.015||0.015||0.014||0.013||0.012||0.012,0.0,0.1,0.13333333333333333
1137,Surg_Endosc-3-1-2169269.txt,pneumoperitoneum||ldn||induct||studi||patient||data analysi||infus||anesthesia||kidney extract||overnight infus||crcl||hour||oper||day||urin output||fluid regimen||devic||earli graft function||bolu||group||pre-hydr||periop fluid manag||kidney||donor,2||group 2||group||group group||group 1||result 2 1 1 1||group 3||0.05 group 1 versu group 2||1 tabl 1||group 2 102||group 2 63||0.05 group 1||group 2 313||lvetc group 1||1 1 depart,0.039||0.039||0.039||0.039||0.038||0.03||0.029||0.028||0.027||0.027||0.026||0.026||0.026||0.025||0.025,0.2,0.1,0.06666666666666667
1138,Calcif_Tissue_Int-3-1-1914229.txt,index date||case||final model||Î²-blocker||histori||data||studi||patient||effect||risk||gprd||prescript||epidemiolog||variabl||pharmo rl||fractur||cumul dose||antihypertens agent||record||osteoporosi||drug||past||date||dutch pharmo record linkag system,1||2||2 3||tabl 2||2007 2 1 5||januari 1||result 1||refer 1||gprd studi popul 2 1||1 souverein||P. 1 3 1 divis||3||2 leufken||circl 2||studi,0.027||0.023||0.018||0.016||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.012||0.012,0.0,0.0,0.06666666666666667
1139,Appl_Microbiol_Biotechnol-4-1-2243256.txt,gene||polyamin||oxidas||putrescin||mutant||putrescin oxidas||plate||amin||enzym||enzym activ||substrat||room temperatur||substrat specif||oxid||spectrum||aromat cage||activ||substrat bind||bind||puo,Rh||Rh Rh||Rh Rh Rh||2 Rh Rh Rh Rh||Rh Rh Rh 1||1 Rh Rh||2 Rh Rh||Rh Rh 2 2 Rh||2005 Rh Rh||Rh Rh lane||stabil Rh Rh||Rh 1||1 Rh||1 Rh Rh Rh 2 2||3 Rh,0.068||0.068||0.068||0.059||0.057||0.053||0.053||0.05||0.049||0.046||0.046||0.045||0.045||0.045||0.042,0.0,0.0,0.0
1140,Breast_Cancer_Res_Treat-3-1-2045691.txt,optic nerv head||data||breast cancer||studi||year||comparison||tamoxifen||anastrozol user||adjuv endocrin therapi||effect||astrocyt||eye||disk area||regress line||women||eye diseas||optic cup||age||analysi||subject||onh||group||anastrozol||report||predict||cup||hrt||visual acuiti||disk margin||tamoxifen-induc effect||contour line||result,2||cancer||1||2 3||breast cancer||breast cancer breast cancer||3 1||2 year||2 4 4||2007 introduct 1 2||30 2||0.242 2||0.210 2||1 fig. 1 graph||control subject 1,0.025||0.021||0.021||0.018||0.017||0.017||0.016||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012,0.2,0.1,0.06666666666666667
1141,Vision_Res-2-1-2386851.txt,respons||mjm||sensat varianc||paramet valu||data||model||valu||stimulu||finger error||contrast discrimin||observ||threshold||discrimin||increment||visual signal||pedest contrast||intrins uncertainti||fit||ratio||low threshold||estim||varianc||result||sensori threshold||uncertainti||second-respons accuraci||compress transduct||pedest||trial||ja||sigma-to-mean ratio||contrast||nois||detect||function||first-choic accuraci,1||1 2 2||Î¨ 1||Ï 1||tabl 1||18 1 1 0 mjm||18 1 1 0 MT||38 1 1 0 mjm||38 1 1 0 MT||2||30 1 0 1 MT||36 1 0 1 mjm||1 Î´||NP 1||1 Îµ,0.046||0.033||0.031||0.029||0.027||0.026||0.026||0.026||0.026||0.026||0.026||0.026||0.025||0.025||0.024,0.0,0.0,0.0
1142,Int_Arch_Occup_Environ_Health-4-1-2175018.txt,emot role function||questionnair||qualiti||studi||patient||year||life||ill percept||percept||complaint||total||upper bodi region||rsi||person control||treatment||respect||work-rel upper extrem musculoskelet disord||health||averag||social function||pain||intens||group||order||differ||ill||treatment control||sick-list chronic rsi patient||work-abl,1||2 3 2||tabl 2||2006 2006 2006||2006 2006||2006||1 year||tabl 3||studi||rsi||result 1||rsi patient||patient||health||sick-list rsi patient,0.02||0.018||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.012||0.012||0.012||0.011,0.0,0.2,0.26666666666666666
1143,J_Med_Internet_Res-4-1-1761926.txt,document||level||technolog||system||diabet||commun||health care profession||lifemast||highest level||data||model||patient||inform||articl||mydiabet||abil||user||site||health inform||web site||criterion||manag||evalu||internet-bas diabet manag||relev||health care||solut||posit effect||internet||framework||more-complet solut||multi-rat kappa||blood glucos level||search||inform deliveri||diseas||result,diabet||1||1 1||diabet care||3 2||2 1 1 3 4||1 4 1||4 2||3 1||type 2 diabet||internet diabet||diabet technolog||tabl 2||diabet care 2000||care,0.025||0.022||0.022||0.02||0.019||0.018||0.018||0.018||0.017||0.017||0.017||0.016||0.016||0.016||0.015,0.2,0.1,0.06666666666666667
1144,J_Fluoresc-4-1-2266787.txt,sodium carbon solut||method||plasma||concentr||dosag form||determin||spike human plasma||pharmaceut prepar||standard deviat||experiment paramet||dilut time||mixtur||pH 10||fluoresc intens||reaction||solut||oxamniquin||analysi||concentr rang||oxm||drug||precis||dansyl chlorid||result,1||1 2||1 5||2||2 fig. 2||26 1 1||2 1 depart||method 2||1 rizk||5 ml||refer 1||3||2 applic||linear 1||scheme 1,0.034||0.032||0.031||0.03||0.026||0.024||0.023||0.021||0.019||0.018||0.018||0.018||0.018||0.018||0.018,0.0,0.0,0.0
1145,Purinergic_Signal-3-4-2072922.txt,receptor-receptor interact||role||function role||ionotrop receptor||releas||presynapt inhibit||studi||adenosin||channel||neurotransmiss||atp||effect||current||synapt transmiss||receptor||adenosin receptor||cell||brain||gpcr||potenti||hippocampu||nmda||regul||neuron||recent studi||pathophysiolog condit||activ||gaba||famili||interact||receptor interact||antagonist||result,1||1 receptor||6 1 1||1 19 1||1 111 1||2A 3 1 1||2007 1 2A 3 1 1||1 2||1 Rs||1 atp||0 1||12 1||1 108||refer 1||1 1 109 110,0.077||0.056||0.054||0.052||0.052||0.049||0.047||0.046||0.041||0.041||0.04||0.04||0.039||0.039||0.039,0.0,0.0,0.0
1146,Cell_Tissue_Res-4-1-2386751.txt,type||complic||elastin||pregnanc||abnorm||patient||uteru||ehlers-danlo syndrom||uterin tissu||human||present||tenascin-x||day||complet defici||collagen||mice||obstetr complic||ed||age||differ||tnx||skin||vagin plug||elast fiber||signific differ||uterin connect tissu||postpartum hemorrhag||ed patient,1||2 1 1||2||patient 1||2 fig. 2||partu 1 1||age 1 4||2 pregnanc||tissu||patient 3||patient||partu 1 3||6||2006||tnx-defici patient,0.024||0.022||0.019||0.018||0.017||0.016||0.014||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.011,0.0,0.0,0.06666666666666667
1147,Neurosurg_Rev-4-1-2279160.txt,case||cranio-vertebr junction||surgic treatment||problem||studi||transor approach||mucosa||remov||compress||muscle-mucos flap||risk||irreduc atlanto-axi disloc||soft palat||nasal caviti||spinal cord||endoscop||endoscop dissect||applic||approach||atla||order||hard palat||anatom studi||clinic applic||endonas approach||endonas||procedur||oral caviti||odontoid process||middl turbin,1||1 fig. 1||4 fig. 4||2 2 3 fig. 2||fig. 3 iwsph||fig. 6||refer 1||4 mm||manfr 4 1 depart||5 6 fig. 5||part 3||7 fig. 7 iwsph||endonas||itali 2 servic||5,0.032||0.03||0.029||0.027||0.018||0.018||0.018||0.017||0.017||0.015||0.014||0.014||0.013||0.012||0.012,0.0,0.0,0.06666666666666667
1148,J_Med_Internet_Res-8-2-1550702.txt,person||organiz task||author||technolog||organiz level||health care profession||practic||preval||rate||person digit assist||data||studi||year||nation sampl||inform||review||medic refer||articl||resid||clinic practic||profession||usag pattern||patient track||patient care||market research firm||adopt||male||medic resid||health||health care||age||handheld usag rate||characterist||care||present review||group||adopt rate||health care provid||pda||student||survey||handheld devic||physician||handheld comput||specialist||systemat review||specif task||result,survey||1||2 survey||2||survey physician||care||survey appendix 1||survey research||10 survey||health care||survey data||survey year||includ survey||physician||health,0.022||0.021||0.02||0.018||0.018||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013,0.2,0.3,0.3333333333333333
1149,Dig_Dis_Sci-3-1-1914244.txt,wide local excis||tumor||surviv||case||anu||melanoma||apr||local recurr||margin||wle||diagnosi||patient||abdominoperin resect||treatment,1||1 1 depart||1 1 fig. 1 melanoma||1 mm||3||refer 1||melanoma||4 mm||anorect melanoma||2 cm||prospect studi||melanoma discuss 4||netherland 2 depart||anorect||netherland 3 depart,0.041||0.031||0.03||0.027||0.024||0.022||0.02||0.02||0.018||0.018||0.017||0.017||0.017||0.016||0.016,0.0,0.1,0.06666666666666667
1150,Mol_Genet_Genomics-2-2-1705487.txt,gene||rna polymeras II||role||level||strain||subunit||cell growth||special role||method strain||cell divis||promot||transcript||presenc||osmot stress||growth||data||express||cell||thiamin||stress condit,rpb4||nmt1 rpb4 1 rpb4 rpb4||rpb4 nmt1||S. pomb rpb4 rpb4 express||cell separ rpb4 rpb4||1 rpb4 fig. 1 rpb4 rpb4||rpb4 transcript||S.||cell||pomb||3 3 rpb4 nmt1 rpb4||rpb4 strain||1 rpb4 nmt1 nmt1||rpb4 nmt1 nmt1 nmt1||S. pomb 2003 rpb4 express,0.043||0.033||0.031||0.03||0.03||0.029||0.028||0.026||0.026||0.025||0.025||0.024||0.024||0.024||0.024,0.0,0.1,0.06666666666666667
1151,Arch_Microbiol-3-1-2111041.txt,isom||fraction||abil||group||compon||earth||speci||glycerol||data||bacteria||diabol acid||alkyl chain||lipid||mass rang||genu,2||2 thermotogal||T.||1||5 T.||1 2 5 6 4 4||2 FA||T. lettinga T.||1 2 5 6 thermotoga maritima||thermotogal T.||2 3 column||1 thermotogal||5||T. maritima||7 T.,0.048||0.032||0.031||0.03||0.026||0.026||0.026||0.025||0.025||0.023||0.023||0.023||0.022||0.022||0.021,0.0,0.0,0.0
1152,Breast_Cancer_Res_Treat-3-1-2092410.txt,gene||cancer||indonesian popul||amino acid||age||uv||popul||famili||breast cancer||mutat||protein function||brca||breast||specif popul||patient||famili member||group,brca2||brca1 brca2||brca1 brca2 brca1||brca1||brca2 1 brca2||mlpa brca1 brca2 brca1 brca2||cancer||brca1 brca2 30 brca1||3 brca1 brca2||brca2 mutat||mutat brca1 brca2 21 brca1 brca2||brca1 mutat||brca1 breast||brca2 protein||brca1 brca2 germlin mutat,0.047||0.044||0.042||0.04||0.037||0.035||0.034||0.033||0.033||0.032||0.032||0.029||0.029||0.028||0.027,0.0,0.1,0.06666666666666667
1153,J_Med_Internet_Res-5-4-1550574.txt,clinic event||type||system||medic event||schema||simpl eav schema||databas||convent relat databas system||physic schema||model||patient||valu||clinic inform||larg clinic repositori||form||exampl||complex||domain||class||user||eav||metadata||convent design||medic informat||object-ori approach||web page||applic||gener design||logic schema||electron patient record||approach||flexibl||literatur||phone number||gener||gener eav tabl||field||record||number||attribut||tabl||data type||object||design||physic layout||larg number||eav model||queri||completely-gener physic schema,tabl||data tabl||databas||tabl 1||1 data tabl||data||tabl 4 data tabl||tabl 5 data tabl||eav tabl||tabl 2||1||1 1||clinic databas||tabl 3||eav databas,0.032||0.029||0.028||0.028||0.027||0.026||0.025||0.025||0.025||0.025||0.023||0.023||0.023||0.023||0.022,0.4,0.2,0.13333333333333333
1154,Crit_Care-6-5-130146.txt,antithrombin iii||subgroup||atiii||find||indic||congenit defici||italian hospit||heparin||clinic condit||data||studi||patient||sepsi||mortal||inform||dic||evid||treatment||rct||meta-analysi||hospit||italian ministri||observ studi||random||previou rct||intens care unit||dissemin intravascular coagul||drug||trial||septic shock||icu||outcom,1||1 2||2||2 1 7 8 9 10||studi||result 1||figur 2||3||4||observ studi||patient||al 9||al 7||7||al 8,0.033||0.033||0.032||0.021||0.02||0.02||0.019||0.019||0.017||0.017||0.016||0.016||0.016||0.016||0.016,0.2,0.2,0.2
1155,Plant_Mol_Biol-3-1-2039854.txt,goslim||orient group||evolutionari relev||categori||adjac pair||occurr||coexpress domain||coexpress||microsynteni||local microsynteni||well-defin categori||rice||orient||rank number||mpss||local coexpress domain||neighbor||express platform||chromosom||domain||MA data||cluster||MA express data||similar||analys||function categori||gene||distanc||annot||arabidopsi||inparanoid||pair||biolog background||list||import||fraction||coexpress pair||number||intergen distanc||signific fraction||well-defin goslim categori||plant||result,2005||2000 2004 2005 2000 2005||arabidopsi 2005 2005 2005||2002 2004 2002||gene 2004||coexpress||3 2005 2006 2004 2006||gene||2004 2003 2004||rice 2005||gene 2004 4 2005 4||coexpress gene pair||2007||2000||gene genom,0.025||0.021||0.02||0.02||0.02||0.02||0.019||0.018||0.018||0.017||0.017||0.016||0.016||0.016||0.016,0.0,0.2,0.13333333333333333
1156,Dev_Genes_Evol-4-1-2362136.txt,antibodi||insect||develop||muscl||crustacea||present studi||myogenesi||embryo||western blot||limb||evolut||hoechst||speci||decapoda||adult||pattern||innerv pattern||studi||isopoda||muscl format,2||1||E. spinifron 2 2 fig. 2||stage 2||1 I.||meru 2||ischium 2||muscl||muscl muscl||1999 fig. 1||3||supplementari fig. 2 I.||basi 2 extensor||muscl cell||basi 2 flexor,0.023||0.018||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.01||0.01||0.01||0.01||0.01,0.0,0.1,0.06666666666666667
1157,Appl_Microbiol_Biotechnol-3-1-2039825.txt,antibodi||method||human vh||advantag||VL domain||single-domain||high stabil||express||antigen||yeast||applic||product||protein||convent antibodi||antibodi fragment||molecular evolut||light chain||function antibodi devoid||egfr||vhh||effici||addit||antigen bind,2006||1||2002 2006 2006 2006||antibodi||2006 2004 2007 2007 2006 2006||2004 2006 2006 2002||2002 2006 2004 2006||2||domain antibodi||2006 cancer||2006 2007 2005a 2007 2007||2004 2006 2002 2005a||antibodi fragment||2006 2002 2003 E.||2002,0.026||0.025||0.023||0.02||0.02||0.02||0.02||0.019||0.016||0.016||0.015||0.014||0.014||0.014||0.014,0.2,0.1,0.13333333333333333
1158,Dig_Dis_Sci-3-1-2140097.txt,unreli result||studi||valu||medic measur system||diagnost accuraci||stenosi||acid product||chronic mesenter ischemia||diagnost evalu||gold standard||gastric||cgi||chronic gastrointestin ischemia||exercis||ischemia||stomach||meal||gastrointestin ischemia||patient group||gastric exercis tonometri||signific differ||diagnosi||chronic abdomin symptom||splanchnic stenosi||detect||result,2||1 2||normal||1||patient||2 2 16||2 2 3 4||2 2 valu||tonometri||ischemia normal 2 36||tonometri 9 2||2 patient characterist||2 test||3||cgi,0.035||0.032||0.031||0.029||0.027||0.026||0.026||0.025||0.024||0.022||0.022||0.022||0.022||0.021||0.02,0.0,0.0,0.06666666666666667
1159,Ann_Surg_Oncol-4-1-2190342.txt,cancer||time||respons||tumor regress grade||studi||patient||regimen||mortal||esophag cancer||paclitaxel||transhiat esophag resect||radiotherapi||treatment||patholog complet tumor regress rate||chemoradi||postop complic||surgeri||stage II||tumor||surviv||neoadjuv chemoradi||trial||neoadjuv treatment,1||patient||cancer||2||esophag cancer||22 patient||20 patient||16 patient||12 patient||result patient characterist 1 tabl 1||19 patient||2 tabl 2||50 patient||phd 1 1 depart||patient recurr,0.025||0.025||0.02||0.019||0.016||0.015||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.014,0.6,0.3,0.2
1160,Clin_Auton_Res-2-2-1705534.txt,type||measur||method||respons||latenc||studi||contralater side||ipsilater||autonom nervou system||amplitud||stimuli||sympathet skin respons||stimul||electr stimul||reflex||subject||ssr record||ssr||compon||differ||type respons||record||millisecond||peak latenc||area||record site||magnet||side,1 2||1 figur 1||2||refer 1||1 norm||2 9||studi||14 10 14 22||2 24||1997 7 1 4 10.1007||2 khz||14 5 14 25||5||13 26 2 19 11||12 17 12 14 4,0.034||0.029||0.027||0.022||0.022||0.02||0.017||0.017||0.016||0.015||0.015||0.015||0.014||0.013||0.013,0.0,0.1,0.06666666666666667
1161,World_J_Urol-4-1-2295251.txt,target||vegf level||g250||vegf||combin||studi||patient||bevacizumab treatment||caix||renal cell carcinoma||effect||clinic trial||antigen||monoclon antibodi||treatment||therapi||partial respons||renal mass||bevacizumab||tumor cell||rcc||tumor||surviv||phase II trial||trial||diseas||result,cell||renal cell||renal cell carcinoma||cell carcinoma||refer 1||rcc cell||cell carcinoma cancer||metastat renal cell carcinoma||human renal cell carcinoma||springer-verlag 2008 introduct 1 2 3||renal cell carcinoma Br||advanc renal cell carcinoma||tumor cell||metastas renal cell carcinoma||nonmetastat renal cell carcinoma,0.023||0.02||0.017||0.017||0.015||0.014||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.2,0.1,0.13333333333333333
1162,Graefes_Arch_Clin_Exp_Ophthalmol-3-1-2082065.txt,measur||tempor resolut||young control||studi||critic flicker fusion frequenc||stimulu||patient||motion||frequenc||threshold||sensit||color percept||test||region||visual function||motion sensit||contrast sensit||eye||retina||double-puls resolut||eccentr||subject||motion contrast threshold||light||arm||group||visual field||dynam process||peripher motion percept||age-match control||signific differ||visual acuiti||loss||function||result,1||2||2 1 fig. 1||3||subject 1||2 2 fig. 3 46 60||2 fig. 2 gabor stimulu||1 age||5||color percept 1||refer 1||eye||vision 4||visual percept||4 2 fig. 4 broken line,0.017||0.016||0.015||0.01||0.01||0.01||0.01||0.01||0.01||0.01||0.009||0.009||0.009||0.009||0.008,0.0,0.0,0.06666666666666667
1163,Oecologia-4-1-2373415.txt,intermedi depth||water depth||veget commun||swan||speci||fulltofta bay||graze intens||plot||tuber||distribut||treatment||ramet||plant,P.||P. perfoliatu P. pectinatu P.||P. perfoliatu P. pectinatu||P. pectinatu P. perfoliatu||P. perfoliatu||2 P. pectinatu P. perfoliatu||P. pectinatu 2||P. pectinatu 2002||5 2 P. perfoliatu P.||2 2 P. pectinatu||squar P. perfoliatu||experi P. perfoliatu||1 potamogeton perfoliatu P. pectinatu||1 5 P. perfoliatu||2 potamogeton perfoliatu P. pectinatu shoot,0.078||0.063||0.059||0.059||0.058||0.052||0.048||0.046||0.046||0.042||0.039||0.039||0.038||0.037||0.032,0.0,0.0,0.0
1164,Cancer_Chemother_Pharmacol-4-1-2270367.txt,level||normal tissu||radiat||sampl||studi||AG adduct||patient||dna adduct||correl||infus||tumor tissu||dose||treatment||cell||schedul||adduct||buccal cell||analysi||concurr chemoradiotherapi schedul||format||total number||wbc||cisplatin||tumor||cervic cancer,cancer||2||1||cancer patient||adduct||method 2 2 2 32||neck cancer||1 fig. 1||neck cancer cervic cancer||cervic cancer||cervix cancer patient||uterin cervic cancer cancer||patient||ovarian cancer patient||breast cancer,0.026||0.021||0.02||0.02||0.018||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013,0.2,0.2,0.2
1165,Diabetologia-4-1-2362135.txt,vascular function||type 2 diabet mellitu,2 2||2||1||1 1 1||type 2 diabet||type 2||1 fig. 1||type 2 diabet patient||type 2 diabet mellitu||editor 1 2 3||2 level||J. 1||e.s.stroes@amc.uva.nl 1 1 depart||diabet mellitu||refer 1,0.065||0.065||0.057||0.057||0.046||0.044||0.041||0.038||0.038||0.037||0.035||0.033||0.031||0.031||0.031,0.0,0.1,0.06666666666666667
1166,Antonie_Van_Leeuwenhoek-3-1-2140093.txt,immunogold||antibodi||igg||high accuraci||cbpp||membran||primari antibodi||host cell||amino acid||domain||immunogold label||lppq||mycoplasma||coverslip||outer surfac||peptid||integr membran domain||electron microscopi||cell||surfac,2||mycoid M. mycoid||M. mycoid||mycoplasma mycoid mycoid||M. mycoid mycoid 2000 M. mycoid||mycoid 2000 M. mycoid||2007 mycoplasma mycoid mycoid M. mycoid||M. mycoid mycoid SC||mycoid 2002 M. mycoid||mycoplasma mycoid||mycoid 2000 fig. 1 M. mycoid||mycoid 3 fig. 3 M. mycoid||1||2 2 product||2 4 2 4,0.041||0.039||0.036||0.035||0.035||0.034||0.031||0.031||0.031||0.03||0.029||0.028||0.028||0.028||0.027,0.0,0.0,0.0
1167,Emerg_Radiol-3-1-1914302.txt,manual||fast||line||radiograph||indic||spine||imag||pulmonari contus||patient||chest||lumbar spine||primari survey||radiologist||abdomen||convent radiographi||emerg measur||fractur||life-threaten injuri||diagnost imag||treatment||evalu||pelvic radiograph||care||chest radiograph||injuri||physic examin||adjunct||thorac||advanc trauma life support||trauma care||radiolog||pneumothorax||abdomin CT||clinic decis rule||trauma||atl,1||1 2||trauma||2||trauma patient||1 29||1 26 28 1||3||thorax 1||refer 1||1 21||trauma care||5||trauma patient care||emerg trauma care,0.027||0.022||0.021||0.018||0.017||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013,0.2,0.1,0.13333333333333333
1168,Cancer_Causes_Control-2-2-1764866.txt,risk||calor restrict||cancer||human||cancer risk||transient,cancer||cancer risk cancer||cancer risk||breast cancer||control cancer||cancer prevent||cancer type||rat cancer||mice cancer||cancer inhibit||breast cancer risk||prostat cancer||refer 1||2006 1 5 6||calor restrict prevent cancer,0.037||0.028||0.024||0.023||0.021||0.02||0.02||0.02||0.019||0.019||0.019||0.019||0.018||0.017||0.016,0.4,0.2,0.13333333333333333
1169,Exp_Brain_Res-3-1-1914280.txt,intersensori||visual toj task||tempor ventriloqu||auditori||locat||effect||frequenc||intersensori interact||av-interv||auditori stream||jnd||experi||rhythm||flanker||light||auditori stimuli||intersensori pair||captur||stream||soa||central loudspeak||tone||sequenc||auditori group||sound,sound||1||experi 1||captur sound||flanker sound||2 flanker sound||sound locat||exp 1||2||sound enhanc||exp. 1||15 sound||method 1||experi 2||flanker sound differ,0.036||0.033||0.026||0.024||0.023||0.022||0.022||0.021||0.021||0.021||0.021||0.02||0.02||0.02||0.019,0.2,0.1,0.06666666666666667
1170,Cancer_Immunol_Immunother-3-1-1914259.txt,control||detect||studi||Hu antibodi||pbmc||individu||cytokin||peptid||patient||nervou system||pn||antigen||cell||hud,2||1||1 1 1||1 1 fig. 1||2 fig. 2||2 1 depart||2 sclc||2 time||2 7||1 13||2 month||1 2 verjan georg||refer 1||patient||netherland 2 depart,0.035||0.034||0.034||0.027||0.026||0.025||0.021||0.021||0.02||0.02||0.018||0.018||0.018||0.018||0.017,0.0,0.0,0.06666666666666667
1171,Mcgill_J_Med-11-1-2322923.txt,report||reaction||wasp sting||acut renal failur||case||direct nephrotox effect||haemolysi||wasp envenom||rhabdomyolysi||interstiti nephriti||direct nephrotox||atn||nepal||acut interstiti nephriti||acut tubular necrosi||intravascular haemolysi||wasp venom||hypersensit reaction||renal failur||patient,1||2||1 2 1 2 blood count||4 1||case 1 tabl 1||4 2||case 2 fig. 1 tabl 1||8 2||14 1||1 rejsman||case||3||5||tabl 1 pertin lab result||100mmhg 2 38 35,0.058||0.056||0.039||0.039||0.039||0.038||0.036||0.034||0.033||0.03||0.025||0.018||0.017||0.017||0.017,0.0,0.0,0.06666666666666667
1172,Pflugers_Arch-3-1-2082653.txt,condit||action potenti||lidocain||restitut||dynam compon||studi||valu||bcl||anti-arrhythm effect||slope||effect||frequenc||hypokalaemia||cycl||baselin cycl length||shortest bcl||hypokalaem langendorff-perfus murin heart||epicardium||map||analysi||experi||alternan||restitut curv||full agreement||critic DI||arrhythmia||record||waveform||heart||arrhythmogen||endocardium,1||2||2 fig. 2||23 1 1||5||clh11@cam.ac.uk 1 1||1 3 90 fig. 3||3||90||90 90||2 fig. 7||4 5 4||7 1 3 8 5 10||1 khz||refer 1,0.021||0.018||0.016||0.015||0.015||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.011||0.011,0.0,0.0,0.0
1173,Bioprocess_Biosyst_Eng-2-2-1705536.txt,induct||periplasm protein||hydrolas activ||sec pathway||growth rate||polyest||induct phase||hcdc||batch cultiv||cell||glucos||glucos concentr||protein||cultiv||periplasm||rtfh||activ||cytoplasm||extracellular space||solubl protein||mobil phase||batch||extracellular medium||purif||medium||result,2 2||2||1 2||1||1 1||broth 1 2 1 2 2||5 2 1||1 1 13 1||1 2 dcw||2 4||1 1 set||1 fig. 2 E.||1 6||3||1 3 3 4,0.044||0.044||0.042||0.039||0.039||0.035||0.031||0.03||0.03||0.029||0.028||0.028||0.028||0.027||0.027,0.0,0.0,0.0
1174,Antonie_Van_Leeuwenhoek-4-1-2268727.txt,sclerotia||applic||carrot||malt extract agar||cold-act enzym||enzym||mycelium||powder wood||hyalina vel fusca||temperatur||natamycin||activ||growth,F. psychrophila||F. psychrophila F.||F.||fibulorhizoctonia psychrophila F. psychrophila||2 F. psychrophila||F. carota F.||2 F. psychrophila A.||2 F. psychrophila F. carota A.||F. psychrophila aspergillu niger||F. psychrophila athelia arachnoidea F. carota||F. psychrophila F. carota athelia arachnoidea||F. psychrophila A. niger 2004 F.||3 3 F. psychrophila||F. psychrophila 2004 2005||F. psychrophila aspergillu niger A.,0.05||0.05||0.05||0.042||0.041||0.039||0.035||0.034||0.032||0.031||0.031||0.031||0.031||0.029||0.028,0.0,0.0,0.0
1175,Anal_Bioanal_Chem-4-1-2045123.txt,assay||androgen||testosteron||yeast||yegfp||recombin yeast cell||progesteron||paper||primer||antagonist||pcr||compound||cell wall disrupt||yeast androgen bioassay||cell line||yeast cultur||yeast cell||transform||estradiol,2||1||Î² Î² Î²||Î²||2 cyc1||50 Î± Î²||_{ 1||Î² bold Î²||Î² lacz lacz||refer 1||2 50 concentr||27 27 Î² Î²||boldenon 1 50 50||50 50||50,0.035||0.033||0.031||0.031||0.024||0.023||0.022||0.021||0.017||0.017||0.017||0.017||0.017||0.017||0.017,0.0,0.0,0.0
1176,Eur_J_Clin_Pharmacol-3-1-2071966.txt,system||problem||patient||effect||inform||clinic practic||sexual problem||side effect||discontinu||patient report||impact||treatment||advers event||hcp||therapi||natur||relev||ineffect||experi||medicin||antidepress||issu||drug||spontan report||previou medic||advers drug reaction,3||report||effect||report side effect||side effect||side effect 2||1||2||patient report||report experi||posit side effect||side effect number||neg side effect||630 side effect||suspect side effect,0.025||0.024||0.024||0.023||0.023||0.022||0.022||0.02||0.019||0.016||0.016||0.016||0.016||0.016||0.016,0.4,0.3,0.2
1177,Histochem_Cell_Biol-4-1-2413113.txt,cell adhes||hemichannel||form||microtubul||protein||interact||brain tissu||migrat||heart||gap junction||connexon||adheren junction||cell||adhes||brain,cell||crest cell||2006 2002 2003||cell adhes||cell adhes junction||cell migrat||beta 1||cell respons||cell biolog||endotheli cell||cell movement||junction||adjac cell||cell interior||lps-prime cell,0.03||0.019||0.019||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.015||0.015||0.015,0.4,0.2,0.13333333333333333
1178,Purinergic_Signal-4-2-2377326.txt,atp||ogd||solut||atp releas||maxi-anion channel||astrocyt||arachidon acid||experi||neuron||studi||cell||calibr curv,2||1||3||3 3||2 2 fig. 2||23 2 2 2||1 1 fig. 1||4 3||1 17 3||3 fig. 3||7 2||2 23 2 cell||23 2 2 cell||17 3 17 3||4,0.035||0.031||0.031||0.031||0.03||0.028||0.027||0.027||0.026||0.025||0.025||0.024||0.024||0.023||0.023,0.0,0.0,0.0
1179,Ann_Surg_Oncol-4-1-2277442.txt,tumor deposit||case||diamet||breast cancer||studi||patient||SN metastas||breast cancer patient||featur||invas breast cancer||lymph node dissect||lymph node||tumor-posit axillari SN||analysi||SN involv||itc||penetr depth||microanatom locat||sentinel node||ajcc||signific predictor||sn||subcapsular locat||morphometri,1||cancer||2||breast cancer||result 1 1 2 tabl 1||breast cancer SN||3||breast cancer studi||breast cancer patient||1 23||tabl 2||cancer patient||invas breast cancer||1 90||21 1 11 2 tumor,0.029||0.024||0.024||0.021||0.02||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016,0.2,0.2,0.2
1180,Glycoconj_J-4-1-2413117.txt,calcul||molecular shape||time||na-domain||random coil||isotrop||heparin||sampl||data||model||valu||polym||amid||anisotrop model||oligosaccharid||dynam||coupl||octasaccharid||analysi||experi||simul||nmr||polysaccharid||consist||central residu||nmr relax||diffus||tabl||experiment data||cross-peak||molecul||result,1||1 2 1||2 1||2||2 2||1 1 15||2 1 15||2 15||1 1 15 1 13||1 1 15 4||tabl 1 1 15||15 20 15 1 1 15||_ 1||15||2 calc 1,0.028||0.027||0.027||0.026||0.026||0.025||0.024||0.022||0.022||0.021||0.02||0.019||0.019||0.019||0.019,0.0,0.0,0.0
1181,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764202.txt,find||import role||prodrom clinic||studi||patient||year||contact||durat||psychologist||mental health||featur||earli psychosi||health profession||privat psychiatrist||social withdraw||gp||psychosi||assess||prodrom servic||group||health system||symptom||number||posit||reliabl||pathway||schizophrenia||referr||untreat psychosi||help-seek pathway,2||1||Ï 2||2 test||3||Ï||symptom||help-seek pathway 1||refer 1||fig. 1||tabl 2 distribut||patient||4||contact symptom||insidi symptom 1 3 20 21,0.028||0.023||0.022||0.015||0.015||0.015||0.014||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.01,0.0,0.1,0.13333333333333333
1182,Clin_Exp_Metastasis-4-1-2413104.txt,antibodi||cancer||find||serum||carcinogenesi||sampl||studi||patient||potenti biomark||differenti express||npc||express||signific||saa||protein marker||maldi-tof-m identif||tissu||protein||confirm elisa||tumor cell||human serum||identif||group||nasopharyng carcinoma||serum level||healthi volunt||elisa||npc patient||biomark,1||1 3||3||1 2||2||6 3||protein||1 5||1 10||6||serum||1 serum sampl||fig. 2||3 8||4,0.023||0.023||0.023||0.023||0.022||0.019||0.017||0.017||0.014||0.014||0.014||0.014||0.014||0.014||0.013,0.0,0.1,0.13333333333333333
1183,Planta-4-1-2413075.txt,pme activ||role||pathogen||oxid stress toler||liquid nitrogen||suscept||pme||spore||wild-typ||abiot stress respons||antifung activ||inocul||seedl||pepper||express||leav||growth chamber||treatment||growth||gene||control||protein||molecular mass||hybrid||incub||cotyledon||hybrid signal||inhibitor||plant||result,capmei1||plant||arabidopsi capmei1||capmei1 arabidopsi||capmei1 capmei1 transcript||capmei1 arabidopsi capmei1 pr1||capmei1 protein capmei1 E. coli capmei1||capmei1 capmei1 xcv xcv 4||capmei1 cabpr1||capmei1 function||capmei1 induct||xcv xcv capmei1 2 capmei1 C.||capmei1 inhibit||crude capmei1||1,0.033||0.023||0.023||0.023||0.023||0.02||0.019||0.019||0.019||0.018||0.017||0.017||0.017||0.017||0.017,0.2,0.1,0.06666666666666667
1184,Apoptosis-4-1-2257993.txt,mechan||endotheli cell||pten||neg regul||wortmannin||apoptot nuclei||effect||atp||reperfus||jasplakinolid||akt activ||inhibit||treatment||cell||control||rho-kinas||apoptosi||cytochalasind||activ||y-27632||simul ischemia||latrunculina||akt||cytoskeleton,2||1||cell||cell 5||apoptosi 4 4 fig. 4||3 fig. 3||endotheli cell||control cell||12||1 groeneveld||refer 1||cell circ||epitheli cell||jasplakinolide-tr cell||latrunculina-tr cell,0.029||0.027||0.027||0.019||0.019||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.014||0.014||0.014,0.2,0.2,0.13333333333333333
1185,Support_Care_Cancer-3-1-2071950.txt,cancer||set||case||incur cancer||questionnair||problem||qualiti||studi||life||process||extent||rel||netherland||bereav rel||treatment||institut||end-of-lif care||cancer patient||health||interview||hospit||research||care||gener practition||death||medic treatment||home||symptom||number||physician||major differ||major concern,patient||cancer patient||2||1||patient 11||patient 12||care||patient prefer||patient âs||patient result||ill patient||patient group||patient age||place 1 1 2||includ patient,0.034||0.024||0.022||0.022||0.021||0.02||0.02||0.02||0.019||0.018||0.018||0.018||0.018||0.018||0.017,0.2,0.2,0.13333333333333333
1186,Mol_Biochem_Parasitol-1-5-2075530.txt,mosquito bite||caspas activ||PS transloc||dna fragment||metacaspas||femal gametocyt||apoptosi||genom dna||cell death||proteas||posit||caspas||mosquito||involv||caspatag||ookinet||stage||result,1||fig. 1 plasmodium fig. 1||fig. 4||fig. 4 fig. 4 P. berghei||fig. 3 fig. 3 pbmc1 pbmc1||2||P.||4||P. berghei||fig. 2 hin hin||P. berghei pbmc1||3||vivo fig. 3 A.||P. berghei P. falciparum||fig. 3 egfp fluoresc,0.038||0.037||0.036||0.031||0.027||0.027||0.024||0.023||0.022||0.021||0.019||0.019||0.019||0.019||0.018,0.0,0.0,0.0
1187,Crit_Care-8-2-420020.txt,prone posit||mechan ventil||acut respiratori distress syndrom||high intrathorac pressur||overdistens||model||studi||arteri oxygen||strategi||patient||alveolar flood||effect||human||investig||increas||posit end-expiratori pressur||volum||rm||recruit||cyclic collaps||oxygen||lung injuri||low peep||ard||bacteri transloc||recruit maneuv||peep||injuri||mechan stress||alveolar unit||ali||lung infect||low tidal volum||acut lung injuri||alveolar collaps||lung||benefit||sigh,2 2||2||1||figur 2 2 2||patient||lung||ard patient||ventil patient||studi||lung injuri||acut lung injuri patient||lung mechan||part 2||lung recruit||recruit lung,0.033||0.033||0.029||0.027||0.026||0.025||0.02||0.019||0.019||0.019||0.018||0.018||0.018||0.017||0.017,0.2,0.4,0.26666666666666666
1188,Eur_Radiol-3-1-1797072.txt,treatment regimen||allogen transplant||neoplast cell||imag||patient||small molecular gd-chelat||inform||bone marrow||bone marrow cellular||increas||infiltr||articl||neoplast marrow||high risk||lymphoma||clinic practic||lesion||adult||specif question||treatment||neoplast infiltr||therapi||extracompartment tumor growth||anti-angiogen drug||contrast agent||cellular||uspio||treatment effect||hypercellular marrow||hematopoiet marrow||reconvers||chang||normal||nhl||long bone||tumor||bone||avn||hematolog malign||diffus||signal intens||irradi||addit||contrast||sequenc||clinic signific||techniqu,marrow||bone marrow||bone||imag||bone marrow cell||bone marrow diseas||bone marrow transplant||bone marrow infiltr||normal bone marrow||bone marrow lesion||bone marrow fig. 7||bone marrow vascular||human bone marrow||patholog bone marrow||bone marrow involv,0.028||0.024||0.02||0.019||0.018||0.017||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.016,0.6,0.3,0.2
1189,J_Gastrointest_Surg-3-1-1852381.txt,biliari ductal system||biliari fistula||hepat arteri thrombosi||approach||anastomosi||skin||tract||oper procedur||biliari surgeri||biliari cutan fistula||fistula tract||procedur||jejun loop||patient||liver||liver transplant||biliari drainag,1||figur 2||4 figur 4||refer 1||discuss 2 3||1-313-9169147 maboulj5@hfhs.org 1 1 divis||7 year||surgic procedur 3 figur 3||biliari fistula||alimentari tract 2007 introduct 1||springer-verlag 2007 biliari||patient âs biliari||biliari cutan fistula||biliari drainag||MI 48202-2689 usa 2 divis,0.054||0.042||0.037||0.03||0.027||0.026||0.022||0.021||0.021||0.02||0.018||0.018||0.017||0.016||0.016,0.0,0.1,0.2
1190,Qual_Life_Res-3-1-1915610.txt,level||measur||categori||respons||permut||instrument||system||common dimens||frequenc distribut||problem||health statu||inform||shannon approach||shannon||classif||discriminatori power||hui||health||gener popul survey||gener popul sampl||absolut||popul||rel inform||total number||distribut||respond||health state||formal measur||differ||number||classif system||health classif system||reliabl,level||level 2||2||3 level||level 3||2 2 2 1.30||1||1 1 1||level 4||5 level||thresholdâ level 2||health||1 level descript||level sever||3 level system,0.03||0.028||0.026||0.022||0.022||0.019||0.019||0.019||0.019||0.019||0.019||0.018||0.017||0.016||0.016,0.2,0.1,0.13333333333333333
1191,Arch_Dermatol_Res-2-2-1705535.txt,placebo||chronic plaqu psoriasi||clinic respons||week||psoriasi||respons||long-term studi||data||studi||patient||previou histori||arthropathi ae||risk||open-label extens||increas||proport||psoriat arthriti||clinic trial||event||efalizumab treatment||joint diseas||treatment||ae||arthropathi||analysi||routin clinic practic||placebo group||incid||group||efalizumab group||long-term treatment||efalizumab-tr patient||arthriti||trial||efalizumab||result,1||1 1||1 1 fig. 1||2||1 mg||re-treat phase 1 1||efalizumab 1 mg||exposur phase 1 1||patient||2 mg||22 1||efalizumab 2 mg||treatment||efalizumab treatment||efalizumab,0.034||0.034||0.027||0.027||0.023||0.022||0.022||0.022||0.02||0.02||0.02||0.02||0.02||0.019||0.019,0.0,0.1,0.26666666666666666
1192,Histochem_Cell_Biol-4-1-2248610.txt,retrograd traffic||secretori rout||golgi apparatu stack||retrograd transport||endosom||golgi network||earli endosom||golgi apparatu||cisterna||toxin||compart||shiga toxin||ER||golgi cisterna||cell||protein||multipl detail||tgn||secretori pathway||stack||traffic||side||plasma membran||molecul||function||endocytosi,cell||2007||mol biol cell||2004||cell biol 15:68||2005||cell biolog||cell surfac||neuron cell exp cell||mammalian cell||cell organ||live cell||exo2-tr cell||cho cell||cell interior,0.034||0.023||0.023||0.022||0.021||0.018||0.018||0.018||0.018||0.018||0.018||0.017||0.017||0.017||0.017,0.2,0.1,0.06666666666666667
1193,Anal_Bioanal_Chem-3-1-1592253.txt,optic molecular imag||method||fluoresc probe||molecular probe||biomolecul||system||imag||abil||high spatial||oct||fc||power tool||dynam||specif||cell||biolog event||greater tissu penetr||fret||applic||tissu||fluoresc protein||protein||fp||real time||qd||chang||bind||red fluoresc||flim||fluoresc||system biolog||interact||shim||system level||omi||quantum dot||addit||vivo,cell||2006||2||fluoresc protein 2||protein||fluoresc protein||fluoresc||2002||2005||live cell||cpfp cell||exp cell||monolay cell||2001||fret fp cell,0.019||0.014||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.01||0.01||0.01||0.01||0.01||0.009,0.4,0.4,0.26666666666666666
1194,Planta-3-1-2039816.txt,chromatin condens||time||preliminari experi||dna degrad||petal desicc||petal cell||sampl||dehydr||flower open||absciss||develop||petal||increas||floral life span||nuclear area||dna breakdown||lower sequenc||wilt||dna content||treatment||cell||program cell death||dapi||petal senesc||nuclear diamet||chang||agaros gel||flower||ethylen treatment||nuclear condens||nuclei||speci||stage||remark nuclear morpholog||flow cytometri||result,P.||P. yedoensi||P. yedoensi D.||D. belladonna P. yedoensi||P. yedoensi D. belladonna||P. yedoensi 1||2 P. yedoensi 2 D.||D. belladonna||D. belladonna P. yedoensi petal||3 P. yedoensi 3 D.||D.||2 D.||2 2 fig. 2 P. yedoensi||P. yedoensi D. belladonna I.||2,0.034||0.031||0.03||0.029||0.029||0.029||0.027||0.027||0.027||0.026||0.026||0.025||0.025||0.025||0.024,0.0,0.0,0.0
1195,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914264.txt,antibodi||target||respons||method||radiat||optim||data||model||studi||patient||amount||gbq||mci||bone marrow||abil||metastas||prospect trial||lymphoma||solid tumour||radiotherapi||whole-bodi||dose||thyroid carcinoma||dosimetri||cell||therapi||maximum toler dose||treatment||tumour||clinic dosimetri||radionuclid therapi||estim||radiat dosimetri||individu patient||phase||radionuclid||activ||abl approach||radiat dose||bone||import||toxic||neuro-endocrin tumour||result,3||dose||1||90 0 3||111 0 3||90 0 3 177 0 3||2||86 0 1 3||177 0 3||therapi dose||therapi 111 0 3||86 0 3||1 absorb dose||111 3 90||131,0.019||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012,0.2,0.1,0.06666666666666667
1196,Exp_Brain_Res-4-1-2373863.txt,condit||level||mechanoreceptor||touch||magnitud||tactil||studi||represent||stimulu||process||explor mode||convex||aftereffect||finger||concav||vogel||shape||experi||subject||curvatur||transfer||singl finger||neural represent||adapt||hand||result,experi||experi 1||experi 2||1||1 1||2||experi 4||experi 3||fourth experi||2 subject||2000||2008||analysi 1||1 1933 1996 1997 fig. 1||finger,0.043||0.038||0.037||0.033||0.033||0.031||0.031||0.029||0.028||0.024||0.02||0.019||0.019||0.019||0.017,0.2,0.1,0.13333333333333333
1197,Matern_Child_Health_J-2-2-1592161.txt,vlbw||program||follow-up||preconcept||commun assess||commun||infant||birth outcom||poor birth outcom||birth||pregnanc||ipc||magnolia project||pregnanc plan||concept||reproduct age||risk||risk reduct||feto-inf mortal rate||case manag||deliveri||intervent||commun outreach||commun develop||subcontractor||manag||infant mortal||gradi memori hospit||reproduct health outcom||poor nutrit||women||success||month||care||servic||prenat care||activ||poor health||clinic servic||northeast florida healthi start coalit||import||famili plan||initi home visit||particip||previou fetal||outcom,health||1||health care||women health||health servic||health educ||health care servic||care||health care visit||primari health care||health statu||poor health||health care compon||health depart||health resourc,0.025||0.022||0.019||0.018||0.016||0.016||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.013,0.0,0.1,0.13333333333333333
1198,J_Struct_Biol-1-5-2048824.txt,antibodi||specif region||vesicl||NE assembl||nuclear pore complex||onm||ER membran||oocyt||membran protein||egg extract||sampl||ER tubul||chromatin||nuclear assembl reaction||structur||npc protein||nuclear envelop||npc||larg ER vesicl||larg sac||junction||stage iii oocyt||edg||scan electron microscopi||ultrathin section||protein||tubul||format||curvatur||incub||nuclei||assembl||pb||membran,fig. 2||fig. 3||fig. 4 fig. 4 fig. 3||fig. 7||fig. 7 fig. 7||fig. 5 fig. 5||ne fig. 2 fig. 2||fig. 7 fig. 7d||1||2006 fig. 7 fig. 7||fig. 7d||1999 fig. 2||fig. 2b||fig. 3d||2006 fig. 7,0.029||0.026||0.025||0.025||0.025||0.025||0.024||0.023||0.022||0.022||0.021||0.021||0.021||0.021||0.02,0.0,0.0,0.0
1199,Breast_Cancer_Res_Treat-3-1-2001223.txt,cancer||clinic respons||respons||neoadjuv therapi||letrozol||endocrin therapi||breast cancer||studi||tamoxifen||patient||diseas progress||letrozole-tr patient||effect||neoadjuv letrozol||chemotherapi||aromatas inhibitor||express||aromatas||postmenopaus women||treatment||women||surgeri||neoadjuv||tumor||trial||diseas||safeti,cancer||breast cancer||breast||breast cancer clin cancer||breast cancer patient||1||primari breast cancer||postmenopaus breast cancer||oper breast cancer||advanc breast cancer clin cancer||human breast cancer clin cancer||advanc breast cancer||larg oper breast cancer breast cancer||breast cancer eur||breast cancer biomark,0.03||0.027||0.024||0.023||0.021||0.02||0.019||0.019||0.019||0.019||0.019||0.019||0.019||0.018||0.018,0.4,0.2,0.13333333333333333
1200,Clin_Oral_Investig-4-1-2238786.txt,condit||dental eros||case||clinic phenomenon||preval||dental clinician||studi||eros||eros index||wear||oral health||develop||criteria||defect||tooth morpholog||dental practic||tooth wear||lesion||intern basi||current diagnost criteria||valid||occlus||basic eros wear examin||research||age||eros challeng||diagnost criteria||capabl||surfac||factor||exposur||eros tooth wear||loss||diagnosi||tooth||index||lesion characterist||progress||result,1||1 2||tooth||eros tooth||eros||2||eros tooth wear||tooth wear||eros wear||wear||dental eros||refer 1||http://www.who.int/oral_health/media/en/orh_report03_en.pdf 1||tooth wear index||eros tooth lesion,0.03||0.026||0.023||0.023||0.023||0.022||0.022||0.021||0.021||0.018||0.018||0.017||0.017||0.017||0.017,0.4,0.5,0.4
1201,Pediatr_Nephrol-3-1-1989763.txt,serum albumin||level||method||fat||infant||eaa||studi||patient||nutrit||ccpd||increas||crf||intak||common practic guidelin||gastrostomi||dietari supplement||energi||growth||htsd||feed||glucos||bodi composit||protein||age||chronic renal failur||report||import||dialysi dose||height||doqi||appetit||fat mass||dialysi||acidosi||diseas||supplement||weight gain||children||result,2||2 10||nutrit||nutrit 2 2 127||2 2 132||pediatr nephrol pediatr nephrolog||pediatr patient||1||pediatr dialysi patient||suppl 2||nutrit statu 2 3||2 year||children 1||2 4 5||dialysi,0.02||0.015||0.015||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.012||0.012||0.012,0.2,0.1,0.13333333333333333
1202,Eur_Arch_Otorhinolaryngol-3-1-2099165.txt,blood||fossa||case||day||boy||lingual arteri||pseudoaneurysm||embolis||mass||vessel wall||patient||posttonsillectomi haemorrhag||carotid arteri,1 2 3 fig. 1 pseudoaneurysm||1 1 depart||2 week||fig. 2 arteriographi||2 3 4 5 6||right-anterior side fig. 3 2||refer 1||netherland 2 depart||day||4 day||5 day||springer-verlag 2008 introduct 1||5||postop day||springer-verlag 2007,0.038||0.036||0.032||0.03||0.03||0.027||0.026||0.026||0.023||0.022||0.021||0.021||0.019||0.019||0.019,0.0,0.1,0.06666666666666667
1203,Osteoporos_Int-4-1-2267486.txt,intern refer||data||previou fractur||fractur risk assess tool||lumbar spine||risk||threshold||clinic practic||femor neck||intervent||fractur probabl||fractur||tool||intervent threshold||present studi||therapeut intervent||bmd||women||age||gradient||equival||order||osteoporosis-rel fractur||japan||femor neck bmd||clinic risk factor||probabl||fractur outcom||hip fractur||bone miner densiti,fractur||fractur 1 fig. 1||refer 1||int||fractur risk||femor neck bmd 1 2 1||suppl 1||2 17||2 orimo||11 2 16||SD 2||japan 2 depart||fractur femor||hip fractur||fractur probabl,0.024||0.023||0.018||0.018||0.018||0.017||0.017||0.017||0.017||0.016||0.015||0.015||0.015||0.014||0.014,0.2,0.1,0.2
1204,Neuroimage-2-1-2278232.txt,syntact process||left pariet lobe||neural system||superior portion||locat||experiment condit||data||phonolog process||bsl task||effect||deaf||languag||region||bsl||sign||phonolog||adult||pariet lobe||phonolog awar||precentr gyru||oral school||hear statu||medial portion||greater extent||primari school||non-n signer||item||neural network||task||analysi||pictur||hear group||english||activ||group||deaf peopl||bsl sign||rhyme||exposur||phonolog represent||left inferior frontal gyru||perform||particip||ifg||left ifg||smg||peopl||network,2||1||3||fig. 2||languag||fig. 3||fig. 4 3||fig. 5 3||tabl 1||tabl 3||languag process||fig. 2 macsweeney||2006 fig. 1||fig. 4||2 stoko,0.017||0.014||0.014||0.014||0.013||0.012||0.011||0.011||0.01||0.01||0.01||0.01||0.01||0.01||0.009,0.2,0.1,0.06666666666666667
1205,Rheumatol_Int-3-1-2134974.txt,antibodi||follow-up||case||studi||patient||system lupu erythematosu||rituximab||rituximab therapi||autoimmun disord||thrombocytopen purpura||infus||refractori||cell-direct biolog therapi||pilot studi||small pilot studi||improv||treatment||cell||therapi||autoimmun diseas||vascul||month||autoimmun||potenti util||report||biolog therapi||sle||number||clinic benefit||cell deplet therapi||trial||diseas||clinic remiss||inadequ respons||result,pt||2 pt||2||1 pt||2 week||2 pt 1 month||4 pt||2 mg||3 pt||6 pt||5 pt||11 pt||1||2007||10 pt,0.018||0.018||0.017||0.015||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012||0.011||0.011||0.011,0.0,0.0,0.0
1206,Biotechnol_Lett-3-1-2151841.txt,gene||protein fold||bip||target||heterolog protein||increas||holdas||pdi||substrat||protein||chaperon||chaperon system||molecular chaperon||unfold protein respons||activ||overexpress||cell||upr,protein||2007||cell||protein respons||heterolog protein||1 2007||protein fold||2004||protein degrad||1 2004 2004 2004||select protein||er-resid protein||protein trb 2005||doxycycline-regul protein||archaeal protein,0.033||0.024||0.02||0.02||0.019||0.019||0.019||0.018||0.018||0.017||0.017||0.017||0.017||0.017||0.017,0.6,0.4,0.26666666666666666
1207,Health_Care_Anal-4-1-2244696.txt,futur||greater orient||individu||studi||valu||social depriv||expect||health inequ||discuss||gain||present orient||egalitarian||aim||impact||welfar||prioritarian||patern||futur orient||evalu||utilitarian||inform choic||autonomi||research||paper||inequ||time orient||uptak||ethic cost||choic||screen uptak||decreas||psycholog||screen||posit outcom||public health approach||particip||dilemma||peopl||greater social depriv||benefit||lower expect||result,health||1||screen||1 1 1 1 fig. 1||health psycholog||2||health expect||1 1 psycholog depart||health inequ||1 5||psycholog||social psycholog||choic||screen uptak||result 1,0.02||0.02||0.02||0.017||0.016||0.015||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.011,0.2,0.2,0.3333333333333333
1208,Doc_Ophthalmol-4-1-2244701.txt,cone-rod dystrophi||cone||case||fmm||data||mutat||patient||retin dystrophi||parafov ring||autofluoresc||retin pigmentosa||visual field preserv||retin dysfunct||rpe||AF abnorm||high densiti autofluoresc||perg||function signific||genotype-phenotyp correl||lipofuscin||ring||field||visual acuiti||high correl||annulu,1 2 guca1a||3||ophthalmol||1 1 depart||3 patient||fig. 4||fig. 5||rpgr||2 3 fitzk fred||2 3 webster andrew||refer 1||2 3 moor anthoni||retin function||fig. 8 rpgr rims1||retin dystrophi,0.021||0.02||0.02||0.018||0.016||0.015||0.015||0.015||0.015||0.014||0.014||0.014||0.013||0.012||0.012,0.0,0.0,0.06666666666666667
1209,Arch_Dermatol_Res-3-1-1910889.txt,predefin evalu sheet||evalu||grade||non-allerg advers event||non-steroid anti-inflammatori drug||nsaid||reaction||urticaria||advers reaction||symptom||intoler||studi||drug||coxib||public||patient||advers event||articl,1||0 1||allergi||0 0 1||2||refer 1||grade 1||allergi clin immunol int||1 ctcae||allergi clin immunol 109||allergi clin immunol 113||allergi clin immunol 56:916||allergi clin immunol 56:1017||allergi clin immunol 15:73||0 0 valdecoxib 69 2 1,0.027||0.02||0.018||0.018||0.017||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.012,0.0,0.0,0.0
1210,Clin_Auton_Res-3-1-1797062.txt,chronic mountain sick||respir||level||respons||week||pulmonari vasoconstrict||rate||pulmonari hypertens||high altitud||altitud||densiti||effect||autonom nervou system||sensit||increas||blood pressur||heart failur||baroreflex control||receptor||point||chemoreceptor||heart rate||hypoxia||day||control||acut hypoxia||blood||acut exposur||subject||recent studi||chang||barometr pressur||exposur||high altitud dweller||result,1||2||physiol||refer 1||lima 1||maria 2 1 institut||10 2||altitud||3||high altitud||physiol 560||physiol 280||12||physiol 93:19||physiol 177:30,0.027||0.022||0.018||0.014||0.014||0.013||0.012||0.012||0.01||0.01||0.01||0.01||0.009||0.009||0.009,0.0,0.2,0.13333333333333333
1211,Clin_Oral_Investig-4-1-2238792.txt,aspect||dental eros||method||instrument||children||indic||fill teeth||non-communic diseas||literatur analysi||world health report||qualiti||studi||eros||oral health||criteria||teeth||health promot||valid||countri||examin||gold standard||result||assess||diseas prevent||cardiovascular diseas||reliabl||diseas||index||qualiti criteria||oral health promot||oral diseas pattern,health||eros||eros index||dental health||index||dental eros index||dental eros||dental eros oral health||oral health||oral dental eros index||eros index 29||2||1||eros tooth||eros index 28,0.023||0.022||0.02||0.019||0.019||0.019||0.018||0.018||0.018||0.017||0.016||0.015||0.015||0.015||0.015,0.4,0.4,0.26666666666666666
1212,J_Abnorm_Child_Psychol-4-1-2206247.txt,level||measur||parent style||boy||behavior||commun||adolescence-limit delinqu||neglect style||sampl||data||theori||distinct delinqu trajectori||studi||risk||develop||style||child||pittsburgh youth studi||delinqu||demograph variabl||variabl||self-report||pattern||similar||neglect parent||analys||authoritarian||posit parent||childhood delinqu||full model||research||age||trajectori||characterist||parent||famili||famili factor||differ||group||late adolesc||delinqu trajectori,1||2||delinqu||trajectori 1||delinqu trajectori||10 1 2||delinqu 4||trajectori||2001||1 delinqu characterist||1 2006||3||delinqu prior delinqu||trajectori 1 6 fig. 1||trajectori 7 1,0.02||0.018||0.017||0.017||0.015||0.014||0.013||0.013||0.013||0.013||0.013||0.013||0.013||0.012||0.012,0.4,0.3,0.2
1213,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998881.txt,anim||acut renal failur||technolog||outer medulla||acut tubular necrosi||imag||anim model||model||studi||apoptot cell||atn||cell||rat||apoptosi||analysi||ddc||injuri||experiment model||diagnost imag agent||detect||kidney,aposens aposens aposens aposens aposens aposens||aposens||aposens aposens||aposens aposens aposens aposens imag||aposens aposens aposens 1 2||aposens aposens 3 aposens 18||3||3 3||3 3 3||1||interest aposens aposens||renal cell||result aposens aposens aposens target||2||4,0.029||0.029||0.029||0.026||0.025||0.022||0.02||0.02||0.02||0.019||0.019||0.019||0.018||0.018||0.017,0.0,0.0,0.0
1214,Eur_J_Pediatr-4-1-2292481.txt,incid rate||case||clinic diagnost criteria||infant||birth||clinic decis||studi||life||torticolli||review||symptomat asymmetri||sign||disord||clinic syndrom||etiolog||current inform||month||literatur||posit prefer||plagiocephali||clinic specialti||craniosynostosi||symptom||differenti diagnosi||screen||movement||asymmetri||diagnosi||young infant||syndrom,pediatr||1||1 disord||pediatr committe||disord||studi||3 7 51||M. 1 1 depart||refer 1||ninety-two pediatr patient||newborn clin pediatr||pediatr physic therapi||3 year||pediatr european journal||case-control studi pediatr 2003 112,0.025||0.02||0.016||0.013||0.012||0.012||0.012||0.011||0.011||0.01||0.01||0.01||0.009||0.009||0.009,0.2,0.2,0.13333333333333333
1215,Immunome_Res-1-_-1289288.txt,antibodi||method||epitop||system||immun system||concentr||databas||data||experiment condit||experiment method||valu||search method||vaccin||complex||mhc molecul||protein antigen||databas system||specif allel||cell||blast search||entri||kinet||protein||immun||antijen||peptid interact||quantit specif data||bind||mhc||archiv||major histocompat complex||number||interact||peptid||tcr||link||sequenc,2||1 2||2 1||1||class 1 class 2||50 2||tabl 1||databas||data||peptid||1 21||2 2 microglobulin complex||2 8 2 7 5||class||1 irini.doytchinova@jenner.ac.uk,0.029||0.029||0.029||0.029||0.022||0.02||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.015||0.015,0.0,0.3,0.2
1216,Purinergic_Signal-3-1-2096770.txt,restenosi||role||atherosclerosi||releas||endothelium||studi||atp||smc||process||intim||receptor||nucleotid receptor||migrat||express||smooth muscl cell||vascular diseas||cell||utp||prolifer||nucleotid||previou studi||activ||earli stage||vascular||extracellular nucleotid||media||function,2||1 2||1||2 receptor||1 receptor||receptor||1 6||6 7 1 2||2 2 72 73 2 receptor||2 6 2 71||2007 2 receptor||1 1 depart||6 receptor||2 receptor Br||cell,0.034||0.032||0.03||0.029||0.027||0.024||0.023||0.023||0.021||0.021||0.021||0.02||0.02||0.02||0.02,0.0,0.1,0.13333333333333333
1217,Ann_Biomed_Eng-2-2-1705502.txt,mit||method||figur||center||case||conduct||border||imag||truncat level||data||model||valu||tsvd||magnet induct tomographi||voltag||increas||resolut||cnr||psf||paramet||regular scheme||radiu||cylind||spatial resolut||chang||imag reconstruct||gener||perturb||snr||regular||regular paramet||VU yield||homogen cylind||contrast||coil,2||2 2||1||3 2||1 2 26 figur 2||figur||2 5||3||figur 7||6 7 2||0 figur 1||imag||tabl 2||10 1||0 1,0.021||0.021||0.018||0.017||0.016||0.015||0.014||0.013||0.013||0.013||0.013||0.012||0.012||0.012||0.011,0.0,0.1,0.13333333333333333
1218,Ann_Biomed_Eng-2-2-1764593.txt,target||system||steadi state||rate||data||model||nucleu||sensit||increas||complex||dephosphoryl||nfat||calcium concentr||experiment result||nuclear local signal||rise||express||cell||calcium||export||control||averag||low calcium concentr||oscil frequenc||transloc||activ||cytoplasm||bind||factor||gene transcript||ikk||oscil||speci||calcineurin||show||initi||gene express||period||result,1||_{ 1||2||2 2||1 22||_{||1 estim||1 10||1 56||1 14||1 12||1 2 yang||1 32||1 60||1 34,0.029||0.023||0.019||0.019||0.019||0.018||0.017||0.017||0.017||0.017||0.016||0.016||0.016||0.016||0.015,0.0,0.0,0.0
1219,Qual_Life_Res-3-1-1832149.txt,random design||subgroup||questionnair||effect size||child health questionnair||sampl||studi||secondari school||effect||scale||form||multi-item scale||test||internet version||valid||onlin questionnair||health||small effect||item||feasibl||chronic condit||paper||result||score differ||chq-cf||differ||standard paper version||chq-cf scale||number||reliabl||adolesc||mode||answer||internet administr||internet,health||child health||health child||2||1||0||2 child||1 child âs health||child health questionnair||child âs health||2 3||child||health research||random 2 2||3 child,0.022||0.018||0.018||0.018||0.018||0.017||0.016||0.016||0.016||0.015||0.015||0.014||0.014||0.014||0.013,0.2,0.2,0.13333333333333333
1220,Int_J_Parasitol-1-5-1906861.txt,mechan||condit||respons||huvec transcriptom||endothelium||data||studi||icam-1||huvec||signific regul||increas||abil||receptor||express||cluster||cell apoptosi||cell||adhes||gene||ec||term||vascular endothelium||malaria infect||critic factor||chang||tnf||sever malaria||human serum||co-cultur||surfac||EC activ||presenc||prbc||co-cultur experi||biolog process||molecul||up-regul||immun respons||result,fig. 2||2||cell||low fig. 1||fig. 2 plasmodium||low tabl 2 low||fig. 3||tabl 2||low low low fig. 6||low fig. 6||endotheli cell||low low tabl 1||1||fig. 6||tabl 2 express,0.018||0.018||0.017||0.015||0.015||0.014||0.014||0.014||0.014||0.013||0.013||0.013||0.012||0.012||0.012,0.2,0.1,0.06666666666666667
1221,J_Autism_Dev_Disord-4-1-2268724.txt,target||affect state||respons||accur||individu||complex pattern||attention-demand strategi||social cognit task||FR task||pdd-no||autism||process||criteria||anxieti||abil||complex condit||disord||pattern||express||social-cognit function||face recognit||emot recognit||pervas development disord||mcdd||emot||task||signific group differ||accuraci||diagnost criteria||cognit capac||identif||social interact||non-target condit||face process||group||facial express recognit||differ||symptom||speed||diagnosi||hypothesi||facial express||children||result,2||1 2||2 3||1||3||disord||2003||1 1 depart||2 1992||2 0.06||2 0.74||task 3||2 fig. 3 accuraci||development disord||face recognit 2003 1 2007,0.025||0.022||0.021||0.019||0.017||0.017||0.016||0.014||0.014||0.013||0.013||0.013||0.013||0.012||0.012,0.0,0.1,0.06666666666666667
1222,J_Mol_Biol-1-5-1892151.txt,condit||construct||recognit sequenc||OC form||concentr||koac||rate||bpli||plasmid||endonucleas||potassium||test enzym||form||singl polypeptid||site||r-m||double-strand break||dna||bcgi||duplex||SC||reaction||restrict enzym||enzym||individu circl||type iif categori||reaction rate||baei||copi||singl ring||act||fll||restrict endonucleas||catenan||cleavag||substrat||linear product||linear fragment||OC||sequenc,1||2||1 figur 2||figur 1 figur 1 figur 1||figur 1 figur 1||figur 2||3 figur 2||3||figur 3||tabl 3 figur 1 figur 3||2 tabl 3||tabl 1||tabl 2||3 tabl 3||tabl 3 figur 5 figur 1,0.032||0.032||0.031||0.031||0.031||0.031||0.031||0.031||0.031||0.03||0.03||0.03||0.03||0.03||0.027,0.0,0.0,0.0
1223,Diabetologia-4-1-2292421.txt,mitochondria||fatti acid||adipocyt,2 consumpt||J. 2 4 1 depart||netherland 2 depart||j.a.maassen@lumc.nl 1 2 romijn||studi||addit studi||obesity-associ type 2 diabet||refer 1||2008||netherland 3 depart||A. 3 hein||springer-verlag 2008||2008 keyword||netherland 4 eli lilli||osmium-fix fat cell,0.041||0.036||0.036||0.035||0.033||0.031||0.027||0.027||0.025||0.025||0.019||0.017||0.015||0.015||0.014,0.0,0.0,0.0
1224,Eur_J_Clin_Pharmacol-4-1-2426925.txt,administr||amodiaquin||cross-ov studi||haematolog paramet||volunt||artesun||combin||sampl||patient||healthi normal volunt||clinic examin||malaria patient||uncompl falciparum malaria||dose||treatment||advers event||day||ratio||main activ metabolit||phase||pharmacokinet||dihydroartemisinin||group||toler||auc||healthi volunt||drug||pharmacokinet paramet||clinic signific,1||1 2||1 1 divis||pharmacokinet||1 6 max 1 6||group 1||2||1 6 7 8 1||tabl 1||1 max max||refer 1||3||1 fig. 1 mono combo||artesun pharmacokinet paramet 1 max||pharmacokinet interact,0.029||0.023||0.019||0.018||0.017||0.017||0.016||0.016||0.016||0.015||0.015||0.013||0.013||0.012||0.012,0.2,0.1,0.06666666666666667
1225,Bioinformation-2-5-2241933.txt,mesh||vector||set||method||biomed literatur||data||studi||gene annot sentenc||text mine||frequenc||sentenc||inform||process||gene express experi||structur||gene||term||annot||protein||analysi||associ||abstract||list||noun||initi test||keyword||larg number||function,gene||gene annot||figur 1||30 gene||sentenc gene||inform gene||10 gene||gene group||19 gene||gene refer||keyword||gene list||20 gene||human gene||gene function annot,0.043||0.027||0.026||0.026||0.026||0.025||0.025||0.024||0.024||0.024||0.024||0.023||0.023||0.023||0.023,0.2,0.1,0.13333333333333333
1226,Eur_J_Pediatr-3-1-1914295.txt,program||pediatr exclus||adult market||pediatr studi||patent extens||fda||infant||data||studi||pharmaceut prepar||effect||develop||patent||prescript||pediatr popul||clinic pharmacolog review||pediatr||wide age rang||medic||adult||research||age||market exclus||literatur||usa||market||order||medicin||drug||industri||trial||children,drug||1||system drug||pediatr||pediatr drug studi||drug studi||4 drug||pediatr drug research||pediatr drug trial||pediatr drug develop||1 parasitolog 1||2||pediatr drug label||drug research||system 2,0.035||0.032||0.027||0.027||0.025||0.024||0.023||0.023||0.022||0.022||0.022||0.022||0.021||0.021||0.02,0.4,0.2,0.13333333333333333
1227,Cult_Med_Psychiatry-2-2-1705533.txt,person commun||muslim||islam||technolog||infertil husband||regard||sperm donat||fatwa||embryo||middl eastern region||practic||moral||patient||gamet donat||infertil muslim||muslim middl east||egg||infertil father||law||third-parti donat||medic anthropolog||jewish man||debat||adulteri||countri||ivf||coupl||marriag||sperm||ayatollah khamanei||scienc||women||world||recent year||lebanon||global||gamet||lebanes ivf clinic||muslim world||anonym donor||donat||cultur||local moral world||donor gamet||muslim marriag||iran||infertil coupl||ethnograph research||children,2||1||2006||minhorn@umich.edu 1 2 1 director||march 2||muslim||2004 2004 2 majli||2004 2004||2004||world âs muslim||usa 2 depart||reproduct||2005 2006 2004||ivf||1996,0.021||0.019||0.014||0.013||0.012||0.012||0.012||0.011||0.011||0.011||0.011||0.01||0.01||0.009||0.009,0.0,0.1,0.13333333333333333
1228,Immunome_Res-1-_-1312312.txt,amino acid differ||databas||mous IG||structur approach||data||hla||concept||allel||section||structur||chain||immunogenet||amino acid||domain||web resourc||tool||singl chain fragment variabl||on-lin tool||web||gene||annot||analysi||polymorph||mhc||immunoinformat||imgt||3D structur||immunoglobulin||number||locu||collier de perl,imgt||imgt 1||imgt gene databas imgt||imgt databas||imgt sequenc databas imgt||2||imgt repertoir||ligm-db imgt||imgt collier||37 imgt||1 2||phylogen imgt||v-quest imgt||junctionanalysi imgt||imgt biotechnolog,0.04||0.03||0.025||0.025||0.025||0.022||0.022||0.022||0.021||0.021||0.021||0.021||0.021||0.021||0.021,0.2,0.1,0.06666666666666667
1229,Neurosci_Lett-1-5-1885960.txt,p53||tau,2||fig. 2 waf fig. 2||fig. 2 waf||1||cell||tau||3||2007 elsevi ireland||5||hek293a cell||alzheim diseas||function studi||tau phosphoryl||alzheim||alzheim diseas tau protein,0.055||0.046||0.039||0.028||0.02||0.017||0.013||0.013||0.013||0.013||0.013||0.013||0.012||0.012||0.012,0.0,0.1,0.06666666666666667
